0001493152-24-011313.txt : 20240326 0001493152-24-011313.hdr.sgml : 20240326 20240326163110 ACCESSION NUMBER: 0001493152-24-011313 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 93 CONFORMED PERIOD OF REPORT: 20231231 FILED AS OF DATE: 20240326 DATE AS OF CHANGE: 20240326 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OXBRIDGE RE HOLDINGS Ltd CENTRAL INDEX KEY: 0001584831 STANDARD INDUSTRIAL CLASSIFICATION: FIRE, MARINE & CASUALTY INSURANCE [6331] ORGANIZATION NAME: 02 Finance IRS NUMBER: 981150254 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36346 FILM NUMBER: 24784067 BUSINESS ADDRESS: STREET 1: SUITE 201, 42 EDWARD STREET STREET 2: P.O. BOX 469 CITY: GEORGETOWN STATE: E9 ZIP: KY1-9006 BUSINESS PHONE: 345-749-7570 MAIL ADDRESS: STREET 1: SUITE 201, 42 EDWARD STREET STREET 2: P.O. BOX 469 CITY: GEORGETOWN STATE: E9 ZIP: KY1-9006 10-K 1 form10-k.htm
false FY 0001584831 0001584831 2023-01-01 2023-12-31 0001584831 OXBR:OrdinarySharesParValue0.001UsdPerShareMember 2023-01-01 2023-12-31 0001584831 OXBR:WarrantsMember 2023-01-01 2023-12-31 0001584831 2023-06-30 0001584831 2024-03-26 0001584831 2023-10-01 2023-12-31 0001584831 2023-12-31 0001584831 2022-12-31 0001584831 2022-01-01 2022-12-31 0001584831 2021-12-31 0001584831 us-gaap:CommonStockMember 2021-12-31 0001584831 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001584831 us-gaap:RetainedEarningsMember 2021-12-31 0001584831 us-gaap:CommonStockMember 2022-12-31 0001584831 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001584831 us-gaap:RetainedEarningsMember 2022-12-31 0001584831 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001584831 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001584831 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001584831 us-gaap:CommonStockMember 2023-01-01 2023-12-31 0001584831 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-12-31 0001584831 us-gaap:RetainedEarningsMember 2023-01-01 2023-12-31 0001584831 us-gaap:CommonStockMember 2023-12-31 0001584831 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001584831 us-gaap:RetainedEarningsMember 2023-12-31 0001584831 OXBR:OxbridgeReinsuranceLimitedMember 2013-04-23 0001584831 OXBR:OxbridgeReNSMember 2017-12-22 0001584831 OXBR:SurancePlusIncMember 2022-12-19 0001584831 OXBR:SurancePlusIncMember 2023-01-01 2023-12-31 0001584831 srt:MaximumMember OXBR:EquityDistributionAgreementMember 2023-12-31 0001584831 us-gaap:FurnitureAndFixturesMember 2023-12-31 0001584831 us-gaap:ComputerEquipmentMember 2023-12-31 0001584831 OXBR:MotorVehiclesMember 2023-12-31 0001584831 OXBR:OxbridgeAcquisitionCorpMember 2023-01-01 2023-12-31 0001584831 OXBR:OxbridgeAcquisitionCorpMember OXBR:SeriesAOnePreferredStockMember 2023-01-01 2023-12-31 0001584831 OXBR:OxbridgeAcquisitionCorpMember OXBR:SeriesAOnePreferredStockMember 2023-12-31 0001584831 OXBR:OxbridgeAcquisitionCorpMember OXBR:PrivatePlacementWarrantsMember 2023-12-31 0001584831 OXBR:JetA1SeriesA1ConvertiblePreferredStockMember 2023-12-31 0001584831 OXBR:JetA1SeriesA1ConvertiblePreferredStockMember 2022-12-31 0001584831 OXBR:JetA1PromissoryNoteMember 2023-12-31 0001584831 OXBR:JetA1PromissoryNoteMember 2022-12-31 0001584831 OXBR:JetA1ClassBOrdinarySharesMember us-gaap:CommonClassBMember 2023-12-31 0001584831 OXBR:JetA1ClassBOrdinarySharesMember us-gaap:CommonClassBMember 2022-12-31 0001584831 us-gaap:FairValueInputsLevel1Member 2023-12-31 0001584831 us-gaap:FairValueInputsLevel2Member 2023-12-31 0001584831 us-gaap:FairValueInputsLevel3Member 2023-12-31 0001584831 us-gaap:FairValueInputsLevel1Member 2022-12-31 0001584831 us-gaap:FairValueInputsLevel2Member 2022-12-31 0001584831 us-gaap:FairValueInputsLevel3Member 2022-12-31 0001584831 us-gaap:FairValueInputsLevel3Member 2021-12-31 0001584831 us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-12-31 0001584831 us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001584831 OXBR:OxbridgeReNSMember 2017-12-22 0001584831 OXBR:OxbridgeReNSMember 2017-12-31 0001584831 OXBR:NotesPayableToSeries20201NoteholdersMember 2020-05-30 2020-06-01 0001584831 OXBR:OxbridgeReNSMember 2023-01-01 2023-12-31 0001584831 OXBR:OxbridgeReNSMember 2022-01-01 2022-12-31 0001584831 OXBR:SurancePlusIncMember 2023-03-27 0001584831 OXBR:SurancePlusIncMember 2023-03-26 2023-03-27 0001584831 OXBR:SurancePlusIncMember OXBR:InvestorsAndNonUSPersonsMember OXBR:SubscriptionAgreementsMember 2023-06-27 2023-06-27 0001584831 OXBR:SurancePlusIncMember OXBR:SubscriptionAgreementsMember OXBR:InvestorsAndNonUSPersonsMember 2023-06-27 0001584831 OXBR:SurancePlusIncMember OXBR:SubscriptionAgreementsMember 2023-06-27 2023-06-27 0001584831 OXBR:SurancePlusIncMember 2023-06-27 0001584831 OXBR:SurancePlusIncMember 2023-06-27 2023-06-27 0001584831 OXBR:SurancePlusIncMember OXBR:ThirdPartyInvestorsMember 2023-06-27 2023-06-27 0001584831 OXBR:SurancePlusIncMember us-gaap:ParentMember 2023-06-27 2023-06-27 0001584831 OXBR:SurancePlusIncMember OXBR:SurancePlusFeeIncomeMember 2023-01-01 2023-12-31 0001584831 OXBR:SurancePlusIncMember OXBR:UnderwritingRelatedIncomeMember 2023-01-01 2023-12-31 0001584831 OXBR:SurancePlusIncMember 2023-12-31 0001584831 OXBR:SurancePlusIncMember us-gaap:RelatedPartyMember 2023-12-31 0001584831 OXBR:SurancePlusIncMember us-gaap:ParentMember 2023-12-31 0001584831 us-gaap:ShortdurationInsuranceContractsAccidentYear2016Member 2016-12-31 0001584831 us-gaap:ShortdurationInsuranceContractsAccidentYear2016Member 2017-12-31 0001584831 us-gaap:ShortdurationInsuranceContractsAccidentYear2016Member 2018-12-31 0001584831 us-gaap:ShortdurationInsuranceContractsAccidentYear2016Member 2019-12-31 0001584831 us-gaap:ShortdurationInsuranceContractsAccidentYear2016Member 2020-12-31 0001584831 us-gaap:ShortdurationInsuranceContractsAccidentYear2016Member 2021-12-31 0001584831 us-gaap:ShortdurationInsuranceContractsAccidentYear2016Member 2022-12-31 0001584831 us-gaap:ShortdurationInsuranceContractsAccidentYear2016Member 2023-12-31 0001584831 us-gaap:ShortDurationInsuranceContractsAccidentYear2017Member 2017-12-31 0001584831 us-gaap:ShortDurationInsuranceContractsAccidentYear2017Member 2018-12-31 0001584831 us-gaap:ShortDurationInsuranceContractsAccidentYear2017Member 2019-12-31 0001584831 us-gaap:ShortDurationInsuranceContractsAccidentYear2017Member 2020-12-31 0001584831 us-gaap:ShortDurationInsuranceContractsAccidentYear2017Member 2021-12-31 0001584831 us-gaap:ShortDurationInsuranceContractsAccidentYear2017Member 2022-12-31 0001584831 us-gaap:ShortDurationInsuranceContractsAccidentYear2017Member 2023-12-31 0001584831 us-gaap:ShortDurationInsuranceContractsAccidentYear2018Member 2018-12-31 0001584831 us-gaap:ShortDurationInsuranceContractsAccidentYear2018Member 2019-12-31 0001584831 us-gaap:ShortDurationInsuranceContractsAccidentYear2018Member 2020-12-31 0001584831 us-gaap:ShortDurationInsuranceContractsAccidentYear2018Member 2021-12-31 0001584831 us-gaap:ShortDurationInsuranceContractsAccidentYear2018Member 2022-12-31 0001584831 us-gaap:ShortDurationInsuranceContractsAccidentYear2018Member 2023-12-31 0001584831 us-gaap:ShortDurationInsuranceContractAccidentYear2019Member 2019-12-31 0001584831 us-gaap:ShortDurationInsuranceContractAccidentYear2019Member 2020-12-31 0001584831 us-gaap:ShortDurationInsuranceContractAccidentYear2019Member 2021-12-31 0001584831 us-gaap:ShortDurationInsuranceContractAccidentYear2019Member 2022-12-31 0001584831 us-gaap:ShortDurationInsuranceContractAccidentYear2019Member 2023-12-31 0001584831 us-gaap:ShortDurationInsuranceContractAccidentYear2020Member 2020-12-31 0001584831 us-gaap:ShortDurationInsuranceContractAccidentYear2020Member 2021-12-31 0001584831 us-gaap:ShortDurationInsuranceContractAccidentYear2020Member 2022-12-31 0001584831 us-gaap:ShortDurationInsuranceContractAccidentYear2020Member 2023-12-31 0001584831 us-gaap:ShortDurationInsuranceContractAccidentYear2021Member 2021-12-31 0001584831 us-gaap:ShortDurationInsuranceContractAccidentYear2021Member 2022-12-31 0001584831 us-gaap:ShortDurationInsuranceContractAccidentYear2021Member 2023-12-31 0001584831 us-gaap:ShortDurationInsuranceContractAccidentYear2022Member 2022-12-31 0001584831 us-gaap:ShortDurationInsuranceContractAccidentYear2022Member 2023-12-31 0001584831 us-gaap:ShortDurationInsuranceContractAccidentYear2023Member 2022-12-31 0001584831 us-gaap:ShortDurationInsuranceContractAccidentYear2023Member 2023-12-31 0001584831 us-gaap:ShortDurationInsuranceContractAccidentYear2023Member 2021-12-31 0001584831 OXBR:PropertyCatastropheReinsuranceMember 2022-12-31 0001584831 us-gaap:CommonStockMember 2023-01-01 2023-12-31 0001584831 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001584831 us-gaap:WarrantMember 2023-12-31 0001584831 us-gaap:WarrantMember 2022-12-31 0001584831 us-gaap:CommonStockMember us-gaap:SubsequentEventMember 2024-01-29 0001584831 us-gaap:CommonStockMember us-gaap:SubsequentEventMember 2024-01-29 2024-01-29 0001584831 OXBR:TwoThousandFourteenOmnibusIncentivePlanMember 2023-01-01 2023-12-31 0001584831 OXBR:TwoThousandTwentyOneOmnibusIncentivePlanMember us-gaap:RestrictedStockMember 2023-01-01 2023-12-31 0001584831 OXBR:TwoThousandTwentyOneOmnibusIncentivePlanMember 2023-12-31 0001584831 OXBR:TwoThousandFourteenOmnibusIncentivePlanMember 2023-12-31 0001584831 us-gaap:GeneralAndAdministrativeExpenseMember 2023-01-01 2023-12-31 0001584831 us-gaap:GeneralAndAdministrativeExpenseMember 2022-01-01 2022-12-31 0001584831 us-gaap:RestrictedStockMember us-gaap:GeneralAndAdministrativeExpenseMember 2023-01-01 2023-12-31 0001584831 us-gaap:RestrictedStockMember us-gaap:GeneralAndAdministrativeExpenseMember 2022-01-01 2022-12-31 0001584831 us-gaap:RestrictedStockMember us-gaap:GeneralAndAdministrativeExpenseMember 2023-12-31 0001584831 us-gaap:RestrictedStockMember us-gaap:GeneralAndAdministrativeExpenseMember 2022-12-31 0001584831 OXBR:OxbridgeReinsuranceLimitedMember 2023-12-31 0001584831 OXBR:OxbridgeReinsuranceLimitedMember 2023-01-01 2023-12-31 0001584831 OXBR:OxbridgeReinsuranceLimitedMember 2022-01-01 2022-12-31 0001584831 OXBR:OxbridgeReNSMember 2023-12-31 0001584831 OXBR:OxbridgeReNSMember 2023-01-01 2023-12-31 0001584831 OXBR:OxbridgeReNSMember 2022-01-01 2022-12-31 0001584831 OXBR:OfficeLeaseMember 2023-12-31 0001584831 OXBR:ResidentialLeaseMember 2023-12-31 0001584831 OXBR:AdministrativeServicesAgreementMember 2023-01-01 2023-12-31 0001584831 OXBR:AdministrativeServicesAgreementMember 2022-01-01 2022-12-31 0001584831 us-gaap:RelatedPartyMember 2023-12-31 0001584831 us-gaap:RelatedPartyMember 2022-12-31 0001584831 OXBR:MrJayMadhuMember 2021-12-31 0001584831 OXBR:MrJayMadhuMember 2023-01-01 2023-12-31 0001584831 OXBR:MrJayMadhuMember 2023-12-31 0001584831 OXBR:ReinsuranceAgreementMember 2023-12-31 0001584831 OXBR:ReinsuranceAgreementMember 2023-01-01 2023-12-31 0001584831 OXBR:BridgeAgreementMember us-gaap:InvestorMember 2023-09-11 0001584831 OXBR:BridgeAgreementMember us-gaap:InvestorMember 2023-09-08 2023-09-11 0001584831 OXBR:BridgeAgreementMember us-gaap:InvestorMember 2023-09-11 2023-09-11 0001584831 us-gaap:SubsequentEventMember 2024-03-11 0001584831 us-gaap:LeaseholdImprovementsMember 2023-12-31 0001584831 us-gaap:LeaseholdImprovementsMember 2022-12-31 0001584831 us-gaap:FurnitureAndFixturesMember 2022-12-31 0001584831 us-gaap:VehiclesMember 2023-12-31 0001584831 us-gaap:VehiclesMember 2022-12-31 0001584831 us-gaap:ComputerEquipmentMember 2022-12-31 0001584831 us-gaap:EquitySecuritiesInvestmentSummaryMember 2023-12-31 0001584831 srt:ParentCompanyMember 2023-12-31 0001584831 srt:ParentCompanyMember 2022-12-31 0001584831 srt:ParentCompanyMember srt:SubsidiariesMember 2023-12-31 0001584831 srt:ParentCompanyMember srt:SubsidiariesMember 2022-12-31 0001584831 srt:ParentCompanyMember us-gaap:RelatedPartyMember 2023-12-31 0001584831 srt:ParentCompanyMember us-gaap:RelatedPartyMember 2022-12-31 0001584831 srt:ParentCompanyMember 2023-01-01 2023-12-31 0001584831 srt:ParentCompanyMember 2022-01-01 2022-12-31 0001584831 srt:ParentCompanyMember us-gaap:RelatedPartyMember 2023-01-01 2023-12-31 0001584831 srt:ParentCompanyMember us-gaap:RelatedPartyMember 2022-01-01 2022-12-31 0001584831 srt:ParentCompanyMember 2021-12-31 0001584831 us-gaap:PropertyLiabilityAndCasualtyInsuranceSegmentMember 2023-12-31 0001584831 us-gaap:PropertyLiabilityAndCasualtyInsuranceSegmentMember 2023-01-01 2023-12-31 0001584831 us-gaap:PropertyLiabilityAndCasualtyInsuranceSegmentMember 2022-12-31 0001584831 us-gaap:PropertyLiabilityAndCasualtyInsuranceSegmentMember 2022-01-01 2022-12-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares OXBR:Claims xbrli:pure OXBR:Integer

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-K

 

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the Fiscal Year Ended December 31, 2023

 

OR

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For The Transition Period From ________ To ________

 

Commission File Number 1-36346

 

OXBRIDGE RE HOLDINGS LIMITED

(Exact name of registrant as specified in its charter)

 

Cayman Islands   98-1150254

(State or other jurisdiction

of incorporation or organization)

 

(I.R.S. Employer

Identification No.)

     

Suite 201

42 Edward Street

P.O. Box 469

Grand Cayman, Cayman Islands

  KY1-9006
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (345) 749-7570

 

Securities Registered Pursuant to Section 12(b) of the Exchange Act:

 

Title of Each Class   Trading Symbols   Name of Each Exchange on Which Registered
Ordinary Shares, par value $0.001 (USD) per share   OXBR   The NASDAQ Capital Market
Warrants   OXBRW   The NASDAQ Capital Market

 

Securities Registered Pursuant to Section 12(g) of the Exchange Act: None

 

Indicate by check mark whether the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Exchange Act. Yes ☐ No

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer Accelerated filer
Non-accelerated Filer Smaller reporting company
Emerging growth company    

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. Yes ☐ No

 

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.

 

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No

 

The aggregate market value of the voting common equity held by non-affiliates of the registrant was $10,013,951 (based upon the quoted closing sale price per share of the registrant’s ordinary shares on The NASDAQ Capital Market) on the last business day of the registrant’s most recently completed second fiscal quarter (June 30, 2023). For purposes of this calculation, the registrant has assumed that its directors and executive officers as of June 30, 2023 were affiliates.

 

As of March 26, 2024, 5,870,234 ordinary shares, par value $0.001 (USD) per share, were outstanding.

 

Documents Incorporated by Reference:

 

Information required by Part III is incorporated by reference from registrant’s Proxy Statement for its 2024 annual meeting of stockholders or an amendment to this Annual Report on Form 10-K, which will be filed with the Securities and Exchange Commission within 120 days after the end of its fiscal year ended December 31, 2023.

 

 

 

 
 

 

OXBRIDGE RE HOLDINGS LIMITED

 

Index to Annual Report on Form 10-K

 

Year Ended December 31, 2023

 

    Page
     
CAUTIONARY STATEMENTS FOR FORWARD-LOOKING INFORMATION 3
     
PART I.  
     
ITEM 1. BUSINESS 3
     
ITEM 1A. RISK FACTORS 13
     
ITEM 1B. UNRESOLVED STAFF COMMENTS 27
     
ITEM 1C. CYBERSECURITY 27
     
ITEM 2. PROPERTIES 28
     
ITEM 3. LEGAL PROCEEDINGS 28
     
ITEM 4. MINE SAFETY DISCLOSURES 28
     
PART II.  
     
ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED SHAREHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES 28
     
ITEM 6. [RESERVED] 29
     
ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 29
     
ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 39
     
ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA 39
     
ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE 39
     
ITEM 9A. CONTROLS AND PROCEDURES 39
     
ITEM 9B. OTHER INFORMATION 40
     
ITEM 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS 40
     
PART III.  
     
ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE 40
     
ITEM 11. EXECUTIVE COMPENSATION 40
     
ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED SHAREHOLDER MATTERS 40
     
ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE 41
     
ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES 41
     
PART IV.  
     
ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES 41
     
ITEM 16. FORM 10-K SUMMARY 41
     
  INDEX TO EXHIBITS 41
     
  SIGNATURES 44

 

2
 

 

SPECIAL NOTE ABOUT FORWARD-LOOKING STATEMENTS

 

Unless the context dictates otherwise, references to “we,” “us,” “our,” “our company,” or “the Company” in this Annual Report on Form 10-K refer to Oxbridge Re Holdings Limited and its wholly-owned subsidiaries, Oxbridge Reinsurance Limited, SurancePlus Holdings Ltd., Oxbridge Re NS, SurancePlus Inc. and DSN Blockchain Technologies Ltd.

 

All statements in this Annual Report on Form 10-K, including in the section entitled “Management’s Discussion and Analysis of Financial Condition and Results of Operations” (refer to Part I, Item 7 of this Annual Report on Form 10-K), other than statements of historical fact, including estimates, projections, statements relating to our business plans, objectives and expected operating results, and the assumptions upon which those statements are based, are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). These forward-looking statements generally are identified by the words such as “believe,” “project,” “predict,” “expect,” “anticipate,” “estimate,” “intend,” “plan,” “may,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. Forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties which may cause actual results to differ materially from our historical results and the forward-looking statements and you should not place undue reliance on the forward-looking statements. A detailed discussion of risks and uncertainties that could cause actual results and events to differ materially from such forward-looking statements is included in the section entitled “Risk Factors” (refer to Part I, Item 1A, of this Annual Report on Form 10-K). We undertake no obligation, other than imposed by law, to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. Readers are cautioned not to place undue reliance on the forward-looking statements which speak only to the dates on which they were made.

 

PART I

 

ITEM 1 BUSINESS

 

Overview

 

We are a Cayman Islands specialty property and casualty reinsurer that provides reinsurance solutions through our reinsurance subsidiaries, Oxbridge Reinsurance Limited and Oxbridge Re NS. We focus on underwriting fully collateralized reinsurance contracts primarily for property and casualty insurance companies in the Gulf Coast region of the United States, with an emphasis on Florida. We specialize in underwriting medium frequency, high severity risks, where we believe sufficient data exists to analyze effectively the risk/return profile of reinsurance contracts. Oxbridge Re NS functions as a reinsurance sidecar which increases the underwriting capacity of Oxbridge Reinsurance Limited. Oxbridge Re NS issues participating notes to third party investors, the proceeds of which are utilized to collateralize Oxbridge Reinsurance Limited’s reinsurance obligations.

 

In addition to our historical reinsurance business operations, in 2023, our new subsidiary SurancePlus Inc. (“SurancePlus”) began developing, offering, and selling a tokenized reinsurance security representing fractionalized interests in reinsurance contracts, with each token representing an interest in participating notes issued by Oxbridge Re NS. These efforts culminated in the development, launch, and issuance of our first tokenized reinsurance security, the DeltaCat Re Token, which we believe is the first “on-chain” reinsurance security of its kind to be developed by a subsidiary of a public company. Following the issuance of the DeltaCat Re Token, we intend to develop, launch, and issue additional series of tokenized reinsurance securities representing fractional interests in reinsurance contracts, and we are also using our tokenization experience and activities as a foundation for developing Web3-focused business offerings and products relating to the tokenization of other real-world assets (RWAs), including RWAs held or being acquired by third parties. Our tokenization business will be conducted through SurancePlus and through other subsidiaries of our wholly owned subsidiary, SurancePlus Holdings Ltd. (“SurancePlus Holdings”), a Cayman Islands exempted company that we have organized to serve as a holding company for subsidiaries that will operate our developing Web3-focused business operations.

 

In our historical reinsurance business operations, we underwrite reinsurance contracts on a selective and opportunistic basis as opportunities arise based on our goal of achieving favorable long-term returns on equity for our shareholders. Our goal is to achieve long-term growth in book value per share by writing business that generates attractive underwriting profits relative to the risk we bear. Additionally, we intend to complement our underwriting profits with investment profits on an opportunistic basis. Our underwriting business focus is on fully collateralized reinsurance contracts for property catastrophes, primarily in the Gulf Coast region of the United States. Within that market and risk category, we attempt to select the most economically attractive opportunities across a variety of property and casualty insurers. As we attempt to grow our capital base, we expect that we will consider growth opportunities in other geographic areas and risk categories.

 

Our level of profitability in our reinsurance business operations is primarily determined by how adequately our premiums assumed and investment income cover our costs and expenses, which consist primarily of acquisition costs and other underwriting expenses, claim payments and general and administrative expenses. One factor leading to variation in our operational results is the timing and magnitude of any follow-on offerings we undertake (if any), and issuance of participating notes to investors as we are able to deploy new capital to collateralize new reinsurance treaties and consequently, earn additional premium revenue. In addition, our results of operations may be seasonal in that hurricanes and other tropical storms typically occur during the period from June 1 through November 30. Further, our results of operations may be subject to significant variations due to factors affecting the property and casualty insurance industry in general, which include competition, legislation, regulation, general economic conditions, judicial trends, and fluctuations in interest rates and other changes in the investment environment.

 

3
 

 

Because we employ an opportunistic underwriting and investment philosophy, period-to-period comparisons of our underwriting results may not be meaningful. In addition, our historical investment results may not necessarily be indicative of future performance. Due to the nature of our reinsurance and investment strategies, our operating results will likely fluctuate from period to period.

 

Organizational Chart

 

 

Other Developments

 

Formation of SurancePlus

 

SurancePlus Inc., an indirect wholly-owned subsidiary of Oxbridge Re Holdings Limited, was incorporated as a British Virgin Islands Business Company on December 19, 2022 for the purposes of tokenizing reinsurance contracts underwritten by its affiliated licensed reinsurer, Oxbridge Re NS.

 

On March 27, 2023, we, through SurancePlus, issued a press release announcing the commencement of an offering by SurancePlus of up to $5.0 million of DeltaCat Re Tokens (“Tokens”) with a purchase price of $10.00 per Token and representing one share of Series DeltaCat Re Preferred Shares per Token (the “Private Placement”).

 

On June 27, 2023, SurancePlus completed the Private Placement. The aggregate amount raised in the Private Placement was $2,447,760 for the issuance of 244,776 Tokens, of which approximately $1,280,000 was received from third-party investors and approximately $1,167,000 was received from Oxbridge Re Holdings Limited.

 

On September 11, 2023, the DeltaCat Re tokens were reclassified as tokenized interests carrying rights equivalent to the DeltaCat Re Preferred Shares in accordance with the provisions of the British Virgin Islands law.

 

4
 

 

Oxbridge Acquisition Corp.

 

On February 28, 2023, the Company announced in a press release that Oxbridge Acquisition Corp. (“Oxbridge Acquisition”) filed a Current Report on Form 8-K with the Securities and Exchange Commission in connection with Oxbridge Acquisition’s business combination with Jet Token Inc., a Delaware corporation. Upon the closing of the transaction, the combined company became Jet.AI Inc. (“Jet.AI”). Jet.AI offers fractional aircraft ownership, jet card, aircraft brokerage and charter service through its fleet of private aircraft and those of Jet.AI’s Argus Platinum operating partner. Jet.AI’s charter app enables travelers to look, book and fly. The funding and capital markets access from this transaction is expected to enable Jet.AI to continue its growth strategy of AI software development and fleet expansion. The business combination was completed on August 10, 2023.

 

The Company’s wholly-owned licensed reinsurance subsidiary, Oxbridge Reinsurance Limited (“Oxbridge Reinsurance”), was the lead investor in Oxbridge Acquisition’s sponsor and currently indirectly holds the equivalent of 1,423,827 of Jet.AI common stock (NASDAQ: JTAI), 3,094,999 of Jet.AI public warrants (NASDAQ: JTAIW) and 285 of Jet.AI Series A-1 Convertible Preferred Stock with purchase price of $285,000.

 

Bridge Loan with Affiliate

 

On September 11, 2023, the Company, along with seven (7) other investors, entered into a binding term sheet (“Bridge Agreement”) with Jet.AI to provide Jet.AI with an aggregate sum of $500,000 of short-term bridge financing pending its receipt of funds from its other existing financing arrangements. During the month of September 2023, and prior to the Bridge Agreement, Jet.AI had engaged in discussions with numerous third parties to secure short-term bridge funding but was not offered terms it found acceptable.

 

The Bridge Agreement provides for the issuance of Notes in an aggregate principal amount of $625,000, reflecting a 20% original issue discount. The Notes bear interest at 5% per annum and mature on March 11, 2024. Jet.AI is required to redeem the Notes with 100% of the proceeds of any equity or debt financing at a redemption premium of 110% of the principal amount of the Notes. Jet.AI anticipates redeeming the Notes in full with proceeds expected to be received over the next several months from existing financing arrangements.

 

An event of default under the Notes includes failing to redeem the Notes as provided above and other typical bankruptcy events of Jet.AI. In an event of default, the outstanding principal amount of the Notes will increase by 120%, and the company may convert its Note into shares of common stock of Jet.AI at the conversion price set forth in the Bridge Agreement with registration rights associated with those shares.

 

The Company invested the sum of $100,000 in the Notes and is recorded as “Loan Receivable” on the consolidated balance sheets at cost. On March 11, 2024, the Notes matured and were redeemed by Jet.AI in accordance with the Bridge Agreement. The Company receive an aggregate of $140,000 upon the redemption of the Notes.

 

Our Business Strategy

 

Our goal is to achieve attractive risk-adjusted returns for our shareholders through the prudent management of underwriting and investments risks relative to our capital base. To achieve this objective, the following are the principal elements of our business strategy.

 

  Maintain a Commitment to Disciplined Underwriting. We employ a disciplined and data-driven underwriting approach to select a diversified portfolio of risks that we believe will generate an attractive return to our shareholders over the long term. Neither our underwriting nor our investment strategies are designed to generate smooth or predictable quarterly earnings, but rather to optimize growth in book value per share over the long term.
     
  Focus on Risk Management. We treat risk management as an integral part of our underwriting and business management processes. All of our reinsurance contracts contain loss limitation provisions that limit our losses to the value of the assets collateralizing our reinsurance contracts.

 

5
 

 

  Deployment of Capital. In order to eliminate the possibility of complete losses, we intend to place only a portion of our total capital at risk in any single year. This means that we expect lower returns than some of our competitors in years where there are lower than average catastrophe losses but that our capital will not be completely eroded in the event of multiple large losses.
     
  Take Advantage of Market Opportunities. Although our business is initially focused on catastrophe coverage for Gulf Coast insurers we intend to continuously evaluate various market opportunities in which our business may be strategically or financially expanded or enhanced in the future. Such opportunities could take the form of investing into related party special purpose acquisition companies, further diversifying our business into other geographic or market areas, which could include quota share reinsurance contracts, joint ventures, renewal rights transactions, corporate acquisitions of other insurers or reinsurers, spinoffs, mergers or the formation of insurance or reinsurance platforms in new markets.
     
  Develop and Pursue Additional Tokenization Business Opportunities. Through SurancePlus Holdings and our Web3-focused subsidiaries, we intend to leverage our experience and knowledge with the tokenization of RWAs (including the initial DeltaCat Re Token) to develop other Web3-focused business offerings and products relating to the tokenization of RWAs, including RWAs held or being acquired by third parties.
     
    We believe the environment in the reinsurance and insurance markets will continue to produce opportunities for us, either through organic expansion, through acquisitions, or a combination of both.

 

The Reinsurance Industry

 

General

 

Reinsurance is an arrangement in which an insurance company, referred to as the reinsurer, agrees to assume from another insurance company, referred to as the ceding company or cedant, all or a portion of the insurance risks that the ceding company has underwritten under one or more insurance contracts. In return, the reinsurer receives a premium for the insured risks that it assumes from the ceding company, although reinsurance does not discharge the ceding company from its liabilities to policyholders. It is standard industry practice for primary insurers to reinsure portions of their insurance risks with other insurance companies under reinsurance agreements or contracts. This permits primary insurers to underwrite policies in amounts larger than the risks they are willing to retain. Reinsurance is generally designed to:

 

  Reduce the ceding company’s net liability on individual risks, thereby assisting it in managing its risk profile and increasing its capacity to underwrite business as well as increasing the limit to which it can underwrite on a single risk;
  assist the ceding company in meeting applicable regulatory and rating agency capital requirements;
  assist the ceding company in reducing the short-term financial impact of sales and other acquisition costs; and
  enhance the ceding company’s financial strength and statutory capital.

 

When reinsurance companies purchase reinsurance to cover their own risks assumed from ceding companies, this is known as retrocessional reinsurance. Reinsurance or retrocessional reinsurance can benefit a ceding company or reinsuring company, referred to herein as a “retrocedant,” as applicable, in various ways, such as by reducing exposure to individual risks and by providing catastrophe protection from larger or multiple losses. Like ceding companies, retrocedants can use retrocessional reinsurance to manage their overall risk profile or to create additional underwriting capacity, allowing them to accept larger risks or to write more business than would otherwise be possible, absent an increase in their capital or surplus.

 

Reinsurance contracts do not discharge ceding companies from their obligations to policyholders. Ceding companies therefore generally require their reinsurers to have, and to maintain, either a strong financial strength rating or security, in the form of collateral, as assurance that their claims will be paid.

 

Insurers generally purchase multiple tranches of reinsurance protection above an initial retention elected by the insurer. The amount of reinsurance protection purchased by an insurer is typically determined by the insurer through both quantitative and qualitative methods. In the event of losses, the amount of loss that exceeds the amount of reinsurance protection purchased is retained by the insurer.

 

As a program is constructed from the ground up, each tranche added generally has a lower probability of loss than the prior tranche and therefore is generally subject to a lower reinsurance premium charged for the reinsurance protection purchased. Insurer catastrophe programs are typically supported by multiple reinsurers per program.

 

6
 

 

Reinsurance brokers play an important role in the reinsurance market. Brokers are intermediaries that assist the ceding company in structuring a particular reinsurance program and in negotiating and placing risks with third-party reinsurers. In this capacity, the broker is selected and retained by the ceding company on a contract-by-contract basis, rather than by the reinsurer. Though brokers are not parties to reinsurance contracts, reinsurers generally receive premium payments from brokers rather than ceding companies, and reinsurers that do not provide collateralized reinsurance are frequently required to pay amounts owed on claims under their policies to brokers. These brokers, in turn, pay these amounts to the ceding companies that have reinsured a portion of their liabilities with reinsurers.

 

Types of Reinsurance Contracts

 

Property reinsurance products are often written in the form of treaty reinsurance contracts, which are contractual arrangements that provide for the automatic reinsurance of a type or category of risk underwritten. Treaty reinsurance premiums, which are typically due in installments, are a function of the number and type of contracts written, as well as prevailing market prices. The timing of premiums written varies by line of business. The majority of property catastrophe business is written at the January and June annual renewal periods, depending on the type and location of the risks covered. Most hurricane and wind-storm coverage, particularly in the Gulf Coast region of the United States, is written at the June annual renewal periods.

 

Property catastrophe reinsurance contracts are typically “all risk” in nature, providing protection to the ceding company against losses from hurricanes and other natural and man-made catastrophes such as floods, earthquakes, tornadoes, storms and fires, referred to herein collectively as “perils.” The predominant exposures covered by these contracts are losses stemming from property damage and business interruption resulting from a covered peril. Coverage can also vary from “all natural” perils, which is the most expansive form, to more limited types such as windstorm-only coverage.

 

Property catastrophe reinsurance contracts are typically written on an “excess-of-loss” basis, which provides coverage to the ceding company when aggregate claims and claim expenses from a single occurrence for a covered peril exceed an amount that is specified in a particular contract. The coverage provided under excess-of-loss reinsurance contracts may be on a worldwide basis or may be limited in scope to specific regions or geographical areas. Under these contracts, protection is provided to an insurer for a portion of the total losses in excess of a specified loss amount, up to a maximum amount per loss specified in the contract.

 

Excess-of-loss contracts are typically written on a losses-occurring basis, which means that they cover losses that occur during the contract term, regardless of when the underlying policies came into force. Premiums from excess-of-loss contracts are earned rateably over the contract term, which is ordinarily 12 months. Most excess-of-loss contracts provide for a reinstatement of coverage following a covered loss event in return for an additional premium.

 

The Florida Property and Casualty Insurance Market

 

General Overview

 

Florida’s property and casualty insurance market has undergone significant changes in the past few decades. This market, which was formerly dominated by large, national, multi-line insurance companies, now includes Citizens Property Insurance Corporation (“Citizens”), a state-sponsored insurance company created by the Florida Legislature; Florida-based insurance companies that focus primarily on writing property insurance policies in the state of Florida; and Florida-based subsidiaries of national insurance companies that focus on writing property insurance policies in the state of Florida. While these four types of companies participate in the market at varying levels, Citizens and the Florida-based insurance companies are now the dominant market participants. Within the private market, which excludes Citizens, there is a strong dependence on small insurance companies, which have limited capitalization and a limited ability to diversify.

 

While the Florida property and casualty insurance market faces various challenges, the primary challenge is the potential for exposure to catastrophic windstorms. According to the Report, the state of Florida has:

 

  more than $1.8 trillion in insured residential property exposure;
  more than $4 billion in expected average annual losses due to windstorms (with respect to residential and commercial residential properties only); and
  nearly $60 billion in 1-in-100 probable maximum losses due to windstorms (with respect to residential and commercial residential properties only).

 

According to the National Oceanic and Atmosphere Administration (“NOAA”) Technical Memorandum NWS NHC-6, entitled “The Deadliest, Costliest, and Most Intense United States Tropical Cyclones from 1851 to 2010 (and Other Frequently Requested Hurricane Facts) (the “NOAA Memorandum”), “forty percent of all U.S. hurricanes and major hurricanes were in Florida,” and “sixty percent of category 4 or higher hurricane strikes have occurred in either Florida or Texas.” The NOAA Memorandum also indicates that, between 1851 and 2010, there were 114 hurricane strikes and 37 major hurricanes in Florida. (For these purposes, a “major hurricane” is a category 3, 4, or 5 hurricane.)

 

Our Reinsurance Contracts and Products

 

We write primarily property catastrophe reinsurance. We currently expect that substantially all of the reinsurance products we write in the foreseeable future will be in the form of treaty reinsurance contracts. When we write treaty reinsurance contracts, we do not evaluate separately each of the individual risks assumed under the contracts and are therefore largely dependent on the individual underwriting decisions made by the cedant. Accordingly, as part of our initial review and renewal process, we carefully review and analyze the cedant’s risk management and underwriting practices in evaluating whether to provide treaty reinsurance and in appropriately pricing the treaty.

 

Our portfolio of business continues to be characterized by relatively large transactions with a relatively few number of cedants. We anticipate that our business will continue to be characterized by a relatively small number of reinsurance contracts for the foreseeable future.

 

Our contracts are written on an excess-of-loss basis, generally with a per-event cap. We generally receive the premium for the risk assumed and indemnify the cedant against all or a specified portion of losses and expenses in excess of a specified dollar or percentage amount. Our contracts are generally both single-year or multi-year contracts and our policy years generally commence on June 1 of each year and end on May 31 of the following year.

 

7
 

 

The bulk of our portfolio of risks is assumed pursuant to traditional reinsurance contracts. However, from time to time we take underwriting risk by purchasing a catastrophe-linked bond, or via a transaction booked as an industry loss warranty (as described below) or an indemnity swap. An indemnity swap is an agreement which provides for the exchange between two parties of different portfolios of catastrophe exposure with similar expected loss characteristics (for example, U.S. earthquake exposure for Asian earthquake exposure).

 

We believe our most attractive near-term opportunity is in property catastrophe reinsurance coverage for insurance companies. In addition to seeking profitable pricing, we manage our risks with contractual limits on our exposure. Property catastrophe reinsurance contracts are typically “all risk” in nature, meaning that they protect against losses from earthquakes and hurricanes, as well as other natural and man-made catastrophes such as tornados, fires, winter storms, and floods (where the contract specifically provides for such coverage). Losses on these contracts typically stem from direct property damage and business interruption. We generally write property catastrophe reinsurance on an excess-of-loss basis. These contracts typically cover only specific regions or geographical areas.

 

We are not licensed or admitted as an insurer in any jurisdiction other than the Cayman Islands. In addition, we do not have a financial rating and do not expect to have one in the near future. Many jurisdictions such as the United States do not permit clients to take credit for reinsurance on their statutory financial statements if such reinsurance is obtained from unlicensed or non-admitted insurers without appropriate collateral. As a result, we anticipate that all of our clients will require us to fully collateralize the reinsurance contracts we bind with them. Each of our contracts are fully collateralized and separately structured, with our liability being limited to the value of the assets held in the trust. We are generally not required to top-up the value of the assets held as collateral in respect of a particular reinsurance agreement, unless such collateral is subject to market risk. For each reinsurance agreement, a reinsurance trust is established in favor of the cedant, and the trustee of the reinsurance trust is a large bank that is agreed upon by our company and the cedant.

 

The premium for the contract is ordinarily deposited into the trust, together with additional capital from our company, up to the coverage limit. Each reinsurance contract contains express limited recourse language to the effect that the liabilities of the relevant reinsurance contract are limited to the realizable value of the collateral held in respect of that contract. Upon the expiration of the reinsurance contract, the assets of the trust net of insured losses and other expenses are transferred to our company.

 

Underwriting

 

Most of our reinsurance contracts have other reinsurers participating as lead underwriters, and these lead underwriters generally set the premium for the risk. We follow the premium pricing of the lead underwriters in most cases subject to the guidance of the Underwriting Committee of our Board of Directors. Each quarter, our Board of Directors will set parameters for the maximum level of capital to be deployed for the quarter and the expected premium and risk profile that each of our contracts must meet.

 

Our reinsurance portfolio of business continues to be characterized by relatively large transactions with a relatively few number of cedants and anticipate that our reinsurance entities business will continue to be characterized by a relatively small number of reinsurance contracts for the foreseeable future.

 

The bulk of our portfolio of risks is assumed pursuant to traditional reinsurance contracts. However, from time to time we take underwriting risk by purchasing a catastrophe-linked bond, or via a transaction booked as an industry loss warranty (as described below) or an indemnity swap. An indemnity swap is an agreement which provides for the exchange between two parties of different portfolios of catastrophe exposure with similar expected loss characteristics (for example, U.S. earthquake exposure for Asian earthquake exposure).

 

Marketing and Distribution

 

We expect that, in the future, the majority of our business will be sourced through reinsurance brokers. Brokerage distribution channels provide us with access to an efficient, variable distribution system without the significant time and expense that would be incurred in creating an in-house marketing and distribution network. Reinsurance brokers receive a brokerage commission that is usually a percentage of gross premiums written.

 

We intend to build relationships with global reinsurance brokers and captive insurance companies located in the Cayman Islands. Our management team has significant relationships with most of the primary and specialty broker intermediaries in the reinsurance marketplace in our target market. We believe that maintaining close relationships with brokers will give us access to a broad range of reinsurance clients and opportunities.

 

Brokers do not have the authority to bind us to any reinsurance contract. We review and approve all contract submissions in our corporate offices located in the Cayman Islands. From time to time, we may also enter into relationships with managing general agents who could bind us to reinsurance contracts based on narrowly defined underwriting guidelines.

 

8
 

 

Investment Strategy

 

Our Company takes an opportunistic approach with respect to investment income and intend to increase shareholder value through supplemental investment income when favorable opportunities are available. The Company, from time to time, and dependent upon favorable investment conditions and our investment guidelines, may invest in real estate and other ventures that have the potential to increase shareholder value. Through its reinsurance subsidiaries, the Company has made and intend to make future investments that can contribute to the growth of capital and surplus in its licensed reinsurance subsidiaries over time.

 

Some of our company’s capital is held in trust accounts that collateralize the reinsurance policies that we write. The investment parameters for capital held in such trust accounts are generally established by the cedant for the relevant policy. Currently, all amounts held in trust accounts are in cash and cash equivalents.

 

Our Board of Directors periodically reviews our investment policy and returns.

 

Claims Management

 

Claims are managed internally by the company’s management team. Management reviews and responds to initial loss reports, administers claims databases, determines whether further investigation is required and where appropriate, retains outside claims counsel, establishes case reserves and approves claims for payment. In addition, we may conduct audits of any significant client throughout the year, and in the process, evaluate our clients’ claims handling abilities, reserving philosophies, loss notification processes and the overall quality of our clients’ performance.

 

Upon receipt, claims notices are recorded within our underwriting, financial and claims systems. When we are notified of insured losses or discover potential losses as part of our claims’ audits, we record a case reserve as appropriate for the estimated amount of the exposure at that time. The estimate reflects the judgment of management based on general reserving practices, the experience and knowledge of the manager regarding the nature of the specific claim and, where appropriate, advice of outside counsel. Reserves are also established to provide for the estimated expense of settling claims, including legal and other fees and the general expenses of administering the claims adjustment process.

 

Loss Reserves

 

Loss reserves represent estimates, including actuarial and statistical projections at a given point in time, of the ultimate settlement and administration costs of claims incurred (including claims incurred but not reported (“IBNR”)). Estimates are not precise in that, among other things, they are based on predictions of future developments and estimates of future trends in claims severity and frequency and other variable factors such as inflation. It is likely that the ultimate liability will be greater or less than such estimates and that, at times, this variance will be material.

 

For our property and other catastrophe policies, we initially establish our loss reserves based on loss payments and case reserves reported by ceding companies. As we are not the only reinsurer on most contracts, the lead reinsurer will set the loss amount estimates for the contract and the cedant will have the ability to pay for case losses consistent with that amount on our pro-rata share of the contract.

 

We then add to these case reserves our estimates for IBNR. To establish our IBNR estimates, in addition to the loss information and estimates communicated by cedants, we also use the services of an independent actuary. We may also use our computer-based vendor and proprietary modeling systems to measure and estimate loss exposure under the actual event scenario, if available. Although the loss modeling systems assist with the analysis of the underlying loss, and provide us with information and the ability to perform an enhanced analysis, the estimation of claims resulting from catastrophic events is inherently difficult because of the variability and uncertainty of property catastrophe claims and the unique characteristics of each loss.

 

If IBNR estimates are made, we assess the validity of the assumptions we use in the reserving process on a quarterly basis during an internal review process. During this process actuaries verify that the assumptions we have made continue to form what they consider to be a sound basis for projection of future liabilities.

 

9
 

 

Although we believe that we are prudent in our assumptions and methodologies, we cannot be certain that our ultimate payments will not vary, perhaps materially, from the estimates we have made. If we determine that adjustments to an earlier estimate are appropriate, such adjustments are recorded in the quarter in which they are identified. The establishment of new reserves, or the adjustment of reserves for reported claims, could result in significant upward or downward changes to our financial condition or results of operations in any particular period. We regularly review and update these estimates, using the most current information available to us.

 

Our estimates are reviewed quarterly by an independent actuary in order to provide additional insight into the reasonableness of our loss reserves.

 

Competition

 

The reinsurance industry is highly competitive. We expect to compete with major reinsurers, most of which are well established with significant operating histories, strong financial strength ratings and long-standing client relationships.

 

Our competitors include Renaissance Re, Berkshire Hathaway, PartnerRe Ltd, Aeolus and Nephila which are dominant companies in the reinsurance industry. Although we seek to provide coverage where capacity and alternatives are limited, we directly compete with these larger companies due to the breadth of their coverage across the property and casualty market in substantially all lines of business. We also compete with smaller companies and other niche reinsurers from time to time.

 

While we have a limited operating history, we believe that our unique approach to multi-year underwriting will allow us to be successful in underwriting transactions against more established competitors.

 

Our Tokenization Business

 

We have decided to develop and pursue business opportunities in the tokenization of RWAs based on the expectation that a successful expansion into this specialization will further increase the underwriting capacity and potential profitability of our reinsurance subsidiaries, Oxbridge Reinsurance Limited and Oxbridge Re NS. We believe this represents a unique opportunity to drive value to our shareholders. The Boston Consulting Group published research projecting the RWA asset tokenization market to reach $16.1 trillion by 2030. A separate publication by Bloomberg reported  that, in 2023, reinsurance was one of the top performing hedge fund strategies. It is at the intersection of these two, i.e., RWA tokenization and reinsurance, that we believe there exist substantial growth opportunities for our business.

 

Accordingly, SurancePlus was incorporated to further innovate upon existing capital raising mechanisms of Oxbridge Re NS for collateralizing reinsurance contracts while simultaneously transforming the corresponding investment product into one that is more accessible to United States accredited investors under Rule 506(c) of Regulation D and to international investors under Regulation S. SurancePlus has since applied insights and technology from the Web3 digital ecosystem to create a multi-year series of real-world asset-backed digital securities, called the Cat Re (short for “catastrophe reinsurance”) token series. Ownership of the tokens confer an indirect fractional interest in reinsurance contracts entered into by Oxbridge Re NS or Oxbridge Reinsurance Limited. The DeltaCat Re token was the first of the token series, and it was issued in 2023 on the Avalanche blockchain network. The subsequent year’s offering of EpsilonCat Re tokens was announced in a Form 8-K filed with the SEC on March 18, 2024. SurancePlus intends to continue to issue the Cat Re token series over several years.

 

We project that SurancePlus Inc. may develop into a significant revenue generating stream for the Oxbridge Re group that may progressively reduces Oxbridge Re’s annual capital deployed into collateralizing reinsurance contracts.. As opportunities arise, Oxbridge Re intends to pursue, through its Web3-focused subsidiaries, additional expansion of its RWA tokenization business to further increase underwriting profit.

 

Employees

 

As of March 26, 2024, we had four employees, all of which were full-time. We believe that our relations with our employees are good. None of our employees are subject to collective bargaining agreements, and we are not aware of any current efforts to implement such agreements. We believe that we will continue to have relatively few employees and intend to outsource some functions to specialist firms in the Cayman Islands if and when we determine that such functions are necessary. We intend to use the expertise of our Board of Directors and where necessary, external consultants to provide any other service we may require from time to time.

 

Legal Proceedings

 

We are not currently involved in any litigation or arbitration. We anticipate that, similar to the rest of the insurance and reinsurance industry, we will be subject to litigation and arbitration in the ordinary course of business.

 

Regulation and Capital Requirements

 

Our wholly-owned reinsurance subsidiaries, Oxbridge Reinsurance Limited and Oxbridge Re NS, each holds a Class C Insurer’s License issued in accordance with the terms of the Insurance Law (as revised) of the Cayman Islands (the “Law”), and is subject to regulation by the Cayman Islands Monetary Authority (“CIMA”), in terms of the Law. As the holder of a Class C Insurer’s License, Oxbridge Reinsurance Limited and Oxbridge Re NS are permitted to undertake insurance business approved by CIMA.

 

Oxbridge Reinsurance Limited and Oxbridge Re NS are subject to minimum capital and surplus requirements, and our failure to meet these requirements could subject us to regulatory action. Pursuant to The Insurance (Capital and Solvency) (Classes B, C and D Insurers) Regulations, 2012 (the “Capital and Solvency Regulations”) published under the Law, Oxbridge Reinsurance Limited and Oxbridge Re NS are required to maintain the statutory minimum capital requirement (as defined under the Capital and Solvency Regulations) of $500 and prescribed capital requirement (as defined under the Capital and Solvency Regulations) of $500, and a minimum margin of solvency equal to or in excess of the total prescribed capital requirement. Any failure to meet the applicable requirements or minimum statutory capital requirements could subject us to further examination or corrective action by CIMA, including restrictions on dividend payments, limitations on our writing of additional business or engaging in finance activities, supervision or liquidation.

 

10
 

 

CIMA may at any time direct Oxbridge Reinsurance Limited and Oxbridge Re NS, in relation to a policy, a line of business or the entire business, to cease or refrain from committing an act or pursing a course of conduct and to perform such acts as in the opinion of CIMA are necessary to remedy or ameliorate the situation. See the discussion in “Risk Factors” under the heading “Any suspension or revocation of our reinsurance license would materially impact our ability to do business and implement our business strategy” for more information.

 

In addition, as a Cayman Islands exempted company, we may not carry on business or trade locally in the Cayman Islands except in furtherance of our business outside the Cayman Islands, and we are prohibited from soliciting the public of the Cayman Islands to subscribe for any of our securities or debt. We are further required to file a return with the Registrar of Companies in January of each year and to pay an annual registration fee at that time.

 

The Cayman Islands has no exchange controls restricting dealings in currencies or securities.

 

Available Information

 

Our website is located at www.oxbridgere.com. Copies of our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and amendments to these reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act are available, free of change, on our website as soon as reasonably practicable after we file such material electronically with or furnish it to the Securities and Exchange Commission (the “SEC”). The SEC also maintains a website that contains our SEC filings. The address of the SEC’s website is www.sec.gov.

 

Summary of Risk Factors

 

Our business is subject to numerous risks and uncertainties, including those highlighted in the section titled “Risk Factors,” that represent challenges that we face in connection with the successful implementation of our strategy. The occurrence of one or more of the events or circumstances described in the section titled “Risk Factors,” alone or in combination with other events or circumstances may have an adverse effect on our business, cash flows, financial condition and results of operations. In that case, the market price of our securities could decline, and you may lose some or all of your investment. Such risks include, but are not limited to:

 

We will need additional capital in the future in order to grow and operate our business. Such capital may not be available to us or may not be available to us on favorable terms. Furthermore, our raising additional capital could dilute your ownership interest in our company.

  Our results of operations will fluctuate from period to period and may not be indicative of our long-term prospects.
  Our tokenization business operations are at an early stage of development and have a limited operating history, and our strategy of developing a Web3-focused tokenization business may not be successful.
  Developing a Web3.0-focused business around the tokenization of RWAs involves significant risks.

Failure to become rated by A.M. Best, or receipt of a negative rating, could significantly and negatively affect our ability to grow.
Established competitors with greater resources may make it difficult for us to effectively market our products or offer our products at a profit.
If actual renewals of our existing contracts do not meet expectations, our premiums assumed in future years and our future results of operations could be materially adversely affected.
Reputation is an important factor in the reinsurance industry, and our lack of an established reputation may make it difficult for us to attract or retain business.
If our losses and loss adjustment expenses greatly exceed our loss reserves, our financial condition may be significantly and negatively affected.
The property and casualty reinsurance market may be affected by cyclical trends and over-supply.
Our property and property catastrophe reinsurance operations will make us vulnerable to losses from catastrophes and may cause our results of operations to vary significantly from period to period.
We could face unanticipated losses from war, terrorism, and political unrest, and these or other unanticipated losses could have a material adverse effect on our financial condition and results of operations.
We depend on our clients’ evaluations of the risks associated with their insurance underwriting, which may subject us to reinsurance losses.
Changing climate conditions may adversely affect our financial condition, profitability or cash flows.
Operational risks, including human or systems failures, are inherent in our business.
The effect of emerging claim and coverage issues on our business is uncertain
We are required to maintain sufficient collateral accounts, which could significantly and negatively affect our ability to implement our business strategy.
The inability to obtain business provided from brokers could adversely affect our business strategy and results of operations.

 

11
 

 

The involvement of reinsurance brokers may subject us to their credit risk.
Our use of fair value accounting of our significant investment in Jet.AI Inc. could result in income statement volatility, which in turn, could cause significant market price and trading volume fluctuations for our securities
U.S. and global economic downturns could harm our business, our liquidity and financial condition and the price of our securities.
Our ability to implement our business strategy could be delayed or adversely affected by Cayman Islands employment restrictions.
Security breaches and other disruptions could compromise our information and expose us to liability, which would cause our business and reputation to suffer.
If we lose or are unable to retain our senior management and other key personnel and are unable to attract qualified personnel, our ability to implement our business strategy could be delayed or hindered, which, in turn, could significantly and negatively affect our business.
There are differences under Cayman Islands corporate law and Delaware corporate law with respect to interested party transactions which may benefit certain of our shareholders at the expense of other shareholders.
Any suspension or revocation of our reinsurance license would materially impact our ability to do business and implement our business strategy.
Our reinsurance subsidiaries are subject to minimum capital and surplus requirements, and our failure to meet these requirements could subject us to regulatory action.
As a holding company, we will depend on the ability of our subsidiaries to pay dividends.
We may be subject to the risk of possibly becoming an investment company under U.S. federal securities law.
Insurance regulations to which we are, or may become, subject, and potential changes thereto, could have a significant and negative effect on our business.
We will likely be exposed to credit risk due to the possibility that counterparties may default on their obligations to us.
Provisions of our Third Amended and Restated Memorandum and Articles of Association (“Articles”) could adversely affect the value of our securities.
Provisions of the Companies Law of the Cayman Islands could prevent a merger or takeover of our company.
Holders of our securities may have difficulty obtaining or enforcing a judgment against us, and they may face difficulties in protecting their interests because we are incorporated under Cayman Islands law.
Provisions of our Articles may reallocate the voting power of our ordinary shares.
We do not currently have an effective registration statement registering the issuance of the shares underlying our publicly traded warrants, and therefore you may not be able to exercise the warrants in a cash exercise.
We may become subject to taxation in the Cayman Islands which would negatively affect our results.
We may be subject to United States federal income taxation.
We may be treated as a PFIC, in which case a U.S. holder of our ordinary shares should be subject to disadvantageous rules under U.S. federal income tax laws. We may be treated as a CFC and may be subject to the rules for related person insurance income, and in either case this may subject a U.S. holder of our ordinary shares to disadvantageous rules under U.S. federal income tax laws.
United States tax-exempt organizations who own ordinary shares may recognize unrelated business taxable income.
Changes in United States tax laws may be retroactive and could subject us, and/or United States persons who own ordinary shares to United States income taxation on our undistributed earnings.
We do not intend to resume paying cash dividends in the foreseeable future.
Outages, computer viruses and similar events could disrupt our operations.
Increased Information Technology (“IT”) security threats and more sophisticated computer crime could pose a risk to our systems, networks, and services.

Increased scrutiny by and changing expectations from investors, employees, and other stakeholders regarding our environmental, social, and governance (“ESG”) practices and reporting could cause us to incur additional costs and adversely impact our reputation, tenant and employee acquisition and retention, and access to capital.

 

12
 

 

ITEM 1A RISK FACTORS

 

Risks Relating to Our Business

 

We will need additional capital in the future in order to grow and operate our business. Such capital may not be available to us or may not be available to us on favorable terms. Furthermore, our raising additional capital could dilute your ownership interest in our company.

 

We expect that we will need to raise additional capital in the future through public or private equity or debt offerings or otherwise in order to:

 

  further capitalize our reinsurance subsidiaries and implement our growth strategy;
  fund liquidity needs caused by underwriting or investment losses;
  replace capital lost in the event of significant reinsurance losses or adverse reserve developments;
  meet applicable statutory jurisdiction requirements;
  fund our business activities relating to our new tokenization business operations; and/or
  respond to competitive pressures.

 

Additional capital may not be available on terms favorable to us, or at all. Further, any additional capital raised through the sale of equity could dilute your ownership interest in our company and may cause the market price of our ordinary shares and warrants to decline. Additional capital raised through the issuance of debt may result in creditors having rights, preferences and privileges senior or otherwise superior to those of our ordinary shares and warrants.

 

Our results of operations will fluctuate from period to period and may not be indicative of our long-term prospects.

 

We anticipate that the performance of our reinsurance operations and our investment portfolio will fluctuate from period to period. Fluctuations will result from a variety of factors, including:

 

  reinsurance contract pricing;
  our assessment of the quality of available reinsurance opportunities;
  the volume and mix of reinsurance products we underwrite;
  loss experienced on our reinsurance liabilities;
  our ability to assess and integrate our risk management strategy properly; and
  the performance of our investment portfolio.

 

In particular, we plan to underwrite products and make investments to achieve favorable return on equity over the long term. In addition, our opportunistic nature and focus on long-term growth in book value will result in fluctuations in total premiums written from period to period as we concentrate on underwriting contracts that we believe will generate better long-term, rather than short-term, results. Accordingly, our short-term results of operations may not be indicative of our long-term prospects.

 

Our tokenization business operations are at an early stage of development and have a limited operating history, and our strategy of developing a Web3-focused RWA tokenization business may not be successful.

 

Our Web3-focused RWA tokenization business is still in the development stage, and our operating history in such business has been limited to the development and issuance of a token for participation in reinsurance contracts underwritten by our Oxbridge Re NS subsidiary. We have not yet announced any revenue-producing activities for tokenization of RWAs that are held by or being acquired by third parties, and we may not be able to successfully complete the development of any products or services relating to tokenization of third-party RWAs. Accordingly, we have only a very limited operating history and limited experience in this business and have not earned any revenues to date in this business (other than limited management fees from the issuance of the DeltaCat Re Tokens). If we are not able to develop this business as planned, we may not be able to generate material revenues from our developing tokenization business.

 

Developing a Web3.0-focused business around the tokenization of RWAs involves significant risks.

 

Our planned tokenization business activities are based on a new area of technology and carries significant risks, including the following:

 

  an active trading market for tokenized RWAs may not develop or be sustained;
  there is no guarantee that tokenized RWAs will hold their value or increase in value;
  tokenized RWAs of SurancePlus may not be listed on any securities exchange and may not be available to trade on any alternative trading system (“ATS”), which would result in limited liquidity for holders;
  if the tokenized RWAs become available for trading on an ATS, the number of securities traded on such ATS may be very small, making the market price more easily manipulated;
  technology on which an ATS relies for its operations may not function properly;
  blockchain networks are relatively new technologies;
 

asset tokenization via blockchain technologies is a relatively new digital innovation;

  blockchain network transaction fees may significantly increase over the duration of the investment;
  smart contracts may have implementation errors that vitiate them;
  blockchain transactions may be taken advantage of for financial crimes; and
  the Avalanche blockchain the tokenized RWAs rely upon and the tokenized RWAs themselves may be the target of malicious cyberattacks.

 

13
 

 

Failure to become rated by A.M. Best, or receipt of a negative rating, could significantly and negatively affect our ability to grow.

 

Companies, insurers and reinsurance brokers use ratings from independent ratings agencies as an important means of assessing the financial strength and quality of reinsurers. This rating reflects the rating agency’s opinion of our financial strength, operating performance and ability to meet obligations. It is not an evaluation directed toward the protection of investors or a recommendation to buy, sell or hold our securities. A.M. Best assigns ratings based on its analysis of balance sheet strength, operating performance and business profile.

 

Currently, A.M Best has not assigned us a financial strength rating, and we do not intend to seek a rating in the foreseeable future. Without a rating, or if we received a negative rating, our growth potential and business strategy will be limited because of the need to collateralize the insurance policies that we write.

 

Established competitors with greater resources may make it difficult for us to effectively market our products or offer our products at a profit.

 

The reinsurance industry is highly competitive. We compete with major reinsurers, all of which have substantially greater financial, marketing and management resources than we do. Competition in the types of business that we seek to underwrite is based on many factors, including:

 

  premium charges;
  the general reputation and perceived financial strength of the reinsurer;
  relationships with reinsurance brokers;
  terms and conditions of products offered;
  ratings assigned by independent rating agencies;
  speed of claims payment and reputation; and
  the experience and reputation of the members of our underwriting team in the particular lines of reinsurance we seek to underwrite.

 

Additionally, although the members of our underwriting team have general experience across many property and casualty lines, they may not have the requisite experience or expertise to compete for all transactions that fall within our strategy of offering customized frequency and severity contracts at times and in markets where capacity and alternatives may be limited.

 

Our competitors Renaissance Re, Berkshire Hathaway, PartnerRe Ltd, Aeolus Re, and Nephila which are dominant companies in the reinsurance industry, as well as smaller companies and other niche reinsurers. Although we seek to provide coverage where capacity and alternatives are limited, we will directly compete with these larger companies due to the breadth of their coverage across the property and casualty market in substantially all lines of business.

 

We cannot assure you that we will be able to compete successfully in the reinsurance market. Our failure to compete effectively could significantly and negatively affect our financial condition and results of operations and may increase the likelihood that we may be deemed to be a passive foreign investment company or an investment company.

 

If actual renewals of our existing contracts do not meet expectations, our premiums assumed in future years and our future results of operations could be materially adversely affected.

 

Many of our contracts are generally written for a one-year term. In our financial forecasting process, we make assumptions about the renewal of our prior year’s contracts. The insurance and reinsurance industries have historically been cyclical businesses with periods of intense competition, often based on price. If actual renewals do not meet expectations or if we choose not to write on a renewal basis because of pricing conditions, our premiums assumed in future years and our future operations would be materially adversely affected.

 

Reputation is an important factor in the reinsurance industry, and our lack of an established reputation may make it difficult for us to attract or retain business.

 

Reputation is a very important factor in the reinsurance industry, and competition for business is, in part, based on reputation. Although our reinsurance policies will be fully collateralized, we are a relatively newly formed reinsurance company and do not yet have a well-established reputation in the reinsurance industry. Our lack of an established reputation may make it difficult for us to attract or retain business. In addition, we do not have or currently intend to obtain financial strength ratings, which may discourage certain counterparties from entering into reinsurance contracts with us.

 

14
 

 

If our losses and loss adjustment expenses greatly exceed our loss reserves, our financial condition may be significantly and negatively affected.

 

Our results of operations and financial condition will depend upon our ability to accurately assess the potential losses and loss adjustment expenses associated with the risks we reinsure. Reserves are estimates at a given time of claims an insurer ultimately expects to pay, based upon facts and circumstances then known, predictions of future events, estimates of future trends in claim severity and other variable factors. The inherent uncertainties of estimating loss reserves are generally greater for reinsurance companies as compared to primary insurers, primarily due to:

 

  the lapse of time from the occurrence of an event to the reporting of the claim and the ultimate resolution or settlement of the claim;
  the diversity of development patterns among different types of reinsurance treaties; and
  the necessary reliance on the client for information regarding claims.

 

Our estimation of reserves may be less reliable than the reserve estimations of a reinsurer with a greater volume of business and an established loss history. Our actual losses and loss adjustment expenses paid may deviate substantially from the estimates of our loss reserves and could negatively affect our results of operations. If our loss reserves are later found to be inadequate, we would increase our loss reserves with a corresponding reduction in our net income and capital in the period in which we identify the deficiency, and such a reduction would also negatively affect our results of operations. If our losses and loss adjustment expenses greatly exceed our loss reserves, our financial condition may be significantly and negatively affected.

 

The property and casualty reinsurance market may be affected by cyclical trends and over-supply.

 

We write reinsurance in the property and casualty markets, which tend to be cyclical in nature. Ceding company underwriting results, prevailing general economic and market conditions, liability retention decisions of companies and ceding companies and reinsurance premium rates each influence the demand for property and casualty reinsurance. Prevailing prices and available surplus to support assumed business then influence reinsurance supply. Supply may fluctuate in response to changes in return on capital realized in the reinsurance industry, the frequency and severity of losses and prevailing general economic and market conditions.

 

Continued increases in the supply of reinsurance may have consequences for the reinsurance industry generally and for us, including lower premium rates, increased expenses for customer acquisition and retention, less favorable policy terms and conditions and/or lower premium volume. Furthermore, unpredictable developments, including courts granting increasingly larger awards for certain damages, increases in the frequency of natural disasters (such as hurricanes, windstorms, tornados, earthquakes, wildfires and floods), fluctuations in interest rates, changes in the investment environment that affect market prices of investments and inflationary pressures, affect the industry’s profitability. The effects of cyclicality could significantly and negatively affect our financial condition and results of operations.

 

Due to the influx of new risk capital from alternative capital market participants such as hedge funds and pension funds, we believe that the reinsurance industry is currently over-capitalized and will continue in this trend for the foreseeable future. The over-capitalization of the market is not uniform as there are a number of insurers and reinsurers that have suffered and continue to suffer from capacity issues. We continue to assess the opportunities that may be available to us with insurance and reinsurance companies with this profile. If the reinsurance market continues to soften, our strategy is to reduce premium writings rather than accept mispriced risk and conserve our capital for a more opportune environment. Significant rate increases could occur if financial and credit markets experience adverse shocks that result in the loss of capital of insurers and reinsurers, or if there are major catastrophic events, especially in North America.

 

Our property and property catastrophe reinsurance operations will make us vulnerable to losses from catastrophes and may cause our results of operations to vary significantly from period to period.

 

Our reinsurance operations expose us to claims arising out of unpredictable catastrophic events, such as hurricanes, hailstorms, tornados, windstorms, earthquakes, floods, fires, explosions, and other natural or man-made disasters. Because of our emphasis on Florida, we are particularly vulnerable to hurricanes and with windstorm losses occurring in Florida. The incidence and severity of catastrophes are inherently unpredictable but the loss experience of property catastrophe reinsurers has been generally characterized as low frequency and high severity. Claims from catastrophic events could reduce our earnings and cause substantial volatility in our results of operations for any fiscal quarter or year and adversely affect our financial condition. Corresponding reductions in our surplus levels could impact our ability to write new reinsurance policies.

 

15
 

 

Catastrophic losses are a function of the insured exposure in the affected area and the severity of the event. Because accounting standards do not permit reinsurers to reserve for catastrophic events until they occur, claims from catastrophic events could cause substantial volatility in our financial results for any fiscal quarter or year and could significantly and negatively affect our financial condition and results of operations.

 

We could face unanticipated losses from war, terrorism, and political unrest, and these or other unanticipated losses could have a material adverse effect on our financial condition and results of operations.

 

Like other reinsurers, we face potential exposure to large, unexpected losses resulting from man-made catastrophic events, such as acts of war, acts of terrorism and political instability. These risks are inherently unpredictable and recent events may indicate that the frequency and severity of these types of losses may increase. It is difficult to predict the timing of these events or to estimate the amount of loss that any given occurrence will generate. To the extent that losses from these risks occur, our financial condition and results of operations could be significantly and negatively affected.

 

We depend on our clients’ evaluations of the risks associated with their insurance underwriting, which may subject us to reinsurance losses.

 

In the proportional reinsurance business, in which we assume an agreed percentage of each underlying insurance contract being reinsured, or quota share contracts, we do not separately evaluate each of the original individual risks assumed under these reinsurance contracts. Therefore, we are largely dependent on the original underwriting decisions made by ceding companies. We are subject to the risk that the clients may not have adequately evaluated the insured risks and that the premiums ceded may not adequately compensate us for the risks we assume. We also do not separately evaluate each of the individual claims made on the underlying insurance contracts under quota share arrangements. Therefore, we are dependent on the original claims decisions made by our clients.

 

Changing climate conditions may adversely affect our financial condition, profitability or cash flows.

 

Climate change, to the extent it produces extreme changes in temperatures and changes in weather patterns, could impact the frequency or severity of weather events and wildfires. Further, it could impact the affordability and availability of homeowners insurance, which could have an impact on pricing. Changes in weather patterns could also affect the frequency and severity of other natural catastrophe events to which we may be exposed. The occurrence of these events would significantly and negatively affect our financial condition and results of operations.

 

Operational risks, including human or systems failures, are inherent in our business.

 

Operational risks and losses can result from, among other things, fraud, errors, failure to document transactions properly or to obtain proper internal authorization, failure to comply with regulatory requirements, information technology failures or external events.

 

We believe that our modeling, underwriting and information technology and application systems are critical to our business and our growth prospects. Moreover, we rely on our information technology and application systems to further our underwriting process and to enhance our ability to compete successfully. A major defect or failure in our internal controls or information technology and application systems could result in management distraction, harm to our reputation or increased expenses.

 

The effect of emerging claim and coverage issues on our business is uncertain.

 

As industry practices and legal, judicial and regulatory conditions change, unexpected issues related to claims and coverage may emerge. It is possible that certain provisions of our future reinsurance contracts, such as limitations or exclusions from coverage or choice of forum, may be difficult to enforce in the manner we intend, due to, among other things, disputes relating to coverage and choice of legal forum. These issues may adversely affect our business by either extending coverage beyond the period that we intended or by increasing the number or size of claims. In some instances, these changes may not manifest themselves until many years after we have issued insurance or reinsurance contracts that are affected by these changes. As a result, we may not be able to ascertain the full extent of our liabilities under our insurance or reinsurance contracts for many years following the issuance of our contracts. The effects of unforeseen development or substantial government intervention could adversely impact our ability to adhere to our goals.

 

16
 

 

We are required to maintain sufficient collateral accounts, which could significantly and negatively affect our ability to implement our business strategy.

 

We are not licensed or admitted as a reinsurer in any jurisdiction other than the Cayman Islands. Certain jurisdictions, including the United States, do not permit insurance companies to take credit for reinsurance obtained from unlicensed or non-admitted insurers on their statutory financial statements unless appropriate security measures are implemented. Consequently, we must continue to maintain sufficient funds in escrow accounts to serve as collateral for our reinsurance contracts. Because we intend to continue to utilize our funds (rather than utilizing the credit markets) to serve as collateral for our reinsurance obligations, we may not be able to fully utilize our capital to expand our reinsurance coverage as rapidly as other reinsurers.

 

The inability to obtain business provided from brokers could adversely affect our business strategy and results of operations.

 

We anticipate that a substantial portion of our business will be placed primarily through brokered transactions, which involve a limited number of reinsurance brokers. If we are unable to identify and grow the brokered business provided through one or more of these reinsurance brokers, many of whom may not be familiar with our Cayman Islands jurisdiction, this failure could significantly and negatively affect our business and results of operations.

 

The involvement of reinsurance brokers may subject us to their credit risk.

 

As a standard practice of the reinsurance industry, reinsurers frequently pay amounts owed on claims under their policies to reinsurance brokers, and these brokers, in turn, remit these amounts to the ceding companies that have reinsured a portion of their liabilities with the reinsurer. In some jurisdictions, if a broker fails to make such a payment, the reinsurer might remain liable to the client for the deficiency notwithstanding the broker’s obligation to make such payment. Conversely, in certain jurisdictions, when the client pays premiums for policies to reinsurance brokers for payment to the reinsurer, these premiums are considered to have been paid and the client will no longer be liable to the reinsurer for these premiums, whether or not the reinsurer has actually received them. Consequently, we assume a degree of credit risk associated with the brokers that we do business with.

 

Our use of fair value accounting of our significant investment in Jet.AI Inc. could result in income statement volatility, which in turn, could cause significant market price and trading volume fluctuations for our securities.

 

Our significant beneficial interests in Jet.AI Inc.’s common stock and public warrants are recorded at fair value with changes in fair value being recorded in the consolidated statements of operations during the period of change. Additionally, the fair value of the investment must be remeasured quarterly. Because of this, and due to significance of our investment in Jet.AI relative to our total assets, our earnings may experience greater volatility in the future as a decline in the fair value of our investment in Jet.AI Inc. could significantly reduce both our earnings and shareholders’ equity, which in turn, could cause significant market price and trading volume fluctuations for our securities.

 

U.S. and global economic downturns could harm our business, our liquidity and financial condition and the price of our securities.

 

Weak economic conditions may adversely affect (among other aspects of our business) the demand for and claims made under our products, the ability of customers, counterparties and others to establish or maintain their relationships with us, our ability to access and efficiently use internal and external capital resources and our investment performance. Volatility in the U.S. and other securities markets may adversely affect our investment portfolio and our resulting results of operations.

 

17
 

 

Our ability to implement our business strategy could be delayed or adversely affected by Cayman Islands employment restrictions.

 

Under Cayman Islands law, persons who are not Caymanian, do not possess Caymanian status, or are not otherwise entitled to reside and work in the Cayman Islands pursuant to provisions of the Immigration Law (2015 Revision) of the Cayman Islands, which we refer to as the Immigration Law, may not engage in any gainful occupation in the Cayman Islands without an appropriate governmental work permit. Although Jay Madhu and Wrendon Timothy have obtained Permanent Residency in the Cayman Islands, the failure to obtain work permits, or extensions thereof, for other employee(s) could prevent us from continuing to implement our business strategy seamlessly.

 

Security breaches and other disruptions could compromise our information and expose us to liability, which would cause our business and reputation to suffer.

 

In the ordinary course of our business, we may collect and store sensitive data, including proprietary business, in our data centers and on our networks. The secure processing, maintenance and transmission of this information is critical to our operations and business strategy. Despite our security measures, our information technology and infrastructure may be vulnerable to attacks by hackers or breached due to employee error, malfeasance or other disruptions. Any such breach could compromise our networks and the information stored there could be accessed, publicly disclosed, lost or stolen. Any such access, disclosure or other loss of information could result in legal claims or proceedings, disrupt our operations, and damage our reputation, which could adversely affect our business, revenues and competitive position.

 

If we lose or are unable to retain our senior management and other key personnel and are unable to attract qualified personnel, our ability to implement our business strategy could be delayed or hindered, which, in turn, could significantly and negatively affect our business.

 

Although we only employ four individuals, two of whom are members of senior management, our future success may depend to a significant extent on the efforts of our senior management and other key personnel (who have not yet been hired) to implement our business strategy. We believe there are only a limited number of available, qualified executives with substantial experience in our industry. In addition, we will need to add personnel, including underwriters, to implement our business strategy. We could face challenges attracting personnel to the Cayman Islands. Accordingly, the loss of the services of one or more of the members of our senior management or other key personnel (when hired), or our inability to hire and retain other key personnel, could delay or prevent us from fully implementing our business strategy and, consequently, significantly and negatively affect our business.

 

We do not currently maintain key man life insurance with respect to any of our senior management. If any member of senior management dies or becomes incapacitated, or leaves the Company to pursue employment opportunities elsewhere, we would be solely responsible for locating an adequate replacement for such senior management and for bearing any related cost. To the extent that we are unable to locate an adequate replacement or are unable to do so within a reasonable period of time, our business may be significantly and negatively affected.

 

There are differences under Cayman Islands corporate law and Delaware corporate law with respect to interested party transactions which may benefit certain of our shareholders at the expense of other shareholders.

 

Under Cayman Islands corporate law, a director may vote on a contract or transaction where the director has an interest as a shareholder, director, officer or employee provided such interest is disclosed. None of our contracts will be deemed to be void because any director is an interested party in such transaction and interested parties will not be held liable for monies owed to the company. In contracts, under Delaware law, interested party transactions are potentially voidable.

 

Risks Relating to Insurance and Other Regulations

 

Any suspension or revocation of our reinsurance licenses would materially impact our ability to do business and implement our business strategy.

 

Oxbridge Reinsurance Limited and Oxbridge Re NS are each licensed as an insurer only in the Cayman Islands by CIMA, and we do not intend to obtain a license in any other jurisdiction. The suspension or revocation of each of our licenses to do business as a reinsurance company in the Cayman Islands for any reason would mean that we would not be able to enter into any new reinsurance contracts until the suspension ended or we became licensed in another jurisdiction. Any such suspension or revocation of our licenses would negatively impact our reputation in the reinsurance marketplace and could have a material adverse effect on our results of operations.

 

18
 

 

As a regulated insurance company, each of Oxbridge Reinsurance Limited and Oxbridge Re NS is subject to the supervision of CIMA and CIMA may at any time direct Oxbridge Reinsurance Limited and/or Oxbridge Re NS, in relation to a policy, a line of business or the entire business, to cease or refrain from committing an act or pursing a course of conduct and to perform such acts as in the opinion of CIMA are necessary to remedy or ameliorate the situation.

 

Furthermore, in certain circumstances, including when CIMA is of the opinion that:

 

  a licensee either is or appears to be likely to become unable to meet its obligations as they fall due;
  a licensee is carrying on its business in a manner which is seen as detrimental to the general public interest or to the interests of its creditors or policy holders;
  the activities of any member of the licensee’s insurance group are detrimental to those interests of the licensee’s creditors, as well as its policy holders;
  a licensee has contravened the Law or the Money Laundering Regulations (2023 Revision) of the Cayman Islands;
  the licensee has failed to comply with a condition of its license such as maintaining a margin of solvency as prescribed by CIMA;
  the direction and/or management of the licensee’s business has not been conducted in a fit and proper manner;
  a director, manager or officer of the licensee’s business is not someone who would qualify or be seen as a person suitable to hold the respective position;
  any person who is either holding or acquiring control or ownership of the licensee is not a fit and proper person to have such control or ownership;
  the licensee has ceased to carry on business; or
  the licensee is placed in liquidation or is dissolved;

 

CIMA may take one of a number of steps, including:

 

  requiring the licensee to take steps to rectify the matter;
  suspending the license of the licensee pending a full inquiry into the licensee’s affairs;
  revoking the license;
  imposing conditions upon the licensee in terms of decisions made by it, including the suspension of voting rights or nullification of votes cast by it, and amending or revoking any such condition;
  requiring the substitution or removal of any director, manager or officer of the licensee, at the expense of the licensee;
  appointing a person to advise the licensee on the proper conduct of its affairs, at the expense of the licensee;
  appointing a person to assume control of the licensee’s affairs; or
  otherwise requiring such action to be taken by the licensee as CIMA considers necessary.

 

Failures to comply with a direction given by CIMA may be punishable by a fine of up to five hundred thousand Cayman Islands dollars (US$609,756.10 based on the Cayman Islands’ pegged exchange rate of CI$0.82 per US$1.00) or imprisonment for a term of five years or both, and a fine of an additional ten thousand Cayman Islands dollars (US$12,195.12) for every day after conviction on which the offense so continues.

 

Our reinsurance subsidiaries are subject to minimum capital and surplus requirements, and our failure to meet these requirements could subject us to regulatory action.

 

Pursuant to the Capital and Solvency Regulations, Oxbridge Reinsurance Limited and Oxbridge Re NS, our reinsurance subsidiaries, are each required to maintain the statutory minimum capital requirement (as defined under the Capital and Solvency Regulations) of $500 and prescribed capital requirement (as defined under the Capital and Solvency Regulations) of $500, and a minimum margin of solvency equal to or in excess of the total prescribed capital requirement. Any failure to meet the applicable requirements or minimum statutory capital requirements could subject us to further examination or corrective action by CIMA, including restrictions on dividend payments, limitations on our writing of additional business or engaging in finance activities, supervision or liquidation.

 

19
 

 

As a holding company, we will depend on the ability of our subsidiaries to pay dividends.

 

We are a holding company and do not have any significant operations or assets other than our ownership of the shares of our subsidiaries Oxbridge Reinsurance Limited and Oxbridge Re NS. Dividends and other permitted distributions from our subsidiaries will be our primary source of funds to meet ongoing cash requirements, including future debt service payments, if any, and other expenses, and to pay dividends to our shareholders if we choose to do so. Our subsidiaries will be subject to applicable law as well as significant regulatory restrictions limiting their ability to declare and pay dividends. The inability of our subsidiaries to pay dividends in an amount sufficient to enable us to meet our cash requirements at the holding company level could have an adverse effect on our operations and our ability to pay dividends to our shareholders if we choose to do so and/or meet our debt service obligations, if any.

 

We are subject to the risk of possibly becoming an investment company under U.S. federal securities law.

 

In the United States, the Investment Company Act of 1940, as amended (the “Investment Company Act”), regulates certain companies that invest in or trade securities. We run the risk of inadvertently being deemed to be an investment company that is required to register under the Investment Company because a significant portion of our assets may be deemed to consist of, or may be deemed to have consisted of, investment securities, including potentially Oxbridge Reinsurance Limited’s interest in Oxbridge Acquisition Corp. However, we rely on an exemption under the Investment Company Act for an entity organized and regulated as a foreign insurance company which is engaged primarily and predominantly in the reinsurance of risks on insurance agreements. The law in this area is subjective and there is a lack of guidance as to the meaning of ‘‘primarily and predominantly’’ under the relevant exemption to the Investment Company Act. For example, there is no standard for the amount of premiums that need to be written relative to the level of an entity’s capital in order to qualify for the exemption. If this exception were deemed inapplicable, we would have to seek to register under the Investment Company Act as an investment company, which, under the Investment Company Act, would require an order from the SEC. Our inability to obtain such an order could have a significant adverse impact on our business, as we might have to cease certain operations or risk substantial penalties for violating the Investment Company Act.

 

Registered investment companies are subject to extensive, restrictive and potentially adverse regulation relating to, among other things, capital structure, leverage, management, dividends and transactions with affiliates. Registered investment companies are not permitted to operate their business in the manner in which we operate (and intend to operate) our business. Specifically, if we were required to register under the Investment Company Act, provisions of the Investment Company Act would limit (and in some cases even prohibit) our ability to raise additional debt and equity securities or issue options or warrants (which could impact our ability to compensate key employees), limit our ability to use financial leverage, limit our ability to incur indebtedness, and require changes to the composition of our Board of Directors. Provisions of the Investment Company Act would also prohibit (subject to certain exceptions) transactions with affiliates.

 

Accordingly, if we were required to register as an investment company, we would not be permitted to have many of the relationships that we have or expect that we may have with affiliated companies.

 

If at any time it were established that we had been operating as an investment company in violation of the registration requirements of the Investment Company Act, there would be a risk, among other material adverse consequences, that we could become subject to monetary penalties or injunctive relief, or both, or that we would be unable to enforce contracts with third parties or that third parties could seek to obtain rescission of transactions with us undertaken during the period in which it was established that we were an unregistered investment company.

 

20
 

 

Insurance regulations to which we are, or may become, subject, and potential changes thereto, could have a significant and negative effect on our business.

 

Although we do not presently expect that we will conduct business in any jurisdiction other than the Cayman Islands, we cannot assure you that insurance regulators in the United States or elsewhere will not review our activities and claim that we are subject to such jurisdiction’s insurance licensing requirements. In addition, we are subject to indirect regulatory requirements imposed by jurisdictions that may limit our ability to provide reinsurance. For example, our ability to write reinsurance may be subject, in certain cases, to arrangements satisfactory to applicable regulatory bodies, and proposed legislation and regulations may have the effect of imposing additional requirements upon, or restricting the market for, non-U.S. reinsurers such as Oxbridge Reinsurance Limited and Oxbridge Re NS, with whom domestic companies may place business. We do not know of any such proposed legislation pending at this time.

 

Furthermore, we may not be able to comply fully with, or obtain desired exemptions from, revised statutes, regulations and policies that currently, or may in the future, govern the conduct of our business. Failure to comply with, or to obtain desired authorizations and/or exemptions under, any applicable laws could result in restrictions on our ability to do business or undertake activities that are regulated in the jurisdictions in which we operate and could subject us to fines and other sanctions. In addition, changes in the laws or regulations to which our reinsurance subsidiary is subject or may become subject, or in the interpretations thereof by enforcement or regulatory agencies, could have a material adverse effect on our business, our business plans, and our growth strategy.

 

We will likely be exposed to credit risk due to the possibility that counterparties may default on their obligations to us.

 

Due to our investments in our portfolio, we are exposed to credit risk due to the possibility that counterparties may default on their obligations to us. Issuers or borrowers whose securities or debt we hold, customers, reinsurers, clearing agents, exchanges, clearing houses and other financial intermediaries and guarantors may default on their obligations to us due to bankruptcy, insolvency, lack of liquidity, adverse economic conditions, operational failure, fraud or other reasons. Such defaults could have a significant and negative effect on our results of operations, financial condition and cash flows.

 

Risks Relating to our Securities

 

Provisions of our Third Amended and Restated Memorandum and Articles of Association (“Articles”) could adversely affect the value of our securities.

 

Our Articles permit our Board of Directors to allot, issue, grant options over or otherwise dispose of further shares (including fractions of such share) with or without preferred, deferred or other rights or restrictions, whether in regard to dividend or other distribution, voting, return of capital or otherwise and to such persons, at such times and on such other terms as they consider appropriate. Accordingly, our Board of Directors may authorize the issuance of preferred shares with terms and conditions and under circumstances that could have an effect of discouraging a takeover or other transaction, deny shareholders the receipt of a premium on their ordinary shares in the event of a tender or other offer for ordinary shares and have a depressive effect on the value of our ordinary shares.

 

Provisions of the Companies Law of the Cayman Islands could prevent a merger or takeover of our company.

 

As compared to mergers under corporate law in the United States, it may be more difficult to consummate a merger of two or more companies in the Cayman Islands or the merger of one or more Cayman Islands companies with one or more overseas companies, even if such transaction would be beneficial to our shareholders. The Companies Law of the Cayman Islands, as amended (the “Companies Law”), permits mergers and consolidations between Cayman Islands companies and between Cayman Islands companies and non-Cayman Islands companies. For these purposes, (a) “merger” means the merging of two or more constituent companies and the vesting of their undertaking, property and liabilities in one of such companies as the surviving company and (b) a “consolidation” means the combination of two or more constituent companies into a combined company and the vesting of the undertaking, property and liabilities of such companies to the consolidated company. In order to effect such a merger or consolidation, the directors of each constituent company must approve a written plan of merger or consolidation, which must then be authorized by (a) a special resolution of the shareholders of each constituent company, and (b) such other authorization, if any, as may be specified in such constituent company’s articles of association. The written plan of merger or consolidation must be filed with the Registrar of Companies together with a declaration as to the solvency of the consolidated or surviving company, a list of the assets and liabilities of each constituent company and an undertaking that a copy of the certificate of merger or consolidation will be given to the shareholders and creditors of each constituent company and that notification of the merger or consolidation will be published in the Cayman Islands Gazette. Dissenting shareholders have the right to be paid the fair value of their shares (which, if not agreed between the parties, will be determined by the Cayman Islands court) if they follow the required procedures, subject to certain exceptions. Court approval is not required for a merger or consolidation which is effected in compliance with these statutory procedures.

 

21
 

 

In addition, there are statutory provisions that facilitate the reconstruction and amalgamation of companies, provided that the arrangement is approved by a majority in number of each class of shareholders or creditors (representing 75% by value) with whom the arrangement is to be made and who must, in addition, represent three-fourths in value of each such class of shareholders or creditors, as the case may be, that are present and voting either in person or by proxy at a meeting, or meetings, convened for that purpose. The convening of the meetings and subsequently the arrangement must be sanctioned by the Grand Court of the Cayman Islands. While a dissenting shareholder has the right to express to the court the view that the transaction ought not to be approved, the court can be expected to approve the arrangement if it determines that:

 

  the statutory provisions as to the required majority vote have been met;
  the shareholders have been fairly represented at the meeting in question and the statutory majority are acting bona fide without coercion of the minority to promote interests adverse to those of the class;
  the arrangement is such that may be reasonably approved by an intelligent and honest man of that class acting in respect of his interest; and
  the arrangement is not one that would more properly be sanctioned under some other provision of the Companies Law.

 

When a takeover offer is made and accepted by holders of 90% of the shares within four months, the offeror may, within a two-month period commencing on the expiration of such four-month period, require the holders of the remaining shares to transfer such shares on the terms of the offer. An objection can be made to the Grand Court of the Cayman Islands, but such objection is unlikely to succeed in the case of an offer which has been so approved unless there is evidence of fraud, bad faith or collusion.

 

If an arrangement and reconstruction is thus approved, the dissenting shareholder would have no rights comparable to appraisal rights, which would otherwise ordinarily be available to dissenting shareholders of certain corporations incorporated in the United States, including Delaware corporations, providing rights to receive payment in cash for the judicially determined value of the shares.

 

Holders of our securities may have difficulty obtaining or enforcing a judgment against us, and they may face difficulties in protecting their interests because we are incorporated under Cayman Islands law.

 

Because we are a Cayman Islands company, there is uncertainty as to whether the Grand Court of the Cayman Islands would recognize or enforce judgments of United States courts obtained against us predicated upon the civil liability provisions of the securities laws of the United States or any state thereof, or be competent to hear original actions brought in the Cayman Islands against us predicated upon the securities laws of the United States or any state thereof.

 

We are incorporated as an exempted company limited by shares under the Companies Law. A significant amount of our assets are located outside of the United States. As a result, it may be difficult for persons purchasing our securities to effect service of process within the United States upon us or to enforce judgments against us or judgments obtained in U.S. courts predicated upon the civil liability provisions of the federal securities laws of the United States or any state of the United States.

 

Although there is no statutory enforcement in the Cayman Islands of judgments obtained in the United States, the courts of the Cayman Islands will, based on the principle that a judgment by a competent foreign court will impose upon the judgment debtor an obligation to pay the sum for which judgment has been given, recognize and enforce a foreign judgment of a court of competent jurisdiction if such judgment is final, for a liquidated sum, not in respect of taxes or a fine or penalty if not inconsistent with a Cayman Islands judgment in respect of the same matters, and was not obtained in a manner, and is not of a kind, the enforcement of which is contrary to the public policy of the Cayman Islands. There is doubt, however, as to whether the courts of the Cayman Islands will, in an original action in the Cayman Islands, recognize or enforce judgments of U.S. courts predicated upon the civil liability provisions of the securities laws of the United States or any state of the United States on the grounds that such provisions are penal in nature. Furthermore, a Cayman Islands court may stay proceedings if concurrent proceedings are being brought elsewhere.

 

22
 

 

Unlike many jurisdictions in the United States, Cayman Islands law does not specifically provide for shareholder appraisal rights on a merger or consolidation of an entity. This may make it more difficult for shareholders to assess the value of any consideration they may receive in a merger or consolidation or to require that the offeror give a shareholder additional consideration if he believes the consideration offered is insufficient. In addition, shareholders of Cayman Islands exempted companies such as ours have no general rights under Cayman Islands law to inspect corporate records and accounts. Our directors have discretion under our Articles to determine whether or not, and under what conditions, the corporate records may be inspected by shareholders, but are not obligated to make them available to shareholders. This fact may make it more difficult for shareholders to obtain the information needed to establish any facts necessary for a shareholder motion or to solicit proxies from other shareholders in connection with a proxy contest. Finally, subject to limited exceptions, under Cayman Islands law, a minority shareholder may not bring a derivative action against our Board of Directors.

 

Provisions of our Articles may reallocate the voting power of our ordinary shares.

 

In certain circumstances, the total voting power of our ordinary shares held by any one person will be reduced to less than 9.9% of the total voting power of the total issued and outstanding ordinary shares. In the event a holder of our ordinary shares acquires shares representing 9.9% or more of the total voting power of our total ordinary shares, there will be an effective reallocation of the voting power of the ordinary shares as described in the Articles.

 

We do not currently have an effective registration statement registering the issuance of the shares underlying our publicly traded warrants, and therefore you may not be able to exercise the warrants in a cash exercise.

 

For you to be able to effect a cash exercise of our publicly traded warrants, the sale of the ordinary shares to be issued to you upon exercise of the warrants must be covered by an effective and current registration statement. We have not maintained a current registration statement relating to the sale of the shares of common stock underlying the warrants. As a result, you would be unable to exercise the warrants in a cash exercise and will be required to engage in a cashless exercise in which a number of warrant shares equal to the fair market value of the exercised shares will be withheld. In those circumstances, we may, but are not required to, redeem the warrants by payment in cash. Consequently, there is a possibility that you will never be able to exercise the warrants and receive the underlying ordinary shares. This potential inability to exercise the warrants in a cash exercise, our right to cancel the warrants under certain circumstances, and the possibility that we may redeem the warrants for nominal value, may have an adverse effect on demand for the warrants and the prices that can be obtained from reselling them.

 

Risks Relating to Taxation

 

We may become subject to taxation in the Cayman Islands which would negatively affect our results.

 

Under current Cayman Islands law, we are not obligated to pay any taxes in the Cayman Islands on either income or capital gains. The Governor-in-Cabinet of Cayman Islands has granted us an exemption from the imposition of any such tax on us for twenty years from April 23, 2013. We cannot be assured that after such date we would not be subject to any such tax. If we were to become subject to taxation in the Cayman Islands, our financial condition and results of operations could be significantly and negatively affected.

 

We may be subject to United States federal income taxation.

 

We are incorporated under the laws of the Cayman Islands and intend to operate in a manner that will not cause us to be treated as engaging in a United States trade or business and will not cause us to be subject to current United States federal income taxation on our income. However, because there are no definitive standards provided by the Internal Revenue Code of 1986, as amended (the “Code”), regulations or court decisions as to the specific activities that constitute being engaged in the conduct of a trade or business within the United States, and as any such determination is essentially factual in nature, we cannot assure you that the United States Internal Revenue Service, or the IRS, will not successfully assert that we are engaged in a trade or business in the United States and thus are subject to current United States federal income taxation.

 

23
 

 

We may be treated as a PFIC, in which case a U.S. holder of our ordinary shares should be subject to disadvantageous rules under U.S. federal income tax laws.

 

Significant potential adverse United States federal income tax consequences generally apply to any United States person who owns shares in a “passive foreign investment company”, or PFIC. In general, a non-U.S. corporation is classified as a PFIC for a taxable year in which, after taking into account the income and assets of the corporation and certain subsidiaries pursuant to certain look-through rules, either (i) 75% or more of its gross income is passive income, or (ii) 50% or more of the average quarterly value of its gross assets is attributable to assets that produce passive income or are held for the production of passive income.

 

Passive income generally includes interest, dividends and other investment income. However, the income derived in the active conduct of an insurance business is excluded from the term “passive income” if (i) for years before 2021, the income is earned by a corporation that is predominantly engaged in an insurance business, and (ii) for years after 2021, the income is earned by a “qualifying insurance corporation”. In order for a non-U.S. property and casualty insurance company to be treated as a “qualifying insurance corporation” for a taxable year, the company’s “applicable insurance liabilities” generally must be greater than 25% of the company’s assets for the taxable year. In the case of a non-U.S. property and casualty insurance company, the term “applicable insurance liabilities” means the amount of loss and loss adjustment expenses, but shall not exceed the amount reported to the applicable regulator in an applicable financial statement. It is not clear whether the term “applicable insurance liabilities” includes not only the unpaid loss and loss adjustment expenses, but also includes the paid loss and loss adjustment expenses during the taxable year. If each of Oxbridge Reinsurance Limited and Oxbridge Re NS is a “qualified insurance corporation” for a taxable year, then neither Oxbridge Re Holdings Limited, nor Oxbridge Reinsurance Limited, nor Oxbridge Re NS should be deemed to be a PFIC for the taxable year.

 

Regardless of whether the term “applicable insurance liabilities” includes not only the unpaid loss and loss adjustment expenses but also the paid loss and loss adjustment expenses, we believe that each of Oxbridge Reinsurance Limited and Oxbridge Re NS met the requirements for being a “qualified insurance corporation” for the 2023 and 2022 years. For years prior to 2022, we also believe that each of those corporations met the requirement of being predominantly engaged in an insurance business. Accordingly, we believe that we have not been a PFIC during 2023 or prior years. We do not have an expectation, however, as to whether or not we may be a PFIC in years after 2023. If you are a United States person, we urge you to consult your own tax advisor concerning the potential tax consequences to you under the PFIC rules.

 

We may be treated as a CFC and may be subject to the rules for related person insurance income, and in either case this may subject a U.S. holder of our ordinary shares to disadvantageous rules under U.S. federal income tax laws.

 

Controlled Foreign Corporation. United States persons who, directly or constructively through attribution rules, own 10% or more of the voting power or value of our ordinary shares, which we refer to as United States 10% shareholders, may be subject to the controlled foreign corporation, or CFC, rules. Under the controlled foreign corporation rules of the Code, each United States 10% shareholder must annually include his pro rata share of the controlled foreign corporation’s ‘‘Subpart F income,’’ even if no distributions are made. In general, a foreign insurance company will be treated as a controlled foreign corporation only if United States 10% shareholders collectively own, directly or constructively, more than 25% of the total combined voting power or total value of the company’s shares. If you are a United States person we urge you to consult your own tax advisor concerning the controlled foreign corporation rules. We believe that certain United States persons may be deemed to own, directly or constructively (including through the ownership of warrants), 10% or more of the voting power or value of our ordinary shares, and we believe that those United States persons collectively own, directly or constructively, more than 25% of the voting power or value of our ordinary shares.

 

Related Person Insurance Income. A different definition of CFC is applicable in the case of a foreign corporation which earns “related person insurance income” (“RPII”). RPII is a Code Subpart F insurance income attributable to insurance policies or reinsurance contracts where the person that is directly or indirectly insured or reinsured is a RPII shareholder or a related person to the RPII shareholder. A “RPII shareholder” is a United States person who owns, directly or indirectly through foreign entities, any amount of our ordinary shares. Generally, for purposes of the RPII rules, a related person is someone who controls or is controlled by the RPII shareholder or someone who is controlled by the same person or persons which control the RPII shareholder. Control is measured by either more than 50% in value or more than 50% in voting power of shares after applying certain constructive ownership rules. For purposes of taking into account RPII, and subject to the exceptions described below, Oxbridge Reinsurance Limited or Oxbridge Re NS will be treated as a CFC if our RPII shareholders collectively own, indirectly, 25% or more of the total combined voting power or value of their respective shares on any day during a taxable year. If Oxbridge Reinsurance Limited or Oxbridge Re NS is a CFC at any time during a taxable year under the special RPII rules, any U.S. Holder that owns ordinary shares on the last day of any such taxable year must include in gross income for U.S. federal income tax purposes the U.S. Holder’s allocable share of the RPII of Oxbridge Reinsurance Limited for the entire taxable year, subject to certain modifications. Among other exceptions, the RPII rules do not apply if the insurance company’s RPII, determined on a gross basis, is less than 20% of such respective entity’s gross insurance income for such taxable year. We do not believe that the 20% gross insurance income threshold will be met. However, we cannot assure you that this is or will continue to be the case. Consequently, we cannot assure you that a person who is a direct or indirect United States shareholder will not be required to include amounts in its income in respect of RPII in any taxable year.

 

24
 

 

United States tax-exempt organizations who own ordinary shares may recognize unrelated business taxable income.

 

If you are a United States tax-exempt organization you may recognize unrelated business taxable income if a portion of our Code Subpart F insurance income is allocated to you. In general, Code Subpart F insurance income will be allocated to you if we are a CFC as discussed above and you are a United States 10% shareholder or there is related person insurance income and certain exceptions do not apply. If you are a United States tax-exempt organization, we advise you to consult your own tax advisor regarding the risk of recognizing unrelated business taxable income.

 

Changes in United States tax laws may be retroactive and could subject us, and/or United States persons who own ordinary shares to United States income taxation on our undistributed earnings.

 

The tax laws and interpretations regarding whether a company is engaged in a United States trade or business, is a CFC, has RPII, or is a PFIC are subject to change, possibly on a retroactive basis. There are currently no regulations regarding the application of the PFIC rules to an insurance company and the regulations regarding RPII are still in proposed form. New regulations or pronouncements interpreting or clarifying such rules may be forthcoming from the IRS. We are not able to predict if, when or in what form such guidance will be provided and whether such guidance will have a retroactive effect.

 

We do not intend to resume paying cash dividends in the foreseeable future.

 

On November 12, 2017, our board of directors decided to suspend our regular quarterly cash dividend. The board of directors intends to reconsider in the future the payment of a quarterly cash dividend, but the timing of such reconsideration has not been determined, and there is no intention to resume dividend payments in the foreseeable future, if at all. Any decision to resume dividend payments will be dependent upon a variety of factors, including the state of our business as well as general market conditions at the time of reconsideration, and there is no assurance that dividend payments will recommence.

 

Outages, computer viruses and similar events could disrupt our operations.

 

We rely on information technology networks and systems, some of which are owned and operated by third parties, to process, transmit and store electronic information. Any of these systems may be susceptible to outages due to fire, floods, power loss, telecommunications failures, terrorist or cyber-attacks and similar events. Despite the implementation of network security measures, our systems and those of third parties on which we rely may also be vulnerable to computer viruses and similar disruptions. If we or the third parties on whom we rely are unable to prevent such outages and breaches, our operations could be disrupted.

 

Increased Information Technology (“IT”) security threats and more sophisticated computer crime could pose a risk to our systems, networks, and services.

 

Cyber incidents can result from deliberate attacks or unintentional events. There have been an increased number of significant cyber-attacks targeted at the retail, insurance, financial and banking industries that include, but are not limited to, gaining unauthorized access to digital systems for purposes of misappropriating assets or sensitive information, corrupting data or causing operational disruption. Cyber-attacks may also be carried out in a manner that does not require gaining unauthorized access, such as by causing denial-of-service attacks on websites. Cyber-attacks by third parties or insiders utilize techniques that range from highly sophisticated efforts to electronically circumvent network security or overwhelm a website to more traditional intelligence gathering, and social engineering aimed at obtaining information necessary to gain access.

 

25
 

 

Increased global IT security threats are more sophisticated and targeted computer crimes pose a risk to the security of our systems and networks and the confidentiality, availability and integrity of our data. The open nature of interconnected technologies may allow for a network or Web outage or a privacy breach that reveals sensitive data or transmission of harmful/malicious code to business partners and clients. Because the techniques used to obtain unauthorized access, disable, or degrade service, or sabotage systems change frequently and may be difficult to detect for long periods of time, we may be unable to anticipate these techniques or implement adequate preventive measures.

 

Cyber-attacks may result in substantial financial and reputational cost, including but are not limited to:

 

  Compromising of confidential information;
  Manipulation and destruction of data;
  Loss of trade secrets;
  System downtimes and operational disruptions;
  Remediation costs that may include liability for stolen assets or information and repairing system damage, as well as incentives offered to business partners in an effort to maintain business relationships;
  Loss of revenues resulting from unauthorized use of proprietary information;
  Cost to deploy additional protection strategies, training employees and engaging third party experts and consultants;
  Reputational damage adversely affecting investor confidence; and
  Costly litigation.

 

The control environment for cybersecurity is an ever-changing risk landscape across the entire attack surface which includes risks from on-premises, cloud infrastructure, software as a service and mobile applications. While we attempt to mitigate these risks by employing a number of cybersecurity measures, such measures may be insufficient to prevent a cyberattack and our systems, networks, and services remain potentially vulnerable to advanced threats.

 

Increased scrutiny by and changing expectations from investors, employees, and other stakeholders regarding our environmental, social, and governance (“ESG”) practices and reporting could cause us to incur additional costs and adversely impact our reputation, tenant and employee acquisition and retention, and access to capital.

 

Companies across all industries are facing increasing scrutiny related to their ESG practices and disclosure. Investors, employees, and other stakeholders have begun to focus increasingly on ESG practices and to place heightened importance on the environmental and social cost of their investments, business decisions and consumer choices. For example, an increasing number of investment funds focus on positive ESG practices and sustainability scores when making an investment decision. Additionally, certain institutional investors have demonstrated increased activism with respect to their existing investments, including by urging companies to take certain actions in areas of perceived ESG significance.

 

Investors, particularly institutional investors, use or may use third-party benchmarks and scores to assess our ESG practices against our peers and if we are perceived as lagging, such investors may decide to not invest in our ordinary shares or to divest from their current investment, and we may face reputational challenges. Alternatively, such investors may decide to actively engage with us to improve ESG disclosure or performance, and may also make voting decisions on this basis. Given increased investor focus and demand, public disclosure regarding ESG practices is becoming more broadly expected. Any disclosure we make may include our policies and practices on a variety of ESG matters, including corporate governance, environmental compliance, human capital management, and workforce inclusion and diversity. It is possible that stakeholders may not be satisfied with our ESG practices, reporting and goals, or with our speed of adoption. If our ESG practices and disclosures do not meet investor, tenant, employee or other stakeholder expectations, which continue to evolve, our reputation and employee retention, and access to capital may be negatively impacted.

 

In 2022, the SEC proposed extensive rules aimed at enhancing and standardizing climate-related disclosures in an effort to foster greater consistency, comparability and reliability of climate-related information among public issuers. In March 2024, the SEC adopted final rules which will require public issuers to include prescribed climate-related information in their registration statements and annual reports, including information regarding greenhouse gas emissions and climate-related risks and opportunities and related financial impacts, governance and strategy. Additionally, we may become subject to new compliance requirements and/or new costs or taxes associated with natural resource or energy usage and related emissions (such as a “carbon tax”), which could increase our operating costs.

 

26
 

 

We could incur additional costs relating to implementing, monitoring and reporting various ESG practices and initiatives, as well as complying with applicable law, which could place a strain on our personnel, systems and resources. Our failure, or perceived failure, to meet the goals and objectives we set in any ESG disclosure within the timelines announced or at all, or the expectations of our various stakeholders could negatively impact our reputation, tenant and employee retention, and access to capital.

 

ITEM 1B UNRESOLVED STAFF COMMENTS

 

The Company has no unresolved written comments regarding its periodic or current reports from the staff of the SEC.

 

ITEM 1C CYBERSECURITY

 

Governance

 

Cybersecurity is an integral part of the Board’s risk analysis and discussions with management. At least annually, the full Board is updated on the Company’s cybersecurity risks and risk mitigation strategy by our Chief Information Officer (“CIO”), who is responsible for management of our Information Technology program. The Board also receives ad hoc updates, as needed, about material changes to the Company’s cybersecurity program and/or the cybersecurity landscape, including briefings on major legislative and regulatory developments.

 

Our CIO regularly evaluates the Company’s cybersecurity risk profile and leads the development of strategies to mitigate risks and address cybersecurity issues that may arise in consultation with members of our senior management team. Our CIO holds a Ph.D. in Information Systems from the London School of Economics and has over 20 years’ experience and certifications in the field of information technology and data security.

 

We have formal policies and procedures that address cybersecurity incident response and disaster recovery from interference with our critical applications. Our Cybersecurity Incident Response Standard provides a documented framework for responding to cybersecurity incidents in coordination across multiple departments. In the event of such an incident, our Cybersecurity Incident Response Team (“CIRT”), which is comprised of our CIO, Chief Executive Officer, Chief Financial Officer, and outside legal counsel, would respond to such incident in accordance with our Cybersecurity Incident Response Standard. Any cybersecurity incident that is designated by the CIRT with a “High” severity classification according to the Cybersecurity Incident Response Standard or that otherwise necessitates regulatory disclosure because of its materiality, will be communicated by the CIRT to the Board within specified timeframes. All cybersecurity incidents, will be evaluated by our CIRT to assess the impact of the incident on the Company, considering qualitative and quantitative factors. In conducting this assessment and responding to an incident, the CIRT Team may utilize the services of third-party consultants. Third-party consultants may be engaged to assist with the identification of the source of any cybersecurity incidents, remediation and recovery from such incident, and the refinement of cybersecurity controls to avert similar future cybersecurity threats and incidents.

 

Cybersecurity user awareness training is mandatory for all new hires and for existing employees on an annual basis to help protect our employees and the Company against cybersecurity threats. Novel cybersecurity threats to the Company that are identified by our CIO are communicated to all employees by email, as needed, in an effort to promote awareness and protect the Company from cyber attacks.

 

Risk Management Strategy

 

We maintain an Enterprise Risk Management (“ERM”) program to identify and respond to the most critical risks to our business, including cybersecurity risks. Risks and vulnerabilities from our increased reliance on information technology systems are assessed at least annually by our CIO and Executive Management Team as part of our ERM program. In response to such assessments, controls are embedded into our processes and technology by our CIO and Executive Management Team to seek to mitigate risks to our systems and processes from cybersecurity incidents. We continuously evaluate whether we have adequate controls in place utilizing a risk-based approach that tailors and applies best practice from various industry standard IT Management frameworks such as Information Technology Infrastructure Library (ITIL), Control Objectives for Information Technologies (COBIT), National Institute of Standards and Technology CyberSecurity Framework, and ISO/IEC 27001.

 

Our daily operations are continuously monitored. We monitor traffic traversing our computer networks and have implemented IT controls and processes to secure our business applications and prevent unauthorized access to or the loss of sensitive data. Our controls include the use of multiple encryption layers for data in transit and at rest, multi-factor authentication, data classification, and data loss prevention. We plan to assess the adequacy of our cybersecurity IT controls through annual cybersecurity vulnerability testing.

 

27
 

 

We maintain a risk-based approach to evaluating and overseeing cybersecurity risks presented by our third-party vendors. Third-party vendors that meet certain criteria, such as owning and operating any information technology networks and systems on which the Company relies, are evaluated to assess their performance across several domains, including data security and operations management. We seek to maintain effective communication with our third-party vendors to facilitate timely notification of cybersecurity incidents that might impact the Company. We also independently monitor reputable cybersecurity publications for notifications about vulnerabilities in widely used software libraries, APIs, and other generally available technologies upon which our third-party vendors’ products might rely.

 

Although risks from cybersecurity threats have to date not materially affected, and we do not believe they are reasonably likely to materially affect, us, our business strategy, results of operations or financial condition, like other companies in our industry, we could, from time to time, experience threats and security incidents related to our and our third-party vendors’ information systems. For more information, please see “Item 1A. Risk Factors - Increased Information Technology (“IT”) security threats and more sophisticated computer crime could pose a risk to our systems, networks, and services.”

 

ITEM 2 PROPERTIES

 

We currently lease office space at Suite 201, 42 Edward Street, Georgetown, Grand Cayman. This lease expires in February 2027. We believe that our current office is suitable and sufficient for us to conduct our operations for the foreseeable future.

 

ITEM 3 LEGAL PROCEEDINGS

 

We are not currently involved in any litigation or arbitration. We anticipate that, similar to the rest of the insurance and reinsurance industry, we will be subject to litigation and arbitration in the ordinary course of business.

 

ITEM 4 MINE SAFETY DISCLOSURES

 

Not applicable.

 

PART II

 

ITEM 5 MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED SHAREHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

 

Market Information for Ordinary Shares

 

The Company’s ordinary shares and warrants are listed on The NASDAQ Capital Market under the symbols “OXBR” and “OXBRW,” respectively.

 

Holders of Record and Tax Information

 

As of March 26, 2024, there were 13 holders of record of our ordinary shares. There are no current applicable Cayman Islands laws, decrees or regulations relating to restrictions on the import or export of capital or exchange controls affecting remittances of dividends, interest and other payments to non-resident holders of our ordinary shares. There are no existing laws or regulations of the Cayman Islands imposing taxes or containing withholding provisions to which United States holders of our ordinary shares are subject. There are no reciprocal tax treaties between the Cayman Islands and the United States.

 

Dividend Policy

 

The declaration and payment of dividends will be at the discretion of our Board of Directors and will depend on our results of operations and cash flows, our financial position and capital requirements, general business conditions, rating agency guidelines (if applicable), any legal, tax, regulatory and contractual restrictions on the payment of dividends, and any other factors considered relevant by our Board of Directors. Our ability to pay dividends will also depend on the requirements of any future financing agreements to which we may be a party and the ability of our reinsurance subsidiaries, or other subsidiaries, to pay dividends to us. Although Oxbridge Re Holdings Limited is not subject to any significant legal prohibitions on the payment of dividends, Oxbridge Reinsurance Limited and Oxbridge Re NS, our reinsurance subsidiaries, are subject to Cayman Islands regulatory constraints that affect their ability to pay dividends to us and include a minimum net worth requirement. Currently, the minimum net worth requirement for Oxbridge Reinsurance Limited and Oxbridge Re NS is $500. As of December 31, 2023, both subsidiaries exceeded the minimum requirement. By law, Oxbridge Reinsurance Limited and Oxbridge Re NS is restricted from paying a dividend if such a dividend would cause its net worth to drop to less than the required minimum.

 

28
 

 

We paid no dividends in both 2023 and 2022.

 

Any future determination to declare cash dividends will be made at the discretion of our Board of Directors, subject to applicable laws, and will depend on a number of factors, including our financial condition, results of operations, capital requirements, contractual restrictions, general business conditions and other factors that our Board of Directors may deem relevant.

 

Unregistered Sales of Equity Securities

 

There were no unregistered sales of equity securities by us during the year ended December 31, 2023, other than as previously disclosed in our Current Report on Form 8-K filed with the SEC on June 28, 2023.

 

Issuer Purchases of Equity Securities

 

The Company did not repurchase any ordinary shares or warrants in 2023.

 

ITEM 6 [RESERVED]

 

Not applicable.

 

ITEM 7 MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The following management discussion and analysis is intended to help the reader understand our business, financial condition, results of operations, liquidity and capital resources. You should read this discussion in conjunction with our Consolidated Financial Statements and the related notes contained elsewhere in this Annual Report on Form 10-K for the fiscal year ended December 31, 2023.

 

This discussion contains forward-looking statements that are not historical facts, including statements about our beliefs and expectations. These statements are based upon current plans, estimates and projections. Our actual results may differ materially from those projected in these forward-looking statements as a result of various factors. See “Forward Looking Statements” appearing at the beginning of this Annual Report on Form 10-K and Item 1A, “Risk Factors.”

 

General

 

The following is a discussion and analysis of our results of operations for the years ended December 31, 2023 and 2022 and our financial condition as of December 31, 2023 and 2022. The following discussion should be read in conjunction with our consolidated financial statements and related notes included elsewhere in this Annual Report on Form 10-K. References to “we,” “us,” “our,” “our company,” or “the Company” refer to Oxbridge Re Holdings Limited and its wholly-owned subsidiaries, Oxbridge Reinsurance Limited, Oxbridge Re NS, SurancePlus Holdings Ltd., SurancePlus, Inc. and DSN Blockchain Technologies Ltd., unless the context dictates otherwise.

 

Overview and Trends

 

We are a Cayman Islands specialty property and casualty reinsurer that provides reinsurance solutions through our reinsurance subsidiaries, Oxbridge Reinsurance Limited and Oxbridge Re NS. We focus on underwriting fully collateralized reinsurance contracts primarily for property and casualty insurance companies in the Gulf Coast region of the United States, with an emphasis on Florida. We specialize in underwriting medium frequency, high severity risks, where we believe sufficient data exists to analyze effectively the risk/return profile of reinsurance contracts. Oxbridge Re NS functions as a reinsurance sidecar which increases the underwriting capacity of Oxbridge Reinsurance Limited. Oxbridge Re NS issues participating notes to third party investors, the proceeds of which are utilized to collateralize Oxbridge Reinsurance Limited’s reinsurance obligations.

 

29
 

 

In addition to our historical reinsurance business operations, in 2023, our new subsidiary, SurancePlus, began developing, offering, and selling a tokenized reinsurance security representing fractionalized interests in reinsurance contracts, with each token representing an interest in participating notes issued by Oxbridge Re NS. These efforts culminated in the development, launch, and issuance of our first tokenized reinsurance security, the DeltaCat Re Token, which we believe is the first “on-chain” reinsurance security of its kind to be developed by a subsidiary of a public company. Following the issuance of the DeltaCat Re Token, we intend to develop, launch, and issue additional series of tokenized reinsurance securities representing fractional interests in reinsurance contracts, and we are also using our tokenization experience and activities as a foundation for developing Web3-focused business offerings and products relating to the tokenization of other RWAs, including RWAs held or being acquired by third parties. Our tokenization business will be conducted through SurancePlus and through other subsidiaries of our wholly owned subsidiary, SurancePlus Holdings Ltd. (“SurancePlus Holdings”), [a Cayman Islands exempted company] that we have organized to serve as a holding company for subsidiaries that will operate our developing Web3-focused business operations.

 

In our historical reinsurance business operations, we underwrite reinsurance contracts on a selective and opportunistic basis as opportunities arise based on our goal of achieving favorable long-term returns on equity for our shareholders. Our goal is to achieve long-term growth in book value per share by writing business that generates attractive underwriting profits relative to the risk we bear. Additionally, we complement our underwriting profits with investment profits on an opportunistic basis. Our underwriting business focus is on fully collateralized reinsurance contracts for property catastrophes, primarily in the Gulf Coast region of the United States, with an emphasis on Florida. Within that market and risk category, we attempt to select the most economically attractive opportunities across a variety of property and casualty insurers. As our capital base grows, however, we expect that we will consider further growth opportunities in other geographic areas and risk categories.

 

Our level of profitability in our historical reinsurance business is primarily determined by how adequately our premiums assumed and investment income cover our costs and expenses, which consist primarily of acquisition costs and other underwriting expenses, claim payments and general and administrative expenses. One factor leading to variation in our operational results is the timing and magnitude of any follow-on offerings we undertake (if any), as we are able to deploy new capital to collateralize new reinsurance treaties and consequently, earn additional premium revenue. In addition, our results of operations may be seasonal in that hurricanes and other tropical storms typically occur during the period from June 1 through November 30. Further, our results of operations may be subject to significant variations due to factors affecting the property and casualty insurance industry in general, which include competition, legislation, regulation, general economic conditions, judicial trends, and fluctuations in interest rates and other changes in the investment environment.

 

Because we employ an opportunistic underwriting and investment philosophy, period-to-period comparisons of our underwriting results may not be meaningful. In addition, our historical investment results may not necessarily be indicative of future performance. Due to the nature of our reinsurance and investment strategies, our operating results will likely fluctuate from period to period.

 

Compared to most of our competitors, we are small and have low overhead expenses. We believe that our expense efficiency, agility and existing relationships support our competitive position and allows us to profitably participate in lines of business that fit within our strategy. Over time we expect our expense advantage could erode as the industry seeks to reduce frictional costs.

 

Recent Developments

 

Formation of SurancePlus

 

SurancePlus, an indirect wholly-owned subsidiary of the Company, was incorporated as a British Virgin Islands Business Company on December 19, 2022 for the purpose of tokenizing reinsurance contracts underwritten by its affiliated licensed reinsurer, Oxbridge Re NS.

 

On March 27, 2023, we, through SurancePlus, issued a press release announcing the commencement of an offering by SurancePlus of up to $5.0 million of DeltaCat Re Tokens with a purchase price of $10.00 per DeltaCat Re Token and representing one share of Series DeltaCat Re Preferred Shares per DeltaCat Re Token (the “Private Placement”).

 

On June 27, 2023, SurancePlus completed the Private Placement. The aggregate amount raised in the Private Placement was $2,447,760 for the issuance of 244,776 DeltaCat Re Tokens, of which approximately $1,280,000 was received from third-party investors and approximately $1,167,000 was received from Oxbridge Re Holdings Limited.

 

On September 11, 2023, the DeltaCat Re tokens were reclassified as tokenized interests carrying rights equivalent to the DeltaCat Re Preferred Shares in accordance with the provisions of British Virgin Islands law.

 

30
 

 

Oxbridge Acquisition Corp.

 

On February 28, 2023, the Company announced in a press release that Oxbridge Acquisition Corp. (“Oxbridge Acquisition”) filed a Current Report on Form 8-K with the Securities and Exchange Commission in connection with Oxbridge Acquisition’s business combination with Jet Token Inc., a Delaware corporation. Upon the closing of the transaction, the combined company became Jet.AI Inc. (“Jet.AI”). Jet.AI offers fractional aircraft ownership, jet card, aircraft brokerage and charter service through its fleet of private aircraft and those of Jet.AI’s Argus Platinum operating partner. Jet AI’s charter app enables travelers to look, book and fly. The funding and capital markets access from this transaction is expected to enable Jet.AI to continue its growth strategy of AI software development and fleet expansion. The business combination was completed on August 10, 2023.

 

The Company’s wholly-owned licensed reinsurance subsidiary, Oxbridge Reinsurance Limited (“Oxbridge Reinsurance”), was the lead investor in Oxbridge Acquisition’s sponsor and currently indirectly holds the equivalent of 1,423,827 of Jet.AI common stock (NASDAQ: JTAI), 3,094,999 of Jet.AI public warrants (NASDAQ: JTAIW) and 285 of Jet.AI Series A-1 Convertible Preferred Stock with purchase price of $285,000.

 

Bridge Loan with Affiliate

 

On September 11, 2023, the Company, along with seven (7) other investors, entered into a binding term sheet (“Bridge Agreement”) with Jet.AI to provide Jet.AI with an aggregate sum of $500,000 of short-term bridge financing pending its receipt of funds from its other existing financing arrangements. During the month of September 2023, and prior to the Bridge Agreement, Jet.AI had engaged in discussions with numerous third parties to secure short-term bridge funding but was not offered terms it found acceptable.

 

The Bridge Agreement provides for the issuance of Notes in an aggregate principal amount of $625,000, reflecting a 20% original issue discount. The Notes bear interest at 5% per annum and mature on March 11, 2024. Jet.AI is required to redeem the Notes with 100% of the proceeds of any equity or debt financing at a redemption premium of 110% of the principal amount of the Notes. Jet.AI anticipates redeeming the Notes in full with proceeds expected to be received over the next several months from existing financing arrangements.

 

An event of default under the Notes includes failing to redeem the Notes as provided above and other typical bankruptcy events of Jet.AI. In an event of default, the outstanding principal amount of the Notes will increase by 120%, and the company may convert its Note into shares of common stock of Jet.AI at the conversion price set forth in the Bridge Agreement with registration rights associated with those shares.

 

The Company invested the sum of $100,000 in the Notes and is recorded as “Loan Receivable” on the consolidated balance sheets at cost. On March 11, 2024, the Notes matured and were redeemed by Jet.AI in accordance with the Bridge Agreement. The Company receive an aggregate of $140,000 upon the redemption of the Notes.

 

31
 

 

PRINCIPAL REVENUE AND EXPENSE ITEMS

 

Revenues

 

We derive our most significant revenues from three principal sources:

 

  premiums assumed from reinsurance on property and casualty business;
  income from investments and unrealized (loss)/ gain on other investments;
  income under our Administrative Services Agreement
  income from SurancePlus ITOM fees

 

Premiums Assumed

 

Premiums assumed include all premiums received by a reinsurance company during a specified accounting period, even if the policy provides coverage beyond the end of the period. Premiums are earned over the term of the related policies. At the end of each accounting period, the portion of the premiums that are not yet earned are included in the unearned premiums reserve and are realized as revenue in subsequent periods over the remaining term of the policy. Our policies typically have a term of twelve months. Thus, for example, for a policy that is written on July 1, 2023, typically one-half of the premiums will be earned in 2023 and the other half will be earned during 2024. However, in the event of limit losses on our policies, premium recognition will be accelerated to match losses incurred in the period, when there is no possibility of any future treaty-year losses under the contracts.

 

Premiums from reinsurance on property and casualty business assumed are directly related to the number, type and pricing of contracts we write.

 

Premiums assumed are recorded net of change in loss experience refund, which consists of changes in amounts due to the cedants under two of our reinsurance contracts. These contracts contain retrospective provisions that adjust premiums in the event losses are minimal or zero. We recognize a liability pro-rata over the period in which the absence of loss experience obligates us to refund premiums under the contracts, and we will derecognize such liability in the period in which a loss experience arises. The change in loss experience refund is negatively correlated to loss and loss adjustment expenses described below.

 

Investment Income

 

Income from our investments is primarily comprised of net realized and unrealized gains (losses) interest income and dividends on investment securities. Such income is primarily from the Company’s investments, which includes other investments in Jet.AI and investments held in trust accounts that collateralize the reinsurance policies that we write. The investment parameters for trust accounts are generally be established by the cedant for the relevant policy.

 

Administrative Services Agreement

 

Commencing on the effective date of the SPAC’s IPO, the Sponsor agreed to pay the Company a total of up to $10,000 per month for office space, utilities, secretarial and administrative support to the Sponsor and the SPAC. Upon completion of the SPAC’s initial Business Combination or the SPAC’s liquidation, the Sponsor will cease paying these monthly fees. For the year ended December 31, 2023, the Company received $80,000, and recorded income of $80,000 from the Sponsor under the Administrative Services Agreement, which is included in “net investment and other income” in the consolidated statements of operations.

 

32
 

 

Incentive, Technology, Origination and Management Fee Income

 

During the year ended December 31, 2023, the Company’s subsidiary, SurancePlus, entered into subscription agreements for the sale of DeltaCat Re Tokens representing fractionalized interest in reinsurance contracts underwritten by Oxbridge Re NS. The DeltaCat Re Tokens were issued on the Avalanche blockchain.

 

SurancePlus receives an incentive, technology, origination and management (“ITOM”) fee to cover costs associated with origination, structuring and the blockchain technology related to the DeltaCat Re Tokens. These fees are included in SurancePlus fees income line item in the consolidated statement of operations.

 

Expenses

 

Our expenses consist primarily of the following:

 

  losses and loss adjustment expenses;
     
  policy acquisition costs and underwriting expenses; and
     
  general and administrative expenses.

 

Loss and Loss Adjustment Expenses

 

Loss and loss adjustment expenses are a function of the amount and type of reinsurance contracts we write and of the loss experience of the underlying coverage. As described below, loss and loss adjustment expenses are based on the claims reported by our Company’s ceding insurers, and may include an actuarial analysis of the estimated losses, including losses incurred during the period and changes in estimates from prior periods. Depending on the nature of the contract, loss and loss adjustment expenses may be paid over a period of years.

 

Policy Acquisition Costs and Underwriting Expenses

 

Policy acquisition costs and underwriting expenses consist primarily of brokerage fees, ceding commissions, premium taxes and other direct expenses that relate to our writing of reinsurance contracts. We amortize deferred acquisition costs over the related contract term.

 

General and Administrative Expenses

 

General and administrative expenses consist of salaries and benefits and related costs, including costs associated with our professional fees, rent and other general operating expenses consistent with operating as a public company.

 

33
 

 

RESULTS OF OPERATIONS

 

The following table summarizes our results of operations for the years ended December 31, 2023 and 2022 (dollars in thousands, except per share amounts):

 

   Years Ended December 31, 
   2023   2022 
         
Revenue          
Assumed premiums  $2,170    645 
Change in unearned premiums reserve   (915)   350 
           
Net premiums earned   1,255    995 
Net investment and other income   303    201 
Management fee income   300    - 
Net realized investment gain   -    27 
Unrealized loss on other investments   (8,945)   (35)
Change in fair value of equity securities   38    (338)
           
Total revenue   (7,049)   850 
           
Expenses          
Losses and loss adjustment expenses   -    1,073 
Policy acquisition costs and underwriting expenses   141    110 
General and administrative expenses   2,183    1,413 
           
Total expenses   2,324    2,596 
           
Loss before income attributable to noteholders   (9,373)   (1,746)
           
Income attributable to noteholders   (542)   (43)
           
Net loss  $(9,915)   (1,789)
           
Loss per share          
Basic and Diluted  $(1.69)   (0.31)
           
Weighted-average shares outstanding          
Basic and Diluted   5,867,129    5,772,396 
           
Performance ratios to net premiums earned:          
Loss ratio   0.0%   107.8%
Acquisition cost ratio   11.2%   11.0%
Expense ratio   185.2%   153.1%
Combined ratio   185.2%   260.9%

 

Comparison of the Year Ended December 31, 2023 to Year Ended December 31, 2022

 

General. Net loss for the year ended December 31, 2023 was $9.9 million or $1.69 basic and diluted loss per share compared to a net loss of $1.8 million or $0.31 basic and diluted earnings per share for the year ended December 31, 2022. The increase in loss is due primarily to an increase in unrealized losses on the Company’s investment in Jet.AI and increased general expenses associated with the launch of SurancePlus during the year ended December 31, 2023, when compared with the prior year.

 

Premium Income. Net premiums earned typically reflects the pro-rata inclusion into income of premiums assumed over the life of the reinsurance contracts. Net premiums earned for the year ended December 31, 2023 increased $260,000, to $1.26 million, from $995,000 for the year ended December 31, 2022. The increase is due to the higher rates on reinsurance contracts during the year ended December 31, 2023, when compared to the prior year.

 

34
 

 

Losses Incurred. Losses incurred for the year ended December 31, 2023 decreased to $0 from $1.07 million, for the year ended December 31, 2022. The decrease during the year is wholly due to the triggering of a limit loss on two of the Company’s reinsurance contracts, due to the impact of Hurricane Ian on our book of business in September 2022.

 

Policy Acquisition Costs and Underwriting Expenses. Acquisition costs represent the amortization of the brokerage fees and federal excise taxes incurred on reinsurance contracts placed. Policy acquisition costs and underwriting expenses for the year ended December 31, 2023 increased by $31,000, to $141,000 from $110,000 for the year ended December 31, 2022. The increase is due wholly due to the higher rates on reinsurance contracts during the year ended December 31, 2023 as mentioned above when compared to the prior year.

 

General and Administrative Expenses. General and administrative expenses for the year ended December 31, 2023 increased by approximately $800,000 to $2.2 million from $1.4 million for the year ended December 31, 2022. The increase is due to expense fluctuations during the year ended December 31, 2023, and all the offering costs associated with Maxim equity distribution agreement along with the costs incurred in the launch of SurancePlus Inc.’s DeltaCat Re Token offering being recognized in the year ended December 31, 2023.

 

MEASUREMENT OF RESULTS

 

We use various measures to analyze the growth and profitability of business operations. For our reinsurance business, we measure growth in terms of premiums assumed and we measure underwriting profitability by examining our loss, underwriting expense and combined ratios. We analyze and measure profitability in terms of net income and return on average equity.

 

Premiums Assumed. We use gross premiums assumed to measure our sales of reinsurance products. Gross premiums assumed also correlates to our ability to generate net premiums earned. See also the analysis above relating to the growth in premiums assumed.

 

Loss Ratio. The loss ratio is the ratio of losses and loss adjustment expenses incurred to premiums earned and measures the underwriting profitability of our reinsurance business. The loss ratio for the year ended December 31, 2023 decreased to 0% from 107.8% for the year ended December 31, 2022. The decrease during the year ended December 31, 2023 is wholly due to the limit losses suffered on two of our reinsurance contracts as a result of Hurricane Ian, in the previous year when compared to no losses during the year ended December 31, 2023.

 

Acquisition Cost Ratio. The acquisition cost ratio is the ratio of policy acquisition costs and other underwriting expenses to net premiums earned. The acquisition cost ratio measures our operational efficiency in producing, underwriting and administering our reinsurance business. The acquisition cost ratio increased marginally to 11.2% for the year ended December 31, 2023.

 

Expense Ratio. The expense ratio is the ratio of policy acquisition costs, other underwriting expenses and general and administrative expenses to net premiums earned. We use the expense ratio to measure our operating performance. The expense ratio increased from 153.1% for the year ended December 31, 2022 to 185.2% for the year ended December 31, 2023. The increase is due to higher general and administrative expenses during the year ended December 31, 2023 primarily from the expenses associated with Maxim’s equity distribution agreement and launch of SurancePlus Inc. private placement offering.

 

Combined Ratio. We use the combined ratio to measure our underwriting performance. The combined ratio is the sum of the loss ratio and the expense ratio. The combined ratio decreased from 260.9% for the year ended December 31, 2022 to 185.2% for the year ended December 31, 2023. The decrease is due to the decrease in loss ratio during the year ending December 31, 2023 as a result of limit loss suffered under two of our reinsurance contracts in the prior year, as well as higher general and administrative expenses.

 

FINANCIAL CONDITION – DECEMBER 31, 2023 COMPARED TO DECEMBER 31, 2022

 

Restricted Cash and Cash Equivalents. As of December 31, 2023, our restricted cash and cash equivalents decreased by $183,000, to $3.7 million from $3.9 million as of December 31, 2023. The decrease is the result of funds being released from the underlying trusts for treaty year ending May 31, 2023 more than offsetting new collateral deposits for treaty year ending May 31, 2024.

 

35
 

 

Investments. As of December 31, 2023, our equity securities increased marginally by $38,000 to $680,000, from $642,000 as of December 31, 2023. The increase is primarily a result of the positive change in value of the equity securities market during the year ended December 31, 2023.

 

Other investments. As of December 31, 2023, our other investments decreased to $2.5 million from $11.4 million at December 31, 2022. The decrease is due to the fair value changes of our investment in Jet.AI in which the Company has an equity investment measured at fair value.

 

Reserve of losses and loss adjustment expenses. As of December 31, 2023, our reserve for loss and loss adjustment expenses decreased to $0 from $1.1 million at December 31, 2022. The decrease is due to the payment made during 2023 and no losses occurring in the current year.

 

Notes Payable to Noteholders. As of December 31, 2023, our notes payable decreased by $98,000 to $118,000 from $216,000 at December 31, 2022, The decrease is due to a payment made to noteholders on the underlying contracts for previous treaty periods.

 

Unearned Premiums Reserve. As of December 31, 2023, our unearned premiums reserve increased by $915,000, to $915,000 from $0 at December 31, 2022. The increase is due wholly to the recognition of premium income on in-force reinsurance contracts during the year ending December 31, 2023.

 

LIQUIDITY AND CAPITAL RESOURCES

 

General

 

We are organized as a holding company and provide administrative and management services to our subsidiaries, as well as to Oxbridge Acquisition Corp., a special purpose acquisition company, up to the time of its business combination with Jet.AI Inc. (“Jet.AI”) in August 2023. Our operations are conducted through our reinsurance subsidiaries, Oxbridge Reinsurance Limited and Oxbridge Re NS and our Web3 focused subsidiary, SurancePlus, which includes the underwriting of risks associated with our property and casualty reinsurance programs, as well as the tokenization of RWAs such as reinsurance contracts. We have minimal continuing cash needs at the holding company level, with such needs principally being related to the payment of administrative expenses and shareholder dividends (if any). There are restrictions on Oxbridge Reinsurance Limited’s and Oxbridge Re NS’ ability to pay dividends which are described in more detail below.

 

Sources and Uses of Funds

 

Our sources of funds primarily consist of premium receipts (net of brokerage fees and federal excise taxes, where applicable) and investment income, including interest, dividends and realized gains. We use cash to pay losses and loss adjustment expenses, other underwriting expenses, dividends, and general and administrative expenses. Substantially all of our surplus funds, net of funds required for cash liquidity purposes, are invested in accordance with our business plan and investment guidelines. Our investment portfolio, except for our investment in Jet.AI, is primarily comprised of cash and highly liquid securities, which can be liquidated, if necessary, to meet current liabilities, We believe that we have sufficient flexibility to liquidate any securities that we own to generate liquidity.

 

As of December 31, 2023, we believe we had sufficient cash flows from operations to meet our liquidity requirements. We expect that our operational needs for liquidity will be met by cash, investment income and funds generated from underwriting activities. We have no current plans to issue debt and expect to fund our operations for the foreseeable future from operating cash flows, as well as from potential future equity offerings. However, we cannot provide assurances that in the future we will not incur indebtedness to implement our business strategy, pay claims or make acquisitions.

 

Although Oxbridge Re Holdings Limited is not subject to any significant legal prohibitions on the payment of dividends, its subsidiaries Oxbridge Reinsurance Limited and Oxbridge Re NS are subject to Cayman Islands regulatory constraints that affect its ability to pay dividends to us and include a minimum net worth requirement. Currently, the minimum net worth requirement for each subsidiary is $500. As of December 31, 2023, each subsidiary exceeded the minimum required. By law, each subsidiary is restricted from paying a dividend if such a dividend would cause its net worth to drop to less than the required minimum.

 

36
 

 

Cash Flows

 

Our cash flows from operating, investing, and financing activities for the years ended December 31, 2023 and 2022 are summarized below.

 

Cash Flows for the Year ended December 31, 2023 (in thousands)

 

Net cash used in operating activities for the year ended December 31, 2023 totaled $1,260, which consisted primarily of cash received on net written premiums less cash disbursed for operating expenses. Net cash used in investing activities of $105 which due mainly to investment in note receivable from Jet.AI. Net cash provided by financing activities was $1,182 which consisted primarily of net proceeds from Delta Cat Re Tokens offset by the partial redemption payment made to noteholders.

 

Cash Flows for the Year ended December 31, 2022 (in thousands)

 

Net cash used in operating activities for the year ended December 31, 2022 totaled $829, which consisted primarily of cash received on net written premiums less cash disbursed for operating expenses and reserve for loss and loss adjustment expenses. Net cash used in investing activities of $661 was primarily due to other investments and the net purchase and sales of equity securities. There was no cash used in or provided by financing activities.

 

OFF-BALANCE SHEET ARRANGEMENTS

 

As of December 31, 2023, we had no off-balance sheet arrangements as defined in Item 303(a)(4) of Regulation S-K.

 

Exposure to Catastrophes

 

As with other reinsurers, our operating results and financial condition could be adversely affected by volatile and unpredictable natural and man-made disasters, such as hurricanes, windstorms, earthquakes, floods, fires, riots and explosions, and particularly to weather events in the State of Florida. Although we attempt to limit our exposure to levels we believe are acceptable, it is possible that an actual catastrophic event or multiple catastrophic events could have a material adverse effect on our financial condition, results of operations and cash flows. As described under “CRITICAL ACCOUNTING POLICIES—Reserves for Losses and Loss Adjustment Expenses” below, under accounting principles generally accepted in the United States of America (“GAAP”), we are not permitted to establish loss reserves with respect to losses that may be incurred under reinsurance contracts until the occurrence of an event which may give rise to a claim. As a result, only loss reserves applicable to losses incurred up to the reporting date may be established, with no provision for a contingency reserve to account for expected future losses.

 

CRITICAL ACCOUNTING POLICIES

 

We are required to make estimates and assumptions in certain circumstances that affect amounts reported in our consolidated financial statements and related footnotes. We evaluate these estimates and assumptions on an on-going basis based on historical developments, market conditions, industry trends and other information that we believe to be reasonable under the circumstances. These accounting policies pertain to fair value measurements, particular with respect to our investment in Jet.AI., premium revenues and risk transfer, reserve for loss and loss adjustment expenses, and deferred acquisition costs.

 

Fair value measurement: GAAP establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements).

 

The three levels of the fair value hierarchy under GAAP are as follows:

 

Level 1 Inputs that reflect unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date;

 

37
 

 

Level 2 Inputs other than quoted prices that are observable for the asset or liability either directly or indirectly, including inputs in markets that are not considered to be active;

 

and

 

Level 3 Inputs that are unobservable.

 

Inputs are used in applying the various valuation techniques and broadly refer to the assumptions that market participants use to make valuation decisions, including assumptions about risk. For fixed maturity securities, inputs may include price information, volatility statistics, specific and broad credit data, liquidity statistics, broker quotes for similar securities and other factors. The fair value of investments in stocks and exchange-traded funds is based on the last traded price. A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. However, the determination of what constitutes “observable” requires significant judgment by the Company’s investment custodians and management. The investment custodians and management consider observable data to be market data which is readily available, regularly distributed or updated, reliable and verifiable, not proprietary, and provided by independent sources that are actively involved in the relevant markets.

 

Premium Revenue and Risk Transfer. We record premiums revenue as earned pro-rata over the terms of the reinsurance agreements and the unearned portion at the balance sheet date is recorded as unearned premiums reserve. A reserve is made for estimated premium deficiencies to the extent that estimated losses and loss adjustment expenses exceed related unearned premiums. Investment income is not considered in determining whether or not a deficiency exists.

 

We account for reinsurance contracts in accordance with ASC 944, ‘‘Financial Services – Insurance.” Assessing whether or not a reinsurance contract meets the conditions for risk transfer requires judgment. The determination of risk transfer is critical to reporting premiums written. If we determine that a reinsurance contract does not transfer sufficient risk, we must account for the contract as a deposit liability.

 

Reserves for Losses and Loss Adjustment Expenses. We determine our reserves for losses and loss adjustment expenses on the basis of the claims reported by our ceding insurers and for losses IBNR, we use the assistance of an independent actuary. The reserves for losses and loss adjustment expenses represent management’s best estimate of the ultimate settlement costs of all losses and loss adjustment expenses.

 

We believe that the amounts are adequate; however, the inherent impossibility of predicting future events with precision, results in uncertainty as to the amount which will ultimately be required for the settlement of losses and loss expenses, and the differences could be material. Adjustments are reflected in the consolidated statements of income in the period in which they are determined.

 

Under GAAP, we are not permitted to establish loss reserves until the occurrence of an actual loss event. As a result, only loss reserves applicable to losses incurred up to the reporting date may be recorded, with no allowance for the provision of a contingency reserve to account for expected future losses. Losses arising from future events, which could be substantial, are estimated and recognized at the time the loss is incurred.

 

As at December 31, 2023 we had no reserves for loss and loss adjustment expenses due to no significant events occurring during the year and no reported claims on contract in force. See Note 7 to the consolidated financial statements.

 

Our reserving methodology does not lend itself well to a statistical calculation of a range of estimates surrounding the best point estimate of our reserve for loss and loss adjustment expense. Due to the low frequency and high severity nature of claims within much of our business, our reserving methodology principally involves arriving at a specific point estimate for the ultimate expected loss on a contract-by-contract basis, and our aggregate loss reserves are the sum of the individual loss reserves established.

 

Deferred Acquisition Costs. We defer certain expenses that are directly related to and vary with producing reinsurance business, including brokerage fees on gross premiums assumed, premium taxes and certain other costs related to the acquisition of reinsurance contracts. These costs are capitalized and the resulting asset, deferred acquisition costs, is amortized and charged to expense in future periods as premiums assumed are earned. The method followed in computing deferred acquisition costs limits the amount of such deferral to its estimated realizable value. The ultimate recoverability of deferred acquisition costs is dependent on the continued profitability of our reinsurance underwriting. If our underwriting ceases to be profitable, we may have to write off a portion of our deferred acquisition costs, resulting in a further charge to income in the period in which the underwriting losses are recognized.

 

38
 

 

ITEM 7A QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

As a smaller reporting company as defined by Rule 229.10(f)(1) of the Exchange Act, we are not required to provide the information under this item.

 

ITEM 8 FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

 

The financial statements and supplementary data have been filed as a part of this Annual Report on Form 10-K as indicated in the Index to Consolidated Financial Statements and Financial Statement Schedules appearing on page 50 of this Annual Report on Form 10-K.

 

ITEM 9 CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

 

None.

 

ITEM 9A CONTROLS AND PROCEDURES

 

Evaluation of Disclosure Controls and Procedures

 

Under the supervision and with the participation of our Chief Executive Officer (our principal executive officer) and our Chief Financial Officer (our principal financial officer), we have evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act) as of the end of the period covered by this Annual Report on Form 10-K (December 31, 2023). Our disclosure controls and procedures are intended to ensure that the information we are required to disclose in the reports that we file or submit under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and (ii) accumulated and communicated to our management, including the principal executive officer and principal financial officer to allow timely decisions regarding required disclosures.

 

Based on that evaluation, our principal executive officer and principal financial officer concluded that, as of the end of the period covered by this Annual Report on Form 10-K, our disclosure controls and procedures were effective.

 

It should be noted that any system of controls, however well designed and operated, can provide only reasonable, and not absolute, assurance that the objectives of the system will be met. In addition, the design of any control system is based in part upon certain assumptions about the likelihood of future events.

 

Management’s Report on Internal Control Over Financial Reporting

 

Management is responsible for establishing and maintaining adequate internal control over our financial reporting (as defined in Rule 13a-15(f) and 15d-15(f) of the Exchange Act). Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted in the United States of America.

 

Our internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of our assets, (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with accounting principles generally accepted in the United States of America, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors, and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on the financial statements.

 

Our management, with the participation of our principal executive officer and principal financial officer, conducted an evaluation of the effectiveness of our internal control over financial reporting based on the framework in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”). Based on this evaluation, our principal executive officer and principal financial officer concluded that, as of December 31, 2023, our internal control over financial reporting was effective.

 

39
 

 

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

This Annual Report does not include an attestation report of our independent registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by our independent registered public accounting firm pursuant to scaled disclosure requirements applicable to non-accelerated filers that permit us to provide only management’s report in this Annual Report.

 

Changes in Internal Control Over Financial Reporting

 

There have been no changes in our internal control over financial reporting that occurred during the three months and the year ended December 31, 2023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

ITEM 9B OTHER INFORMATION

 

None of our directors or executive officers adopted, modified or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule-10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K, during the fiscal quarter ended December 31, 2023.

 

ITEM 9C DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS

 

Not applicable.

 

PART III

 

ITEM 10 DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

 

Other than the information regarding our code of ethics set forth below, the information required by this Item is incorporated herein by reference to the definitive proxy statement for our 2024 Annual Meeting of Shareholders to be filed with the SEC not later than 120 days after December 31, 2023.

 

We have adopted a code of ethics applicable to all employees and directors, including our principal executive officer, principal financial officer and principal accounting officer. We have posted the text of our code of ethics to our internet website: www.oxbridgere.com. To access our code of ethics, select “Investor Information” on our website and then select “Corporate Governance,” then “Code of Conduct.” We intend to disclose any change to or waiver from our code of ethics by posting such change or waiver to our internet website within the same section as described above.

 

ITEM 11 EXECUTIVE COMPENSATION

 

The information required by this Item is incorporated herein by reference to the definitive proxy statement for our 2024 Annual Meeting of Shareholders or an amendment to this Form 10-K to be filed with the SEC not later than 120 days after December 31, 2023.

 

ITEM 12 SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED SHAREHOLDER MATTERS

 

The information required by this Item is incorporated herein by reference to the definitive proxy statement for our 2024 Annual Meeting of Shareholders or an amendment to this Form 10-K to be filed with the SEC not later than 120 days after December 31, 2023.

 

40
 

 

ITEM 13 CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

 

The information required by this Item is incorporated herein by reference to the definitive proxy statement for our 2024 Annual Meeting of Shareholders or an amendment to this Form 10-K to be filed with the SEC not later than 120 days after December 31, 2023.

 

ITEM 14 PRINCIPAL ACCOUNTING FEES AND SERVICES

 

The information required by this Item is incorporated herein by reference to the definitive proxy statement for our 2024 Annual Meeting of Shareholders or an amendment to this Form 10-K to be filed with the SEC not later than 120 days after December 31, 2023.

 

PART IV

 

ITEM 15 EXHIBITS, FINANCIAL STATEMENT SCHEDULES

 

(a) Documents Filed as Part of the Report

 

The Consolidated Financial Statements, other financial information, financial statement schedules and report of independent registered public accounting firm have been filed as part of this Annual Report on Form 10-K as indicated in the Index to Consolidated Financial Statements and Financial Statement Schedules appearing on page 50 of this Annual Report on Form 10-K.

 

(b) Exhibits

 

Reference is made to the separate exhibit index contained on page 48 filed herewith.

 

(c) Financial Statement Schedules

 

The financial statement schedules and report of independent registered public accounting firm have been filed as part of this Annual Report on Form 10-K as indicated in the Index to Consolidated Financial Statements and Financial Statement Schedules appearing on page 50 of this Annual Report on Form 10-K.

 

ITEM 16 FORM 10-K SUMMARY

 

None.

 

Oxbridge Re Holdings Limited

Index to Exhibits

 

Exhibit   Title
     
3   Third Amended and Restated Memorandum and Articles of Association of Oxbridge Re Holdings Limited, as amended through December 19, 2014 (incorporated by reference to Exhibit 3.1 to Oxbridge Re Holdings Limited’s Current Report on Form 8-K filed December 24, 2014) (Commission File No. 1-36346).
     
4.1   Warrant Agreement, dated March 26, 2014, between Oxbridge Re Holdings Limited and Broadridge Corporate Issuer Solutions, Inc. (incorporated by reference to Exhibit 4.1 to Oxbridge Re Holdings Limited’s Current Report on Form 8-K filed May 28, 2014) (Commission File No. 1-36346).
     
4.3   Amendment #1 to Warrant Agreement between Oxbridge Re Holdings Limited and Broadridge Corporate Issuer Solutions, Inc. (incorporated by reference to Exhibit 4.1 to Oxbridge Re Holdings Limited’s Current Report on Form 8-K filed on November 19, 2018) (Commission File No. 1-36346).
     
4.4#   Description of Securities Registered under Section 12 of the Securities Exchange Act of 1934, as amended.
     
4.5   Amendment #2 to Warrant Agreement between Oxbridge Re Holdings Limited and Broadridge Corporate Issuer Solutions, LLC (incorporated by reference to Exhibit 4.1 to Oxbridge Re Holdings Limited’s Current Report on Form 8-K filed on February 2, 2024) (Commission File No. 1-36346).

 

41
 

 

10.2*   Oxbridge Re Holdings Limited 2014 Omnibus Incentive Plan (incorporated by reference to Exhibit 10.10 to Oxbridge Re Holdings Limited’s Current Report on Form 8-K filed December 24, 2014) (Commission File No. 1-36346).
     
10.4*   Amended and Restated Employment Agreement, dated January 9, 2023, with Jay Madhu (incorporated by reference to Exhibit 10.3 to Oxbridge Re Holdings Limited’s Current Report on Form 8-K filed January 13, 2023) (Commission File No. 1-36346).
     
10.5*   Amended and Restated Employment Agreement, dated January 9, 2023, with Wrendon Timothy (incorporated by reference to Exhibit 10.4 to Oxbridge Re Holdings Limited’s Current Report on Form 8-K filed January 13, 2023) (Commission File No. 1-36346).
     
10.6*   Form of Oxbridge Re Holdings Limited 2014 Omnibus Incentive Plan Restricted Share Award (incorporated by reference to Exhibit 10.1 to Oxbridge Re Holdings Limited’s Current Report on Form 8-K filed January 28, 2015) (Commission File No. 1-36346).
     
10.7*   Form of Oxbridge Re Holdings Limited 2014 Omnibus Incentive Plan Share Option Award Agreement (incorporated by reference to Exhibit 10.2 to Oxbridge Re Holdings Limited’s Current Report on Form 8-K filed January 28, 2015) (Commission File No. 1-36346).
     
10.8*   Oxbridge Re Holdings 2021 Omnibus Incentive Plan (incorporated by reference to Exhibit 10.1 to Oxbridge Re Holdings Limited’s Current Report on Form 8-K filed January 13, 2023) (Commission File No.1-36346).
     
10.9*   Form of Restricted Stock Agreement under the Oxbridge Re Holdings Limited 2021 Omnibus Incentive Plan (incorporated by reference to Exhibit 10.5 to Oxbridge Re Holdings Limited’s Current Report on Form 8-K filed January 13, 2023) (Commission File No.1-36346).
     
10.10   Oxbridge Re Holdings Limited Non-Employee Director Compensation Program (incorporated by reference to Exhibit 10.1 to Oxbridge Re Holdings Limited’s Current Report on Form 8-K filed January 13, 2023) (Commission File No.1-36346).
     
10.11   Share Purchase Agreement, dated August 11, 2021, by and between Oxbridge Reinsurance Limited and OAC Sponsor Ltd. (incorporated by reference to Exhibit 10.7 to Oxbridge Re Holdings Limited’s Quarterly Report on Form 10-Q filed November 7, 2021) (Commission File No. 1-36346).
     
10.12   Equity Distribution Agreement, dated September 20, 2022, between Oxbridge Re Holdings Limited and Maxim Group LLC (incorporated by reference to Exhibit 1.1 to Oxbridge Re Holdings Limited’s Current Report on Form 8-K filed September 30, 2022) (Commission File No.1-36346).
     
97.1#   Clawback Policy.
     
21.1   List of Subsidiaries of Oxbridge Re Holdings Limited.
     
23.1   Consent of Independent Registered Public Accounting Firm.
     
31.1   Certifications of the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act and Rule 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934.

 

42
 

 

31.2   Certifications of the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act and Rule 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934.
     
32   Written Statement of the Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. § 1350.
     
101   The following materials from Oxbridge Re Holdings Limited’s Annual Report on Form 10-K for the fiscal year ended December 31, 2023 are filed herewith, formatted in iXBRL (Inline Extensible Business Reporting Language): (i) Consolidated Balance Sheets, (ii) Consolidated Statements of Operations, (iii) Consolidated Statements of Cash Flows, (iv) Consolidated Statements of Changes in Shareholders’ Equity and (v) Notes to Consolidated Financial Statements.
     
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

* Indicates a management contract or compensatory plan or arrangement.

# Filed herewith

 

 

43
 

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  OXBRIDGE RE HOLDINGS LIMITED
     
  By /s/ JAY MADHU
    Jay Madhu
   

Chief Executive Officer and President

(Principal Executive Officer)

     
  Date: March 26, 2024

 

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below as of March 25, 2024 by the following persons on behalf of the registrant and in the capacities indicated:

 

/s/ WRENDON TIMOTHY   /s/ JAY MADHU
Wrendon Timothy   Jay Madhu
Chief Financial Officer and Secretary   Chief Executive Officer, President and Director
(Principal Financial Officer and Principal Accounting Officer)   (Principal Executive Officer)

 

/s/ LESLEY THOMPSON   /s/ DWIGHT MERREN
Lesley Thompson   Dwight Merren
Director   Director

 

/s/ ARUN GOWDA    
Arun Gowda    
Director    

 

44
 

 

Index to Consolidated Financial Statements and Financial Statement Schedules

 

    Form 10-K
    Page(s)
     
Consolidated Financial Statements    
     
Report of Independent Registered Public Accounting Firm - (PCAOB ID 400)   F-1
     
Consolidated Balance Sheets at December 31, 2023 and 2022   F-2
     
Consolidated Statements of Operations for the years ended December 31, 2023 and 2022   F-3
     
Consolidated Statements of Cash Flows for the years ended December 31, 2023 and 2022   F-4
     
Consolidated Statements of Changes in Shareholders’ Equity for the years ended December 31, 2023 and 2022   F-6
     
Notes to Consolidated Financial Statements   F-7
     
Financial Statements Schedules    
     
Schedule I – Summary of Investments – Other than Investments in Related Parties   F-31
     
Schedule II – Condensed Financial Information of the Registrant   F-32
     
Schedule III – Supplementary Insurance Information   F-35
     
Schedule IV – Supplementary Reinsurance Information   F-36

 

45
 

 

Report of Independent Registered Public Accounting Firm

 

To the Shareholders and the Board of Directors

Oxbridge Re Holdings Limited

Grand Cayman, Cayman Islands:

 

Opinion on the Consolidated Financial Statements

 

We have audited the accompanying consolidated balance sheets of Oxbridge Re Holdings Limited and Subsidiaries (the “Company”), as of December 31, 2023 and 2022 and the related consolidated statements of operations, changes in shareholders’ equity and cash flows for the years then ended and the related notes and the consolidated financial statement schedules (collectively referred to as the “consolidated financial statements”). In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the consolidated financial position of the Company as of December 31, 2023 and 2022, and the consolidated results of its operations and its cash flows for the years then ended, in conformity with accounting principles generally accepted in the United States of America.

 

Basis for Opinion

 

These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

 

Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.

 

HACKER, JOHNSON & SMITH PA

We have served as the Company’s auditor since 2013.

Tampa, Florida

March 26, 2024

 

F-1
 

 

OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES

Consolidated Balance Sheets

(expressed in thousands of U.S. Dollars, except per share and share amounts)

 

   2023   2022 
   At December 31, 
   2023   2022 
         
Assets          
Investments:          
Equity securities, at fair value (cost: $1,926)  $680    642 
Cash and cash equivalents   495    1,207 
Restricted cash and cash equivalents   3,250    2,721 
Premiums receivable   977    282 
Other investments   2,478    11,423 
Loan receivable   

100

    

-

 
Due from related parties   63    45 
Deferred policy acquisition costs   101    - 
Operating lease right-of-use assets   9    44 
Prepayment and other assets   96    114 
Prepaid offering costs   -    133 
Property and equipment, net   4    5 
Total assets  $8,253    16,616 
           
Liabilities and Shareholders’ Equity          
Liabilities:          
Other Liabilities – Delta Cat Re Tokenholders  $1,523    - 
Notes payable to noteholders   118    216 
Reserve for losses and loss adjustment expenses   -    1,073 
Unearned premiums reserve   915    - 
Operating lease liabilities   9    44 
Accounts payable and other liabilities   356    294 
Total liabilities   2,921    1,627 
           
Shareholders’ equity:          
Ordinary share capital, (par value $0.001, 50,000,000 shares authorized; 5,870,234 and 5,769,587 shares issued and outstanding)   6    6 
Additional paid-in capital   32,740    32,482 
Accumulated Deficit   (27,414)   (17,499)
Total shareholders’ equity   5,332    14,989 
Total liabilities and shareholders’ equity  $8,253    16,616 

 

See accompanying Notes to Consolidated Financial Statements

 

F-2
 

 

OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES

Consolidated Statements of Operations

(expressed in thousands of U.S. Dollars, except per share amounts)

 

   2023   2022 
   Years Ended December 31, 
   2023   2022 
         
         
Revenue          
Assumed premiums  $2,170    645 
Change in unearned premiums reserve   (915)   350 
           
Net premiums earned   1,255    995 
SurancePlus fee income   300    - 
Net investment and other income   303    201 
Net realized investment gain   -    27 
Unrealized loss on other investments   (8,945)   (35)
Change in fair value of equity securities   38    (338)
           
Total revenue  $(7,049)   850 
           
Expenses          
Losses and loss adjustment expenses  $-    1,073 
Policy acquisition costs and underwriting expenses   141    110 
General and administrative expenses   2,183    1,413 
           
Total expenses  $2,324    2,596 
           
Loss before income attributable to noteholders and tokenholders  $(9,373)   (1,746)
           
Income attributable to noteholders and tokenholders   (542)   (43)
           
Net loss  $(9,915)   (1,789)
           
Loss per share          
Basic and Diluted   (1.69)   (0.31)
           
Weighted-average shares outstanding          
Basic and Diluted   5,867,129    5,772,396 

 

See accompanying Notes to Consolidated Financial Statements

 

F-3
 

 

OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES

Consolidated Statements of Cash Flows

(expressed in thousands of U.S. Dollars)

 

   2023   2022 
   Years ended December 31 
   2023   2022 
Operating activities           
Net loss   $(9,915)   (1,789)
Adjustments to reconcile net loss to net cash used in operating activities:           
Share-based compensation    258    127 
Depreciation and amortization    6    4 
Net realized investment gains    -    (27)
SurancePlus fee income   

(300

)   - 
Change in fair value of equity securities    (38)   338 
Change in fair value of other investments    8,945    35 
Change in operating assets and liabilities:           
Premiums receivable    (695)   2 
Due from related parties    (18)   (40)
Deferred policy acquisition costs    (101)   38 
Prepayment and other assets    18    (64)
Prepaid offering costs    133    (133)
Other Liablities Delta Cat Re Tokenholders   543    - 
Losses payable    (1,073)   1,073 
Unearned premiums reserve    915    (350)
Accounts payable and other liabilities    62    (43)
           
Net cash used in operating activities   $(1,260)   (829)
           
Investing activities           
Purchase of equity securities    -    (1,002)
Purchase of loan receivable   (100)   - 
Purchase of other investments    -    (285)
Proceeds from sale of equity securities    -    626 
Purchase of property and equipment    (5)   - 
           
Net cash used in investing activities   $(105)   (661)
           
Financing activities           
Partial redemption of notes payable to noteholders    (98)   - 
Gross proceeds from the issuance of Delta Cat Re tokens   1,280    - 
Net cash provided by financing activities    $1,182    - 
           
   (continued) 

 

F-4
 

 

OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES

Consolidated Statements of Cash Flows, continued

(expressed in thousands of U.S. Dollars)

 

   Years ended December 31 
   2023   2022 
         
Cash and cash equivalents, and restricted cash and cash equivalents:          
Net change during the year  $(183)   (1,490)
Balance at beginning of year  $3,928    5,418 
           
Balance at end of year  $3,745    3,928 

 

See accompanying Notes to Consolidated Financial Statements

 

F-5
 

 

OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES

Consolidated Statements of Changes in Shareholders’ Equity

Years ended December 31, 2023 and 2022

(expressed in thousands of U.S. Dollars, except per share amounts)

 

   Shares   Amount   Capital   Deficit   Equity 
   Ordinary Share Capital   Additional Paid-in   Accumulated   Total Shareholders’ 
   Shares   Amount   Capital   Deficit   Equity 
                     
Balance at December 31, 2021   5,749,587   $6   $32,355   $(15,710)  $16,651 
Net loss for the year   -    -    -    (1,789)   (1,789)
Issuance of restricted stock   20,000    -    -    -    - 
Share-based compensation   -    -    127    -    127 
Balance at December 31, 2022   5,769,587   $6   $32,482   $(17,499)  $14,989 
                          
Balance at December 31, 2022   5,769,587   $6    32,482    (17,499)   14,989 
                          
Net loss for the year   -    -    -    (9,915)   (9,915)
Issuance of Restricted stock, net   100,647    -    -    -    - 
Share-based compensation   -          -    258    -    258 
Balance at December 31, 2023   5,870,234   $6   $32,740   $(27,414)  $5,332 

 

See accompanying Notes to Consolidated Financial Statements

 

F-6
 

 

OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES

Notes to Consolidated Financial Statements

 

1. ORGANIZATION AND BASIS OF PRESENTATION

 

(a) Organization

 

Oxbridge Re Holdings Limited (the “Company”) was incorporated as an exempted company on April 4, 2013 under the laws of the Cayman Islands. The Company directly owns 100% of the equity interest in Oxbridge Reinsurance Limited, an exempted entity incorporated on April 23, 2013 under the laws of the Cayman Islands and for which a Class “C” Insurer’s license was granted on April 29, 2013 under the provisions of the Cayman Islands Insurance Law. The Company also indirectly owns 100% of the equity interest in Oxbridge Re NS, an entity incorporated as an exempted company on December 22, 2017 under the laws of the Cayman Islands to function as a reinsurance sidecar facility and to increase the underwriting capacity of Oxbridge Reinsurance Limited. The Company also indirectly owns 100% of the equity interest in SurancePlus, an entity incorporated as a business company on December 19, 2022 under the laws of the British Virgin Islands to issue digital securities. The Company and its subsidiaries (collectively “Oxbridge Re”) provide the following: SurancePlus; is a Web3-focused subsidiary that currently leverages blockchain technology to democratize access to high-return reinsurance contracts via digital securities. Oxbridge Reinsurance Limited; is a licensed reinsurance subsidiary that provides reinsurance business solutions primarily to property and casualty insurers in the Gulf Coast region of the United States; Oxbridge Re NS; a licensed reinsurance SPV/side car that provides third-party investors with access to reinsurance contracts with returns uncorrelated to the financial markets. The Company operates as a single business segment through its wholly-owned subsidiaries. The Company’s headquarters and principal executive offices are located at Suite 201, 42 Edward Street, George Town, Grand Cayman, Cayman Islands, and have their registered offices at P.O. Box 309, Ugland House, Grand Cayman, Cayman Islands.

 

The Company’s ordinary shares and warrants are listed on The NASDAQ Capital Market under the symbols “OXBR” and “OXBRW,” respectively.

 

(b) Basis of Presentation and Consolidation

 

The accompanying consolidated financial statements for the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). All significant intercompany transactions and balances have been eliminated upon consolidation.

 

The Company consolidates in these consolidated financial statements the results of operations and financial position of all voting interest entities (“VOE”) in which the Company has a controlling financial interest and all variable interest entities (“VIE”) in which the Company is considered to be the primary beneficiary. The consolidation assessment, including the determination as to whether an entity qualifies as a VIE or VOE, depends on the facts and circumstances surrounding each entity.

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Use of Estimates: In preparing the consolidated financial statements, management was required to make certain estimates and assumptions that affect the reported amounts of the consolidated assets, liabilities, revenues, expenses and related disclosures at the financial reporting date and throughout the periods being reported upon. Certain of the estimates result from judgments that can be subjective and complex and consequently actual results may differ from these estimates, which would be reflected in future periods. Material estimates that are particularly susceptible to significant change in the near-term relate to the determination of the reserve for losses and loss adjustment expenses (if any), which may include amounts estimated for claims incurred but not yet reported. The Company uses various assumptions and actuarial data it believes to be reasonable under the circumstances to make these estimates. Although considerable variability is likely to be inherent in these estimates, management believes that the amounts provided are reasonable. These estimates are continually reviewed and adjusted if necessary. Such adjustments are reflected in current operations.

 

F-7
 

 

OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES

Notes to Consolidated Financial Statements, Continued

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

 

Revenue Recognition

 

SurancePlus incentive, technology, origination and management (“ITOM”) fee income represents fee income related to the completion of the DeltaCat tokenized reinsurance securities as well as placement of the underlying insurance policies. The Company recognizes the associated revenue at the time of the placement of the underlying insurance policies as the performance obligation is satisfied at that time.

 

Cash and cash equivalents: Cash and cash equivalents are comprised of cash and short- term investments with original maturities of three months or less.

 

Restricted cash and cash equivalents: Restricted cash and cash equivalents represent funds held in accordance with the Company’s trust agreements with ceding insurers and trustees, which requires the Company to maintain collateral with a market value greater than or equal to the limit of liability, less unpaid premium.

 

Investments: The Company from time to time invests in fixed-maturity securities and equity securities, and for which its fixed-maturity securities are classified as available-for-sale. The Company’s available for sale fixed-maturity investments are carried at fair value with changes in fair value included as a separate component of accumulated other comprehensive income (loss) in shareholders’ equity. For the Company’s investment in equity securities, and for the Company’s investment in Jet.AI. classified as “other investments”, the changes in fair value are recorded within the consolidated statements of operations. At December 31, 2023 and 2022 the company did not own any fixed maturity debt securities.

 

Unrealized gains or losses are determined by comparing the fair market value of the securities with their cost or amortized cost. Realized gains and losses on investments are recorded on the trade date and are included in the consolidated statements of operations. The cost of securities sold is based on the specified identification method. Investment income is recognized as earned and discounts or premiums arising from the purchase of debt securities are recognized in investment income using the interest method over the remaining term of the security.

 

Fair value measurement: GAAP establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy under GAAP are as follows:

 

Level 1 Inputs that reflect unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date;
   
Level 2 Inputs other than quoted prices that are observable for the asset or liability either directly or indirectly, including inputs in markets that are not considered to be active; and
   
Level 3 Inputs that are unobservable.

 

Inputs are used in applying the various valuation techniques and broadly refer to the assumptions that market participants use to make valuation decisions, including assumptions about risk. For fixed maturity securities, inputs may include price information, volatility statistics, specific and broad credit data, liquidity statistics, broker quotes for similar securities and other factors. The fair value of investments in stocks and exchange-traded funds is based on the last traded price. A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. However, the determination of what constitutes “observable” requires significant judgment by the Company’s investment custodians and management. The investment custodians consider observable data to be market data which is readily available, regularly distributed or updated, reliable and verifiable, not proprietary, and provided by independent sources that are actively involved in the relevant markets.

 

F-8
 

 

OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES

Notes to Consolidated Financial Statements, Continued

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

 

Deferred policy acquisition costs (“DAC”): Policy acquisition costs consist of brokerage fees, federal excise taxes and other costs related directly to the successful acquisition of new or renewal insurance contracts and are deferred and amortized over the terms of the reinsurance agreements to which they relate. The Company evaluates the recoverability of DAC by determining if the sum of future earned premiums and anticipated investment income is greater than the expected future claims and expenses. If a loss is probable on the unexpired portion of policies in force, a premium deficiency loss is recognized.

 

Offering Expenses:

 

During the year ended December 31, 2023 the Company recognized offering costs totaling $133,000 on the consolidated statements of operations which was related to an equity distribution agreement with Maxim Group LLC (“Maxim”) for the sale of the ordinary shares. During the year ended December 31, 2023, the Company recognized in the consolidated statements of operations $236,000 of offering expenses in relation to the offering of Delta Cat Re digital securities issuable by the Company’s new subsidiary, SurancePlus Inc. (See Note 6)

 

In accordance with the terms of the equity distribution agreement with Maxim, we intend to offer and sell ordinary shares having an aggregate offering price of up to $6.3 million from time to time.

 

Property and equipment: Property and equipment are recorded at cost when acquired. Property and equipment are comprised of motor vehicles, furniture and fixtures, computer equipment and leasehold improvements and are depreciated, using the straight-line method, over their estimated useful lives, which are five years for furniture and fixtures and computer equipment and four years for motor vehicles. Leasehold improvements are amortized over the lesser of the estimated useful lives of the assets or remaining lease term. The Company periodically reviews property and equipment that have finite lives, and that are not held for sale, for impairment by comparing the carrying value of the assets to their estimated future undiscounted cash flows. For the years ended December 31, 2023 and 2022, there were no impairments in property and equipment.

 

Reserves for losses and loss adjustment expenses: The Company determines its reserves for losses and loss adjustment expenses, if any, on the basis of the claims reported by the Company’s ceding insurers and for losses incurred but not reported (“IBNR”), management uses the assistance of an independent actuary. The reserves for losses and loss adjustment expenses represent management’s best estimate of the ultimate settlement costs of all losses and loss adjustment expenses. Management believes that the amounts are adequate; however, the inherent impossibility of predicting future events with precision, results in uncertainty as to the amount which will ultimately be required for the settlement of losses and loss expenses, and the differences could be material. Adjustments are reflected in the consolidated statements of operations in the period in which they are determined.

 

Loss experience refund payable: Certain contracts include retrospective provisions that adjust premiums or result in profit commissions in the event losses are minimal or zero. In accordance with GAAP, the Company will recognize a liability in the period in which the absence of loss experience obligates the Company to pay cash or other consideration under the contracts. On the contrary, the Company will derecognize such liability in the period in which a loss experience arises. Such adjustments to the liability, which accrue throughout the contract terms, will reduce the liability should a catastrophic loss event covered by the Company occur.

 

Premiums assumed: The Company records premiums assumed, net of loss experience refunds, as earned pro-rata over the terms of the reinsurance agreements, or period of risk, where applicable, and the unearned portion at the consolidated balance sheet date is recorded as unearned premiums reserve. A reserve is made for estimated premium deficiencies to the extent that estimated losses and loss adjustment expenses exceed related unearned premiums. Investment income is not considered in determining whether or not a deficiency exists.

 

F-9
 

 

OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES

Notes to Consolidated Financial Statements, Continued

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

 

Subsequent adjustments of premiums assumed, based on reports of actual premium by the ceding companies, or revisions in estimates of ultimate premium, are recorded in the period in which they are determined. Such adjustments are generally determined after the associated risk periods have expired, in which case the premium adjustments are fully earned when assumed.

 

Certain contracts allow for reinstatement premiums in the event of a full limit loss prior to the expiration of the contract. A reinstatement premium is not due until there is a full limit loss event and therefore, in accordance with GAAP, the Company records a reinstatement premium as written only in the event that the reinsured incurs a full limit loss on the contract and the contract allows for a reinstatement of coverage upon payment of an additional premium. For catastrophe contracts which contractually require the payment of a reinstatement premium equal to or greater than the original premium upon the occurrence of a full limit loss, the reinstatement premiums are earned over the original contract period. Reinstatement premiums that are contractually calculated on a pro-rata basis of the original premiums are earned over the remaining coverage period.

 

Unearned Premiums Ceded: The Company may reduce the risk of future losses on business assumed by reinsuring certain risks and exposures with other reinsurers (retrocessionaires). The Company remains liable to the extent that any retrocessionaire fails to meet its obligations and to the extent that the Company does not hold sufficient security for their unpaid obligations.

 

Ceded premiums are written during the period in which the risk incept and are expensed over the contract period in proportion to the period of protection. Unearned premiums ceded consist of the unexpired portion of the reinsurance obtained. There were no unearned premiums ceded at December 31, 2023 and 2022.

 

SurancePlus Fee Income: SurancePlus incentive, technology, origination and management (“ITOM”) fee income represents fee income related to the completion of the DeltaCat tokenized reinsurance securities as well as placement of the underlying insurance policies. The Company recognizes the associated revenue at the time of the placement of the underlying insurance policies as the performance obligation is satisfied at that time.

 

Uncertain income tax positions: The authoritative GAAP guidance on accounting for, and disclosure of, uncertainty in income tax positions requires the Company to determine whether an income tax position of the Company is more likely than not to be sustained upon examination by the relevant tax authority, including resolution of any related appeals or litigation processes, based on the technical merits of the position. For income tax positions meeting the more likely than not threshold, the tax amount recognized in the consolidated financial statements, if any, is reduced by the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate settlement with the relevant taxing authority. The application of this authoritative guidance has had no effect on the Company’s consolidated financial statements because the Company had no uncertain tax positions at December 31, 2023.

 

Loss Per Share: Basic loss per share has been computed on the basis of the weighted-average number of ordinary shares outstanding during the years presented. Diluted loss per share is computed based on the weighted-average number of ordinary shares outstanding and reflects the assumed exercise or conversion of diluted securities, such as stock options and warrants, computed using the treasury stock method.

 

Share-Based Compensation: The Company accounts for share-based compensation under the fair value recognition provisions of GAAP which requires the measurement and recognition of compensation for all stock-based awards made to employees and directors, including stock options and restricted stock issuances based on estimated fair values. The Company measures compensation for restricted stock based on the price of the Company’s ordinary shares at the grant date. Determining the fair value of stock options at the grant date requires significant estimation and judgment. The Company uses an option-pricing model (Black-Scholes option pricing model) to assist in the calculation of fair value for stock options. When estimating the expected volatility, the Company takes into consideration the historical volatility of entities similar to itself. The Company considers factors such as an entity’s industry, stage of life cycle, size and financial leverage when selecting similar entities. The Company may use a sample peer group of companies in the reinsurance industry and/or the Company’s own historical volatility in determining the expected volatility

 

F-10
 

 

OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES

Notes to Consolidated Financial Statements, Continued

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

 

Additionally, the Company uses the guidance in the SEC’s Staff Accounting Bulletin No. 107 to determine the estimated life of options issued and has assumed no forfeitures during the life of the options.

 

The Company uses the straight-line attribution method for all grants that include only a service condition. Compensation expense related to all awards is included in general and administrative expenses.

 

Segment Information: Under GAAP, operating segments are based on the internal information that management uses for allocating resources and assessing performance as the source of the Company’s reportable segments. The Company manages its business on the basis of one operating segment, Property and Casualty Reinsurance, in accordance with the qualitative and quantitative criteria established under GAAP.

 

Reclassifications: Any reclassifications of prior period amounts have been made to conform to the current period presentation.

 

3. CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AND CASH EQUIVALENTS

 

   2023   2022 
   December 31, 
   2023   2022 
   (in thousands) 
Cash held on deposit  $495   $1,207 
Restricted cash held in trust   3,250    2,721 
Total  $3,745   $3,928 

 

Cash and cash equivalents are held by large and reputable counterparties in the United States of America and in the Cayman Islands. Restricted cash held in trust is custodied with Truist Bank, and is held in accordance with the Company’s trust agreements with the ceding insurers and trustees, which require that the Company provide collateral having a market value greater than or equal to the limit of liability, less unpaid premium.

 

F-11
 

 

OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES

Notes to Consolidated Financial Statements, Continued

 

4. INVESTMENTS

 

The Company from time to time invests in fixed-maturity securities and equity securities, with its fixed-maturity securities classified as available-for-sale. At December 31, 2023 and 2022, the Company did not hold any available-for-sale securities.

 

Proceeds received, and the gross realized gains and losses from sale of equity securities, for the years ended December 31, 2023 and 2022 are as follows:

 

  

Gross

proceeds

from sales

  

Gross

Realized

Gains

  

Gross

Realized

Losses

 
   ($ in thousands) 
             
Year ended December 31, 2023               
Equity securities  $-   $-   $- 
                
Year ended December 31, 2022               
Equity securities  $626   $27   $- 

 

Other Investments

 

On August 7, 2023, OXAC held an extraordinary general meeting at which the business combination with Jet Token, Inc. was approved by OXAC shareholders. In conjunction with the business combination, OXAC was redomesticated as a Delaware entity, and changed its name to Jet.AI Inc (“Jet.AI”). The business combination was closed on August 10, 2023, and on August 11, 2023, OXAC common stock and warrants began trading on the Nasdaq under the new ticker symbols JTAI and JTAIW.

 

The Company’s beneficial interests in Jet. AI’s ordinary shares, public warrants and Extension Loan are recorded at fair value and are classified in “Other Investments” on the consolidated balance sheets. The fair value calculation of the Company’s beneficial interest in Jet.AI’s ordinary shares and public warrants is dependent on the observable trading prices of JetAI’s Class A shares and public warrants. The fair value calculation of the Company’s beneficial interest in the Extension Loan is estimated to be the pro-rata original principal amount of the Extension Loan due to the short-term nature.

 


The Sponsor holds 2,875,000 ordinary shares, 575 Series A-1 preferred shares with purchase price of $1,000 each, along with the 4,897,500 warrants. One of the Company’s executive officers is an independent member of Jet.AI’s board.

 

As a result of the re-measurement of our investment in Jet.AI, we recognized for the year ended December 31, 2023, an unrealized loss of $8,945,000 within our consolidated statements of operations.

 

Other investments as of December 31, 2023 and 2022 consist of the following (in thousands):

 

   2023   2022 
   December 31, 
   2023   2022 
Jet.AI Series A-1 Convertible Preferred Stock  $285   $- 
Jet.AI. Promissory Note   -    214 
Jet.AI. common stock (2022: Class B Ordinary Shares)   2,193    11,209 
Total  $2,478   $11,423 
           
Beginning of year  $11,423   $11,173 
Investment in affiliate   -    285 
Unrealized loss on investment in affiliate   (8,945)   (35)
End of year  $2,478   $11,423 

 

F-12
 

 

OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES

Notes to Consolidated Financial Statements, Continued

 

 

4. INVESTMENTS (continued)

 

Assets Measured at Estimated Fair Value on a Recurring Basis

 

The following table presents information about the Company’s financial assets measured at estimated fair value on a recurring basis that is reflected in the consolidated balance sheets at carrying value. The table indicates the fair value hierarchy of the valuation techniques utilized by the Company to determine such fair value as of December 31, 2023 and 2022:

 

   (Level 1)   (Level 2)   (Level 3)   Total 
   Fair Value Measurements Using     
   (Level 1)   (Level 2)   (Level 3)   Total 
As of December 31, 2023  ($ in thousands) 
Financial Assets:                    
Cash and cash equivalents  $495   $   -   $-   $495 
                     
Restricted cash and cash equivalents  $3,250   $-   $-   $3,250 
                     
Other investments  $

2,193

   $-   $285   $2,478 
                     
Equity securities  $680   $-   $-   $680 
                     
Total  $6,618   $-   $285   $6,903 

 

   (Level 1)   (Level 2)   (Level 3)   Total 
   Fair Value Measurements Using     
   (Level 1)   (Level 2)   (Level 3)   Total 
As of December 31, 2022  ($ in thousands) 
Financial Assets:                    
Cash and cash equivalents  $1,207   $-   $-   $1,207 
                     
Restricted cash and cash equivalents  $2,721   $-   $-   $2,721 
                     
Other investments  $-   $-   $11,423   $11,423 
                     
Equity securities  $642   $-   $-   $642 
                     
Total  $4,570   $-   $11,423   $15,993 

 

F-13
 

 

OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES

Notes to Consolidated Financial Statements, Continued

 

4. INVESTMENTS (continued)

 

Assets Measured at Estimated Fair Value on a Recurring Basis

 

There were no transfers between Levels 1, 2 or 3 during the years ended December 31, 2023 and 2022 except as disclosed below.

 

In the financial statements for the year ended December 31, 2023, there has been a notable change in the classification of our investment in Jet.AI from Level 3 to Level 1 within the fair value hierarchy. This change is attributed to Oxbridge Acquisition Corp. (“OXAC”) successfully completing a business combination with Jet.AI Inc (“Jet.AI”) in August 2023, resulting in the investment now having an active market with readily available quoted prices.

Previously classified as Level 3 due to the reliance on unobservable inputs, the investment is now categorized as Level 1, as it is valued based on quoted prices in an active market. This change reflects the increased liquidity and transparency associated with Jet.AI’s publicly traded status, allowing for a more reliable and market-driven valuation of our investments.

 

The following table provides a reconciliation of changes in fair value of the beginning and ending balances for the other investments classified as Level 3:

 

   Year ended 
   December 31, 
   2023   2022 
   ($ in thousands) 
Fair value of Level 3 other investments at beginning of year  $11,423   $11,173 
Transfer to Level 1   (11,138)     
Investment in affiliate   -    285 
Change in valuation inputs or other assumptions   -    (35)
Fair value of Level 3 other investment at December 31, 2023  $285   $11,423 

 

F-14
 

 

OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES

Notes to Consolidated Financial Statements, Continued

 

5. TAXATION

 

Under current Cayman Islands law, no corporate entity, including the Company and the subsidiaries, is obligated to pay taxes in the Cayman Islands on either income or capital gains. The Company and Oxbridge Reinsurance Limited have an undertaking from the Governor-in-Cabinet of the Cayman Islands, pursuant to the provisions of the Tax Concessions Law, as amended, that, in the event that the Cayman Islands enacts any legislation that imposes tax on profits, income, gains or appreciations, or any tax in the nature of estate duty or inheritance tax, such tax will not be applicable to the Company and Oxbridge Reinsurance Limited, or their operations, or to the ordinary shares or related obligations, until April 23, 2033 and May 17, 2033, respectively.

 

The Company and its subsidiaries intend to conduct substantially all of their operations in the Cayman Islands in a manner such that they will not be engaged in a trade or business in the U.S. However, because there is no definitive authority regarding activities that constitute being engaged in a trade or business in the U.S. for federal income tax purposes, the Company cannot assure that the U.S. Internal Revenue Service will not contend, perhaps successfully, that the Company or its subsidiaries are engaged in a trade or business in the U.S. A foreign corporation deemed to be so engaged would be subject to U.S. federal income tax, as well as branch profits tax, on its income that is treated as effectively connected with the conduct of that trade or business unless the corporation is entitled to relief under an applicable tax treaty.

 

6. VARIABLE INTEREST ENTITIES

 

Oxbridge Re NS. On December 22, 2017, the Company established Oxbridge Re NS, a Cayman domiciled and licensed special purpose insurer, formed to provide additional collateralized capacity to support Oxbridge Reinsurance Limited’s reinsurance business. In respect of the debt issued by Oxbridge Re NS to investors, Oxbridge Re NS has entered into a retrocession agreement with Oxbridge Reinsurance Limited effective June 1, 2020. Under this agreement, Oxbridge Re NS receives a quota share of Oxbridge Reinsurance Limited’s catastrophe business. Oxbridge Re NS is a non-rated insurer and the risks have been fully collateralized by way of funds held in trust for the benefit of Oxbridge Reinsurance Limited. Oxbridge Re NS is able to provide investors with access to natural catastrophe risk backed by the distribution, underwriting, analysis and research expertise of Oxbridge Re.

 

The Company has determined that Oxbridge Re NS meets the definition of a VIE as it does not have sufficient equity capital to finance its activities. The Company concluded that it is the primary beneficiary and has consolidated the subsidiary upon its formation, as it owns 100% of the voting shares, 100% of the issued share capital and has a significant financial interest and the power to control the activities of Oxbridge Re NS that most significantly impacts its economic performance. The Company has no other obligation to provide financial support to Oxbridge Re NS. Neither the creditors nor beneficial interest holders of Oxbridge Re NS have recourse to the Company’s general credit.

 

Upon issuance of a series of participating notes by Oxbridge Re NS, all of the proceeds from the issuance are deposited into collateral accounts, to fund any potential obligation under the reinsurance agreements entered into with Oxbridge Reinsurance Limited underlying such series of notes. The outstanding principal amount of each series of notes generally is expected to be returned to holders of such notes upon the expiration of the risk period underlying such notes, unless an event occurs which causes a loss under the applicable series of notes, in which case the amount returned is expected to be reduced by such noteholder’s pro rata share of such loss, as specified in the applicable governing documents of such notes.

 

In addition, holders of such notes are generally entitled to interest payments, payable annually, as determined by the applicable governing documents of each series of notes.

 

Oxbridge Re Holdings Limited receives an origination and structuring fee in connection with the formation, operation, and management of Oxbridge Re NS.

 

F-15
 

 

OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES

Notes to Consolidated Financial Statements, Continued

 

6. VARIABLE INTEREST ENTITIES (continued)

 

Notes Payable to Series 2020-1 noteholders

 

Oxbridge Re NS entered into a retrocession agreement with Oxbridge Reinsurance Ltd on June 1, 2020 and issued $216,000 of participating notes which provides quota share support for Oxbridge Re’s global property catastrophe excess of loss reinsurance business. The participating notes have been assigned Series 2020-1 and matured on June 1, 2023. Participating notes totaling $98,000 were redeemed during the year-ended December 31, 2023 resulting in a balance due of $118,000 at December 31, 2023. None of the participating notes were redeemed during the year ended December 31, 2022.

 

The income from Oxbridge Re NS operations that are attributable to the participating notes noteholders for year ended December 31, 2023 was $0. The income from Oxbridge Re NS operations that are attributable to the participating notes noteholders for the year ended December 31, 2022 was $43,000 and are included within accounts payable and other liabilities at December 31, 2023 and 2022.

 

SurancePlus Inc.

 

SurancePlus Inc., a wholly-owned subsidiary of Oxbridge Re Holdings Limited, was incorporated as a British Virgin Islands Business Company on December 19, 2022 for the purposes of tokenizing reinsurance contracts underwritten by its affiliated licensed reinsurer, Oxbridge Re NS.

 

On March 27, 2023, the Company and SurancePlus Inc. (“SurancePlus”), issued a press release announcing the commencement of an offering by SurancePlus of DeltaCat Re tokenized reinsurance securities (the “Tokens”), which represent Series DeltaCat Preferred Shares of SurancePlus (“Preferred Shares”, and together with the Tokens, the “Securities”). Each digital security or token, which will have a purchase price of $10.00 per Token, will represent one Preferred Share of SurancePlus. On September 11, 2023, the DeltaCat Re tokens were reclassified as tokenized interests carrying rights equivalent to the DeltaCat Re Preferred Shares in accordance with the provisions of British Virgin Islands law.

 

The proceeds from the offer and sale of the Securities will be used by SurancePlus to purchase one or more participating notes of Oxbridge Re NS, and the proceeds from the sale of participating notes will be invested in collateralized reinsurance contracts to be underwritten by Oxbridge Re NS. The holders of the digital Securities will generally be entitled to proceeds from the payment of participating notes in the amount of a preferred return of 20% plus an additional 80% of any proceeds in excess of the amount necessary to pay the preferred return. Assuming no casualty losses to properties reinsured by Oxbridge Re’s reinsurance subsidiaries, DeltaCat Re token investors are expected to receive an annual return on the original purchase price of 42%.

 

On June 27, 2023, SurancePlus Inc. completed its private placement (the “Private Placement”) of Series DeltaCat Re Preferred Shares represented by DeltaCat Re Tokens (the “Securities”). On June 27, 2023, SurancePlus entered into subscription agreements with accredited investors and non-U.S. persons in the Private Placement with respect to 229,766 of the Securities at a purchase price of $10.00 per token for aggregate gross proceeds of $2,297,660. SurancePlus also previously entered into subscription agreements for and sold 15,010 of the Securities between April 5, 2023 and May 18, 2023 for gross proceeds of $150,100, also at a purchase price of $10.00 per token. The aggregate amount raised in the Private Placement was $2,447,760 for the issuance of 244,776 Securities of which approximately $1,280,000 was received from third-party investors and approximately $1,167,000 from Oxbridge Re Holdings Limited. Approximately $300,000 and $274,000 of ITOM fees were deducted from the gross proceeds from the third-party investors and Oxbridge Re Holdings Limited, respectively., The tokens were issued on the Avalanche blockchain. Ownership of DeltaCat Re tokenized reinsurance securities indirectly confers fractionalized interests in reinsurance contracts underwritten by Oxbridge Re’s reinsurance subsidiary, Oxbridge Re NS, for the 2023-2024 treaty year.

 

On June 28, 2023, Oxbridge issued a press release announcing the completion of the Private Placement

 

The Securities have not been registered under the Securities Act of 1933, as amended (the “Securities Act”), or any state or other securities laws and may not be offered or sold in the United States absent an effective registration statement or an applicable exemption from registration requirements or a transaction not subject to the registration requirements of the Securities Act or any state or other securities laws. The Securities were sold in a transaction exempt from registration under the Securities Act and were sold only to persons reasonably believed to be accredited investors in the United States under SEC Rule 506(c) under the Securities Act and outside the United States only to non-U.S. persons in accordance with Regulation S under the Securities Act.

 

F-16
 

 

The selected unconsolidated historical financial information and other data presented below is derived from SurancePlus’ standalone unaudited financial statements for year ended December 31, 2023 and the balance sheet data as of December 31, 2023.

 

SCHEDULE OF FINANCIAL STATEMENTS

   For Year Ended 
Statement of Operations Data:  December 31, 2023 
      (Unaudited)   
      
Surance Plus fee income   $574 
Underwriting related income    1,140 
Total revenue   $1,714 
Expenses   $(272)
Income attributable to tokenholders   $(1,036)
Net income   $406 

 

Balance Sheet Data:  At December 31, 2023 
    (Unaudited) 
    (In thousands) 
Total assets  $3,588 
Amounts due to Delta Cat Re Tokenholders*  $2,016 
Due to Parent  $47 
Total shareholder’s equity  $1,525 

 

* includes underwriting profit of $494,000 due to Parent.

 

F-17
 

 

OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES

Notes to Consolidated Financial Statements, Continued

 

7. RESERVE FOR LOSSES AND LOSS ADJUSTMENT EXPENSES

 

The following table summarizes the Company’s loss and loss adjustment expenses (“LAE”) and the reserve for loss and LAE reserve movements for the years ended December 31, 2023 and 2022

  

   2023   2022 
   Year ended 
   December 31, 
   2023   2022 
   ($ in thousands) 
         
Gross balance, beginning of year  $1,073    - 
Incurred, net of reinsurance, related to:          
Current year   -    1,073 
Prior year   -    - 
Total incurred   -    1,073 
Paid related to:          
Current year   -    - 
Prior year   (1,073)   - 
Total paid   -    - 
Balance, end of year  $-    1,073 

 

When losses occur, the reserves for losses and LAE are typically comprised of case reserves (which are based on claims that have been reported) and IBNR reserves (which are based on losses that are believed to have occurred but for which claims have not yet been reported and include a provision for expected future development on existing case reserves). The Company typically suffers limit losses in the event of a Category 3 or above hurricane making landfall in a populated area where the Company has catastrophe risk exposure. For the year ended December 31, 2023, the Company has recorded it’s reserves for losses and LAE based on the contractual maximum loss the Company can suffer under the affected contracts.

 

The uncertainties inherent in the reserving process and potential delays by cedants and brokers in the reporting of loss information, together with the potential for unforeseen adverse developments, may result in the reserve for losses and LAE ultimately being significantly greater or less than the reserve provided at the end of any given reporting period. The degree of uncertainty is further increased when a significant loss event takes place near the end of a reporting period. Reserve for losses and LAE estimates are reviewed periodically on a contract-by-contract basis and updated as new information becomes known. Any resulting adjustments are reflected in income in the period in which they become known.

 

The Company’s reserving process is highly dependent on the timing of loss information received from its cedants and related brokers.

 

There were no losses incurred during the year ended December 31, 2023. The losses incurred during the year ended December 31, 2022 related to a first limit loss suffered by the Company as a result of underwriting exposure to Hurricane Ian, which made landfall in Florida on September 28, 2022.

 

F-18
 

 

OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES

Notes to Consolidated Financial Statements, Continued

 

7. RESERVE FOR LOSSES AND LOSS ADJUSTMENT EXPENSES (continued)

 

Reserving methodologies and assumptions

 

Loss reserves are generally established based on loss payments and case reserves reported by clients when, and if, received. Estimates for IBNR losses are added to the case reserves. To establish IBNR loss estimates, the Company uses quarterly actuarial estimates from its independent actuary, who utilizes loss data reported by the Company along with industry loss data and information, knowledge of the business written and actuary’s own professional judgment.

 

The independent actuary employs standard actuarial methods for its analysis each quarter. Such methods may include the:

 

  Reported Loss Development Method. Ultimate losses are estimated by calculating past reported loss development factors and applying them to exposure periods with further expected reported loss development. Since reported losses include payments and case reserves, changes in both of these amounts are incorporated in this method.
     
  Expected Loss Ratio Method. Ultimate losses are estimated by multiplying earned premiums by an expected loss ratio. The expected loss ratio is selected using industry data, historical company data and actuarial professional judgment. This method is typically used for lines of business and contracts where there are no historical losses or where past loss experience is not credible.
     
  Bornhuetter-Ferguson Reported Loss Method. Ultimate losses are estimated by modifying expected loss ratios to the extent reported losses experienced to date differ from what would have been expected to have been reported based upon the selected reported loss development pattern. This method avoids some of the distortions that could result from a large development factor being applied to a small base of reported losses to calculate ultimate losses.
     
  Frequency / Severity Method. Ultimate losses are estimated under this method by multiplying the ultimate number of claims (i.e. the frequency multiplied by the exposure base on which the frequency has been determined), by the estimated ultimate average cost per claim (i.e. the severity). By analyzing claims experience by its frequency and severity components, the Company can examine trends and patterns in the rates of claims emergence (i.e. reporting) and settlement (i.e. closure) as well as in the average cost of claims.
     
    The approach is valuable because sometimes there is more inherent stability in the frequency and severity data when viewed separately rather than in the total losses

 

F-19
 

 

OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES

Notes to Consolidated Financial Statements, Continued

 

7. RESERVE FOR LOSSES AND LOSS ADJUSTMENT EXPENSES (continued)

 

Reserving methodologies and assumptions (continued)

 

In addition, the Company may supplement its analysis with other reserving methodologies that are deemed to be relevant to specific contracts.

 

For each contract, the Company utilizes reserving methodologies that are deemed appropriate to calculate a best estimate, or point estimate, of reserves. The decision of whether to use a single methodology or a combination of multiple methodologies depends upon the judgment of the independent actuary, if utilized. The Company’s reserving methodology does not require a fixed weighting of the various methods used. Certain methods are considered more appropriate depending on the type and structure of the contract, the age and maturity of the contract, and the duration of the expected paid losses on the contract.

 

The Company’s gross aggregate reserves are the sum of the point estimate reserves of all portfolio exposures. Generally, IBNR loss reserves are calculated by estimating the ultimate incurred losses at any point in time and subtracting cumulative paid claims and case reserves, which incorporate specific exposures, loss payment and reporting patterns and other relevant factors.

 

There were no significant changes in the Company’s methodology or assumptions relating to the Company’s reserve for loss and loss adjustment expenses for the years ended December 31, 2023 or 2022.

 

Claims Development Tables, IBNR Reserves and Claims Frequency

 

The following table discloses information about the Company’s incurred and paid claims development as of December 31, 2023, as well as cumulative claim frequency and the total of incurred-but-not-reporting and expected development on reported claims included within the net incurred claims amounts. A claim is defined as a reported loss from a cedant on an excess-of-loss reinsurance contract arising from a loss event for which the Company records a paid loss or case reserve. The Company operates a single business segment, being property catastrophe reinsurance.

 

F-20
 

 

OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES

Notes to Consolidated Financial Statements, Continued

 

7. RESERVE FOR LOSSES AND LOSS ADJUSTMENT EXPENSES (continued)

 

Property Catastrophe Reinsurance

 

(in thousands)

 

Incurred Losses and Loss Adjustment Expenses

 

Accident Year  2016   2017   2018   2019   2020   2021   2022    2023   

As of December 31, 2023 Total of Incurred-but
-Not-Reported Liabilities
Plus Expected Development on
Reported Claims

   Cumulative Number of Reported Claims 
                                       (dollars in thousands) 
2016  $14,775   $18,801   $17,795   $17,689   $17,689   $17,689   $17,689    $ 17,689    $-    5 
2017       $38,401   $38,401   $38,401   $38,401   $38,401   $38,401    $ 38,401    $-    8 
2018            $10,000   $10,000   $10,000   $10,000   $10,000    $ 10,000    $-    2 
2019                 $-   $-   $-   $-    $ -    $-    - 
2020                      $-   $-   $-    $ -    $-    - 
2021                           $158   $158    $ 158    $-    1 
2022                                $1,073    $ 1,073    $              -          1 
2023                                $-    $ -    $-    - 
    Total                             $67,321    $ 67,321    $-      

 

Cumulative Paid Losses and Loss Adjustment Expenses

 

Accident Year  2016   2017   2018   2019   2020   2021   2022  2023  
2016  $6,073   $16,073   $17,687   $17,689   $17,689   $17,689   $17,689  $ 17,689  
2017       $36,293   $38,401   $38,401   $38,401   $38,401   $38,401  $

38,401

 
2018            $6,000   $10,000   $10,000   $10,000   $10,000  $ 10,000  
2019                 $-   $-   $-   $-  $ -  
2020                      $-   $-   $-  $ -  
2021                           $158   $158  $ 158  
2022                                $1,073  $ 1,073  
2023                           $-       $ -  
    Total                            $67,321  $ 67,321  
Reserve for loss and loss adjustment expenses at December 31, 2023, net of reinsurance                                $ -   $ -  

 

The following table shows the historical average annual percentage payout of claims at December 31, 2022.

 

   Average Annual Percentage Payout of Incurred Claims by Age 
                         
Years   1    2    3    4    5    6 
                               
Property Catastrophe Reinsurance   57.8%   34.0%   9.1%   0.0%   0.0%   0%

 

F-21
 

 

OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES

Notes to Consolidated Financial Statements, Continued

 

8. LOSS PER SHARE

 

A summary of the numerator and denominator of the basic and diluted loss per share is presented below (dollars in thousands except per share amounts):

 

SCHEDULE OF COMPUTATION OF BASIC AND DILUTED LOSS EARNING PER SHARE

   2023   2022 
   Years ended December 31 
   2023   2022 
         
Numerator:          
Net loss  $(9,915)   (1,789)
           
Denominator:          
Weighted average shares - basic   5,867,129    5,772,396 
Effect of dilutive securities - Stock options   -    - 
Shares issuable upon conversion of warrants   -    - 
Weighted average shares - diluted   5,867,129    5,772,396 
Loss per share - basic  $(1.69)   (0.31)
Loss earnings per share - diluted  $(1.69)   (0.31)

 

For the years ended December 31, 2023, and 2022, options to purchase 871,250 ordinary shares were anti-dilutive due to the net losses during those years.

 

GAAP requires the Company to use the two-class method in computing basic loss per share since holders of the Company’s restricted stock have the right to share in dividends, if declared, equally with common stockholders. These participating securities effect the computation of both basic and diluted loss per share during the years ended December 31, 2023 and 2022.

 

F-22
 

 

OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES

Notes to Consolidated Financial Statements, Continued

 

9. WARRANTS

 

There were 8,230,700 warrants outstanding at December 31, 2023 and 2022. One warrant may be exercised to acquire one ordinary share at an exercise price equal to $7.50 per share on or before March 26, 2024. The Company at its option may cancel the warrants in whole or in part, provided that the closing price per ordinary share has exceeded $9.38 for at least ten trading days within any period of twenty consecutive trading days, including the last trading day of the period. No warrants were exercised during the years ended December 31, 2023 and 2022.

 

On January 29, 2024, the Company extended the expiration date of the warrants (NASDAQ: OXBRW) (the “Warrants”) to 5:00 p.m. Philadelphia time on the earlier to occur of (a) March 26, 2029 and (b) the date fixed for cancellation by the Company following any 20-trading day period in which the Company’s ordinary shares traded above $9.38 per share for at least ten trading days.

 

10. DIVIDENDS

 

As of December 31, 2023, none of the Company’s accumulated deficit were restricted from payment of dividends to the company’s shareholders. However, since most of the Company’s capital and retained earnings may be invested in its subsidiaries, a dividend from the subsidiaries would likely be required in order to fund a dividend to the Company’s shareholders and would require notification to the Cayman Islands Monetary Authority (“CIMA”).

 

Under Cayman Islands law, the use of additional paid-in capital is restricted, and the Company will not be allowed to pay dividends out of additional paid-in capital if such payments result in breaches of the prescribed and minimum capital requirement.

 

11. SHARE-BASED COMPENSATION

 

The Company currently has outstanding share-based awards granted under the 2014 Omnibus Incentive Plan (the “2014 Plan”) and the 2021 Omnibus Incentive Plan (the “2021 Plan”) (herein collectively referred to as “the Plans”). Under each of the Plans, the Company has discretion to grant equity and cash incentive awards to eligible individuals, including the issuance of up to 1,000,000 of the Company’s ordinary shares. During the year ended December 31, 2023, the Company granted an aggregated of 100,647 of restricted stock to directors, officers and employees under the 2021 Plan. At December 31, 2023, there were 895,353 shares and 11,750 shares available for grant under the 2021 Plan and the 2014 Plan, respectively.

 

Stock options

 

Stock options granted and outstanding under the Plans vests quarterly over four years and are exercisable over the contractual term of ten years.

 

A summary of the stock option activity for the years ended December 31, 2023 and 2022 is as follows (option amounts not in thousands):

 

   Number of Options  

Weighted-

Average

Exercise

Price

   Weighted- Average Remaining Contractual Term   Aggregate Intrinsic Value 
                 
Outstanding at December 31, 2022   871,250   $4.67    5.8 years   $- 
Exercisable at December 31, 2022   721,250   $4.39    5.3 years   $- 
                     
Outstanding at December 31, 2022   871,250    4.67    5.8 years   $     - 
Forfeited   (25,000)   (6.00)          
Outstanding at December 31, 2023   846,250   $4.63    4.8 years   $- 
Exercisable at December 31, 2023   783,750   $4.52    4.6 years   $- 

 

F-23
 

 

OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES

Notes to Consolidated Financial Statements, Continued

 

11. SHARE-BASED COMPENSATION (continued)

 

Compensation expense recognized for the years ended December 31, 2023 and 2022 totaled $20,000 and $58,000, respectively, and is included in general and administrative expenses. At December 31, 2023 and 2022, there was approximately $20,000 and $48,000, respectively, of total unrecognized compensation expense related to non-vested stock options granted under the Plans. The Company expects to recognize the remaining compensation expense over a weighted-average period of twelve (12) months.

 

There were no options granted during the year ended December 31, 2023 or 2022.

 

Restricted Stock Awards

 

The Company may grant restricted stock awards to eligible individuals in connection with their service to the Company. The terms of the Company’s outstanding restricted stock grants may include service, performance and market-based conditions. The fair value of the awards with market-based conditions is determined using a Monte Carlo simulation method, which calculates many potential outcomes for an award and then establishes fair value based on the most likely outcome. The determination of fair value with respect to the awards with only performance or service-based conditions is based on the value of the Company’s stock on the grant date.

 

Information with respect to the activity of unvested restricted stock awards during the year ended December 31, 2023 is as follows (share amounts not in thousands):

 

  

Weighted-

Number of

Restricted

Stock Awards

  

Weighted-

Average

Grant Date

Fair Value

 
         
Nonvested at January 1, 2022   15,000      
Granted   32,000   $3.57 
Vested   (12,000)     
Forfeited   (12,000)   3.57 
Nonvested at December 31, 2022   23,000      
Granted   100,647   $2.37 
Vested   (77,574)   2.37 
Nonvested at December 31, 2023   46,073      

 

Compensation expense recognized for the years ended December 31, 2023 and 2022 totaled $238,000 and $69,000, respectively, and is included in general and administrative expenses. At December 31, 2023 and 2022, there was approximately $133,000 and $121,000, respectively, of unrecognized compensation expense related to non-vested restricted stock granted under the Plans. The Company expects to recognize the remaining compensation expense over a weighted-average period of seven (7) months.

 

F-24
 

 

OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES

Notes to Consolidated Financial Statements, Continued

 

12. NET WORTH FOR REGULATORY PURPOSES

 

The subsidiaries are subject to a minimum and prescribed capital requirement as established by CIMA. Under the terms of their respective licenses, Oxbridge Reinsurance Limited and Oxbridge Re NS are required to maintain a minimum and prescribed capital requirement of $500 in accordance with the relevant subsidiary’s approved business plan filed with CIMA.

 

At December 31, 2023, the Oxbridge Reinsurance Limited’s net worth of $10 thousand exceeded the minimum and prescribed capital requirement. For the years ended December 31, 2023 and 2022, Oxbridge Reinsurance Ltd.’s net loss was approximately $11.29 million and $2.0 million, respectively.

 

At December 31, 2023, the Oxbridge Re NS’ net worth of $223 thousand exceeded the minimum and prescribed capital requirement. For the years ended December 31, 2023 and 2022, Oxbridge Re NS’ net income was approximately $68,000 and $11,000, respectively.

 

The Subsidiaries are not required to prepare separate statutory financial statements for filing with CIMA, and there were no material differences between the Subsidiaries’ GAAP capital, surplus and net income, and its statutory capital, surplus and net income as of December 31, 2023 or for the year then ended.

 

13. FAIR VALUE AND CERTAIN RISKS AND UNCERTAINTIES

 

Fair values

 

With the exception of balances in respect of insurance contracts (which are specifically excluded from fair value disclosures under GAAP) and investment securities as disclosed in Note 4 of these consolidated financial statements, the carrying amounts of all other financial instruments, which consist of cash and cash equivalents, restricted cash and cash equivalents, premiums receivable and other assets, loan receivable, notes payable, and accounts payable and other liabilities, approximate their fair values due to their short-term nature.

 

Concentration of underwriting risk

 

A substantial portion of the Company’s current reinsurance business ultimately relates to the risks of a limited number of entities; accordingly, the Company’s underwriting risks are not diversified.

 

Concentrations of Credit and Counterparty Risk

 

The Company markets retrocessional and reinsurance policies worldwide through its brokers. Credit risk exists to the extent that any of these brokers may be unable to fulfill their contractual obligations to the Company. For example, the Company is required to pay amounts owed on claims under policies to brokers, and these brokers, may fail to pay over the money to the cedants. In some jurisdictions, if a broker fails to make such a payment, the Company might remain liable to the ceding company for the deficiency. In addition, in certain jurisdictions, when the ceding company pays premiums for these policies to brokers, these premiums are considered to have been paid and the ceding insurer is no longer liable to the Company for those amounts, whether or not the premiums have actually been received.

 

The Company remains liable for losses it incurs to the extent that any third-party reinsurer is unable or unwilling to make timely payments under reinsurance agreements. The Company would also be liable in the event that its ceding companies were unable to collect amounts due from underlying third-party reinsurers.

 

The Company mitigates its concentration of credit risk and counterparty risk by using reputable several counterparties which decreases the likelihood of any significant concentration of credit risk with any one counterparty.

 

F-25
 

 

OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES

Notes to Consolidated Financial Statements, Continued

 

13. FAIR VALUE AND CERTAIN RISKS AND UNCERTAINTIES (continued)

 

Market risk

 

Market risk exists to the extent that the values of the Company’s monetary assets fluctuate as a result of changes in market prices. Changes in market prices can arise from factors specific to individual securities or their respective issuers, or factors affecting all securities traded in a particular market. Relevant factors for the Company are both volatility and liquidity of specific securities and markets in which the Company holds investments. The Company has established investment guidelines that seek to mitigate significant exposure to market risk.

 

14. LEASES

 

Operating lease right-of-use assets and operating lease liabilities are recognized in the consolidated balance sheets. We determine if a contract contains a lease at inception and recognize operating lease right-of-use assets and operating lease liabilities based on the present value of the future minimum lease payments at the commencement date. As our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at the commencement date in determining the present value of future payments. Lease agreements that have lease and non-lease components, are accounted for as a single lease component. Lease expense is recognized on a straight-line basis over the lease term.

 

The Company has two operating lease obligations namely for the Company’s office facilities located at Suite 201, 42 Edward Street Grand Cayman, Cayman Islands and residential space at Turnberry Villas in Grand Cayman, Cayman Islands. The office lease has a remaining lease term of approximately two (2) month and was renewed subsequent to year end for a period of five (5) years. The residential lease has a remaining lease term of less than 1 month and was renewed subsequent to year end for a period of three (3) years.

 

F-26
 

 

OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES

Notes to Consolidated Financial Statements, Continued

 

14. LEASES (continued)

 

The components of lease expense and other lease information as of and during the years ended December 31, 2023 and 2022 are as follows:

 

(in thousands)  2023   2022 
  

Year Ended December 31,

 
(in thousands)  2023   2022 
Operating Lease Cost (1)  $108   $96 
           
Cash paid for amounts included in the measurement of lease liabilities          
Operating cash flows from operating leases  $108   $96 

 

(1) Includes short-term leases

 

(in thousands)  2023   2022 
   At December 31, 
(in thousands)  2023   2022 
Operating lease right-of-use assets  $9   $44 
           
Operating lease liabilities  $9   $44 
           
Weighted-average remaining lease term - operating leases   0.39 years     1.17 years 
           
Weighted-average discount rate - operating leases   7.13%   6.5%

 

Future minimum lease payments under non-cancellable leases as of December 31, 2023 and 2022, reconciled to our discounted operating lease liability presented on the consolidated balance sheets are as follows:

 

(in thousands)  2023   2022 
   At December 31, 
(in thousands)  2023   2022 
2023  $-   $40 
2024            9           6 
Total future minimum lease payments  $9   $46 
           
Less imputed interest   -    (2)
Total operating lease liabilities  $9   $44 

 

F-27
 

 

OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES

Notes to Consolidated Financial Statements, Continued

 

15. RELATED PARTY TRANSACTIONS

 

Administrative Services Agreement

 

Commencing on the effective date of the SPAC’s IPO, the Sponsor agreed to pay the Company a total of up to $10,000 per month for office space, utilities, secretarial and administrative support to the Sponsor and the SPAC. Upon completion of the SPAC’s initial Business Combination or the SPAC’s liquidation, the Sponsor will cease paying these monthly fees. For the years ended December 31, 2023 and 2022, the company recorded income of $80,000 and $90,000, respectively, from the Sponsor under the Administrative Services Agreement, which is included in “net investment and other income” in the consolidated statements of operations. At December 31, 2023, the Company recorded a receivable of $62,000 relating to the Oxbridge Reinsurance portion of the working capital loan which is included in “due from related parties” in the consolidated balance sheets. At December 31, 2022, the Company recorded a receivable of $45,000 which is included in “due from related parties” in the consolidated balance sheets.

 

Participating Notes

 

During the year ending December 31, 2021, Mr. Jay Madhu, a director and officer of the Company and its subsidiaries, invested a principal amount of $68,000 in Series 2020-1 participating notes. During the year ended December 31, 2023, Mr. Madhu received a payment of $76,000 representing partial redemption of principal and return on investment.

 

DeltaCat Re Tokens

 

During the year ended December 31, 2023, Mr. Jay Madhu, a director and officer of the Company and its subsidiaries, entered into subscription agreement to purchase a total of 6,200 Series DeltaCat Re tokens at a purchase price of $10.00 per token for aggregate gross proceeds of $62,000. Ownership of DeltaCat Re tokenized reinsurance securities indirectly confers fractionalized interests in reinsurance contracts underwritten by Oxbridge Re NS for the 2023-2024 treaty year.

 

TypTap Insurance Company (“TypTap”) Contract

 

During the year ended December 31, 2023 the Company entered into a reinsurance agreement with TypTap, an insurance subsidiary of HCI Group, Inc., which is a related entity through common directorship. At December 31, 2023, included within premium receivable, deferred acquisition costs and unearned premiums on the consolidated balance sheets are amounts equal to $489,000, $50,000 and $458,000 respectively, relating to the reinsurance agreement with TypTap. During the year ended December 31, 2023, included within assumed premiums, change in unearned premium reserve and policy acquisition costs and underwriting expenses on the consolidated statements of operations are amounts equal to $1,099,000, ($458,000) and $70,000, respectively.

 

Bridge Loan with Affiliate

 

On September 11, 2023, the Company, along with seven (7) other investors, entered into a binding term sheet (“Bridge Agreement”) with Jet.AI to provide Jet.AI with an aggregate sum of $500,000 of short-term bridge financing pending its receipt of funds from its other existing financing arrangements. During the month of September 2023, and prior to the Bridge Agreement, Jet.AI had engaged in discussions with numerous third parties to secure short-term bridge funding but was not offered terms it found acceptable.

 

The Bridge Agreement provides for the issuance of Notes in an aggregate principal amount of $625,000, reflecting a 20% original issue discount. The Notes bear interest at 5% per annum and mature on March 11, 2024. Jet.AI is required to redeem the Notes with 100% of the proceeds of any equity or debt financing at a redemption premium of 110% of the principal amount of the Notes. Jet.AI anticipates redeeming the Notes in full with proceeds expected to be received over the next several months from existing financing arrangements.

 

An event of default under the Notes includes failing to redeem the Notes as provided above and other typical bankruptcy events of Jet.AI. In an event of default, the outstanding principal amount of the Notes will increase by 120%, and the company may convert its Note into shares of common stock of Jet.AI at the conversion price set forth in the Bridge Agreement with registration rights associated with those shares.

 

The Company invested the sum of $100,000 in the Notes and is recorded as “Loan Receivable” on the consolidated balance sheets at cost. On March 11, 2024, the Notes matured and were redeemed by Jet.AI in accordance with the Bridge Agreement. The Company receive an aggregate of $140,000 upon the redemption of the Notes.

 

F-28
 

 

16. PROPERTY AND EQUIPMENT, NET

 

Property and equipment, net consist of the following (in thousands):

 

   2023   2022 
   At December 31, 
   2023   2022 
         
Leasehold improvements  $21   $21 
Furniture and Fixtures   41    38 
Motor vehicle   34    34 
Computer equipment and software   39    37 
Total, at cost   135    130 
less accumulated depreciation and amortization   (131)   (125)
Property and equipment, net  $4   $5 

 

F-29
 

 

OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES

Notes to Consolidated Financial Statements, Continued

 

17. SUBSEQUENT EVENTS

 

We evaluate all subsequent events and transactions for potential recognition or disclosure in our consolidated financial statements.

 

Other than as disclosed in Notes 9 and 15 above, there were no events subsequent to December 31, 2023 for which disclosure was required.

 

F-30
 

 

SCHEDULE I

 

OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES

SUMMARY OF INVESTMENTS - OTHER THAN INVESTMENTS IN RELATED PARTIES

AS OF DECEMBER 31, 2023

 

(expressed in thousands of U.S. dollars)

 

   Cost or       Consolidated 
   Amortized   Fair   Balance Sheet 
Type of investment  Cost   Value   Value 
             
Equity securities  $1,926   $680   $680 
                
Total investments  $1,926   $680   $680 

 

F-31
 

 

SCHEDULE II

 

OXBRIDGE RE HOLDINGS LIMITED

CONDENSED FINANCIAL INFORMATION OF REGISTRANT

CONDENSED BALANCE SHEET - PARENT COMPANY ONLY

(expressed in thousands of U.S. Dollars)

 

Schedule II - Condensed Financial Information of Registrant 

   2023   2022 
   At December 31, 
   2023   2022 
         
Assets          
           
Cash and cash equivalents   247    931 
Equity securities   680    642 
Investment in subsidiaries   1,757    9,389 
Due from subsidiaries   2,905    3,872 
Due from related party   -    35 
Loan receivable   

100

    - 
Prepayment and other assets   82    105 
Prepaid offering costs   -    133 
Operating lease right-of-use assets   9    44 
Property and equipment, net   4    5 
Total assets  $5,784    15,156 
           
Liabilities and Shareholders’ Equity          
Liabilities:          
Operating lease liabilities   9    44 
Due to Subsidiary   250    - 
Accounts payable and other liabilities   193    123 
Total liabilities   452    167 
           
Shareholders’ equity:          
Ordinary share capital   6    6 
Additional paid-in capital   32,740    32,482 
Accumulated Deficit   (27,414)   (17,499)
Total shareholders’ equity   5,332    14,989 
Total liabilities and shareholders’ equity  $5,784    15,156 

 

F-32
 

 

SCHEDULE II (continued)

 

OXBRIDGE RE HOLDINGS LIMITED

CONDENSED FINANCIAL INFORMATION OF REGISTRANT

CONDENSED STATEMENTS OF OPERATIONS - PARENT COMPANY ONLY

(expressed in thousands of U.S. Dollars)

 

   2023   2022 
   Years Ended December 31, 
   2023   2022 
         
Revenue          
Net investment income  $71    47 
Change in fair value of equity securities   38    (338)
Net realized investment gain   -    27 
Management fees and other income   2,978    1,883 
Operating expenses   (1,912)   (1,406)
Income before equity in loss of subsidiaries   1,175    213 
Equity in loss of subsidiaries   (11,090)   (2,002)
           
Net loss  $(9,915)   (1,789)

 

F-33
 

 

SCHEDULE II (continued)

 

OXBRIDGE RE HOLDINGS LIMITED

CONDENSED FINANCIAL INFORMATION OF REGISTRANT

CONDENSED STATEMENT OF CASH FLOWS - PARENT COMPANY ONLY

(expressed in thousands of U.S. Dollars)

 

   2023   2022 
   Years Ended December 31, 
   2023   2022 
Operating activities          
Net loss  $(9,915)   (1,789)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:          
Equity in loss of subsidiaries   11,090    2,002 
Share-based compensation   258    127 
Underwriting Income – SurancePlus   (494)   - 
Depreciation   6    4 
Net realized investment gain   -    (27)
Change in fair value of equity securities   (38)   338 
Change in operating assets and liabilities:          
Due from subsidiary   967    (1,763)
Due from related party   35   (30)
Due to subsidiary   250    - 
Prepayment and other assets   23    (55)
Prepaid offering costs   133    (133)
Accounts payable and other liabilities   70    (87)
           
Net cash provided by (used in) operating activities  $2,385    (1,413)
           
Investing activities          
Purchase of equity securities   -    (1,002)
Purchase of loan receivable   (100)   - 
Investment in subsidiary   (2,964)   (507)
Proceeds from sale of equity securities   -    626 
Purchase of property and equipment   (5)   - 
           
Net cash used in investing activities  $(3,069)   (883)
           
Net change in cash and cash equivalents   (684)   (2,296)
Cash and cash equivalents at beginning of year   931    3,227 
Cash and cash equivalents at end of year  $247   931 

 

F-34
 

 

SCHEDULE III

 

OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES

SUPPLEMENTARY INSURANCE INFORMATION

FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

(expressed in thousands of U.S. dollars)

Schedule III - Supplementary Insurance Information  

                                        
Year  Segment 

Deferred

acquisition

costs, net

  

Reserves

for losses

and loss

adjustment

expenses

– gross

  

Unearned

premiums

– gross

  

Net

premiums

earned

  

Investment

income

  

Net losses,

and loss

adjustment

expenses

  

Amortization

of deferred

acquisition

costs

  

Operating

expenses

  

Gross

premiums

written

 
2023  Property & Casualty  $        -   $    -   $-   $1,255   $   -   $-   $141   $2,183   $2,170 
                                                 
2022  Property & Casualty  $-   $1,073   $-   $995   $27   $1,073   $110   $1,413   $645 

 

F-35
 

 

SCHEDULE IV

 

OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES

REINSURANCE INFORMATION

FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

 

(expressed in thousands of U.S. dollars)

Schedule IV - Reinsurance Information 

 

                        
Year  Segment 

Direct

Gross

Premiums

  

Premiums

ceded to

other

companies

  

Premiums

assumed

from other

companies

   Net amount  

Percentage

of amount

assumed to

net

 
2023  Property & Casualty  $-   $-   $2,170   $2,170    100%
                                  
2022  Property & Casualty  $-   $      -   $645   $645    100%

 

F-36

 

EX-4.4 2 ex4-4.htm

 

Exhibit 4.4

 

Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934, as amended

 

As of December 31, 2023, Oxbridge Re Holdings Limited (the “Company,” “we,” “us,” and “our”) had two classes of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) – our ordinary shares and warrants to purchase ordinary shares.

 

The following description of our capital stock is a summary and does not purport to be complete. It is subject to and qualified in its entirety by reference to our Third Amended and Restated Memorandum and Articles of Association (“Articles”) and our form of Warrant Agreement (as amended by Amendment #2 to Warrant Agreement), each of which is filed as an exhibit to our Annual Report on Form 10-K for the fiscal year ended December 31, 2023 and incorporated by reference herein.

 

Ordinary Shares

 

General

 

The ordinary shares constitute common equity of our company. We are authorized to issue up to 50,000,000 ordinary shares, par value $0.001. As of the date of this Annual Report on Form 10-K, our share capital consists of only the ordinary shares. However, subject to the provisions in the Articles and without prejudice to any rights of existing shares, the Board of Directors may create different classes of shares and may vary the rights of such classes of shares.

 

Dividends

 

The Board of Directors may declare dividends and other distributions out of funds legally available for dividends and in accordance with the Companies Law of the Cayman Islands (“Companies Law”) and the Articles. Our ability to pay dividends depends on the ability of Oxbridge Reinsurance Limited and/or Oxbridge Re NS, our wholly owned subsidiaries, to pay dividends to us. Oxbridge Reinsurance Limited and Oxbridge Re NS are subject to the Cayman Islands regulatory constraints that affect its ability to pay dividends to us. Under the Cayman Islands law and related regulations, both Oxbridge Reinsurance Limited and Oxbridge Re NS must maintain a minimum net worth and may not declare or pay dividends that would result in non-compliance with such requirements. In addition, under the Cayman Islands law, Oxbridge Reinsurance Limited or Oxbridge Re NS may not pay or declare a dividend unless immediately following the date on which the dividend is proposed to be paid by us, Oxbridge Reinsurance Limited or Oxbridge Re NS, as the case may be, are able to pay our or their debts as they fall due in the ordinary course of business. Accordingly, we may not be able to declare or pay dividends on the ordinary shares. Except as otherwise provided by the rights attached to any shares, the Board of Directors may deduct from any dividend or other distribution payable to any holder of our shares all sums of money payable by such holder to the company.

 

Voting

 

Holders of our ordinary shares are generally entitled to one vote per share, other than in circumstances set forth in the Articles. In certain circumstances, the total voting power of our ordinary shares held by any one person will be reduced to less than 9.9% of the total voting power of the total issued and outstanding ordinary shares. In the event a holder of our ordinary shares acquires shares representing 9.9% or more of the total voting power of our total ordinary shares, there will be an effective reallocation of the voting power of the ordinary shares as described in the Articles.

 

An ordinary resolution to be passed by the shareholders requires the affirmative vote of a simple majority of votes attached to the ordinary shares cast in a general meeting, while a special resolution requires the affirmative vote of no less than two-thirds of votes cast attached to the ordinary shares. A special resolution will be required for important matters such as a change of name or making changes to our Articles.

 

 
 

 

Selection of Directors

 

There are currently five (5) directors on our Board of Directors. The number of directors may be increased or reduced by an ordinary resolution passed by a simple majority of the holders of our shares. Directors may be appointed by an ordinary resolution passed by a simple majority of the holders of our shares. However, the Board of Directors may also appoint an additional director, provided that the appointment does not cause the number of directors to exceed the number fixed in accordance with the Articles as the maximum number of directors.

 

Liquidation

 

On a return of capital on winding up or otherwise (other than on conversion, redemption, or purchase of ordinary shares), assets available for distribution among the holders of ordinary shares will be distributed among the holders of the ordinary shares on a pro rata basis. If our assets available for distribution are insufficient to repay all of the paid-up capital, the assets will be distributed so that the losses are borne by our shareholders proportionately.

 

Preemptive Rights; Redemption Rights; Further Calls and Assessment

 

Although our Articles allow us to issue shares with preemptive rights and redemption rights provisions, the ordinary shares are not subject to any preemptive rights or redemption rights provisions.

 

Our Articles also permit our Board of Directors to make calls upon holders in respect of monies unpaid on their shares.

 

Variations of Rights of Shares

 

If at any time, our share capital is divided into different classes of shares, all or any of the special rights attached to any class of shares may, subject to the provisions of the Companies Law, be varied with the sanction of a special resolution passed at a general meeting of the holders of the shares of that class. Consequently, the rights of any class of shares cannot be detrimentally altered without a majority of two-thirds of the vote of all of the shares in that class. The rights conferred upon the holders of the shares of any class issued with preferred or other rights will not, unless otherwise expressly provided by the terms of issue of the shares of that class, be deemed to be varied by the creation or issue of further shares ranking pari passu with such existing class of shares.

 

General Meetings of Shareholders

 

Shareholders’ meetings may be convened by our Board of Directors. Additionally, on the requisition of shareholders representing not less than 66.66% of the voting rights entitled to vote at general meetings, the board shall convene an extraordinary general meeting. Advance notice of at least ten days is required for the convening of our annual general shareholders’ meeting and any other general meeting of our shareholders. A quorum required for a meeting of shareholders consists of at least two shareholders present or by proxy, representing not less than a majority in par value of the total issued voting shares in our company.

 

Proceedings of Board of Directors

 

Our Articles provide that our business is to be managed and conducted by our Board of Directors. The quorum necessary for the board meeting may be fixed by the board and, unless so fixed at another number, will be a majority of the directors.

 

2
 

 

Exempted Company

 

As a Cayman Islands exempted companies, each of Oxbridge Re Holdings Limited and Oxbridge Reinsurance Limited is prohibited from trading in the Cayman Islands with any person, firm or corporation except in furtherance of our business carried on outside the Cayman Islands.

 

Register of Members

 

Under Cayman Islands law, the register of members (shareholders) is prima facie evidence of title to shares and this register would not record a third-party interest in such shares. However, there are certain limited circumstances where an application may be made to a Cayman Islands court for a determination on whether the register of members reflects the correct legal position. Further, the Cayman Islands court has the power to order that the register of members maintained by a company be rectified where it considers that such register of members does not reflect the correct legal position. The register of members is not filed with, and it does not need to be approved by, the Cayman Islands authorities. Under Cayman Islands law, every person or entity that acquires our shares must have his, her or its name entered on our register of members in order to be considered a shareholder.

 

Warrants

 

Each warrant may be exercised to purchase one ordinary share from us at a purchase price of $7.50 per share. The warrants can be exercised at any time until March 26, 2029. The warrants are exercised by surrendering to us the warrants to be exercised, with an exercise form included therein duly completed and executed and paying to us the exercise price per share in cash or check payable to us. At any time while there is an effective registration statement available for the issuance of shares issuable pursuant to the warrants, the warrants may be exercised only with a cash payment. If a registration statement is not available for the issuance of the underlying shares, the warrants may be exercised on a cashless net-share basis. We are obligated under the warrants to use our best efforts to maintain an effective registration statement with respect to the issuance of the underlying shares. However, under no circumstances will a holder of warrants be entitled to settle the warrants for cash, even in the absence of an effective registration statement.

 

As long as any warrants remain outstanding, ordinary shares to be issued upon the exercise of warrants will be adjusted in the event of one or more stock splits, readjustments or reclassifications. In the event of the foregoing, the remaining number of ordinary shares still subject to the warrants shall be increased or decreased to reflect proportionately the increase or decrease in the number of ordinary shares outstanding and the exercise price per share shall be decreased or increased as the case may be, in the same proportion.

 

We have reserved a sufficient number of ordinary shares for issuance upon exercise of the warrants and such shares, when issued in accordance with the terms of the warrants, will be fully paid and non-assessable. Fractional shares will not be issued upon the exercise of warrants, and no payment will be made with respect to any fractional shares to which any warrant holder might otherwise be entitled upon exercise of warrants. No adjustments as to previously declared or paid cash dividends, if any, will be made upon any exercise of warrants.

 

3
 

 

The holders of the warrants as such are not entitled to vote, receive dividends or to exercise any of the rights of holders of ordinary shares for any purpose until such warrants shall have been duly exercised and payment of the purchase price shall have been made.

 

If for at least ten (10) trading days within any period of twenty (20) consecutive trading days, including the last trading day of the period, the closing price per ordinary exceeds 125% of the warrant’s exercise price, we may cancel any warrants remaining outstanding and unexercised. The date upon which we may cancel such warrants must be a date which is more than thirty (30) calendar days, but less than sixty (60) calendar days, after a notice is mailed by first class mail to all registered holders of the warrants following the satisfaction of the conditions described above, or such longer time as may be required by regulatory authorities. The notice of cancellation must be mailed by us on or before the ninetieth (90th) calendar day following the last trading day of any twenty (20) consecutive trading day period that triggers our right to cancel any warrants.

 

Book-Entry Form

 

Individual certificates will not be issued for the ordinary shares and warrants. Instead, one or more global certificates are deposited by us with DTC and registered in the name of Cede & Co., as nominee for DTC. The global certificates evidence all of the ordinary shares and warrants outstanding at any time. Accordingly, holders of our shares and warrants are limited to (1) participants in DTC such as banks, brokers, dealers and trust companies (“DTC Participants”), (2) those who maintain, either directly or indirectly, a custodial relationship with a DTC Participant (“Indirect Participants”), and (3) those banks, brokers, dealers, trust companies and others who hold interests in the securities through DTC Participants or Indirect Participants. The securities are only transferable through the book-entry system of DTC. Holders who are not DTC Participants may transfer their securities through DTC by instructing the DTC Participant holding their securities (or by instructing the Indirect Participant or other entity through which their securities are held) to transfer the securities. Transfers will be made in accordance with standard securities industry practice.

 

Anti-Takeover Provisions

 

Some provisions of our Articles may discourage, delay or prevent a change of control of our company or management that shareholders may consider favorable, including provisions that:

 

  authorize our Board of Directors to issue shares in one or more series and to designate the price, rights, preferences, privileges and restrictions of such shares without any further vote or action by our shareholders;

 

  prohibit cumulative voting (the ordinary shares will generally be entitled to one vote per share other than in the circumstances noted in the Articles); and

 

  establish requirements for proposing matters that can be acted on by shareholders at extraordinary general meetings.

 

However, under Cayman Islands law, our directors may only exercise the rights and powers granted to them under our Articles for a proper purpose and for what they believe in good faith to be in the best interests of our company.

 

4

 

EX-21.1 3 ex21-1.htm

 

Exhibit 21.1

 

Subsidiaries of Oxbridge Re Holdings Limited

 

Oxbridge Re Holdings Limited owns 100% of the equity interests in:

 

  Oxbridge Reinsurance Limited, which was incorporated on April 23, 2013 under the laws of the Cayman Islands.
     
  Oxbridge Re NS Limited, which was incorporated on December 22, 2017 under the laws of the Cayman Islands.
     
  SurancePlus Holdings Ltd (f/k/a Oxbridge VT Ltd.), which was incorporated on January 27, 2022 under the laws of the Cayman Islands.
     
  DSN Blockchain Technologies Ltd., which was incorporated on February 18, 2022 under the laws of the Cayman Islands.
     
 

OAC Equity Holdings LLC, which was incorporated on May 18, 2021 under the laws of the Cayman Islands.

     
  SurancePlus, Inc. which was incorporated on December 19, 2022 under the laws of the British Virgin Islands.

 

 

 

EX-23.1 4 ex23-1.htm

 

Exhibit 23.1

 

Consent of Independent Registered Public Accounting Firm

 

We have issued our report dated March 26, 2024, with respect to the consolidated financial statements included in the Annual Report of Oxbridge Re Holdings Limited on Form 10-K for the year ended December 31, 2023. We consent to the incorporation by reference of said report in the Registration Statement of Oxbridge Re Holdings Limited on Form S-3 (File No. 333-262590).

 

/s/ Hacker, Johnson & Smith PA  
   
HACKER, JOHNSON & SMITH PA  
Tampa, Florida  
March 26, 2024  

 

 

 

EX-31.1 5 ex31-1.htm

 

Exhibit 31.1

 

Certifications of the Chief Executive Officer
Pursuant to Section 302 of the Sarbanes-Oxley Act and
Rule 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934

 

I, Jay Madhu, certify that:

 

1. I have reviewed this Annual Report on Form 10-K of Oxbridge Re Holdings Limited;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: March 26, 2024

 

  By: /s/ JAY MADHU
    Jay Madhu
   

Chief Executive Officer and President

(Principal Executive Officer)

 

 

 

EX-31.2 6 ex31-2.htm

 

Exhibit 31.2

 

Certifications of the Chief Financial Officer
Pursuant to Section 302 of the Sarbanes-Oxley Act and
Rule 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934

 

I, Wrendon Timothy, certify that:

 

1. I have reviewed this Annual Report on Form 10-K of Oxbridge Re Holdings Limited;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: March 26, 2024

 

  By: /s/ WRENDON TIMOTHY
    Wrendon Timothy
    Chief Financial Officer and Secretary
    (Principal Financial Officer and Principal
    Accounting Officer)

 

   

 

EX-32 7 ex32.htm

 

Exhibit 32

 

Written Statement of the Chief Executive Officer and Chief Financial Officer
Pursuant to 18 U.S.C. §1350

 

Solely for the purposes of complying with 18 U.S.C. §1350, we, the undersigned Chief Executive Officer and Chief Financial Officer of Oxbridge Re Holdings Limited (the “Company”), hereby certify, based on our knowledge, that the Annual Report on Form 10-K of the Company for the year ended December 31, 2023 (the “Report”) fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934, as amended and that information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

/s/ JAY MADHU  
Jay Madhu  
Chief Executive Officer and President  
(Principal Executive Officer)  
   
/s/ WRENDON TIMOTHY  
Wrendon Timothy  
Chief Financial Officer and Secretary  
(Principal Financial Officer and Principal  
Accounting Officer)  
   
Date: March 26, 2024  

 

   

 

EX-97.1 8 ex97-1.htm

 

Exhibit 97.1

 

OXBRIDGE RE HOLDINGS LIMITED
Compensation Recovery Policy

 

1.Purpose. The purpose of this Compensation Recovery Policy (this “Policy”) is to describe the circumstances under which Oxbridge RE Holdings Limited (the “Company”) is required to recover certain compensation paid to certain employees. Any references in compensation plans, agreements, equity awards or other policies to the Company’s “recoupment”, “clawback” or similarly-named policy shall be deemed to refer to this Policy with respect to Incentive-Based Compensation Received on or after the Effective Date. With respect to Incentive-Based Compensation Received prior to the Effective Date, such references to the Company’s “recoupment”, “clawback” or similarly-named policy in compensation plans, agreements, equity awards or other policies shall be deemed to refer to the Company’s “recoupment,” “clawback” or similarly-named policy, if any, in effect prior to the Effective Date.

 

2.Mandatory Recovery of Compensation. In the event that the Company is required to prepare an Accounting Restatement, the Company shall recover reasonably promptly the amount of Erroneously Awarded Compensation.

 

3.Definitions. For purposes of this Policy, the following terms, when capitalized, shall have the meanings set forth below:

 

(a)Accounting Restatement” shall mean any accounting restatement required due to material noncompliance of the Company with any financial reporting requirement under the securities laws, including to correct an error in previously issued financial statements that is material to the previously issued financial statements, or that would result in a material misstatement if the error were corrected in the current period or left uncorrected in the current period.

 

(b)Covered Officer” shall mean the Company’s president; principal financial officer; principal accounting officer (or if there is no such accounting officer, the controller); any vice-president of the Company in charge of a principal business unit, division, or function (such as sales, administration, or finance); any other officer who performs a significant policy-making function; or any other person who performs similar significant policy-making functions for the Company.

 

(c)Effective Date” shall mean November 28, 2023.

 

(d)Erroneously Awarded Compensation” shall mean the excess of (i) the amount of Incentive-Based Compensation Received by a person (A) after beginning service as a Covered Officer, (B) who served as a Covered Officer at any time during the performance period for that Incentive-Based Compensation, (C) while the Company has a class of securities listed on a national securities exchange or a national securities association and (D) during the Recovery Period; over (ii) the Recalculated Compensation. For the avoidance of doubt, a person who served as a Covered Officer during the periods set forth in clauses (A) and (B) of the preceding sentence shall continue to be subject to this Policy even after such person’s service as a Covered Officer has ended.

 

1 
 

 

(e)Incentive-Based Compensation” shall mean any compensation that is granted, earned, or vested based wholly or in part upon the attainment of a financial reporting measure. A financial reporting measure is a measure that is determined and presented in accordance with the accounting principles used in preparing the Company’s financial statements, and any measures that are derived wholly or in part from such measures, regardless of whether such measure is presented within the financial statements or included in a filing with the Securities and Exchange Commission. Each of stock price and total shareholder return is a financial reporting measure. For the avoidance of doubt, incentive-based compensation subject to this Policy does not include stock options, restricted stock, restricted stock units or similar equity-based awards for which the grant is not contingent upon achieving any financial reporting measure performance goal and vesting is contingent solely upon completion of a specified employment period and/or attaining one or more non-financial reporting measures.

 

(f)Recalculated Compensation” shall mean the amount of Incentive-Based Compensation that otherwise would have been Received had it been determined based on the restated amounts in the Accounting Restatement, computed without regard to any taxes paid. For Incentive-Based Compensation based on stock price or total shareholder return, where the amount of the Erroneously Awarded Compensation is not subject to mathematical recalculation directly from the information in an Accounting Restatement, the amount of the Recalculated Compensation must be based on a reasonable estimate of the effect of the Accounting Restatement on the stock price or total shareholder return, as the case may be, on the compensation Received. The Company must maintain documentation of the determination of that reasonable estimate and provide such documentation to the national securities exchange or association on which its securities are listed.

 

(g)Incentive-Based Compensation is deemed “Received” in the Company’s fiscal period during which the financial reporting measure specified in the award of such Incentive-Based Compensation is attained, even if the payment or grant of the Incentive-Based Compensation occurs after the end of that period.

 

(h)Recovery Period” shall mean the three completed fiscal years of the Company immediately preceding the date the Company is required to prepare an Accounting Restatement; provided that the Recovery Period shall not begin before the Effective Date. For purposes of determining the Recovery Period, the Company is considered to be “required to prepare an Accounting Restatement” on the earlier to occur of: (i) the date the Company’s Board of Directors, a committee thereof, or the Company’s authorized officers conclude, or reasonably should have concluded, that the Company is required to prepare an Accounting Restatement, or (ii) the date a court, regulator, or other legally authorized body directs the Company to prepare an Accounting Restatement. If the Company changes its fiscal year, then the transition period within or immediately following such three completed fiscal years also shall be included in the Recovery Period, provided that if the transition period between the last day of the Company’s prior fiscal year end and the first day of its new fiscal year comprises a period of nine to 12 months, then such transition period shall instead be deemed one of the three completed fiscal years and shall not extend the length of the Recovery Period.

 

2 
 

 

4.Exceptions. Notwithstanding anything to the contrary in this Policy, recovery of Erroneously Awarded Compensation will not be required to the extent the Company’s committee of independent directors responsible for executive compensation decisions (or a majority of the independent directors on the Company’s board of directors in the absence of such a committee) has made a determination that such recovery would be impracticable and one of the following conditions have been satisfied:

 

(a)The direct expense paid to a third party to assist in enforcing this Policy would exceed the amount to be recovered; provided that, before concluding that it would be impracticable to recover any amount of Erroneously Awarded Compensation that was Incentive-Based Compensation based on the expense of enforcement, the Company must make a reasonable attempt to recover such Erroneously Awarded Compensation, document such reasonable attempt(s) to recover, and provide that documentation to the national securities exchange or association on which its securities are listed.

 

(b)Recovery would violate home country law where, with respect to Incentive-Based Compensation, that law was adopted prior to November 28, 2022; provided that, before concluding that it would be impracticable to recover any amount of Erroneously Awarded Compensation that was Incentive-Based Compensation based on violation of home country law, the Company must obtain an opinion of home country counsel, acceptable to the national securities exchange or association on which its securities are listed, that recovery would result in such a violation, and must provide such opinion to the exchange or association.

 

(c)Recovery would likely cause an otherwise tax-qualified retirement plan, under which benefits are broadly available to employees of the Company, to fail to meet the requirements of 26 U.S.C. 401(a)(13) or 26 U.S.C. 411(a) and regulations thereunder.

 

5.Manner of Recovery. In addition to any other actions permitted by law or contract, the Company may take any or all of the following actions to recover any Erroneously Awarded Compensation: (a) require the Covered Officer to repay such amount; (b) offset such amount from any other compensation owed by the Company or any of its affiliates to the Covered Officer, regardless of whether the contract or other documentation governing such other compensation specifically permits or specifically prohibits such offsets; and (c) subject to Section 4(c), to the extent the Erroneously Awarded Compensation was deferred into a plan of deferred compensation, whether or not qualified, forfeit such amount (as well as the earnings on such amounts) from the Covered Officer’s balance in such plan, regardless of whether the plan specifically permits or specifically prohibits such forfeiture. If the Erroneously Awarded Compensation consists of shares of the Company’s common stock, and the Covered Officer still owns such shares, then the Company may satisfy its recovery obligations by requiring the Covered Officer to transfer such shares back to the Company.

 

6.Other.

 

(a)This Policy shall be administered and interpreted, and may be amended from time to time, by the Company’s board of directors or any committee to which the board may delegate its authority in its sole discretion in compliance with the applicable listing standards of the national securities exchange or association on which the Company’s securities are listed, and the determinations of the board or such committee shall be binding on all Covered Officers.

 

(b)The Company shall not indemnify any Covered Officer against the loss of Erroneously Awarded Compensation.

 

(c)The Company shall file all disclosures with respect to this Policy in accordance with the requirements of the Federal securities laws, including disclosure required by the Securities and Exchange Commission filings.

 

(d)Any right to recovery under this Policy shall be in addition to, and not in lieu of, any other rights of recovery that may be available to the Company.

 

3 

 

 

 

GRAPHIC 9 form10-k_001.jpg begin 644 form10-k_001.jpg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end EX-101.SCH 10 oxbr-20231231.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Consolidated Statements of Operations link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Consolidated Statements of Changes in Shareholders' Equity link:presentationLink link:calculationLink link:definitionLink 995512 - Disclosure - ORGANIZATION AND BASIS OF PRESENTATION link:presentationLink link:calculationLink link:definitionLink 995513 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 995514 - Disclosure - CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AND CASH EQUIVALENTS link:presentationLink link:calculationLink link:definitionLink 995515 - Disclosure - INVESTMENTS link:presentationLink link:calculationLink link:definitionLink 995516 - Disclosure - TAXATION link:presentationLink link:calculationLink link:definitionLink 995517 - Disclosure - VARIABLE INTEREST ENTITIES link:presentationLink link:calculationLink link:definitionLink 995518 - Disclosure - RESERVE FOR LOSSES AND LOSS ADJUSTMENT EXPENSES link:presentationLink link:calculationLink link:definitionLink 995519 - Disclosure - LOSS PER SHARE link:presentationLink link:calculationLink link:definitionLink 995520 - Disclosure - WARRANTS link:presentationLink link:calculationLink link:definitionLink 995521 - Disclosure - DIVIDENDS link:presentationLink link:calculationLink link:definitionLink 995522 - Disclosure - SHARE-BASED COMPENSATION link:presentationLink link:calculationLink link:definitionLink 995523 - Disclosure - NET WORTH FOR REGULATORY PURPOSES link:presentationLink link:calculationLink link:definitionLink 995524 - Disclosure - FAIR VALUE AND CERTAIN RISKS AND UNCERTAINTIES link:presentationLink link:calculationLink link:definitionLink 995525 - Disclosure - LEASES link:presentationLink link:calculationLink link:definitionLink 995526 - Disclosure - RELATED PARTY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 995527 - Disclosure - PROPERTY AND EQUIPMENT, NET link:presentationLink link:calculationLink link:definitionLink 995528 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 995529 - Disclosure - Schedule I - Summary of Investments - Other Than Investments in Related Parties link:presentationLink link:calculationLink link:definitionLink 995530 - Disclosure - Schedule II - Condensed Financial Information of Registrant link:presentationLink link:calculationLink link:definitionLink 995531 - Disclosure - Schedule III - Supplementary Insurance Information link:presentationLink link:calculationLink link:definitionLink 995532 - Disclosure - Schedule IV - Reinsurance Information link:presentationLink link:calculationLink link:definitionLink 995533 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 995534 - Disclosure - CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AND CASH EQUIVALENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 995535 - Disclosure - INVESTMENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 995536 - Disclosure - VARIABLE INTEREST ENTITIES (Tables) link:presentationLink link:calculationLink link:definitionLink 995537 - Disclosure - RESERVE FOR LOSSES AND LOSS ADJUSTMENT EXPENSES (Tables) link:presentationLink link:calculationLink link:definitionLink 995538 - Disclosure - LOSS PER SHARE (Tables) link:presentationLink link:calculationLink link:definitionLink 995539 - Disclosure - SHARE-BASED COMPENSATION (Tables) link:presentationLink link:calculationLink link:definitionLink 995540 - Disclosure - LEASES (Tables) link:presentationLink link:calculationLink link:definitionLink 995541 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables) link:presentationLink link:calculationLink link:definitionLink 995542 - Disclosure - ORGANIZATION AND BASIS OF PRESENTATION (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995543 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995544 - Disclosure - SUMMARY OF CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AND CASH EQUIVALENTS (Details) link:presentationLink link:calculationLink link:definitionLink 995545 - Disclosure - SCHEDULE OF GROSS REALIZED GAINS AND LOSSES FROM SALE OF EQUITY SECURITIES (Details) link:presentationLink link:calculationLink link:definitionLink 995546 - Disclosure - SCHEDULE OF OTHER INVESTMENT (Details) link:presentationLink link:calculationLink link:definitionLink 995547 - Disclosure - SCHEDULE OF FAIR VALUE OF ASSETS MEASURED ON RECURRING BASIS (Details) link:presentationLink link:calculationLink link:definitionLink 995548 - Disclosure - SCHEDULE OF RECONCILIATION OF CHANGES IN FAIR VALUE (Details) link:presentationLink link:calculationLink link:definitionLink 995549 - Disclosure - INVESTMENTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995550 - Disclosure - SCHEDULE OF FINANCIAL STATEMENTS (Details) link:presentationLink link:calculationLink link:definitionLink 995551 - Disclosure - SCHEDULE OF FINANCIAL STATEMENTS (Details) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 995552 - Disclosure - VARIABLE INTEREST ENTITIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995553 - Disclosure - SCHEDULE OF LOSS ADJUSTMENT EXPENSE (Details) link:presentationLink link:calculationLink link:definitionLink 995554 - Disclosure - SCHEDULE OF INCURRED LOSSES AND ADJUSTMENT EXPENSES (Details) link:presentationLink link:calculationLink link:definitionLink 995555 - Disclosure - SCHEDULE OF HISTORICAL AVERAGE ANNUAL PERCENTAGE PAYOUT (Details) link:presentationLink link:calculationLink link:definitionLink 995556 - Disclosure - SCHEDULE OF COMPUTATION OF BASIC AND DILUTED LOSS EARNING PER SHARE (Details) link:presentationLink link:calculationLink link:definitionLink 995557 - Disclosure - LOSS PER SHARE (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995558 - Disclosure - WARRANTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995559 - Disclosure - SCHEDULE OF STOCK OPTION ACTIVITY (Details) link:presentationLink link:calculationLink link:definitionLink 995560 - Disclosure - SCHEDULE OF ACTIVITY OF UNVESTED RESTRICTED STOCK AWARDS (Details) link:presentationLink link:calculationLink link:definitionLink 995561 - Disclosure - SHARE-BASED COMPENSATION (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995562 - Disclosure - NET WORTH FOR REGULATORY PURPOSES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995563 - Disclosure - SCHEDULE OF OPERATING LEASE COST (Details) link:presentationLink link:calculationLink link:definitionLink 995564 - Disclosure - SCHEDULE OF OPERATING LEASE OBLIGATIONS (Details) link:presentationLink link:calculationLink link:definitionLink 995565 - Disclosure - SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS (Details) link:presentationLink link:calculationLink link:definitionLink 995566 - Disclosure - LEASES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995567 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995568 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT,NET (Details) link:presentationLink link:calculationLink link:definitionLink 995569 - Disclosure - Schedule I - Summary of Investments - Other Than Investments in Related Parties (Details) link:presentationLink link:calculationLink link:definitionLink 995570 - Disclosure - Schedule II Condensed Balance Sheet Parent Company Only (Details) link:presentationLink link:calculationLink link:definitionLink 995571 - Disclosure - Schedule II Condensed Statements of Income Parent Company Only (Details) link:presentationLink link:calculationLink link:definitionLink 995572 - Disclosure - Schedule II Condensed Statement of Cash Flows - Parent Company Only (Details) link:presentationLink link:calculationLink link:definitionLink 995573 - Disclosure - Schedule III Supplementary Insurance Information (Details) link:presentationLink link:calculationLink link:definitionLink 995574 - Disclosure - Schedule IV Reinsurance Information (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 11 oxbr-20231231_cal.xml XBRL CALCULATION FILE EX-101.DEF 12 oxbr-20231231_def.xml XBRL DEFINITION FILE EX-101.LAB 13 oxbr-20231231_lab.xml XBRL LABEL FILE Class of Stock [Axis] Ordinary Shares, par value $0.001 (USD) per share Warrants Equity Components [Axis] Common Stock [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] Investment, Name [Axis] Oxbridge Reinsurance Limited [Member] Oxbridge Re NS [Member] Surance Plus Inc [Member] Legal Entity [Axis] Statistical Measurement [Axis] Maximum [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Equity Distribution Agreement [Member] Long-Lived Tangible Asset [Axis] Furniture and Fixtures [Member] Computer Equipment [Member] Motor Vehicles [Member] Related Party, Type [Axis] Oxbridge Acquisition Corp [Member] Series A-1 Preferred Stock [Member] Sale of Stock [Axis] Private Placement Warrants [Member] Jet A 1 Series A 1 Convertible Preferred Stock [Member] Jet A1 Promissory Note [Member] Jet A1 Class B Ordinary Shares [Member] Common Class B [Member] Fair Value Hierarchy and NAV [Axis] Fair Value, Inputs, Level 1 [Member] Fair Value, Inputs, Level 2 [Member] Fair Value, Inputs, Level 3 [Member] Business Acquisition [Axis] Long-Term Debt, Type [Axis] Notes Payable to Series 2020 -1 Noteholders [Member] Title of Individual [Axis] Investors and non US persons [Member] Subscription agreements [Member] Third Party Investors [Member] Parent [Member] Product and Service [Axis] Surance Plus Fee Income [Member] Underwriting Related Income [Member] Related Party [Member] Short-Duration Insurance Contracts, Accident Year [Axis] Short-Duration Insurance Contracts, Accident Year 2016 [Member] Short-Duration Insurance Contracts, Accident Year 2017 [Member] Short-Duration Insurance Contracts, Accident Year 2018 [Member] Short-Duration Insurance Contract, Accident Year 2019 [Member] Short-Duration Insurance Contract, Accident Year 2020 [Member] Short-Duration Insurance Contract, Accident Year 2021 [Member] Short-Duration Insurance Contract, Accident Year 2022 [Member] Short-Duration Insurance Contract, Accident Year 2023 [Member] Plan Name [Axis] Property Catastrophe Reinsurance [Member] Antidilutive Securities [Axis] Warrant [Member] Subsequent Event Type [Axis] Subsequent Event [Member] 2014 Omnibus Incentive Plan [Member] 2021 Omnibus Incentive Plan [Member] Award Type [Axis] Restricted Stock [Member] Income Statement Location [Axis] General and Administrative Expense [Member] Lease Contractual Term [Axis] Office Lease [Member] Residential Lease [Member] Administrative Services Agreement [Member] Related Party Transaction [Axis] Mr Jay Madhu [Member] Reinsurance Agreement [Member] Bridge Agreement [Member] Investor [Member] Leasehold Improvements [Member] Vehicles [Member] Investment Type [Axis] Equity Securities, Investment Summary [Member] Consolidated Entities [Axis] Parent Company [Member] Subsidiaries [Member] Property, Liability and Casualty Insurance Product Line [Member] Statement [Table] Statement [Line Items] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] ICFR Auditor Attestation Flag Document Financial Statement Error Correction [Flag] Auditor Firm ID Auditor Name Auditor Location Statement of Financial Position [Abstract] Assets Investments: Equity securities, at fair value (cost: $1,926) Cash and cash equivalents Restricted cash and cash equivalents Premiums receivable Other investments Loan receivable Due from related parties Deferred policy acquisition costs Operating lease right-of-use assets Prepayment and other assets Prepaid offering costs Property and equipment, net Total assets Liabilities and Shareholders’ Equity Liabilities: Other Liabilities – Delta Cat Re Tokenholders Notes payable to noteholders Reserve for losses and loss adjustment expenses Unearned premiums reserve Operating lease liabilities Accounts payable and other liabilities Total liabilities Shareholders’ equity: Ordinary share capital, (par value $0.001, 50,000,000 shares authorized; 5,870,234 and 5,769,587 shares issued and outstanding) Additional paid-in capital Accumulated Deficit Total shareholders’ equity Total liabilities and shareholders’ equity Equity Securities, FV-NI, Cost Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] Revenue Assumed premiums Change in unearned premiums reserve Net premiums earned SurancePlus fee income Net investment and other income Net realized investment gain Unrealized loss on other investments Change in fair value of equity securities Total revenue Expenses Losses and loss adjustment expenses Policy acquisition costs and underwriting expenses General and administrative expenses Total expenses Loss before income attributable to noteholders and tokenholders Income attributable to noteholders and tokenholders Net loss Loss per share Loss per share, basic Loss per share, diluted Weighted-average shares outstanding Weighted average number of shares outstanding, basic Weighted average number of shares outstanding, diluted Statement of Cash Flows [Abstract] Operating activities Net loss Adjustments to reconcile net loss to net cash used in operating activities: Share-based compensation Depreciation and amortization Net realized investment gains SurancePlus fee income Change in fair value of equity securities Change in fair value of other investments Change in operating assets and liabilities: Premiums receivable Due from related parties Deferred policy acquisition costs Prepayment and other assets Prepaid offering costs Other Liablities Delta Cat Re Tokenholders Losses payable Unearned premiums reserve Accounts payable and other liabilities Net cash used in operating activities Investing activities Purchase of equity securities Purchase of loan receivable Purchase of other investments Proceeds from sale of equity securities Purchase of property and equipment Net cash used in investing activities Financing activities Partial redemption of notes payable to noteholders Gross proceeds from the issuance of Delta Cat Re tokens Net cash provided by financing activities   Cash and cash equivalents, and restricted cash and cash equivalents: Net change during the year Balance at beginning of year Balance at end of year Balance Balance, shares Net loss for the year Issuance of Restricted stock, net Issurance of Restricted stock, net, shares Share-based compensation Balance Balance, shares Pay vs Performance Disclosure [Table] Executive Category [Axis] Individual [Axis] Adjustment to Compensation [Axis] Measure [Axis] Pay vs Performance [Table Text Block] Company Selected Measure Name Named Executive Officers, Footnote [Text Block] Peer Group Issuers, Footnote [Text Block] Changed Peer Group, Footnote [Text Block] PEO Total Compensation Amount PEO Actually Paid Compensation Amount Adjustment To PEO Compensation, Footnote [Text Block] Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Compensation Actually Paid Amount Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Equity Valuation Assumption Difference, Footnote [Text Block] Compensation Actually Paid vs. Total Shareholder Return [Text Block] Compensation Actually Paid vs. Net Income [Text Block] Compensation Actually Paid vs. Company Selected Measure [Text Block] Total Shareholder Return Vs Peer Group [Text Block] Compensation Actually Paid vs. Other Measure [Text Block] Tabular List [Table Text Block] Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Net Income (Loss) Attributable to Parent Company Selected Measure Amount Other Performance Measure Amount Adjustment to Compensation Amount PEO Name Measure Name Non-GAAP Measure Description [Text Block] Additional 402(v) Disclosure [Text Block] Erroneously Awarded Compensation Recovery [Table] Restatement Determination Date [Axis] Restatement Determination Date Aggregate Erroneous Compensation Amount Erroneous Compensation Analysis [Text Block] Stock Price or TSR Estimation Method [Text Block] Outstanding Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Not Yet Determined [Text Block] Forgone Recovery, Individual Name Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery, Explanation of Impracticability [Text Block] Outstanding Recovery, Individual Name Outstanding Recovery Compensation Amount Restatement Does Not Require Recovery [Text Block] Awards Close in Time to MNPI Disclosures [Table] Award Timing MNPI Disclosure [Text Block] Award Timing Method [Text Block] Award Timing Predetermined [Flag] Award Timing MNPI Considered [Flag] Award Timing, How MNPI Considered [Text Block] MNPI Disclosure Timed for Compensation Value [Flag] Awards Close in Time to MNPI Disclosures [Table Text Block] Awards Close in Time to MNPI Disclosures, Individual Name Award Underlying Securities Amount Award Exercise Price Award Grant Date Fair Value Underlying Security Market Price Change, Percent Insider Trading Arrangements [Line Items] Material Terms of Trading Arrangement Name Title Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted Adoption Date Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated Termination Date Arrangement Duration Aggregate Available Insider Trading Policies and Procedures [Line Items] Insider Trading Policies and Procedures Adopted [Flag] Insider Trading Policies and Procedures Not Adopted [Text Block] Accounting Policies [Abstract] ORGANIZATION AND BASIS OF PRESENTATION SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Cash and Cash Equivalents [Abstract] CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AND CASH EQUIVALENTS Investments, All Other Investments [Abstract] INVESTMENTS Income Tax Disclosure [Abstract] TAXATION Organization, Consolidation and Presentation of Financial Statements [Abstract] VARIABLE INTEREST ENTITIES Reserve For Losses And Loss Adjustment Expenses RESERVE FOR LOSSES AND LOSS ADJUSTMENT EXPENSES Earnings Per Share [Abstract] LOSS PER SHARE Warrants WARRANTS Dividends [Abstract] DIVIDENDS Share-Based Payment Arrangement [Abstract] SHARE-BASED COMPENSATION Net Worth For Regulatory Purposes NET WORTH FOR REGULATORY PURPOSES Fair Value Disclosures [Abstract] FAIR VALUE AND CERTAIN RISKS AND UNCERTAINTIES Leases [Abstract] LEASES Related Party Transactions [Abstract] RELATED PARTY TRANSACTIONS Property, Plant and Equipment [Abstract] PROPERTY AND EQUIPMENT, NET Subsequent Events [Abstract] SUBSEQUENT EVENTS SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Abstract] Schedule I - Summary of Investments - Other Than Investments in Related Parties Condensed Financial Information Disclosure [Abstract] Schedule II - Condensed Financial Information of Registrant SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Abstract] Schedule III - Supplementary Insurance Information SEC Schedule, 12-17, Insurance Companies, Reinsurance [Abstract] Schedule IV - Reinsurance Information Use of Estimates Revenue Recognition Cash and cash equivalents Restricted cash and cash equivalents Investments Fair value measurement Deferred policy acquisition costs Offering Expenses Property and equipment Reserves for losses and loss adjustment expenses Loss experience refund payable Premiums assumed Unearned Premiums Ceded SurancePlus Fee Income Uncertain income tax positions Loss Per Share Share-Based Compensation Segment Information Reclassifications SUMMARY OF CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AND CASH EQUIVALENTS SCHEDULE OF GROSS REALIZED GAINS AND LOSSES FROM SALE OF EQUITY SECURITIES SCHEDULE OF OTHER INVESTMENT SCHEDULE OF FAIR VALUE OF ASSETS MEASURED ON RECURRING BASIS SCHEDULE OF RECONCILIATION OF CHANGES IN FAIR VALUE SCHEDULE OF FINANCIAL STATEMENTS SCHEDULE OF LOSS ADJUSTMENT EXPENSE SCHEDULE OF INCURRED LOSSES AND ADJUSTMENT EXPENSES SCHEDULE OF HISTORICAL AVERAGE ANNUAL PERCENTAGE PAYOUT SCHEDULE OF COMPUTATION OF BASIC AND DILUTED LOSS EARNING PER SHARE SCHEDULE OF STOCK OPTION ACTIVITY SCHEDULE OF ACTIVITY OF UNVESTED RESTRICTED STOCK AWARDS SCHEDULE OF OPERATING LEASE COST SCHEDULE OF OPERATING LEASE OBLIGATIONS SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS SCHEDULE OF PROPERTY AND EQUIPMENT,NET Equity Method Investment, Ownership Percentage Property, Plant and Equipment [Table] Property, Plant and Equipment [Line Items] Prepaid offering costs Offering expenses Aggregate offering price Estimated useful life Impairments in property and equipment Cash held on deposit Restricted cash held in trust Total Proceeds from Sale of Equity Securities, FV-NI Equity Securities, FV-NI, Realized Gain Equity Securities, FV-NI, Realized Loss Schedule of Defined Benefit Plans Disclosures [Table] Defined Benefit Plan Disclosure [Line Items] End of year Beginning of year Investment in affiliate Unrealized loss on investment in affiliate Platform Operator, Crypto-Asset [Table] Platform Operator, Crypto-Asset [Line Items] Cash and cash equivalents Restricted cash and cash equivalents Equity securities Total Fair value of Level 3 other investment, Beginning balance Transfer to Level 1 Change in valuation inputs or other assumptions Fair value of Level 3 other investment, Ending balance Number of shares issued Number of shares in hold, par value per share Number of warrants shares Unrealized loss on other investments Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Total revenue Expenses Income attributable to tokenholders Total assets Due to Parent Total shareholder’s equity Underwriting profit Voting percentage Share capital percentage Notes issued Debt Instrument, Maturity Date Repayments of Debt Convertible Notes Payable, Current Noncontrolling interest Shares issued, price per share Description for offer and sale of securities Proceeds from issuance of private placement Sale of stock number of shares issued in transaction Management fee Schedule Of Loss Adjustment Expense Gross balance, beginning of year Current year Prior year Total incurred Current year Prior year Total paid Balance, end of year Short-Duration Insurance Contracts, Claims Development [Table] Claims Development [Line Items] Incurred Losses and Loss Adjustment Expenses Total of Incurred but Not Reported Liabilities Plus Expected Development on Reported Claims Cumulative Number of Reported Claims Cumulative Paid Losses and Loss Adjustment Expenses Cumulative Paid Losses and Loss Adjustment Expenses Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Average Annual Percentage Payout of Incurred Claims by Age, Net of Reinsurance, Year 1 Average Annual Percentage Payout of Incurred Claims by Age, Net of Reinsurance, Year 2 Average Annual Percentage Payout of Incurred Claims by Age, Net of Reinsurance, Year 3 Average Annual Percentage Payout of Incurred Claims by Age, Net of Reinsurance, Year 4 Average Annual Percentage Payout of Incurred Claims by Age, Net of Reinsurance, Year 5 Average Annual Percentage Payout of Incurred Claims by Age, Net of Reinsurance, Year 6 Weighted average shares - basic Effect of dilutive securities - Stock options Shares issuable upon conversion of warrants Weighted average shares - diluted Loss per share - basic Loss earnings per share - diluted Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Anti-dilutive shares Warrant outstanding Exercise price Ordinary share price, per share Warrants exercised Warrant expiration date Trading days Number of Options, Outstanding, Beginning Balance Weighted-Average Exercise Price, Outstanding, Beginning Balance Weighted-Average Remaining Contractual Term, Outstanding Aggregate Intrinsic Value Number of Options, Exercisable, Beginning Balance Weighted-Average Exercise Price, Exercisable, Beginning Balance Weighted-Average Remaining Contractual Term, Exercisable Aggregate Intrinsic Value Number of Options, Forfeited Weighted-Average Exercise Price, Forfeited Number of Options Outstanding, Ending Balance Weighted-Average Exercise Price, Outstanding, Ending Balance Aggregate Intrinsic Value Number of Options Exercisable, Ending Balance Weighted-Average Exercise Price, Exercisable, Ending Balance Aggregate Intrinsic Value Weighted-Number of Restricted Stock Awards, Beginning balance Weighted-Number of Restricted Stock Awards, Granted Weighted-Average Grant Date Fair Value, Granted Weighted-Number of Restricted Stock Awards, Vested Weighted-Number of Restricted Stock Awards, Forfeited Weighted-Average Grant Date Fair Value, Forfeited Weighted-Average Grant Date Fair Value, Vested Weighted-Number of Restricted Stock Awards, Ending balance Number of options granted Restricted stock, grant Shares available for grant Vesting period, contractual term Compensation expense Unrecognized compensation expense, non-vested stock options Weighted-average period Minimum prescribed capital requirement description Subsidiary net worth Net income Operating Lease Cost Operating cash flows from operating leases Weighted-average remaining lease term - operating leases Weighted-average discount rate - operating leases 2023 2024 Total future minimum lease payments Less imputed interest Total operating lease liabilities Lessee, Lease, Description [Table] Lessee, Lease, Description [Line Items] Remaining lease term Renewal term Schedule of Related Party Transactions, by Related Party [Table] Related Party Transaction [Line Items] Administrative services agreement description Administrative fees expense Debt face amount Proceeds from Related Party Debt Number of shares issued Aggregate purchase price Deferred acquisition cost Unearned premiums Change in unearned premium reserve Deferred policy acquisition cost Underwriting expenses Short-term bridge funds Percentage of original issue discount Notes interest rate Notes maturity date Debt, description Policy Loans Receivable Redemption of notes payable Total, at cost less accumulated depreciation and amortization Property and equipment, net SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Table] SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items] Total investments, Cost or amortized cost Total investments, Fair value Total investments, Balance sheet value Condensed Financial Statements [Table] Condensed Financial Statements, Captions [Line Items] Investment in subsidiaries Due from related party Due to Subsidiary Total liabilities Ordinary share capital Additional paid-in capital Total shareholders’ equity Total liabilities and shareholders’ equity Net investment income Management fees and other income Operating expenses Income before equity in loss of subsidiaries Equity in loss of subsidiaries Adjustments to reconcile net loss to net cash provided by (used in) operating activities: Equity in loss of subsidiaries Underwriting Income – SurancePlus Depreciation Net realized investment gain Due from subsidiary Due from related party Due to subsidiary Net cash provided by (used in) operating activities Investing activities Investment in subsidiary Net cash used in investing activities Net change in cash and cash equivalents Cash and cash equivalents at beginning of year Cash and cash equivalents at end of year Deferred acquisition costs, net Reserves for losses and loss adjustment expenses - gross Unearned premiums - gross Net premiums earned Investment income (loss) Net losses, and loss adjustment expenses Amortization of deferred acquisition costs Operating expenses Gross premiums written SEC Schedule, 12-17, Insurance Companies, Reinsurance [Table] SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items] Direct gross premiums Premiums ceded to other companies Premiums assumed from other companies Net premiums earned Percentage of amount assumed to net Oxbridge Acquisition Corp [Member] Private Placement Warrants [Member] Prepaid offering costs. Reserve for losses and loss adjustment expenses. Ordinary Shares [Member] Capital Risk Percentage. Ordinary shares percentage. Preferred shares percentage. Sponsor [Member] Series A-1 Preferred Stock [Member] Schedule Of Other Investments [Table Text Block] Jet A1 Promissory Note [Member] Jet A1 Series A1 Preferred Shares [Member] Jet A1 Class B Ordinary Shares [Member] Increase decrease in prepaid offering costs. Investment in affiliate. Oxbridge Reinsurance Limited [Member] Change in valuation inputs or other assumptions. Oxbridge Re NS [Member] Notes Payable to Series 2020 -1 Noteholders [Member] Surance Plus Inc [Member] Description for offer and sale of securities. Investors and non US persons [Member] Subscription agreements [Member] Third Party Investors [Member] Reserve for Losses and Loss Adjustment Expenses Disclosure [Text Block] Offering Expenses [Policy Text Block] Prepaid offering cost. Aggregate offering price. Equity Distribution Agreement [Member] Motor Vehicles [Member] Unearned Premiums Ceded [Policy Text Block] SurancePlus Fee Income [Policy Text Block] Property plant and equipments estimated useful lives. Property Catastrophe Reinsurance [Member] Shares issuable upon conversion of warrants. Disclosure of Warrants [Text Block] Dividends [Text Block] Two Thousand Fourteen Omnibus Incentive Plan [Member] Two Thousand Twenty One Omnibus Incentive Plan [Member] Net Worth For Regulatory Purposes [Text Block] Statutory Accounting Practice Statutory Capital and Surplus Required. Schedule of Operating Lease Obligations [Table Text Block] Lessee operating lease liability payments due after next twelve months. Administrative Services Agreement Description. Administrative Services Agreement [Member] Mr Jay Madhu [Member] Reinsurance Agreement [Member] Bridge Agreement [Member] Net realized investment gain. Underwriting income suranceplus. Equity securities fair value net unrealized gain loss. Investment in subsidiary. Purchase of debt securities. Change in fair value of equity securities. Gain loss from equity method investments. Due to subsidiary. Increase decrease in due from related party. Due from subsidiaries. Lessee operating lease liability payments due previouly reported. Income loss attributable to noteholders. Office Lease [Member] Residential Lease [Member] Surance Plus Fee Income [Member] Underwriting Related Income [Member] Percentage of original issue discount. Income attributable to noteholders and tokenholders. Income loss attributable to noteholders and tokenholders. Liabilities Premiums Earned, Net Benefits, Losses and Expenses Net Income (Loss) Attributable to Noncontrolling Interest Increase (Decrease) in Due from Related Parties Increase (Decrease) in Deferred Policy Acquisition Costs Increase (Decrease) in Prepaid Expense and Other Assets IncreaseDecreaseInPrepaidOfferingCosts Increase (Decrease) in Unearned Premiums Increase (Decrease) in Accounts Payable and Other Operating Liabilities Payments to Acquire Equity Securities, FV-NI Payments to Acquire Loans Receivable Payments to Acquire Other Investments Payments to Acquire Property, Plant, and Equipment Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Shares, Outstanding APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Cash and Cash Equivalents, Policy [Policy Text Block] Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block] Deferred Policy Acquisition Costs, Policy [Policy Text Block] Prepaid offering cost Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Cash and Cash Equivalents, Fair Value Disclosure Restricted Cash and Cash Equivalents, Current Assets, Fair Value Disclosure Investment Owned, Fair Value TransferToLevelOne Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid Short-Duration Insurance Contracts, Liability for Unpaid Claims and Allocated Claim Adjustment Expense, Net Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Lessee, Operating Lease, Liability, to be Paid Lessee, Operating Lease, Liability, Undiscounted Excess Amount Stock Issued During Period, Shares, Acquisitions Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Additional Paid in Capital Income (Loss) from Equity Method Investments Increase (Decrease) in Due from Affiliates, Current InvestmentInSubsidiary SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information, Other Operating Expense EX-101.PRE 14 oxbr-20231231_pre.xml XBRL PRESENTATION FILE XML 16 R1.htm IDEA: XBRL DOCUMENT v3.24.1
Cover - USD ($)
12 Months Ended
Dec. 31, 2023
Mar. 26, 2024
Jun. 30, 2023
Document Type 10-K    
Amendment Flag false    
Document Annual Report true    
Document Transition Report false    
Document Period End Date Dec. 31, 2023    
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2023    
Current Fiscal Year End Date --12-31    
Entity File Number 1-36346    
Entity Registrant Name OXBRIDGE RE HOLDINGS LIMITED    
Entity Central Index Key 0001584831    
Entity Tax Identification Number 98-1150254    
Entity Incorporation, State or Country Code E9    
Entity Address, Address Line One Suite 201    
Entity Address, Address Line Two 42 Edward Street    
Entity Address, Address Line Three P.O. Box 469    
Entity Address, City or Town Grand Cayman    
Entity Address, Country KY    
Entity Address, Postal Zip Code KY1-9006    
City Area Code (345)    
Local Phone Number 749-7570    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company false    
Entity Shell Company false    
Entity Public Float     $ 10,013,951
Entity Common Stock, Shares Outstanding   5,870,234  
Documents Incorporated by Reference [Text Block] Information required by Part III is incorporated by reference from registrant’s Proxy Statement for its 2024 annual meeting of stockholders or an amendment to this Annual Report on Form 10-K, which will be filed with the Securities and Exchange Commission within 120 days after the end of its fiscal year ended December 31, 2023.    
ICFR Auditor Attestation Flag false    
Document Financial Statement Error Correction [Flag] false    
Auditor Firm ID 400    
Auditor Name HACKER, JOHNSON & SMITH PA    
Auditor Location Tampa, Florida    
Ordinary Shares, par value $0.001 (USD) per share      
Title of 12(b) Security Ordinary Shares, par value $0.001 (USD) per share    
Trading Symbol OXBR    
Security Exchange Name NASDAQ    
Warrants      
Title of 12(b) Security Warrants    
Trading Symbol OXBRW    
Security Exchange Name NASDAQ    
XML 17 R2.htm IDEA: XBRL DOCUMENT v3.24.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Investments:    
Equity securities, at fair value (cost: $1,926) $ 680 $ 642
Cash and cash equivalents 495 1,207
Restricted cash and cash equivalents 3,250 2,721
Premiums receivable 977 282
Other investments 2,478 11,423
Loan receivable 100
Due from related parties 63 45
Deferred policy acquisition costs 101
Operating lease right-of-use assets 9 44
Prepayment and other assets 96 114
Prepaid offering costs 133
Property and equipment, net 4 5
Total assets 8,253 16,616
Liabilities:    
Other Liabilities – Delta Cat Re Tokenholders 1,523
Notes payable to noteholders 118 216
Reserve for losses and loss adjustment expenses 1,073
Unearned premiums reserve 915
Operating lease liabilities 9 44
Accounts payable and other liabilities 356 294
Total liabilities 2,921 1,627
Shareholders’ equity:    
Ordinary share capital, (par value $0.001, 50,000,000 shares authorized; 5,870,234 and 5,769,587 shares issued and outstanding) 6 6
Additional paid-in capital 32,740 32,482
Accumulated Deficit (27,414) (17,499)
Total shareholders’ equity 5,332 14,989
Total liabilities and shareholders’ equity $ 8,253 $ 16,616
XML 18 R3.htm IDEA: XBRL DOCUMENT v3.24.1
Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Statement of Financial Position [Abstract]    
Equity Securities, FV-NI, Cost $ 1,926  
Common stock, par value $ 0.001 $ 0.001
Common stock, shares authorized 50,000,000 50,000,000
Common stock, shares issued 5,870,234 5,769,587
Common stock, shares outstanding 5,870,234 5,769,587
XML 19 R4.htm IDEA: XBRL DOCUMENT v3.24.1
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Revenue    
Assumed premiums $ 2,170,000 $ 645,000
Change in unearned premiums reserve (915,000) 350,000
Net premiums earned 1,255,000 995,000
SurancePlus fee income 300,000
Net investment and other income 303,000 201,000
Net realized investment gain 27,000
Unrealized loss on other investments (8,945,000) (35,000)
Change in fair value of equity securities 38,000 (338,000)
Total revenue (7,049,000) 850,000
Expenses    
Losses and loss adjustment expenses 1,073,000
Policy acquisition costs and underwriting expenses 141,000 110,000
General and administrative expenses 2,183,000 1,413,000
Total expenses 2,324,000 2,596,000
Loss before income attributable to noteholders and tokenholders (9,373,000) (1,746,000)
Income attributable to noteholders and tokenholders (542,000) (43,000)
Net loss $ (9,915,000) $ (1,789,000)
Loss per share    
Loss per share, basic $ (1.69) $ (0.31)
Loss per share, diluted $ (1.69) $ (0.31)
Weighted-average shares outstanding    
Weighted average number of shares outstanding, basic 5,867,129 5,772,396
Weighted average number of shares outstanding, diluted 5,867,129 5,772,396
XML 20 R5.htm IDEA: XBRL DOCUMENT v3.24.1
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Operating activities    
Net loss $ (9,915,000) $ (1,789,000)
Adjustments to reconcile net loss to net cash used in operating activities:    
Share-based compensation 258,000 127,000
Depreciation and amortization 6,000 4,000
Net realized investment gains (27,000)
SurancePlus fee income (300,000)
Change in fair value of equity securities (38,000) 338,000
Change in fair value of other investments 8,945,000 35,000
Change in operating assets and liabilities:    
Premiums receivable (695,000) 2,000
Due from related parties (18,000) (40,000)
Deferred policy acquisition costs (101,000) 38,000
Prepayment and other assets 18,000 (64,000)
Prepaid offering costs 133,000 (133,000)
Other Liablities Delta Cat Re Tokenholders 543,000
Losses payable (1,073,000) 1,073,000
Unearned premiums reserve 915,000 (350,000)
Accounts payable and other liabilities 62,000 (43,000)
Net cash used in operating activities (1,260,000) (829,000)
Investing activities    
Purchase of equity securities (1,002,000)
Purchase of loan receivable (100,000)
Purchase of other investments (285,000)
Proceeds from sale of equity securities 626,000
Purchase of property and equipment (5,000)
Net cash used in investing activities (105,000) (661,000)
Financing activities    
Partial redemption of notes payable to noteholders (98,000)
Gross proceeds from the issuance of Delta Cat Re tokens 1,280,000
Net cash provided by financing activities   1,182,000
Cash and cash equivalents, and restricted cash and cash equivalents:    
Net change during the year (183,000) (1,490,000)
Balance at beginning of year 3,928,000 5,418,000
Balance at end of year $ 3,745,000 $ 3,928,000
XML 21 R6.htm IDEA: XBRL DOCUMENT v3.24.1
Consolidated Statements of Changes in Shareholders' Equity - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance at Dec. 31, 2021 $ 6,000 $ 32,355,000 $ (15,710,000) $ 16,651,000
Balance, shares at Dec. 31, 2021 5,749,587      
Net loss for the year (1,789,000) (1,789,000)
Issuance of Restricted stock, net
Issurance of Restricted stock, net, shares 20,000      
Share-based compensation 127,000 127,000
Balance at Dec. 31, 2022 $ 6,000 32,482,000 (17,499,000) 14,989,000
Balance, shares at Dec. 31, 2022 5,769,587      
Net loss for the year (9,915,000) (9,915,000)
Issuance of Restricted stock, net
Issurance of Restricted stock, net, shares 100,647      
Share-based compensation 258,000 258,000
Balance at Dec. 31, 2023 $ 6,000 $ 32,740,000 $ (27,414,000) $ 5,332,000
Balance, shares at Dec. 31, 2023 5,870,234      
XML 22 R7.htm IDEA: XBRL DOCUMENT v3.24.1
Pay vs Performance Disclosure - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Pay vs Performance Disclosure [Table]    
Net Income (Loss) Attributable to Parent $ (9,915,000) $ (1,789,000)
XML 23 R8.htm IDEA: XBRL DOCUMENT v3.24.1
Insider Trading Arrangements
3 Months Ended
Dec. 31, 2023
Insider Trading Arrangements [Line Items]  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
XML 24 R9.htm IDEA: XBRL DOCUMENT v3.24.1
ORGANIZATION AND BASIS OF PRESENTATION
12 Months Ended
Dec. 31, 2023
Accounting Policies [Abstract]  
ORGANIZATION AND BASIS OF PRESENTATION

1. ORGANIZATION AND BASIS OF PRESENTATION

 

(a) Organization

 

Oxbridge Re Holdings Limited (the “Company”) was incorporated as an exempted company on April 4, 2013 under the laws of the Cayman Islands. The Company directly owns 100% of the equity interest in Oxbridge Reinsurance Limited, an exempted entity incorporated on April 23, 2013 under the laws of the Cayman Islands and for which a Class “C” Insurer’s license was granted on April 29, 2013 under the provisions of the Cayman Islands Insurance Law. The Company also indirectly owns 100% of the equity interest in Oxbridge Re NS, an entity incorporated as an exempted company on December 22, 2017 under the laws of the Cayman Islands to function as a reinsurance sidecar facility and to increase the underwriting capacity of Oxbridge Reinsurance Limited. The Company also indirectly owns 100% of the equity interest in SurancePlus, an entity incorporated as a business company on December 19, 2022 under the laws of the British Virgin Islands to issue digital securities. The Company and its subsidiaries (collectively “Oxbridge Re”) provide the following: SurancePlus; is a Web3-focused subsidiary that currently leverages blockchain technology to democratize access to high-return reinsurance contracts via digital securities. Oxbridge Reinsurance Limited; is a licensed reinsurance subsidiary that provides reinsurance business solutions primarily to property and casualty insurers in the Gulf Coast region of the United States; Oxbridge Re NS; a licensed reinsurance SPV/side car that provides third-party investors with access to reinsurance contracts with returns uncorrelated to the financial markets. The Company operates as a single business segment through its wholly-owned subsidiaries. The Company’s headquarters and principal executive offices are located at Suite 201, 42 Edward Street, George Town, Grand Cayman, Cayman Islands, and have their registered offices at P.O. Box 309, Ugland House, Grand Cayman, Cayman Islands.

 

The Company’s ordinary shares and warrants are listed on The NASDAQ Capital Market under the symbols “OXBR” and “OXBRW,” respectively.

 

(b) Basis of Presentation and Consolidation

 

The accompanying consolidated financial statements for the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). All significant intercompany transactions and balances have been eliminated upon consolidation.

 

The Company consolidates in these consolidated financial statements the results of operations and financial position of all voting interest entities (“VOE”) in which the Company has a controlling financial interest and all variable interest entities (“VIE”) in which the Company is considered to be the primary beneficiary. The consolidation assessment, including the determination as to whether an entity qualifies as a VIE or VOE, depends on the facts and circumstances surrounding each entity.

 

XML 25 R10.htm IDEA: XBRL DOCUMENT v3.24.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
12 Months Ended
Dec. 31, 2023
Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Use of Estimates: In preparing the consolidated financial statements, management was required to make certain estimates and assumptions that affect the reported amounts of the consolidated assets, liabilities, revenues, expenses and related disclosures at the financial reporting date and throughout the periods being reported upon. Certain of the estimates result from judgments that can be subjective and complex and consequently actual results may differ from these estimates, which would be reflected in future periods. Material estimates that are particularly susceptible to significant change in the near-term relate to the determination of the reserve for losses and loss adjustment expenses (if any), which may include amounts estimated for claims incurred but not yet reported. The Company uses various assumptions and actuarial data it believes to be reasonable under the circumstances to make these estimates. Although considerable variability is likely to be inherent in these estimates, management believes that the amounts provided are reasonable. These estimates are continually reviewed and adjusted if necessary. Such adjustments are reflected in current operations.

 

 

 

 

Revenue Recognition

 

SurancePlus incentive, technology, origination and management (“ITOM”) fee income represents fee income related to the completion of the DeltaCat tokenized reinsurance securities as well as placement of the underlying insurance policies. The Company recognizes the associated revenue at the time of the placement of the underlying insurance policies as the performance obligation is satisfied at that time.

 

Cash and cash equivalents: Cash and cash equivalents are comprised of cash and short- term investments with original maturities of three months or less.

 

Restricted cash and cash equivalents: Restricted cash and cash equivalents represent funds held in accordance with the Company’s trust agreements with ceding insurers and trustees, which requires the Company to maintain collateral with a market value greater than or equal to the limit of liability, less unpaid premium.

 

Investments: The Company from time to time invests in fixed-maturity securities and equity securities, and for which its fixed-maturity securities are classified as available-for-sale. The Company’s available for sale fixed-maturity investments are carried at fair value with changes in fair value included as a separate component of accumulated other comprehensive income (loss) in shareholders’ equity. For the Company’s investment in equity securities, and for the Company’s investment in Jet.AI. classified as “other investments”, the changes in fair value are recorded within the consolidated statements of operations. At December 31, 2023 and 2022 the company did not own any fixed maturity debt securities.

 

Unrealized gains or losses are determined by comparing the fair market value of the securities with their cost or amortized cost. Realized gains and losses on investments are recorded on the trade date and are included in the consolidated statements of operations. The cost of securities sold is based on the specified identification method. Investment income is recognized as earned and discounts or premiums arising from the purchase of debt securities are recognized in investment income using the interest method over the remaining term of the security.

 

Fair value measurement: GAAP establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy under GAAP are as follows:

 

Level 1 Inputs that reflect unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date;
   
Level 2 Inputs other than quoted prices that are observable for the asset or liability either directly or indirectly, including inputs in markets that are not considered to be active; and
   
Level 3 Inputs that are unobservable.

 

Inputs are used in applying the various valuation techniques and broadly refer to the assumptions that market participants use to make valuation decisions, including assumptions about risk. For fixed maturity securities, inputs may include price information, volatility statistics, specific and broad credit data, liquidity statistics, broker quotes for similar securities and other factors. The fair value of investments in stocks and exchange-traded funds is based on the last traded price. A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. However, the determination of what constitutes “observable” requires significant judgment by the Company’s investment custodians and management. The investment custodians consider observable data to be market data which is readily available, regularly distributed or updated, reliable and verifiable, not proprietary, and provided by independent sources that are actively involved in the relevant markets.

 

 

 

 

Deferred policy acquisition costs (“DAC”): Policy acquisition costs consist of brokerage fees, federal excise taxes and other costs related directly to the successful acquisition of new or renewal insurance contracts and are deferred and amortized over the terms of the reinsurance agreements to which they relate. The Company evaluates the recoverability of DAC by determining if the sum of future earned premiums and anticipated investment income is greater than the expected future claims and expenses. If a loss is probable on the unexpired portion of policies in force, a premium deficiency loss is recognized.

 

Offering Expenses:

 

During the year ended December 31, 2023 the Company recognized offering costs totaling $133,000 on the consolidated statements of operations which was related to an equity distribution agreement with Maxim Group LLC (“Maxim”) for the sale of the ordinary shares. During the year ended December 31, 2023, the Company recognized in the consolidated statements of operations $236,000 of offering expenses in relation to the offering of Delta Cat Re digital securities issuable by the Company’s new subsidiary, SurancePlus Inc. (See Note 6)

 

In accordance with the terms of the equity distribution agreement with Maxim, we intend to offer and sell ordinary shares having an aggregate offering price of up to $6.3 million from time to time.

 

Property and equipment: Property and equipment are recorded at cost when acquired. Property and equipment are comprised of motor vehicles, furniture and fixtures, computer equipment and leasehold improvements and are depreciated, using the straight-line method, over their estimated useful lives, which are five years for furniture and fixtures and computer equipment and four years for motor vehicles. Leasehold improvements are amortized over the lesser of the estimated useful lives of the assets or remaining lease term. The Company periodically reviews property and equipment that have finite lives, and that are not held for sale, for impairment by comparing the carrying value of the assets to their estimated future undiscounted cash flows. For the years ended December 31, 2023 and 2022, there were no impairments in property and equipment.

 

Reserves for losses and loss adjustment expenses: The Company determines its reserves for losses and loss adjustment expenses, if any, on the basis of the claims reported by the Company’s ceding insurers and for losses incurred but not reported (“IBNR”), management uses the assistance of an independent actuary. The reserves for losses and loss adjustment expenses represent management’s best estimate of the ultimate settlement costs of all losses and loss adjustment expenses. Management believes that the amounts are adequate; however, the inherent impossibility of predicting future events with precision, results in uncertainty as to the amount which will ultimately be required for the settlement of losses and loss expenses, and the differences could be material. Adjustments are reflected in the consolidated statements of operations in the period in which they are determined.

 

Loss experience refund payable: Certain contracts include retrospective provisions that adjust premiums or result in profit commissions in the event losses are minimal or zero. In accordance with GAAP, the Company will recognize a liability in the period in which the absence of loss experience obligates the Company to pay cash or other consideration under the contracts. On the contrary, the Company will derecognize such liability in the period in which a loss experience arises. Such adjustments to the liability, which accrue throughout the contract terms, will reduce the liability should a catastrophic loss event covered by the Company occur.

 

Premiums assumed: The Company records premiums assumed, net of loss experience refunds, as earned pro-rata over the terms of the reinsurance agreements, or period of risk, where applicable, and the unearned portion at the consolidated balance sheet date is recorded as unearned premiums reserve. A reserve is made for estimated premium deficiencies to the extent that estimated losses and loss adjustment expenses exceed related unearned premiums. Investment income is not considered in determining whether or not a deficiency exists.

 

 

 

 

Subsequent adjustments of premiums assumed, based on reports of actual premium by the ceding companies, or revisions in estimates of ultimate premium, are recorded in the period in which they are determined. Such adjustments are generally determined after the associated risk periods have expired, in which case the premium adjustments are fully earned when assumed.

 

Certain contracts allow for reinstatement premiums in the event of a full limit loss prior to the expiration of the contract. A reinstatement premium is not due until there is a full limit loss event and therefore, in accordance with GAAP, the Company records a reinstatement premium as written only in the event that the reinsured incurs a full limit loss on the contract and the contract allows for a reinstatement of coverage upon payment of an additional premium. For catastrophe contracts which contractually require the payment of a reinstatement premium equal to or greater than the original premium upon the occurrence of a full limit loss, the reinstatement premiums are earned over the original contract period. Reinstatement premiums that are contractually calculated on a pro-rata basis of the original premiums are earned over the remaining coverage period.

 

Unearned Premiums Ceded: The Company may reduce the risk of future losses on business assumed by reinsuring certain risks and exposures with other reinsurers (retrocessionaires). The Company remains liable to the extent that any retrocessionaire fails to meet its obligations and to the extent that the Company does not hold sufficient security for their unpaid obligations.

 

Ceded premiums are written during the period in which the risk incept and are expensed over the contract period in proportion to the period of protection. Unearned premiums ceded consist of the unexpired portion of the reinsurance obtained. There were no unearned premiums ceded at December 31, 2023 and 2022.

 

SurancePlus Fee Income: SurancePlus incentive, technology, origination and management (“ITOM”) fee income represents fee income related to the completion of the DeltaCat tokenized reinsurance securities as well as placement of the underlying insurance policies. The Company recognizes the associated revenue at the time of the placement of the underlying insurance policies as the performance obligation is satisfied at that time.

 

Uncertain income tax positions: The authoritative GAAP guidance on accounting for, and disclosure of, uncertainty in income tax positions requires the Company to determine whether an income tax position of the Company is more likely than not to be sustained upon examination by the relevant tax authority, including resolution of any related appeals or litigation processes, based on the technical merits of the position. For income tax positions meeting the more likely than not threshold, the tax amount recognized in the consolidated financial statements, if any, is reduced by the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate settlement with the relevant taxing authority. The application of this authoritative guidance has had no effect on the Company’s consolidated financial statements because the Company had no uncertain tax positions at December 31, 2023.

 

Loss Per Share: Basic loss per share has been computed on the basis of the weighted-average number of ordinary shares outstanding during the years presented. Diluted loss per share is computed based on the weighted-average number of ordinary shares outstanding and reflects the assumed exercise or conversion of diluted securities, such as stock options and warrants, computed using the treasury stock method.

 

Share-Based Compensation: The Company accounts for share-based compensation under the fair value recognition provisions of GAAP which requires the measurement and recognition of compensation for all stock-based awards made to employees and directors, including stock options and restricted stock issuances based on estimated fair values. The Company measures compensation for restricted stock based on the price of the Company’s ordinary shares at the grant date. Determining the fair value of stock options at the grant date requires significant estimation and judgment. The Company uses an option-pricing model (Black-Scholes option pricing model) to assist in the calculation of fair value for stock options. When estimating the expected volatility, the Company takes into consideration the historical volatility of entities similar to itself. The Company considers factors such as an entity’s industry, stage of life cycle, size and financial leverage when selecting similar entities. The Company may use a sample peer group of companies in the reinsurance industry and/or the Company’s own historical volatility in determining the expected volatility

 

 

 

Additionally, the Company uses the guidance in the SEC’s Staff Accounting Bulletin No. 107 to determine the estimated life of options issued and has assumed no forfeitures during the life of the options.

 

The Company uses the straight-line attribution method for all grants that include only a service condition. Compensation expense related to all awards is included in general and administrative expenses.

 

Segment Information: Under GAAP, operating segments are based on the internal information that management uses for allocating resources and assessing performance as the source of the Company’s reportable segments. The Company manages its business on the basis of one operating segment, Property and Casualty Reinsurance, in accordance with the qualitative and quantitative criteria established under GAAP.

 

Reclassifications: Any reclassifications of prior period amounts have been made to conform to the current period presentation.

 

XML 26 R11.htm IDEA: XBRL DOCUMENT v3.24.1
CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AND CASH EQUIVALENTS
12 Months Ended
Dec. 31, 2023
Cash and Cash Equivalents [Abstract]  
CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AND CASH EQUIVALENTS

3. CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AND CASH EQUIVALENTS

 

   2023   2022 
   December 31, 
   2023   2022 
   (in thousands) 
Cash held on deposit  $495   $1,207 
Restricted cash held in trust   3,250    2,721 
Total  $3,745   $3,928 

 

Cash and cash equivalents are held by large and reputable counterparties in the United States of America and in the Cayman Islands. Restricted cash held in trust is custodied with Truist Bank, and is held in accordance with the Company’s trust agreements with the ceding insurers and trustees, which require that the Company provide collateral having a market value greater than or equal to the limit of liability, less unpaid premium.

 

 

 

XML 27 R12.htm IDEA: XBRL DOCUMENT v3.24.1
INVESTMENTS
12 Months Ended
Dec. 31, 2023
Investments, All Other Investments [Abstract]  
INVESTMENTS

4. INVESTMENTS

 

The Company from time to time invests in fixed-maturity securities and equity securities, with its fixed-maturity securities classified as available-for-sale. At December 31, 2023 and 2022, the Company did not hold any available-for-sale securities.

 

Proceeds received, and the gross realized gains and losses from sale of equity securities, for the years ended December 31, 2023 and 2022 are as follows:

 

  

Gross

proceeds

from sales

  

Gross

Realized

Gains

  

Gross

Realized

Losses

 
   ($ in thousands) 
             
Year ended December 31, 2023               
Equity securities  $-   $-   $- 
                
Year ended December 31, 2022               
Equity securities  $626   $27   $- 

 

Other Investments

 

On August 7, 2023, OXAC held an extraordinary general meeting at which the business combination with Jet Token, Inc. was approved by OXAC shareholders. In conjunction with the business combination, OXAC was redomesticated as a Delaware entity, and changed its name to Jet.AI Inc (“Jet.AI”). The business combination was closed on August 10, 2023, and on August 11, 2023, OXAC common stock and warrants began trading on the Nasdaq under the new ticker symbols JTAI and JTAIW.

 

The Company’s beneficial interests in Jet. AI’s ordinary shares, public warrants and Extension Loan are recorded at fair value and are classified in “Other Investments” on the consolidated balance sheets. The fair value calculation of the Company’s beneficial interest in Jet.AI’s ordinary shares and public warrants is dependent on the observable trading prices of JetAI’s Class A shares and public warrants. The fair value calculation of the Company’s beneficial interest in the Extension Loan is estimated to be the pro-rata original principal amount of the Extension Loan due to the short-term nature.

 


The Sponsor holds 2,875,000 ordinary shares, 575 Series A-1 preferred shares with purchase price of $1,000 each, along with the 4,897,500 warrants. One of the Company’s executive officers is an independent member of Jet.AI’s board.

 

As a result of the re-measurement of our investment in Jet.AI, we recognized for the year ended December 31, 2023, an unrealized loss of $8,945,000 within our consolidated statements of operations.

 

Other investments as of December 31, 2023 and 2022 consist of the following (in thousands):

 

   2023   2022 
   December 31, 
   2023   2022 
Jet.AI Series A-1 Convertible Preferred Stock  $285   $- 
Jet.AI. Promissory Note   -    214 
Jet.AI. common stock (2022: Class B Ordinary Shares)   2,193    11,209 
Total  $2,478   $11,423 
           
Beginning of year  $11,423   $11,173 
Investment in affiliate   -    285 
Unrealized loss on investment in affiliate   (8,945)   (35)
End of year  $2,478   $11,423 

 

 

 

 

 

Assets Measured at Estimated Fair Value on a Recurring Basis

 

The following table presents information about the Company’s financial assets measured at estimated fair value on a recurring basis that is reflected in the consolidated balance sheets at carrying value. The table indicates the fair value hierarchy of the valuation techniques utilized by the Company to determine such fair value as of December 31, 2023 and 2022:

 

   (Level 1)   (Level 2)   (Level 3)   Total 
   Fair Value Measurements Using     
   (Level 1)   (Level 2)   (Level 3)   Total 
As of December 31, 2023  ($ in thousands) 
Financial Assets:                    
Cash and cash equivalents  $495   $   -   $-   $495 
                     
Restricted cash and cash equivalents  $3,250   $-   $-   $3,250 
                     
Other investments  $

2,193

   $-   $285   $2,478 
                     
Equity securities  $680   $-   $-   $680 
                     
Total  $6,618   $-   $285   $6,903 

 

   (Level 1)   (Level 2)   (Level 3)   Total 
   Fair Value Measurements Using     
   (Level 1)   (Level 2)   (Level 3)   Total 
As of December 31, 2022  ($ in thousands) 
Financial Assets:                    
Cash and cash equivalents  $1,207   $-   $-   $1,207 
                     
Restricted cash and cash equivalents  $2,721   $-   $-   $2,721 
                     
Other investments  $-   $-   $11,423   $11,423 
                     
Equity securities  $642   $-   $-   $642 
                     
Total  $4,570   $-   $11,423   $15,993 

 

 

 

 

Assets Measured at Estimated Fair Value on a Recurring Basis

 

There were no transfers between Levels 1, 2 or 3 during the years ended December 31, 2023 and 2022 except as disclosed below.

 

In the financial statements for the year ended December 31, 2023, there has been a notable change in the classification of our investment in Jet.AI from Level 3 to Level 1 within the fair value hierarchy. This change is attributed to Oxbridge Acquisition Corp. (“OXAC”) successfully completing a business combination with Jet.AI Inc (“Jet.AI”) in August 2023, resulting in the investment now having an active market with readily available quoted prices.

Previously classified as Level 3 due to the reliance on unobservable inputs, the investment is now categorized as Level 1, as it is valued based on quoted prices in an active market. This change reflects the increased liquidity and transparency associated with Jet.AI’s publicly traded status, allowing for a more reliable and market-driven valuation of our investments.

 

The following table provides a reconciliation of changes in fair value of the beginning and ending balances for the other investments classified as Level 3:

 

   Year ended 
   December 31, 
   2023   2022 
   ($ in thousands) 
Fair value of Level 3 other investments at beginning of year  $11,423   $11,173 
Transfer to Level 1   (11,138)     
Investment in affiliate   -    285 
Change in valuation inputs or other assumptions   -    (35)
Fair value of Level 3 other investment at December 31, 2023  $285   $11,423 

 

 

 

XML 28 R13.htm IDEA: XBRL DOCUMENT v3.24.1
TAXATION
12 Months Ended
Dec. 31, 2023
Income Tax Disclosure [Abstract]  
TAXATION

5. TAXATION

 

Under current Cayman Islands law, no corporate entity, including the Company and the subsidiaries, is obligated to pay taxes in the Cayman Islands on either income or capital gains. The Company and Oxbridge Reinsurance Limited have an undertaking from the Governor-in-Cabinet of the Cayman Islands, pursuant to the provisions of the Tax Concessions Law, as amended, that, in the event that the Cayman Islands enacts any legislation that imposes tax on profits, income, gains or appreciations, or any tax in the nature of estate duty or inheritance tax, such tax will not be applicable to the Company and Oxbridge Reinsurance Limited, or their operations, or to the ordinary shares or related obligations, until April 23, 2033 and May 17, 2033, respectively.

 

The Company and its subsidiaries intend to conduct substantially all of their operations in the Cayman Islands in a manner such that they will not be engaged in a trade or business in the U.S. However, because there is no definitive authority regarding activities that constitute being engaged in a trade or business in the U.S. for federal income tax purposes, the Company cannot assure that the U.S. Internal Revenue Service will not contend, perhaps successfully, that the Company or its subsidiaries are engaged in a trade or business in the U.S. A foreign corporation deemed to be so engaged would be subject to U.S. federal income tax, as well as branch profits tax, on its income that is treated as effectively connected with the conduct of that trade or business unless the corporation is entitled to relief under an applicable tax treaty.

 

XML 29 R14.htm IDEA: XBRL DOCUMENT v3.24.1
VARIABLE INTEREST ENTITIES
12 Months Ended
Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
VARIABLE INTEREST ENTITIES

6. VARIABLE INTEREST ENTITIES

 

Oxbridge Re NS. On December 22, 2017, the Company established Oxbridge Re NS, a Cayman domiciled and licensed special purpose insurer, formed to provide additional collateralized capacity to support Oxbridge Reinsurance Limited’s reinsurance business. In respect of the debt issued by Oxbridge Re NS to investors, Oxbridge Re NS has entered into a retrocession agreement with Oxbridge Reinsurance Limited effective June 1, 2020. Under this agreement, Oxbridge Re NS receives a quota share of Oxbridge Reinsurance Limited’s catastrophe business. Oxbridge Re NS is a non-rated insurer and the risks have been fully collateralized by way of funds held in trust for the benefit of Oxbridge Reinsurance Limited. Oxbridge Re NS is able to provide investors with access to natural catastrophe risk backed by the distribution, underwriting, analysis and research expertise of Oxbridge Re.

 

The Company has determined that Oxbridge Re NS meets the definition of a VIE as it does not have sufficient equity capital to finance its activities. The Company concluded that it is the primary beneficiary and has consolidated the subsidiary upon its formation, as it owns 100% of the voting shares, 100% of the issued share capital and has a significant financial interest and the power to control the activities of Oxbridge Re NS that most significantly impacts its economic performance. The Company has no other obligation to provide financial support to Oxbridge Re NS. Neither the creditors nor beneficial interest holders of Oxbridge Re NS have recourse to the Company’s general credit.

 

Upon issuance of a series of participating notes by Oxbridge Re NS, all of the proceeds from the issuance are deposited into collateral accounts, to fund any potential obligation under the reinsurance agreements entered into with Oxbridge Reinsurance Limited underlying such series of notes. The outstanding principal amount of each series of notes generally is expected to be returned to holders of such notes upon the expiration of the risk period underlying such notes, unless an event occurs which causes a loss under the applicable series of notes, in which case the amount returned is expected to be reduced by such noteholder’s pro rata share of such loss, as specified in the applicable governing documents of such notes.

 

In addition, holders of such notes are generally entitled to interest payments, payable annually, as determined by the applicable governing documents of each series of notes.

 

Oxbridge Re Holdings Limited receives an origination and structuring fee in connection with the formation, operation, and management of Oxbridge Re NS.

 

 

 

 

Notes Payable to Series 2020-1 noteholders

 

Oxbridge Re NS entered into a retrocession agreement with Oxbridge Reinsurance Ltd on June 1, 2020 and issued $216,000 of participating notes which provides quota share support for Oxbridge Re’s global property catastrophe excess of loss reinsurance business. The participating notes have been assigned Series 2020-1 and matured on June 1, 2023. Participating notes totaling $98,000 were redeemed during the year-ended December 31, 2023 resulting in a balance due of $118,000 at December 31, 2023. None of the participating notes were redeemed during the year ended December 31, 2022.

 

The income from Oxbridge Re NS operations that are attributable to the participating notes noteholders for year ended December 31, 2023 was $0. The income from Oxbridge Re NS operations that are attributable to the participating notes noteholders for the year ended December 31, 2022 was $43,000 and are included within accounts payable and other liabilities at December 31, 2023 and 2022.

 

SurancePlus Inc.

 

SurancePlus Inc., a wholly-owned subsidiary of Oxbridge Re Holdings Limited, was incorporated as a British Virgin Islands Business Company on December 19, 2022 for the purposes of tokenizing reinsurance contracts underwritten by its affiliated licensed reinsurer, Oxbridge Re NS.

 

On March 27, 2023, the Company and SurancePlus Inc. (“SurancePlus”), issued a press release announcing the commencement of an offering by SurancePlus of DeltaCat Re tokenized reinsurance securities (the “Tokens”), which represent Series DeltaCat Preferred Shares of SurancePlus (“Preferred Shares”, and together with the Tokens, the “Securities”). Each digital security or token, which will have a purchase price of $10.00 per Token, will represent one Preferred Share of SurancePlus. On September 11, 2023, the DeltaCat Re tokens were reclassified as tokenized interests carrying rights equivalent to the DeltaCat Re Preferred Shares in accordance with the provisions of British Virgin Islands law.

 

The proceeds from the offer and sale of the Securities will be used by SurancePlus to purchase one or more participating notes of Oxbridge Re NS, and the proceeds from the sale of participating notes will be invested in collateralized reinsurance contracts to be underwritten by Oxbridge Re NS. The holders of the digital Securities will generally be entitled to proceeds from the payment of participating notes in the amount of a preferred return of 20% plus an additional 80% of any proceeds in excess of the amount necessary to pay the preferred return. Assuming no casualty losses to properties reinsured by Oxbridge Re’s reinsurance subsidiaries, DeltaCat Re token investors are expected to receive an annual return on the original purchase price of 42%.

 

On June 27, 2023, SurancePlus Inc. completed its private placement (the “Private Placement”) of Series DeltaCat Re Preferred Shares represented by DeltaCat Re Tokens (the “Securities”). On June 27, 2023, SurancePlus entered into subscription agreements with accredited investors and non-U.S. persons in the Private Placement with respect to 229,766 of the Securities at a purchase price of $10.00 per token for aggregate gross proceeds of $2,297,660. SurancePlus also previously entered into subscription agreements for and sold 15,010 of the Securities between April 5, 2023 and May 18, 2023 for gross proceeds of $150,100, also at a purchase price of $10.00 per token. The aggregate amount raised in the Private Placement was $2,447,760 for the issuance of 244,776 Securities of which approximately $1,280,000 was received from third-party investors and approximately $1,167,000 from Oxbridge Re Holdings Limited. Approximately $300,000 and $274,000 of ITOM fees were deducted from the gross proceeds from the third-party investors and Oxbridge Re Holdings Limited, respectively., The tokens were issued on the Avalanche blockchain. Ownership of DeltaCat Re tokenized reinsurance securities indirectly confers fractionalized interests in reinsurance contracts underwritten by Oxbridge Re’s reinsurance subsidiary, Oxbridge Re NS, for the 2023-2024 treaty year.

 

On June 28, 2023, Oxbridge issued a press release announcing the completion of the Private Placement

 

The Securities have not been registered under the Securities Act of 1933, as amended (the “Securities Act”), or any state or other securities laws and may not be offered or sold in the United States absent an effective registration statement or an applicable exemption from registration requirements or a transaction not subject to the registration requirements of the Securities Act or any state or other securities laws. The Securities were sold in a transaction exempt from registration under the Securities Act and were sold only to persons reasonably believed to be accredited investors in the United States under SEC Rule 506(c) under the Securities Act and outside the United States only to non-U.S. persons in accordance with Regulation S under the Securities Act.

 

 

The selected unconsolidated historical financial information and other data presented below is derived from SurancePlus’ standalone unaudited financial statements for year ended December 31, 2023 and the balance sheet data as of December 31, 2023.

 

SCHEDULE OF FINANCIAL STATEMENTS

   For Year Ended 
Statement of Operations Data:  December 31, 2023 
      (Unaudited)   
      
Surance Plus fee income   $574 
Underwriting related income    1,140 
Total revenue   $1,714 
Expenses   $(272)
Income attributable to tokenholders   $(1,036)
Net income   $406 

 

Balance Sheet Data:  At December 31, 2023 
    (Unaudited) 
    (In thousands) 
Total assets  $3,588 
Amounts due to Delta Cat Re Tokenholders*  $2,016 
Due to Parent  $47 
Total shareholder’s equity  $1,525 

 

* includes underwriting profit of $494,000 due to Parent.

 

 

 

XML 30 R15.htm IDEA: XBRL DOCUMENT v3.24.1
RESERVE FOR LOSSES AND LOSS ADJUSTMENT EXPENSES
12 Months Ended
Dec. 31, 2023
Reserve For Losses And Loss Adjustment Expenses  
RESERVE FOR LOSSES AND LOSS ADJUSTMENT EXPENSES

7. RESERVE FOR LOSSES AND LOSS ADJUSTMENT EXPENSES

 

The following table summarizes the Company’s loss and loss adjustment expenses (“LAE”) and the reserve for loss and LAE reserve movements for the years ended December 31, 2023 and 2022

  

   2023   2022 
   Year ended 
   December 31, 
   2023   2022 
   ($ in thousands) 
         
Gross balance, beginning of year  $1,073    - 
Incurred, net of reinsurance, related to:          
Current year   -    1,073 
Prior year   -    - 
Total incurred   -    1,073 
Paid related to:          
Current year   -    - 
Prior year   (1,073)   - 
Total paid   -    - 
Balance, end of year  $-    1,073 

 

When losses occur, the reserves for losses and LAE are typically comprised of case reserves (which are based on claims that have been reported) and IBNR reserves (which are based on losses that are believed to have occurred but for which claims have not yet been reported and include a provision for expected future development on existing case reserves). The Company typically suffers limit losses in the event of a Category 3 or above hurricane making landfall in a populated area where the Company has catastrophe risk exposure. For the year ended December 31, 2023, the Company has recorded it’s reserves for losses and LAE based on the contractual maximum loss the Company can suffer under the affected contracts.

 

The uncertainties inherent in the reserving process and potential delays by cedants and brokers in the reporting of loss information, together with the potential for unforeseen adverse developments, may result in the reserve for losses and LAE ultimately being significantly greater or less than the reserve provided at the end of any given reporting period. The degree of uncertainty is further increased when a significant loss event takes place near the end of a reporting period. Reserve for losses and LAE estimates are reviewed periodically on a contract-by-contract basis and updated as new information becomes known. Any resulting adjustments are reflected in income in the period in which they become known.

 

The Company’s reserving process is highly dependent on the timing of loss information received from its cedants and related brokers.

 

There were no losses incurred during the year ended December 31, 2023. The losses incurred during the year ended December 31, 2022 related to a first limit loss suffered by the Company as a result of underwriting exposure to Hurricane Ian, which made landfall in Florida on September 28, 2022.

 

 

 

 

Reserving methodologies and assumptions

 

Loss reserves are generally established based on loss payments and case reserves reported by clients when, and if, received. Estimates for IBNR losses are added to the case reserves. To establish IBNR loss estimates, the Company uses quarterly actuarial estimates from its independent actuary, who utilizes loss data reported by the Company along with industry loss data and information, knowledge of the business written and actuary’s own professional judgment.

 

The independent actuary employs standard actuarial methods for its analysis each quarter. Such methods may include the:

 

  Reported Loss Development Method. Ultimate losses are estimated by calculating past reported loss development factors and applying them to exposure periods with further expected reported loss development. Since reported losses include payments and case reserves, changes in both of these amounts are incorporated in this method.
     
  Expected Loss Ratio Method. Ultimate losses are estimated by multiplying earned premiums by an expected loss ratio. The expected loss ratio is selected using industry data, historical company data and actuarial professional judgment. This method is typically used for lines of business and contracts where there are no historical losses or where past loss experience is not credible.
     
  Bornhuetter-Ferguson Reported Loss Method. Ultimate losses are estimated by modifying expected loss ratios to the extent reported losses experienced to date differ from what would have been expected to have been reported based upon the selected reported loss development pattern. This method avoids some of the distortions that could result from a large development factor being applied to a small base of reported losses to calculate ultimate losses.
     
  Frequency / Severity Method. Ultimate losses are estimated under this method by multiplying the ultimate number of claims (i.e. the frequency multiplied by the exposure base on which the frequency has been determined), by the estimated ultimate average cost per claim (i.e. the severity). By analyzing claims experience by its frequency and severity components, the Company can examine trends and patterns in the rates of claims emergence (i.e. reporting) and settlement (i.e. closure) as well as in the average cost of claims.
     
    The approach is valuable because sometimes there is more inherent stability in the frequency and severity data when viewed separately rather than in the total losses

 

 

 

 

Reserving methodologies and assumptions (continued)

 

In addition, the Company may supplement its analysis with other reserving methodologies that are deemed to be relevant to specific contracts.

 

For each contract, the Company utilizes reserving methodologies that are deemed appropriate to calculate a best estimate, or point estimate, of reserves. The decision of whether to use a single methodology or a combination of multiple methodologies depends upon the judgment of the independent actuary, if utilized. The Company’s reserving methodology does not require a fixed weighting of the various methods used. Certain methods are considered more appropriate depending on the type and structure of the contract, the age and maturity of the contract, and the duration of the expected paid losses on the contract.

 

The Company’s gross aggregate reserves are the sum of the point estimate reserves of all portfolio exposures. Generally, IBNR loss reserves are calculated by estimating the ultimate incurred losses at any point in time and subtracting cumulative paid claims and case reserves, which incorporate specific exposures, loss payment and reporting patterns and other relevant factors.

 

There were no significant changes in the Company’s methodology or assumptions relating to the Company’s reserve for loss and loss adjustment expenses for the years ended December 31, 2023 or 2022.

 

Claims Development Tables, IBNR Reserves and Claims Frequency

 

The following table discloses information about the Company’s incurred and paid claims development as of December 31, 2023, as well as cumulative claim frequency and the total of incurred-but-not-reporting and expected development on reported claims included within the net incurred claims amounts. A claim is defined as a reported loss from a cedant on an excess-of-loss reinsurance contract arising from a loss event for which the Company records a paid loss or case reserve. The Company operates a single business segment, being property catastrophe reinsurance.

 

 

 

 

Property Catastrophe Reinsurance

 

(in thousands)

 

Incurred Losses and Loss Adjustment Expenses

 

Accident Year  2016   2017   2018   2019   2020   2021   2022    2023   

As of December 31, 2023 Total of Incurred-but
-Not-Reported Liabilities
Plus Expected Development on
Reported Claims

   Cumulative Number of Reported Claims 
                                       (dollars in thousands) 
2016  $14,775   $18,801   $17,795   $17,689   $17,689   $17,689   $17,689    $ 17,689    $-    5 
2017       $38,401   $38,401   $38,401   $38,401   $38,401   $38,401    $ 38,401    $-    8 
2018            $10,000   $10,000   $10,000   $10,000   $10,000    $ 10,000    $-    2 
2019                 $-   $-   $-   $-    $ -    $-    - 
2020                      $-   $-   $-    $ -    $-    - 
2021                           $158   $158    $ 158    $-    1 
2022                                $1,073    $ 1,073    $              -          1 
2023                                $-    $ -    $-    - 
    Total                             $67,321    $ 67,321    $-      

 

Cumulative Paid Losses and Loss Adjustment Expenses

 

Accident Year  2016   2017   2018   2019   2020   2021   2022  2023  
2016  $6,073   $16,073   $17,687   $17,689   $17,689   $17,689   $17,689  $ 17,689  
2017       $36,293   $38,401   $38,401   $38,401   $38,401   $38,401  $

38,401

 
2018            $6,000   $10,000   $10,000   $10,000   $10,000  $ 10,000  
2019                 $-   $-   $-   $-  $ -  
2020                      $-   $-   $-  $ -  
2021                           $158   $158  $ 158  
2022                                $1,073  $ 1,073  
2023                           $-       $ -  
    Total                            $67,321  $ 67,321  
Reserve for loss and loss adjustment expenses at December 31, 2023, net of reinsurance                                $ -   $ -  

 

The following table shows the historical average annual percentage payout of claims at December 31, 2022.

 

   Average Annual Percentage Payout of Incurred Claims by Age 
                         
Years   1    2    3    4    5    6 
                               
Property Catastrophe Reinsurance   57.8%   34.0%   9.1%   0.0%   0.0%   0%

 

 

 

XML 31 R16.htm IDEA: XBRL DOCUMENT v3.24.1
LOSS PER SHARE
12 Months Ended
Dec. 31, 2023
Earnings Per Share [Abstract]  
LOSS PER SHARE

8. LOSS PER SHARE

 

A summary of the numerator and denominator of the basic and diluted loss per share is presented below (dollars in thousands except per share amounts):

 

SCHEDULE OF COMPUTATION OF BASIC AND DILUTED LOSS EARNING PER SHARE

   2023   2022 
   Years ended December 31 
   2023   2022 
         
Numerator:          
Net loss  $(9,915)   (1,789)
           
Denominator:          
Weighted average shares - basic   5,867,129    5,772,396 
Effect of dilutive securities - Stock options   -    - 
Shares issuable upon conversion of warrants   -    - 
Weighted average shares - diluted   5,867,129    5,772,396 
Loss per share - basic  $(1.69)   (0.31)
Loss earnings per share - diluted  $(1.69)   (0.31)

 

For the years ended December 31, 2023, and 2022, options to purchase 871,250 ordinary shares were anti-dilutive due to the net losses during those years.

 

GAAP requires the Company to use the two-class method in computing basic loss per share since holders of the Company’s restricted stock have the right to share in dividends, if declared, equally with common stockholders. These participating securities effect the computation of both basic and diluted loss per share during the years ended December 31, 2023 and 2022.

 

 

 

XML 32 R17.htm IDEA: XBRL DOCUMENT v3.24.1
WARRANTS
12 Months Ended
Dec. 31, 2023
Disclosure Warrants Abstract  
WARRANTS

9. WARRANTS

 

There were 8,230,700 warrants outstanding at December 31, 2023 and 2022. One warrant may be exercised to acquire one ordinary share at an exercise price equal to $7.50 per share on or before March 26, 2024. The Company at its option may cancel the warrants in whole or in part, provided that the closing price per ordinary share has exceeded $9.38 for at least ten trading days within any period of twenty consecutive trading days, including the last trading day of the period. No warrants were exercised during the years ended December 31, 2023 and 2022.

 

On January 29, 2024, the Company extended the expiration date of the warrants (NASDAQ: OXBRW) (the “Warrants”) to 5:00 p.m. Philadelphia time on the earlier to occur of (a) March 26, 2029 and (b) the date fixed for cancellation by the Company following any 20-trading day period in which the Company’s ordinary shares traded above $9.38 per share for at least ten trading days.

 

XML 33 R18.htm IDEA: XBRL DOCUMENT v3.24.1
DIVIDENDS
12 Months Ended
Dec. 31, 2023
Dividends [Abstract]  
DIVIDENDS

10. DIVIDENDS

 

As of December 31, 2023, none of the Company’s accumulated deficit were restricted from payment of dividends to the company’s shareholders. However, since most of the Company’s capital and retained earnings may be invested in its subsidiaries, a dividend from the subsidiaries would likely be required in order to fund a dividend to the Company’s shareholders and would require notification to the Cayman Islands Monetary Authority (“CIMA”).

 

Under Cayman Islands law, the use of additional paid-in capital is restricted, and the Company will not be allowed to pay dividends out of additional paid-in capital if such payments result in breaches of the prescribed and minimum capital requirement.

 

XML 34 R19.htm IDEA: XBRL DOCUMENT v3.24.1
SHARE-BASED COMPENSATION
12 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
SHARE-BASED COMPENSATION

11. SHARE-BASED COMPENSATION

 

The Company currently has outstanding share-based awards granted under the 2014 Omnibus Incentive Plan (the “2014 Plan”) and the 2021 Omnibus Incentive Plan (the “2021 Plan”) (herein collectively referred to as “the Plans”). Under each of the Plans, the Company has discretion to grant equity and cash incentive awards to eligible individuals, including the issuance of up to 1,000,000 of the Company’s ordinary shares. During the year ended December 31, 2023, the Company granted an aggregated of 100,647 of restricted stock to directors, officers and employees under the 2021 Plan. At December 31, 2023, there were 895,353 shares and 11,750 shares available for grant under the 2021 Plan and the 2014 Plan, respectively.

 

Stock options

 

Stock options granted and outstanding under the Plans vests quarterly over four years and are exercisable over the contractual term of ten years.

 

A summary of the stock option activity for the years ended December 31, 2023 and 2022 is as follows (option amounts not in thousands):

 

   Number of Options  

Weighted-

Average

Exercise

Price

   Weighted- Average Remaining Contractual Term   Aggregate Intrinsic Value 
                 
Outstanding at December 31, 2022   871,250   $4.67    5.8 years   $- 
Exercisable at December 31, 2022   721,250   $4.39    5.3 years   $- 
                     
Outstanding at December 31, 2022   871,250    4.67    5.8 years   $     - 
Forfeited   (25,000)   (6.00)          
Outstanding at December 31, 2023   846,250   $4.63    4.8 years   $- 
Exercisable at December 31, 2023   783,750   $4.52    4.6 years   $- 

 

 

 

 

Compensation expense recognized for the years ended December 31, 2023 and 2022 totaled $20,000 and $58,000, respectively, and is included in general and administrative expenses. At December 31, 2023 and 2022, there was approximately $20,000 and $48,000, respectively, of total unrecognized compensation expense related to non-vested stock options granted under the Plans. The Company expects to recognize the remaining compensation expense over a weighted-average period of twelve (12) months.

 

There were no options granted during the year ended December 31, 2023 or 2022.

 

Restricted Stock Awards

 

The Company may grant restricted stock awards to eligible individuals in connection with their service to the Company. The terms of the Company’s outstanding restricted stock grants may include service, performance and market-based conditions. The fair value of the awards with market-based conditions is determined using a Monte Carlo simulation method, which calculates many potential outcomes for an award and then establishes fair value based on the most likely outcome. The determination of fair value with respect to the awards with only performance or service-based conditions is based on the value of the Company’s stock on the grant date.

 

Information with respect to the activity of unvested restricted stock awards during the year ended December 31, 2023 is as follows (share amounts not in thousands):

 

  

Weighted-

Number of

Restricted

Stock Awards

  

Weighted-

Average

Grant Date

Fair Value

 
         
Nonvested at January 1, 2022   15,000      
Granted   32,000   $3.57 
Vested   (12,000)     
Forfeited   (12,000)   3.57 
Nonvested at December 31, 2022   23,000      
Granted   100,647   $2.37 
Vested   (77,574)   2.37 
Nonvested at December 31, 2023   46,073      

 

Compensation expense recognized for the years ended December 31, 2023 and 2022 totaled $238,000 and $69,000, respectively, and is included in general and administrative expenses. At December 31, 2023 and 2022, there was approximately $133,000 and $121,000, respectively, of unrecognized compensation expense related to non-vested restricted stock granted under the Plans. The Company expects to recognize the remaining compensation expense over a weighted-average period of seven (7) months.

 

 

 

XML 35 R20.htm IDEA: XBRL DOCUMENT v3.24.1
NET WORTH FOR REGULATORY PURPOSES
12 Months Ended
Dec. 31, 2023
Net Worth For Regulatory Purposes  
NET WORTH FOR REGULATORY PURPOSES

12. NET WORTH FOR REGULATORY PURPOSES

 

The subsidiaries are subject to a minimum and prescribed capital requirement as established by CIMA. Under the terms of their respective licenses, Oxbridge Reinsurance Limited and Oxbridge Re NS are required to maintain a minimum and prescribed capital requirement of $500 in accordance with the relevant subsidiary’s approved business plan filed with CIMA.

 

At December 31, 2023, the Oxbridge Reinsurance Limited’s net worth of $10 thousand exceeded the minimum and prescribed capital requirement. For the years ended December 31, 2023 and 2022, Oxbridge Reinsurance Ltd.’s net loss was approximately $11.29 million and $2.0 million, respectively.

 

At December 31, 2023, the Oxbridge Re NS’ net worth of $223 thousand exceeded the minimum and prescribed capital requirement. For the years ended December 31, 2023 and 2022, Oxbridge Re NS’ net income was approximately $68,000 and $11,000, respectively.

 

The Subsidiaries are not required to prepare separate statutory financial statements for filing with CIMA, and there were no material differences between the Subsidiaries’ GAAP capital, surplus and net income, and its statutory capital, surplus and net income as of December 31, 2023 or for the year then ended.

 

XML 36 R21.htm IDEA: XBRL DOCUMENT v3.24.1
FAIR VALUE AND CERTAIN RISKS AND UNCERTAINTIES
12 Months Ended
Dec. 31, 2023
Fair Value Disclosures [Abstract]  
FAIR VALUE AND CERTAIN RISKS AND UNCERTAINTIES

13. FAIR VALUE AND CERTAIN RISKS AND UNCERTAINTIES

 

Fair values

 

With the exception of balances in respect of insurance contracts (which are specifically excluded from fair value disclosures under GAAP) and investment securities as disclosed in Note 4 of these consolidated financial statements, the carrying amounts of all other financial instruments, which consist of cash and cash equivalents, restricted cash and cash equivalents, premiums receivable and other assets, loan receivable, notes payable, and accounts payable and other liabilities, approximate their fair values due to their short-term nature.

 

Concentration of underwriting risk

 

A substantial portion of the Company’s current reinsurance business ultimately relates to the risks of a limited number of entities; accordingly, the Company’s underwriting risks are not diversified.

 

Concentrations of Credit and Counterparty Risk

 

The Company markets retrocessional and reinsurance policies worldwide through its brokers. Credit risk exists to the extent that any of these brokers may be unable to fulfill their contractual obligations to the Company. For example, the Company is required to pay amounts owed on claims under policies to brokers, and these brokers, may fail to pay over the money to the cedants. In some jurisdictions, if a broker fails to make such a payment, the Company might remain liable to the ceding company for the deficiency. In addition, in certain jurisdictions, when the ceding company pays premiums for these policies to brokers, these premiums are considered to have been paid and the ceding insurer is no longer liable to the Company for those amounts, whether or not the premiums have actually been received.

 

The Company remains liable for losses it incurs to the extent that any third-party reinsurer is unable or unwilling to make timely payments under reinsurance agreements. The Company would also be liable in the event that its ceding companies were unable to collect amounts due from underlying third-party reinsurers.

 

The Company mitigates its concentration of credit risk and counterparty risk by using reputable several counterparties which decreases the likelihood of any significant concentration of credit risk with any one counterparty.

 

 

 

 

Market risk

 

Market risk exists to the extent that the values of the Company’s monetary assets fluctuate as a result of changes in market prices. Changes in market prices can arise from factors specific to individual securities or their respective issuers, or factors affecting all securities traded in a particular market. Relevant factors for the Company are both volatility and liquidity of specific securities and markets in which the Company holds investments. The Company has established investment guidelines that seek to mitigate significant exposure to market risk.

 

XML 37 R22.htm IDEA: XBRL DOCUMENT v3.24.1
LEASES
12 Months Ended
Dec. 31, 2023
Leases [Abstract]  
LEASES

14. LEASES

 

Operating lease right-of-use assets and operating lease liabilities are recognized in the consolidated balance sheets. We determine if a contract contains a lease at inception and recognize operating lease right-of-use assets and operating lease liabilities based on the present value of the future minimum lease payments at the commencement date. As our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at the commencement date in determining the present value of future payments. Lease agreements that have lease and non-lease components, are accounted for as a single lease component. Lease expense is recognized on a straight-line basis over the lease term.

 

The Company has two operating lease obligations namely for the Company’s office facilities located at Suite 201, 42 Edward Street Grand Cayman, Cayman Islands and residential space at Turnberry Villas in Grand Cayman, Cayman Islands. The office lease has a remaining lease term of approximately two (2) month and was renewed subsequent to year end for a period of five (5) years. The residential lease has a remaining lease term of less than 1 month and was renewed subsequent to year end for a period of three (3) years.

 

 

 

 

The components of lease expense and other lease information as of and during the years ended December 31, 2023 and 2022 are as follows:

 

(in thousands)  2023   2022 
  

Year Ended December 31,

 
(in thousands)  2023   2022 
Operating Lease Cost (1)  $108   $96 
           
Cash paid for amounts included in the measurement of lease liabilities          
Operating cash flows from operating leases  $108   $96 

 

(1) Includes short-term leases

 

(in thousands)  2023   2022 
   At December 31, 
(in thousands)  2023   2022 
Operating lease right-of-use assets  $9   $44 
           
Operating lease liabilities  $9   $44 
           
Weighted-average remaining lease term - operating leases   0.39 years     1.17 years 
           
Weighted-average discount rate - operating leases   7.13%   6.5%

 

Future minimum lease payments under non-cancellable leases as of December 31, 2023 and 2022, reconciled to our discounted operating lease liability presented on the consolidated balance sheets are as follows:

 

(in thousands)  2023   2022 
   At December 31, 
(in thousands)  2023   2022 
2023  $-   $40 
2024            9           6 
Total future minimum lease payments  $9   $46 
           
Less imputed interest   -    (2)
Total operating lease liabilities  $9   $44 

 

 

 

XML 38 R23.htm IDEA: XBRL DOCUMENT v3.24.1
RELATED PARTY TRANSACTIONS
12 Months Ended
Dec. 31, 2023
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS

15. RELATED PARTY TRANSACTIONS

 

Administrative Services Agreement

 

Commencing on the effective date of the SPAC’s IPO, the Sponsor agreed to pay the Company a total of up to $10,000 per month for office space, utilities, secretarial and administrative support to the Sponsor and the SPAC. Upon completion of the SPAC’s initial Business Combination or the SPAC’s liquidation, the Sponsor will cease paying these monthly fees. For the years ended December 31, 2023 and 2022, the company recorded income of $80,000 and $90,000, respectively, from the Sponsor under the Administrative Services Agreement, which is included in “net investment and other income” in the consolidated statements of operations. At December 31, 2023, the Company recorded a receivable of $62,000 relating to the Oxbridge Reinsurance portion of the working capital loan which is included in “due from related parties” in the consolidated balance sheets. At December 31, 2022, the Company recorded a receivable of $45,000 which is included in “due from related parties” in the consolidated balance sheets.

 

Participating Notes

 

During the year ending December 31, 2021, Mr. Jay Madhu, a director and officer of the Company and its subsidiaries, invested a principal amount of $68,000 in Series 2020-1 participating notes. During the year ended December 31, 2023, Mr. Madhu received a payment of $76,000 representing partial redemption of principal and return on investment.

 

DeltaCat Re Tokens

 

During the year ended December 31, 2023, Mr. Jay Madhu, a director and officer of the Company and its subsidiaries, entered into subscription agreement to purchase a total of 6,200 Series DeltaCat Re tokens at a purchase price of $10.00 per token for aggregate gross proceeds of $62,000. Ownership of DeltaCat Re tokenized reinsurance securities indirectly confers fractionalized interests in reinsurance contracts underwritten by Oxbridge Re NS for the 2023-2024 treaty year.

 

TypTap Insurance Company (“TypTap”) Contract

 

During the year ended December 31, 2023 the Company entered into a reinsurance agreement with TypTap, an insurance subsidiary of HCI Group, Inc., which is a related entity through common directorship. At December 31, 2023, included within premium receivable, deferred acquisition costs and unearned premiums on the consolidated balance sheets are amounts equal to $489,000, $50,000 and $458,000 respectively, relating to the reinsurance agreement with TypTap. During the year ended December 31, 2023, included within assumed premiums, change in unearned premium reserve and policy acquisition costs and underwriting expenses on the consolidated statements of operations are amounts equal to $1,099,000, ($458,000) and $70,000, respectively.

 

Bridge Loan with Affiliate

 

On September 11, 2023, the Company, along with seven (7) other investors, entered into a binding term sheet (“Bridge Agreement”) with Jet.AI to provide Jet.AI with an aggregate sum of $500,000 of short-term bridge financing pending its receipt of funds from its other existing financing arrangements. During the month of September 2023, and prior to the Bridge Agreement, Jet.AI had engaged in discussions with numerous third parties to secure short-term bridge funding but was not offered terms it found acceptable.

 

The Bridge Agreement provides for the issuance of Notes in an aggregate principal amount of $625,000, reflecting a 20% original issue discount. The Notes bear interest at 5% per annum and mature on March 11, 2024. Jet.AI is required to redeem the Notes with 100% of the proceeds of any equity or debt financing at a redemption premium of 110% of the principal amount of the Notes. Jet.AI anticipates redeeming the Notes in full with proceeds expected to be received over the next several months from existing financing arrangements.

 

An event of default under the Notes includes failing to redeem the Notes as provided above and other typical bankruptcy events of Jet.AI. In an event of default, the outstanding principal amount of the Notes will increase by 120%, and the company may convert its Note into shares of common stock of Jet.AI at the conversion price set forth in the Bridge Agreement with registration rights associated with those shares.

 

The Company invested the sum of $100,000 in the Notes and is recorded as “Loan Receivable” on the consolidated balance sheets at cost. On March 11, 2024, the Notes matured and were redeemed by Jet.AI in accordance with the Bridge Agreement. The Company receive an aggregate of $140,000 upon the redemption of the Notes.

 

 

XML 39 R24.htm IDEA: XBRL DOCUMENT v3.24.1
PROPERTY AND EQUIPMENT, NET
12 Months Ended
Dec. 31, 2023
Property, Plant and Equipment [Abstract]  
PROPERTY AND EQUIPMENT, NET

16. PROPERTY AND EQUIPMENT, NET

 

Property and equipment, net consist of the following (in thousands):

 

   2023   2022 
   At December 31, 
   2023   2022 
         
Leasehold improvements  $21   $21 
Furniture and Fixtures   41    38 
Motor vehicle   34    34 
Computer equipment and software   39    37 
Total, at cost   135    130 
less accumulated depreciation and amortization   (131)   (125)
Property and equipment, net  $4   $5 

 

 

 

XML 40 R25.htm IDEA: XBRL DOCUMENT v3.24.1
SUBSEQUENT EVENTS
12 Months Ended
Dec. 31, 2023
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS

17. SUBSEQUENT EVENTS

 

We evaluate all subsequent events and transactions for potential recognition or disclosure in our consolidated financial statements.

 

Other than as disclosed in Notes 9 and 15 above, there were no events subsequent to December 31, 2023 for which disclosure was required.

XML 41 R26.htm IDEA: XBRL DOCUMENT v3.24.1
Schedule I - Summary of Investments - Other Than Investments in Related Parties
12 Months Ended
Dec. 31, 2023
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Abstract]  
Schedule I - Summary of Investments - Other Than Investments in Related Parties

 

   Cost or       Consolidated 
   Amortized   Fair   Balance Sheet 
Type of investment  Cost   Value   Value 
             
Equity securities  $1,926   $680   $680 
                
Total investments  $1,926   $680   $680 
XML 42 R27.htm IDEA: XBRL DOCUMENT v3.24.1
Schedule II - Condensed Financial Information of Registrant
12 Months Ended
Dec. 31, 2023
Condensed Financial Information Disclosure [Abstract]  
Schedule II - Condensed Financial Information of Registrant

Schedule II - Condensed Financial Information of Registrant 

   2023   2022 
   At December 31, 
   2023   2022 
         
Assets          
           
Cash and cash equivalents   247    931 
Equity securities   680    642 
Investment in subsidiaries   1,757    9,389 
Due from subsidiaries   2,905    3,872 
Due from related party   -    35 
Loan receivable   

100

    - 
Prepayment and other assets   82    105 
Prepaid offering costs   -    133 
Operating lease right-of-use assets   9    44 
Property and equipment, net   4    5 
Total assets  $5,784    15,156 
           
Liabilities and Shareholders’ Equity          
Liabilities:          
Operating lease liabilities   9    44 
Due to Subsidiary   250    - 
Accounts payable and other liabilities   193    123 
Total liabilities   452    167 
           
Shareholders’ equity:          
Ordinary share capital   6    6 
Additional paid-in capital   32,740    32,482 
Accumulated Deficit   (27,414)   (17,499)
Total shareholders’ equity   5,332    14,989 
Total liabilities and shareholders’ equity  $5,784    15,156 

 

 

SCHEDULE II (continued)

 

OXBRIDGE RE HOLDINGS LIMITED

CONDENSED FINANCIAL INFORMATION OF REGISTRANT

CONDENSED STATEMENTS OF OPERATIONS - PARENT COMPANY ONLY

(expressed in thousands of U.S. Dollars)

 

   2023   2022 
   Years Ended December 31, 
   2023   2022 
         
Revenue          
Net investment income  $71    47 
Change in fair value of equity securities   38    (338)
Net realized investment gain   -    27 
Management fees and other income   2,978    1,883 
Operating expenses   (1,912)   (1,406)
Income before equity in loss of subsidiaries   1,175    213 
Equity in loss of subsidiaries   (11,090)   (2,002)
           
Net loss  $(9,915)   (1,789)

 

 

SCHEDULE II (continued)

 

OXBRIDGE RE HOLDINGS LIMITED

CONDENSED FINANCIAL INFORMATION OF REGISTRANT

CONDENSED STATEMENT OF CASH FLOWS - PARENT COMPANY ONLY

(expressed in thousands of U.S. Dollars)

 

   2023   2022 
   Years Ended December 31, 
   2023   2022 
Operating activities          
Net loss  $(9,915)   (1,789)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:          
Equity in loss of subsidiaries   11,090    2,002 
Share-based compensation   258    127 
Underwriting Income – SurancePlus   (494)   - 
Depreciation   6    4 
Net realized investment gain   -    (27)
Change in fair value of equity securities   (38)   338 
Change in operating assets and liabilities:          
Due from subsidiary   967    (1,763)
Due from related party   35   (30)
Due to subsidiary   250    - 
Prepayment and other assets   23    (55)
Prepaid offering costs   133    (133)
Accounts payable and other liabilities   70    (87)
           
Net cash provided by (used in) operating activities  $2,385    (1,413)
           
Investing activities          
Purchase of equity securities   -    (1,002)
Purchase of loan receivable   (100)   - 
Investment in subsidiary   (2,964)   (507)
Proceeds from sale of equity securities   -    626 
Purchase of property and equipment   (5)   - 
           
Net cash used in investing activities  $(3,069)   (883)
           
Net change in cash and cash equivalents   (684)   (2,296)
Cash and cash equivalents at beginning of year   931    3,227 
Cash and cash equivalents at end of year  $247   931 
XML 43 R28.htm IDEA: XBRL DOCUMENT v3.24.1
Schedule III - Supplementary Insurance Information
12 Months Ended
Dec. 31, 2023
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Abstract]  
Schedule III - Supplementary Insurance Information

Schedule III - Supplementary Insurance Information  

                                        
Year  Segment 

Deferred

acquisition

costs, net

  

Reserves

for losses

and loss

adjustment

expenses

– gross

  

Unearned

premiums

– gross

  

Net

premiums

earned

  

Investment

income

  

Net losses,

and loss

adjustment

expenses

  

Amortization

of deferred

acquisition

costs

  

Operating

expenses

  

Gross

premiums

written

 
2023  Property & Casualty  $        -   $    -   $-   $1,255   $   -   $-   $141   $2,183   $2,170 
                                                 
2022  Property & Casualty  $-   $1,073   $-   $995   $27   $1,073   $110   $1,413   $645 
XML 44 R29.htm IDEA: XBRL DOCUMENT v3.24.1
Schedule IV - Reinsurance Information
12 Months Ended
Dec. 31, 2023
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Abstract]  
Schedule IV - Reinsurance Information

Schedule IV - Reinsurance Information 

 

                        
Year  Segment 

Direct

Gross

Premiums

  

Premiums

ceded to

other

companies

  

Premiums

assumed

from other

companies

   Net amount  

Percentage

of amount

assumed to

net

 
2023  Property & Casualty  $-   $-   $2,170   $2,170    100%
                                  
2022  Property & Casualty  $-   $      -   $645   $645    100%
XML 45 R30.htm IDEA: XBRL DOCUMENT v3.24.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
12 Months Ended
Dec. 31, 2023
Accounting Policies [Abstract]  
Use of Estimates

Use of Estimates: In preparing the consolidated financial statements, management was required to make certain estimates and assumptions that affect the reported amounts of the consolidated assets, liabilities, revenues, expenses and related disclosures at the financial reporting date and throughout the periods being reported upon. Certain of the estimates result from judgments that can be subjective and complex and consequently actual results may differ from these estimates, which would be reflected in future periods. Material estimates that are particularly susceptible to significant change in the near-term relate to the determination of the reserve for losses and loss adjustment expenses (if any), which may include amounts estimated for claims incurred but not yet reported. The Company uses various assumptions and actuarial data it believes to be reasonable under the circumstances to make these estimates. Although considerable variability is likely to be inherent in these estimates, management believes that the amounts provided are reasonable. These estimates are continually reviewed and adjusted if necessary. Such adjustments are reflected in current operations.

 

 

 

 

Revenue Recognition

Revenue Recognition

 

SurancePlus incentive, technology, origination and management (“ITOM”) fee income represents fee income related to the completion of the DeltaCat tokenized reinsurance securities as well as placement of the underlying insurance policies. The Company recognizes the associated revenue at the time of the placement of the underlying insurance policies as the performance obligation is satisfied at that time.

 

Cash and cash equivalents

Cash and cash equivalents: Cash and cash equivalents are comprised of cash and short- term investments with original maturities of three months or less.

 

Restricted cash and cash equivalents

Restricted cash and cash equivalents: Restricted cash and cash equivalents represent funds held in accordance with the Company’s trust agreements with ceding insurers and trustees, which requires the Company to maintain collateral with a market value greater than or equal to the limit of liability, less unpaid premium.

 

Investments

Investments: The Company from time to time invests in fixed-maturity securities and equity securities, and for which its fixed-maturity securities are classified as available-for-sale. The Company’s available for sale fixed-maturity investments are carried at fair value with changes in fair value included as a separate component of accumulated other comprehensive income (loss) in shareholders’ equity. For the Company’s investment in equity securities, and for the Company’s investment in Jet.AI. classified as “other investments”, the changes in fair value are recorded within the consolidated statements of operations. At December 31, 2023 and 2022 the company did not own any fixed maturity debt securities.

 

Unrealized gains or losses are determined by comparing the fair market value of the securities with their cost or amortized cost. Realized gains and losses on investments are recorded on the trade date and are included in the consolidated statements of operations. The cost of securities sold is based on the specified identification method. Investment income is recognized as earned and discounts or premiums arising from the purchase of debt securities are recognized in investment income using the interest method over the remaining term of the security.

 

Fair value measurement

Fair value measurement: GAAP establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy under GAAP are as follows:

 

Level 1 Inputs that reflect unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date;
   
Level 2 Inputs other than quoted prices that are observable for the asset or liability either directly or indirectly, including inputs in markets that are not considered to be active; and
   
Level 3 Inputs that are unobservable.

 

Inputs are used in applying the various valuation techniques and broadly refer to the assumptions that market participants use to make valuation decisions, including assumptions about risk. For fixed maturity securities, inputs may include price information, volatility statistics, specific and broad credit data, liquidity statistics, broker quotes for similar securities and other factors. The fair value of investments in stocks and exchange-traded funds is based on the last traded price. A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. However, the determination of what constitutes “observable” requires significant judgment by the Company’s investment custodians and management. The investment custodians consider observable data to be market data which is readily available, regularly distributed or updated, reliable and verifiable, not proprietary, and provided by independent sources that are actively involved in the relevant markets.

 

 

 

 

Deferred policy acquisition costs

Deferred policy acquisition costs (“DAC”): Policy acquisition costs consist of brokerage fees, federal excise taxes and other costs related directly to the successful acquisition of new or renewal insurance contracts and are deferred and amortized over the terms of the reinsurance agreements to which they relate. The Company evaluates the recoverability of DAC by determining if the sum of future earned premiums and anticipated investment income is greater than the expected future claims and expenses. If a loss is probable on the unexpired portion of policies in force, a premium deficiency loss is recognized.

 

Offering Expenses

Offering Expenses:

 

During the year ended December 31, 2023 the Company recognized offering costs totaling $133,000 on the consolidated statements of operations which was related to an equity distribution agreement with Maxim Group LLC (“Maxim”) for the sale of the ordinary shares. During the year ended December 31, 2023, the Company recognized in the consolidated statements of operations $236,000 of offering expenses in relation to the offering of Delta Cat Re digital securities issuable by the Company’s new subsidiary, SurancePlus Inc. (See Note 6)

 

In accordance with the terms of the equity distribution agreement with Maxim, we intend to offer and sell ordinary shares having an aggregate offering price of up to $6.3 million from time to time.

 

Property and equipment

Property and equipment: Property and equipment are recorded at cost when acquired. Property and equipment are comprised of motor vehicles, furniture and fixtures, computer equipment and leasehold improvements and are depreciated, using the straight-line method, over their estimated useful lives, which are five years for furniture and fixtures and computer equipment and four years for motor vehicles. Leasehold improvements are amortized over the lesser of the estimated useful lives of the assets or remaining lease term. The Company periodically reviews property and equipment that have finite lives, and that are not held for sale, for impairment by comparing the carrying value of the assets to their estimated future undiscounted cash flows. For the years ended December 31, 2023 and 2022, there were no impairments in property and equipment.

 

Reserves for losses and loss adjustment expenses

Reserves for losses and loss adjustment expenses: The Company determines its reserves for losses and loss adjustment expenses, if any, on the basis of the claims reported by the Company’s ceding insurers and for losses incurred but not reported (“IBNR”), management uses the assistance of an independent actuary. The reserves for losses and loss adjustment expenses represent management’s best estimate of the ultimate settlement costs of all losses and loss adjustment expenses. Management believes that the amounts are adequate; however, the inherent impossibility of predicting future events with precision, results in uncertainty as to the amount which will ultimately be required for the settlement of losses and loss expenses, and the differences could be material. Adjustments are reflected in the consolidated statements of operations in the period in which they are determined.

 

Loss experience refund payable

Loss experience refund payable: Certain contracts include retrospective provisions that adjust premiums or result in profit commissions in the event losses are minimal or zero. In accordance with GAAP, the Company will recognize a liability in the period in which the absence of loss experience obligates the Company to pay cash or other consideration under the contracts. On the contrary, the Company will derecognize such liability in the period in which a loss experience arises. Such adjustments to the liability, which accrue throughout the contract terms, will reduce the liability should a catastrophic loss event covered by the Company occur.

 

Premiums assumed

Premiums assumed: The Company records premiums assumed, net of loss experience refunds, as earned pro-rata over the terms of the reinsurance agreements, or period of risk, where applicable, and the unearned portion at the consolidated balance sheet date is recorded as unearned premiums reserve. A reserve is made for estimated premium deficiencies to the extent that estimated losses and loss adjustment expenses exceed related unearned premiums. Investment income is not considered in determining whether or not a deficiency exists.

 

 

 

 

Subsequent adjustments of premiums assumed, based on reports of actual premium by the ceding companies, or revisions in estimates of ultimate premium, are recorded in the period in which they are determined. Such adjustments are generally determined after the associated risk periods have expired, in which case the premium adjustments are fully earned when assumed.

 

Certain contracts allow for reinstatement premiums in the event of a full limit loss prior to the expiration of the contract. A reinstatement premium is not due until there is a full limit loss event and therefore, in accordance with GAAP, the Company records a reinstatement premium as written only in the event that the reinsured incurs a full limit loss on the contract and the contract allows for a reinstatement of coverage upon payment of an additional premium. For catastrophe contracts which contractually require the payment of a reinstatement premium equal to or greater than the original premium upon the occurrence of a full limit loss, the reinstatement premiums are earned over the original contract period. Reinstatement premiums that are contractually calculated on a pro-rata basis of the original premiums are earned over the remaining coverage period.

 

Unearned Premiums Ceded

Unearned Premiums Ceded: The Company may reduce the risk of future losses on business assumed by reinsuring certain risks and exposures with other reinsurers (retrocessionaires). The Company remains liable to the extent that any retrocessionaire fails to meet its obligations and to the extent that the Company does not hold sufficient security for their unpaid obligations.

 

Ceded premiums are written during the period in which the risk incept and are expensed over the contract period in proportion to the period of protection. Unearned premiums ceded consist of the unexpired portion of the reinsurance obtained. There were no unearned premiums ceded at December 31, 2023 and 2022.

 

SurancePlus Fee Income

SurancePlus Fee Income: SurancePlus incentive, technology, origination and management (“ITOM”) fee income represents fee income related to the completion of the DeltaCat tokenized reinsurance securities as well as placement of the underlying insurance policies. The Company recognizes the associated revenue at the time of the placement of the underlying insurance policies as the performance obligation is satisfied at that time.

 

Uncertain income tax positions

Uncertain income tax positions: The authoritative GAAP guidance on accounting for, and disclosure of, uncertainty in income tax positions requires the Company to determine whether an income tax position of the Company is more likely than not to be sustained upon examination by the relevant tax authority, including resolution of any related appeals or litigation processes, based on the technical merits of the position. For income tax positions meeting the more likely than not threshold, the tax amount recognized in the consolidated financial statements, if any, is reduced by the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate settlement with the relevant taxing authority. The application of this authoritative guidance has had no effect on the Company’s consolidated financial statements because the Company had no uncertain tax positions at December 31, 2023.

 

Loss Per Share

Loss Per Share: Basic loss per share has been computed on the basis of the weighted-average number of ordinary shares outstanding during the years presented. Diluted loss per share is computed based on the weighted-average number of ordinary shares outstanding and reflects the assumed exercise or conversion of diluted securities, such as stock options and warrants, computed using the treasury stock method.

 

Share-Based Compensation

Share-Based Compensation: The Company accounts for share-based compensation under the fair value recognition provisions of GAAP which requires the measurement and recognition of compensation for all stock-based awards made to employees and directors, including stock options and restricted stock issuances based on estimated fair values. The Company measures compensation for restricted stock based on the price of the Company’s ordinary shares at the grant date. Determining the fair value of stock options at the grant date requires significant estimation and judgment. The Company uses an option-pricing model (Black-Scholes option pricing model) to assist in the calculation of fair value for stock options. When estimating the expected volatility, the Company takes into consideration the historical volatility of entities similar to itself. The Company considers factors such as an entity’s industry, stage of life cycle, size and financial leverage when selecting similar entities. The Company may use a sample peer group of companies in the reinsurance industry and/or the Company’s own historical volatility in determining the expected volatility

 

 

 

Additionally, the Company uses the guidance in the SEC’s Staff Accounting Bulletin No. 107 to determine the estimated life of options issued and has assumed no forfeitures during the life of the options.

 

The Company uses the straight-line attribution method for all grants that include only a service condition. Compensation expense related to all awards is included in general and administrative expenses.

 

Segment Information

Segment Information: Under GAAP, operating segments are based on the internal information that management uses for allocating resources and assessing performance as the source of the Company’s reportable segments. The Company manages its business on the basis of one operating segment, Property and Casualty Reinsurance, in accordance with the qualitative and quantitative criteria established under GAAP.

 

Reclassifications

Reclassifications: Any reclassifications of prior period amounts have been made to conform to the current period presentation.

XML 46 R31.htm IDEA: XBRL DOCUMENT v3.24.1
CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AND CASH EQUIVALENTS (Tables)
12 Months Ended
Dec. 31, 2023
Cash and Cash Equivalents [Abstract]  
SUMMARY OF CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AND CASH EQUIVALENTS

 

   2023   2022 
   December 31, 
   2023   2022 
   (in thousands) 
Cash held on deposit  $495   $1,207 
Restricted cash held in trust   3,250    2,721 
Total  $3,745   $3,928 
XML 47 R32.htm IDEA: XBRL DOCUMENT v3.24.1
INVESTMENTS (Tables)
12 Months Ended
Dec. 31, 2023
Investments, All Other Investments [Abstract]  
SCHEDULE OF GROSS REALIZED GAINS AND LOSSES FROM SALE OF EQUITY SECURITIES

Proceeds received, and the gross realized gains and losses from sale of equity securities, for the years ended December 31, 2023 and 2022 are as follows:

 

  

Gross

proceeds

from sales

  

Gross

Realized

Gains

  

Gross

Realized

Losses

 
   ($ in thousands) 
             
Year ended December 31, 2023               
Equity securities  $-   $-   $- 
                
Year ended December 31, 2022               
Equity securities  $626   $27   $- 
SCHEDULE OF OTHER INVESTMENT

Other investments as of December 31, 2023 and 2022 consist of the following (in thousands):

 

   2023   2022 
   December 31, 
   2023   2022 
Jet.AI Series A-1 Convertible Preferred Stock  $285   $- 
Jet.AI. Promissory Note   -    214 
Jet.AI. common stock (2022: Class B Ordinary Shares)   2,193    11,209 
Total  $2,478   $11,423 
           
Beginning of year  $11,423   $11,173 
Investment in affiliate   -    285 
Unrealized loss on investment in affiliate   (8,945)   (35)
End of year  $2,478   $11,423 
SCHEDULE OF FAIR VALUE OF ASSETS MEASURED ON RECURRING BASIS

 

   (Level 1)   (Level 2)   (Level 3)   Total 
   Fair Value Measurements Using     
   (Level 1)   (Level 2)   (Level 3)   Total 
As of December 31, 2023  ($ in thousands) 
Financial Assets:                    
Cash and cash equivalents  $495   $   -   $-   $495 
                     
Restricted cash and cash equivalents  $3,250   $-   $-   $3,250 
                     
Other investments  $

2,193

   $-   $285   $2,478 
                     
Equity securities  $680   $-   $-   $680 
                     
Total  $6,618   $-   $285   $6,903 

 

   (Level 1)   (Level 2)   (Level 3)   Total 
   Fair Value Measurements Using     
   (Level 1)   (Level 2)   (Level 3)   Total 
As of December 31, 2022  ($ in thousands) 
Financial Assets:                    
Cash and cash equivalents  $1,207   $-   $-   $1,207 
                     
Restricted cash and cash equivalents  $2,721   $-   $-   $2,721 
                     
Other investments  $-   $-   $11,423   $11,423 
                     
Equity securities  $642   $-   $-   $642 
                     
Total  $4,570   $-   $11,423   $15,993 
SCHEDULE OF RECONCILIATION OF CHANGES IN FAIR VALUE

The following table provides a reconciliation of changes in fair value of the beginning and ending balances for the other investments classified as Level 3:

 

   Year ended 
   December 31, 
   2023   2022 
   ($ in thousands) 
Fair value of Level 3 other investments at beginning of year  $11,423   $11,173 
Transfer to Level 1   (11,138)     
Investment in affiliate   -    285 
Change in valuation inputs or other assumptions   -    (35)
Fair value of Level 3 other investment at December 31, 2023  $285   $11,423 
XML 48 R33.htm IDEA: XBRL DOCUMENT v3.24.1
VARIABLE INTEREST ENTITIES (Tables)
12 Months Ended
Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
SCHEDULE OF FINANCIAL STATEMENTS

SCHEDULE OF FINANCIAL STATEMENTS

   For Year Ended 
Statement of Operations Data:  December 31, 2023 
      (Unaudited)   
      
Surance Plus fee income   $574 
Underwriting related income    1,140 
Total revenue   $1,714 
Expenses   $(272)
Income attributable to tokenholders   $(1,036)
Net income   $406 

 

Balance Sheet Data:  At December 31, 2023 
    (Unaudited) 
    (In thousands) 
Total assets  $3,588 
Amounts due to Delta Cat Re Tokenholders*  $2,016 
Due to Parent  $47 
Total shareholder’s equity  $1,525 

 

* includes underwriting profit of $494,000 due to Parent.
XML 49 R34.htm IDEA: XBRL DOCUMENT v3.24.1
RESERVE FOR LOSSES AND LOSS ADJUSTMENT EXPENSES (Tables)
12 Months Ended
Dec. 31, 2023
Reserve For Losses And Loss Adjustment Expenses  
SCHEDULE OF LOSS ADJUSTMENT EXPENSE

The following table summarizes the Company’s loss and loss adjustment expenses (“LAE”) and the reserve for loss and LAE reserve movements for the years ended December 31, 2023 and 2022

  

   2023   2022 
   Year ended 
   December 31, 
   2023   2022 
   ($ in thousands) 
         
Gross balance, beginning of year  $1,073    - 
Incurred, net of reinsurance, related to:          
Current year   -    1,073 
Prior year   -    - 
Total incurred   -    1,073 
Paid related to:          
Current year   -    - 
Prior year   (1,073)   - 
Total paid   -    - 
Balance, end of year  $-    1,073 
SCHEDULE OF INCURRED LOSSES AND ADJUSTMENT EXPENSES

Property Catastrophe Reinsurance

 

(in thousands)

 

Incurred Losses and Loss Adjustment Expenses

 

Accident Year  2016   2017   2018   2019   2020   2021   2022    2023   

As of December 31, 2023 Total of Incurred-but
-Not-Reported Liabilities
Plus Expected Development on
Reported Claims

   Cumulative Number of Reported Claims 
                                       (dollars in thousands) 
2016  $14,775   $18,801   $17,795   $17,689   $17,689   $17,689   $17,689    $ 17,689    $-    5 
2017       $38,401   $38,401   $38,401   $38,401   $38,401   $38,401    $ 38,401    $-    8 
2018            $10,000   $10,000   $10,000   $10,000   $10,000    $ 10,000    $-    2 
2019                 $-   $-   $-   $-    $ -    $-    - 
2020                      $-   $-   $-    $ -    $-    - 
2021                           $158   $158    $ 158    $-    1 
2022                                $1,073    $ 1,073    $              -          1 
2023                                $-    $ -    $-    - 
    Total                             $67,321    $ 67,321    $-      

 

Cumulative Paid Losses and Loss Adjustment Expenses

 

Accident Year  2016   2017   2018   2019   2020   2021   2022  2023  
2016  $6,073   $16,073   $17,687   $17,689   $17,689   $17,689   $17,689  $ 17,689  
2017       $36,293   $38,401   $38,401   $38,401   $38,401   $38,401  $

38,401

 
2018            $6,000   $10,000   $10,000   $10,000   $10,000  $ 10,000  
2019                 $-   $-   $-   $-  $ -  
2020                      $-   $-   $-  $ -  
2021                           $158   $158  $ 158  
2022                                $1,073  $ 1,073  
2023                           $-       $ -  
    Total                            $67,321  $ 67,321  
Reserve for loss and loss adjustment expenses at December 31, 2023, net of reinsurance                                $ -   $ -  
SCHEDULE OF HISTORICAL AVERAGE ANNUAL PERCENTAGE PAYOUT

The following table shows the historical average annual percentage payout of claims at December 31, 2022.

 

   Average Annual Percentage Payout of Incurred Claims by Age 
                         
Years   1    2    3    4    5    6 
                               
Property Catastrophe Reinsurance   57.8%   34.0%   9.1%   0.0%   0.0%   0%
XML 50 R35.htm IDEA: XBRL DOCUMENT v3.24.1
LOSS PER SHARE (Tables)
12 Months Ended
Dec. 31, 2023
Earnings Per Share [Abstract]  
SCHEDULE OF COMPUTATION OF BASIC AND DILUTED LOSS EARNING PER SHARE

A summary of the numerator and denominator of the basic and diluted loss per share is presented below (dollars in thousands except per share amounts):

 

SCHEDULE OF COMPUTATION OF BASIC AND DILUTED LOSS EARNING PER SHARE

   2023   2022 
   Years ended December 31 
   2023   2022 
         
Numerator:          
Net loss  $(9,915)   (1,789)
           
Denominator:          
Weighted average shares - basic   5,867,129    5,772,396 
Effect of dilutive securities - Stock options   -    - 
Shares issuable upon conversion of warrants   -    - 
Weighted average shares - diluted   5,867,129    5,772,396 
Loss per share - basic  $(1.69)   (0.31)
Loss earnings per share - diluted  $(1.69)   (0.31)
XML 51 R36.htm IDEA: XBRL DOCUMENT v3.24.1
SHARE-BASED COMPENSATION (Tables)
12 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
SCHEDULE OF STOCK OPTION ACTIVITY

A summary of the stock option activity for the years ended December 31, 2023 and 2022 is as follows (option amounts not in thousands):

 

   Number of Options  

Weighted-

Average

Exercise

Price

   Weighted- Average Remaining Contractual Term   Aggregate Intrinsic Value 
                 
Outstanding at December 31, 2022   871,250   $4.67    5.8 years   $- 
Exercisable at December 31, 2022   721,250   $4.39    5.3 years   $- 
                     
Outstanding at December 31, 2022   871,250    4.67    5.8 years   $     - 
Forfeited   (25,000)   (6.00)          
Outstanding at December 31, 2023   846,250   $4.63    4.8 years   $- 
Exercisable at December 31, 2023   783,750   $4.52    4.6 years   $- 
SCHEDULE OF ACTIVITY OF UNVESTED RESTRICTED STOCK AWARDS

Information with respect to the activity of unvested restricted stock awards during the year ended December 31, 2023 is as follows (share amounts not in thousands):

 

  

Weighted-

Number of

Restricted

Stock Awards

  

Weighted-

Average

Grant Date

Fair Value

 
         
Nonvested at January 1, 2022   15,000      
Granted   32,000   $3.57 
Vested   (12,000)     
Forfeited   (12,000)   3.57 
Nonvested at December 31, 2022   23,000      
Granted   100,647   $2.37 
Vested   (77,574)   2.37 
Nonvested at December 31, 2023   46,073      
XML 52 R37.htm IDEA: XBRL DOCUMENT v3.24.1
LEASES (Tables)
12 Months Ended
Dec. 31, 2023
Leases [Abstract]  
SCHEDULE OF OPERATING LEASE COST

The components of lease expense and other lease information as of and during the years ended December 31, 2023 and 2022 are as follows:

 

(in thousands)  2023   2022 
  

Year Ended December 31,

 
(in thousands)  2023   2022 
Operating Lease Cost (1)  $108   $96 
           
Cash paid for amounts included in the measurement of lease liabilities          
Operating cash flows from operating leases  $108   $96 

 

(1) Includes short-term leases
SCHEDULE OF OPERATING LEASE OBLIGATIONS
(in thousands)  2023   2022 
   At December 31, 
(in thousands)  2023   2022 
Operating lease right-of-use assets  $9   $44 
           
Operating lease liabilities  $9   $44 
           
Weighted-average remaining lease term - operating leases   0.39 years     1.17 years 
           
Weighted-average discount rate - operating leases   7.13%   6.5%
SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS

Future minimum lease payments under non-cancellable leases as of December 31, 2023 and 2022, reconciled to our discounted operating lease liability presented on the consolidated balance sheets are as follows:

 

(in thousands)  2023   2022 
   At December 31, 
(in thousands)  2023   2022 
2023  $-   $40 
2024            9           6 
Total future minimum lease payments  $9   $46 
           
Less imputed interest   -    (2)
Total operating lease liabilities  $9   $44 
XML 53 R38.htm IDEA: XBRL DOCUMENT v3.24.1
PROPERTY AND EQUIPMENT, NET (Tables)
12 Months Ended
Dec. 31, 2023
Property, Plant and Equipment [Abstract]  
SCHEDULE OF PROPERTY AND EQUIPMENT,NET

Property and equipment, net consist of the following (in thousands):

 

   2023   2022 
   At December 31, 
   2023   2022 
         
Leasehold improvements  $21   $21 
Furniture and Fixtures   41    38 
Motor vehicle   34    34 
Computer equipment and software   39    37 
Total, at cost   135    130 
less accumulated depreciation and amortization   (131)   (125)
Property and equipment, net  $4   $5 
XML 54 R39.htm IDEA: XBRL DOCUMENT v3.24.1
ORGANIZATION AND BASIS OF PRESENTATION (Details Narrative)
Dec. 19, 2022
Dec. 31, 2017
Dec. 22, 2017
Apr. 23, 2013
Oxbridge Reinsurance Limited [Member]        
Equity Method Investment, Ownership Percentage       100.00%
Oxbridge Re NS [Member]        
Equity Method Investment, Ownership Percentage   100.00% 100.00%  
Surance Plus Inc [Member]        
Equity Method Investment, Ownership Percentage 100.00%      
XML 55 R40.htm IDEA: XBRL DOCUMENT v3.24.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Property, Plant and Equipment [Line Items]    
Prepaid offering costs $ 133,000  
Impairments in property and equipment $ 0 $ 0
Furniture and Fixtures [Member]    
Property, Plant and Equipment [Line Items]    
Estimated useful life 5 years  
Computer Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Estimated useful life 5 years  
Motor Vehicles [Member]    
Property, Plant and Equipment [Line Items]    
Estimated useful life 4 years  
Maximum [Member] | Equity Distribution Agreement [Member]    
Property, Plant and Equipment [Line Items]    
Aggregate offering price $ 6,300,000  
Surance Plus Inc [Member]    
Property, Plant and Equipment [Line Items]    
Offering expenses $ 236,000  
XML 56 R41.htm IDEA: XBRL DOCUMENT v3.24.1
SUMMARY OF CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AND CASH EQUIVALENTS (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Cash and Cash Equivalents [Abstract]    
Cash held on deposit $ 495 $ 1,207
Restricted cash held in trust 3,250 2,721
Total $ 3,745 $ 3,928
XML 57 R42.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF GROSS REALIZED GAINS AND LOSSES FROM SALE OF EQUITY SECURITIES (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Investments, All Other Investments [Abstract]    
Proceeds from Sale of Equity Securities, FV-NI $ 626
Equity Securities, FV-NI, Realized Gain 27
Equity Securities, FV-NI, Realized Loss
XML 58 R43.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF OTHER INVESTMENT (Details) - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Defined Benefit Plan Disclosure [Line Items]    
End of year $ 2,478,000 $ 11,423,000
Beginning of year 11,423,000 11,173,000
Investment in affiliate 285,000
Unrealized loss on investment in affiliate (8,945,000) (35,000)
Jet A 1 Series A 1 Convertible Preferred Stock [Member]    
Defined Benefit Plan Disclosure [Line Items]    
End of year 285,000
Beginning of year  
Jet A1 Promissory Note [Member]    
Defined Benefit Plan Disclosure [Line Items]    
End of year 214,000
Beginning of year 214,000  
Jet A1 Class B Ordinary Shares [Member] | Common Class B [Member]    
Defined Benefit Plan Disclosure [Line Items]    
End of year 2,193,000 $ 11,209,000
Beginning of year $ 11,209,000  
XML 59 R44.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF FAIR VALUE OF ASSETS MEASURED ON RECURRING BASIS (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Platform Operator, Crypto-Asset [Line Items]      
Cash and cash equivalents $ 495 $ 1,207  
Restricted cash and cash equivalents 3,250 2,721  
Other investments 2,478 11,423 $ 11,173
Equity securities 680 642  
Total 6,903 15,993  
Fair Value, Inputs, Level 1 [Member]      
Platform Operator, Crypto-Asset [Line Items]      
Cash and cash equivalents 495 1,207  
Restricted cash and cash equivalents 3,250 2,721  
Other investments 2,193  
Equity securities 680 642  
Total 6,618 4,570  
Fair Value, Inputs, Level 2 [Member]      
Platform Operator, Crypto-Asset [Line Items]      
Cash and cash equivalents  
Restricted cash and cash equivalents  
Other investments  
Equity securities  
Total  
Fair Value, Inputs, Level 3 [Member]      
Platform Operator, Crypto-Asset [Line Items]      
Cash and cash equivalents  
Restricted cash and cash equivalents  
Other investments 285 11,423  
Equity securities  
Total $ 285 $ 11,423  
XML 60 R45.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF RECONCILIATION OF CHANGES IN FAIR VALUE (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Platform Operator, Crypto-Asset [Line Items]    
Investment in affiliate $ 285
Fair Value, Inputs, Level 3 [Member]    
Platform Operator, Crypto-Asset [Line Items]    
Fair value of Level 3 other investment, Beginning balance 11,423 11,173
Transfer to Level 1 (11,138)  
Investment in affiliate 285
Change in valuation inputs or other assumptions (35)
Fair value of Level 3 other investment, Ending balance $ 285 $ 11,423
XML 61 R46.htm IDEA: XBRL DOCUMENT v3.24.1
INVESTMENTS (Details Narrative) - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Defined Benefit Plan Disclosure [Line Items]    
Unrealized loss on other investments $ 8,945,000 $ 35,000
Oxbridge Acquisition Corp [Member]    
Defined Benefit Plan Disclosure [Line Items]    
Number of shares issued 2,875,000  
Oxbridge Acquisition Corp [Member] | Private Placement Warrants [Member]    
Defined Benefit Plan Disclosure [Line Items]    
Number of warrants shares 4,897,500  
Oxbridge Acquisition Corp [Member] | Series A-1 Preferred Stock [Member]    
Defined Benefit Plan Disclosure [Line Items]    
Number of shares issued 575  
Number of shares in hold, par value per share $ 1,000  
XML 62 R47.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF FINANCIAL STATEMENTS (Details) - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Total revenue $ (7,049,000) $ 850,000  
Income attributable to tokenholders (9,373,000) (1,746,000)  
Net loss (9,915,000) (1,789,000)  
Total assets 8,253,000 16,616,000  
Total shareholder’s equity 5,332,000 $ 14,989,000 $ 16,651,000
Surance Plus Inc [Member]      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Total revenue 1,714,000    
Expenses (272,000)    
Income attributable to tokenholders (1,036,000)    
Net loss 406,000    
Total assets 3,588,000    
Total shareholder’s equity 1,525,000    
Surance Plus Inc [Member] | Related Party [Member]      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Due to Parent [1] 2,016,000    
Surance Plus Inc [Member] | Parent [Member]      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Due to Parent 47,000    
Surance Plus Inc [Member] | Surance Plus Fee Income [Member]      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Total revenue 574,000    
Surance Plus Inc [Member] | Underwriting Related Income [Member]      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Total revenue $ 1,140,000    
[1] includes underwriting profit of $494,000 due to Parent.
XML 63 R48.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF FINANCIAL STATEMENTS (Details) (Parenthetical)
$ in Thousands
12 Months Ended
Dec. 31, 2023
USD ($)
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Underwriting profit $ 494,000
XML 64 R49.htm IDEA: XBRL DOCUMENT v3.24.1
VARIABLE INTEREST ENTITIES (Details Narrative) - USD ($)
12 Months Ended
Jun. 27, 2023
Mar. 27, 2023
Jun. 01, 2020
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2017
Dec. 22, 2017
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Repayments of Debt       $ 98,000    
Convertible Notes Payable, Current       118,000      
Management fee       300,000    
Surance Plus Inc [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Shares issued, price per share $ 10.00 $ 10.00          
Description for offer and sale of securities   The proceeds from the offer and sale of the Securities will be used by SurancePlus to purchase one or more participating notes of Oxbridge Re NS, and the proceeds from the sale of participating notes will be invested in collateralized reinsurance contracts to be underwritten by Oxbridge Re NS. The holders of the digital Securities will generally be entitled to proceeds from the payment of participating notes in the amount of a preferred return of 20% plus an additional 80% of any proceeds in excess of the amount necessary to pay the preferred return. Assuming no casualty losses to properties reinsured by Oxbridge Re’s reinsurance subsidiaries, DeltaCat Re token investors are expected to receive an annual return on the original purchase price of 42%.          
Number of shares issued 244,776            
Proceeds from issuance of private placement $ 2,447,760            
Surance Plus Inc [Member] | Parent [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Proceeds from issuance of private placement 1,167,000            
Management fee 274,000            
Surance Plus Inc [Member] | Third Party Investors [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Proceeds from issuance of private placement 1,280,000            
Management fee 300,000            
Surance Plus Inc [Member] | Subscription agreements [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Proceeds from issuance of private placement $ 150,100            
Surance Plus Inc [Member] | Investors and non US persons [Member] | Subscription agreements [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Shares issued, price per share $ 10.00            
Number of shares issued 229,766            
Proceeds from issuance of private placement $ 2,297,660            
Sale of stock number of shares issued in transaction 15,010            
Notes Payable to Series 2020 -1 Noteholders [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Notes issued     $ 216,000        
Debt Instrument, Maturity Date     Jun. 01, 2023        
Oxbridge Re NS [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Share capital percentage           100.00% 100.00%
Oxbridge Re NS [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Voting percentage             100.00%
Noncontrolling interest       $ 0 $ 43,000    
XML 65 R50.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF LOSS ADJUSTMENT EXPENSE (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Reserve For Losses And Loss Adjustment Expenses    
Gross balance, beginning of year $ 1,073
Current year 1,073
Prior year
Total incurred 1,073
Current year
Prior year (1,073)
Total paid
Balance, end of year $ 1,073
XML 66 R51.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF INCURRED LOSSES AND ADJUSTMENT EXPENSES (Details)
Claims in Thousands, $ in Thousands
Dec. 31, 2023
USD ($)
Claims
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Dec. 31, 2020
USD ($)
Dec. 31, 2019
USD ($)
Dec. 31, 2018
USD ($)
Dec. 31, 2017
USD ($)
Dec. 31, 2016
USD ($)
Claims Development [Line Items]                
Incurred Losses and Loss Adjustment Expenses $ 67,321 $ 67,321            
Total of Incurred but Not Reported Liabilities Plus Expected Development on Reported Claims              
Cumulative Paid Losses and Loss Adjustment Expenses 67,321 67,321            
Cumulative Paid Losses and Loss Adjustment Expenses            
Short-Duration Insurance Contracts, Accident Year 2016 [Member]                
Claims Development [Line Items]                
Incurred Losses and Loss Adjustment Expenses 17,689 17,689 $ 17,689 $ 17,689 $ 17,689 $ 17,795 $ 18,801 $ 14,775
Total of Incurred but Not Reported Liabilities Plus Expected Development on Reported Claims              
Cumulative Number of Reported Claims | Claims 5              
Cumulative Paid Losses and Loss Adjustment Expenses $ 17,689 17,689 17,689 17,689 17,689 17,687 16,073 $ 6,073
Short-Duration Insurance Contracts, Accident Year 2017 [Member]                
Claims Development [Line Items]                
Incurred Losses and Loss Adjustment Expenses 38,401 38,401 38,401 38,401 38,401 38,401 38,401  
Total of Incurred but Not Reported Liabilities Plus Expected Development on Reported Claims              
Cumulative Number of Reported Claims | Claims 8              
Cumulative Paid Losses and Loss Adjustment Expenses $ 38,401 38,401 38,401 38,401 38,401 38,401 $ 36,293  
Short-Duration Insurance Contracts, Accident Year 2018 [Member]                
Claims Development [Line Items]                
Incurred Losses and Loss Adjustment Expenses 10,000 10,000 10,000 10,000 10,000 10,000    
Total of Incurred but Not Reported Liabilities Plus Expected Development on Reported Claims              
Cumulative Number of Reported Claims | Claims 2              
Cumulative Paid Losses and Loss Adjustment Expenses $ 10,000 10,000 10,000 10,000 10,000 $ 6,000    
Short-Duration Insurance Contract, Accident Year 2019 [Member]                
Claims Development [Line Items]                
Incurred Losses and Loss Adjustment Expenses      
Total of Incurred but Not Reported Liabilities Plus Expected Development on Reported Claims              
Cumulative Number of Reported Claims | Claims              
Cumulative Paid Losses and Loss Adjustment Expenses      
Short-Duration Insurance Contract, Accident Year 2020 [Member]                
Claims Development [Line Items]                
Incurred Losses and Loss Adjustment Expenses        
Total of Incurred but Not Reported Liabilities Plus Expected Development on Reported Claims              
Cumulative Number of Reported Claims | Claims              
Cumulative Paid Losses and Loss Adjustment Expenses        
Short-Duration Insurance Contract, Accident Year 2021 [Member]                
Claims Development [Line Items]                
Incurred Losses and Loss Adjustment Expenses 158 158 158          
Total of Incurred but Not Reported Liabilities Plus Expected Development on Reported Claims              
Cumulative Number of Reported Claims | Claims 1              
Cumulative Paid Losses and Loss Adjustment Expenses $ 158 158 158          
Short-Duration Insurance Contract, Accident Year 2022 [Member]                
Claims Development [Line Items]                
Incurred Losses and Loss Adjustment Expenses 1,073 1,073            
Total of Incurred but Not Reported Liabilities Plus Expected Development on Reported Claims              
Cumulative Number of Reported Claims | Claims 1              
Cumulative Paid Losses and Loss Adjustment Expenses $ 1,073 1,073            
Short-Duration Insurance Contract, Accident Year 2023 [Member]                
Claims Development [Line Items]                
Incurred Losses and Loss Adjustment Expenses            
Total of Incurred but Not Reported Liabilities Plus Expected Development on Reported Claims              
Cumulative Number of Reported Claims | Claims              
Cumulative Paid Losses and Loss Adjustment Expenses            
XML 67 R52.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF HISTORICAL AVERAGE ANNUAL PERCENTAGE PAYOUT (Details) - Property Catastrophe Reinsurance [Member]
Dec. 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Average Annual Percentage Payout of Incurred Claims by Age, Net of Reinsurance, Year 1 57.80%
Average Annual Percentage Payout of Incurred Claims by Age, Net of Reinsurance, Year 2 34.00%
Average Annual Percentage Payout of Incurred Claims by Age, Net of Reinsurance, Year 3 9.10%
Average Annual Percentage Payout of Incurred Claims by Age, Net of Reinsurance, Year 4 0.00%
Average Annual Percentage Payout of Incurred Claims by Age, Net of Reinsurance, Year 5 0.00%
Average Annual Percentage Payout of Incurred Claims by Age, Net of Reinsurance, Year 6 0.00%
XML 68 R53.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF COMPUTATION OF BASIC AND DILUTED LOSS EARNING PER SHARE (Details) - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Earnings Per Share [Abstract]    
Net loss $ (9,915,000) $ (1,789,000)
Weighted average shares - basic 5,867,129 5,772,396
Effect of dilutive securities - Stock options
Shares issuable upon conversion of warrants
Weighted average shares - diluted 5,867,129 5,772,396
Loss per share - basic $ (1.69) $ (0.31)
Loss earnings per share - diluted $ (1.69) $ (0.31)
XML 69 R54.htm IDEA: XBRL DOCUMENT v3.24.1
LOSS PER SHARE (Details Narrative) - shares
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Common Stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Anti-dilutive shares 871,250 871,250
XML 70 R55.htm IDEA: XBRL DOCUMENT v3.24.1
WARRANTS (Details Narrative)
12 Months Ended
Jan. 29, 2024
Integer
$ / shares
Dec. 31, 2023
$ / shares
shares
Dec. 31, 2022
shares
Warrants exercised | shares   0 0
Warrant [Member]      
Warrant outstanding | shares   8,230,700 8,230,700
Exercise price   $ 7.50  
Common Stock [Member]      
Ordinary share price, per share   $ 9.38  
Common Stock [Member] | Subsequent Event [Member]      
Ordinary share price, per share $ 9.38    
Warrant expiration date Mar. 26, 2029    
Trading days | Integer 20    
XML 71 R56.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF STOCK OPTION ACTIVITY (Details) - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]    
Number of Options, Outstanding, Beginning Balance 871,250 871,250
Weighted-Average Exercise Price, Outstanding, Beginning Balance $ 4.67 $ 4.67
Weighted-Average Remaining Contractual Term, Outstanding 4 years 9 months 18 days 5 years 9 months 18 days
Aggregate Intrinsic Value
Number of Options, Exercisable, Beginning Balance   721,250
Weighted-Average Exercise Price, Exercisable, Beginning Balance   $ 4.39
Weighted-Average Remaining Contractual Term, Exercisable 4 years 7 months 6 days 5 years 3 months 18 days
Aggregate Intrinsic Value  
Number of Options, Forfeited (25,000)  
Weighted-Average Exercise Price, Forfeited $ (6.00)  
Number of Options Outstanding, Ending Balance 846,250 871,250
Weighted-Average Exercise Price, Outstanding, Ending Balance $ 4.63 $ 4.67
Aggregate Intrinsic Value
Number of Options Exercisable, Ending Balance 783,750  
Weighted-Average Exercise Price, Exercisable, Ending Balance $ 4.52  
Aggregate Intrinsic Value  
XML 72 R57.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF ACTIVITY OF UNVESTED RESTRICTED STOCK AWARDS (Details) - $ / shares
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]    
Weighted-Number of Restricted Stock Awards, Beginning balance 23,000 15,000
Weighted-Number of Restricted Stock Awards, Granted 100,647 32,000
Weighted-Average Grant Date Fair Value, Granted $ 2.37 $ 3.57
Weighted-Number of Restricted Stock Awards, Vested (77,574) (12,000)
Weighted-Number of Restricted Stock Awards, Forfeited   (12,000)
Weighted-Average Grant Date Fair Value, Forfeited   $ 3.57
Weighted-Average Grant Date Fair Value, Vested $ 2.37  
Weighted-Number of Restricted Stock Awards, Ending balance 46,073 23,000
XML 73 R58.htm IDEA: XBRL DOCUMENT v3.24.1
SHARE-BASED COMPENSATION (Details Narrative) - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Number of options granted 0 0
Restricted stock, grant 100,647 32,000
Vesting period, contractual term 10 years  
Unrecognized compensation expense, non-vested stock options $ 20,000 $ 48,000
Weighted-average period 12 months  
General and Administrative Expense [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Compensation expense $ 20,000 58,000
Restricted Stock [Member] | General and Administrative Expense [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Compensation expense 238,000 69,000
Unrecognized compensation expense, non-vested stock options $ 133,000 $ 121,000
2014 Omnibus Incentive Plan [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Number of options granted 1,000,000  
Shares available for grant 11,750  
2021 Omnibus Incentive Plan [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Shares available for grant 895,353  
2021 Omnibus Incentive Plan [Member] | Restricted Stock [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Restricted stock, grant 100,647  
XML 74 R59.htm IDEA: XBRL DOCUMENT v3.24.1
NET WORTH FOR REGULATORY PURPOSES (Details Narrative) - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Minimum prescribed capital requirement description Under the terms of their respective licenses, Oxbridge Reinsurance Limited and Oxbridge Re NS are required to maintain a minimum and prescribed capital requirement of $500 in accordance with the relevant subsidiary’s approved business plan filed with CIMA.  
Oxbridge Reinsurance Limited [Member]    
Subsidiary net worth $ 10,000  
Net income 11,290,000 $ 2,000,000.0
Oxbridge Re NS [Member]    
Subsidiary net worth 223,000  
Net income $ 68,000 $ 11,000
XML 75 R60.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF OPERATING LEASE COST (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Leases [Abstract]    
Operating Lease Cost [1] $ 108 $ 96
Operating cash flows from operating leases $ 108 $ 96
[1] Includes short-term leases
XML 76 R61.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF OPERATING LEASE OBLIGATIONS (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Leases [Abstract]    
Operating lease right-of-use assets $ 9 $ 44
Operating lease liabilities $ 9 $ 44
Weighted-average remaining lease term - operating leases 4 months 20 days 1 year 2 months 1 day
Weighted-average discount rate - operating leases 7.13% 6.50%
XML 77 R62.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Leases [Abstract]    
2023 $ 40
2024 9 6
Total future minimum lease payments 9 46
Less imputed interest (2)
Total operating lease liabilities $ 9 $ 44
XML 78 R63.htm IDEA: XBRL DOCUMENT v3.24.1
LEASES (Details Narrative)
Dec. 31, 2023
Office Lease [Member]  
Lessee, Lease, Description [Line Items]  
Remaining lease term 2 months
Renewal term 5 years
Residential Lease [Member]  
Lessee, Lease, Description [Line Items]  
Remaining lease term 1 month
Renewal term 3 years
XML 79 R64.htm IDEA: XBRL DOCUMENT v3.24.1
RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)
12 Months Ended
Sep. 11, 2023
Sep. 11, 2023
Dec. 31, 2023
Dec. 31, 2022
Mar. 11, 2024
Dec. 31, 2021
Related Party Transaction [Line Items]            
Due from related parties     $ 63,000 $ 45,000    
Premiums receivable     977,000 282,000    
Deferred acquisition cost     101,000    
Unearned premiums     915,000    
Change in unearned premium reserve     695,000 (2,000)    
Underwriting expenses     141,000 110,000    
Policy Loans Receivable     100,000      
Subsequent Event [Member]            
Related Party Transaction [Line Items]            
Redemption of notes payable         $ 140,000  
Mr Jay Madhu [Member]            
Related Party Transaction [Line Items]            
Debt face amount           $ 68,000,000
Proceeds from Related Party Debt     $ 76,000      
Number of shares issued     6,200      
Shares issued, price per share     $ 10.00      
Aggregate purchase price     $ 62,000      
Related Party [Member]            
Related Party Transaction [Line Items]            
Due from related parties     $ 62,000 45,000    
Administrative Services Agreement [Member]            
Related Party Transaction [Line Items]            
Administrative services agreement description     Commencing on the effective date of the SPAC’s IPO, the Sponsor agreed to pay the Company a total of up to $10,000      
Administrative fees expense     $ 80,000 $ 90,000    
Reinsurance Agreement [Member]            
Related Party Transaction [Line Items]            
Premiums receivable     489,000      
Deferred acquisition cost     50,000      
Unearned premiums     458,000      
Change in unearned premium reserve     1,099,000      
Deferred policy acquisition cost     458,000      
Underwriting expenses     $ 70,000      
Bridge Agreement [Member] | Investor [Member]            
Related Party Transaction [Line Items]            
Debt face amount $ 625,000 $ 625,000        
Short-term bridge funds $ 500,000 $ 500,000        
Percentage of original issue discount 20.00% 20.00%        
Notes interest rate 5.00% 5.00%        
Notes maturity date   Mar. 11, 2024        
Debt, description Notes with 100% of the proceeds of any equity or debt financing at a redemption premium of 110% of the principal amount of the Notes          
XML 80 R65.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF PROPERTY AND EQUIPMENT,NET (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Property, Plant and Equipment [Line Items]    
Total, at cost $ 135 $ 130
less accumulated depreciation and amortization (131) (125)
Property and equipment, net 4 5
Leasehold Improvements [Member]    
Property, Plant and Equipment [Line Items]    
Total, at cost 21 21
Furniture and Fixtures [Member]    
Property, Plant and Equipment [Line Items]    
Total, at cost 41 38
Vehicles [Member]    
Property, Plant and Equipment [Line Items]    
Total, at cost 34 34
Computer Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Total, at cost $ 39 $ 37
XML 81 R66.htm IDEA: XBRL DOCUMENT v3.24.1
Schedule I - Summary of Investments - Other Than Investments in Related Parties (Details)
$ in Thousands
Dec. 31, 2023
USD ($)
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]  
Total investments, Cost or amortized cost $ 1,926
Total investments, Fair value 680
Total investments, Balance sheet value 680
Equity Securities, Investment Summary [Member]  
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]  
Total investments, Cost or amortized cost 1,926
Total investments, Fair value 680
Total investments, Balance sheet value $ 680
XML 82 R67.htm IDEA: XBRL DOCUMENT v3.24.1
Schedule II Condensed Balance Sheet Parent Company Only (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Assets      
Cash and cash equivalents $ 495 $ 1,207  
Equity securities 680 642  
Due from related party 63 45  
Loan receivable 100  
Prepayment and other assets 96 114  
Prepaid offering costs 133  
Operating lease right-of-use assets 9 44  
Property and equipment, net 4 5  
Total assets 8,253 16,616  
Liabilities:      
Operating lease liabilities 9 44  
Due to Subsidiary 1,523  
Accounts payable and other liabilities 356 294  
Shareholders’ equity:      
Ordinary share capital 6 6  
Accumulated Deficit (27,414) (17,499)  
Total shareholders’ equity 5,332 14,989 $ 16,651
Total liabilities and shareholders’ equity 8,253 16,616  
Parent Company [Member]      
Assets      
Cash and cash equivalents 247 931  
Equity securities 680 642  
Investment in subsidiaries 1,757 9,389  
Prepayment and other assets 82 105  
Prepaid offering costs 133  
Operating lease right-of-use assets 9 44  
Property and equipment, net 4 5  
Total assets 5,784 15,156  
Liabilities:      
Operating lease liabilities 9 44  
Accounts payable and other liabilities 193 123  
Total liabilities 452 167  
Shareholders’ equity:      
Ordinary share capital 6 6  
Additional paid-in capital 32,740 32,482  
Accumulated Deficit (27,414) (17,499)  
Total shareholders’ equity 5,332 14,989  
Total liabilities and shareholders’ equity 5,784 15,156  
Parent Company [Member] | Subsidiaries [Member]      
Assets      
Due from related party 2,905 3,872  
Liabilities:      
Due to Subsidiary 250  
Parent Company [Member] | Related Party [Member]      
Assets      
Due from related party 35  
Loan receivable $ 100  
XML 83 R68.htm IDEA: XBRL DOCUMENT v3.24.1
Schedule II Condensed Statements of Income Parent Company Only (Details) - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Revenue    
Change in fair value of equity securities $ 38,000 $ (338,000)
Net realized investment gain 27,000
Net loss (9,915,000) (1,789,000)
Parent Company [Member]    
Revenue    
Net investment income 71,000 47,000
Change in fair value of equity securities 38,000 (338,000)
Net realized investment gain 27,000
Management fees and other income 2,978,000 1,883,000
Operating expenses (1,912,000) (1,406,000)
Income before equity in loss of subsidiaries 1,175,000 213,000
Equity in loss of subsidiaries (11,090,000) (2,002,000)
Net loss $ (9,915,000) $ (1,789,000)
XML 84 R69.htm IDEA: XBRL DOCUMENT v3.24.1
Schedule II Condensed Statement of Cash Flows - Parent Company Only (Details) - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Operating activities    
Net loss $ (9,915,000) $ (1,789,000)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Share-based compensation 258,000 127,000
Underwriting Income – SurancePlus 494,000,000  
Net realized investment gain (27,000)
Change in fair value of equity securities (38,000) 338,000
Change in operating assets and liabilities:    
Due from related party (18,000) (40,000)
Prepayment and other assets 18,000 (64,000)
Prepaid offering costs 133,000 (133,000)
Accounts payable and other liabilities 62,000 (43,000)
Net cash provided by (used in) operating activities (1,260,000) (829,000)
Investing activities    
Purchase of equity securities (1,002,000)
Purchase of loan receivable (100,000)
Proceeds from sale of equity securities 626,000
Purchase of property and equipment (5,000)
Net cash used in investing activities (105,000) (661,000)
Cash and cash equivalents at beginning of year 3,928,000  
Cash and cash equivalents at end of year 3,745,000 3,928,000
Parent Company [Member]    
Operating activities    
Net loss (9,915,000) (1,789,000)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Equity in loss of subsidiaries 11,090,000 2,002,000
Share-based compensation 258,000 127,000
Underwriting Income – SurancePlus (494,000)
Depreciation 6,000 4,000
Net realized investment gain (27,000)
Change in fair value of equity securities (38,000) 338,000
Change in operating assets and liabilities:    
Due from subsidiary 967,000 (1,763,000)
Due to subsidiary 250,000
Prepayment and other assets 23,000 (55,000)
Prepaid offering costs 133,000 (133,000)
Accounts payable and other liabilities 70,000 (87,000)
Net cash provided by (used in) operating activities 2,385,000 (1,413,000)
Investing activities    
Purchase of equity securities (1,002,000)
Purchase of loan receivable (100,000)
Investment in subsidiary (2,964) (507)
Proceeds from sale of equity securities 626,000
Purchase of property and equipment (5,000)
Net cash used in investing activities (3,069,000) (883,000)
Net change in cash and cash equivalents (684,000) (2,296,000)
Cash and cash equivalents at beginning of year 931,000 3,227,000
Cash and cash equivalents at end of year 247,000 931,000
Parent Company [Member] | Related Party [Member]    
Change in operating assets and liabilities:    
Due from related party $ 35,000 $ (30,000)
XML 85 R70.htm IDEA: XBRL DOCUMENT v3.24.1
Schedule III Supplementary Insurance Information (Details) - Property, Liability and Casualty Insurance Product Line [Member] - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Deferred acquisition costs, net
Reserves for losses and loss adjustment expenses - gross 1,073
Unearned premiums - gross
Net premiums earned 1,255 995
Investment income (loss) 27
Net losses, and loss adjustment expenses 1,073
Amortization of deferred acquisition costs 141 110
Operating expenses 2,183 1,413
Gross premiums written $ 2,170 $ 645
XML 86 R71.htm IDEA: XBRL DOCUMENT v3.24.1
Schedule IV Reinsurance Information (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]    
Premiums assumed from other companies $ 2,170 $ 645
Net premiums earned 1,255 995
Property, Liability and Casualty Insurance Product Line [Member]    
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]    
Direct gross premiums
Premiums ceded to other companies
Premiums assumed from other companies 2,170 645
Net premiums earned $ 2,170 $ 645
Percentage of amount assumed to net 100.00% 100.00%
EXCEL 87 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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�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

EC' M7D%-( 8 .,N / " 6UP 0!X;"]W;W)K8F]O:RYX;6Q0 M2P$"% ,4 " #=@WI8L 4 O38" <*@ &@ @ &Z=@$ M>&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4 " #=@WI8X0$ 6T-O;G1E;G1?5'EP97-=+GAM 7;%!+!08 3P!/ * 5 !6>P$ ! end XML 88 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 89 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 91 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1 html 169 314 1 true 66 0 false 6 false false R1.htm 00000001 - Document - Cover Sheet http://oxbridgere.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - Consolidated Balance Sheets Sheet http://oxbridgere.com/role/BalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://oxbridgere.com/role/BalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Consolidated Statements of Operations Sheet http://oxbridgere.com/role/StatementsOfOperations Consolidated Statements of Operations Statements 4 false false R5.htm 00000005 - Statement - Consolidated Statements of Cash Flows Sheet http://oxbridgere.com/role/StatementsOfCashFlows Consolidated Statements of Cash Flows Statements 5 false false R6.htm 00000006 - Statement - Consolidated Statements of Changes in Shareholders' Equity Sheet http://oxbridgere.com/role/StatementsOfChangesInShareholdersEquity Consolidated Statements of Changes in Shareholders' Equity Statements 6 false false R7.htm 995410 - Disclosure - Pay vs Performance Disclosure Sheet http://xbrl.sec.gov/ecd/role/PvpDisclosure Pay vs Performance Disclosure Notes 7 false false R8.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 8 false false R9.htm 995512 - Disclosure - ORGANIZATION AND BASIS OF PRESENTATION Sheet http://oxbridgere.com/role/OrganizationAndBasisOfPresentation ORGANIZATION AND BASIS OF PRESENTATION Notes 9 false false R10.htm 995513 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://oxbridgere.com/role/SummaryOfSignificantAccountingPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 10 false false R11.htm 995514 - Disclosure - CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AND CASH EQUIVALENTS Sheet http://oxbridgere.com/role/CashAndCashEquivalentsAndRestrictedCashAndCashEquivalents CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AND CASH EQUIVALENTS Notes 11 false false R12.htm 995515 - Disclosure - INVESTMENTS Sheet http://oxbridgere.com/role/Investments INVESTMENTS Notes 12 false false R13.htm 995516 - Disclosure - TAXATION Sheet http://oxbridgere.com/role/Taxation TAXATION Notes 13 false false R14.htm 995517 - Disclosure - VARIABLE INTEREST ENTITIES Sheet http://oxbridgere.com/role/VariableInterestEntities VARIABLE INTEREST ENTITIES Notes 14 false false R15.htm 995518 - Disclosure - RESERVE FOR LOSSES AND LOSS ADJUSTMENT EXPENSES Sheet http://oxbridgere.com/role/ReserveForLossesAndLossAdjustmentExpenses RESERVE FOR LOSSES AND LOSS ADJUSTMENT EXPENSES Notes 15 false false R16.htm 995519 - Disclosure - LOSS PER SHARE Sheet http://oxbridgere.com/role/LossPerShare LOSS PER SHARE Notes 16 false false R17.htm 995520 - Disclosure - WARRANTS Sheet http://oxbridgere.com/role/Warrants WARRANTS Notes 17 false false R18.htm 995521 - Disclosure - DIVIDENDS Sheet http://oxbridgere.com/role/Dividends DIVIDENDS Notes 18 false false R19.htm 995522 - Disclosure - SHARE-BASED COMPENSATION Sheet http://oxbridgere.com/role/Share-basedCompensation SHARE-BASED COMPENSATION Notes 19 false false R20.htm 995523 - Disclosure - NET WORTH FOR REGULATORY PURPOSES Sheet http://oxbridgere.com/role/NetWorthForRegulatoryPurposes NET WORTH FOR REGULATORY PURPOSES Notes 20 false false R21.htm 995524 - Disclosure - FAIR VALUE AND CERTAIN RISKS AND UNCERTAINTIES Sheet http://oxbridgere.com/role/FairValueAndCertainRisksAndUncertainties FAIR VALUE AND CERTAIN RISKS AND UNCERTAINTIES Notes 21 false false R22.htm 995525 - Disclosure - LEASES Sheet http://oxbridgere.com/role/Leases LEASES Notes 22 false false R23.htm 995526 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://oxbridgere.com/role/RelatedPartyTransactions RELATED PARTY TRANSACTIONS Notes 23 false false R24.htm 995527 - Disclosure - PROPERTY AND EQUIPMENT, NET Sheet http://oxbridgere.com/role/PropertyAndEquipmentNet PROPERTY AND EQUIPMENT, NET Notes 24 false false R25.htm 995528 - Disclosure - SUBSEQUENT EVENTS Sheet http://oxbridgere.com/role/SubsequentEvents SUBSEQUENT EVENTS Notes 25 false false R26.htm 995529 - Disclosure - Schedule I - Summary of Investments - Other Than Investments in Related Parties Sheet http://oxbridgere.com/role/ScheduleI-SummaryOfInvestments-OtherThanInvestmentsInRelatedParties Schedule I - Summary of Investments - Other Than Investments in Related Parties Notes 26 false false R27.htm 995530 - Disclosure - Schedule II - Condensed Financial Information of Registrant Sheet http://oxbridgere.com/role/ScheduleIi-CondensedFinancialInformationOfRegistrant Schedule II - Condensed Financial Information of Registrant Notes 27 false false R28.htm 995531 - Disclosure - Schedule III - Supplementary Insurance Information Sheet http://oxbridgere.com/role/ScheduleIii-SupplementaryInsuranceInformation Schedule III - Supplementary Insurance Information Notes 28 false false R29.htm 995532 - Disclosure - Schedule IV - Reinsurance Information Sheet http://oxbridgere.com/role/ScheduleIv-ReinsuranceInformation Schedule IV - Reinsurance Information Notes 29 false false R30.htm 995533 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://oxbridgere.com/role/SummaryOfSignificantAccountingPoliciesPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 30 false false R31.htm 995534 - Disclosure - CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AND CASH EQUIVALENTS (Tables) Sheet http://oxbridgere.com/role/CashAndCashEquivalentsAndRestrictedCashAndCashEquivalentsTables CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AND CASH EQUIVALENTS (Tables) Tables http://oxbridgere.com/role/CashAndCashEquivalentsAndRestrictedCashAndCashEquivalents 31 false false R32.htm 995535 - Disclosure - INVESTMENTS (Tables) Sheet http://oxbridgere.com/role/InvestmentsTables INVESTMENTS (Tables) Tables http://oxbridgere.com/role/Investments 32 false false R33.htm 995536 - Disclosure - VARIABLE INTEREST ENTITIES (Tables) Sheet http://oxbridgere.com/role/VariableInterestEntitiesTables VARIABLE INTEREST ENTITIES (Tables) Tables http://oxbridgere.com/role/VariableInterestEntities 33 false false R34.htm 995537 - Disclosure - RESERVE FOR LOSSES AND LOSS ADJUSTMENT EXPENSES (Tables) Sheet http://oxbridgere.com/role/ReserveForLossesAndLossAdjustmentExpensesTables RESERVE FOR LOSSES AND LOSS ADJUSTMENT EXPENSES (Tables) Tables http://oxbridgere.com/role/ReserveForLossesAndLossAdjustmentExpenses 34 false false R35.htm 995538 - Disclosure - LOSS PER SHARE (Tables) Sheet http://oxbridgere.com/role/LossPerShareTables LOSS PER SHARE (Tables) Tables http://oxbridgere.com/role/LossPerShare 35 false false R36.htm 995539 - Disclosure - SHARE-BASED COMPENSATION (Tables) Sheet http://oxbridgere.com/role/Share-basedCompensationTables SHARE-BASED COMPENSATION (Tables) Tables http://oxbridgere.com/role/Share-basedCompensation 36 false false R37.htm 995540 - Disclosure - LEASES (Tables) Sheet http://oxbridgere.com/role/LeasesTables LEASES (Tables) Tables http://oxbridgere.com/role/Leases 37 false false R38.htm 995541 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables) Sheet http://oxbridgere.com/role/PropertyAndEquipmentNetTables PROPERTY AND EQUIPMENT, NET (Tables) Tables http://oxbridgere.com/role/PropertyAndEquipmentNet 38 false false R39.htm 995542 - Disclosure - ORGANIZATION AND BASIS OF PRESENTATION (Details Narrative) Sheet http://oxbridgere.com/role/OrganizationAndBasisOfPresentationDetailsNarrative ORGANIZATION AND BASIS OF PRESENTATION (Details Narrative) Details http://oxbridgere.com/role/OrganizationAndBasisOfPresentation 39 false false R40.htm 995543 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Sheet http://oxbridgere.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Details http://oxbridgere.com/role/SummaryOfSignificantAccountingPoliciesPolicies 40 false false R41.htm 995544 - Disclosure - SUMMARY OF CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AND CASH EQUIVALENTS (Details) Sheet http://oxbridgere.com/role/SummaryOfCashAndCashEquivalentsAndRestrictedCashAndCashEquivalentsDetails SUMMARY OF CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AND CASH EQUIVALENTS (Details) Details 41 false false R42.htm 995545 - Disclosure - SCHEDULE OF GROSS REALIZED GAINS AND LOSSES FROM SALE OF EQUITY SECURITIES (Details) Sheet http://oxbridgere.com/role/ScheduleOfGrossRealizedGainsAndLossesFromSaleOfEquitySecuritiesDetails SCHEDULE OF GROSS REALIZED GAINS AND LOSSES FROM SALE OF EQUITY SECURITIES (Details) Details 42 false false R43.htm 995546 - Disclosure - SCHEDULE OF OTHER INVESTMENT (Details) Sheet http://oxbridgere.com/role/ScheduleOfOtherInvestmentDetails SCHEDULE OF OTHER INVESTMENT (Details) Details 43 false false R44.htm 995547 - Disclosure - SCHEDULE OF FAIR VALUE OF ASSETS MEASURED ON RECURRING BASIS (Details) Sheet http://oxbridgere.com/role/ScheduleOfFairValueOfAssetsMeasuredOnRecurringBasisDetails SCHEDULE OF FAIR VALUE OF ASSETS MEASURED ON RECURRING BASIS (Details) Details 44 false false R45.htm 995548 - Disclosure - SCHEDULE OF RECONCILIATION OF CHANGES IN FAIR VALUE (Details) Sheet http://oxbridgere.com/role/ScheduleOfReconciliationOfChangesInFairValueDetails SCHEDULE OF RECONCILIATION OF CHANGES IN FAIR VALUE (Details) Details 45 false false R46.htm 995549 - Disclosure - INVESTMENTS (Details Narrative) Sheet http://oxbridgere.com/role/InvestmentsDetailsNarrative INVESTMENTS (Details Narrative) Details http://oxbridgere.com/role/InvestmentsTables 46 false false R47.htm 995550 - Disclosure - SCHEDULE OF FINANCIAL STATEMENTS (Details) Sheet http://oxbridgere.com/role/ScheduleOfFinancialStatementsDetails SCHEDULE OF FINANCIAL STATEMENTS (Details) Details 47 false false R48.htm 995551 - Disclosure - SCHEDULE OF FINANCIAL STATEMENTS (Details) (Parenthetical) Sheet http://oxbridgere.com/role/ScheduleOfFinancialStatementsDetailsParenthetical SCHEDULE OF FINANCIAL STATEMENTS (Details) (Parenthetical) Details 48 false false R49.htm 995552 - Disclosure - VARIABLE INTEREST ENTITIES (Details Narrative) Sheet http://oxbridgere.com/role/VariableInterestEntitiesDetailsNarrative VARIABLE INTEREST ENTITIES (Details Narrative) Details http://oxbridgere.com/role/VariableInterestEntitiesTables 49 false false R50.htm 995553 - Disclosure - SCHEDULE OF LOSS ADJUSTMENT EXPENSE (Details) Sheet http://oxbridgere.com/role/ScheduleOfLossAdjustmentExpenseDetails SCHEDULE OF LOSS ADJUSTMENT EXPENSE (Details) Details 50 false false R51.htm 995554 - Disclosure - SCHEDULE OF INCURRED LOSSES AND ADJUSTMENT EXPENSES (Details) Sheet http://oxbridgere.com/role/ScheduleOfIncurredLossesAndAdjustmentExpensesDetails SCHEDULE OF INCURRED LOSSES AND ADJUSTMENT EXPENSES (Details) Details 51 false false R52.htm 995555 - Disclosure - SCHEDULE OF HISTORICAL AVERAGE ANNUAL PERCENTAGE PAYOUT (Details) Sheet http://oxbridgere.com/role/ScheduleOfHistoricalAverageAnnualPercentagePayoutDetails SCHEDULE OF HISTORICAL AVERAGE ANNUAL PERCENTAGE PAYOUT (Details) Details 52 false false R53.htm 995556 - Disclosure - SCHEDULE OF COMPUTATION OF BASIC AND DILUTED LOSS EARNING PER SHARE (Details) Sheet http://oxbridgere.com/role/ScheduleOfComputationOfBasicAndDilutedLossEarningPerShareDetails SCHEDULE OF COMPUTATION OF BASIC AND DILUTED LOSS EARNING PER SHARE (Details) Details 53 false false R54.htm 995557 - Disclosure - LOSS PER SHARE (Details Narrative) Sheet http://oxbridgere.com/role/LossPerShareDetailsNarrative LOSS PER SHARE (Details Narrative) Details http://oxbridgere.com/role/LossPerShareTables 54 false false R55.htm 995558 - Disclosure - WARRANTS (Details Narrative) Sheet http://oxbridgere.com/role/WarrantsDetailsNarrative WARRANTS (Details Narrative) Details http://oxbridgere.com/role/Warrants 55 false false R56.htm 995559 - Disclosure - SCHEDULE OF STOCK OPTION ACTIVITY (Details) Sheet http://oxbridgere.com/role/ScheduleOfStockOptionActivityDetails SCHEDULE OF STOCK OPTION ACTIVITY (Details) Details 56 false false R57.htm 995560 - Disclosure - SCHEDULE OF ACTIVITY OF UNVESTED RESTRICTED STOCK AWARDS (Details) Sheet http://oxbridgere.com/role/ScheduleOfActivityOfUnvestedRestrictedStockAwardsDetails SCHEDULE OF ACTIVITY OF UNVESTED RESTRICTED STOCK AWARDS (Details) Details 57 false false R58.htm 995561 - Disclosure - SHARE-BASED COMPENSATION (Details Narrative) Sheet http://oxbridgere.com/role/Share-basedCompensationDetailsNarrative SHARE-BASED COMPENSATION (Details Narrative) Details http://oxbridgere.com/role/Share-basedCompensationTables 58 false false R59.htm 995562 - Disclosure - NET WORTH FOR REGULATORY PURPOSES (Details Narrative) Sheet http://oxbridgere.com/role/NetWorthForRegulatoryPurposesDetailsNarrative NET WORTH FOR REGULATORY PURPOSES (Details Narrative) Details http://oxbridgere.com/role/NetWorthForRegulatoryPurposes 59 false false R60.htm 995563 - Disclosure - SCHEDULE OF OPERATING LEASE COST (Details) Sheet http://oxbridgere.com/role/ScheduleOfOperatingLeaseCostDetails SCHEDULE OF OPERATING LEASE COST (Details) Details 60 false false R61.htm 995564 - Disclosure - SCHEDULE OF OPERATING LEASE OBLIGATIONS (Details) Sheet http://oxbridgere.com/role/ScheduleOfOperatingLeaseObligationsDetails SCHEDULE OF OPERATING LEASE OBLIGATIONS (Details) Details 61 false false R62.htm 995565 - Disclosure - SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS (Details) Sheet http://oxbridgere.com/role/ScheduleOfFutureMinimumLeasePaymentsDetails SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS (Details) Details 62 false false R63.htm 995566 - Disclosure - LEASES (Details Narrative) Sheet http://oxbridgere.com/role/LeasesDetailsNarrative LEASES (Details Narrative) Details http://oxbridgere.com/role/LeasesTables 63 false false R64.htm 995567 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) Sheet http://oxbridgere.com/role/RelatedPartyTransactionsDetailsNarrative RELATED PARTY TRANSACTIONS (Details Narrative) Details http://oxbridgere.com/role/RelatedPartyTransactions 64 false false R65.htm 995568 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT,NET (Details) Sheet http://oxbridgere.com/role/ScheduleOfPropertyAndEquipmentnetDetails SCHEDULE OF PROPERTY AND EQUIPMENT,NET (Details) Details 65 false false R66.htm 995569 - Disclosure - Schedule I - Summary of Investments - Other Than Investments in Related Parties (Details) Sheet http://oxbridgere.com/role/ScheduleI-SummaryOfInvestments-OtherThanInvestmentsInRelatedPartiesDetails Schedule I - Summary of Investments - Other Than Investments in Related Parties (Details) Details http://oxbridgere.com/role/ScheduleI-SummaryOfInvestments-OtherThanInvestmentsInRelatedParties 66 false false R67.htm 995570 - Disclosure - Schedule II Condensed Balance Sheet Parent Company Only (Details) Sheet http://oxbridgere.com/role/ScheduleIiCondensedBalanceSheetParentCompanyOnlyDetails Schedule II Condensed Balance Sheet Parent Company Only (Details) Details 67 false false R68.htm 995571 - Disclosure - Schedule II Condensed Statements of Income Parent Company Only (Details) Sheet http://oxbridgere.com/role/ScheduleIiCondensedStatementsOfIncomeParentCompanyOnlyDetails Schedule II Condensed Statements of Income Parent Company Only (Details) Details 68 false false R69.htm 995572 - Disclosure - Schedule II Condensed Statement of Cash Flows - Parent Company Only (Details) Sheet http://oxbridgere.com/role/ScheduleIiCondensedStatementOfCashFlows-ParentCompanyOnlyDetails Schedule II Condensed Statement of Cash Flows - Parent Company Only (Details) Details 69 false false R70.htm 995573 - Disclosure - Schedule III Supplementary Insurance Information (Details) Sheet http://oxbridgere.com/role/ScheduleIiiSupplementaryInsuranceInformationDetails Schedule III Supplementary Insurance Information (Details) Details 70 false false R71.htm 995574 - Disclosure - Schedule IV Reinsurance Information (Details) Sheet http://oxbridgere.com/role/ScheduleIvReinsuranceInformationDetails Schedule IV Reinsurance Information (Details) Details 71 false false All Reports Book All Reports form10-k.htm oxbr-20231231.xsd oxbr-20231231_cal.xml oxbr-20231231_def.xml oxbr-20231231_lab.xml oxbr-20231231_pre.xml form10-k_001.jpg http://fasb.org/srt/2023 http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 http://xbrl.sec.gov/ecd/2023 true true JSON 93 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "form10-k.htm": { "nsprefix": "OXBR", "nsuri": "http://oxbridgere.com/20231231", "dts": { "inline": { "local": [ "form10-k.htm" ] }, "schema": { "local": [ "oxbr-20231231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd" ] }, "calculationLink": { "local": [ "oxbr-20231231_cal.xml" ] }, "definitionLink": { "local": [ "oxbr-20231231_def.xml" ] }, "labelLink": { "local": [ "oxbr-20231231_lab.xml" ] }, "presentationLink": { "local": [ "oxbr-20231231_pre.xml" ] } }, "keyStandard": 290, "keyCustom": 24, "axisStandard": 24, "axisCustom": 0, "memberStandard": 31, "memberCustom": 28, "hidden": { "total": 146, "http://fasb.org/us-gaap/2023": 135, "http://xbrl.sec.gov/dei/2023": 3, "http://oxbridgere.com/20231231": 8 }, "contextCount": 169, "entityCount": 1, "segmentCount": 66, "elementCount": 589, "unitCount": 6, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 755, "http://xbrl.sec.gov/dei/2023": 43, "http://xbrl.sec.gov/ecd/2023": 4, "http://fasb.org/srt/2023": 3 }, "report": { "R1": { "role": "http://oxbridgere.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R2": { "role": "http://oxbridgere.com/role/BalanceSheets", "longName": "00000002 - Statement - Consolidated Balance Sheets", "shortName": "Consolidated Balance Sheets", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:EquitySecuritiesFvNi", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:NotesPayable", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R3": { "role": "http://oxbridgere.com/role/BalanceSheetsParenthetical", "longName": "00000003 - Statement - Consolidated Balance Sheets (Parenthetical)", "shortName": "Consolidated Balance Sheets (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:EquitySecuritiesFvNiCost", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:EquitySecuritiesFvNiCost", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R4": { "role": "http://oxbridgere.com/role/StatementsOfOperations", "longName": "00000004 - Statement - Consolidated Statements of Operations", "shortName": "Consolidated Statements of Operations", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:AssumedPremiumsEarned", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:IncreaseDecreaseInUnearnedPremiumsNet", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R5": { "role": "http://oxbridgere.com/role/StatementsOfCashFlows", "longName": "00000005 - Statement - Consolidated Statements of Cash Flows", "shortName": "Consolidated Statements of Cash Flows", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:NetIncomeLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:DepreciationAndAmortization", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R6": { "role": "http://oxbridgere.com/role/StatementsOfChangesInShareholdersEquity", "longName": "00000006 - Statement - Consolidated Statements of Changes in Shareholders' Equity", "shortName": "Consolidated Statements of Changes in Shareholders' Equity", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "AsOf2021-12-31_us-gaap_CommonStockMember", "name": "us-gaap:StockholdersEquity", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2021-12-31_us-gaap_CommonStockMember", "name": "us-gaap:StockholdersEquity", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R7": { "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure", "longName": "995410 - Disclosure - Pay vs Performance Disclosure", "shortName": "Pay vs Performance Disclosure", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "7", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:NetIncomeLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": null }, "R8": { "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "longName": "995445 - Disclosure - Insider Trading Arrangements", "shortName": "Insider Trading Arrangements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "8", "firstAnchor": { "contextRef": "From2023-10-012023-12-31", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-10-012023-12-31", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R9": { "role": "http://oxbridgere.com/role/OrganizationAndBasisOfPresentation", "longName": "995512 - Disclosure - ORGANIZATION AND BASIS OF PRESENTATION", "shortName": "ORGANIZATION AND BASIS OF PRESENTATION", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R10": { "role": "http://oxbridgere.com/role/SummaryOfSignificantAccountingPolicies", "longName": "995513 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R11": { "role": "http://oxbridgere.com/role/CashAndCashEquivalentsAndRestrictedCashAndCashEquivalents", "longName": "995514 - Disclosure - CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AND CASH EQUIVALENTS", "shortName": "CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AND CASH EQUIVALENTS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:CashAndCashEquivalentsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:CashAndCashEquivalentsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R12": { "role": "http://oxbridgere.com/role/Investments", "longName": "995515 - Disclosure - INVESTMENTS", "shortName": "INVESTMENTS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:InvestmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:InvestmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R13": { "role": "http://oxbridgere.com/role/Taxation", "longName": "995516 - Disclosure - TAXATION", "shortName": "TAXATION", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R14": { "role": "http://oxbridgere.com/role/VariableInterestEntities", "longName": "995517 - Disclosure - VARIABLE INTEREST ENTITIES", "shortName": "VARIABLE INTEREST ENTITIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:VariableInterestEntityDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:VariableInterestEntityDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R15": { "role": "http://oxbridgere.com/role/ReserveForLossesAndLossAdjustmentExpenses", "longName": "995518 - Disclosure - RESERVE FOR LOSSES AND LOSS ADJUSTMENT EXPENSES", "shortName": "RESERVE FOR LOSSES AND LOSS ADJUSTMENT EXPENSES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "OXBR:ReserveForLossesAndLossAdjustmentExpensesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "OXBR:ReserveForLossesAndLossAdjustmentExpensesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R16": { "role": "http://oxbridgere.com/role/LossPerShare", "longName": "995519 - Disclosure - LOSS PER SHARE", "shortName": "LOSS PER SHARE", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R17": { "role": "http://oxbridgere.com/role/Warrants", "longName": "995520 - Disclosure - WARRANTS", "shortName": "WARRANTS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "OXBR:DisclosureOfWarrantsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "OXBR:DisclosureOfWarrantsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R18": { "role": "http://oxbridgere.com/role/Dividends", "longName": "995521 - Disclosure - DIVIDENDS", "shortName": "DIVIDENDS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "OXBR:DividendsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "OXBR:DividendsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R19": { "role": "http://oxbridgere.com/role/Share-basedCompensation", "longName": "995522 - Disclosure - SHARE-BASED COMPENSATION", "shortName": "SHARE-BASED COMPENSATION", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R20": { "role": "http://oxbridgere.com/role/NetWorthForRegulatoryPurposes", "longName": "995523 - Disclosure - NET WORTH FOR REGULATORY PURPOSES", "shortName": "NET WORTH FOR REGULATORY PURPOSES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "OXBR:NetWorthForRegulatoryPurposesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "OXBR:NetWorthForRegulatoryPurposesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R21": { "role": "http://oxbridgere.com/role/FairValueAndCertainRisksAndUncertainties", "longName": "995524 - Disclosure - FAIR VALUE AND CERTAIN RISKS AND UNCERTAINTIES", "shortName": "FAIR VALUE AND CERTAIN RISKS AND UNCERTAINTIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "21", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R22": { "role": "http://oxbridgere.com/role/Leases", "longName": "995525 - Disclosure - LEASES", "shortName": "LEASES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "22", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R23": { "role": "http://oxbridgere.com/role/RelatedPartyTransactions", "longName": "995526 - Disclosure - RELATED PARTY TRANSACTIONS", "shortName": "RELATED PARTY TRANSACTIONS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "23", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R24": { "role": "http://oxbridgere.com/role/PropertyAndEquipmentNet", "longName": "995527 - Disclosure - PROPERTY AND EQUIPMENT, NET", "shortName": "PROPERTY AND EQUIPMENT, NET", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "24", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R25": { "role": "http://oxbridgere.com/role/SubsequentEvents", "longName": "995528 - Disclosure - SUBSEQUENT EVENTS", "shortName": "SUBSEQUENT EVENTS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "25", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R26": { "role": "http://oxbridgere.com/role/ScheduleI-SummaryOfInvestments-OtherThanInvestmentsInRelatedParties", "longName": "995529 - Disclosure - Schedule I - Summary of Investments - Other Than Investments in Related Parties", "shortName": "Schedule I - Summary of Investments - Other Than Investments in Related Parties", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "26", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "srt:SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "srt:SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R27": { "role": "http://oxbridgere.com/role/ScheduleIi-CondensedFinancialInformationOfRegistrant", "longName": "995530 - Disclosure - Schedule II - Condensed Financial Information of Registrant", "shortName": "Schedule II - Condensed Financial Information of Registrant", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "27", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R28": { "role": "http://oxbridgere.com/role/ScheduleIii-SupplementaryInsuranceInformation", "longName": "995531 - Disclosure - Schedule III - Supplementary Insurance Information", "shortName": "Schedule III - Supplementary Insurance Information", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "28", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "srt:SupplementaryInsuranceInformationForInsuranceCompaniesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "srt:SupplementaryInsuranceInformationForInsuranceCompaniesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R29": { "role": "http://oxbridgere.com/role/ScheduleIv-ReinsuranceInformation", "longName": "995532 - Disclosure - Schedule IV - Reinsurance Information", "shortName": "Schedule IV - Reinsurance Information", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "29", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "srt:SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "srt:SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R30": { "role": "http://oxbridgere.com/role/SummaryOfSignificantAccountingPoliciesPolicies", "longName": "995533 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "30", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:UseOfEstimates", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:UseOfEstimates", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R31": { "role": "http://oxbridgere.com/role/CashAndCashEquivalentsAndRestrictedCashAndCashEquivalentsTables", "longName": "995534 - Disclosure - CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AND CASH EQUIVALENTS (Tables)", "shortName": "CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AND CASH EQUIVALENTS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "31", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:CashAndCashEquivalentsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:CashAndCashEquivalentsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R32": { "role": "http://oxbridgere.com/role/InvestmentsTables", "longName": "995535 - Disclosure - INVESTMENTS (Tables)", "shortName": "INVESTMENTS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "32", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfRealizedGainLossTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:InvestmentTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfRealizedGainLossTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:InvestmentTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R33": { "role": "http://oxbridgere.com/role/VariableInterestEntitiesTables", "longName": "995536 - Disclosure - VARIABLE INTEREST ENTITIES (Tables)", "shortName": "VARIABLE INTEREST ENTITIES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "33", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:VariableInterestEntityDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:VariableInterestEntityDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R34": { "role": "http://oxbridgere.com/role/ReserveForLossesAndLossAdjustmentExpensesTables", "longName": "995537 - Disclosure - RESERVE FOR LOSSES AND LOSS ADJUSTMENT EXPENSES (Tables)", "shortName": "RESERVE FOR LOSSES AND LOSS ADJUSTMENT EXPENSES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "34", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "OXBR:ReserveForLossesAndLossAdjustmentExpensesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "OXBR:ReserveForLossesAndLossAdjustmentExpensesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R35": { "role": "http://oxbridgere.com/role/LossPerShareTables", "longName": "995538 - Disclosure - LOSS PER SHARE (Tables)", "shortName": "LOSS PER SHARE (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "35", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R36": { "role": "http://oxbridgere.com/role/Share-basedCompensationTables", "longName": "995539 - Disclosure - SHARE-BASED COMPENSATION (Tables)", "shortName": "SHARE-BASED COMPENSATION (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "36", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R37": { "role": "http://oxbridgere.com/role/LeasesTables", "longName": "995540 - Disclosure - LEASES (Tables)", "shortName": "LEASES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "37", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:LeaseCostTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:LeaseCostTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R38": { "role": "http://oxbridgere.com/role/PropertyAndEquipmentNetTables", "longName": "995541 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables)", "shortName": "PROPERTY AND EQUIPMENT, NET (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "38", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R39": { "role": "http://oxbridgere.com/role/OrganizationAndBasisOfPresentationDetailsNarrative", "longName": "995542 - Disclosure - ORGANIZATION AND BASIS OF PRESENTATION (Details Narrative)", "shortName": "ORGANIZATION AND BASIS OF PRESENTATION (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "39", "firstAnchor": { "contextRef": "AsOf2013-04-23_custom_OxbridgeReinsuranceLimitedMember", "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2013-04-23_custom_OxbridgeReinsuranceLimitedMember", "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R40": { "role": "http://oxbridgere.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "longName": "995543 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "40", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "OXBR:PrepaidOfferingCost", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "OXBR:OfferingExpensesPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "OXBR:PrepaidOfferingCost", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "OXBR:OfferingExpensesPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R41": { "role": "http://oxbridgere.com/role/SummaryOfCashAndCashEquivalentsAndRestrictedCashAndCashEquivalentsDetails", "longName": "995544 - Disclosure - SUMMARY OF CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AND CASH EQUIVALENTS (Details)", "shortName": "SUMMARY OF CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AND CASH EQUIVALENTS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "41", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:CashEquivalentsAtCarryingValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "us-gaap:CashAndCashEquivalentsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:CashEquivalentsAtCarryingValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "us-gaap:CashAndCashEquivalentsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R42": { "role": "http://oxbridgere.com/role/ScheduleOfGrossRealizedGainsAndLossesFromSaleOfEquitySecuritiesDetails", "longName": "995545 - Disclosure - SCHEDULE OF GROSS REALIZED GAINS AND LOSSES FROM SALE OF EQUITY SECURITIES (Details)", "shortName": "SCHEDULE OF GROSS REALIZED GAINS AND LOSSES FROM SALE OF EQUITY SECURITIES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "42", "firstAnchor": { "contextRef": "From2022-01-012022-12-31", "name": "us-gaap:ProceedsFromSaleOfEquitySecuritiesFvNi", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2022-01-012022-12-31", "name": "us-gaap:EquitySecuritiesFvNiRealizedGain", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfRealizedGainLossTableTextBlock", "us-gaap:InvestmentTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R43": { "role": "http://oxbridgere.com/role/ScheduleOfOtherInvestmentDetails", "longName": "995546 - Disclosure - SCHEDULE OF OTHER INVESTMENT (Details)", "shortName": "SCHEDULE OF OTHER INVESTMENT (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "43", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:OtherInvestments", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31_custom_JetA1SeriesA1ConvertiblePreferredStockMember", "name": "us-gaap:OtherInvestments", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "OXBR:ScheduleOfOtherInvestmentsTableTextBlock", "us-gaap:InvestmentTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R44": { "role": "http://oxbridgere.com/role/ScheduleOfFairValueOfAssetsMeasuredOnRecurringBasisDetails", "longName": "995547 - Disclosure - SCHEDULE OF FAIR VALUE OF ASSETS MEASURED ON RECURRING BASIS (Details)", "shortName": "SCHEDULE OF FAIR VALUE OF ASSETS MEASURED ON RECURRING BASIS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "44", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "us-gaap:InvestmentTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "us-gaap:InvestmentTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R45": { "role": "http://oxbridgere.com/role/ScheduleOfReconciliationOfChangesInFairValueDetails", "longName": "995548 - Disclosure - SCHEDULE OF RECONCILIATION OF CHANGES IN FAIR VALUE (Details)", "shortName": "SCHEDULE OF RECONCILIATION OF CHANGES IN FAIR VALUE (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "45", "firstAnchor": { "contextRef": "From2022-01-012022-12-31", "name": "OXBR:InvestmentInAffiliate", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "OXBR:ScheduleOfOtherInvestmentsTableTextBlock", "us-gaap:InvestmentTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2021-12-31_us-gaap_FairValueInputsLevel3Member", "name": "us-gaap:InvestmentOwnedAtFairValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "us-gaap:InvestmentTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R46": { "role": "http://oxbridgere.com/role/InvestmentsDetailsNarrative", "longName": "995549 - Disclosure - INVESTMENTS (Details Narrative)", "shortName": "INVESTMENTS (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "46", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:UnrealizedGainLossOnInvestments", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:InvestmentTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-12-31_custom_OxbridgeAcquisitionCorpMember", "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "us-gaap:InvestmentTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R47": { "role": "http://oxbridgere.com/role/ScheduleOfFinancialStatementsDetails", "longName": "995550 - Disclosure - SCHEDULE OF FINANCIAL STATEMENTS (Details)", "shortName": "SCHEDULE OF FINANCIAL STATEMENTS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "47", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:Revenues", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-12-31_custom_SurancePlusIncMember", "name": "us-gaap:Revenues", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock", "us-gaap:VariableInterestEntityDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R48": { "role": "http://oxbridgere.com/role/ScheduleOfFinancialStatementsDetailsParenthetical", "longName": "995551 - Disclosure - SCHEDULE OF FINANCIAL STATEMENTS (Details) (Parenthetical)", "shortName": "SCHEDULE OF FINANCIAL STATEMENTS (Details) (Parenthetical)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "48", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:UnderwritingIncomeLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "link:footnote", "span", "td", "tr", "table", "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock", "us-gaap:VariableInterestEntityDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": null }, "R49": { "role": "http://oxbridgere.com/role/VariableInterestEntitiesDetailsNarrative", "longName": "995552 - Disclosure - VARIABLE INTEREST ENTITIES (Details Narrative)", "shortName": "VARIABLE INTEREST ENTITIES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "49", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:RepaymentsOfDebt", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:VariableInterestEntityDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:ConvertibleNotesPayableCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:VariableInterestEntityDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R50": { "role": "http://oxbridgere.com/role/ScheduleOfLossAdjustmentExpenseDetails", "longName": "995553 - Disclosure - SCHEDULE OF LOSS ADJUSTMENT EXPENSE (Details)", "shortName": "SCHEDULE OF LOSS ADJUSTMENT EXPENSE (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "50", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2022-01-012022-12-31", "name": "us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense", "OXBR:ReserveForLossesAndLossAdjustmentExpensesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R51": { "role": "http://oxbridgere.com/role/ScheduleOfIncurredLossesAndAdjustmentExpensesDetails", "longName": "995554 - Disclosure - SCHEDULE OF INCURRED LOSSES AND ADJUSTMENT EXPENSES (Details)", "shortName": "SCHEDULE OF INCURRED LOSSES AND ADJUSTMENT EXPENSES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "51", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock", "OXBR:ReserveForLossesAndLossAdjustmentExpensesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock", "OXBR:ReserveForLossesAndLossAdjustmentExpensesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R52": { "role": "http://oxbridgere.com/role/ScheduleOfHistoricalAverageAnnualPercentagePayoutDetails", "longName": "995555 - Disclosure - SCHEDULE OF HISTORICAL AVERAGE ANNUAL PERCENTAGE PAYOUT (Details)", "shortName": "SCHEDULE OF HISTORICAL AVERAGE ANNUAL PERCENTAGE PAYOUT (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "52", "firstAnchor": { "contextRef": "AsOf2022-12-31_custom_PropertyCatastropheReinsuranceMember", "name": "us-gaap:ShortdurationInsuranceContractsHistoricalClaimsDurationYearOne", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ShortdurationInsuranceContractsScheduleOfHistoricalClaimsDurationTableTextBlock", "OXBR:ReserveForLossesAndLossAdjustmentExpensesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2022-12-31_custom_PropertyCatastropheReinsuranceMember", "name": "us-gaap:ShortdurationInsuranceContractsHistoricalClaimsDurationYearOne", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ShortdurationInsuranceContractsScheduleOfHistoricalClaimsDurationTableTextBlock", "OXBR:ReserveForLossesAndLossAdjustmentExpensesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R53": { "role": "http://oxbridgere.com/role/ScheduleOfComputationOfBasicAndDilutedLossEarningPerShareDetails", "longName": "995556 - Disclosure - SCHEDULE OF COMPUTATION OF BASIC AND DILUTED LOSS EARNING PER SHARE (Details)", "shortName": "SCHEDULE OF COMPUTATION OF BASIC AND DILUTED LOSS EARNING PER SHARE (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "53", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:NetIncomeLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": null }, "R54": { "role": "http://oxbridgere.com/role/LossPerShareDetailsNarrative", "longName": "995557 - Disclosure - LOSS PER SHARE (Details Narrative)", "shortName": "LOSS PER SHARE (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "54", "firstAnchor": { "contextRef": "From2023-01-012023-12-31_us-gaap_CommonStockMember44833671", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "span", "p", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-12-31_us-gaap_CommonStockMember44833671", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "span", "p", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R55": { "role": "http://oxbridgere.com/role/WarrantsDetailsNarrative", "longName": "995558 - Disclosure - WARRANTS (Details Narrative)", "shortName": "WARRANTS (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "55", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "span", "p", "OXBR:DisclosureOfWarrantsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "span", "p", "OXBR:DisclosureOfWarrantsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R56": { "role": "http://oxbridgere.com/role/ScheduleOfStockOptionActivityDetails", "longName": "995559 - Disclosure - SCHEDULE OF STOCK OPTION ACTIVITY (Details)", "shortName": "SCHEDULE OF STOCK OPTION ACTIVITY (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "56", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2021-12-31", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R57": { "role": "http://oxbridgere.com/role/ScheduleOfActivityOfUnvestedRestrictedStockAwardsDetails", "longName": "995560 - Disclosure - SCHEDULE OF ACTIVITY OF UNVESTED RESTRICTED STOCK AWARDS (Details)", "shortName": "SCHEDULE OF ACTIVITY OF UNVESTED RESTRICTED STOCK AWARDS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "57", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2021-12-31", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R58": { "role": "http://oxbridgere.com/role/Share-basedCompensationDetailsNarrative", "longName": "995561 - Disclosure - SHARE-BASED COMPENSATION (Details Narrative)", "shortName": "SHARE-BASED COMPENSATION (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "58", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "span", "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "span", "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R59": { "role": "http://oxbridgere.com/role/NetWorthForRegulatoryPurposesDetailsNarrative", "longName": "995562 - Disclosure - NET WORTH FOR REGULATORY PURPOSES (Details Narrative)", "shortName": "NET WORTH FOR REGULATORY PURPOSES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "59", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "OXBR:StatutoryAccountingPracticeStatutoryCapitalAndSurplusRequired", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "p", "OXBR:NetWorthForRegulatoryPurposesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "OXBR:StatutoryAccountingPracticeStatutoryCapitalAndSurplusRequired", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "p", "OXBR:NetWorthForRegulatoryPurposesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R60": { "role": "http://oxbridgere.com/role/ScheduleOfOperatingLeaseCostDetails", "longName": "995563 - Disclosure - SCHEDULE OF OPERATING LEASE COST (Details)", "shortName": "SCHEDULE OF OPERATING LEASE COST (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "60", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:OperatingLeaseCost", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:LeaseCostTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:OperatingLeaseCost", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:LeaseCostTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R61": { "role": "http://oxbridgere.com/role/ScheduleOfOperatingLeaseObligationsDetails", "longName": "995564 - Disclosure - SCHEDULE OF OPERATING LEASE OBLIGATIONS (Details)", "shortName": "SCHEDULE OF OPERATING LEASE OBLIGATIONS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "61", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:OperatingLeaseRightOfUseAsset", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "td", "tr", "table", "OXBR:ScheduleOfOperatingLeaseObligationsTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R62": { "role": "http://oxbridgere.com/role/ScheduleOfFutureMinimumLeasePaymentsDetails", "longName": "995565 - Disclosure - SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS (Details)", "shortName": "SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "62", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "OXBR:LesseeOperatingLeaseLiabilityPaymentsDuePrevioulyReported", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2022-12-31", "name": "OXBR:LesseeOperatingLeaseLiabilityPaymentsDuePrevioulyReported", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R63": { "role": "http://oxbridgere.com/role/LeasesDetailsNarrative", "longName": "995566 - Disclosure - LEASES (Details Narrative)", "shortName": "LEASES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "63", "firstAnchor": { "contextRef": "AsOf2023-12-31_custom_OfficeLeaseMember", "name": "us-gaap:LesseeOperatingLeaseRemainingLeaseTerm", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "p", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31_custom_OfficeLeaseMember", "name": "us-gaap:LesseeOperatingLeaseRemainingLeaseTerm", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "p", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R64": { "role": "http://oxbridgere.com/role/RelatedPartyTransactionsDetailsNarrative", "longName": "995567 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)", "shortName": "RELATED PARTY TRANSACTIONS (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "64", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:OtherReceivables", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:PolicyLoansReceivable", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R65": { "role": "http://oxbridgere.com/role/ScheduleOfPropertyAndEquipmentnetDetails", "longName": "995568 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT,NET (Details)", "shortName": "SCHEDULE OF PROPERTY AND EQUIPMENT,NET (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "65", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:PropertyPlantAndEquipmentGross", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:PropertyPlantAndEquipmentGross", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R66": { "role": "http://oxbridgere.com/role/ScheduleI-SummaryOfInvestments-OtherThanInvestmentsInRelatedPartiesDetails", "longName": "995569 - Disclosure - Schedule I - Summary of Investments - Other Than Investments in Related Parties (Details)", "shortName": "Schedule I - Summary of Investments - Other Than Investments in Related Parties (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "66", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesCost", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "srt:SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesCost", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "srt:SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R67": { "role": "http://oxbridgere.com/role/ScheduleIiCondensedBalanceSheetParentCompanyOnlyDetails", "longName": "995570 - Disclosure - Schedule II Condensed Balance Sheet Parent Company Only (Details)", "shortName": "Schedule II Condensed Balance Sheet Parent Company Only (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "67", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31_srt_ParentCompanyMember", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R68": { "role": "http://oxbridgere.com/role/ScheduleIiCondensedStatementsOfIncomeParentCompanyOnlyDetails", "longName": "995571 - Disclosure - Schedule II Condensed Statements of Income Parent Company Only (Details)", "shortName": "Schedule II Condensed Statements of Income Parent Company Only (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "68", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:EquitySecuritiesFvNiGainLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-12-31_srt_ParentCompanyMember", "name": "us-gaap:InvestmentIncomeNet", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R69": { "role": "http://oxbridgere.com/role/ScheduleIiCondensedStatementOfCashFlows-ParentCompanyOnlyDetails", "longName": "995572 - Disclosure - Schedule II Condensed Statement of Cash Flows - Parent Company Only (Details)", "shortName": "Schedule II Condensed Statement of Cash Flows - Parent Company Only (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "69", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:NetIncomeLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-12-31_srt_ParentCompanyMember", "name": "us-gaap:IncomeLossFromEquityMethodInvestments", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R70": { "role": "http://oxbridgere.com/role/ScheduleIiiSupplementaryInsuranceInformationDetails", "longName": "995573 - Disclosure - Schedule III Supplementary Insurance Information (Details)", "shortName": "Schedule III Supplementary Insurance Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "70", "firstAnchor": { "contextRef": "AsOf2022-12-31_us-gaap_PropertyLiabilityAndCasualtyInsuranceSegmentMember", "name": "us-gaap:SupplementaryInsuranceInformationLiabilityForFuturePolicyBenefitsLossesClaimsAndLossExpenseReserves", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "srt:SupplementaryInsuranceInformationForInsuranceCompaniesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2022-12-31_us-gaap_PropertyLiabilityAndCasualtyInsuranceSegmentMember", "name": "us-gaap:SupplementaryInsuranceInformationLiabilityForFuturePolicyBenefitsLossesClaimsAndLossExpenseReserves", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "srt:SupplementaryInsuranceInformationForInsuranceCompaniesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R71": { "role": "http://oxbridgere.com/role/ScheduleIvReinsuranceInformationDetails", "longName": "995574 - Disclosure - Schedule IV Reinsurance Information (Details)", "shortName": "Schedule IV Reinsurance Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "71", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:AssumedPremiumsEarned", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-12-31_us-gaap_PropertyLiabilityAndCasualtyInsuranceSegmentMember", "name": "us-gaap:AssumedPremiumsEarned", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "srt:SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } } }, "tag": { "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AccountsPayableAndOtherAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableAndOtherAccruedLiabilities", "crdr": "credit", "calculation": { "http://oxbridgere.com/role/BalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://oxbridgere.com/role/BalanceSheets", "http://oxbridgere.com/role/ScheduleIiCondensedBalanceSheetParentCompanyOnlyDetails" ], "lang": { "en-us": { "role": { "label": "Accounts payable and other liabilities", "documentation": "Amount of liabilities incurred and payable to vendors for goods and services received, and accrued liabilities classified as other." } } }, "auth_ref": [ "r499" ] }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://oxbridgere.com/role/ScheduleOfPropertyAndEquipmentnetDetails": { "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://oxbridgere.com/role/ScheduleOfPropertyAndEquipmentnetDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "less accumulated depreciation and amortization", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services." } } }, "auth_ref": [ "r43", "r157", "r412" ] }, "ecd_Additional402vDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Additional402vDisclosureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Additional 402(v) Disclosure [Text Block]" } } }, "auth_ref": [ "r681" ] }, "us-gaap_AdditionalPaidInCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapital", "crdr": "credit", "presentation": [ "http://oxbridgere.com/role/ScheduleIiCondensedBalanceSheetParentCompanyOnlyDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Additional paid-in capital", "label": "Additional Paid in Capital", "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock." } } }, "auth_ref": [ "r79", "r618", "r824" ] }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalCommonStock", "crdr": "credit", "calculation": { "http://oxbridgere.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://oxbridgere.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Additional paid-in capital", "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital." } } }, "auth_ref": [ "r79" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://oxbridgere.com/role/StatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r313", "r314", "r315", "r475", "r744", "r745", "r746", "r791", "r827" ] }, "ecd_AdjToCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation Amount" } } }, "auth_ref": [ "r687" ] }, "ecd_AdjToCompAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation [Axis]" } } }, "auth_ref": [ "r687" ] }, "ecd_AdjToNonPeoNeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToNonPeoNeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]" } } }, "auth_ref": [ "r687" ] }, "ecd_AdjToPeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToPeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment To PEO Compensation, Footnote [Text Block]" } } }, "auth_ref": [ "r687" ] }, "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://oxbridgere.com/role/ScheduleIiCondensedStatementOfCashFlows-ParentCompanyOnlyDetails", "http://oxbridgere.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net loss to net cash used in operating activities:", "verboseLabel": "Adjustments to reconcile net loss to net cash provided by (used in) operating activities:" } } }, "auth_ref": [] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "crdr": "credit", "presentation": [ "http://oxbridgere.com/role/StatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "verboseLabel": "Share-based compensation", "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition", "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement." } } }, "auth_ref": [ "r52", "r53", "r276" ] }, "us-gaap_AdministrativeFeesExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdministrativeFeesExpense", "crdr": "debit", "presentation": [ "http://oxbridgere.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Administrative fees expense", "documentation": "Amount of expense for administrative fee from service provided, including, but not limited to, salary, rent, or overhead cost." } } }, "auth_ref": [ "r63", "r527", "r826" ] }, "OXBR_AdministrativeServicesAgreementDescription": { "xbrltype": "stringItemType", "nsuri": "http://oxbridgere.com/20231231", "localname": "AdministrativeServicesAgreementDescription", "presentation": [ "http://oxbridgere.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Administrative services agreement description", "documentation": "Administrative Services Agreement Description." } } }, "auth_ref": [] }, "OXBR_AdministrativeServicesAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://oxbridgere.com/20231231", "localname": "AdministrativeServicesAgreementMember", "presentation": [ "http://oxbridgere.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Administrative Services Agreement [Member]", "documentation": "Administrative Services Agreement [Member]" } } }, "auth_ref": [] }, "OXBR_AggregateOfferingPrice": { "xbrltype": "monetaryItemType", "nsuri": "http://oxbridgere.com/20231231", "localname": "AggregateOfferingPrice", "crdr": "debit", "presentation": [ "http://oxbridgere.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Aggregate offering price", "documentation": "Aggregate offering price." } } }, "auth_ref": [] }, "ecd_AggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r651", "r663", "r673", "r699" ] }, "ecd_AggtErrCompNotYetDeterminedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompNotYetDeterminedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]" } } }, "auth_ref": [ "r654", "r666", "r676", "r702" ] }, "ecd_AllAdjToCompMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllAdjToCompMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "auth_ref": [ "r687" ] }, "ecd_AllExecutiveCategoriesMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllExecutiveCategoriesMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "auth_ref": [ "r694" ] }, "ecd_AllIndividualsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllIndividualsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "auth_ref": [ "r658", "r667", "r677", "r694", "r703", "r707", "r715" ] }, "us-gaap_AllocatedShareBasedCompensationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllocatedShareBasedCompensationExpense", "crdr": "debit", "presentation": [ "http://oxbridgere.com/role/Share-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Compensation expense", "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized." } } }, "auth_ref": [ "r308", "r320" ] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://oxbridgere.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://oxbridgere.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://oxbridgere.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r659" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "presentation": [ "http://oxbridgere.com/role/LossPerShareDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Anti-dilutive shares", "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented." } } }, "auth_ref": [ "r205" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "presentation": [ "http://oxbridgere.com/role/LossPerShareDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Antidilutive Securities [Axis]", "documentation": "Information by type of antidilutive security." } } }, "auth_ref": [ "r37" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "presentation": [ "http://oxbridgere.com/role/LossPerShareDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesNameDomain", "presentation": [ "http://oxbridgere.com/role/LossPerShareDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented." } } }, "auth_ref": [ "r37" ] }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ArrangementsAndNonarrangementTransactionsMember", "presentation": [ "http://oxbridgere.com/role/RelatedPartyTransactionsDetailsNarrative", "http://oxbridgere.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://oxbridgere.com/role/VariableInterestEntitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r332" ] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Assets", "crdr": "debit", "calculation": { "http://oxbridgere.com/role/BalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://oxbridgere.com/role/BalanceSheets", "http://oxbridgere.com/role/ScheduleIiCondensedBalanceSheetParentCompanyOnlyDetails", "http://oxbridgere.com/role/ScheduleOfFinancialStatementsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total assets", "label": "Total assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r110", "r158", "r175", "r212", "r224", "r228", "r237", "r246", "r247", "r248", "r249", "r250", "r251", "r252", "r253", "r254", "r333", "r335", "r349", "r404", "r520", "r618", "r632", "r758", "r759", "r802" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsAbstract", "presentation": [ "http://oxbridgere.com/role/BalanceSheets", "http://oxbridgere.com/role/ScheduleIiCondensedBalanceSheetParentCompanyOnlyDetails" ], "lang": { "en-us": { "role": { "label": "Assets" } } }, "auth_ref": [] }, "us-gaap_AssetsFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsFairValueDisclosure", "crdr": "debit", "calculation": { "http://oxbridgere.com/role/ScheduleOfFairValueOfAssetsMeasuredOnRecurringBasisDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://oxbridgere.com/role/ScheduleOfFairValueOfAssetsMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total", "label": "Assets, Fair Value Disclosure", "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r59" ] }, "us-gaap_AssumedPremiumsEarned": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssumedPremiumsEarned", "crdr": "credit", "calculation": { "http://oxbridgere.com/role/StatementsOfOperations": { "parentTag": "us-gaap_PremiumsEarnedNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://oxbridgere.com/role/ScheduleIvReinsuranceInformationDetails", "http://oxbridgere.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Assumed premiums", "verboseLabel": "Premiums assumed from other companies", "documentation": "Amount of earned premiums assumed from other entities." } } }, "auth_ref": [ "r437", "r457", "r460", "r815" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://oxbridgere.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r659" ] }, "dei_AuditorFirmId": { "xbrltype": "nonemptySequenceNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorFirmId", "presentation": [ "http://oxbridgere.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Auditor Firm ID", "documentation": "PCAOB issued Audit Firm Identifier" } } }, "auth_ref": [ "r644", "r646", "r659" ] }, "dei_AuditorLocation": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorLocation", "presentation": [ "http://oxbridgere.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Auditor Location" } } }, "auth_ref": [ "r644", "r646", "r659" ] }, "dei_AuditorName": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorName", "presentation": [ "http://oxbridgere.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Auditor Name" } } }, "auth_ref": [ "r644", "r646", "r659" ] }, "ecd_AwardExrcPrice": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardExrcPrice", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Exercise Price" } } }, "auth_ref": [ "r710" ] }, "ecd_AwardGrantDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardGrantDateFairValue", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Grant Date Fair Value" } } }, "auth_ref": [ "r711" ] }, "ecd_AwardTmgDiscLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgDiscLineItems", "auth_ref": [ "r706" ] }, "ecd_AwardTmgHowMnpiCnsdrdTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgHowMnpiCnsdrdTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing, How MNPI Considered [Text Block]" } } }, "auth_ref": [ "r706" ] }, "ecd_AwardTmgMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing Method [Text Block]" } } }, "auth_ref": [ "r706" ] }, "ecd_AwardTmgMnpiCnsdrdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiCnsdrdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Considered [Flag]" } } }, "auth_ref": [ "r706" ] }, "ecd_AwardTmgMnpiDiscTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiDiscTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Disclosure [Text Block]" } } }, "auth_ref": [ "r706" ] }, "ecd_AwardTmgPredtrmndFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgPredtrmndFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing Predetermined [Flag]" } } }, "auth_ref": [ "r706" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardTypeAxis", "presentation": [ "http://oxbridgere.com/role/Share-basedCompensationDetailsNarrative", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Type [Axis]", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r279", "r280", "r281", "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r303", "r304", "r305", "r306", "r307" ] }, "ecd_AwardUndrlygSecuritiesAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardUndrlygSecuritiesAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Underlying Securities Amount" } } }, "auth_ref": [ "r709" ] }, "ecd_AwardsCloseToMnpiDiscIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures, Individual Name" } } }, "auth_ref": [ "r708" ] }, "ecd_AwardsCloseToMnpiDiscTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures [Table]" } } }, "auth_ref": [ "r707" ] }, "ecd_AwardsCloseToMnpiDiscTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]" } } }, "auth_ref": [ "r707" ] }, "us-gaap_BenefitsLossesAndExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BenefitsLossesAndExpenses", "crdr": "debit", "calculation": { "http://oxbridgere.com/role/StatementsOfOperations": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://oxbridgere.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Total expenses", "label": "Benefits, Losses and Expenses", "documentation": "The total amount of expense recognized during the period for future policy benefits, claims and claims adjustment costs, and for selling, general and administrative costs." } } }, "auth_ref": [ "r119" ] }, "OXBR_BridgeAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://oxbridgere.com/20231231", "localname": "BridgeAgreementMember", "presentation": [ "http://oxbridgere.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Bridge Agreement [Member]", "documentation": "Bridge Agreement [Member]" } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionAcquireeDomain", "presentation": [ "http://oxbridgere.com/role/VariableInterestEntitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree." } } }, "auth_ref": [ "r331", "r613", "r614" ] }, "us-gaap_BusinessAcquisitionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionAxis", "presentation": [ "http://oxbridgere.com/role/VariableInterestEntitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Business Acquisition [Axis]", "documentation": "Information by business combination or series of individually immaterial business combinations." } } }, "auth_ref": [ "r54", "r56", "r331", "r613", "r614" ] }, "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired", "presentation": [ "http://oxbridgere.com/role/VariableInterestEntitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Voting percentage", "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination." } } }, "auth_ref": [ "r55" ] }, "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock", "presentation": [ "http://oxbridgere.com/role/OrganizationAndBasisOfPresentation" ], "lang": { "en-us": { "role": { "label": "ORGANIZATION AND BASIS OF PRESENTATION", "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)." } } }, "auth_ref": [ "r71", "r97", "r98" ] }, "us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CapitalizationOfDeferredPolicyAcquisitionCostsPolicy", "presentation": [ "http://oxbridgere.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Deferred policy acquisition costs", "label": "Deferred Policy Acquisition Costs, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for deferred policy acquisition costs, including the nature, type, and amount of capitalized costs incurred to write or acquire insurance contracts, and the basis for and methodologies applied in capitalizing and amortizing such costs." } } }, "auth_ref": [ "r123", "r124" ] }, "us-gaap_CashAndCashEquivalentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsAbstract", "lang": { "en-us": { "role": { "label": "Cash and Cash Equivalents [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://oxbridgere.com/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://oxbridgere.com/role/BalanceSheets", "http://oxbridgere.com/role/ScheduleIiCondensedBalanceSheetParentCompanyOnlyDetails" ], "lang": { "en-us": { "role": { "label": "Cash and cash equivalents", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r32", "r155", "r597" ] }, "us-gaap_CashAndCashEquivalentsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsDisclosureTextBlock", "presentation": [ "http://oxbridgere.com/role/CashAndCashEquivalentsAndRestrictedCashAndCashEquivalents" ], "lang": { "en-us": { "role": { "label": "CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AND CASH EQUIVALENTS", "documentation": "The entire disclosure for cash and cash equivalent footnotes, which may include the types of deposits and money market instruments, applicable carrying amounts, restricted amounts and compensating balance arrangements. Cash and equivalents include: (1) currency on hand (2) demand deposits with banks or financial institutions (3) other kinds of accounts that have the general characteristics of demand deposits (4) short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only investments maturing within three months from the date of acquisition qualify." } } }, "auth_ref": [ "r155", "r405" ] }, "us-gaap_CashAndCashEquivalentsFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsFairValueDisclosure", "crdr": "debit", "calculation": { "http://oxbridgere.com/role/ScheduleOfFairValueOfAssetsMeasuredOnRecurringBasisDetails": { "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://oxbridgere.com/role/ScheduleOfFairValueOfAssetsMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Cash and cash equivalents", "label": "Cash and Cash Equivalents, Fair Value Disclosure", "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [] }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsPolicyTextBlock", "presentation": [ "http://oxbridgere.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Cash and cash equivalents", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value." } } }, "auth_ref": [ "r33" ] }, "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy", "presentation": [ "http://oxbridgere.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Restricted cash and cash equivalents", "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]", "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits." } } }, "auth_ref": [ "r33", "r109" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "calculation": { "http://oxbridgere.com/role/SummaryOfCashAndCashEquivalentsAndRestrictedCashAndCashEquivalentsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://oxbridgere.com/role/ScheduleIiCondensedStatementOfCashFlows-ParentCompanyOnlyDetails", "http://oxbridgere.com/role/SummaryOfCashAndCashEquivalentsAndRestrictedCashAndCashEquivalentsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total", "periodStartLabel": "Cash and cash equivalents at beginning of year", "periodEndLabel": "Cash and cash equivalents at end of year", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r32", "r94", "r173" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "crdr": "debit", "presentation": [ "http://oxbridgere.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "periodStartLabel": "Balance at beginning of year", "periodEndLabel": "Balance at end of year", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r32", "r94", "r173" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "crdr": "debit", "presentation": [ "http://oxbridgere.com/role/ScheduleIiCondensedStatementOfCashFlows-ParentCompanyOnlyDetails" ], "lang": { "en-us": { "role": { "label": "Net change in cash and cash equivalents", "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r1", "r94" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://oxbridgere.com/role/StatementsOfCashFlows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://oxbridgere.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net change during the year", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r1", "r94" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectAbstract", "presentation": [ "http://oxbridgere.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash and cash equivalents, and restricted cash and cash equivalents:" } } }, "auth_ref": [] }, "us-gaap_CashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://oxbridgere.com/role/SummaryOfCashAndCashEquivalentsAndRestrictedCashAndCashEquivalentsDetails": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://oxbridgere.com/role/SummaryOfCashAndCashEquivalentsAndRestrictedCashAndCashEquivalentsDetails" ], "lang": { "en-us": { "role": { "label": "Cash held on deposit", "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r734", "r811" ] }, "us-gaap_CededPremiumsEarned": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CededPremiumsEarned", "crdr": "debit", "presentation": [ "http://oxbridgere.com/role/ScheduleIvReinsuranceInformationDetails" ], "lang": { "en-us": { "role": { "label": "Premiums ceded to other companies", "documentation": "Amount of earned premiums ceded to other entities." } } }, "auth_ref": [ "r436", "r454", "r455", "r458", "r460", "r815" ] }, "OXBR_ChangeInValuationInputsOrOtherAssumptions": { "xbrltype": "monetaryItemType", "nsuri": "http://oxbridgere.com/20231231", "localname": "ChangeInValuationInputsOrOtherAssumptions", "crdr": "debit", "presentation": [ "http://oxbridgere.com/role/ScheduleOfReconciliationOfChangesInFairValueDetails" ], "lang": { "en-us": { "role": { "label": "Change in valuation inputs or other assumptions", "documentation": "Change in valuation inputs or other assumptions." } } }, "auth_ref": [] }, "ecd_ChangedPeerGroupFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ChangedPeerGroupFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Changed Peer Group, Footnote [Text Block]" } } }, "auth_ref": [ "r685" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://oxbridgere.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_ClaimsDevelopmentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClaimsDevelopmentLineItems", "presentation": [ "http://oxbridgere.com/role/ScheduleOfIncurredLossesAndAdjustmentExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Claims Development [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockDomain", "presentation": [ "http://oxbridgere.com/role/Cover", "http://oxbridgere.com/role/InvestmentsDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "auth_ref": [ "r142", "r160", "r161", "r162", "r175", "r196", "r200", "r202", "r204", "r210", "r211", "r237", "r246", "r248", "r249", "r250", "r253", "r254", "r258", "r259", "r260", "r261", "r262", "r349", "r466", "r467", "r468", "r469", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r482", "r483", "r484", "r485", "r486", "r507", "r529", "r552", "r587", "r588", "r589", "r590", "r591", "r724", "r742", "r747" ] }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "presentation": [ "http://oxbridgere.com/role/WarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Exercise price", "documentation": "Exercise price per share or per unit of warrants or rights outstanding." } } }, "auth_ref": [ "r263" ] }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight", "presentation": [ "http://oxbridgere.com/role/InvestmentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of warrants shares", "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares." } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightOutstanding", "presentation": [ "http://oxbridgere.com/role/WarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrant outstanding", "documentation": "Number of warrants or rights outstanding." } } }, "auth_ref": [] }, "ecd_CoSelectedMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Amount" } } }, "auth_ref": [ "r686" ] }, "ecd_CoSelectedMeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Name" } } }, "auth_ref": [ "r686" ] }, "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems", "presentation": [ "http://oxbridgere.com/role/ScheduleOfFinancialStatementsDetails", "http://oxbridgere.com/role/VariableInterestEntitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r332" ] }, "us-gaap_CommonClassBMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonClassBMember", "presentation": [ "http://oxbridgere.com/role/ScheduleOfOtherInvestmentDetails" ], "lang": { "en-us": { "role": { "label": "Common Class B [Member]", "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation." } } }, "auth_ref": [ "r827" ] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockMember", "presentation": [ "http://oxbridgere.com/role/LossPerShareDetailsNarrative", "http://oxbridgere.com/role/StatementsOfChangesInShareholdersEquity", "http://oxbridgere.com/role/WarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r623", "r624", "r625", "r627", "r628", "r629", "r630", "r744", "r745", "r791", "r821", "r827" ] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://oxbridgere.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common stock, par value", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r78" ] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://oxbridgere.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common stock, shares authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r78", "r507" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesIssued", "presentation": [ "http://oxbridgere.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common stock, shares issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r78" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://oxbridgere.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common stock, shares outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r9", "r78", "r507", "r526", "r827", "r828" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://oxbridgere.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://oxbridgere.com/role/BalanceSheets", "http://oxbridgere.com/role/ScheduleIiCondensedBalanceSheetParentCompanyOnlyDetails" ], "lang": { "en-us": { "role": { "label": "Ordinary share capital, (par value $0.001, 50,000,000 shares authorized; 5,870,234 and 5,769,587 shares issued and outstanding)", "verboseLabel": "Ordinary share capital", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r78", "r406", "r618" ] }, "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]" } } }, "auth_ref": [ "r691" ] }, "ecd_CompActuallyPaidVsNetIncomeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsNetIncomeTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Net Income [Text Block]" } } }, "auth_ref": [ "r690" ] }, "ecd_CompActuallyPaidVsOtherMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsOtherMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Other Measure [Text Block]" } } }, "auth_ref": [ "r692" ] }, "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]" } } }, "auth_ref": [ "r689" ] }, "us-gaap_ComputerEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComputerEquipmentMember", "presentation": [ "http://oxbridgere.com/role/ScheduleOfPropertyAndEquipmentnetDetails", "http://oxbridgere.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Computer Equipment [Member]", "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems." } } }, "auth_ref": [] }, "srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Condensed Financial Information Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock", "presentation": [ "http://oxbridgere.com/role/ScheduleIi-CondensedFinancialInformationOfRegistrant" ], "lang": { "en-us": { "role": { "label": "Schedule II - Condensed Financial Information of Registrant", "documentation": "The entire disclosure for condensed financial information, including the financial position, cash flows, and the results of operations of the registrant (parent company) as of the same dates or for the same periods for which audited consolidated financial statements are being presented. Alternatively, the details of this disclosure can be reported by the specific parent company taxonomy elements, indicating the appropriate date and period contexts in an instance document." } } }, "auth_ref": [ "r153", "r179", "r725" ] }, "srt_CondensedFinancialStatementsCaptionsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "CondensedFinancialStatementsCaptionsLineItems", "presentation": [ "http://oxbridgere.com/role/ScheduleIiCondensedBalanceSheetParentCompanyOnlyDetails", "http://oxbridgere.com/role/ScheduleIiCondensedStatementOfCashFlows-ParentCompanyOnlyDetails", "http://oxbridgere.com/role/ScheduleIiCondensedStatementsOfIncomeParentCompanyOnlyDetails" ], "lang": { "en-us": { "role": { "label": "Condensed Financial Statements, Captions [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r143", "r148", "r149", "r150", "r179", "r725" ] }, "srt_ConsolidatedEntitiesAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidatedEntitiesAxis", "presentation": [ "http://oxbridgere.com/role/ScheduleIiCondensedBalanceSheetParentCompanyOnlyDetails", "http://oxbridgere.com/role/ScheduleIiCondensedStatementOfCashFlows-ParentCompanyOnlyDetails", "http://oxbridgere.com/role/ScheduleIiCondensedStatementsOfIncomeParentCompanyOnlyDetails" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Axis]", "documentation": "Information by consolidated entity or group of entities." } } }, "auth_ref": [ "r147", "r179", "r333", "r334", "r335", "r336", "r377", "r592", "r730", "r731", "r732", "r757", "r760", "r761" ] }, "srt_ConsolidatedEntitiesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidatedEntitiesDomain", "presentation": [ "http://oxbridgere.com/role/ScheduleIiCondensedBalanceSheetParentCompanyOnlyDetails", "http://oxbridgere.com/role/ScheduleIiCondensedStatementOfCashFlows-ParentCompanyOnlyDetails", "http://oxbridgere.com/role/ScheduleIiCondensedStatementsOfIncomeParentCompanyOnlyDetails" ], "lang": { "en-us": { "role": { "documentation": "Entity or group of entities consolidated into reporting entity." } } }, "auth_ref": [ "r147", "r179", "r333", "r334", "r335", "r336", "r377", "r592", "r730", "r731", "r732", "r757", "r760", "r761" ] }, "us-gaap_ConvertibleNotesPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConvertibleNotesPayableCurrent", "crdr": "credit", "presentation": [ "http://oxbridgere.com/role/VariableInterestEntitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Convertible Notes Payable, Current", "documentation": "Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder." } } }, "auth_ref": [ "r26" ] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://oxbridgere.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://oxbridgere.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentConvertibleThresholdTradingDays": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentConvertibleThresholdTradingDays", "presentation": [ "http://oxbridgere.com/role/WarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Trading days", "documentation": "Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature." } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentDescription": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentDescription", "presentation": [ "http://oxbridgere.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Debt, description", "documentation": "Identification of the lender and information about a contractual promise to repay a short-term or long-term obligation, which includes borrowings under lines of credit, notes payable, commercial paper, bonds payable, debentures, and other contractual obligations for payment. This may include rationale for entering into the arrangement, significant terms of the arrangement, which may include amount, repayment terms, priority, collateral required, debt covenants, borrowing capacity, call features, participation rights, conversion provisions, sinking-fund requirements, voting rights, basis for conversion if convertible and remarketing provisions. The description may be provided for individual debt instruments, rational groupings of debt instruments, or by debt in total." } } }, "auth_ref": [ "r24", "r45", "r66", "r75", "r111", "r112" ] }, "us-gaap_DebtInstrumentFaceAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentFaceAmount", "crdr": "credit", "presentation": [ "http://oxbridgere.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Debt face amount", "documentation": "Face (par) amount of debt instrument at time of issuance." } } }, "auth_ref": [ "r61", "r62", "r255", "r357", "r606", "r607" ] }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentInterestRateStatedPercentage", "presentation": [ "http://oxbridgere.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Notes interest rate", "documentation": "Contractual interest rate for funds borrowed, under the debt agreement." } } }, "auth_ref": [ "r27", "r256" ] }, "us-gaap_DebtInstrumentMaturityDate": { "xbrltype": "dateItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentMaturityDate", "presentation": [ "http://oxbridgere.com/role/RelatedPartyTransactionsDetailsNarrative", "http://oxbridgere.com/role/VariableInterestEntitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Maturity Date", "verboseLabel": "Notes maturity date", "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format." } } }, "auth_ref": [ "r138", "r605", "r792" ] }, "us-gaap_DeferredPolicyAcquisitionCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredPolicyAcquisitionCosts", "crdr": "debit", "calculation": { "http://oxbridgere.com/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://oxbridgere.com/role/BalanceSheets", "http://oxbridgere.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Deferred policy acquisition costs", "verboseLabel": "Deferred acquisition cost", "documentation": "Amount of deferred policy acquisition cost capitalized on contract remaining in force." } } }, "auth_ref": [ "r126", "r410", "r441", "r442", "r451", "r619" ] }, "us-gaap_DeferredPolicyAcquisitionCostsAdditions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredPolicyAcquisitionCostsAdditions", "crdr": "debit", "presentation": [ "http://oxbridgere.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Deferred policy acquisition cost", "documentation": "Amount of deferred policy acquisition cost capitalized." } } }, "auth_ref": [ "r619", "r817", "r820" ] }, "us-gaap_DefinedBenefitPlanDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanDisclosureLineItems", "presentation": [ "http://oxbridgere.com/role/InvestmentsDetailsNarrative", "http://oxbridgere.com/role/ScheduleOfOtherInvestmentDetails" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan Disclosure [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_Depreciation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Depreciation", "crdr": "debit", "presentation": [ "http://oxbridgere.com/role/ScheduleIiCondensedStatementOfCashFlows-ParentCompanyOnlyDetails" ], "lang": { "en-us": { "role": { "label": "Depreciation", "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation." } } }, "auth_ref": [ "r5", "r42" ] }, "us-gaap_DepreciationAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DepreciationAndAmortization", "crdr": "debit", "calculation": { "http://oxbridgere.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://oxbridgere.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Depreciation and amortization", "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production." } } }, "auth_ref": [ "r5", "r42" ] }, "us-gaap_DirectPremiumsEarned": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DirectPremiumsEarned", "crdr": "credit", "presentation": [ "http://oxbridgere.com/role/ScheduleIvReinsuranceInformationDetails" ], "lang": { "en-us": { "role": { "label": "Direct gross premiums", "documentation": "Amount, before premiums ceded to other entities and premiums assumed by the entity, of premiums earned." } } }, "auth_ref": [ "r435", "r456", "r459", "r815" ] }, "OXBR_DisclosureNetWorthForRegulatoryPurposesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://oxbridgere.com/20231231", "localname": "DisclosureNetWorthForRegulatoryPurposesAbstract", "lang": { "en-us": { "role": { "label": "Net Worth For Regulatory Purposes" } } }, "auth_ref": [] }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "presentation": [ "http://oxbridgere.com/role/Share-basedCompensation" ], "lang": { "en-us": { "role": { "label": "SHARE-BASED COMPENSATION", "documentation": "The entire disclosure for share-based payment arrangement." } } }, "auth_ref": [ "r274", "r278", "r309", "r310", "r312", "r616" ] }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement [Abstract]" } } }, "auth_ref": [] }, "OXBR_DisclosureOfWarrantsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://oxbridgere.com/20231231", "localname": "DisclosureOfWarrantsTextBlock", "presentation": [ "http://oxbridgere.com/role/Warrants" ], "lang": { "en-us": { "role": { "label": "WARRANTS", "documentation": "Disclosure of Warrants [Text Block]" } } }, "auth_ref": [] }, "OXBR_DisclosureReserveForLossesAndLossAdjustmentExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://oxbridgere.com/20231231", "localname": "DisclosureReserveForLossesAndLossAdjustmentExpensesAbstract", "lang": { "en-us": { "role": { "label": "Reserve For Losses And Loss Adjustment Expenses", "verboseLabel": "Schedule Of Loss Adjustment Expense" } } }, "auth_ref": [] }, "OXBR_DisclosureWarrantsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://oxbridgere.com/20231231", "localname": "DisclosureWarrantsAbstract", "lang": { "en-us": { "role": { "verboseLabel": "Warrants" } } }, "auth_ref": [] }, "us-gaap_DividendsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DividendsAbstract", "lang": { "en-us": { "role": { "label": "Dividends [Abstract]" } } }, "auth_ref": [] }, "OXBR_DividendsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://oxbridgere.com/20231231", "localname": "DividendsTextBlock", "presentation": [ "http://oxbridgere.com/role/Dividends" ], "lang": { "en-us": { "role": { "label": "DIVIDENDS", "documentation": "Dividends [Text Block]" } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://oxbridgere.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r646" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://oxbridgere.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r644", "r646", "r659" ] }, "dei_DocumentFinStmtErrorCorrectionFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFinStmtErrorCorrectionFlag", "presentation": [ "http://oxbridgere.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Financial Statement Error Correction [Flag]", "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction." } } }, "auth_ref": [ "r644", "r646", "r659", "r695" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://oxbridgere.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://oxbridgere.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://oxbridgere.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://oxbridgere.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://oxbridgere.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r645" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://oxbridgere.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r633" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://oxbridgere.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r646" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://oxbridgere.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r646" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://oxbridgere.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r680" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://oxbridgere.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://oxbridgere.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r636" ] }, "us-gaap_EarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareAbstract", "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasic", "presentation": [ "http://oxbridgere.com/role/ScheduleOfComputationOfBasicAndDilutedLossEarningPerShareDetails", "http://oxbridgere.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Loss per share, basic", "verboseLabel": "Loss per share - basic", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r170", "r185", "r186", "r187", "r188", "r189", "r194", "r196", "r202", "r203", "r204", "r208", "r344", "r345", "r399", "r420", "r600" ] }, "us-gaap_EarningsPerShareBasicAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasicAbstract", "presentation": [ "http://oxbridgere.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Loss per share" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareDiluted", "presentation": [ "http://oxbridgere.com/role/ScheduleOfComputationOfBasicAndDilutedLossEarningPerShareDetails", "http://oxbridgere.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Loss per share, diluted", "verboseLabel": "Loss earnings per share - diluted", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r170", "r185", "r186", "r187", "r188", "r189", "r196", "r202", "r203", "r204", "r208", "r344", "r345", "r399", "r420", "r600" ] }, "us-gaap_EarningsPerSharePolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerSharePolicyTextBlock", "presentation": [ "http://oxbridgere.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Loss Per Share", "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements." } } }, "auth_ref": [ "r37", "r38" ] }, "us-gaap_EarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareTextBlock", "presentation": [ "http://oxbridgere.com/role/LossPerShare" ], "lang": { "en-us": { "role": { "label": "LOSS PER SHARE", "documentation": "The entire disclosure for earnings per share." } } }, "auth_ref": [ "r193", "r205", "r206", "r207" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "crdr": "debit", "presentation": [ "http://oxbridgere.com/role/Share-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Unrecognized compensation expense, non-vested stock options", "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement." } } }, "auth_ref": [ "r311" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "presentation": [ "http://oxbridgere.com/role/Share-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Weighted-average period", "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r311" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://oxbridgere.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://oxbridgere.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://oxbridgere.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://oxbridgere.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://oxbridgere.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://oxbridgere.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://oxbridgere.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://oxbridgere.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r639" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://oxbridgere.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r635" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://oxbridgere.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://oxbridgere.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityDomain", "presentation": [ "http://oxbridgere.com/role/NetWorthForRegulatoryPurposesDetailsNarrative", "http://oxbridgere.com/role/ScheduleOfFinancialStatementsDetails", "http://oxbridgere.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://oxbridgere.com/role/VariableInterestEntitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://oxbridgere.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r635" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://oxbridgere.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r723" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://oxbridgere.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://oxbridgere.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r635" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://oxbridgere.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://oxbridgere.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r720" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://oxbridgere.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r659" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://oxbridgere.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://oxbridgere.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r635" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://oxbridgere.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r635" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://oxbridgere.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r635" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://oxbridgere.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r635" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://oxbridgere.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://oxbridgere.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r721" ] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityComponentDomain", "presentation": [ "http://oxbridgere.com/role/StatementsOfChangesInShareholdersEquity", "http://oxbridgere.com/role/VariableInterestEntitiesDetailsNarrative", "http://oxbridgere.com/role/WarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r9", "r152", "r166", "r167", "r168", "r180", "r181", "r182", "r184", "r190", "r192", "r209", "r238", "r239", "r264", "r313", "r314", "r315", "r325", "r326", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r350", "r351", "r352", "r353", "r354", "r355", "r368", "r448", "r449", "r450", "r475", "r552" ] }, "OXBR_EquityDistributionAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://oxbridgere.com/20231231", "localname": "EquityDistributionAgreementMember", "presentation": [ "http://oxbridgere.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Equity Distribution Agreement [Member]", "documentation": "Equity Distribution Agreement [Member]" } } }, "auth_ref": [] }, "srt_EquityMethodInvesteeNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "EquityMethodInvesteeNameDomain", "presentation": [ "http://oxbridgere.com/role/OrganizationAndBasisOfPresentationDetailsNarrative", "http://oxbridgere.com/role/VariableInterestEntitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Name of investment including named security. Excludes entity that is consolidated." } } }, "auth_ref": [ "r234", "r235", "r236" ] }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestmentOwnershipPercentage", "presentation": [ "http://oxbridgere.com/role/OrganizationAndBasisOfPresentationDetailsNarrative", "http://oxbridgere.com/role/VariableInterestEntitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Equity Method Investment, Ownership Percentage", "verboseLabel": "Share capital percentage", "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting." } } }, "auth_ref": [ "r234" ] }, "us-gaap_EquitySecuritiesFvNi": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquitySecuritiesFvNi", "crdr": "debit", "calculation": { "http://oxbridgere.com/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 }, "http://oxbridgere.com/role/ScheduleOfFairValueOfAssetsMeasuredOnRecurringBasisDetails": { "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://oxbridgere.com/role/BalanceSheets", "http://oxbridgere.com/role/ScheduleIiCondensedBalanceSheetParentCompanyOnlyDetails", "http://oxbridgere.com/role/ScheduleOfFairValueOfAssetsMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Equity securities, at fair value (cost: $1,926)", "verboseLabel": "Equity securities", "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current." } } }, "auth_ref": [ "r159", "r348", "r598" ] }, "us-gaap_EquitySecuritiesFvNiCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquitySecuritiesFvNiCost", "crdr": "debit", "presentation": [ "http://oxbridgere.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Equity Securities, FV-NI, Cost", "documentation": "Cost of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI). Excludes equity method investment and investment in equity security without readily determinable fair value." } } }, "auth_ref": [ "r403" ] }, "us-gaap_EquitySecuritiesFvNiGainLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquitySecuritiesFvNiGainLoss", "crdr": "credit", "calculation": { "http://oxbridgere.com/role/StatementsOfOperations": { "parentTag": "us-gaap_Revenues", "weight": 1.0, "order": 6.0 }, "http://oxbridgere.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://oxbridgere.com/role/ScheduleIiCondensedStatementOfCashFlows-ParentCompanyOnlyDetails", "http://oxbridgere.com/role/ScheduleIiCondensedStatementsOfIncomeParentCompanyOnlyDetails", "http://oxbridgere.com/role/StatementsOfCashFlows", "http://oxbridgere.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Change in fair value of equity securities", "negatedLabel": "Change in fair value of equity securities", "documentation": "Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI)." } } }, "auth_ref": [ "r423", "r752" ] }, "us-gaap_EquitySecuritiesFvNiRealizedGain": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquitySecuritiesFvNiRealizedGain", "crdr": "credit", "presentation": [ "http://oxbridgere.com/role/ScheduleOfGrossRealizedGainsAndLossesFromSaleOfEquitySecuritiesDetails" ], "lang": { "en-us": { "role": { "label": "Equity Securities, FV-NI, Realized Gain", "documentation": "Amount of realized gain from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI)." } } }, "auth_ref": [ "r752" ] }, "us-gaap_EquitySecuritiesFvNiRealizedLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquitySecuritiesFvNiRealizedLoss", "crdr": "debit", "presentation": [ "http://oxbridgere.com/role/ScheduleOfGrossRealizedGainsAndLossesFromSaleOfEquitySecuritiesDetails" ], "lang": { "en-us": { "role": { "label": "Equity Securities, FV-NI, Realized Loss", "documentation": "Amount of realized loss from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI)." } } }, "auth_ref": [ "r752" ] }, "us-gaap_EquitySecuritiesInvestmentSummaryMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquitySecuritiesInvestmentSummaryMember", "presentation": [ "http://oxbridgere.com/role/ScheduleI-SummaryOfInvestments-OtherThanInvestmentsInRelatedPartiesDetails" ], "lang": { "en-us": { "role": { "label": "Equity Securities, Investment Summary [Member]", "documentation": "This element provides types of investments that may be contained within the equity securities category. Examples of items within this category may include common stocks and nonredeemable preferred stocks which may, at a minimum, be further categorized by investments in companies within the following industries: (1) public utilities; (2) banks, trust and insurance companies; (3) industrial, miscellaneous and all other." } } }, "auth_ref": [] }, "ecd_EquityValuationAssumptionDifferenceFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "EquityValuationAssumptionDifferenceFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Equity Valuation Assumption Difference, Footnote [Text Block]" } } }, "auth_ref": [ "r688" ] }, "ecd_ErrCompAnalysisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompAnalysisTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Erroneous Compensation Analysis [Text Block]" } } }, "auth_ref": [ "r651", "r663", "r673", "r699" ] }, "ecd_ErrCompRecoveryTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompRecoveryTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Erroneously Awarded Compensation Recovery [Table]" } } }, "auth_ref": [ "r648", "r660", "r670", "r696" ] }, "ecd_ExecutiveCategoryAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ExecutiveCategoryAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Executive Category [Axis]" } } }, "auth_ref": [ "r694" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://oxbridgere.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock", "presentation": [ "http://oxbridgere.com/role/InvestmentsTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF FAIR VALUE OF ASSETS MEASURED ON RECURRING BASIS", "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)." } } }, "auth_ref": [ "r59", "r108" ] }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByFairValueHierarchyLevelAxis", "presentation": [ "http://oxbridgere.com/role/ScheduleOfFairValueOfAssetsMeasuredOnRecurringBasisDetails", "http://oxbridgere.com/role/ScheduleOfReconciliationOfChangesInFairValueDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value Hierarchy and NAV [Axis]", "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient." } } }, "auth_ref": [ "r257", "r266", "r267", "r268", "r269", "r270", "r271", "r347", "r381", "r382", "r383", "r606", "r607", "r610", "r611", "r612" ] }, "us-gaap_FairValueDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueDisclosuresAbstract", "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "auth_ref": [] }, "us-gaap_FairValueDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueDisclosuresTextBlock", "presentation": [ "http://oxbridgere.com/role/FairValueAndCertainRisksAndUncertainties" ], "lang": { "en-us": { "role": { "label": "FAIR VALUE AND CERTAIN RISKS AND UNCERTAINTIES", "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information." } } }, "auth_ref": [ "r346" ] }, "us-gaap_FairValueInputsLevel1Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel1Member", "presentation": [ "http://oxbridgere.com/role/ScheduleOfFairValueOfAssetsMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Inputs, Level 1 [Member]", "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date." } } }, "auth_ref": [ "r257", "r266", "r271", "r347", "r381", "r610", "r611", "r612" ] }, "us-gaap_FairValueInputsLevel2Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel2Member", "presentation": [ "http://oxbridgere.com/role/ScheduleOfFairValueOfAssetsMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Inputs, Level 2 [Member]", "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets." } } }, "auth_ref": [ "r257", "r266", "r271", "r347", "r382", "r606", "r607", "r610", "r611", "r612" ] }, "us-gaap_FairValueInputsLevel3Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel3Member", "presentation": [ "http://oxbridgere.com/role/ScheduleOfFairValueOfAssetsMeasuredOnRecurringBasisDetails", "http://oxbridgere.com/role/ScheduleOfReconciliationOfChangesInFairValueDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Inputs, Level 3 [Member]", "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r257", "r266", "r267", "r268", "r269", "r270", "r271", "r347", "r383", "r606", "r607", "r610", "r611", "r612" ] }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "presentation": [ "http://oxbridgere.com/role/InvestmentsTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF RECONCILIATION OF CHANGES IN FAIR VALUE", "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability." } } }, "auth_ref": [ "r10", "r60" ] }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementPolicyPolicyTextBlock", "presentation": [ "http://oxbridgere.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Fair value measurement", "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities." } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementsFairValueHierarchyDomain", "presentation": [ "http://oxbridgere.com/role/ScheduleOfFairValueOfAssetsMeasuredOnRecurringBasisDetails", "http://oxbridgere.com/role/ScheduleOfReconciliationOfChangesInFairValueDetails" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "auth_ref": [ "r257", "r266", "r267", "r268", "r269", "r270", "r271", "r381", "r382", "r383", "r606", "r607", "r610", "r611", "r612" ] }, "us-gaap_ForeignReinsuranceTransactionsExpenseAdditionsToUnderwritingBalances": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignReinsuranceTransactionsExpenseAdditionsToUnderwritingBalances", "crdr": "debit", "calculation": { "http://oxbridgere.com/role/StatementsOfOperations": { "parentTag": "us-gaap_BenefitsLossesAndExpenses", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://oxbridgere.com/role/RelatedPartyTransactionsDetailsNarrative", "http://oxbridgere.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Policy acquisition costs and underwriting expenses", "verboseLabel": "Underwriting expenses", "documentation": "The amount of expenses on insured risks paid or due and owing to the ceding entity, recorded as additions to net premiums written minus net losses paid minus the sum of loss adjustment expenses and underwriting costs and expenses on insurance ceded to companies outside the United States." } } }, "auth_ref": [ "r70" ] }, "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount" } } }, "auth_ref": [ "r655", "r667", "r677", "r703" ] }, "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Expense of Enforcement, Amount" } } }, "auth_ref": [ "r655", "r667", "r677", "r703" ] }, "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Violation of Home Country Law, Amount" } } }, "auth_ref": [ "r655", "r667", "r677", "r703" ] }, "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery, Explanation of Impracticability [Text Block]" } } }, "auth_ref": [ "r655", "r667", "r677", "r703" ] }, "ecd_ForgoneRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery, Individual Name" } } }, "auth_ref": [ "r655", "r667", "r677", "r703" ] }, "us-gaap_FurnitureAndFixturesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FurnitureAndFixturesMember", "presentation": [ "http://oxbridgere.com/role/ScheduleOfPropertyAndEquipmentnetDetails", "http://oxbridgere.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Furniture and Fixtures [Member]", "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases." } } }, "auth_ref": [] }, "OXBR_GainLossFromEquityMethodInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://oxbridgere.com/20231231", "localname": "GainLossFromEquityMethodInvestments", "crdr": "credit", "presentation": [ "http://oxbridgere.com/role/ScheduleIiCondensedStatementsOfIncomeParentCompanyOnlyDetails" ], "lang": { "en-us": { "role": { "label": "Equity in loss of subsidiaries", "documentation": "Gain loss from equity method investments." } } }, "auth_ref": [] }, "us-gaap_GeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://oxbridgere.com/role/StatementsOfOperations": { "parentTag": "us-gaap_BenefitsLossesAndExpenses", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://oxbridgere.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "General and administrative expenses", "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line." } } }, "auth_ref": [ "r89", "r531" ] }, "us-gaap_GeneralAndAdministrativeExpenseMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GeneralAndAdministrativeExpenseMember", "presentation": [ "http://oxbridgere.com/role/Share-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "General and Administrative Expense [Member]", "documentation": "Primary financial statement caption encompassing general and administrative expense." } } }, "auth_ref": [ "r87" ] }, "dei_IcfrAuditorAttestationFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "IcfrAuditorAttestationFlag", "presentation": [ "http://oxbridgere.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag" } } }, "auth_ref": [ "r644", "r646", "r659" ] }, "us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ImpairmentOfLongLivedAssetsToBeDisposedOf", "crdr": "debit", "presentation": [ "http://oxbridgere.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Impairments in property and equipment", "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale." } } }, "auth_ref": [ "r5", "r101" ] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "crdr": "credit", "calculation": { "http://oxbridgere.com/role/StatementsOfOperations": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 1.0 }, "http://oxbridgere.com/role/ScheduleOfFinancialStatementsDetails": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://oxbridgere.com/role/ScheduleOfFinancialStatementsDetails", "http://oxbridgere.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Loss before income attributable to noteholders and tokenholders", "label": "Income attributable to tokenholders", "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r0", "r84", "r117", "r212", "r223", "r227", "r229", "r400", "r415", "r602" ] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "crdr": "credit", "presentation": [ "http://oxbridgere.com/role/ScheduleIiCondensedStatementsOfIncomeParentCompanyOnlyDetails" ], "lang": { "en-us": { "role": { "label": "Income before equity in loss of subsidiaries", "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments." } } }, "auth_ref": [ "r212", "r223", "r227", "r229", "r424", "r602" ] }, "us-gaap_IncomeLossFromEquityMethodInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromEquityMethodInvestments", "crdr": "credit", "presentation": [ "http://oxbridgere.com/role/ScheduleIiCondensedStatementOfCashFlows-ParentCompanyOnlyDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Equity in loss of subsidiaries", "label": "Income (Loss) from Equity Method Investments", "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss)." } } }, "auth_ref": [ "r5", "r85", "r116", "r215", "r233", "r414" ] }, "us-gaap_IncomeLossFromSubsidiariesNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromSubsidiariesNetOfTax", "crdr": "credit", "presentation": [ "http://oxbridgere.com/role/NetWorthForRegulatoryPurposesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Net income", "documentation": "Amount after tax of income (loss) of subsidiary attributable to the parent entity." } } }, "auth_ref": [] }, "us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "presentation": [ "http://oxbridgere.com/role/VariableInterestEntitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Noncontrolling interest", "documentation": "Amount, before tax, of income (loss) including portion attributable to noncontrolling interest. Includes, but is not limited to, income (loss) from continuing operations, discontinued operations and equity method investments." } } }, "auth_ref": [ "r88", "r738" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeStatementLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementLocationAxis", "presentation": [ "http://oxbridgere.com/role/Share-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Income Statement Location [Axis]", "documentation": "Information by location in the income statement." } } }, "auth_ref": [ "r240", "r241", "r536" ] }, "us-gaap_IncomeStatementLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementLocationDomain", "presentation": [ "http://oxbridgere.com/role/Share-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Location in the income statement." } } }, "auth_ref": [ "r241", "r536" ] }, "us-gaap_IncomeTaxDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureTextBlock", "presentation": [ "http://oxbridgere.com/role/Taxation" ], "lang": { "en-us": { "role": { "label": "TAXATION", "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information." } } }, "auth_ref": [ "r176", "r321", "r322", "r323", "r324", "r327", "r328", "r329", "r330", "r471" ] }, "us-gaap_IncomeTaxUncertaintiesPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxUncertaintiesPolicy", "presentation": [ "http://oxbridgere.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Uncertain income tax positions", "documentation": "Disclosure of accounting policy for tax positions taken in the tax return filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other types of contingencies related to income taxes." } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsPayable", "crdr": "debit", "calculation": { "http://oxbridgere.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 14.0 } }, "presentation": [ "http://oxbridgere.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Losses payable", "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business." } } }, "auth_ref": [ "r4" ] }, "us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities", "crdr": "debit", "calculation": { "http://oxbridgere.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 16.0 } }, "presentation": [ "http://oxbridgere.com/role/ScheduleIiCondensedStatementOfCashFlows-ParentCompanyOnlyDetails", "http://oxbridgere.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Accounts payable and other liabilities", "label": "Increase (Decrease) in Accounts Payable and Other Operating Liabilities", "documentation": "Amount of increase (decrease) in obligations incurred but not paid, and operating obligations classified as other." } } }, "auth_ref": [ "r741" ] }, "us-gaap_IncreaseDecreaseInDeferredPolicyAcquisitionCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInDeferredPolicyAcquisitionCosts", "crdr": "credit", "calculation": { "http://oxbridgere.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 10.0 } }, "presentation": [ "http://oxbridgere.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Deferred policy acquisition costs", "label": "Increase (Decrease) in Deferred Policy Acquisition Costs", "documentation": "The increase (decrease) during the reporting period in the balance sheet value of capitalized sales costs that are associated with acquiring a new insurance customers." } } }, "auth_ref": [ "r4" ] }, "us-gaap_IncreaseDecreaseInDueFromAffiliatesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInDueFromAffiliatesCurrent", "crdr": "credit", "presentation": [ "http://oxbridgere.com/role/ScheduleIiCondensedStatementOfCashFlows-ParentCompanyOnlyDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Due from subsidiary", "label": "Increase (Decrease) in Due from Affiliates, Current", "documentation": "The increase (decrease) during the reporting period in current receivables (due within one year or one operating cycle) to be collected from an entity that is controlling, under the control of, or within the same control group as the reporting entity by means of direct or indirect ownership." } } }, "auth_ref": [ "r4" ] }, "us-gaap_IncreaseDecreaseInDueFromRelatedParties": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInDueFromRelatedParties", "crdr": "credit", "calculation": { "http://oxbridgere.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 9.0 } }, "presentation": [ "http://oxbridgere.com/role/ScheduleIiCondensedStatementOfCashFlows-ParentCompanyOnlyDetails", "http://oxbridgere.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Due from related parties", "negatedTerseLabel": "Due from related party", "label": "Increase (Decrease) in Due from Related Parties", "documentation": "The increase (decrease) during the reporting period in receivables to be collected from other entities that could exert significant influence over the reporting entity." } } }, "auth_ref": [ "r4" ] }, "us-gaap_IncreaseDecreaseInDueToEmployeesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInDueToEmployeesCurrent", "crdr": "debit", "presentation": [ "http://oxbridgere.com/role/ScheduleIiCondensedStatementOfCashFlows-ParentCompanyOnlyDetails" ], "lang": { "en-us": { "role": { "label": "Due to subsidiary", "documentation": "The increase (decrease) during the reporting period in obligations due within one year (or one business cycle) to employees other than officers." } } }, "auth_ref": [ "r4" ] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://oxbridgere.com/role/ScheduleIiCondensedStatementOfCashFlows-ParentCompanyOnlyDetails", "http://oxbridgere.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Change in operating assets and liabilities:" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOtherOperatingLiabilities", "crdr": "debit", "calculation": { "http://oxbridgere.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 13.0 } }, "presentation": [ "http://oxbridgere.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Other Liablities Delta Cat Re Tokenholders", "documentation": "Amount of increase (decrease) in operating liabilities classified as other." } } }, "auth_ref": [ "r4" ] }, "us-gaap_IncreaseDecreaseInPremiumsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInPremiumsReceivable", "crdr": "credit", "calculation": { "http://oxbridgere.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 8.0 } }, "presentation": [ "http://oxbridgere.com/role/RelatedPartyTransactionsDetailsNarrative", "http://oxbridgere.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Premiums receivable", "label": "Change in unearned premium reserve", "documentation": "The change in the premium receivable balance on the balance sheet." } } }, "auth_ref": [ "r4" ] }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "crdr": "credit", "calculation": { "http://oxbridgere.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 11.0 } }, "presentation": [ "http://oxbridgere.com/role/ScheduleIiCondensedStatementOfCashFlows-ParentCompanyOnlyDetails", "http://oxbridgere.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Prepayment and other assets", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other." } } }, "auth_ref": [ "r4" ] }, "OXBR_IncreaseDecreaseInPrepaidOfferingCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://oxbridgere.com/20231231", "localname": "IncreaseDecreaseInPrepaidOfferingCosts", "crdr": "credit", "calculation": { "http://oxbridgere.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 12.0 } }, "presentation": [ "http://oxbridgere.com/role/ScheduleIiCondensedStatementOfCashFlows-ParentCompanyOnlyDetails", "http://oxbridgere.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Prepaid offering costs", "documentation": "Increase decrease in prepaid offering costs.", "label": "IncreaseDecreaseInPrepaidOfferingCosts" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInUnearnedPremiums": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInUnearnedPremiums", "crdr": "debit", "calculation": { "http://oxbridgere.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 15.0 } }, "presentation": [ "http://oxbridgere.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Unearned premiums reserve", "label": "Increase (Decrease) in Unearned Premiums", "documentation": "Amount of increase (decrease) unearned premiums written. Excludes portion of unearned premiums amortized into income." } } }, "auth_ref": [ "r4" ] }, "us-gaap_IncreaseDecreaseInUnearnedPremiumsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInUnearnedPremiumsNet", "crdr": "credit", "calculation": { "http://oxbridgere.com/role/StatementsOfOperations": { "parentTag": "us-gaap_PremiumsEarnedNet", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://oxbridgere.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Change in unearned premiums reserve", "documentation": "Amount, after premiums ceded to other entities and premiums assumed by the entity, of decrease (increase) in unearned premiums." } } }, "auth_ref": [] }, "us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncrementalCommonSharesAttributableToCallOptionsAndWarrants", "presentation": [ "http://oxbridgere.com/role/ScheduleOfComputationOfBasicAndDilutedLossEarningPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Effect of dilutive securities - Stock options", "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of call options and warrants using the treasury stock method." } } }, "auth_ref": [ "r197", "r198", "r199", "r204" ] }, "ecd_IndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "IndividualAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Individual [Axis]" } } }, "auth_ref": [ "r658", "r667", "r677", "r694", "r703", "r707", "r715" ] }, "ecd_InsiderTradingArrLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingArrLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Arrangements [Line Items]" } } }, "auth_ref": [ "r713" ] }, "ecd_InsiderTradingPoliciesProcLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingPoliciesProcLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures [Line Items]" } } }, "auth_ref": [ "r647", "r719" ] }, "ecd_InsiderTrdPoliciesProcAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Adopted [Flag]" } } }, "auth_ref": [ "r647", "r719" ] }, "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]" } } }, "auth_ref": [ "r647", "r719" ] }, "us-gaap_InsuranceAgencyManagementFee": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InsuranceAgencyManagementFee", "crdr": "credit", "calculation": { "http://oxbridgere.com/role/StatementsOfOperations": { "parentTag": "us-gaap_Revenues", "weight": 1.0, "order": 2.0 }, "http://oxbridgere.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://oxbridgere.com/role/StatementsOfCashFlows", "http://oxbridgere.com/role/StatementsOfOperations", "http://oxbridgere.com/role/VariableInterestEntitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "SurancePlus fee income", "negatedLabel": "SurancePlus fee income", "verboseLabel": "Management fee", "documentation": "Fees earned during the period for providing management services." } } }, "auth_ref": [] }, "OXBR_InvestmentInAffiliate": { "xbrltype": "monetaryItemType", "nsuri": "http://oxbridgere.com/20231231", "localname": "InvestmentInAffiliate", "crdr": "debit", "presentation": [ "http://oxbridgere.com/role/ScheduleOfOtherInvestmentDetails", "http://oxbridgere.com/role/ScheduleOfReconciliationOfChangesInFairValueDetails" ], "lang": { "en-us": { "role": { "label": "Investment in affiliate", "documentation": "Investment in affiliate." } } }, "auth_ref": [] }, "OXBR_InvestmentInSubsidiary": { "xbrltype": "monetaryItemType", "nsuri": "http://oxbridgere.com/20231231", "localname": "InvestmentInSubsidiary", "crdr": "credit", "presentation": [ "http://oxbridgere.com/role/ScheduleIiCondensedStatementOfCashFlows-ParentCompanyOnlyDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Investment in subsidiary", "documentation": "Investment in subsidiary.", "label": "InvestmentInSubsidiary" } } }, "auth_ref": [] }, "us-gaap_InvestmentIncomeNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentIncomeNet", "crdr": "credit", "presentation": [ "http://oxbridgere.com/role/ScheduleIiCondensedStatementsOfIncomeParentCompanyOnlyDetails" ], "lang": { "en-us": { "role": { "label": "Net investment income", "documentation": "Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities." } } }, "auth_ref": [ "r90", "r91" ] }, "us-gaap_InvestmentOwnedAtFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentOwnedAtFairValue", "crdr": "debit", "presentation": [ "http://oxbridgere.com/role/ScheduleOfReconciliationOfChangesInFairValueDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Fair value of Level 3 other investment, Beginning balance", "periodEndLabel": "Fair value of Level 3 other investment, Ending balance", "label": "Investment Owned, Fair Value", "documentation": "Fair value of investment in security owned." } } }, "auth_ref": [ "r462", "r487", "r488", "r489", "r491", "r492", "r493", "r494", "r495", "r498", "r500", "r510", "r511", "r558", "r560", "r561", "r562", "r569", "r570", "r571", "r572", "r573", "r576", "r577", "r579", "r580", "r581", "r625", "r632", "r822" ] }, "us-gaap_InvestmentPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentPolicyTextBlock", "presentation": [ "http://oxbridgere.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Investments", "documentation": "Disclosure of accounting policy for investment in financial asset." } } }, "auth_ref": [ "r422", "r462", "r463", "r464", "r465", "r563", "r564" ] }, "us-gaap_InvestmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentTextBlock", "presentation": [ "http://oxbridgere.com/role/Investments" ], "lang": { "en-us": { "role": { "label": "INVESTMENTS", "documentation": "The entire disclosure for investment." } } }, "auth_ref": [ "r728", "r729", "r750" ] }, "us-gaap_InvestmentTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentTypeAxis", "presentation": [ "http://oxbridgere.com/role/ScheduleI-SummaryOfInvestments-OtherThanInvestmentsInRelatedPartiesDetails" ], "lang": { "en-us": { "role": { "label": "Investment Type [Axis]", "documentation": "Information by type of investments." } } }, "auth_ref": [ "r488", "r490", "r491", "r493", "r495", "r558", "r560", "r566", "r570", "r571", "r574", "r575", "r580", "r582", "r583", "r584", "r585", "r625" ] }, "us-gaap_InvestmentTypeCategorizationMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentTypeCategorizationMember", "presentation": [ "http://oxbridgere.com/role/ScheduleI-SummaryOfInvestments-OtherThanInvestmentsInRelatedPartiesDetails" ], "lang": { "en-us": { "role": { "documentation": "Asset obtained to generate income or appreciate in value." } } }, "auth_ref": [ "r488", "r490", "r491", "r493", "r495", "r558", "r560", "r566", "r570", "r571", "r574", "r575", "r580", "r582", "r583", "r584", "r585", "r625" ] }, "us-gaap_InvestmentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentsAbstract", "presentation": [ "http://oxbridgere.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Investments:" } } }, "auth_ref": [] }, "us-gaap_InvestmentsAllOtherInvestmentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentsAllOtherInvestmentsAbstract", "lang": { "en-us": { "role": { "label": "Investments, All Other Investments [Abstract]" } } }, "auth_ref": [] }, "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures", "crdr": "debit", "presentation": [ "http://oxbridgere.com/role/ScheduleIiCondensedBalanceSheetParentCompanyOnlyDetails" ], "lang": { "en-us": { "role": { "label": "Investment in subsidiaries", "documentation": "Amount of investment in equity method investee and investment in and advance to affiliate." } } }, "auth_ref": [ "r736" ] }, "us-gaap_InvestorMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestorMember", "presentation": [ "http://oxbridgere.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Investor [Member]", "documentation": "Business entity or individual that puts money, by purchase or expenditure, in something offering potential profitable returns, such as interest income or appreciation in value." } } }, "auth_ref": [ "r798", "r799" ] }, "OXBR_InvestorsAndNonUSPersonsMember": { "xbrltype": "domainItemType", "nsuri": "http://oxbridgere.com/20231231", "localname": "InvestorsAndNonUSPersonsMember", "presentation": [ "http://oxbridgere.com/role/VariableInterestEntitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Investors and non US persons [Member]", "documentation": "Investors and non US persons [Member]" } } }, "auth_ref": [] }, "OXBR_JetA1ClassBOrdinarySharesMember": { "xbrltype": "domainItemType", "nsuri": "http://oxbridgere.com/20231231", "localname": "JetA1ClassBOrdinarySharesMember", "presentation": [ "http://oxbridgere.com/role/ScheduleOfOtherInvestmentDetails" ], "lang": { "en-us": { "role": { "label": "Jet A1 Class B Ordinary Shares [Member]", "documentation": "Jet A1 Class B Ordinary Shares [Member]" } } }, "auth_ref": [] }, "OXBR_JetA1PromissoryNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://oxbridgere.com/20231231", "localname": "JetA1PromissoryNoteMember", "presentation": [ "http://oxbridgere.com/role/ScheduleOfOtherInvestmentDetails" ], "lang": { "en-us": { "role": { "label": "Jet A1 Promissory Note [Member]", "documentation": "Jet A1 Promissory Note [Member]" } } }, "auth_ref": [] }, "OXBR_JetA1SeriesA1ConvertiblePreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://oxbridgere.com/20231231", "localname": "JetA1SeriesA1ConvertiblePreferredStockMember", "presentation": [ "http://oxbridgere.com/role/ScheduleOfOtherInvestmentDetails" ], "lang": { "en-us": { "role": { "label": "Jet A 1 Series A 1 Convertible Preferred Stock [Member]" } } }, "auth_ref": [] }, "us-gaap_LeaseContractualTermAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeaseContractualTermAxis", "presentation": [ "http://oxbridgere.com/role/LeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Lease Contractual Term [Axis]", "documentation": "Information by contractual term of lease arrangement." } } }, "auth_ref": [ "r726" ] }, "us-gaap_LeaseContractualTermDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeaseContractualTermDomain", "presentation": [ "http://oxbridgere.com/role/LeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Contractual term of lease arrangement." } } }, "auth_ref": [ "r726" ] }, "us-gaap_LeaseCostTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeaseCostTableTextBlock", "presentation": [ "http://oxbridgere.com/role/LeasesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF OPERATING LEASE COST", "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income." } } }, "auth_ref": [ "r796" ] }, "us-gaap_LeaseholdImprovementsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeaseholdImprovementsMember", "presentation": [ "http://oxbridgere.com/role/ScheduleOfPropertyAndEquipmentnetDetails" ], "lang": { "en-us": { "role": { "label": "Leasehold Improvements [Member]", "documentation": "Additions or improvements to assets held under a lease arrangement." } } }, "auth_ref": [ "r102" ] }, "us-gaap_LeasesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeasesAbstract", "lang": { "en-us": { "role": { "label": "Leases [Abstract]" } } }, "auth_ref": [] }, "dei_LegalEntityAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LegalEntityAxis", "presentation": [ "http://oxbridgere.com/role/NetWorthForRegulatoryPurposesDetailsNarrative", "http://oxbridgere.com/role/ScheduleOfFinancialStatementsDetails", "http://oxbridgere.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://oxbridgere.com/role/VariableInterestEntitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Legal Entity [Axis]", "documentation": "The set of legal entities associated with a report." } } }, "auth_ref": [] }, "us-gaap_LesseeLeaseDescriptionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeLeaseDescriptionLineItems", "presentation": [ "http://oxbridgere.com/role/LeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Lessee, Lease, Description [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r362" ] }, "us-gaap_LesseeLeaseDescriptionTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeLeaseDescriptionTable", "presentation": [ "http://oxbridgere.com/role/LeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Lessee, Lease, Description [Table]", "documentation": "Disclosure of information about lessee's leases." } } }, "auth_ref": [ "r362" ] }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "presentation": [ "http://oxbridgere.com/role/LeasesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS", "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position." } } }, "auth_ref": [ "r797" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "crdr": "credit", "calculation": { "http://oxbridgere.com/role/ScheduleOfFutureMinimumLeasePaymentsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://oxbridgere.com/role/ScheduleOfFutureMinimumLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total future minimum lease payments", "label": "Lessee, Operating Lease, Liability, to be Paid", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease." } } }, "auth_ref": [ "r367" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "crdr": "credit", "calculation": { "http://oxbridgere.com/role/ScheduleOfFutureMinimumLeasePaymentsDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://oxbridgere.com/role/ScheduleOfFutureMinimumLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "label": "2024", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r367" ] }, "OXBR_LesseeOperatingLeaseLiabilityPaymentsDuePrevioulyReported": { "xbrltype": "monetaryItemType", "nsuri": "http://oxbridgere.com/20231231", "localname": "LesseeOperatingLeaseLiabilityPaymentsDuePrevioulyReported", "crdr": "credit", "calculation": { "http://oxbridgere.com/role/ScheduleOfFutureMinimumLeasePaymentsDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://oxbridgere.com/role/ScheduleOfFutureMinimumLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "label": "2023", "documentation": "Lessee operating lease liability payments due previouly reported." } } }, "auth_ref": [] }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "crdr": "credit", "presentation": [ "http://oxbridgere.com/role/ScheduleOfFutureMinimumLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Less imputed interest", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease." } } }, "auth_ref": [ "r367" ] }, "us-gaap_LesseeOperatingLeaseRemainingLeaseTerm": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseRemainingLeaseTerm", "presentation": [ "http://oxbridgere.com/role/LeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Remaining lease term", "documentation": "Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r794" ] }, "us-gaap_LesseeOperatingLeaseRenewalTerm": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseRenewalTerm", "presentation": [ "http://oxbridgere.com/role/LeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Renewal term", "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r795" ] }, "us-gaap_LesseeOperatingLeasesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeasesTextBlock", "presentation": [ "http://oxbridgere.com/role/Leases" ], "lang": { "en-us": { "role": { "label": "LEASES", "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability." } } }, "auth_ref": [ "r358" ] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://oxbridgere.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://oxbridgere.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities", "label": "Liabilities", "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future." } } }, "auth_ref": [ "r25", "r175", "r237", "r246", "r247", "r248", "r249", "r250", "r251", "r252", "r253", "r254", "r334", "r335", "r336", "r349", "r506", "r601", "r632", "r758", "r802", "r803" ] }, "us-gaap_LiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAbstract", "presentation": [ "http://oxbridgere.com/role/BalanceSheets", "http://oxbridgere.com/role/ScheduleIiCondensedBalanceSheetParentCompanyOnlyDetails" ], "lang": { "en-us": { "role": { "label": "Liabilities:" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://oxbridgere.com/role/BalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://oxbridgere.com/role/BalanceSheets", "http://oxbridgere.com/role/ScheduleIiCondensedBalanceSheetParentCompanyOnlyDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities and shareholders\u2019 equity", "label": "Total liabilities and shareholders\u2019 equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r83", "r113", "r409", "r618", "r743", "r753", "r793" ] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://oxbridgere.com/role/BalanceSheets", "http://oxbridgere.com/role/ScheduleIiCondensedBalanceSheetParentCompanyOnlyDetails" ], "lang": { "en-us": { "role": { "label": "Liabilities and Shareholders\u2019 Equity" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesNoncurrent", "crdr": "credit", "presentation": [ "http://oxbridgere.com/role/ScheduleIiCondensedBalanceSheetParentCompanyOnlyDetails" ], "lang": { "en-us": { "role": { "label": "Total liabilities", "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer." } } }, "auth_ref": [ "r24", "r72", "r73", "r74", "r76", "r175", "r237", "r246", "r247", "r248", "r249", "r250", "r251", "r252", "r253", "r254", "r334", "r335", "r336", "r349", "r758", "r802", "r803" ] }, "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilityForClaimsAndClaimsAdjustmentExpense", "crdr": "credit", "calculation": { "http://oxbridgere.com/role/BalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://oxbridgere.com/role/BalanceSheets", "http://oxbridgere.com/role/ScheduleOfLossAdjustmentExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Reserve for losses and loss adjustment expenses", "periodStartLabel": "Gross balance, beginning of year", "periodEndLabel": "Balance, end of year", "documentation": "The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date." } } }, "auth_ref": [ "r68", "r122" ] }, "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1", "crdr": "credit", "calculation": { "http://oxbridgere.com/role/ScheduleOfLossAdjustmentExpenseDetails": { "parentTag": "us-gaap_PaymentsForLossesAndLossAdjustmentExpense", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://oxbridgere.com/role/ScheduleOfLossAdjustmentExpenseDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Current year", "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year", "documentation": "Amount, after effects of reinsurance, of payments to settle claims incurred in the current period and related claims settlement costs." } } }, "auth_ref": [ "r14" ] }, "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1", "crdr": "credit", "calculation": { "http://oxbridgere.com/role/ScheduleOfLossAdjustmentExpenseDetails": { "parentTag": "us-gaap_PaymentsForLossesAndLossAdjustmentExpense", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://oxbridgere.com/role/ScheduleOfLossAdjustmentExpenseDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Prior year", "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years", "documentation": "Amount, after effects of reinsurance, of payments to settle claims incurred in prior periods and related claims settlement costs." } } }, "auth_ref": [ "r14" ] }, "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1", "crdr": "debit", "calculation": { "http://oxbridgere.com/role/ScheduleOfLossAdjustmentExpenseDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://oxbridgere.com/role/ScheduleOfLossAdjustmentExpenseDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total incurred", "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims", "documentation": "Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred and costs incurred in the claim settlement process." } } }, "auth_ref": [ "r121" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://oxbridgere.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "us-gaap_LongtermDebtTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongtermDebtTypeAxis", "presentation": [ "http://oxbridgere.com/role/VariableInterestEntitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Long-Term Debt, Type [Axis]", "documentation": "Information by type of long-term debt." } } }, "auth_ref": [ "r28" ] }, "us-gaap_LongtermDebtTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongtermDebtTypeDomain", "presentation": [ "http://oxbridgere.com/role/VariableInterestEntitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "auth_ref": [ "r28", "r44" ] }, "us-gaap_ManagementFeeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ManagementFeeExpense", "crdr": "debit", "presentation": [ "http://oxbridgere.com/role/ScheduleIiCondensedStatementsOfIncomeParentCompanyOnlyDetails" ], "lang": { "en-us": { "role": { "label": "Management fees and other income", "documentation": "Amount of expense for investment management fee, including, but not limited to, expense in connection with research, selection, supervision, and custody of investment." } } }, "auth_ref": [ "r63", "r531", "r631", "r825" ] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MaximumMember", "presentation": [ "http://oxbridgere.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]", "documentation": "Upper limit of the provided range." } } }, "auth_ref": [ "r242", "r243", "r244", "r245", "r273", "r385", "r447", "r496", "r497", "r559", "r565", "r567", "r568", "r578", "r593", "r594", "r604", "r608", "r615", "r620", "r762", "r804", "r805", "r806", "r807", "r808", "r809" ] }, "ecd_MeasureAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Measure [Axis]" } } }, "auth_ref": [ "r686" ] }, "ecd_MeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Measure Name" } } }, "auth_ref": [ "r686" ] }, "ecd_MnpiDiscTimedForCompValFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MnpiDiscTimedForCompValFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "MNPI Disclosure Timed for Compensation Value [Flag]" } } }, "auth_ref": [ "r706" ] }, "OXBR_MotorVehiclesMember": { "xbrltype": "domainItemType", "nsuri": "http://oxbridgere.com/20231231", "localname": "MotorVehiclesMember", "presentation": [ "http://oxbridgere.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Motor Vehicles [Member]", "documentation": "Motor Vehicles [Member]" } } }, "auth_ref": [] }, "OXBR_MrJayMadhuMember": { "xbrltype": "domainItemType", "nsuri": "http://oxbridgere.com/20231231", "localname": "MrJayMadhuMember", "presentation": [ "http://oxbridgere.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Mr Jay Madhu [Member]", "documentation": "Mr Jay Madhu [Member]" } } }, "auth_ref": [] }, "ecd_MtrlTermsOfTrdArrTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MtrlTermsOfTrdArrTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Material Terms of Trading Arrangement" } } }, "auth_ref": [ "r714" ] }, "ecd_NamedExecutiveOfficersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NamedExecutiveOfficersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Named Executive Officers, Footnote [Text Block]" } } }, "auth_ref": [ "r687" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://oxbridgere.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://oxbridgere.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by financing activities", "label": "Net Cash Provided by (Used in) Financing Activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r172" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://oxbridgere.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Financing activities" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://oxbridgere.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://oxbridgere.com/role/ScheduleIiCondensedStatementOfCashFlows-ParentCompanyOnlyDetails", "http://oxbridgere.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in investing activities", "label": "Net cash used in investing activities", "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r172" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://oxbridgere.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Investing activities" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract", "presentation": [ "http://oxbridgere.com/role/ScheduleIiCondensedStatementOfCashFlows-ParentCompanyOnlyDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Investing activities" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://oxbridgere.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://oxbridgere.com/role/ScheduleIiCondensedStatementOfCashFlows-ParentCompanyOnlyDetails", "http://oxbridgere.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in operating activities", "label": "Net cash provided by (used in) operating activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r94", "r95", "r96" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://oxbridgere.com/role/ScheduleIiCondensedStatementOfCashFlows-ParentCompanyOnlyDetails", "http://oxbridgere.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Operating activities" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://oxbridgere.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 1.0 }, "http://oxbridgere.com/role/StatementsOfOperations": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://oxbridgere.com/role/ScheduleOfFinancialStatementsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://oxbridgere.com/role/ScheduleIiCondensedStatementOfCashFlows-ParentCompanyOnlyDetails", "http://oxbridgere.com/role/ScheduleIiCondensedStatementsOfIncomeParentCompanyOnlyDetails", "http://oxbridgere.com/role/ScheduleOfComputationOfBasicAndDilutedLossEarningPerShareDetails", "http://oxbridgere.com/role/ScheduleOfFinancialStatementsDetails", "http://oxbridgere.com/role/StatementsOfCashFlows", "http://oxbridgere.com/role/StatementsOfChangesInShareholdersEquity", "http://oxbridgere.com/role/StatementsOfOperations", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "totalLabel": "Net loss", "label": "Net loss", "verboseLabel": "Net loss for the year", "terseLabel": "Net Income (Loss) Attributable to Parent", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r86", "r96", "r118", "r154", "r164", "r165", "r168", "r175", "r183", "r185", "r186", "r187", "r188", "r191", "r192", "r201", "r212", "r223", "r227", "r229", "r237", "r246", "r247", "r248", "r249", "r250", "r251", "r252", "r253", "r254", "r345", "r349", "r417", "r528", "r550", "r551", "r602", "r631", "r758" ] }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "crdr": "debit", "calculation": { "http://oxbridgere.com/role/StatementsOfOperations": { "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://oxbridgere.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "negatedLabel": "Income attributable to noteholders and tokenholders", "label": "Net Income (Loss) Attributable to Noncontrolling Interest", "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r58", "r107", "r164", "r165", "r191", "r192", "r416", "r738" ] }, "us-gaap_NetInvestmentIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetInvestmentIncome", "crdr": "credit", "calculation": { "http://oxbridgere.com/role/StatementsOfOperations": { "parentTag": "us-gaap_Revenues", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://oxbridgere.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Net investment and other income", "documentation": "Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments." } } }, "auth_ref": [ "r127", "r418", "r419", "r537", "r631" ] }, "OXBR_NetWorthForRegulatoryPurposesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://oxbridgere.com/20231231", "localname": "NetWorthForRegulatoryPurposesTextBlock", "presentation": [ "http://oxbridgere.com/role/NetWorthForRegulatoryPurposes" ], "lang": { "en-us": { "role": { "label": "NET WORTH FOR REGULATORY PURPOSES", "documentation": "Net Worth For Regulatory Purposes [Text Block]" } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://oxbridgere.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "ecd_NonGaapMeasureDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonGaapMeasureDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-GAAP Measure Description [Text Block]" } } }, "auth_ref": [ "r686" ] }, "ecd_NonPeoNeoAvgCompActuallyPaidAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgCompActuallyPaidAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Compensation Actually Paid Amount" } } }, "auth_ref": [ "r684" ] }, "ecd_NonPeoNeoAvgTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Total Compensation Amount" } } }, "auth_ref": [ "r683" ] }, "ecd_NonRule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Adopted" } } }, "auth_ref": [ "r714" ] }, "ecd_NonRule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Terminated" } } }, "auth_ref": [ "r714" ] }, "us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NonvestedRestrictedStockSharesActivityTableTextBlock", "presentation": [ "http://oxbridgere.com/role/Share-basedCompensationTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF ACTIVITY OF UNVESTED RESTRICTED STOCK AWARDS", "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock shares." } } }, "auth_ref": [ "r23" ] }, "us-gaap_NotesIssued1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NotesIssued1", "crdr": "credit", "presentation": [ "http://oxbridgere.com/role/VariableInterestEntitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Notes issued", "documentation": "The fair value of notes issued in noncash investing and financing activities." } } }, "auth_ref": [ "r34", "r35", "r36" ] }, "us-gaap_NotesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NotesPayable", "crdr": "credit", "calculation": { "http://oxbridgere.com/role/BalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://oxbridgere.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Notes payable to noteholders", "documentation": "Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer." } } }, "auth_ref": [ "r24", "r112", "r810" ] }, "OXBR_NotesPayableToSeries20201NoteholdersMember": { "xbrltype": "domainItemType", "nsuri": "http://oxbridgere.com/20231231", "localname": "NotesPayableToSeries20201NoteholdersMember", "presentation": [ "http://oxbridgere.com/role/VariableInterestEntitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Notes Payable to Series 2020 -1 Noteholders [Member]", "documentation": "Notes Payable to Series 2020 -1 Noteholders [Member]" } } }, "auth_ref": [] }, "OXBR_OfferingExpensesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://oxbridgere.com/20231231", "localname": "OfferingExpensesPolicyTextBlock", "presentation": [ "http://oxbridgere.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Offering Expenses", "documentation": "Offering Expenses [Policy Text Block]" } } }, "auth_ref": [] }, "OXBR_OfficeLeaseMember": { "xbrltype": "domainItemType", "nsuri": "http://oxbridgere.com/20231231", "localname": "OfficeLeaseMember", "presentation": [ "http://oxbridgere.com/role/LeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Office Lease [Member]", "documentation": "Office Lease [Member]" } } }, "auth_ref": [] }, "us-gaap_OperatingExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingExpenses", "crdr": "debit", "calculation": { "http://oxbridgere.com/role/ScheduleOfFinancialStatementsDetails": { "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://oxbridgere.com/role/ScheduleIiCondensedStatementsOfIncomeParentCompanyOnlyDetails", "http://oxbridgere.com/role/ScheduleOfFinancialStatementsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Expenses", "label": "Operating expenses", "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense." } } }, "auth_ref": [] }, "us-gaap_OperatingExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingExpensesAbstract", "presentation": [ "http://oxbridgere.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Expenses" } } }, "auth_ref": [] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingIncomeLoss", "crdr": "credit", "presentation": [ "http://oxbridgere.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Offering expenses", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r212", "r223", "r227", "r229", "r602" ] }, "us-gaap_OperatingLeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseCost", "crdr": "debit", "presentation": [ "http://oxbridgere.com/role/ScheduleOfOperatingLeaseCostDetails" ], "lang": { "en-us": { "role": { "label": "Operating Lease Cost", "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability." } } }, "auth_ref": [ "r363", "r617" ] }, "us-gaap_OperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiability", "crdr": "credit", "calculation": { "http://oxbridgere.com/role/BalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://oxbridgere.com/role/BalanceSheets", "http://oxbridgere.com/role/ScheduleIiCondensedBalanceSheetParentCompanyOnlyDetails", "http://oxbridgere.com/role/ScheduleOfFutureMinimumLeasePaymentsDetails", "http://oxbridgere.com/role/ScheduleOfOperatingLeaseObligationsDetails" ], "lang": { "en-us": { "role": { "label": "Operating lease liabilities", "verboseLabel": "Total operating lease liabilities", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease." } } }, "auth_ref": [ "r360" ] }, "us-gaap_OperatingLeasePayments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeasePayments", "crdr": "credit", "presentation": [ "http://oxbridgere.com/role/ScheduleOfOperatingLeaseCostDetails" ], "lang": { "en-us": { "role": { "label": "Operating cash flows from operating leases", "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use." } } }, "auth_ref": [ "r361", "r364" ] }, "us-gaap_OperatingLeaseRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseRightOfUseAsset", "crdr": "debit", "calculation": { "http://oxbridgere.com/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://oxbridgere.com/role/BalanceSheets", "http://oxbridgere.com/role/ScheduleIiCondensedBalanceSheetParentCompanyOnlyDetails", "http://oxbridgere.com/role/ScheduleOfOperatingLeaseObligationsDetails" ], "lang": { "en-us": { "role": { "label": "Operating lease right-of-use assets", "documentation": "Amount of lessee's right to use underlying asset under operating lease." } } }, "auth_ref": [ "r359" ] }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "presentation": [ "http://oxbridgere.com/role/ScheduleOfOperatingLeaseObligationsDetails" ], "lang": { "en-us": { "role": { "label": "Weighted-average discount rate - operating leases", "documentation": "Weighted average discount rate for operating lease calculated at point in time." } } }, "auth_ref": [ "r366", "r617" ] }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "presentation": [ "http://oxbridgere.com/role/ScheduleOfOperatingLeaseObligationsDetails" ], "lang": { "en-us": { "role": { "label": "Weighted-average remaining lease term - operating leases", "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r365", "r617" ] }, "OXBR_OrdinarySharesParValue0.001UsdPerShareMember": { "xbrltype": "domainItemType", "nsuri": "http://oxbridgere.com/20231231", "localname": "OrdinarySharesParValue0.001UsdPerShareMember", "presentation": [ "http://oxbridgere.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Ordinary Shares, par value $0.001 (USD) per share" } } }, "auth_ref": [] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherInvestments", "crdr": "debit", "calculation": { "http://oxbridgere.com/role/ScheduleOfFairValueOfAssetsMeasuredOnRecurringBasisDetails": { "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0, "order": 3.0 }, "http://oxbridgere.com/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://oxbridgere.com/role/BalanceSheets", "http://oxbridgere.com/role/ScheduleOfFairValueOfAssetsMeasuredOnRecurringBasisDetails", "http://oxbridgere.com/role/ScheduleOfOtherInvestmentDetails" ], "lang": { "en-us": { "role": { "label": "Other investments", "periodEndLabel": "End of year", "periodStartLabel": "Beginning of year", "documentation": "Amount of investments classified as other." } } }, "auth_ref": [ "r735" ] }, "us-gaap_OtherLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLiabilities", "crdr": "credit", "calculation": { "http://oxbridgere.com/role/BalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://oxbridgere.com/role/BalanceSheets", "http://oxbridgere.com/role/ScheduleIiCondensedBalanceSheetParentCompanyOnlyDetails" ], "lang": { "en-us": { "role": { "label": "Other Liabilities \u2013 Delta Cat Re Tokenholders", "verboseLabel": "Due to Subsidiary", "documentation": "Amount of liabilities classified as other." } } }, "auth_ref": [ "r65", "r402", "r502", "r503", "r632", "r823" ] }, "us-gaap_OtherLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLiabilitiesCurrent", "crdr": "credit", "presentation": [ "http://oxbridgere.com/role/ScheduleOfFinancialStatementsDetails" ], "lang": { "en-us": { "role": { "label": "Due to Parent", "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r26", "r618" ] }, "ecd_OtherPerfMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OtherPerfMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Other Performance Measure Amount" } } }, "auth_ref": [ "r686" ] }, "us-gaap_OtherReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherReceivables", "crdr": "debit", "calculation": { "http://oxbridgere.com/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://oxbridgere.com/role/BalanceSheets", "http://oxbridgere.com/role/RelatedPartyTransactionsDetailsNarrative", "http://oxbridgere.com/role/ScheduleIiCondensedBalanceSheetParentCompanyOnlyDetails" ], "lang": { "en-us": { "role": { "label": "Due from related parties", "verboseLabel": "Due from related party", "documentation": "Amount due from parties in nontrade transactions, classified as other." } } }, "auth_ref": [ "r163", "r515" ] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://oxbridgere.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r646" ] }, "ecd_OutstandingAggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingAggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r653", "r665", "r675", "r701" ] }, "ecd_OutstandingRecoveryCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Recovery Compensation Amount" } } }, "auth_ref": [ "r656", "r668", "r678", "r704" ] }, "ecd_OutstandingRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Recovery, Individual Name" } } }, "auth_ref": [ "r656", "r668", "r678", "r704" ] }, "OXBR_OxbridgeAcquisitionCorpMember": { "xbrltype": "domainItemType", "nsuri": "http://oxbridgere.com/20231231", "localname": "OxbridgeAcquisitionCorpMember", "presentation": [ "http://oxbridgere.com/role/InvestmentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Oxbridge Acquisition Corp [Member]", "documentation": "Oxbridge Acquisition Corp [Member]" } } }, "auth_ref": [] }, "OXBR_OxbridgeReNSMember": { "xbrltype": "domainItemType", "nsuri": "http://oxbridgere.com/20231231", "localname": "OxbridgeReNSMember", "presentation": [ "http://oxbridgere.com/role/NetWorthForRegulatoryPurposesDetailsNarrative", "http://oxbridgere.com/role/OrganizationAndBasisOfPresentationDetailsNarrative", "http://oxbridgere.com/role/VariableInterestEntitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Oxbridge Re NS [Member]", "documentation": "Oxbridge Re NS [Member]" } } }, "auth_ref": [] }, "OXBR_OxbridgeReinsuranceLimitedMember": { "xbrltype": "domainItemType", "nsuri": "http://oxbridgere.com/20231231", "localname": "OxbridgeReinsuranceLimitedMember", "presentation": [ "http://oxbridgere.com/role/NetWorthForRegulatoryPurposesDetailsNarrative", "http://oxbridgere.com/role/OrganizationAndBasisOfPresentationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Oxbridge Reinsurance Limited [Member]", "documentation": "Oxbridge Reinsurance Limited [Member]" } } }, "auth_ref": [] }, "srt_ParentCompanyMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ParentCompanyMember", "presentation": [ "http://oxbridgere.com/role/ScheduleIiCondensedBalanceSheetParentCompanyOnlyDetails", "http://oxbridgere.com/role/ScheduleIiCondensedStatementOfCashFlows-ParentCompanyOnlyDetails", "http://oxbridgere.com/role/ScheduleIiCondensedStatementsOfIncomeParentCompanyOnlyDetails" ], "lang": { "en-us": { "role": { "label": "Parent Company [Member]", "documentation": "Registrant with controlling financial interest in one or more subsidiaries. Controlling interest in subsidiary includes, but is not limited to, primary beneficiary of variable interest entity (VIE). Controlling interest in subsidiary excludes broker-dealer with controlling financial interest in subsidiary but control is likely to be temporary." } } }, "auth_ref": [ "r179" ] }, "us-gaap_ParentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ParentMember", "presentation": [ "http://oxbridgere.com/role/ScheduleOfFinancialStatementsDetails", "http://oxbridgere.com/role/VariableInterestEntitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Parent [Member]", "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests." } } }, "auth_ref": [] }, "ecd_PayVsPerformanceDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PayVsPerformanceDisclosureLineItems", "auth_ref": [ "r682" ] }, "us-gaap_PaymentsForLossesAndLossAdjustmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsForLossesAndLossAdjustmentExpense", "crdr": "credit", "calculation": { "http://oxbridgere.com/role/ScheduleOfLossAdjustmentExpenseDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://oxbridgere.com/role/ScheduleOfLossAdjustmentExpenseDetails" ], "lang": { "en-us": { "role": { "negatedTotalLabel": "Total paid", "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid", "documentation": "Amount, after effects of reinsurance, of payments to settle insured claims and pay costs incurred in the claims settlement process." } } }, "auth_ref": [ "r3", "r14" ] }, "us-gaap_PaymentsToAcquireEquitySecuritiesFvNi": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireEquitySecuritiesFvNi", "crdr": "credit", "calculation": { "http://oxbridgere.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://oxbridgere.com/role/ScheduleIiCondensedStatementOfCashFlows-ParentCompanyOnlyDetails", "http://oxbridgere.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchase of equity securities", "label": "Payments to Acquire Equity Securities, FV-NI", "documentation": "Amount of cash outflow to acquire investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as investing activity." } } }, "auth_ref": [ "r125", "r171" ] }, "us-gaap_PaymentsToAcquireLoansReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireLoansReceivable", "crdr": "credit", "calculation": { "http://oxbridgere.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://oxbridgere.com/role/ScheduleIiCondensedStatementOfCashFlows-ParentCompanyOnlyDetails", "http://oxbridgere.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchase of loan receivable", "label": "Payments to Acquire Loans Receivable", "documentation": "The cash outflow for the purchase of loan receivable arising from the financing of goods and services." } } }, "auth_ref": [ "r30" ] }, "us-gaap_PaymentsToAcquireOtherInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireOtherInvestments", "crdr": "credit", "calculation": { "http://oxbridgere.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://oxbridgere.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchase of other investments", "label": "Payments to Acquire Other Investments", "documentation": "Amount of cash outflow to acquire investments classified as other." } } }, "auth_ref": [ "r92" ] }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://oxbridgere.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://oxbridgere.com/role/ScheduleIiCondensedStatementOfCashFlows-ParentCompanyOnlyDetails", "http://oxbridgere.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchase of property and equipment", "label": "Payments to Acquire Property, Plant, and Equipment", "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets." } } }, "auth_ref": [ "r93" ] }, "ecd_PeerGroupIssuersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupIssuersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Peer Group Issuers, Footnote [Text Block]" } } }, "auth_ref": [ "r685" ] }, "ecd_PeerGroupTotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupTotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Peer Group Total Shareholder Return Amount" } } }, "auth_ref": [ "r685" ] }, "ecd_PeoActuallyPaidCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoActuallyPaidCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Actually Paid Compensation Amount" } } }, "auth_ref": [ "r684" ] }, "ecd_PeoName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Name" } } }, "auth_ref": [ "r687" ] }, "ecd_PeoTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Total Compensation Amount" } } }, "auth_ref": [ "r683" ] }, "OXBR_PercentageOfOriginalIssueDiscount": { "xbrltype": "percentItemType", "nsuri": "http://oxbridgere.com/20231231", "localname": "PercentageOfOriginalIssueDiscount", "presentation": [ "http://oxbridgere.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Percentage of original issue discount", "documentation": "Percentage of original issue discount." } } }, "auth_ref": [] }, "us-gaap_PlanNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PlanNameAxis", "presentation": [ "http://oxbridgere.com/role/ScheduleOfHistoricalAverageAnnualPercentagePayoutDetails", "http://oxbridgere.com/role/Share-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Plan Name [Axis]", "documentation": "Information by plan name for share-based payment arrangement." } } }, "auth_ref": [ "r765", "r766", "r767", "r768", "r769", "r770", "r771", "r772", "r773", "r774", "r775", "r776", "r777", "r778", "r779", "r780", "r781", "r782", "r783", "r784", "r785", "r786", "r787", "r788", "r789", "r790" ] }, "us-gaap_PlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PlanNameDomain", "presentation": [ "http://oxbridgere.com/role/ScheduleOfHistoricalAverageAnnualPercentagePayoutDetails", "http://oxbridgere.com/role/Share-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement." } } }, "auth_ref": [ "r765", "r766", "r767", "r768", "r769", "r770", "r771", "r772", "r773", "r774", "r775", "r776", "r777", "r778", "r779", "r780", "r781", "r782", "r783", "r784", "r785", "r786", "r787", "r788", "r789", "r790" ] }, "srt_PlatformOperatorCryptoAssetLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "PlatformOperatorCryptoAssetLineItems", "presentation": [ "http://oxbridgere.com/role/ScheduleOfFairValueOfAssetsMeasuredOnRecurringBasisDetails", "http://oxbridgere.com/role/ScheduleOfReconciliationOfChangesInFairValueDetails" ], "lang": { "en-us": { "role": { "label": "Platform Operator, Crypto-Asset [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r151" ] }, "srt_PlatformOperatorCryptoAssetTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "PlatformOperatorCryptoAssetTable", "presentation": [ "http://oxbridgere.com/role/ScheduleOfFairValueOfAssetsMeasuredOnRecurringBasisDetails", "http://oxbridgere.com/role/ScheduleOfReconciliationOfChangesInFairValueDetails" ], "lang": { "en-us": { "role": { "label": "Platform Operator, Crypto-Asset [Table]", "documentation": "Disclosure of information about crypto-asset held for platform user." } } }, "auth_ref": [ "r151" ] }, "us-gaap_PolicyLoansReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PolicyLoansReceivable", "crdr": "debit", "presentation": [ "http://oxbridgere.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Policy Loans Receivable", "documentation": "Carrying amount of loans made to policyholders against the cash surrender value (CSV) or other policyholder funds, and secured by the CSV, policyholder funds or the death benefit provided by the insurance contracts." } } }, "auth_ref": [ "r67" ] }, "us-gaap_PolicyholderBenefitsAndClaimsIncurredNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PolicyholderBenefitsAndClaimsIncurredNet", "crdr": "debit", "calculation": { "http://oxbridgere.com/role/StatementsOfOperations": { "parentTag": "us-gaap_BenefitsLossesAndExpenses", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://oxbridgere.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Losses and loss adjustment expenses", "documentation": "Amount, after effects of policies assumed or ceded, of expense related to the provision for policy benefits and costs incurred." } } }, "auth_ref": [ "r816" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://oxbridgere.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r640" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://oxbridgere.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r641" ] }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockParOrStatedValuePerShare", "presentation": [ "http://oxbridgere.com/role/InvestmentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of shares in hold, par value per share", "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer." } } }, "auth_ref": [ "r77", "r258" ] }, "us-gaap_PremiumsEarnedNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PremiumsEarnedNet", "crdr": "credit", "calculation": { "http://oxbridgere.com/role/StatementsOfOperations": { "parentTag": "us-gaap_Revenues", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://oxbridgere.com/role/ScheduleIvReinsuranceInformationDetails", "http://oxbridgere.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Net premiums earned", "verboseLabel": "Net premiums earned", "label": "Premiums Earned, Net", "documentation": "Amount, after premiums ceded to other entities and premiums assumed by the entity, of premiums earned." } } }, "auth_ref": [ "r140", "r141", "r438", "r461" ] }, "us-gaap_PremiumsPercentageAssumedToNet": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PremiumsPercentageAssumedToNet", "presentation": [ "http://oxbridgere.com/role/ScheduleIvReinsuranceInformationDetails" ], "lang": { "en-us": { "role": { "label": "Percentage of amount assumed to net", "documentation": "Percentage of assumed premium earned to premium earned after effects of reinsurance, as disclosed in supplementary reinsurance information." } } }, "auth_ref": [ "r439" ] }, "us-gaap_PremiumsReceivableAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PremiumsReceivableAtCarryingValue", "crdr": "debit", "calculation": { "http://oxbridgere.com/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://oxbridgere.com/role/BalanceSheets", "http://oxbridgere.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Premiums receivable", "documentation": "The carrying amount as of the balance sheet date due the entity from (a) agents and insureds, (b) uncollected premiums and (c) others, net of the allowance for doubtful accounts." } } }, "auth_ref": [ "r812", "r813", "r814" ] }, "us-gaap_PremiumsReceivableBasisOfAccountingPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PremiumsReceivableBasisOfAccountingPolicy", "presentation": [ "http://oxbridgere.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Premiums assumed", "documentation": "Disclosure of accounting policy for determining the gross carrying amount of premiums due from policyholders, insureds, and other insurance entities." } } }, "auth_ref": [ "r818" ] }, "us-gaap_PrepaidExpenseAndOtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrepaidExpenseAndOtherAssets", "crdr": "debit", "calculation": { "http://oxbridgere.com/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://oxbridgere.com/role/BalanceSheets", "http://oxbridgere.com/role/ScheduleIiCondensedBalanceSheetParentCompanyOnlyDetails" ], "lang": { "en-us": { "role": { "label": "Prepayment and other assets", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets." } } }, "auth_ref": [] }, "OXBR_PrepaidOfferingCost": { "xbrltype": "monetaryItemType", "nsuri": "http://oxbridgere.com/20231231", "localname": "PrepaidOfferingCost", "crdr": "debit", "presentation": [ "http://oxbridgere.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Prepaid offering costs", "documentation": "Prepaid offering cost.", "label": "Prepaid offering cost" } } }, "auth_ref": [] }, "OXBR_PrepaidOfferingCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://oxbridgere.com/20231231", "localname": "PrepaidOfferingCosts", "crdr": "debit", "calculation": { "http://oxbridgere.com/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://oxbridgere.com/role/BalanceSheets", "http://oxbridgere.com/role/ScheduleIiCondensedBalanceSheetParentCompanyOnlyDetails" ], "lang": { "en-us": { "role": { "label": "Prepaid offering costs", "documentation": "Prepaid offering costs." } } }, "auth_ref": [] }, "us-gaap_PriorPeriodReclassificationAdjustmentDescription": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PriorPeriodReclassificationAdjustmentDescription", "presentation": [ "http://oxbridgere.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Reclassifications", "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error." } } }, "auth_ref": [ "r733" ] }, "OXBR_PrivatePlacementWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://oxbridgere.com/20231231", "localname": "PrivatePlacementWarrantsMember", "presentation": [ "http://oxbridgere.com/role/InvestmentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Private Placement Warrants [Member]", "documentation": "Private Placement Warrants [Member]" } } }, "auth_ref": [] }, "us-gaap_ProceedsFromIssuanceOfDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOfDebt", "crdr": "debit", "calculation": { "http://oxbridgere.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://oxbridgere.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Gross proceeds from the issuance of Delta Cat Re tokens", "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt." } } }, "auth_ref": [ "r739" ] }, "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOfPrivatePlacement", "crdr": "debit", "presentation": [ "http://oxbridgere.com/role/VariableInterestEntitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Proceeds from issuance of private placement", "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement." } } }, "auth_ref": [ "r2" ] }, "us-gaap_ProceedsFromRelatedPartyDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromRelatedPartyDebt", "crdr": "debit", "presentation": [ "http://oxbridgere.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Proceeds from Related Party Debt", "documentation": "The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates." } } }, "auth_ref": [ "r31" ] }, "us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromSaleOfEquitySecuritiesFvNi", "crdr": "debit", "calculation": { "http://oxbridgere.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://oxbridgere.com/role/ScheduleIiCondensedStatementOfCashFlows-ParentCompanyOnlyDetails", "http://oxbridgere.com/role/ScheduleOfGrossRealizedGainsAndLossesFromSaleOfEquitySecuritiesDetails", "http://oxbridgere.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from sale of equity securities", "verboseLabel": "Proceeds from Sale of Equity Securities, FV-NI", "documentation": "Amount of cash inflow from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as investing activity." } } }, "auth_ref": [ "r125", "r171" ] }, "srt_ProductOrServiceAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ProductOrServiceAxis", "presentation": [ "http://oxbridgere.com/role/ScheduleIiiSupplementaryInsuranceInformationDetails", "http://oxbridgere.com/role/ScheduleIvReinsuranceInformationDetails", "http://oxbridgere.com/role/ScheduleOfFinancialStatementsDetails" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]", "documentation": "Information by product and service, or group of similar products and similar services." } } }, "auth_ref": [ "r230", "r386", "r434", "r435", "r436", "r437", "r438", "r439", "r596", "r609", "r619", "r727", "r755", "r756", "r763", "r817" ] }, "srt_ProductsAndServicesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ProductsAndServicesDomain", "presentation": [ "http://oxbridgere.com/role/ScheduleIiiSupplementaryInsuranceInformationDetails", "http://oxbridgere.com/role/ScheduleIvReinsuranceInformationDetails", "http://oxbridgere.com/role/ScheduleOfFinancialStatementsDetails" ], "lang": { "en-us": { "role": { "documentation": "Product or service, or a group of similar products or similar services." } } }, "auth_ref": [ "r230", "r386", "r434", "r435", "r436", "r437", "r438", "r439", "r596", "r609", "r619", "r727", "r755", "r756", "r763", "r817" ] }, "OXBR_PropertyCatastropheReinsuranceMember": { "xbrltype": "domainItemType", "nsuri": "http://oxbridgere.com/20231231", "localname": "PropertyCatastropheReinsuranceMember", "presentation": [ "http://oxbridgere.com/role/ScheduleOfHistoricalAverageAnnualPercentagePayoutDetails" ], "lang": { "en-us": { "role": { "label": "Property Catastrophe Reinsurance [Member]", "documentation": "Property Catastrophe Reinsurance [Member]" } } }, "auth_ref": [] }, "us-gaap_PropertyLiabilityAndCasualtyInsuranceSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyLiabilityAndCasualtyInsuranceSegmentMember", "presentation": [ "http://oxbridgere.com/role/ScheduleIiiSupplementaryInsuranceInformationDetails", "http://oxbridgere.com/role/ScheduleIvReinsuranceInformationDetails" ], "lang": { "en-us": { "role": { "label": "Property, Liability and Casualty Insurance Product Line [Member]", "documentation": "Contract providing insurance coverage against property-related loss. Includes, but is not limited to, damage, theft, or legal liability for personal injury." } } }, "auth_ref": [ "r434", "r435", "r436", "r437", "r438", "r439", "r819" ] }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentAbstract", "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentByTypeAxis", "presentation": [ "http://oxbridgere.com/role/ScheduleOfPropertyAndEquipmentnetDetails", "http://oxbridgere.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Long-Lived Tangible Asset [Axis]", "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale." } } }, "auth_ref": [ "r6" ] }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "presentation": [ "http://oxbridgere.com/role/PropertyAndEquipmentNet" ], "lang": { "en-us": { "role": { "label": "PROPERTY AND EQUIPMENT, NET", "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections." } } }, "auth_ref": [ "r100", "r131", "r134", "r135" ] }, "us-gaap_PropertyPlantAndEquipmentGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentGross", "crdr": "debit", "calculation": { "http://oxbridgere.com/role/ScheduleOfPropertyAndEquipmentnetDetails": { "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://oxbridgere.com/role/ScheduleOfPropertyAndEquipmentnetDetails" ], "lang": { "en-us": { "role": { "label": "Total, at cost", "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r102", "r156", "r413" ] }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentLineItems", "presentation": [ "http://oxbridgere.com/role/ScheduleOfPropertyAndEquipmentnetDetails", "http://oxbridgere.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentNet", "crdr": "debit", "calculation": { "http://oxbridgere.com/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 12.0 }, "http://oxbridgere.com/role/ScheduleOfPropertyAndEquipmentnetDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://oxbridgere.com/role/BalanceSheets", "http://oxbridgere.com/role/ScheduleIiCondensedBalanceSheetParentCompanyOnlyDetails", "http://oxbridgere.com/role/ScheduleOfPropertyAndEquipmentnetDetails" ], "lang": { "en-us": { "role": { "label": "Property and equipment, net", "totalLabel": "Property and equipment, net", "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r6", "r401", "r413", "r618" ] }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "presentation": [ "http://oxbridgere.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Property and equipment", "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections." } } }, "auth_ref": [ "r6", "r131", "r134", "r411" ] }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentTextBlock", "presentation": [ "http://oxbridgere.com/role/PropertyAndEquipmentNetTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF PROPERTY AND EQUIPMENT,NET", "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r6" ] }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentTypeDomain", "presentation": [ "http://oxbridgere.com/role/ScheduleOfPropertyAndEquipmentnetDetails", "http://oxbridgere.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "auth_ref": [ "r102" ] }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentUsefulLife", "presentation": [ "http://oxbridgere.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Estimated useful life", "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment." } } }, "auth_ref": [] }, "ecd_PvpTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Table]" } } }, "auth_ref": [ "r682" ] }, "ecd_PvpTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance [Table Text Block]" } } }, "auth_ref": [ "r682" ] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeAxis", "presentation": [ "http://oxbridgere.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]", "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median." } } }, "auth_ref": [ "r242", "r243", "r244", "r245", "r265", "r273", "r304", "r305", "r306", "r384", "r385", "r447", "r496", "r497", "r559", "r565", "r567", "r568", "r578", "r593", "r594", "r604", "r608", "r615", "r620", "r625", "r754", "r762", "r805", "r806", "r807", "r808", "r809" ] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeMember", "presentation": [ "http://oxbridgere.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median." } } }, "auth_ref": [ "r242", "r243", "r244", "r245", "r265", "r273", "r304", "r305", "r306", "r384", "r385", "r447", "r496", "r497", "r559", "r565", "r567", "r568", "r578", "r593", "r594", "r604", "r608", "r615", "r620", "r625", "r754", "r762", "r805", "r806", "r807", "r808", "r809" ] }, "us-gaap_RealizedInvestmentGainsLosses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RealizedInvestmentGainsLosses", "crdr": "credit", "calculation": { "http://oxbridgere.com/role/StatementsOfOperations": { "parentTag": "us-gaap_Revenues", "weight": 1.0, "order": 4.0 }, "http://oxbridgere.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://oxbridgere.com/role/ScheduleIiCondensedStatementOfCashFlows-ParentCompanyOnlyDetails", "http://oxbridgere.com/role/ScheduleIiCondensedStatementsOfIncomeParentCompanyOnlyDetails", "http://oxbridgere.com/role/StatementsOfCashFlows", "http://oxbridgere.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Net realized investment gain", "negatedLabel": "Net realized investment gains", "negatedTerseLabel": "Net realized investment gain", "documentation": "Amount of realized gain (loss) on investment." } } }, "auth_ref": [ "r421" ] }, "us-gaap_ReceivablesNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReceivablesNetCurrent", "crdr": "debit", "calculation": { "http://oxbridgere.com/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://oxbridgere.com/role/BalanceSheets", "http://oxbridgere.com/role/ScheduleIiCondensedBalanceSheetParentCompanyOnlyDetails" ], "lang": { "en-us": { "role": { "label": "Loan receivable", "documentation": "The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value." } } }, "auth_ref": [ "r618" ] }, "ecd_RecoveryOfErrCompDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RecoveryOfErrCompDisclosureLineItems", "auth_ref": [ "r648", "r660", "r670", "r696" ] }, "OXBR_RedemptionOfNotesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://oxbridgere.com/20231231", "localname": "RedemptionOfNotesPayable", "crdr": "credit", "presentation": [ "http://oxbridgere.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Redemption of notes payable" } } }, "auth_ref": [] }, "us-gaap_ReinsuranceAccountingPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReinsuranceAccountingPolicy", "presentation": [ "http://oxbridgere.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Loss experience refund payable", "documentation": "Disclosure of reinsurance accounting policy, for example, but not limited to, description of the methodologies and assumptions underlying determination of reinsurance recoverables, reinsurance payables and retention policy." } } }, "auth_ref": [ "r621", "r622" ] }, "OXBR_ReinsuranceAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://oxbridgere.com/20231231", "localname": "ReinsuranceAgreementMember", "presentation": [ "http://oxbridgere.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Reinsurance Agreement [Member]", "documentation": "Reinsurance Agreement [Member]" } } }, "auth_ref": [] }, "srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ReinsurancePremiumsForInsuranceCompaniesByProductSegmentLineItems", "presentation": [ "http://oxbridgere.com/role/ScheduleIvReinsuranceInformationDetails" ], "lang": { "en-us": { "role": { "label": "SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r146", "r434", "r435", "r436", "r437", "r438", "r439" ] }, "srt_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ReinsurancePremiumsForInsuranceCompaniesByProductSegmentTable", "presentation": [ "http://oxbridgere.com/role/ScheduleIvReinsuranceInformationDetails" ], "lang": { "en-us": { "role": { "label": "SEC Schedule, 12-17, Insurance Companies, Reinsurance [Table]", "documentation": "Disclosure of supplemental information about reinsurance including, but not limited to, type of insurance, gross amount of premium, premium ceded to another company, premium assumed from another company, net amount of premium revenue, and percentage of premium assumed to net premium revenue." } } }, "auth_ref": [ "r146", "r434", "r435", "r436", "r437", "r438", "r439" ] }, "us-gaap_RelatedPartyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyDomain", "presentation": [ "http://oxbridgere.com/role/InvestmentsDetailsNarrative", "http://oxbridgere.com/role/RelatedPartyTransactionsDetailsNarrative", "http://oxbridgere.com/role/ScheduleIiCondensedBalanceSheetParentCompanyOnlyDetails", "http://oxbridgere.com/role/ScheduleIiCondensedStatementOfCashFlows-ParentCompanyOnlyDetails", "http://oxbridgere.com/role/ScheduleOfFinancialStatementsDetails", "http://oxbridgere.com/role/ScheduleOfOtherInvestmentDetails", "http://oxbridgere.com/role/VariableInterestEntitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "auth_ref": [ "r272", "r372", "r373", "r501", "r502", "r503", "r504", "r505", "r525", "r527", "r557" ] }, "us-gaap_RelatedPartyMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyMember", "presentation": [ "http://oxbridgere.com/role/RelatedPartyTransactionsDetailsNarrative", "http://oxbridgere.com/role/ScheduleIiCondensedBalanceSheetParentCompanyOnlyDetails", "http://oxbridgere.com/role/ScheduleIiCondensedStatementOfCashFlows-ParentCompanyOnlyDetails", "http://oxbridgere.com/role/ScheduleOfFinancialStatementsDetails" ], "lang": { "en-us": { "role": { "label": "Related Party [Member]", "documentation": "Party related to reporting entity. Includes, but is not limited to, affiliate, entity for which investment is accounted for by equity method, trust for benefit of employees, and principal owner, management, and members of immediate family." } } }, "auth_ref": [ "r177", "r178", "r372", "r373", "r374", "r375", "r501", "r502", "r503", "r504", "r505", "r525", "r527", "r557" ] }, "us-gaap_RelatedPartyTransactionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionAxis", "presentation": [ "http://oxbridgere.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction [Axis]", "documentation": "Information by type of related party transaction." } } }, "auth_ref": [ "r372", "r373", "r801" ] }, "us-gaap_RelatedPartyTransactionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionDomain", "presentation": [ "http://oxbridgere.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Transaction between related party." } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionLineItems", "presentation": [ "http://oxbridgere.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r532", "r533", "r536" ] }, "us-gaap_RelatedPartyTransactionsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsAbstract", "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "presentation": [ "http://oxbridgere.com/role/InvestmentsDetailsNarrative", "http://oxbridgere.com/role/RelatedPartyTransactionsDetailsNarrative", "http://oxbridgere.com/role/ScheduleIiCondensedBalanceSheetParentCompanyOnlyDetails", "http://oxbridgere.com/role/ScheduleIiCondensedStatementOfCashFlows-ParentCompanyOnlyDetails", "http://oxbridgere.com/role/ScheduleOfFinancialStatementsDetails", "http://oxbridgere.com/role/ScheduleOfOtherInvestmentDetails", "http://oxbridgere.com/role/VariableInterestEntitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Related Party, Type [Axis]", "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "auth_ref": [ "r272", "r372", "r373", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r501", "r502", "r503", "r504", "r505", "r525", "r527", "r557", "r801" ] }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsDisclosureTextBlock", "presentation": [ "http://oxbridgere.com/role/RelatedPartyTransactions" ], "lang": { "en-us": { "role": { "label": "RELATED PARTY TRANSACTIONS", "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates." } } }, "auth_ref": [ "r369", "r370", "r371", "r373", "r376", "r472", "r473", "r474", "r534", "r535", "r536", "r555", "r556" ] }, "us-gaap_RepaymentsOfDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RepaymentsOfDebt", "crdr": "credit", "calculation": { "http://oxbridgere.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://oxbridgere.com/role/StatementsOfCashFlows", "http://oxbridgere.com/role/VariableInterestEntitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "negatedLabel": "Partial redemption of notes payable to noteholders", "label": "Repayments of Debt", "documentation": "Amount of cash outflow for short-term and long-term debt. Excludes payment of lease obligation." } } }, "auth_ref": [ "r740" ] }, "OXBR_ReserveForLossesAndLossAdjustmentExpensesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://oxbridgere.com/20231231", "localname": "ReserveForLossesAndLossAdjustmentExpensesDisclosureTextBlock", "presentation": [ "http://oxbridgere.com/role/ReserveForLossesAndLossAdjustmentExpenses" ], "lang": { "en-us": { "role": { "label": "RESERVE FOR LOSSES AND LOSS ADJUSTMENT EXPENSES", "documentation": "Reserve for Losses and Loss Adjustment Expenses Disclosure [Text Block]" } } }, "auth_ref": [] }, "OXBR_ResidentialLeaseMember": { "xbrltype": "domainItemType", "nsuri": "http://oxbridgere.com/20231231", "localname": "ResidentialLeaseMember", "presentation": [ "http://oxbridgere.com/role/LeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Residential Lease [Member]", "documentation": "Residential Lease [Member]" } } }, "auth_ref": [] }, "ecd_RestatementDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDateAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date [Axis]" } } }, "auth_ref": [ "r649", "r661", "r671", "r697" ] }, "ecd_RestatementDeterminationDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDeterminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date" } } }, "auth_ref": [ "r650", "r662", "r672", "r698" ] }, "ecd_RestatementDoesNotRequireRecoveryTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDoesNotRequireRecoveryTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Does Not Require Recovery [Text Block]" } } }, "auth_ref": [ "r657", "r669", "r679", "r705" ] }, "us-gaap_RestrictedCashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedCashAndCashEquivalents", "crdr": "debit", "calculation": { "http://oxbridgere.com/role/SummaryOfCashAndCashEquivalentsAndRestrictedCashAndCashEquivalentsDetails": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0, "order": 2.0 }, "http://oxbridgere.com/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://oxbridgere.com/role/BalanceSheets", "http://oxbridgere.com/role/SummaryOfCashAndCashEquivalentsAndRestrictedCashAndCashEquivalentsDetails" ], "lang": { "en-us": { "role": { "label": "Restricted cash and cash equivalents", "verboseLabel": "Restricted cash held in trust", "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r32", "r109", "r155", "r173", "r405" ] }, "us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedCashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://oxbridgere.com/role/ScheduleOfFairValueOfAssetsMeasuredOnRecurringBasisDetails": { "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://oxbridgere.com/role/ScheduleOfFairValueOfAssetsMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Restricted cash and cash equivalents", "label": "Restricted Cash and Cash Equivalents, Current", "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r32", "r155", "r173" ] }, "us-gaap_RestrictedStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedStockMember", "presentation": [ "http://oxbridgere.com/role/Share-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Restricted Stock [Member]", "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met." } } }, "auth_ref": [ "r37" ] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://oxbridgere.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://oxbridgere.com/role/BalanceSheets", "http://oxbridgere.com/role/ScheduleIiCondensedBalanceSheetParentCompanyOnlyDetails" ], "lang": { "en-us": { "role": { "label": "Accumulated Deficit", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r80", "r103", "r407", "r452", "r453", "r470", "r508", "r618" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsMember", "presentation": [ "http://oxbridgere.com/role/StatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Retained Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r152", "r180", "r181", "r182", "r184", "r190", "r192", "r238", "r239", "r313", "r314", "r315", "r325", "r326", "r337", "r339", "r340", "r342", "r343", "r448", "r450", "r475", "r827" ] }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueRecognitionPolicyTextBlock", "presentation": [ "http://oxbridgere.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Revenue Recognition", "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources." } } }, "auth_ref": [ "r530", "r595", "r599" ] }, "us-gaap_Revenues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Revenues", "crdr": "credit", "calculation": { "http://oxbridgere.com/role/StatementsOfOperations": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 1.0 }, "http://oxbridgere.com/role/ScheduleOfFinancialStatementsDetails": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://oxbridgere.com/role/ScheduleOfFinancialStatementsDetails", "http://oxbridgere.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Total revenue", "label": "Total revenue", "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)." } } }, "auth_ref": [ "r169", "r175", "r213", "r214", "r222", "r225", "r226", "r230", "r231", "r232", "r237", "r246", "r247", "r248", "r249", "r250", "r251", "r252", "r253", "r254", "r349", "r400", "r758" ] }, "us-gaap_RevenuesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenuesAbstract", "presentation": [ "http://oxbridgere.com/role/ScheduleIiCondensedStatementsOfIncomeParentCompanyOnlyDetails", "http://oxbridgere.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Revenue" } } }, "auth_ref": [] }, "ecd_Rule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Adopted" } } }, "auth_ref": [ "r714" ] }, "ecd_Rule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Terminated" } } }, "auth_ref": [ "r714" ] }, "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SaleOfStockConsiderationReceivedOnTransaction", "crdr": "debit", "presentation": [ "http://oxbridgere.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Aggregate purchase price", "documentation": "Cash received on stock transaction after deduction of issuance costs." } } }, "auth_ref": [] }, "us-gaap_SaleOfStockDescriptionOfTransaction": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SaleOfStockDescriptionOfTransaction", "presentation": [ "http://oxbridgere.com/role/VariableInterestEntitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Description for offer and sale of securities", "documentation": "Description of stock transaction which may include details of the offering (IPO, private placement), a description of the stock sold, percentage of subsidiary's or equity investee's stock sold, a description of the investors and whether the stock was issued in a business combination." } } }, "auth_ref": [ "r8", "r57", "r106" ] }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SaleOfStockNameOfTransactionDomain", "presentation": [ "http://oxbridgere.com/role/InvestmentsDetailsNarrative", "http://oxbridgere.com/role/ScheduleOfOtherInvestmentDetails" ], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement." } } }, "auth_ref": [] }, "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SaleOfStockNumberOfSharesIssuedInTransaction", "presentation": [ "http://oxbridgere.com/role/VariableInterestEntitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Sale of stock number of shares issued in transaction", "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "presentation": [ "http://oxbridgere.com/role/LossPerShareDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]", "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities." } } }, "auth_ref": [ "r37" ] }, "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock", "presentation": [ "http://oxbridgere.com/role/CashAndCashEquivalentsAndRestrictedCashAndCashEquivalentsTables" ], "lang": { "en-us": { "role": { "label": "SUMMARY OF CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AND CASH EQUIVALENTS", "documentation": "Tabular disclosure of the components of cash and cash equivalents." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable", "presentation": [ "http://oxbridgere.com/role/ScheduleOfFinancialStatementsDetails", "http://oxbridgere.com/role/VariableInterestEntitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]", "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r332" ] }, "srt_ScheduleOfCondensedFinancialStatementsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScheduleOfCondensedFinancialStatementsTable", "presentation": [ "http://oxbridgere.com/role/ScheduleIiCondensedBalanceSheetParentCompanyOnlyDetails", "http://oxbridgere.com/role/ScheduleIiCondensedStatementOfCashFlows-ParentCompanyOnlyDetails", "http://oxbridgere.com/role/ScheduleIiCondensedStatementsOfIncomeParentCompanyOnlyDetails" ], "lang": { "en-us": { "role": { "label": "Condensed Financial Statements [Table]", "documentation": "Disclosure of information about condensed financial statements, including, but not limited to, the balance sheet, income statement, and statement of cash flows." } } }, "auth_ref": [ "r143", "r148", "r149", "r150", "r179", "r725" ] }, "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable", "presentation": [ "http://oxbridgere.com/role/InvestmentsDetailsNarrative", "http://oxbridgere.com/role/ScheduleOfOtherInvestmentDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Defined Benefit Plans Disclosures [Table]", "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)." } } }, "auth_ref": [ "r7", "r46", "r47", "r48", "r49" ] }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "presentation": [ "http://oxbridgere.com/role/LossPerShareTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF COMPUTATION OF BASIC AND DILUTED LOSS EARNING PER SHARE", "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations." } } }, "auth_ref": [ "r748" ] }, "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "presentation": [ "http://oxbridgere.com/role/OrganizationAndBasisOfPresentationDetailsNarrative", "http://oxbridgere.com/role/VariableInterestEntitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Investment, Name [Axis]", "documentation": "Information by name of investment including named security. Excludes entity that is consolidated." } } }, "auth_ref": [ "r234", "r235", "r236" ] }, "us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense", "presentation": [ "http://oxbridgere.com/role/ReserveForLossesAndLossAdjustmentExpensesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF LOSS ADJUSTMENT EXPENSE", "documentation": "Tabular disclosure of the activity in the reserve for settling insured claims and expenses incurred in the claims settlement process for the period. The estimated liability includes the amount of money that will be required for future payments of (a) claims that have been reported to the insurer, (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated, and (c) claim adjustment expenses. Claim adjustment expenses include costs incurred in the claim settlement process such as legal fees; outside adjuster fees; and costs to record, process, and adjust claims." } } }, "auth_ref": [ "r120" ] }, "OXBR_ScheduleOfOperatingLeaseObligationsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://oxbridgere.com/20231231", "localname": "ScheduleOfOperatingLeaseObligationsTableTextBlock", "presentation": [ "http://oxbridgere.com/role/LeasesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF OPERATING LEASE OBLIGATIONS", "documentation": "Schedule of Operating Lease Obligations [Table Text Block]" } } }, "auth_ref": [] }, "OXBR_ScheduleOfOtherInvestmentsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://oxbridgere.com/20231231", "localname": "ScheduleOfOtherInvestmentsTableTextBlock", "presentation": [ "http://oxbridgere.com/role/InvestmentsTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF OTHER INVESTMENT", "documentation": "Schedule Of Other Investments [Table Text Block]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "presentation": [ "http://oxbridgere.com/role/ScheduleOfPropertyAndEquipmentnetDetails", "http://oxbridgere.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Table]", "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r6" ] }, "us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfQuarterlyFinancialInformationTableTextBlock", "presentation": [ "http://oxbridgere.com/role/VariableInterestEntitiesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF FINANCIAL STATEMENTS", "documentation": "Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data." } } }, "auth_ref": [ "r128" ] }, "us-gaap_ScheduleOfRealizedGainLossTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRealizedGainLossTableTextBlock", "presentation": [ "http://oxbridgere.com/role/InvestmentsTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF GROSS REALIZED GAINS AND LOSSES FROM SALE OF EQUITY SECURITIES", "documentation": "Tabular disclosure of the proceeds from sales of available-for-sale securities and the gross realized gains and gross realized losses that have been included in earnings as a result of those sales." } } }, "auth_ref": [ "r751" ] }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "presentation": [ "http://oxbridgere.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Schedule of Related Party Transactions, by Related Party [Table]", "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates." } } }, "auth_ref": [ "r63", "r64", "r532", "r533", "r536" ] }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "presentation": [ "http://oxbridgere.com/role/ScheduleOfHistoricalAverageAnnualPercentagePayoutDetails", "http://oxbridgere.com/role/Share-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]", "documentation": "Disclosure of information about share-based payment arrangement." } } }, "auth_ref": [ "r275", "r277", "r279", "r280", "r281", "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r303", "r304", "r305", "r306", "r307" ] }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "presentation": [ "http://oxbridgere.com/role/Share-basedCompensationTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF STOCK OPTION ACTIVITY", "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value." } } }, "auth_ref": [ "r12", "r13", "r51" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://oxbridgere.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r634" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://oxbridgere.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r638" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://oxbridgere.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r637" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://oxbridgere.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r642" ] }, "us-gaap_SegmentReportingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingPolicyPolicyTextBlock", "presentation": [ "http://oxbridgere.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Segment Information", "documentation": "Disclosure of accounting policy for segment reporting." } } }, "auth_ref": [ "r216", "r217", "r218", "r219", "r220", "r221", "r231", "r603" ] }, "OXBR_SeriesAOnePreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://oxbridgere.com/20231231", "localname": "SeriesAOnePreferredStockMember", "presentation": [ "http://oxbridgere.com/role/InvestmentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Series A-1 Preferred Stock [Member]", "documentation": "Series A-1 Preferred Stock [Member]" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensation", "crdr": "debit", "calculation": { "http://oxbridgere.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://oxbridgere.com/role/ScheduleIiCondensedStatementOfCashFlows-ParentCompanyOnlyDetails", "http://oxbridgere.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Share-based compensation", "documentation": "Amount of noncash expense for share-based payment arrangement." } } }, "auth_ref": [ "r4" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "presentation": [ "http://oxbridgere.com/role/Share-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Vesting period, contractual term", "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition." } } }, "auth_ref": [ "r616" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "presentation": [ "http://oxbridgere.com/role/ScheduleOfActivityOfUnvestedRestrictedStockAwardsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Weighted-Number of Restricted Stock Awards, Forfeited", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period", "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period." } } }, "auth_ref": [ "r296" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "presentation": [ "http://oxbridgere.com/role/ScheduleOfActivityOfUnvestedRestrictedStockAwardsDetails", "http://oxbridgere.com/role/Share-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Weighted-Number of Restricted Stock Awards, Granted", "verboseLabel": "Restricted stock, grant", "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r294" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "presentation": [ "http://oxbridgere.com/role/ScheduleOfActivityOfUnvestedRestrictedStockAwardsDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Weighted-Number of Restricted Stock Awards, Beginning balance", "periodEndLabel": "Weighted-Number of Restricted Stock Awards, Ending balance", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date." } } }, "auth_ref": [ "r291", "r292" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "presentation": [ "http://oxbridgere.com/role/ScheduleOfActivityOfUnvestedRestrictedStockAwardsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Weighted-Number of Restricted Stock Awards, Vested", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period", "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period." } } }, "auth_ref": [ "r295" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "presentation": [ "http://oxbridgere.com/role/ScheduleOfHistoricalAverageAnnualPercentagePayoutDetails", "http://oxbridgere.com/role/Share-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r275", "r277", "r279", "r280", "r281", "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r303", "r304", "r305", "r306", "r307" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised", "presentation": [ "http://oxbridgere.com/role/WarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrants exercised", "documentation": "Number of non-option equity instruments exercised by participants." } } }, "auth_ref": [ "r11" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "presentation": [ "http://oxbridgere.com/role/Share-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Shares available for grant", "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable." } } }, "auth_ref": [ "r50" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "presentation": [ "http://oxbridgere.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Number of Options, Exercisable, Beginning Balance", "periodEndLabel": "Number of Options Exercisable, Ending Balance", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number", "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan." } } }, "auth_ref": [ "r285" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "presentation": [ "http://oxbridgere.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Weighted-Average Exercise Price, Exercisable, Beginning Balance", "periodEndLabel": "Weighted-Average Exercise Price, Exercisable, Ending Balance", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan." } } }, "auth_ref": [ "r285" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "presentation": [ "http://oxbridgere.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Number of Options, Forfeited", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period", "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan." } } }, "auth_ref": [ "r289" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "presentation": [ "http://oxbridgere.com/role/Share-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of options granted", "documentation": "Gross number of share options (or share units) granted during the period." } } }, "auth_ref": [ "r287" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://oxbridgere.com/role/ScheduleOfActivityOfUnvestedRestrictedStockAwardsDetails" ], "lang": { "en-us": { "role": { "label": "Weighted-Average Grant Date Fair Value, Granted", "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology." } } }, "auth_ref": [ "r297" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "crdr": "debit", "presentation": [ "http://oxbridgere.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Aggregate Intrinsic Value", "periodEndLabel": "Aggregate Intrinsic Value", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value", "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding." } } }, "auth_ref": [ "r50" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "presentation": [ "http://oxbridgere.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Number of Options, Outstanding, Beginning Balance", "periodEndLabel": "Number of Options Outstanding, Ending Balance", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number", "documentation": "Number of options outstanding, including both vested and non-vested options." } } }, "auth_ref": [ "r283", "r284" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "presentation": [ "http://oxbridgere.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Weighted-Average Exercise Price, Outstanding, Beginning Balance", "periodEndLabel": "Weighted-Average Exercise Price, Outstanding, Ending Balance", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan." } } }, "auth_ref": [ "r283", "r284" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://oxbridgere.com/role/Share-basedCompensationDetailsNarrative", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r279", "r280", "r281", "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r303", "r304", "r305", "r306", "r307" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "presentation": [ "http://oxbridgere.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Weighted-Average Exercise Price, Forfeited", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price", "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated." } } }, "auth_ref": [ "r289" ] }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "presentation": [ "http://oxbridgere.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation", "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost." } } }, "auth_ref": [ "r274", "r282", "r301", "r302", "r303", "r304", "r307", "r316", "r317", "r318", "r319" ] }, "us-gaap_SharePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharePrice", "presentation": [ "http://oxbridgere.com/role/WarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Ordinary share price, per share", "documentation": "Price of a single share of a number of saleable stocks of a company." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1", "crdr": "debit", "presentation": [ "http://oxbridgere.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Aggregate Intrinsic Value", "periodEndLabel": "Aggregate Intrinsic Value", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value", "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable." } } }, "auth_ref": [ "r50" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "presentation": [ "http://oxbridgere.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Weighted-Average Remaining Contractual Term, Exercisable", "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r50" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue", "presentation": [ "http://oxbridgere.com/role/ScheduleOfActivityOfUnvestedRestrictedStockAwardsDetails" ], "lang": { "en-us": { "role": { "label": "Weighted-Average Grant Date Fair Value, Forfeited", "documentation": "Weighted average grant-date fair value of non-vested options forfeited." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "presentation": [ "http://oxbridgere.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Weighted-Average Remaining Contractual Term, Outstanding", "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r104" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue", "presentation": [ "http://oxbridgere.com/role/ScheduleOfActivityOfUnvestedRestrictedStockAwardsDetails" ], "lang": { "en-us": { "role": { "label": "Weighted-Average Grant Date Fair Value, Vested", "documentation": "Weighted average grant-date fair value of options vested." } } }, "auth_ref": [] }, "OXBR_SharesIssuableUponConversionOfWarrants": { "xbrltype": "sharesItemType", "nsuri": "http://oxbridgere.com/20231231", "localname": "SharesIssuableUponConversionOfWarrants", "presentation": [ "http://oxbridgere.com/role/ScheduleOfComputationOfBasicAndDilutedLossEarningPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Shares issuable upon conversion of warrants", "documentation": "Shares issuable upon conversion of warrants." } } }, "auth_ref": [] }, "us-gaap_SharesIssuedPricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesIssuedPricePerShare", "presentation": [ "http://oxbridgere.com/role/RelatedPartyTransactionsDetailsNarrative", "http://oxbridgere.com/role/VariableInterestEntitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Shares issued, price per share", "documentation": "Per share or per unit amount of equity securities issued." } } }, "auth_ref": [] }, "us-gaap_SharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesOutstanding", "presentation": [ "http://oxbridgere.com/role/StatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "periodStartLabel": "Balance, shares", "periodEndLabel": "Balance, shares", "label": "Shares, Outstanding", "documentation": "Number of shares issued which are neither cancelled nor held in the treasury." } } }, "auth_ref": [] }, "us-gaap_ShortDurationInsuranceContractAccidentYear2019Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortDurationInsuranceContractAccidentYear2019Member", "presentation": [ "http://oxbridgere.com/role/ScheduleOfIncurredLossesAndAdjustmentExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Short-Duration Insurance Contract, Accident Year 2019 [Member]", "documentation": "Accident year 2019 in which covered event occurs under terms of short-duration insurance contract." } } }, "auth_ref": [ "r446" ] }, "us-gaap_ShortDurationInsuranceContractAccidentYear2020Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortDurationInsuranceContractAccidentYear2020Member", "presentation": [ "http://oxbridgere.com/role/ScheduleOfIncurredLossesAndAdjustmentExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Short-Duration Insurance Contract, Accident Year 2020 [Member]", "documentation": "Accident year 2020 in which covered event occurs under terms of short-duration insurance contract." } } }, "auth_ref": [ "r446" ] }, "us-gaap_ShortDurationInsuranceContractAccidentYear2021Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortDurationInsuranceContractAccidentYear2021Member", "presentation": [ "http://oxbridgere.com/role/ScheduleOfIncurredLossesAndAdjustmentExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Short-Duration Insurance Contract, Accident Year 2021 [Member]", "documentation": "Accident year 2021 in which covered event occurs under terms of short-duration insurance contract." } } }, "auth_ref": [ "r446" ] }, "us-gaap_ShortDurationInsuranceContractAccidentYear2022Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortDurationInsuranceContractAccidentYear2022Member", "presentation": [ "http://oxbridgere.com/role/ScheduleOfIncurredLossesAndAdjustmentExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Short-Duration Insurance Contract, Accident Year 2022 [Member]", "documentation": "Accident year 2022 in which covered event occurs under terms of short-duration insurance contract." } } }, "auth_ref": [ "r446" ] }, "us-gaap_ShortDurationInsuranceContractAccidentYear2023Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortDurationInsuranceContractAccidentYear2023Member", "presentation": [ "http://oxbridgere.com/role/ScheduleOfIncurredLossesAndAdjustmentExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Short-Duration Insurance Contract, Accident Year 2023 [Member]", "documentation": "Accident year 2023 in which covered event occurs under terms of short-duration insurance contract." } } }, "auth_ref": [ "r446" ] }, "us-gaap_ShortDurationInsuranceContractsAccidentYear2017Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortDurationInsuranceContractsAccidentYear2017Member", "presentation": [ "http://oxbridgere.com/role/ScheduleOfIncurredLossesAndAdjustmentExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Short-Duration Insurance Contracts, Accident Year 2017 [Member]", "documentation": "Accident year 2017 in which a covered event occurs under the terms of the short-duration insurance contract." } } }, "auth_ref": [ "r15" ] }, "us-gaap_ShortDurationInsuranceContractsAccidentYear2018Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortDurationInsuranceContractsAccidentYear2018Member", "presentation": [ "http://oxbridgere.com/role/ScheduleOfIncurredLossesAndAdjustmentExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Short-Duration Insurance Contracts, Accident Year 2018 [Member]", "documentation": "Accident year 2018 in which covered event occurs under terms of short-duration insurance contract." } } }, "auth_ref": [ "r446" ] }, "us-gaap_ShortTermInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortTermInvestments", "crdr": "debit", "presentation": [ "http://oxbridgere.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Short-term bridge funds", "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current." } } }, "auth_ref": [ "r114", "r115", "r737" ] }, "us-gaap_ShortdurationInsuranceContractsAccidentYear2016Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortdurationInsuranceContractsAccidentYear2016Member", "presentation": [ "http://oxbridgere.com/role/ScheduleOfIncurredLossesAndAdjustmentExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Short-Duration Insurance Contracts, Accident Year 2016 [Member]", "documentation": "Accident year 2016 in which a covered event occurs under the terms of the short-duration insurance contract." } } }, "auth_ref": [ "r15" ] }, "us-gaap_ShortdurationInsuranceContractsAccidentYearAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortdurationInsuranceContractsAccidentYearAxis", "presentation": [ "http://oxbridgere.com/role/ScheduleOfIncurredLossesAndAdjustmentExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Short-Duration Insurance Contracts, Accident Year [Axis]", "documentation": "Information by accident year in which a covered event occurs under the terms of the short-duration insurance contract." } } }, "auth_ref": [ "r15" ] }, "us-gaap_ShortdurationInsuranceContractsAccidentYearDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortdurationInsuranceContractsAccidentYearDomain", "presentation": [ "http://oxbridgere.com/role/ScheduleOfIncurredLossesAndAdjustmentExpensesDetails" ], "lang": { "en-us": { "role": { "documentation": "Accident year in which a covered event occurs under the terms of the short-duration insurance contract." } } }, "auth_ref": [ "r15" ] }, "us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortdurationInsuranceContractsClaimsDevelopmentTable", "presentation": [ "http://oxbridgere.com/role/ScheduleOfIncurredLossesAndAdjustmentExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Short-Duration Insurance Contracts, Claims Development [Table]", "documentation": "Disclosure of information about undiscounted information about claims development by accident year for short-duration insurance contracts." } } }, "auth_ref": [ "r15" ] }, "us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock", "presentation": [ "http://oxbridgere.com/role/ReserveForLossesAndLossAdjustmentExpensesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF INCURRED LOSSES AND ADJUSTMENT EXPENSES", "documentation": "Tabular disclosure of undiscounted information about claims development by accident year for short-duration insurance contracts." } } }, "auth_ref": [ "r15" ] }, "us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet", "crdr": "debit", "presentation": [ "http://oxbridgere.com/role/ScheduleOfIncurredLossesAndAdjustmentExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Cumulative Paid Losses and Loss Adjustment Expenses", "documentation": "Amount, after reinsurance, of paid claims and allocated claim adjustment expense used in claims development for short-duration insurance contracts. Excludes unallocated claim adjustment expense." } } }, "auth_ref": [ "r17" ] }, "us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearFive": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortdurationInsuranceContractsHistoricalClaimsDurationYearFive", "presentation": [ "http://oxbridgere.com/role/ScheduleOfHistoricalAverageAnnualPercentagePayoutDetails" ], "lang": { "en-us": { "role": { "label": "Average Annual Percentage Payout of Incurred Claims by Age, Net of Reinsurance, Year 5", "documentation": "Percentage of average annual payout, after reinsurance, in the fifth year after a claim is incurred, beginning with the earliest accident year disclosed for short-duration insurance contracts." } } }, "auth_ref": [ "r22" ] }, "us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearFour": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortdurationInsuranceContractsHistoricalClaimsDurationYearFour", "presentation": [ "http://oxbridgere.com/role/ScheduleOfHistoricalAverageAnnualPercentagePayoutDetails" ], "lang": { "en-us": { "role": { "label": "Average Annual Percentage Payout of Incurred Claims by Age, Net of Reinsurance, Year 4", "documentation": "Percentage of average annual payout, after reinsurance, in the fourth year after a claim is incurred, beginning with the earliest accident year disclosed for short-duration insurance contracts." } } }, "auth_ref": [ "r22" ] }, "us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearOne": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortdurationInsuranceContractsHistoricalClaimsDurationYearOne", "presentation": [ "http://oxbridgere.com/role/ScheduleOfHistoricalAverageAnnualPercentagePayoutDetails" ], "lang": { "en-us": { "role": { "label": "Average Annual Percentage Payout of Incurred Claims by Age, Net of Reinsurance, Year 1", "documentation": "Percentage of average annual payout, after reinsurance, in the first year after a claim is incurred, beginning with the earliest accident year disclosed for short-duration insurance contracts." } } }, "auth_ref": [ "r22" ] }, "us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearSix": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortdurationInsuranceContractsHistoricalClaimsDurationYearSix", "presentation": [ "http://oxbridgere.com/role/ScheduleOfHistoricalAverageAnnualPercentagePayoutDetails" ], "lang": { "en-us": { "role": { "label": "Average Annual Percentage Payout of Incurred Claims by Age, Net of Reinsurance, Year 6", "documentation": "Percentage of average annual payout, after reinsurance, in the sixth year after a claim is incurred, beginning with the earliest accident year disclosed for short-duration insurance contracts." } } }, "auth_ref": [ "r22" ] }, "us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearThree": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortdurationInsuranceContractsHistoricalClaimsDurationYearThree", "presentation": [ "http://oxbridgere.com/role/ScheduleOfHistoricalAverageAnnualPercentagePayoutDetails" ], "lang": { "en-us": { "role": { "label": "Average Annual Percentage Payout of Incurred Claims by Age, Net of Reinsurance, Year 3", "documentation": "Percentage of average annual payout, after reinsurance, in the third year after a claim is incurred, beginning with the earliest accident year disclosed for short-duration insurance contracts." } } }, "auth_ref": [ "r22" ] }, "us-gaap_ShortdurationInsuranceContractsHistoricalClaimsDurationYearTwo": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortdurationInsuranceContractsHistoricalClaimsDurationYearTwo", "presentation": [ "http://oxbridgere.com/role/ScheduleOfHistoricalAverageAnnualPercentagePayoutDetails" ], "lang": { "en-us": { "role": { "label": "Average Annual Percentage Payout of Incurred Claims by Age, Net of Reinsurance, Year 2", "documentation": "Percentage of average annual payout, after reinsurance, in the second year after a claim is incurred, beginning with the earliest accident year disclosed for short-duration insurance contracts." } } }, "auth_ref": [ "r22" ] }, "us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet", "crdr": "credit", "presentation": [ "http://oxbridgere.com/role/ScheduleOfIncurredLossesAndAdjustmentExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Total of Incurred but Not Reported Liabilities Plus Expected Development on Reported Claims", "documentation": "Undiscounted amount, after reinsurance, of incurred-but-not-reported (IBNR) liabilities plus expected development on reported claims, for claims and allocated claim adjustment expense for short-duration insurance contracts. Excludes unallocated claim adjustment expense." } } }, "auth_ref": [ "r19", "r21" ] }, "us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet", "crdr": "credit", "presentation": [ "http://oxbridgere.com/role/ScheduleOfIncurredLossesAndAdjustmentExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Incurred Losses and Loss Adjustment Expenses", "documentation": "Undiscounted amount, after reinsurance, of incurred claims and allocated claim adjustment expense used in claims development for short-duration insurance contracts. Excludes unallocated claim adjustment expense." } } }, "auth_ref": [ "r16" ] }, "us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet", "crdr": "credit", "presentation": [ "http://oxbridgere.com/role/ScheduleOfIncurredLossesAndAdjustmentExpensesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Cumulative Paid Losses and Loss Adjustment Expenses", "label": "Short-Duration Insurance Contracts, Liability for Unpaid Claims and Allocated Claim Adjustment Expense, Net", "documentation": "Undiscounted amount, after reinsurance, of the liability for unpaid claims and allocated claim adjustment expense for short-duration insurance contracts. Excludes unallocated claim adjustment expense." } } }, "auth_ref": [ "r15", "r18" ] }, "us-gaap_ShortdurationInsuranceContractsNumberOfReportedClaims": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortdurationInsuranceContractsNumberOfReportedClaims", "presentation": [ "http://oxbridgere.com/role/ScheduleOfIncurredLossesAndAdjustmentExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Cumulative Number of Reported Claims", "documentation": "Cumulative number of reported claims for short-duration insurance contracts." } } }, "auth_ref": [ "r20" ] }, "us-gaap_ShortdurationInsuranceContractsScheduleOfHistoricalClaimsDurationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortdurationInsuranceContractsScheduleOfHistoricalClaimsDurationTableTextBlock", "presentation": [ "http://oxbridgere.com/role/ReserveForLossesAndLossAdjustmentExpensesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF HISTORICAL AVERAGE ANNUAL PERCENTAGE PAYOUT", "documentation": "Tabular disclosure of average annual percentage payout of incurred claims by age, after reinsurance, for short-duration insurance contracts." } } }, "auth_ref": [ "r22" ] }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SignificantAccountingPoliciesTextBlock", "presentation": [ "http://oxbridgere.com/role/SummaryOfSignificantAccountingPolicies" ], "lang": { "en-us": { "role": { "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "documentation": "The entire disclosure for all significant accounting policies of the reporting entity." } } }, "auth_ref": [ "r97", "r174" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://oxbridgere.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r643" ] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementClassOfStockAxis", "presentation": [ "http://oxbridgere.com/role/Cover", "http://oxbridgere.com/role/InvestmentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]", "documentation": "Information by the different classes of stock of the entity." } } }, "auth_ref": [ "r142", "r160", "r161", "r162", "r175", "r196", "r200", "r202", "r204", "r210", "r211", "r237", "r246", "r248", "r249", "r250", "r253", "r254", "r258", "r259", "r260", "r261", "r262", "r349", "r466", "r467", "r468", "r469", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r482", "r483", "r484", "r485", "r486", "r507", "r529", "r552", "r587", "r588", "r589", "r590", "r591", "r724", "r742", "r747" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://oxbridgere.com/role/StatementsOfChangesInShareholdersEquity", "http://oxbridgere.com/role/VariableInterestEntitiesDetailsNarrative", "http://oxbridgere.com/role/WarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r9", "r29", "r152", "r166", "r167", "r168", "r180", "r181", "r182", "r184", "r190", "r192", "r209", "r238", "r239", "r264", "r313", "r314", "r315", "r325", "r326", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r350", "r351", "r352", "r353", "r354", "r355", "r368", "r448", "r449", "r450", "r475", "r552" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementLineItems", "presentation": [ "http://oxbridgere.com/role/Cover", "http://oxbridgere.com/role/NetWorthForRegulatoryPurposesDetailsNarrative", "http://oxbridgere.com/role/OrganizationAndBasisOfPresentationDetailsNarrative", "http://oxbridgere.com/role/ScheduleIiiSupplementaryInsuranceInformationDetails", "http://oxbridgere.com/role/StatementsOfChangesInShareholdersEquity", "http://oxbridgere.com/role/WarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r180", "r181", "r182", "r209", "r386", "r462", "r486", "r498", "r501", "r502", "r503", "r504", "r505", "r507", "r510", "r511", "r512", "r513", "r514", "r516", "r517", "r518", "r519", "r521", "r522", "r523", "r524", "r525", "r527", "r530", "r531", "r538", "r539", "r540", "r541", "r542", "r543", "r544", "r545", "r546", "r547", "r548", "r549", "r552", "r626" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfStockholdersEquityAbstract", "auth_ref": [] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://oxbridgere.com/role/Cover", "http://oxbridgere.com/role/NetWorthForRegulatoryPurposesDetailsNarrative", "http://oxbridgere.com/role/OrganizationAndBasisOfPresentationDetailsNarrative", "http://oxbridgere.com/role/ScheduleIiiSupplementaryInsuranceInformationDetails", "http://oxbridgere.com/role/StatementsOfChangesInShareholdersEquity", "http://oxbridgere.com/role/WarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Statement [Table]", "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed." } } }, "auth_ref": [ "r180", "r181", "r182", "r209", "r386", "r462", "r486", "r498", "r501", "r502", "r503", "r504", "r505", "r507", "r510", "r511", "r512", "r513", "r514", "r516", "r517", "r518", "r519", "r521", "r522", "r523", "r524", "r525", "r527", "r530", "r531", "r538", "r539", "r540", "r541", "r542", "r543", "r544", "r545", "r546", "r547", "r548", "r549", "r552", "r626" ] }, "OXBR_StatutoryAccountingPracticeStatutoryCapitalAndSurplusRequired": { "xbrltype": "stringItemType", "nsuri": "http://oxbridgere.com/20231231", "localname": "StatutoryAccountingPracticeStatutoryCapitalAndSurplusRequired", "presentation": [ "http://oxbridgere.com/role/NetWorthForRegulatoryPurposesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Minimum prescribed capital requirement description", "documentation": "Statutory Accounting Practice Statutory Capital and Surplus Required." } } }, "auth_ref": [] }, "us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance", "crdr": "credit", "presentation": [ "http://oxbridgere.com/role/NetWorthForRegulatoryPurposesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Subsidiary net worth", "documentation": "The amount of statutory capital and surplus (stockholders' equity) as of the balance sheet date using prescribed or permitted statutory accounting practices (rather than GAAP, if different) of the state or country." } } }, "auth_ref": [ "r69", "r408" ] }, "ecd_StkPrcOrTsrEstimationMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "StkPrcOrTsrEstimationMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Stock Price or TSR Estimation Method [Text Block]" } } }, "auth_ref": [ "r652", "r664", "r674", "r700" ] }, "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesAcquisitions", "presentation": [ "http://oxbridgere.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Number of shares issued", "label": "Stock Issued During Period, Shares, Acquisitions", "documentation": "Number of shares of stock issued during the period pursuant to acquisitions." } } }, "auth_ref": [ "r77", "r78", "r103" ] }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesNewIssues", "presentation": [ "http://oxbridgere.com/role/InvestmentsDetailsNarrative", "http://oxbridgere.com/role/VariableInterestEntitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of shares issued", "documentation": "Number of new stock issued during the period." } } }, "auth_ref": [ "r9", "r77", "r78", "r103", "r466", "r552", "r588" ] }, "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross", "presentation": [ "http://oxbridgere.com/role/StatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Issurance of Restricted stock, net, shares", "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards." } } }, "auth_ref": [ "r9", "r103" ] }, "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardGross", "crdr": "credit", "presentation": [ "http://oxbridgere.com/role/StatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Issuance of Restricted stock, net", "documentation": "Aggregate value of stock related to Restricted Stock Awards issued during the period." } } }, "auth_ref": [ "r9", "r77", "r78", "r103" ] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://oxbridgere.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://oxbridgere.com/role/BalanceSheets", "http://oxbridgere.com/role/ScheduleIiCondensedBalanceSheetParentCompanyOnlyDetails", "http://oxbridgere.com/role/ScheduleOfFinancialStatementsDetails", "http://oxbridgere.com/role/StatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "totalLabel": "Total shareholders\u2019 equity", "periodStartLabel": "Balance", "periodEndLabel": "Balance", "label": "Total shareholder\u2019s equity", "verboseLabel": "Total shareholders\u2019 equity", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r78", "r81", "r82", "r99", "r509", "r526", "r553", "r554", "r618", "r632", "r743", "r753", "r793", "r827" ] }, "us-gaap_StockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityAbstract", "presentation": [ "http://oxbridgere.com/role/BalanceSheets", "http://oxbridgere.com/role/ScheduleIiCondensedBalanceSheetParentCompanyOnlyDetails" ], "lang": { "en-us": { "role": { "label": "Shareholders\u2019 equity:" } } }, "auth_ref": [] }, "OXBR_SubscriptionAgreementsMember": { "xbrltype": "domainItemType", "nsuri": "http://oxbridgere.com/20231231", "localname": "SubscriptionAgreementsMember", "presentation": [ "http://oxbridgere.com/role/VariableInterestEntitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Subscription agreements [Member]", "documentation": "Subscription agreements [Member]" } } }, "auth_ref": [] }, "us-gaap_SubsequentEventMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventMember", "presentation": [ "http://oxbridgere.com/role/RelatedPartyTransactionsDetailsNarrative", "http://oxbridgere.com/role/WarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Subsequent Event [Member]", "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r356", "r379" ] }, "us-gaap_SubsequentEventTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTypeAxis", "presentation": [ "http://oxbridgere.com/role/RelatedPartyTransactionsDetailsNarrative", "http://oxbridgere.com/role/WarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Subsequent Event Type [Axis]", "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r356", "r379" ] }, "us-gaap_SubsequentEventTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTypeDomain", "presentation": [ "http://oxbridgere.com/role/RelatedPartyTransactionsDetailsNarrative", "http://oxbridgere.com/role/WarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r356", "r379" ] }, "us-gaap_SubsequentEventsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventsAbstract", "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SubsequentEventsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventsTextBlock", "presentation": [ "http://oxbridgere.com/role/SubsequentEvents" ], "lang": { "en-us": { "role": { "label": "SUBSEQUENT EVENTS", "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business." } } }, "auth_ref": [ "r378", "r380" ] }, "srt_SubsidiariesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "SubsidiariesMember", "presentation": [ "http://oxbridgere.com/role/ScheduleIiCondensedBalanceSheetParentCompanyOnlyDetails" ], "lang": { "en-us": { "role": { "label": "Subsidiaries [Member]", "documentation": "Entity in which controlling financial interest is held. Includes, but is not limited to, variable interest entity (VIE) consolidated by primary beneficiary. Excludes entity in which broker-dealer holds controlling financial interest but control is likely to be temporary." } } }, "auth_ref": [ "r764", "r798", "r799", "r801" ] }, "us-gaap_SubsidiarySaleOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsidiarySaleOfStockAxis", "presentation": [ "http://oxbridgere.com/role/InvestmentsDetailsNarrative", "http://oxbridgere.com/role/ScheduleOfOtherInvestmentDetails" ], "lang": { "en-us": { "role": { "label": "Sale of Stock [Axis]", "documentation": "Information by type of sale of the entity's stock." } } }, "auth_ref": [] }, "srt_SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesAbstract", "lang": { "en-us": { "role": { "label": "SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesCarryingAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesCarryingAmount", "crdr": "debit", "presentation": [ "http://oxbridgere.com/role/ScheduleI-SummaryOfInvestments-OtherThanInvestmentsInRelatedPartiesDetails" ], "lang": { "en-us": { "role": { "label": "Total investments, Balance sheet value", "documentation": "Amount of investment held by insurance company, excluding investment in related party." } } }, "auth_ref": [ "r585" ] }, "us-gaap_SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesCost", "crdr": "debit", "presentation": [ "http://oxbridgere.com/role/ScheduleI-SummaryOfInvestments-OtherThanInvestmentsInRelatedPartiesDetails" ], "lang": { "en-us": { "role": { "label": "Total investments, Cost or amortized cost", "documentation": "Cost of investment held by insurance company, excluding investment in related party." } } }, "auth_ref": [ "r583" ] }, "us-gaap_SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesFairValue", "crdr": "debit", "presentation": [ "http://oxbridgere.com/role/ScheduleI-SummaryOfInvestments-OtherThanInvestmentsInRelatedPartiesDetails" ], "lang": { "en-us": { "role": { "label": "Total investments, Fair value", "documentation": "Fair value of investment held by insurance company, excluding investment in related party." } } }, "auth_ref": [ "r584" ] }, "srt_SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesReportableDataLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesReportableDataLineItems", "presentation": [ "http://oxbridgere.com/role/ScheduleI-SummaryOfInvestments-OtherThanInvestmentsInRelatedPartiesDetails" ], "lang": { "en-us": { "role": { "label": "SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r144", "r586" ] }, "srt_SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesTable", "presentation": [ "http://oxbridgere.com/role/ScheduleI-SummaryOfInvestments-OtherThanInvestmentsInRelatedPartiesDetails" ], "lang": { "en-us": { "role": { "label": "SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Table]", "documentation": "Disclosure of information about investment held by insurance company, excluding investment in related party." } } }, "auth_ref": [ "r144", "r586" ] }, "srt_SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesTextBlock", "presentation": [ "http://oxbridgere.com/role/ScheduleI-SummaryOfInvestments-OtherThanInvestmentsInRelatedParties" ], "lang": { "en-us": { "role": { "label": "Schedule I - Summary of Investments - Other Than Investments in Related Parties", "documentation": "The entire disclosure of information about investment held by insurance company, excluding investment in related party." } } }, "auth_ref": [ "r144", "r586" ] }, "us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense", "crdr": "debit", "calculation": { "http://oxbridgere.com/role/ScheduleOfLossAdjustmentExpenseDetails": { "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://oxbridgere.com/role/ScheduleOfLossAdjustmentExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Current year", "documentation": "Amount, after effects of reinsurance, of expense for claims incurred in the current reporting period and related claims settlement costs." } } }, "auth_ref": [ "r444" ] }, "us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense", "crdr": "debit", "calculation": { "http://oxbridgere.com/role/ScheduleOfLossAdjustmentExpenseDetails": { "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://oxbridgere.com/role/ScheduleOfLossAdjustmentExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Prior year", "documentation": "Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred in prior reporting periods and related claims settlement costs." } } }, "auth_ref": [ "r444" ] }, "srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesAbstract", "lang": { "en-us": { "role": { "label": "SEC Schedule, 12-17, Insurance Companies, Reinsurance [Abstract]" } } }, "auth_ref": [] }, "srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock", "presentation": [ "http://oxbridgere.com/role/ScheduleIv-ReinsuranceInformation" ], "lang": { "en-us": { "role": { "label": "Schedule IV - Reinsurance Information", "documentation": "The entire disclosure for the supplemental schedule of reinsurance information. Reinsurance schedule includes, but is not limited to, the type of insurance, gross amount of premiums, premiums ceded to other entities, premiums assumed from other entities, net amount of premium revenue, and the percentage of the premiums assumed to net premium revenue." } } }, "auth_ref": [ "r146", "r440" ] }, "srt_SupplementaryInsuranceInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "SupplementaryInsuranceInformationAbstract", "lang": { "en-us": { "role": { "label": "SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SupplementaryInsuranceInformationAmortizationOfDeferredPolicyAcquisitionCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplementaryInsuranceInformationAmortizationOfDeferredPolicyAcquisitionCosts", "crdr": "debit", "presentation": [ "http://oxbridgere.com/role/ScheduleIiiSupplementaryInsuranceInformationDetails" ], "lang": { "en-us": { "role": { "label": "Amortization of deferred acquisition costs", "documentation": "Amount of amortization of deferred policy acquisition cost recognized, as disclosed in supplementary insurance information." } } }, "auth_ref": [ "r431" ] }, "us-gaap_SupplementaryInsuranceInformationBenefitsClaimsLossesAndSettlementExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplementaryInsuranceInformationBenefitsClaimsLossesAndSettlementExpense", "crdr": "debit", "presentation": [ "http://oxbridgere.com/role/ScheduleIiiSupplementaryInsuranceInformationDetails" ], "lang": { "en-us": { "role": { "label": "Net losses, and loss adjustment expenses", "documentation": "Amount of insurance benefit, claim, loss and settlement expenses incurred, as disclosed in supplementary insurance information." } } }, "auth_ref": [ "r430" ] }, "us-gaap_SupplementaryInsuranceInformationDeferredPolicyAcquisitionCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplementaryInsuranceInformationDeferredPolicyAcquisitionCosts", "crdr": "debit", "presentation": [ "http://oxbridgere.com/role/ScheduleIiiSupplementaryInsuranceInformationDetails" ], "lang": { "en-us": { "role": { "label": "Deferred acquisition costs, net", "documentation": "Amount of deferred policy acquisition cost capitalized on contract remaining in force, as disclosed in supplementary insurance information." } } }, "auth_ref": [ "r425" ] }, "srt_SupplementaryInsuranceInformationForInsuranceCompaniesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "SupplementaryInsuranceInformationForInsuranceCompaniesDisclosureTextBlock", "presentation": [ "http://oxbridgere.com/role/ScheduleIii-SupplementaryInsuranceInformation" ], "lang": { "en-us": { "role": { "label": "Schedule III - Supplementary Insurance Information", "documentation": "The entire disclosure for supplementary insurance information by segment. Includes, but is not limited to, deferred policy acquisition cost; future policy benefit, loss, claim and loss expenses; unearned premium; other policy claim and benefit payable; premium revenue; net investment income; benefit, claim, loss and settlement expenses; amortization of deferred policy acquisition cost; other operating expense; and premium written." } } }, "auth_ref": [ "r136", "r137", "r145" ] }, "us-gaap_SupplementaryInsuranceInformationLiabilityForFuturePolicyBenefitsLossesClaimsAndLossExpenseReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplementaryInsuranceInformationLiabilityForFuturePolicyBenefitsLossesClaimsAndLossExpenseReserves", "crdr": "credit", "presentation": [ "http://oxbridgere.com/role/ScheduleIiiSupplementaryInsuranceInformationDetails" ], "lang": { "en-us": { "role": { "label": "Reserves for losses and loss adjustment expenses - gross", "documentation": "Amount of reserve for future policy claim payable and loss expense to be incurred, disclosed in supplementary insurance information." } } }, "auth_ref": [ "r426" ] }, "us-gaap_SupplementaryInsuranceInformationNetInvestmentIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplementaryInsuranceInformationNetInvestmentIncome", "crdr": "credit", "presentation": [ "http://oxbridgere.com/role/ScheduleIiiSupplementaryInsuranceInformationDetails" ], "lang": { "en-us": { "role": { "label": "Investment income (loss)", "documentation": "Amount of net investment income earned, disclosed in supplementary insurance information." } } }, "auth_ref": [ "r429" ] }, "us-gaap_SupplementaryInsuranceInformationOtherOperatingExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplementaryInsuranceInformationOtherOperatingExpense", "crdr": "debit", "presentation": [ "http://oxbridgere.com/role/ScheduleIiiSupplementaryInsuranceInformationDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Operating expenses", "label": "SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information, Other Operating Expense", "documentation": "Amount of operating expense classified as other, disclosed in supplementary insurance information." } } }, "auth_ref": [ "r432" ] }, "us-gaap_SupplementaryInsuranceInformationPremiumRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplementaryInsuranceInformationPremiumRevenue", "crdr": "credit", "presentation": [ "http://oxbridgere.com/role/ScheduleIiiSupplementaryInsuranceInformationDetails" ], "lang": { "en-us": { "role": { "label": "Net premiums earned", "documentation": "Amount of premium revenue earned, disclosed in supplementary insurance information." } } }, "auth_ref": [ "r428" ] }, "us-gaap_SupplementaryInsuranceInformationPremiumsWritten": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplementaryInsuranceInformationPremiumsWritten", "crdr": "credit", "presentation": [ "http://oxbridgere.com/role/ScheduleIiiSupplementaryInsuranceInformationDetails" ], "lang": { "en-us": { "role": { "label": "Gross premiums written", "documentation": "Amount, after premiums ceded and assumed, of premium written, disclosed in supplementary insurance information." } } }, "auth_ref": [ "r433" ] }, "us-gaap_SupplementaryInsuranceInformationUnearnedPremiums": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplementaryInsuranceInformationUnearnedPremiums", "crdr": "credit", "presentation": [ "http://oxbridgere.com/role/ScheduleIiiSupplementaryInsuranceInformationDetails" ], "lang": { "en-us": { "role": { "label": "Unearned premiums - gross", "documentation": "Amount of premium not yet earned, disclosed in supplementary insurance information." } } }, "auth_ref": [ "r427" ] }, "OXBR_SurancePlusFeeIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://oxbridgere.com/20231231", "localname": "SurancePlusFeeIncomeMember", "presentation": [ "http://oxbridgere.com/role/ScheduleOfFinancialStatementsDetails" ], "lang": { "en-us": { "role": { "label": "Surance Plus Fee Income [Member]", "documentation": "Surance Plus Fee Income [Member]" } } }, "auth_ref": [] }, "OXBR_SurancePlusFeeIncomePolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://oxbridgere.com/20231231", "localname": "SurancePlusFeeIncomePolicyTextBlock", "presentation": [ "http://oxbridgere.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "SurancePlus Fee Income", "documentation": "SurancePlus Fee Income [Policy Text Block]" } } }, "auth_ref": [] }, "OXBR_SurancePlusIncMember": { "xbrltype": "domainItemType", "nsuri": "http://oxbridgere.com/20231231", "localname": "SurancePlusIncMember", "presentation": [ "http://oxbridgere.com/role/OrganizationAndBasisOfPresentationDetailsNarrative", "http://oxbridgere.com/role/ScheduleOfFinancialStatementsDetails", "http://oxbridgere.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://oxbridgere.com/role/VariableInterestEntitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Surance Plus Inc [Member]", "documentation": "Surance Plus Inc [Member]" } } }, "auth_ref": [] }, "ecd_TabularListTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TabularListTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Tabular List [Table Text Block]" } } }, "auth_ref": [ "r693" ] }, "OXBR_ThirdPartyInvestorsMember": { "xbrltype": "domainItemType", "nsuri": "http://oxbridgere.com/20231231", "localname": "ThirdPartyInvestorsMember", "presentation": [ "http://oxbridgere.com/role/VariableInterestEntitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Third Party Investors [Member]", "documentation": "Third Party Investors [Member]" } } }, "auth_ref": [] }, "srt_TitleOfIndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "TitleOfIndividualAxis", "presentation": [ "http://oxbridgere.com/role/RelatedPartyTransactionsDetailsNarrative", "http://oxbridgere.com/role/VariableInterestEntitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]", "documentation": "Information by title of individual or nature of relationship to individual or group of individuals." } } }, "auth_ref": [ "r749", "r800" ] }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "presentation": [ "http://oxbridgere.com/role/RelatedPartyTransactionsDetailsNarrative", "http://oxbridgere.com/role/VariableInterestEntitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Title of individual, or nature of relationship to individual or group of individuals." } } }, "auth_ref": [] }, "ecd_TotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Amount" } } }, "auth_ref": [ "r685" ] }, "ecd_TotalShareholderRtnVsPeerGroupTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnVsPeerGroupTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Vs Peer Group [Text Block]" } } }, "auth_ref": [ "r692" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://oxbridgere.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "OXBR_TransferToLevelOne": { "xbrltype": "monetaryItemType", "nsuri": "http://oxbridgere.com/20231231", "localname": "TransferToLevelOne", "crdr": "credit", "presentation": [ "http://oxbridgere.com/role/ScheduleOfReconciliationOfChangesInFairValueDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Transfer to Level 1", "label": "TransferToLevelOne" } } }, "auth_ref": [] }, "ecd_TrdArrAdoptionDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrAdoptionDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Adoption Date" } } }, "auth_ref": [ "r716" ] }, "ecd_TrdArrDuration": { "xbrltype": "durationItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrDuration", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Arrangement Duration" } } }, "auth_ref": [ "r717" ] }, "ecd_TrdArrIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Name" } } }, "auth_ref": [ "r715" ] }, "ecd_TrdArrIndTitle": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndTitle", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Title" } } }, "auth_ref": [ "r715" ] }, "ecd_TrdArrSecuritiesAggAvailAmt": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrSecuritiesAggAvailAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Aggregate Available" } } }, "auth_ref": [ "r718" ] }, "ecd_TrdArrTerminationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrTerminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Termination Date" } } }, "auth_ref": [ "r716" ] }, "OXBR_TwoThousandFourteenOmnibusIncentivePlanMember": { "xbrltype": "domainItemType", "nsuri": "http://oxbridgere.com/20231231", "localname": "TwoThousandFourteenOmnibusIncentivePlanMember", "presentation": [ "http://oxbridgere.com/role/Share-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "2014 Omnibus Incentive Plan [Member]", "documentation": "Two Thousand Fourteen Omnibus Incentive Plan [Member]" } } }, "auth_ref": [] }, "OXBR_TwoThousandTwentyOneOmnibusIncentivePlanMember": { "xbrltype": "domainItemType", "nsuri": "http://oxbridgere.com/20231231", "localname": "TwoThousandTwentyOneOmnibusIncentivePlanMember", "presentation": [ "http://oxbridgere.com/role/Share-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "2021 Omnibus Incentive Plan [Member]", "documentation": "Two Thousand Twenty One Omnibus Incentive Plan [Member]" } } }, "auth_ref": [] }, "us-gaap_TypeOfArrangementAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TypeOfArrangementAxis", "presentation": [ "http://oxbridgere.com/role/RelatedPartyTransactionsDetailsNarrative", "http://oxbridgere.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://oxbridgere.com/role/VariableInterestEntitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]", "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r332" ] }, "us-gaap_UnderwritingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnderwritingIncomeLoss", "crdr": "credit", "presentation": [ "http://oxbridgere.com/role/ScheduleIiCondensedStatementOfCashFlows-ParentCompanyOnlyDetails", "http://oxbridgere.com/role/ScheduleOfFinancialStatementsDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Underwriting profit", "verboseLabel": "Underwriting Income \u2013 SurancePlus", "documentation": "The difference between the price paid by the public and the contract price less the related expenses. A broker-dealer may underwrite a security offering by contracting to buy the issue either at a fixed price or a price based on selling the offering on a best-effort basis." } } }, "auth_ref": [] }, "OXBR_UnderwritingRelatedIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://oxbridgere.com/20231231", "localname": "UnderwritingRelatedIncomeMember", "presentation": [ "http://oxbridgere.com/role/ScheduleOfFinancialStatementsDetails" ], "lang": { "en-us": { "role": { "label": "Underwriting Related Income [Member]", "documentation": "Underwriting Related Income [Member]" } } }, "auth_ref": [] }, "ecd_UndrlygSecurityMktPriceChngPct": { "xbrltype": "pureItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "UndrlygSecurityMktPriceChngPct", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Underlying Security Market Price Change, Percent" } } }, "auth_ref": [ "r712" ] }, "us-gaap_UnearnedPremiums": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnearnedPremiums", "crdr": "credit", "calculation": { "http://oxbridgere.com/role/BalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://oxbridgere.com/role/BalanceSheets", "http://oxbridgere.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Unearned premiums reserve", "verboseLabel": "Unearned premiums", "documentation": "Carrying amount of premiums written on insurance contracts that have not been earned as of the balance sheet date." } } }, "auth_ref": [ "r139" ] }, "OXBR_UnearnedPremiumsCededPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://oxbridgere.com/20231231", "localname": "UnearnedPremiumsCededPolicyTextBlock", "presentation": [ "http://oxbridgere.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Unearned Premiums Ceded", "documentation": "Unearned Premiums Ceded [Policy Text Block]" } } }, "auth_ref": [] }, "us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy", "presentation": [ "http://oxbridgere.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Reserves for losses and loss adjustment expenses", "documentation": "Disclosure of accounting policy for estimating the ultimate cost of settling insurance claims relating to insured events that have occurred on or before a particular date (ordinarily, the statement of financial position date). The estimated liability includes the amount of money that will be required for future payments of (a) claims that have been reported to the insurer, (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated, and (c) claim adjustment expenses. Claims adjustment expenses include costs incurred in the claim settlement process such as legal fees; outside adjuster fees; and costs to record, process, and adjust claims." } } }, "auth_ref": [ "r443", "r445" ] }, "us-gaap_UnrealizedGainLossOnInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrealizedGainLossOnInvestments", "crdr": "credit", "calculation": { "http://oxbridgere.com/role/StatementsOfOperations": { "parentTag": "us-gaap_Revenues", "weight": 1.0, "order": 5.0 }, "http://oxbridgere.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://oxbridgere.com/role/InvestmentsDetailsNarrative", "http://oxbridgere.com/role/ScheduleOfOtherInvestmentDetails", "http://oxbridgere.com/role/StatementsOfCashFlows", "http://oxbridgere.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Unrealized loss on other investments", "negatedLabel": "Change in fair value of other investments", "verboseLabel": "Unrealized loss on investment in affiliate", "negatedTerseLabel": "Unrealized loss on other investments", "documentation": "Amount of unrealized gain (loss) on investment." } } }, "auth_ref": [ "r5" ] }, "us-gaap_UseOfEstimates": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UseOfEstimates", "presentation": [ "http://oxbridgere.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Use of Estimates", "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles." } } }, "auth_ref": [ "r39", "r40", "r41", "r129", "r130", "r132", "r133" ] }, "us-gaap_VariableInterestEntityDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableInterestEntityDisclosureTextBlock", "presentation": [ "http://oxbridgere.com/role/VariableInterestEntities" ], "lang": { "en-us": { "role": { "label": "VARIABLE INTEREST ENTITIES", "documentation": "The entire disclosure for a variable interest entity (VIE), including but not limited to, judgments and assumptions in determining whether to consolidate and in identifying the primary beneficiary, gain (loss) recognized on the initial consolidation of the VIE, terms of arrangements, amounts and classification of the VIE's assets and liabilities, and the entity's maximum exposure to loss." } } }, "auth_ref": [ "r105" ] }, "us-gaap_VehiclesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VehiclesMember", "presentation": [ "http://oxbridgere.com/role/ScheduleOfPropertyAndEquipmentnetDetails" ], "lang": { "en-us": { "role": { "label": "Vehicles [Member]", "documentation": "Equipment used primarily for road transportation." } } }, "auth_ref": [] }, "us-gaap_WarrantMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WarrantMember", "presentation": [ "http://oxbridgere.com/role/WarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrant [Member]", "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount." } } }, "auth_ref": [ "r623", "r624", "r627", "r628", "r629", "r630" ] }, "us-gaap_WarrantsAndRightsOutstandingMaturityDate": { "xbrltype": "dateItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WarrantsAndRightsOutstandingMaturityDate", "presentation": [ "http://oxbridgere.com/role/WarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrant expiration date", "documentation": "Expiration date of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in YYYY-MM-DD format." } } }, "auth_ref": [ "r792" ] }, "OXBR_WarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://oxbridgere.com/20231231", "localname": "WarrantsMember", "presentation": [ "http://oxbridgere.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Warrants" } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "presentation": [ "http://oxbridgere.com/role/ScheduleOfComputationOfBasicAndDilutedLossEarningPerShareDetails", "http://oxbridgere.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Weighted average number of shares outstanding, diluted", "verboseLabel": "Weighted average shares - diluted", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r195", "r204" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "presentation": [ "http://oxbridgere.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Weighted-average shares outstanding" } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "presentation": [ "http://oxbridgere.com/role/ScheduleOfComputationOfBasicAndDilutedLossEarningPerShareDetails", "http://oxbridgere.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Weighted average number of shares outstanding, basic", "verboseLabel": "Weighted average shares - basic", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r194", "r204" ] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://oxbridgere.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r722" ] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "SubTopic": "20", "Topic": "940", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(g)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "20", "Topic": "715", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1B" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(2)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-3" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4B" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(a)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4B" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(b)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4B" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4C" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4D" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(b)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4D" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4E", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4E" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4G", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4G" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Subparagraph": "(c)", "Paragraph": "2", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19-26)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29-31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-4" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-5" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-5" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-2" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-3" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-4" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-12" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-13" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-3" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4J", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "820", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "820", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "850", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "850", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.15)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "470", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "944", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03.(a),1(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "944", "SubTopic": "40", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-3" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "944", "SubTopic": "505", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479989/944-505-50-1" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "944", "SubTopic": "605", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479655/944-605-50-1" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//205/tableOfContent" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 201.5-02(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 201.5-02(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 201.5-02(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.18)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r89": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r90": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.7(a),(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r91": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.8)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r92": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r93": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r94": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r95": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r96": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r97": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//235/tableOfContent" }, "r98": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "275", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//275/tableOfContent" }, "r99": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2" }, "r100": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//360/tableOfContent" }, "r101": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-15" }, "r102": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r103": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r104": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(e)(1)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r105": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//810/tableOfContent" }, "r106": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-23" }, "r107": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r108": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r109": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r110": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r111": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r112": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r113": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r114": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r115": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r116": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(13)(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r117": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r118": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r119": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04.5,6,7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r120": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-3" }, "r121": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-3" }, "r122": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(cc)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-3" }, "r123": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-1" }, "r124": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-1" }, "r125": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "10", "Topic": "321", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479567/321-10-45-1" }, "r126": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "825", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479408/944-825-45-1" }, "r127": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "SubTopic": "220", "Topic": "946", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-5" }, "r128": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "270", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482964/270-10-50-1" }, "r129": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r130": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r131": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1" }, "r132": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11" }, "r133": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12" }, "r134": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6" }, "r135": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-7" }, "r136": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column G)(Footnote 3))", "SubTopic": "235", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r137": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column J)(Footnote 3))", "SubTopic": "235", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r138": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22(a)(2))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r139": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(13)(a)(2))", "SubTopic": "210", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r140": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(1))", "SubTopic": "220", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r141": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(13)(c))", "SubTopic": "220", "Topic": "942", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r142": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(a)", "Publisher": "SEC" }, "r143": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "04", "Paragraph": "a", "Publisher": "SEC" }, "r144": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "15", "Publisher": "SEC" }, "r145": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "16", "Publisher": "SEC" }, "r146": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "17", "Publisher": "SEC" }, "r147": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Footnote": "4", "Publisher": "SEC" }, "r148": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "5", "Subsection": "04", "Paragraph": "c", "Subparagraph": "Schedule I", "Publisher": "SEC" }, "r149": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "7", "Subsection": "05", "Paragraph": "c", "Subparagraph": "Schedule II", "Publisher": "SEC" }, "r150": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "9", "Subsection": "06", "Publisher": "SEC" }, "r151": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Staff Accounting Bulletin (SAB)", "Number": "Topic 5", "Section": "FF", "Subsection": "Q2", "Publisher": "SEC" }, "r152": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.5-04(Schedule I))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480922/205-10-S99-6" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(3)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-19" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//260/tableOfContent" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-22" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-23" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "26", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-26" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481664/323-10-45-1" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(n)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//718/tableOfContent" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-2" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.C.Q3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.1.Q5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.2.Q6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.3.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.F)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//740/tableOfContent" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 11.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "270", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "808", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482736/825-10-45-1A" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//842-20/tableOfContent" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//850/tableOfContent" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-6" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481435/852-10-45-14" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//855/tableOfContent" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "33", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "33", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "35A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "35A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r417": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r418": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(2)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r419": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r420": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r421": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r422": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r423": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(3)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r424": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r425": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r426": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r427": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r428": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r429": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r430": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r431": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r432": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column J))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r433": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column K))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r434": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r435": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r436": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r437": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r438": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r439": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r440": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r441": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B" }, "r442": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B" }, "r443": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-1" }, "r444": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-3" }, "r445": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4" }, "r446": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4B" }, "r447": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A" }, "r448": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r449": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r450": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r451": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r452": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r453": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r454": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "605", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479686/944-605-45-1" }, "r455": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "605", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479655/944-605-50-1" }, "r456": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "605", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479655/944-605-50-1" }, "r457": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "605", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479655/944-605-50-1" }, "r458": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "605", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479655/944-605-50-1" }, "r459": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "605", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479655/944-605-50-1" }, "r460": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "605", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479655/944-605-50-1" }, "r461": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "605", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479655/944-605-50-1" }, "r462": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r463": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(f)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r464": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(f)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r465": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(f)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r466": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r467": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r468": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r469": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r470": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11" }, "r471": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13" }, "r472": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-2" }, "r473": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-5" }, "r474": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-6" }, "r475": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r476": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2" }, "r477": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "27", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27" }, "r478": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r479": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r480": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r481": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r482": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r483": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r484": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r485": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r486": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4" }, "r487": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r488": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r489": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r490": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r491": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r492": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-2" }, "r493": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r494": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r495": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r496": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r497": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r498": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r499": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(10)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r500": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r501": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r502": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r503": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r504": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r505": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r506": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r507": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r508": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r509": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r510": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r511": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r512": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r513": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r514": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r515": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(5)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r516": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r517": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r518": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r519": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r520": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r521": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r522": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r523": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r524": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r525": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r526": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r527": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r528": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7" }, "r529": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3" }, "r530": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r531": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r532": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r533": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r534": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r535": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r536": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r537": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r538": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r539": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r540": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r541": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r542": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r543": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r544": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r545": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r546": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r547": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r548": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r549": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r550": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r551": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r552": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r553": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r554": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r555": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r556": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r557": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r558": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r559": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r560": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r561": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r562": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r563": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "12", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-12" }, "r564": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "19", "Subparagraph": "(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-19" }, "r565": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r566": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r567": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r568": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r569": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r570": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r571": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r572": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r573": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r574": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5D", "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5D" }, "r575": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5D", "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5D" }, "r576": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r577": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r578": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r579": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r580": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r581": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r582": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SX 210.12-15(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7" }, "r583": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SX 210.12-15(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7" }, "r584": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SX 210.12-15(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7" }, "r585": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SX 210.12-15(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7" }, "r586": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SX 210.12-15)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7" }, "r587": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1" }, "r588": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r589": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r590": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r591": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r592": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r593": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1" }, "r594": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1" }, "r595": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r596": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(a)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r597": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r598": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r599": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r600": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52" }, "r601": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r602": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r603": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482785/280-10-55-47" }, "r604": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A" }, "r605": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r606": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B" }, "r607": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C" }, "r608": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r609": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r610": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r611": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r612": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17" }, "r613": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r614": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6" }, "r615": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8" }, "r616": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r617": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "53", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53" }, "r618": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10" }, "r619": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479401/944-30-55-2" }, "r620": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F" }, "r621": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "605", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479629/944-605-55-12" }, "r622": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "605", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479629/944-605-55-15" }, "r623": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r624": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r625": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1" }, "r626": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r627": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r628": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r629": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r630": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r631": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10" }, "r632": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12" }, "r633": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r634": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r635": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r636": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r637": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r638": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r639": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r640": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r641": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r642": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r643": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r644": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r645": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r646": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r647": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16", "Subsection": "J", "Paragraph": "a" }, "r648": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1" }, "r649": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i" }, "r650": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r651": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r652": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r653": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r654": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r655": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii" }, "r656": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "iii" }, "r657": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "2" }, "r658": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii", "Section": "6" }, "r659": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r660": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a" }, "r661": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1" }, "r662": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r663": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r664": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r665": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r666": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r667": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "2" }, "r668": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "3" }, "r669": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "b" }, "r670": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a" }, "r671": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1" }, "r672": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r673": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r674": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r675": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r676": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r677": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "2" }, "r678": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "3" }, "r679": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "b" }, "r680": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r681": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v" }, "r682": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "1" }, "r683": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "ii" }, "r684": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii" }, "r685": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iv" }, "r686": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "vi" }, "r687": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "3" }, "r688": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "4" }, "r689": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "i" }, "r690": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "ii" }, "r691": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iii" }, "r692": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iv" }, "r693": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6" }, "r694": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6", "Subparagraph": "i" }, "r695": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w" }, "r696": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1" }, "r697": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i" }, "r698": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r699": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r700": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r701": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r702": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r703": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "ii" }, "r704": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "iii" }, "r705": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "2" }, "r706": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "1" }, "r707": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2" }, "r708": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "A" }, "r709": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "C" }, "r710": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "D" }, "r711": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "E" }, "r712": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "F" }, "r713": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a" }, "r714": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "1" }, "r715": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "A" }, "r716": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "B" }, "r717": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "C" }, "r718": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "D" }, "r719": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "b", "Paragraph": "1" }, "r720": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r721": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r722": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r723": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" }, "r724": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3" }, "r725": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-11" }, "r726": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "SubTopic": "20", "Topic": "842", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3" }, "r727": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4H", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H" }, "r728": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Topic": "321", "Publisher": "FASB", "URI": "https://asc.fasb.org//321/tableOfContent" }, "r729": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Topic": "325", "Publisher": "FASB", "URI": "https://asc.fasb.org//325/tableOfContent" }, "r730": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "01", "Paragraph": "(a)", "Subparagraph": "(4)(i)", "Publisher": "SEC" }, "r731": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "01", "Paragraph": "(a)", "Subparagraph": "(4)(iv)", "Publisher": "SEC" }, "r732": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "02", "Paragraph": "(a)", "Subparagraph": "(4)(iv)", "Publisher": "SEC" }, "r733": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "205", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483504/205-10-50-1" }, "r734": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r735": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r736": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r737": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r738": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r739": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r740": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r741": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r742": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r743": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r744": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r745": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r746": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r747": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "55", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55" }, "r748": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r749": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-13" }, "r750": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//320/tableOfContent" }, "r751": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9" }, "r752": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-4" }, "r753": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r754": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10" }, "r755": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r756": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r757": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r758": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r759": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r760": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r761": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r762": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r763": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r764": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(n)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r765": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r766": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r767": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r768": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r769": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r770": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r771": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r772": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r773": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r774": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r775": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r776": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r777": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r778": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r779": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r780": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r781": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r782": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r783": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r784": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r785": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r786": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r787": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r788": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r789": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r790": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r791": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r792": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r793": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r794": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3" }, "r795": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3" }, "r796": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r797": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6" }, "r798": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r799": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r800": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2" }, "r801": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r802": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r803": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r804": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r805": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r806": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r807": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r808": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r809": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r810": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r811": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r812": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(5)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r813": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(5)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r814": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(5)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r815": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r816": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r817": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B" }, "r818": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "310", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//944-310/tableOfContent" }, "r819": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "9C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-9C" }, "r820": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r821": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r822": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r823": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r824": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r825": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r826": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r827": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r828": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" } } } ZIP 94 0001493152-24-011313-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-24-011313-xbrl.zip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

M$/_8XUCL,AYS'-B:+FD*B(L*D6@Q&)S3[]AU]B.G=L(PCDD]@C_V0QP2^X.6 M:[*OY^8=AR6*G[&1ZZ\;W 5]2I\F,[*8B@=Q*&>"AQ!L]Z/<)EK-/=X)\4[R M%J,F?.K+Y&OR/;I=EX4F+8+E=NEMM'[/]NL;?SF9[$/>;'*N(94(G@"! ]6, MCJV(':8K4>.DOXV_Q7PG?8=6G,[MZ&^HK_79U7=R*Q^YO1I1D/5.ST/']8'F M"V\*Z )DJ:ULPDY=<^>"A?2#1+]7.9!TE\552+^7OS@ R=T0^*\KKXGIN/ @ M=>/6*GG#AN+K(*9PX%:B9O>=RS<.R?CVE'WX]"%W6@W@#[D0OS'44LZ^]4>> M[$H+]"#T2)2WRFYYJ[(ZQ%RTO8\.4]B3\>4O\]N<;>R##DQ\%3='PKZ S4D( M2[62(2RKLTUCUY+6L6S7T9 MW+*VZ&M97;4MU3"ONNAK.1Z:.]E>9AUD3.&)0G],X*.S1\B9B=EA?,TO*6V^ MYF'?W\=J_0_^WO6_%228TEUI_4\_?^'K>NP/]Z5<_Q-?%D*_.'ERRF$7A'[Y M"/V+(T%!Z)>!T+^\+EF0_-_9>S,&C ]M/>!K7D=#%$'N#@,V4,4K-4F,>2L M7>#$Q&:\$A;(0UJP9Z5ZH+"@+2[ A1=C5>0WCP=YV_&:SI;JP>*<+5,#]=<% M)QSF?CQE/R;(M$$G&9CETNJN-A1:A>R)B6 MG+:"&(-4Y!++6@E"M(@!I>'+$PV:8WA@%3UK_NQR\Y MS=<@"L(_6-^UO3=S]XD)Y"Q\[8[\P7QDJ9AE2FF$P]5' [U^X!6( %Q4%>!' M(_V7'!4U=R<*X75V;$K4'X;5".OG/M8"%>5_AG@?0%TJ^$+# #^EZ$[@WL)0V:=LS+KB2JW E77!E86G1.71E0O0=US.@W!T%D1K M4)7K>8B1MPMOB6(46+!D6/ JM(!TB*-LW3HI)&>#/\6#;Q5-IF_32\G&V;!4 M_33>$M$JT+5 UR6GKHD/VG)%^<^6/XPC?LINF%==?81,EG4T2CY^@5FLT.Z/ M:)%C?NCIV["NA.LQF% K,$';AK>,"5L%)FC;L*Z8,)XG7G"')>4.+UZDIN . M2\H=E@(3"NZP!-QAX9@P7J&PP(0EQ83%%2U\,&&_P(EEPHDECN=YL$91@4E+ MBTG+5;;HL2F@VWB\N_M[JXP]1S%W?6R-G@; O,5,3S'!9!Q5D>^[=%BP2#&D M4J[LE+?8I#&6Q0W>8*9JPPI+LG-'LL4K6E1NAAM7R'??&=6++ MTR:^_R#F L)CBF3<=]*O>=UVM:OSV.NVNYCKIC==?=PENV]3'W<1BTNV'!B^ M!#=]8:++[J)%EZ=SIX+O+/^5*(A^(7:_01)5'/,;N?FS\*^KOAN*'(2$Z1?8 M\X0IGYWG,77C"Z1^/E*K" G85[;*]>)>$9$?669=W^$"8Y]=8#?GMQ/&X.=@ ML,(IO:]DO+H( R>VH_.PS<(;UYY2X7EL?PL'WLS(>^T[++P-WY+;%1@\ M;PQ^8),+-+XG4[[0CM8I%>LQE"EM@Y,*W\6Y/V'*Y^@U>>\4J%CH)*^"A*^E MH+QD]Z?=L<2 =C\((P=. W>GI=H<->#%$':,UVV;D.(O9H7X]NKB8J*L/G[! M6>QXUDZ]#AJI4UX<&NT5:/0&T&AQ,><2C?8+-'H#:+2_:#0Z*-#H#:#1P:)% M\TJ!1NN/1NJ4%X=&XYG]!1JM(QHMKBS E%(A!1JM(QJ]>(W" HW6$8T6;C?* M5?B/'[LY>V\=C9ZZ4V]*X2_0:,W0Z'44_@*-U@R-7D?A+]!HO=#HE13^ HW6 M#(U>1^$OT&C-T.AU%/X"C=8,C1:N\,^FJ>T7:/2TG2HTM0*-5A>-EEQ3*]!H M)=!HV36U HU6 XV67%,KT&@UT&C)-;4"C58#C1:NJ3U-Q![;FX,"BYZT486 M72#1BB+1LHG7!1*M(A(MF7!=(-$J(M&2B=8%$JTB$BT\57L6F:A6*9#H21M5 MR$0%$JTJ$BVU3%0@T6H@T5++1 42K082+5PFFHF=K4&W^Y=!HFK!S@HD6FTD M6FYV5B#12B#1PMG93)2H5B#1DS:JH$0%$JTJ$BTW)=HJD.A)&U50H@*)5A6) MEEO%+Y!H)9#HQ51\6>;X(@Q@L&C4L"*+1_!'GUTR5VW1ZN/,A6?Y9]9 K[[_ MF"6O'1^:VA-"$9-&,!@$?CL*[)]BK=MP/%N[>]55/OTZC.JX7ARY-ZS-[!A; M+C#>O+.]V&$.[@GVQ(DC(@SGW:85^J[?XQMD!V-\@?(4I>)G7M)Y%GB M_@T2Y6H)RHU+T@7*K3[*U9Z!?R+(/*ZA5V:]ZRH- MCU.3XI#725Z1A[R-Y*5V,)UEI,I0W.'L[QBW[8:](31X.BMX$A#97<6VSF.J M5=ZVOQ(V2F19G/0L)RCPLL#+!_$R(R6-8>:CI*2Q=UZP/^#5;7#5#V)N^^I^'1U"VL>G?ML^J9J_=YX M%+IVQ!R-BJPONCUB:^9*0NNW5NA,$L[<72\0_9Y.<4\[PP*!UU 7+1CH\C/0 M%\&'!\WLGYG/0LNK^T[=&;B^"\36PCUIW@UA<]? X2(:&2=*PFE@DZ4SRV0> MM0L%TWF<&;U J>5'J>4RDS](I7*%P+>#<',5C=\8IJ\8\2PPO<#TM:#I4UR? M!7X7^+UD.M(4_VV!J06F+J<3>LRZ3.*XW^MXU]%/:- FF5"FJ46V2=0Y:R]WLBAUO>&68C: M HQ\WMG:.2B.NF 7!8(4K&$*:^AV76"ES%H'A9>6H7+P8LN[8N% 1XWQM:X= ME\@_8U#XQ8Y;WMLXZ/P%K]UI/R039.TJ;1;> /KS>B]D9)99?31 V]9YMXY) M"SU:DH8#CUI\(3L\2G8H$&EI$6FI98S4#N_!!,X%P#9:?6315W,%&,.!!TU8 MMR>7O';L9ZK3I3CLM?5;5+.,X6OXFS7Z:CG]>'5/FH?1QRLW\H !M'S'O7$= M$"@U^C^^QE\=D?^ M$*$O#G\)%+HE90"5@W(U090CLK"/[5BB +3\&P:/A>N-.KE[\"#6S$'UX$L)I+=^U>C8(0M"Z5@!^7*?H&8!6(^G;HBYCR1NF;0>2%),SA!@S])5BLA6,MA;#C*<8^\GCV@\\IS48AL$-W5J^ M^H>N2KQBIGE4]QTL533$X8Y&DPAPSQZLG58YQ0U0H,$RHL'"'03C:' 2A[X; MQ2&#O3IQ[_#36\."Z5NPKD@PSA+^8'W7]M[7_58(?W'8:WRS<^IM#^.( MA#@16N00!(NJ3)TW_D\M>5\BML MX&'T_<(* 4R\#I:_PJ>.;N%&X// 0[#8O'EA>-DC;V;;'& MU48!6*D3V]%Y*$LV9.G"T_=A[6P-#[9L*'!E%7!EB26F*4$C!5ZM EZ]I(5I M>C.- E=6 5>63,Z-?5>@UW7[>!P=!@QV+62'+@^V:]6]C_"(&DK]E!D?Q\H? MO-T',9)/&U\NGIYYY@0 VD7^)%2P8')#\,!"*PHF=:S'KWT$R69B4>>>4P7\.S]6#"$C\\< MO 78W9LD:AGHY3./FN&3>_>^.S2[0($O69<#+09U&DC=7J6V84:! M_"X((C^(&'V_M_'A44-4J[O5O"'@^]W'#Y$+A3;$!QJ#!W%H,P[?T!=]9CE( MXSY] !PY- SCT]#DT<@#ZMX%0O'1K%:&D7D%E)>;9^S6O P&EE\27Y1,H+QN M]Q=S8(4]U_]HXJ/)_WXQD1#ZN1Q?/5S1WU1KKUB#+R_[4U?,@L8F5/956@?L0]Z 2> M8U;WEV\!^[3MG>K\[.2<;S9V#1K ME9WM@P?755RC!>+=R?GE5T.,B*+0G7/W_:"R_9TYS"V7CP,[5E'YWVTT8U2J ME>KW[_BI"O_]_L^!__5D&.[]W3O;@>% ./ #GR19US:EU@#BQ;@=+ I2D\B& MT%&%7%2I;F^8OH6*(E:?U^??.*Q6RK^3 )+.D2+..N%09'4\!G-Y'GQKNW[O MUXW*!OT]M!Q'_?WD]6FL/N'8=N!YUI #..H32<&?HO#IX]^ [NS:EJPO>[[H/)?LF$01OE8?](>-NSF[E:SM?]L MK.\&X<"*?MUP[Z*/G2#PF.5'8A MWX$?,8_<[FBN)](YK)^=7==/"<++YL7YY95Y<7W9OJZ?79E7YR9PQRM@@69U MRSR_-*L[[YSWYOF)>?6E:::,,V6:]<85_EP]V-K.4 ;8 _B_4*@V=,L.5YM2 MK KLR&B"T(CZ#"1^#C3"_(M9H=GT'>:8F6D(#H?904B*ZTZV7'FOK2)9>WIRYH&Y\;A,;.% M'1;-CKGTJ62.K[XR=JKIL"?P#<]?O'T4WQS_SGN[M]7YR"'[>>7:F M$M[[Z?$Z"2RK CN0H?/+]=KZ0E9\45GQ:%PSPA I%SG5??+B[?_:OQU\O?[Y M^\&/>7EW6S]HM% (+&7%MB3/*B%<@ M(Z;X:@I1R<2;87Z7_S&O@N3S>E'S58$=SJH1# 8N1]>Z<>(""P(2@H+>.,$\ MD023 @1'^*1X,)]0^A?G.ZW6;S^VO.VYB'&UBDX.QV'8.*R6MW:WMG??A%4I M@?TA9XT8;P5LE^.XMI/!M4O6HXY2?G0&&##%D-/YW^#/_W2[N]M[\\&WZB2^ M9>$0%5=;QY^;QF73_')^>MPZ^]PV3UM?T9VQ=H@(I_2N>0>[8^"VF$'7#)/M M,"UN\B&S,<;',5TXR8B;=M\* 8;WJ[ODMR:E/Y:V MY=M!.)1FJ'9D1:P1Q'X4CAJ!,X6:_#.JGL1;-[?]<"[&I3)G]D?F]*P0"UO: M8O9Q2TRM-DEQ[@5]X[!AC6"'Z!A;W+-\AS^&[,QD/Y98GB )H4=RW+6%G_;8 MGZ3OOZX^!'^[^]!]W,P'V=>;6L2-Z< M'%X ML%^N5GPVRMHXHW-J\W&QO/@F' MFX.A%XPP?'-%T39+,PGVLV!S E&7AR:N#NH7D$Z'= 9\6JRBD(NK*W.;<\2V MK)VL[C@AXUS^<^KZK)HOLOVG'?SUY_%?1SVW-Q^1;7M29,L!9N.P';M/E"-J ME6D^X'%=?Z4H<\Y95A\XRUK^6?[^S^[Y/R=L>+S[? =^YBQW'G.6M8W#[1IM M>=.YM4+';$UM7%XL7DN M))^CX,[TG7=,#?AX'EX%MW[^(77_^%J_K/Y>N1D\/THO')P?127=N!B=I9\*%3MB: M]J=O@'A+&9>>8EB:6<>:8ES*$1%>7]1;I PD!GV%V]G(0]R+@$>6][_N<+J] M=/]TZ^3,&<5VU9K/!3V8BI\9:#8.?_^K6CZH5![E^'M3:M4[N5\$7] UAZ'K MV^[0\DQVQ^PX_]6G7O%VY$S&/#?N STR>[=0DMB5Z,_,>T0F8!W7)@B&>'-#=5Z"^2+AAO M.O%L-W_>G7_[LM,^<.="/+J/V=V,^@;M;&0_\. P;AWO;!^6]G;U*$9Z[?+!C&F32Y\40MX^% MS#$OXI#'&#$0!? R.2#,:NU=YSVR*$PJ:-[9?>QK:];MZ.-Z'=X;"AWH3$K# MTV3<)R]T:_ZH /=7GPH"!PHQN%E+FG"/H"O?.N[\$W*?)99%WP% M$\>XM%>3TIYDW*-JK4-$,%?:4Q7'X'$,0\#4!**/Y]UV%-@_L1K7]^]VS %Y MRN7S$&Z=%8Y$=:8+*_S#\F)6V:Q4JM?X>_8AWF?WG4RRR M6D%&,>WWI\PZ)GEF(K'&]V/C4(TLZ @-7S*'5FC>X SFOV@.\]UU^_B].<2* M:?C(BV7U*MJ3[UA;2GU\";!?Z3J210CN\-*H?Q7:O3_;VS^^/,D9,5?4SP1Z M939#Q#L7:+Q4:'S5%_QO6@2L(EZ*+TX-H%\@5K-C_^C6^>OJZLON"V+U1/@M M[$">*V1K.X_8Z_NU<7A6;Q_7_S/-;-*PAFYD>>97*_R)[M9"PIA"8P\6)F%\ MLT(T[G&%+2CF4B/ESF(8_SA& M1;X;+U\ +/!GEN^2W[I^AA8OHC*&2W?P6AU M9G1&IMUG]D\$Z:=YVV>43(+'IJ6"NMRTS%OF>>6??G +$#"+PS$Z\ ./T0.JUL4*"B'59N'F,(_<;6&24O(7%3?)(7X9S)\HZYG%_#\" M+_8CT(RQ($(XI:Y6X\M?7R_/JW9[/O48MG(BM,;@*!!]11%]"F5_5WUO]H%Z M(XH[IN5Y"9[K%Z##Y ,P9A;GI^*ZZ0#)]WM45' 8,IM1$$ZU9E+1.FZ^@Y=! MF#1Y;/=-W@^PK( INEO 6%8T#NBMQ2?O)+TL 7X/7,AWS'^<' M@&O \_0HO(10R'%0HN8$! %I\<@\J)B.->*;$VSI.',Y94D]4:X)]3$0T*?5 MOOOSYUW]CTKG][^/MN9R2;=SBJ;DP[-Q^!>;9JE0EQ7$,3.I-E79NWQVI))$O'E5*S_W6Q!3_7+.#W")+),/@!+ 1*%B M"88M>GUN LB,YB>%CFSB ?4[7D#YS 0,IH1! M/ELRM(>!&^.1]&-Q&_;%'$ZVR6NN4:[FR]1HA_#H'%3X9W-K.O^>YWZ>( MWP34! J;\[$Y+P;N<;*^A"#6TPTET%9R4Y?'O?L2D3%IS<6P >?6"Z;E,IZ= M_H?_\%K?;@=/\?<_4#R+)B7DXVZ$[9SZ61EHT1Z1X8*TV_3(U(R()2N? M.VXV61*PVH)[$R@3''SI-G$F MC0KUW7S(6X1V.+*^@1*!;J,H,&,N]&M8 *,..E%:+UT:N-'0A7-Y(Z1RMRY, MC;3-!_ #U)=O7$Y*B6_YMFMYJ*I@!0>$%/N..U;HZI%W0R5&FQ;G(%G@ M5PHG6+?+R,2((H?4 X9#AAX)D!R @:'J9R("5))]BV7=G6TCW; M5MBQ8-CR^9W'1N0,>E?=,:\WV]A5QY='M5V]J-^#J(GC-I+9Z-KE7[GM :__^.VH M^9_G^UH>>>5R^\!-A_?1@G%Q]9:0MZ*H15)^$_B:T0& M; ?D,P4^ZXVX2Q<.;AC:LVY8N6.A\(;B'?,Y46L#_9WP$\5/)+/K%S1AU.-U M?$*N.TY#$#5OD&PD($B!4J(I[O]2V*YO5RG&Y"D2ED/E6 B_SG(*\SSPO M,7Z\RXFSG.H1>_^@/%3)&LEP*F6BF"H'_3/\X_??]RN_83FO!1/EG()^.HR% M_+/4R(YY$%:O!PB-$LR HOAE,K5$UIM F90'('0@?8U&)APPD4ER;G=13H'7 MD3YQX@15]=UL2GW>W*B!:_-6I./_9N:QWTO),)Q1S 9", M(YTVS$8&Q^O\O"MP?+>,!9HRV+N?Q7,_'CA!Y##;'5C>ABD_A@>1BU M _P(&8Y!N>_W,+% )G6*)'F.JBKVC1/Y'F.)'>]-.:6'\7<=:0/'*+Q[)A@$ M/"*FZD<@E)(EA2&\(' '/HJGU,3X[YB:%9GO?HM]9FY52B8>%I#%$^#XP#&' MP/\E9@&MA3=L&:]4RE._084&^B*#$U'U=%P4&8*04QA##N.V:/#,Y.8MB/]F MBMZ;M5TZHNW)RJ_9QF4-(E>4@B62EL_CB(QR<%&0 MR@Q=ARC-=F6KMOO]G\\C/MJKUMO7__GQ,*6Y;^Q1G_'X_7">C)/ ^2%=3(/YK)' IS98;:1,J MH94 !L )@0ZS9O795D;LFR:;)T>FG]C1*#FO*P#KR .",:6([_GQS^9?@Q_G MX;.E=0;,= C+FW1E[U3RS"8/0HJ*D*!/0C>6BC5@X04P;+/5:J'NXXYA:*C& M,;L ;)Y4!3V:I(*Z>.TRL;F#[#" (RO_#C2-:E'=NJ"@)0D2Y,L9RWE#\2!1 MS-+&K/2LBW8_D70 8@%<"$J8 "A,:9*7LLR( 8D5[J1CD'NHF>M650@5F^NO M /U7N6R>N* :?"2EMWQAP5:6RX>?'/=&32J@+4?!4$H4\@M5&:VB];3#&,B- MS-LR'I+>GE+W6T&)X^16"M]6SZ>+@!D.Y?]K:_B06<0J'<[ZX%0&J? H?H&W M_XZ)!YI5.A<*'IC$D7O*PS^$@[NTAVE\KQ[/.Q[OFYUT,E!W+*!W\JC2F* ' MRR!XK$MO)($2F7NB=D^%+JBX!8'8D]L4,NMGN<. _@(P0]I:?6-V\R_G4SY41K!3\>^HV/GY)^H6=[:[F@?,(NHK*Y-V?3V:):=R2FO\>O M\E7K+2^D1U!R:G!H+T K4+B98R'E.5 *G_76C]@Q^L."3_629_1!-K&8:-^?=4Z/ZM?_F6VK^I7S:_-LZNV>7)^B?_[5K\\+I^>G_\.@K#9 M.H-OOM;QZ4\?K#E5_GL=]-A:(&9\Z[L1*XC32L!?$*=9,7/A=6I9"&RKBY4%H5Q/0EE?'TJYO7%XV6K_;I[4&U?GERM/+:L%N5Q=U"S( MY7J2RZ/U(9<[&X?79Y?-]OGI'\UC-!N>G)B-\Z]D.EQUVEG;*VCGRN)I03O7 MDW8VUH=V[FX<-OXZ:EZVFXWKR];57P6]+.AE02\+>CE/>EE;'W*YMW%X<7E^ MT;R\:C577[;<+VCERB)F02O7DE9NK0^MW-\X/&U^KI^:0#$;S29%KQ;V^I#,@XW#KZVSIMFNGS2O_C*/6^W&Z7G[^K*0-0O"61#.%26< MJQWC6*VH&,R7DN;'-/G9V;S/]>MJ[]*\,1I_0J]UE_JETW,\6Y>FE_K5U?-R[99/SLV M6^WV-7QU<7W9^%)O-]OF^8E\UY0NF\(06=#D@B87-'G.-'EW?6AR;>/P_P,5 MNGGY1_/X_U]Y6GE0T,J51M,[J9XU6_10DV[/CUI5Z!@CN]>D5/8+^V-P_]JWUM47L]YH MG%\#2<4OT"H@_L3:;?A"2HQ3J;:@N@75+:AN077G2G77R#ZP!V3W_.SJ\OQ4 MR*T467^\#O&A!>4L*&=!.9<"&U/*N3XU0JK[&X?G5U^:E^M4-GB[4M#,E<7/ M@F:N)\UKHKQWV:2:PR6S^6>S<4U11^G%_6KYKFY_,_FI?H MPUEYMTTAXA6$M2"L2X&-*6%=G\X7M=K&84I-&^=?+YIG[<("61#.@G 6A'/^ MA'-]RFW6MC8.56%B\_S;&51_V/PJ%>$**"$"TY"JZD M1+<^Q4!K>^CW^=(Z:EV!7IR3?&ZV&U^:Q]>GA4A74-*"DA:4=,Z4='U*>-;V M-PXQ;0=^+/]NMJ^_?JU?KGRKRH)F%C2SH)D%-LZ?6AX %S@[;OYI7IV;2@ M MJ&5!+0MJ65#+)3O-UZ>66Y6-PW;K\UG]:AWJ:&QOY^+HA\CJ>.S0^#1\^D(& M5MAS 5A\-/G? O%I>&@8QJ?_*I?-$Y=YSD?SPNJQ7^#MOV/FV_!6[1?S?!BY M@<\_XBQM9N,?OYA_6%Z,/YOELCPWQ[U1$':"T&%A69S"1_/(@QMH5C=W8#$\ M\%Q'K3-Y8I=0A?8-SLGSAI;CN'[OUXW*!OT-T-KJ[^P<<*,]:\@!%/7I%_/6 M=:(^+KCR[SR,3&G(@T9^CW7IC00E)Q$J,QT\J^VEVL5?S*O1$.:OAU;'M7\Q MSZP!$SM]%N#^U?27/JBW\)<4L116??H ^YRSXR&S?I8[K!N$,/20#E'N,2QJ MA38XLYD*6>_;!'WK<$L)(5?F[LT-SESJ/E="WLD.1M,YS Y""RG"1Q/X*PL] MUV=J5M?Y=8,Z;58W%)G'1/56_=0X.[]JRJ+*)^>7W^J7Q^73\_/?T0.?5@M- M-JISN*)[]N('+K]TX2AP\,KFCNO/8R'=>.K A&">#; M\-;EK&0"PV@H3BFY3NF&W'SM@^$;U0.;GWF&#SN<-=QK=#%?=+>=WT> MAQ;2;?D^[*+XXL*+N39ZY&QF7C0QD"_S;,NW-PV<_;A]!LPSL'_:?0N6=<7L MO@\2; _FIG&*:[$0;'6S" \?DC,+ $S]A>C!@AGF8F%Y*5"2.XD0?H M)S'\DWOXU?*!L>'8LDD(-X]=;L>%LELP4K,O?PC0?6\[XDKC\\ M9_GZ5L"K\&84A"@%F%W+CO2E,SB= 1*/DCD,@Q]B!^ /;8"0>0 I/ M@(2GH MQ!Q8#.?FT+/PT:!#K]W >>$BV=T0_H3="\02_9X1BG67Z'?<:8OS>"!D6C,> MPC)N^Z[=AY\"SO2IK9"![LCQ)N-'>1X@8=U:H5/V@N GPI6^H/;QUH7=$HV7$()X/7&/[IT5G OG9Q/^MVA-M6/3C808P36%'; MJXMCR+R]1ELV/3],'O,AT, VDG[Y^+E<[LNC-T9$3BW(&%RH*BP^3"QG*O# M/)?=3/ *B1^37S-D0.-?"S08_]:"^6UW"/!-/"\147VOV(L+/,YW)B8%U!O_ M;F"-QK_B_2#V)EZ^=3UOXKMI#QJ="5#Q:V*^KA_G_^BY/QGLN<#[Y E$"0Z< MR;-"O"7P*U(/OHF7>-H!)C? #P"U &>'LDK)L@'C:K?)[C_$;T&?!+/"Z]M MZ/*?XLD8.%P8 2LC[!77#C;.M*T8, F( Y(7>5_Q3 :R'& M !Q!^!A.4*V7IO("(^4%F^8W)K2!R/K)8).!2'N2R.E\PG0'0R"Y1 X\Z[:$ M\PUC>-2&U<9#!REE$,+^W+BX6_[HGO,H 38Q'-E $B;W%('U@8F[/A)6.7\W MCF+ 3['3)9P@$5PW83D6@"T0'PX)WV "31"VQV.*?B0"S?D0%'1X&I8&0^$K MCI":4_;#1N8MB,UPY@Y;D&BWTE+\E!,(,G1D*,)K$.#O(6]!"A%\+F=KN@Q:$F M A*4!>H(: (D,EMH!(&9&$C.9!+PA)J)(WT(&8A]/NY$%V1VDM/S-F[3R)X& M[+EO2U5'");:,0-JV*!-"?D-Q.Z0@:[$:<[,4FT+O2NP)C2]W(,-F\FOAIC< M!3PT*$?\2QO&"I$L&,X/2S39LPA^XL #Z\#H*W M&7@Y@T7W0J5L3H:^]E2BYYNO=\T547ZM^><82.H;Z)$C14U:NC(:;KKSB0$L M2(QX:%(S:Y7:5HE>1)4G(4&C"%=Z=%AR6F%I11,6P(,3DP$+N868G(A\%V.%Q)/(/=/; "RM MLU4FYHR;F]Q$>44XL7.@O4YLCYFN<2 3 Z3"Z O;?L1LJ6ZIB!+ $X&#CRTT )?-@A^X9@HB<0(HP M.I$0=C0IVA",ND"CL%]XQ4SRBFDHEO%Z&1FO5Q[A2?QBB@*5)H4V=@?B!0(K M,5;(9G#,?>L&+41 L117 S2[8>(0^V)@]9*!)YE9AQ@%=T104D;+>OBP$[*; ML=&\=66@4, >R^B?S-QOF9&(DVR*O(\^/F3.0O"E*QP,T30;^S 34/L.B><6 M3[\6]"Y$VRK9^'$,!*T7 %#(*.P^,"8BPM9-$&+@C>$%?J\,9'A@"GF:)@8! M'OD07C!\G_>!_.+M8R$'B5:-Z H9G09E9CI0+PQN(Q2?S4X0_#1O,*[,'#(Y M#I(W)4:KS3'HY@KG$K)Z*Z)-P'5GQ&Z2]1,Z?,,4'49]0'!>*]PTZPF3\D:X MUQIK0]+AD167%I8WN)!3A/1-#ZI)R>F:=P9B2S)C):%657K@DS0[4-Z4$Q.V&D;XR2)"*MH[F(+U@E!L%^P^DF=!?1'_ MR-,Y"& "!B & T1R= &FIS2&@G88<*38-TB7A4!SC\)*6 7L,#LU8A$=$NA: M;F1Y!J(TP2?<50G/4.XS5-Y"A7Q9@ @NWU6- +K2%(:BA16'QB!Y#=%D3T MY8DHW"##0T8M<05NG-4!W99P9,(, M DZ,]A,V<.,!%ZY.$1ID:)<>)+5@@#?RA@D:: <\2@,2?$ZV$I+X"?5XI,U. MI!9(*!?:7_JJ0,(,I4A'LSW+'1A#D)02QZ9TMPN1UH'UP#RAH'SJ/2 ^/J,P M#"#6'K,<*9[BU1.RHMR_9*LT!Z744")W('0PQQA8/;@SL4/*@G#0H2I1)JHB M96*\=*DS\)U+#[Z?U*BF&#D2PP;R+B7:8Q1K%!@.&WK!B/1=>>TG+1OXHXX, M$5QD07:0LL!AD/DI0MH/[,#7=19YZNB 9'[,-D%[3GXF35N%EI!(G.(6>K0[ MJ-)87"HN@OKTXQ YOL_TXT5*36( +A(P+!H-)<$,;!OET3A4FAGJ+($C_,"_ MQ7".54.)Z6> >8,.#+=5 7TN#G'HDKP(]X&8.NDYW%^WB^!%*39P$WV=\*O M&(!;F-8$0%-LJ.E>P_T'>A#2I93(64JM9>BD)A;+(KFE'C D[DD_+7"G6'U6 MF*T8"JI\XAS@)OP '8G"G>!H05T0F-7U8O2NR\NNF0NDR)#LOPAL20R?VJ5F M_HT;!CY^7J- NWN#_;>*N/YYQO5O%7']15S_*L:S'C&*4$)#'PC8R&,G=)F, M6$*\7-.!^JX7<-! @*D*I@7(6I;LB^PQ($0C89:FI,Q8BF$AB\+ FPXS9!0E M:$23/%C7I#40QD?QF0T2H!"X.L29X VAC'152! 2'%"<$,XT1=]"W\V M)+"Z,#&V;A*W6(^\?IH0I2U*C\]3+(H)CBZW!^.,Z-.J\IPUN@9O7+5[V+\_ MU\@08<>52H?1Z(,^,!XELJ SF'&S!">F\%=PO%W]RK#NXT/19[58@4%1',* M4CU.?8Q\A?/;,!YOKM#/&3B%%_,$\44VU3T\41'+*'=H#C,,TY[C@IY NQ:S MU+D?T;-6].)S+EITT9VP&/11$C$3CANBO4?/:!P+#[@O([)DWEJ47Q"$0PRY M14,H&NZ/4'3G??,/%]>>^&V/E-U5)FAB$LDQR.%DJ*H>E#!DI49N([)NQ2%F M ^@Q D)RSO-X)!I#Q'RTV:+'Q>IV7<\EJ#S71G-GXB]!8U@VM&I>TO7KWI^Y M\KWE0^)SW_AJA7;?K.V59'S3+2OEQ2R45+R/95)F$_K\,!@/L-X/8M]6)E10 M/@=H@Q$^O2ZIM=)0C6BD!R; K_$0U;%_[6Q6#%B )YUE$P$Q/ EL$'^J4 89 M'8F8;?<1F"&HJ:1P_JM:V:Q4R,M)KPC'DA[W$OA,.D"1_(O@&34Q8O %9>A@ M_$<;G^+:6'KBGDHXO,#4%95 2ME[:XLTZW\GR/:?7@D=:87'6@3VI.FFR>E3 M\)MI]7HAZ^$/U@ N!]K$79[&OTV\153_7[72]O9>:6^W(C88?&(I ]4ECE%N-Q8'MX%:1/41T]HL2%I,5PDRP8AR:&+ M05Q !F7?N)1TJV(NI@A.GG4[I]BRN9W8(C%GXTVLSK[MPMGW M)IQ]*VJJ>XUL;3)D)7)770MR:@3A<#,U915;^:I^KG/?/&&=,$834&U?%Z*D MY4:IT4))&->Q*;@I,:],''.B'>=A0J(K=ZF2AF4V9)61L2)#^^7?4T%*JX"# MFD!2G0:@';BB#H?K8XR0+TM?T)O3IJ=Z2DF,(&A0'G*,Y89V:'4CRL<(>=\=ELP? #E(LE@.2/YJ=$)8 M28@$ED*VT,>&D=:8DXVQ<=*P@M:TKL=8),(KA3J8S"#20[!6$OR: DC;6 ][ MH(5>4-Y+/- RA-B0)L(6,+1NPF9A D MQ??2- X4B<-S=$4$6:4\ .$$\$:4(B5B>C4%%VN!E;:! >S7]M(;CBGB@P"W M- MX-U9O7U<_\]'\[>K>@O@VRI5#K9+!P<'Z0LJRQ#N"2P&L]KT=[Z])ZAJ M^SO:&]+,62]7L7(=29THZ6KJ-4U.5#G'I@J#H?UG56_.@MR5+[V&(R$%G :6 MY)]UY999[76]RMF\HOE,TCR0'3!52QPEUF;PS7=[[V7LM%9T@+1H84,+0$3J MN(([4X87[R-75)3N2!*L7L@R'@E#25N2#\O:&^H;56DB-5YS%##@WN]4R(*, MGWD?9$:15B;I8E<4PT0)A F01$:8S=QA)&+_T.)&H@*F3?05&5O;,F2AZX&>O"*"?CRDUGO+TX'W9K1&?I"K-GLSF ML !G_VT&H0L;0+F:F+Z/>(AO;1HHQHH9,&Q.B1S8(&T(#$%H3R:CI257!4S,622D M-%ITV\>!$>P[B",>68('W(OO(B1=%2_"((@JD(*T6+(R4E"95B&5$PO%EXG; M&UPXO6#0C(Z0RO56)$?"M[FXF"[5_$ 6%(KD[SP&*>X6IBF+1$9X4SKD+,X# M6\3Z2*M0P)F$I+@I2W)3--59BHHR+D%);E4IN"\D*1U08UX9IK3\HML,JZ=M0$#RBGD(A65@(K,Y0M!^$A$3,\#98=>)Q:7NK-U]_6X>_O)"\QXMZ=ZP3>>W50PMVW>\QO827 KF[7% M!H#-U&5O84 *3_'_^>^#W;V#7R8R'.;=\W#^D'_%&O_P/P+3$GY(D1(*I %; MM;A#CUQ^UQI52?S?6"A5I=F2TJV>1K*#-4[+3NBBY2U+DS#^4=1'E(5WZ&T2 ML3&VC6!!'RI0&C=(&Q.H0CBJ[B#)_ZJ8$HDH&D4515,E?L*?8UD3\W3;6@;[)@D:@ZIDFH5(R,#+$]-"2B M2R"WF@*RD$1\U-XG@R6GBE!USQ-P3-8W2!.N\!.VH/.P5)N'SFM+FEB3F&9B M+/03C8-/,JY\'X+D2IU6UCG5"S4I+C$5@GR*O%:M=G>*@-QY!N3N% &Y;R(@ MMU J"Z5R'26$8ZINB-Q:L>>&,#"EX@$6$PX=H? P9+T^JDQD3 +NZ\J2F,(S M0Z&&DBN/U;D5C*ND#M0%"0#=+D>:KB@IE6P(:I!AH'7+2]QI@]B+0!&'(8& MJ8%QZPMY?[6A*A3#I3N2@NRGD%]9/QF!6'=N+%"Z>D0COXH2W.=ZH>K4@%CW MHG[2B2I1]Z@7*#QI4?=0V<< *PQK]))*%N,D,1-^8W[? M4FDHY$6ARGV;9AO;HF8G%9U6J>BP;-!)3F=A?A1]MRDJPR.'L<@PE^VJ5"V2 ML;K,LD=6B8#IBB*[B<5UI!J-I-N/XT\4$@_"I)PZ1ERD9:$16E45]^\8N*XT M3N;WQS%_!*X4#)!AP29P#.CRV2T6;!9!$EK6 _R8%&W15\73/B3JQ$7+5?57 M"?;$]8-N%SX-&#!"\8#:43("*/%$ZPZ55>)!OHBZ5-T8C@U 5(D:!3==?:C> M.#?5=.E9!I',:@'G(%4)RE,B:^!%'&)P9]KV0F2WJ5Y!*@:"X)C";JYRF@8E M)34HB WH8*9[3K8C8H:?>$QR('QIK#'33S^X]1CF$Q ;4M$VXXV4J#W2N[1= MDBCD39QOLEK/>ZUIE21]#W1U,O6N3@3)0YV=$*!G]V]:5QR?>9 I*#YNSEJ2 M75M&8KV<4"V,2(_5.2H %$8;VB# MHC26))/>\*25&A6XM0F4)$4TK6:F2V74EM[*)(P"5>D M5H/-\CJ1"P!_\0P M5CUULR6[6A3!@EH8<"WB0:DSDTBEL7Q-I)Q(I+WQC87J> M!>2>"+%F$Q>RI1I7"ZG*&:IOC54J%7DB6-L1S0!!"/N1X^G&'@?"4%[*KE<% MDG-1@H-RFY)D,'K$T2%R([DK22F$<0AQB<)RE&DMZP1,9 QB,%J?S-\YJU,Y MDZ;GBN9;,B=Q&'BN/4H: +8B-$11,HH5.FE/H"$%F=E,-BC';E@C(S%"D&E& M_*5V7U5-<\.) R#-(/_,$2BQ[1G^K@+UR9JA;3TZ,(PA=@-+FJBG?><0*JT3 M(RU4VK=$9@T7S@+AHTAZ#1*:C2IHY^5^AMZ2B>A/#WY.X%A6WB-8)HL<4K,&-0V#QB9J-RM MWJ9H5XK5@M=D2S:L%N3K8XBFLL*_BZ LK15N&:]/<5\04^X+X3MC*IP= MN"GQ!MGY+PA%8T%90^3"$G'E[@98&7\\;+$ F]HI1:?8W$.VFZ M\*Q-H2+A@'LM6TT(:#6U_JF:H]-:GF&6PA MOQOEH<)_T:WFFU0A/Q)Y *K12KLI%'L#[39)8* ,"3QU?[*X:=PEC ]K''IQ49IC62B.;I)-DWR<8,SJ-X[4B1T1T;,#$%O",#=I]6N, MOTGZ+N91I!8N)<.+ 8TTZ(B(@H69\I:($1C(_-K$IV8AJPO28DDZ[Y/Z F*= MJ!,\*B7A8C((+,T\*A'9X M1?W $2Z#)'H=ZZ2I./\H RYE[Y%O@-V)>F71M.68N @4E6H(B+N"$@4\EMZJ/@EE(N\" MQNQ8:4J)PB5?%2]!,4(-XSM&2O!UKP9&@F$=%))%DJ00'>N$6TLP("=Q;SV$ MF7@#Q.49$^)P&V!'D,LD-X_'%*\A<#BA%QK_&8KEXKMKA-?W)I_N%LFG\TP^ MW2V23]]L\NE*LP]=,Q#=(CC&[PLQ9H!DT\*.@8''\N+F1*3!;L2!@/+H+!8.P:-=9P)$(<37C'39[T )+BDY@&F-(H& M;DE\@-Y*,*7U4G1"1IEHS0B66#N%+DA1T!!-.K/2S[BUPZ>P/:%0E3NCLOJ, M1<%<- K( C7(-^40"2PH7 JY3]L]5,BT@L]AGN)6TGF7KEZ)LH.*IPZMD0AY M(#% 3:)#-&G$$&M.%3,\/*DFRN*EAE[&8:P- BZ@&Q+QBU)]3^2<(DK)H F0 M D1BDE"YDFJJH(4E,1983U= 3#(X5R?$A7*'P3(&CAG1;VID&9\]H#D5-S=FOJ&2.*.L#3JEA3*:,$R_1).O7DM;7'_58$!U MLK5BD%N!@]B9@;'F.*H.9'JU,5,Q$(W2R2RK1_#%B:"2 F+@J/ M1_ WP58B7<7" OZV'G/HQ]1:@ QB!$U7J\XC(2CIP1XP\XVL/BT3#JGJLB"? M9N0.9(\J!6&RV3?$IPW@3EB%C@+/I3U8O#JP?@2A5 *'\B S6I>>@*H&E0&2 MOUE^;$F_/K4QQKKQ9'<1F8N8_1,XL%L.D_T:#%D9EQ:-KWF!;>D;(S@\^4-0 M#?P:@%S1CT-8J^6+-VX!C\O8IV*0I+N6S%2LH)XX-)26_XI%I],YKGULUF.T M(ZP&7\I;U_2U%(QBV8B.CJOYU:ZRMU3ZI)0O1M6=1JF3*D:7-!>29IO(DST M\WL67G=#%JH@42Q!5SV(@,9&PD4]%?SRP'(RI2YXXO#J>@'=&08HW?\[MGZ2 MX2\(?0L#>4LFH;X8NNO*1.$T"EIZWU"*$_5IL0I(4G,;D=CCFVK-5V1484Z MI4;\*/&O)1=0"K5\?#?EAB.-5 ]Z?3T:8 Q%L6P808TTZ@7 MK60Z@F\3+FU2"P3NI,<#I&(R1%D[/KFG:C5B<9(T8VBZZ.?"DQ9N-X+GE,@' M@:8L3[;M0FJ4'@ 2&-KD,M50442FN/FK?O,5E0^HTX)$)#2=$3J)/^%$(ERZY\R@[*L@ZD"=\& MH>?@&D>*(L/6B'4*T2_=,UJSV-&2&0^%!7M@W;D#['PC M=AH-Q_1<9JME>P*QPP516 ZBT,P@L_$8$B"Y6%GX5)7R(&!U5 M!Y.J4>&+(/4GS<,2\Q":R$H&TH'0\23R$77 I^CV>51A)+&'4,M8*C$"*&VS M36R3*.1XV4THLP@<%1<.%Y$(%N@%GC8'49V M+9*B]M2)-/6*NC*1DA,E]?6UPC-)(?R$CM%0PI?IJEPH,9"O![U(U66N5VH% M+](TD.=S2=4U74!6[8D'BJ1CF8H_$^=K6!RT*/BCE3 74?QH_@:<12QM8<>; M$L*Y9^,DF;/&^0VV@F:WPF"VB+T>6TUM&UV(RWT $\"_+*.2MR1IF3W4;XNM M;LNX#R9-/NUAOBFF$J)LA4J;Z);.E60R1'M'%\!QF TZ)E=5'&D8Q02PAR2J M0E1S7ZA_:!%!(Q$ZZDNF*%. 57D4"^3[2@GHA6>#&[3!FD-H.7_@(R;TH"6 M9KY-VJLGW4/5\VEO9,L@OE*6W8Z9,S$K<&**ETR<-HKNG&)G,8]T^%_4E^6. M"'3)B<4E%DYE8F1F*/+#0%@I4:I/#D8S_VDIHI1($,G63W(V2@P8FUJOE8./ MJIU]"*;9(-DTO_4QP%2(U5TJ_4E*KJP>*L.1266@KHAJ(%7-+"*5&_DX5O0! MM=I(SE;UDGMXBX7'ZY:>3HP,RGRIYJ8.K-_/44R.%:QN):0D+]5/C.:WLU"5#1;:4>Y^1_L\Y;?PIY_,R?+W()<^D M::]"*OG<891I72N0SD4%/T0N%XSXK^KFOAF%6!""$L33"AX,V+^D#0D-4@2B M2'5]-:A6%M&VS4Z*94F#:E4]77HMI9G*$87-4K9COI.!+WPHPW9U_"36& Q M+;!%^/P$ZJ(KF>K#^M[H?9$'6V#PHV#U&?KE";Q_[59T_*V"B%$&SBS#T3V6 MF.!?!(.GE"R>6Q)M(=3/-1="2;VN+ [F%;/[/OFCOC*@M# "(-_9M[9Y]J51WBV9B#V1!Q16OHP> MM6-F.1X@$@CKC8!'\B-.3D;T%E;#Y2K.Q!1Q)N85X!_-TQC97N!+-Z!1W=^I M(A;7*M6*^0['.*> @9,TT/(2/U$7W"])),P)6N7?F^]P&[1E:8M(;2KR=VS. M/D*?EBV-]J@>7V^V-XVQB 4*"=+#&*A]-MQ6J8RH'%YZ6 [.W;OLX$EPU38Z M_OIN#Q>51O+ H;@_86C2P:4'U$'W@$P)5'H/O'O%[JQLS,+82D6( "8$V[33 M:$4IF1T6W3(&) 8W&"'%'596 UI1M;J= Q%FNVSM36Y"NOY-\]U)H%R6LK@\ M!M>JO1A[-8DP04M%LBU;)7.;"H/NI$]NOG^+%O&7K?^)C:=SHTI%.6T9M5B$ MERZ/:_<;,V2%OL1,FQNHJ-<[P":\(JHB$GTG2%9 ZRK:8S'I072D0!*H(@_S M@E=OFBKZ3O96@JJ3*4(#!';B=_?]EDD6PTK3W?.HI@7<.&MQ# M:@$OM 4R6U' W:9Q'H=CT4WI:JA^@HB9+&-'05-5[Q%_93D;WC)1Q$1V'TS' M(?N ]!%2I'\5020^2@.A H#=3.#GKQ8(ZE7%7M/8)FJ/N#X7Z=Y4\KTBE7R> MJ>1[12IYD4J^BOP*0_PZL?=3B? 9P4JH&VZJ<0RQ+Q5R$#35A582Y#E%'_H2 MW&+CJ)*L:0*0T(OX+Z@!U/8OHWD0]^HD=8)DO&FJ#&+ TD^4G@+?(2O+C6MA MYE\JQ,%/ 3YA<1%0+NO8$Z^]I?1"$/[?P:\.XW;H=G P!N3_O2D"5R6[C$8& MOT7&6]>^,O$K4S9'4+7IQY,)%",&+DD17(G!*KH-DAQQV%K'QB#QI1L M5]&<>"HJNJ "N=$V#QK'3YD^UW4%'Y):,FGULBXBPJD5=-#3>RGNBF+@9!LY MPK;--*SPP=0?XZE)?QCN+]1X%? O,U 2&5C/\=.2\TC<3.W$>M:N\=3I]55BMA K-8!8.PH192'$OS&U! R M(S.."I*U-"1+E40!/0VU1FJH:#D#5(-3SBR+[8G^]#]BN+^.*Y/ITUHG> \: MU@CF-5O< \S,4B7=BDHN)RNM-6FHDO2^DQA:[Y1S6?BG_,2\BX0TZ5/\=1PB M[2;WQ_U_JLX*=:,Q;:#5JJ0)SK^^P'?CG9ZZ0D#)+B((X,S<:IU=<$,8>3.0KS=VE/4^N6 M+ 4D#.I(MM42R<:EBH/&M&1AT\V4FIFPP:>D'*;IN)3Y+SJ&#C;-IK1Z!Q/V M@IRA'5% .[69JY)$S"G)9D-QJ'7X$"T]D^1@\C4;:"MFRA( 4BYV$*0>H!(Q M8$@>"8-?QFJ!9ZY7R@&MJ(SIAGWLLCUE2(MK"Q#EZRG:P2!3RI022HF@6<*# M1I(LB7XZ$-?K]I%'7>@#RG=(\T.\->K>@\@#@W-TB_F]6,OZ9J"/*6]B1(UWTK)2 M"7)[[(8JJ^44^!(5%#+4!9ZCU .4E#-40;N]BMBHR"=ZPHJT9._KH?37P5)< M&?,R>=L2.$HZW5&YTW03L>&1Z@ OU4>F%[-(C+PD9*-.G99_UPZDN(^O$^)P MK5E*BD"&Y2&+&!QF2*$EWVTGI$VZ8WK]VB1-B\14(%',TOS:5#5/(LA(!ORL61<1@I_[:D$)/#8]LG-#?8%M6$224,*DT))7\WOFHGU><4 4/$LV15J''R0!&H*%PL.FK >+&H@36+BR[\ M,84_9@G],4M+601QYC$X'9BO"B%1+\\$OTW9FBQQ6EC MHECXE**Q^JJ3H7_ N#E\:Z/N+-O$Z!0YJ9$M*K"C$<+14(%J?_C,HRHB%+0: M*]'#IM K42V-=;M8+ *-<9C83FP],PP?D:]'VGY% KI6883(OA;<)<04T4B, M I_3[ TJS2&,Z?!]&8;C*K4^,;'K,_M 8X/P9[9O>E++7(:O6?(;J@B)*@/U M6TOL@S'F\F,LMQ90AFI6+T0R.UX0MS!*+,_=09^A: G6B5W/D0(KR,]]=R@1 MN><%G3$Q):FG3X4FK'?>%XP&KQ.ZRV))__,32PBY]*P*=/@AL96JI0@HB#N2VG*)H?"; M*..$J-/%3 KC@7MV,JY!R!B0D4C;H[A*8?S/NVUX01';I0V+^H:C3[&/35.) M 8FE&MEN&IH%1I0G0EX#6D1P2SZ'+CE%,YDA:*AB6.9JG5#]WL#>_2*P=YZ! MO?M%8&\1V+OL- (TRY9_PWA$,D\;,^-9;U2HE,O#W]$\W9"%#B,97YB*8F@J M$JP:O0WCE3#MT(FNOM*?[/2/K&9HD<2L>49D^-1 M$6,*\R BE!$1R1ML89<2_$W4'F\HU_R$'5&XK-)44PKO2$=.IT9_M3!7IID] M&F IWRZ14"%^$HYRD!>8J*26^JXQ58I:'*1-H[(%W*;LDP@ PE6)C<+X5%W@ MT.L\"LU?G2(J%13RF3V, 1KN9 YQNAX)%S8^(!$&%>4D\@ TVMNH;V@N+-(\ M1#=N*CH5\326;AITLD TG,$:23JK?>G;<+>,Q'=(:*-RFI.C=K5X,XK2 )5. MMD4382#W!=.EC=?(=",3S\4=U2Y3ZCTE7Y":6LU+ 65CDV>CW?2 L$PZN-;Z M58;&B.R\3;.ATO2IOWW2ZPWG-";7*EH0HJ^YKRHY]DT,KX/KB=>G0.DE06GD M8SF.>M%&2<9N"_63CY-TF;Y9J[I*$1U-[-TIK MT<+/2[)+*Y*)",NYJ<8ZR!$X\TH:T^$4A&1@]$)X(T,6I6%+ 4F,2/9.G4P1 M0 D2YB*L-DN&\0&H[+17I5JAVI6.!L.1\QA<(J M<7'H/@E8*1:$G!5T+RG&0\LO22(O8'\'9$J6_9>$F\5(8A\L%76-N@O)KNH5 M[(&'#>]$XLV/V.FISC0:P4LLPHE(3\@:JD:O[\](-;CSG"K2B< MNC@HAFEAAQ]5_4>D$BKG4)*-)II_61CXDD/<+.?&M64 I"1O@JZA3U21,7R) MC.6I>&UHI8HF-U!Y:F%8SJ+($PXC/*22[-8@2OOW)(X(W;C+- JB-BD)]D9" MF-!\N69#-3ES\'8(Z4W0HH*>O([(AIF=AL*<0EQ;'KI.!Y-()B!&X6=LNBDO M;>9F4AYTJ"@XVK#(]"?*H_U@,LH4\^W(PPL20."2E4[:UB0-PNHX1!Z)""0U MT0PK6QC5#K@0=.1M5A$=YKL4HO&?.B#UB-PVE ?Q69ECW3HZNU2U1]]OFDVU M/,5O,"+#=CDCY9ZB9H#:8WRY3.:$R005'M$;"='&1J4JRQ) E98S!X.Z@Z$P MG5&,2C)?^E 4,A1EW:0G/&ZA91?AXEKM+ "= RHXUV1? YV@M7 MM*0@4XX:#9]'#"D([9)<\!.0F"@05^\T(M!)CPU5ICB2CZ1JI5O.1#*J4+4D ML4CN 'TME1<5 )/*53RYC-C)*=.IF*HTU+DF]@DMP?>2Z #*HI>9'$%2?#)) M^4B?2G(MZ+>TC:9V]:1 HJ6\91(UQ1!IZ$+:70?69@K+(T^Z#,,@'&4.>H\R M@)'N20E1B+^PY66@998PV*?)(3\ M!(3]8.R&X-=9WIEH\LI=0K@)!!LUW*2I4TIJ,90P]EU;]1*3.1DBK1VE[9@+ M_"0EP982L @K5UXKP:='%$R3A+3@>\J2'T<80D'W%]BT$XBT(B'_LPA>-08! M^:]Z2D$CWQ"SA,*C 2S;:"I=*"WI*FNFB"* W&:861N4L"2 YHRK>QC;V>NG M&S,^KV%QO&9)EKVHLTI]?J4PD?8MQ0%*:B69P-/Q[1Z_W\+@0%&I?A_YF9/, M4Q+*GEBNS%V5_'JL8;C>4TFLFXM:-GTF*_YBD#[FR(/2QVPKY@E-$(Q=P".J MP]I JS&LCB)TDQ[F.L76&CF+?7!!7IB(WUVZU9H6 M^VA3"&62F(71YB#R"@C)$IJH$YJ\K&6TKQ$FWQL,=U $P\TS&.Z@"(8K@N%6 MD6$H.8F*#NFA]U)S&H:Q(^*A2,33:3*5=V/PNA-X04]I>+;EH[:%&;I"T$B3 M?!-30:+1D5Z$CV/SU1)*2WU 3T.I^EX22*49>[/,8//_L?>U36X;5[K?\2M0 MWMU;4A4TD>38B9.]6R7+=C*[=NPK.=9L3\^GN>\]+= ,'1 MC#VR.#+VP\8:DD #??J\/N6:N:ZL_J;ADL_/^J:@O*&G"\ZV))GCS+2D M/,(/DT'Q08VA-6J;;1=XD !! MI$](#BJE4;?,D$\CSZ+Q@7 Q%-F[KIC;<<_K@((28<" :"P"P$[2X1+R?]FY M*QD2%)@>Y1-G?4?_J&,.GLSW_8F5XW$-('F- 8_:[.^-4*(&A/0]17A=+=!@ MG54>TSB2!=@ RBI.\\P: B+;X4;MR..)_],Y$Z&>0A8E4S'Q*/JD]? MN2HOVI8E\17Y4U^ZY@WM'$G.7W-RRJYS\N9^(+-1N>:52[_M5EGZPM5 < MKL 1:6.N.N%0922G/TC*<*',4VA>;:+EZ?!.+!'1W*JS255%$U:0+[E/6_II MIV:T*U$EXX_'L[L8^$\73:RM7A@XD84=G&?FOQFL+11G*GK!+CKKQ[T*\U$[ MDZ/V$QT)EUB\DWL6Q;&B/;"L#N(W04EQYM;WSR#3'@;(#-I!.1++F0RM-PXH M"HB0HEOW<-:2P=<'Y$]&&([!S0,#$6F)ARI2#W39[^,D_%K3*G^LW[BJ^)?$ MAE^JGKM_M_/7>!S;AE_59?X5JIJLCC -<24DJ(I*D0H9F+=W2\ MQV0C7_WT(BK[!Q9"^8*D=&)]1)^2 L+X!0T?P?4LC!1V5=9H 8.M'6Z^L&>: M;. *!-RGC7*0RMD$B>6@_RWY_NVB*58;-^!U^5:U-0\Y#E](__9ZQ'111/@H MD$*KWHY'5^ E-^"VT/9%R>E$_7KM18*LTY?DMM/#OR2]K!7$OS1UOZ==,:6, MV^2-,(%Q*433,[0%0HX[W!SU1IAN #;DWY]]?O&,]+_.-*?P__G33Y^2]^6' M=,J]%*E-GW]9UC5X^#8!.R7GPG,(/7_Z_--L\':O\Y99Z(VFEV1+2ZEL](!- MI;UEJ!BW],I4#@"4$JT><1&J#:4><=FZ:U2*+]Q%QL\[>%)I _!KR'P>-&P4 M?$?W%E7CR#73-L6AH',_6HL$!,JD=IX1"* #^YQ:<4DVWX[;MEK4Q> M2&-D Z[LDB7X)]T2Y%BJ)OM T%O7K,3^:2 ME_3^:!,?M5LZV;R1"OH\,=/%<*"B6/3^%^GWUQ3S(HD1]!E]S$BOM3,V1YDY MLV[$J^872:^57F7"O=U35"]=*T(\&CY=YDEZ1,\94C6=/GE%5?ZSB/ M==$$ZB?^*)$'TJ:?3DY.2]9^95KCB,C/<%\H4"Z3 M=MQ(Y!NV:K!-*O_RU_NV*.LJ7AT?UP0UII[!-"A48)K#+OWCD_])P4XZ>_3'#$G\_E$'I3V\E(19@!?Q42N\3O1H3*/2(,*8V+Q,>MSEK M]P_OE*H_(UHOWN/+:GG!:#5S4_F\Y"/FLRN'O9TCE$)5HO)?-[5+TLR.?R7OY YNIOO: M,5<<%3ZB9Y286<8;*4OYR09=2 #?R-_%%KRAU^'@U0 M@ )T,L!Q0:]/B1\]@[4Z'A&F/[]6^#O "@8M<.LU.K;9C.^4W$?!'?Y*%\GX M6:[=,I 1C!+1W@U 6GA)PB7Y5?@X-(;'CNLQ8#T-\R9"#WKBKY;1#P7! MR7A*#D;D??HR/KUN*28H5MQZR6WLV5Q2.(?%HST2+:_)#P#;.%TRDN-.5Z) MBF8S."N#\U$&*'U=;\D#.CRIKZL;^.RR&[,Z$]6&3!IU4"= =>%EF5/ ]I+" M8J[_^]CT6R'22T)&)^>4J7;A:DX%/HEOD;H,=\^O>5H)$((44SZV;PS9D=-' M^)OFT.@GEB_3C)*?IB7LQCYOJ-P^HVM]1RXE.LK2%YX*VGJR7UY^]R)<&RHJ M7C7=F(-H_+>20O*@47TQR8D7<^?W+@!JGG^K:66.B'F:3$3O;B&T$O>@-R_! M \QZ\UQ.INYJ6Q3')9-I(PS3_>YSHN2^_AK'J6FM:OXNXE@ MP>TN MG0$X.AR9)$ODA_B,8@_3@XL(]>1LMY#8^C6AX>TY]+;A)+O\Q(1? L M%E,4[>,HE]\BCGSV/(D/]-05XY_X['@H1H:N3CJ4/^^ &9M6PARC,B] VEC] M".GQ#D1O4D$N!D#7JM!+L':YH#2:H+OG,'X+[GHQ&T,ZP9.@' GR,Q=;4T'-PNZP,DM MTIF-/EWA:3 EAVK,#9(X1K4]]WG;>D^63ZIB>!'#7*S$+CNW.G"^9N?*0N;' MR)BQKM?DS6LG?P+I8"\3ONCRZDK]9_%?KS!B\ANA8_K/WQ7_I=Y3Y$%L7SG=W%5+SW,;@QB4^YTG6T6VBZ1..=7A9;/P&:QJJ-H!0&; M3Z\/)KTI)NN@*TZP>E11&882-?Y]1&;S5S[-S^^;-J)* BULSDF"8:SMWKK= MOE-(-P\XT(0_YR[SAGR_N!J,4]J J@&SDEB>IF8E8?2HVW.G@_J#G(P<#PXT MGLCC"PSJ010\;XL%*QD^^"WS3GEXHX 23Z0E4*/I%^(?<\&?'M'6$:!!W%WK M%C)**N?2F'BQGM 7GBT@7+D2>8>T"3GVS#_'J8:7<4/+?^<5MTL:GPHCETP) MY8<$6DM0 XU>@T_SVHWX0>?#=":'Z4<&C@WD"TBWJ@ZC=AG-49=MB&5(2ES7G#W_,(OG3+E;D"_EF)%2Y_&A MB']]?5&K=]FX"S)6%Z1L]PH"A39_(:KTE;"ZPV@Q>/#9TR?_DZ7_QW>U3WS^ M?S(;W6&?)O;I'_%C3M*0,[3RK!.6MI-+"3:Q9E[X2K)?\9#RUPI5?_;IHYQG M?#_[[%%(HW]MFN,%/-1X[E &/D]Q8/D;F7$$VAL"R+9&X:X-'?8'(X#FL#!? M@]'BVHGM8H?77,'4 9#1U)5.L!",AW\&@$#E09/7P4SB3?@%OPP#;.-NO M7UHZ4/"@P&IR'Z/E\."%V#/HQ)?*>/$;_CHM%_I2?D_^"R!XQEBMU^?\?20K M$!#2IA>;^FI6I>]:O.0Y[EF3ONYWF"&+?1I&..]+ESZ4=W_QA\]^A3GQT)W> MLPX%-YSBJM^YID91@O:E';$%%L(Y:3G8;HMAO,PQ ,!^X,>QCINNZ$IN].'3 M'N]T9F$A'^K "TWZHBR=,-8H(&NMDX+IY%=Z7>]0Q\VI%H8.XER+0D4]U$MU MJ00+57&B &I*0RE5402NFB6_0[=/4#QKGS:_,Y/2/I,;\3/L%M8IENTJ"3 M^;;)T6T16TG3+W@^K]#*!& ;MDKUN\]]R$RH=5E?M]DDRX_.-SFF^>%Y(#I_ MK25+(E3_W.^U;SQ+_R $DF3^RBV1F1&C=ZA[7B[/9V;P&P(HP1$>AJ..@+TG MZR("IKP!&5-K&PY&.YR3KO[3 ]7/\[(_M#4,R>XXN3U.?M_Y 0>Y[Y,Y\D^0 MG8X2X;>__D3*_!--=824O_Y%YW>32\M7@: ;4OO M8Y?_&,OFO4D-(&Y)Y1 TA%J@'SPH>MZ/J@PL5FCTE"(]JU W;/ 4W697L>38 MPHWYS=CR^$^3HT_CL:",6[E(OY%$$^Q5)DE<;3R<6+YJZ*+$($W6O[5O/[.6 MLC#>RXL4E1>?][$Q][$%[_V= M3S=)1:\_E_%.2DQY (9BPV\U&O#!L,UW,[\8:L@^,\B"%3Q M7X.LQ'MPG.YMY=\(R+^*<&HL/J,+RCB_AMO3_-<7!(-'(P*G-M/]=[NBQV01 ML(A+1DVC+"91"/AG^6-P7'D9D?J<;RC@58Q*S1 /9<=I(K'S*$\.@&QTBTY:Q] MSE]J@-'!VJ89>&-UHUZ-[KYM+L]/.RQ+'E&JXS99'=%>/6G[_;X\S/M_QON/ M,NC1_OM_G&#W.DJ?L4DA"W+5EV -TARNJJ'1Y#953) C'= 64G.BP0;I.;H. M9J*,U,UDEFX6M#,6M)^W5>A9W\U$);KO,F0\6_JIFAW.F^P1N\] MM$Q?-1S ZU@^@;I+$7GRDG)+31^:GRP6:K*>?+?*\2QS9R]S,I'%ME=&*K0* MBDH=>&1S/UV:G6R!?;1MO2Q8D QK4311NW),ZI4I3Q"4VK@5-9!+8"TBD[/4 MG+'4O 1>#TQMK*]*&9+E58&D@L8Q]BG%D8WYDYL(I#)+P1E+P?>FXM56L%*( MD5_;'L!V@-)U?*\V#:,9@\OE,I/6*LQS#/T -MVB(7,(UJG;N68CDWCR8B?1 MD0TP87Z0=@Q#0P;'PP7GS3[?S5;O(*9.2&/JA+9'?HSG+P5"4J:"Z65:.)O\ MGUTE\F!-G[8YZAN<=<49BX_I"C+Z85/KQ2!A:CR!VHFW:.HWF#,D,C/I0QS) MP%U##RN?/VCDXLWD"\]F\H5[)5]X-I,O_&;)%V8@S0RD>8=Y8]16&,P<$;:I M.3O.>NBD/QZEP9'3[,F<\58#I]D+]P?%L(U.5E)'5ZFB&%<9X?:B:2MHW7?= MQ8O+A.<+C(=S8Z+,3DC(1(I(GLB!@<=D/C2*VWU3&>1*R@+QW0:].)SW;83Q M@Z[5@V1:X;MPB_S H="L,PO?^0K?WR]>7T@<1MNZ*>N%S+.IZEVQY!'ND(R0 MQ&]VHYXO+EPS YG-+CN5OY=!HY/=7+-Z.F,)L1+E5.Q\(F;RL*B5*_.#=)L? MPZ*84V]$Q,*D]CN9N1S8]2;E(_GP C)[+A,KUP9\ :$L>%B?B\?^KHJVZ?R]6*:U!4G)B0JN NMHI"/U8;0<[>N . "2UZMDNEBX\O MHUB[%)2EY.B !L.^S6;M/I3>%NP^#8_PAK!F8U?K%GG+H_3D++MG++L_\@03 MRVL#XNFXV=^&$([LG1_VF):Y='1^1<+#PV2&'W$)'-,6E2/!&B@AM3F@0H-! MV#*['JL0N%CEUA0(:DW$NU_1S-94AY4J/)&_(F-5XL&NL^"=K^"]J,3@!M;% M],.P+LHJY@K*^8N,.?:GYCO\&OSQ8@=5B_C6DQ"4A0'YL,44OF'>\T':094! M.B/M:&7??U=D021SGI^/ 2<%#$C;-V*\'(SZJ2=A8E,4;Q^I" MQ[,#KX (%)!)-"D&* &,*J)PA&+U2P'9R<'?Y5(7'U7U($OQ7U6_E+*L[]OR,-AIG6I26A? MB^3S6CA%7,O0:0(HWVLB<#6=0YS]XO.6N&GKY6V23*O.2V$/%QM3,^QC7U\' MW>+GVG)&=K8UY[SCUO=6CR8J&X^N)ZL93M(($!WY,UU=9X:@TR%7RF"F_F49 M$'50'E@U@=:$)XN4!QEYLD(;9X.!Z9G'=W D!8RHY\HU9DBMB;FWCK2;3FVW MW_,$5NF;LL]G\3M_\0L1]B OD[_-XWG9(V,2U]2G6R@4"S]+P$.1@'CW_UXQ M>>-K:)K6)]D4(FBB,6_M@]G:CHG25C(JZX=O+E\RPD [H_(6>3).IX;ITA.^ M!/V/01>O:)B7PQ MWV+-=.A;/?\MGO;DD\YGY7S/ MBF@[7IYJ/-JV)S)"CH1@DQM'*NQ>#7KJ(]$0[WQ9;^BKCJDO1#!](1Q*$\Z3 MR,4L#FS"OH=J:KA941AG98G M;X-CJ1S97RM;D/9!<% L>MS Y4W%4X9F$3M?$1M&?DCJR/Q$.,VTP_N<@S4. MI7Q]V_/\U^!^Y# 7A5-;W1Z;4'[DMNT&C]B M@ '%8MKC]MS?SEN[K):8J49J(AH+F/[HEMNJ+NO-P9Z)J!A>- M7W#"HW';>@]2]T+&V?F-6#:T$$N'U^Q<]Y^'(*&[LKNOFC29#6\RJ M7[K?UG[\XO[3=^YSNVSZKJ@.:*)@^Z2L.0.Z6VY[3P1I@7E0VE_AG&&T!..) M.H8!01L*^IN5I91<1:>OKGBF59FE7#HKY;<;5#XJ=LI-N+Y^_1O_2;]Y M\?+'[U^]]N\C Q>,FI3S_(&+QB5J7QXB>7K']$BR4N^?3BGENP23 EF/)S M@(.<(J>3HU#^3H&EZ+KN-UNMSD/8]DUQ!6E%&XQPDJ[3[E:]R@ MJ!(3^(JVJ75)_OE<\[SG*(^_>0&LI'842'=@D%I)J3&G2LR,+D/??:>5 MT)_/\C;+VVV7W+A]F6M/ESDX)$6=>3F"BJ_7@WZL09.Y3($(#$ VXBB>,#N+ MY"R2MUXR6LD%TKK?8_ 1'$E@9WON%O]'WQ3M2HBC!JWF9RMBYSY]&"9G1*T$ M7(1T3#11P@G?J>C2DZ.=DU":_;-B)\YN)^;#?G:''9PWM;H\J-GIJ%C 'J60+ M9V%6/LO"W1%YR9T2FE\1AI$[)>!&$])PT0$%Z@D<*7[EFR8 *G5+E%(NTHDW M,K'NN,N#,T("/C0B5^E_QHSD;7X%C=L4FRW85N@<>)8I&1]'RKET:)U7?K1! M0JGM>5Q;DS#JMFYO]3@7'U'JZ<$L7O+CH.F9'$ @Z4CCWG730_F\*.OQHU,/ M7 _TIVY[65>;)SB(Z$QD@K%V3D"?A2+]R25AGIXDH9GQP#6,\:J")CHQ'-)X MF*(, ' XZ[HLZEM)#^G?F-J9?Z(:B;^?8SADX83)1T8EM]&0ICEA/2>LYX3U M!_:?AP,0E_0%ICV%)T-2>[91\3F*UF]9)R^U!^,'Y\UGX9N&[@PV=2!I,907F5/I998 NJX1Y+)=]F3=,IKPOZ=)( MDWLO)S@_DNI[XZ*=Y3QTOMP6[LI%>?;&80H%[)N!$$%C!T\>V4!.RU^DEY5/ MN&>)-%>J$X_>P+3*&=_((Y_JI2!E0RY1(4X8QEK7;W2F69P_HD_BL6&,)ZB1 M&=\W;E?T._+EZ.DZ5\69J23*:[*S1^$L6GA$=U9#Z(N%NJW';RYZ-?>Y;2G[?\/K"-6WIF^[MRWR0OEDO.EF_*0Z;#%.Q;T\-B?TX* M=H:]_ZII_5\QG3]9(!\D;G&P.N8*R\G@ ]ZPT;J0Q\SPR5,RY++8,0N!7H*$ M'PV\=7,(7/S>BPA7 05AGO[D%I\^X1-,%WCUTXOI\GTLP&W//93KOGQ/A8)? M:2M,BN[_$3Z L?ASNLB7;TCMD@Y$!KEN_@0BH,[)H(=;[G*!@4;0C@KOBN6- MA3 (U)&LI3RT?;D-5]OFX+,D%:[RF2C1SUB*X\IG+BMC&B"Q?2A_*&-9'(D% M]>ZU/JS%XL"K^_[MHBE6=&A>N?1OKP,@]W!!KT*.#:3YX+""BE[:DDF$47"] MOG#"R@,7I4NGW)#QJ\/;J@[!_M>-[[8?X'+&*^9E/)&Y05C]R)Y= MZ_NI*S"_(3XXG%8PO'_V:8B=17Y(F@838_QK!YG)\'W#44E6,,='OWQ4!VML M=XK"H[5STN@^297XE2N[_"5M#LG!CW@/[6/R;-9&KXK%V$O75YN,UMVRSU7Q M$*_)S?*.A$W0"<_$RX(X!HT[??#NV=S/!OBTUO]J;/PNGGK%&':=]2A+T.1Y MU[',[1#VBA;,V22>C4D4RZ>G]X3!BY0[],$B;R7OES.2D?Z4LR8)3"I,MI$W MW-EQM/E1[5LY?YLN.T65D)Q;87LR MU79N2]2DVR]=XWTNBBXC''&T%)N)KDC!R%44CSN$4.H,B(^(B7T@F'>KB7K" M^0GA.4K=1R]FG4X5);^T(G^SSX')= 8)&PH9Y[; YJ23!23SQFU@PAT%!YO_ M.,O;6:SI'.7-1(J6PD)%+M!K";M_P+3'* @J"QY"RUQ;AWB4AGLK\[O& -0! MOP(SU=N/\[(#HQ@G1DV9"JD<+ A[2RQ8BA0Q*Z6 G.9J$_ MBS6=H= 7G#" (1\J5.70#W++EEWEDT4W):',V-^O^MU">*:CDZ#C&&K-CM&7 MC6264ROM+B_+#(4;BQK$@Z"52+8):T'H)$BA?):=S4+$X/69Q^:9[I7B/RMM7N\-O^WR O>%7D:1#J@=@B M^LK']58<)!K%J941'4VX MFV7K+-9TAK(UT&R11O,35< R#T2A3EGBCE$*0M8%2.1YWCOF"[0GP,VSE,U2 MYMN!7ESE)0D-6;W85PNU>DO=-'#3^KT. ICX E1:Z[B0;U**+Y%SZAA>LR,Y M6188"+8\+! H=_GRS13?B(=(?RRUW0=60?Z(&LUO&MKPZ3RTX5Z'-GPZ#VTX MVZ$-'XEF^@@8:+[)B[)O'-"[6@R1\=+\Q^0WB#OWS'.%N-&=F@Q IYNYRB$8$GB/DF/J//A M0MLUKMIT6X911P0$NA1:P47Z(Z"\"EANW+ITT@UDZY*['U!0?O:'/Z,84E2: M4H$('M\KBP#0<4<=1J=% @N&RK1>T,[D,HLNO>P$O"$]'8!?2)R]*NC,=(Q. MO,X;\5'W3=VYI>5V_/0N9D7C8:0[BM-7\GL3$EO2%A($?W.[AZX\7 MX9#B79*TM/[M>[ACP>UC>7EH"W[I"W:P,6D>CW*+QP^(2EK^NBC=0V4,>S_+ M/F]5\H[7^]Z52M^0?)$YR!(259%4M([P<6&))2'MD7T_/I'>NF@SQ='HS=:Y M-S@W(K6G9VVF/Q7=MN[ICHE=$B52[A1@NW:%AH5CJQ;QN>]KGC1'JQL<"-]Y MQ= LQLP(0(6,*?,+:@;7!DNPM]=AVC2]HT1RNY[HHD9 ZD)+([> /M2S]A'X M1E^W<(P+TI.KQ,A)H:RO29I(+C#[''Y12V*RU"R#M.AVI/O7:W3V"E94AB$Z M=H#$&5(@*00L;O'A.2'#OZ+W2/1N-_M)9Z;FVV&RU MP4M);4D-.?VW$QG:Y?^HF\BIR<"+"I4AJ Y.WJ.[#4X3J1ZZG$F=5Y:9BA*W MO%2#YJD@F=Q>Q0KT(GUI"Y*N.\Z)42 MGH&??*X:B!7LL".]B#R+':!],S7@ M3 UX!CP@[Y<:\('.+%>^!6$'W"+U/3,;?:A5/5PI,IXV:88MHRG-PDGM&G6A M)UQX]7^]C9O%;Q:_.ZY<8%EU!59WX7%CYVDB+34+URQ<=]5MF%(@]&UH_JTK M(45B=SA$9@C+)E'YLWC-XG6C[I)DK%'K2KIK<9A(E_ML^2QELY3=<>7MWCD9 MHT-::UGFQ:Y-]_G!<_ $AVVFEYP%[!=$ !$)T%"NS,_?.33)M59E&W#V=2[? M69!PPPDU'GR$L46'7ST3H'@)*=%EK%\+9N: MJ>DJ(\?MC*"E[>D6!Q$<[LT\^/XVOEK':=E_]D6+A&5TS;J1?W68E>0GCDG7 M)S*O V@KYT#7^#/"#1TB%3/MV5#O=$EON=XQ\G#=",Z(EYJTCC2DS*DR4#:: M^OGM"C>P9F_;]!HT )A\E2\+?="H9]I#&+6\-!>%SD3R04(4EX9>N2HOVI9U MV"N7I5^ZY@W%K;2U?\U)H*[S0Y;^0+J/Q/V52[_M5EGZPM7HNW^E]'M_<_MM M4>;6V-D@:[]#7J73"6;GH714KU"U(E $$&PIJ^ , 6Y.1D MC_#Q2N -M+R8X=LF&\**37TP2_<'@Q!@FI[0&6M M^!9&F,%/68IOW6:*"%#N;)P,2 98MAG?DAY9Y3G<&$=>6>0"X"X?M08T&/D+$4 MO%]30X$J">H;)R*V5[6U ')*="J+L*UCCTFC+'L>9.F7!GAFC&T:XTC56X&Y M9Y==&&>12R@/0BN\/"PQ +ST-MHI\$8XXMN$\9/TO*T+((N:WF2]9JI@PR@P MSPK3PHX/XJGC%K!A2]++K1#)DAH6_ /S1^HU<)>B32*LETY>BQ+)/^_PQI- M;WMBYY/Z873\*Y\%28H1T%FP,5,^2>2NZ\YS/P_3/J =C_W;6Y^>DST;2/&Q'$1<[\!C<9HM"[HPR%(4[(VF8"4> MAFKNMC&51\A5">UXDL&(-:-D1K:=&ZK[>/:VJEVPL^N$ T2K3Z9E/KGA%8A# M?V_')ITX-L,Y*0&"+!SJ9(H-W1R!DNL%7^,DG+DU;CNL:U6TY)%Q1+ND&!8_ MI'^C!4Z9Y*6[@IOB!./:_]DK^?^R7/ME_R M0=O2]Q)5RV@EC@IX2@62@?D*=^3,!_SY"A\R8)KTLWN[1 N&_0S1L6NNG+KG M4XD<3N8 MOBWHM# F7ACIA_6RX/Y:2X#+; %I1)),_$7Z2F63'2QR:@I$?MH)LB'!J[B$ M%-7Z.>O'6?R4GIB_SB*_EY[(&F" +!$WD)]MG=M,N671+"DN[>!,\"-5Z9NJ MOJ8W3"'KJEAZ,)0&IIA^TM&+#\L*G\'/67%Q@M>5^O)7*#I]H+8]:$KZVW@^@R.[2CUX=LBZF;"[]065/Y'(RE5BM-)6 ]) MZ+R0OX"'5>H/,5:*BK()(<2#% MU$SG+ @544W&&63JDINEREZ@+.BP[CJA3!O\;(;FS<9%*;I7&6QMM(8^50[R$'B"G#9:9> MI7JNX,%[G'UD$@C6B0W%/#Q$4%W.&8IWQH&/.QK',1DI&SZ" <*B!_Y$G;[_?E84ZLG9E]^A!<,!7ES5$:>F,+$'G!<> M.4Z:H]X52T79L;C%( R8.\GE-8Y3=B#HGM-G+6]&>B!U[2'XJJ)P?/O!Q#I:NPC2-7 MST:_A*!)<5&'KI^0HRB_:R>I;^,IO&5][3RT*N&3F'FG:Q6@#O%%\DW?(-F-V5X9 M:3!-I/,UH\A_\"@ 71PE^#;+H#Z-8@56^2[?Q$_M-\$? M/^#D6+GF@.&W>=NA'>>1.(/DF?<-8'?<27--;QY^^@Y=-75#+FV-3'].3T.N M[1OY2KE:%XT>WW59UZOV<>:5";^;HF(T1 .J-]T4U2F&YH@@RJZZ*IJZXO]F M +2ZGWKR51EZKD1^<=H[LQ9: $2Q](H9+DZWTM_+;420/#Q1:+34$%PD*#T( M^%LL@)HC:=BY"Y_IG7#@LPH[$Q7V5<^TMR(I),%OL4\5_1PE.6_Q.,:,QU?: M!R:AW,E8T*)HH_VI"OKX]3N&2%J[.D4D%K D_&X M6D5^A8F(4WRQSF:,*(V9<"B8(I7ULCO#G'?\FGU744&G&>RF/[G!=Z/":\U. M$"VL\XR)%EW$0TA[#;5/(Y&#BZ1#%QC43@)R#YN+;P5*9[FT'W9@".$[:;;U\H^\[3&7E1A:$ M]="BNLK34F'DFT&4A =OF7=DG=67IHN0_&?_VM.+9R9/1;,SJ3(D"9"(X8$P 9Z(2W)==V> MB[1#/WM2ETSYO%LR%D<^;Q)[P@/_5SQ>^M^"G4U:%XFL9!BBSEIUMTFGT7,_ MV6$.MG>]P=;MVT6X$6RWW^9,S5VEWY1U4ZQR0U.C; 8#XM6F2O2#8:U .T&4HR-Z,&G5-A M OA8)TL K2W!,C\E(D=[IH)\%C1Z#"%JDIAC#S;.5"F>_R,RES<#PS^;@>'W M"@S_; :&S\#PA^A0O(QL0F)99XY<_1AT/V 5=FDE?@:@K!K4^$H5_2SWH+'8 M6G+U^8JC+K/K%,ZAA0?J'*9EQ5D[:1Q*R(CLBFX0(M>^]+Z>#H)27*P4GALV MZ)FY0.^P?#=9N*08-P2;K;N%=;O7[%@R9\<^].(EJ /W!F_L.B?UWH-RAA-; MD/\X,+O.20([GB);M#MQ?.%DL"JEWS4\,DH/2\M]-F6-LYE3H9N66!EZ$3'0H=@'RW%K7 M!DXBYI H6$HLW ZV"N^DK&WP [2_])E$V&K.VDBTUB%_+(ES$AA?N8EU1!>] M+K59MSO 213U>ZZ2&01TKHOWED,[IU11"XJTU<);-!2M]83PE(=D5=3!S\"-\<^^[O*TW4*-^_;Y M+!HPUKI]KJU^*KE.[J6R2\:"7BM;" KTBA6SRI@\,R:'%V5*<*I;GXO/#)]]A[[D?@.2'E[LFJ 4F^Y M'=$N:%S$+T1?WHWRT>I.L4@D(A)YTP"LP$@#MONC;3J]/7KWXXV)5.)LI3Z8 ME7H)$ HP@[05[/]$>!X(ZVUSMMD01\(\('F[16W@>K8\YV9Y7LIF)P)!RDP' MJN-:=#KEP:&"T9$&%; UXYGS%*+M M1(BJT1M2Z5LI0&70 MVCD(9:[G%-0'/[KO 5=@FY"7XA;$&,EM3Q?BDW1HZ6"VQN6*VFL4D5OA;.8^ M.U.-?+3)OH4(Z<"\,F 1$@F9ML76BI82_JQUD_>K+.6\#?X9.'U7];(7+&E, MY2[5Z/*@"1!EZ)*_"E85:\G[;DN^G #ALC%3, @V9>S4IB]S=+.ES#'?. _F M#>V2G5MNJ[JL-PTPB+H4>CRU MTVR+]WM@B/DC4U,<9S::5(3X1[KC6AR*XPD,2OPJ<5R=NFK+2901KF"*9_LB?:&PO943,QNXM0M;ITH[ M1UMU*<2J=UI\8A .0QKNPGC;5=%R#,>'E2*WG;W;>"I),]$/,!^[#]HM:"6= M=4K[B*5L(DX.S^\O"& 3^8C7,G $S8;]S-3H"S1X*')]ST?3&ME*\LK+C-:Q M*CS8.#*D42!N85I4\%%18)Y186_RM%>1P"!^8($";)NK(Q1(M(7VN'>^988' M6OBNOP%?^D1^*)2.>*:%Y;!ARLDMEB?I_59HL7?*))HI#=6T T2ZCW2I5-'LS$X4,4:N*Z#=R\KL3*6 MOM&320]_W!;T3@N)5!$O:WI1;[-PAUH1$8:MU0D&\@CH]VYDV)TU,W'"T=H& MR)$GX0DT9LRVVJ+9G2MOZ _+-.BSL-MRBO2VBC7ZB^CC':T>+?6"DMBA>*64 MVNM.WBAG-/F95R$B3HZHPBPE*#6P9MBG/%@'&;^6.^EAEC*+7K&P:#I%WIK( M<91,1M.2#L91H"VIA6L324.*U?3XUU,+7 NPU)YS79=E??DQF=^;<8B?SSC$>\4A?C[C$&<-N:YO$F_)K2UM=IK/S&E648'S0-$O E1VF_+5 M#M-#Q"I^ M]/<*$]N2UYTT;&OI5>&J4]V2J*.@ATM[!L?,JY)CXXF(Y!WW5?QL55T]\<_G M@;!232V@%/.N1UR0Q!SZM*Z=HF&Y3S_?(W_7""N46_9<=-B1FRFU&J0A["2@ MG/#26 ?H((G'1ML[:"Z=.J#Q=9W/:PAA[@W'\Y#4O0/?PH:A1-Y&/;LF&WYN.[K*E>D(SG*@C3[JM, M?8@7I)V=Z)FFV,P25\-'M0@$#:[[8L5DR>D8\_<1>8 /9_$A 4.'*I@+S85[ M.Z'S'O7<+IKZ#<[FV-F?BA5]X_.,R'U(ML<3U6',MRFJJ[IDO+<."DT"D\ %";2QX1S"K[I*]-/ MGNH.XH;LN0X,U?L>"[0MK:XXM);^>:LJQQ!"O6TF,3:J]5L&&'L5R:^[R)40 M$2]F:'('EC832@'+C=_:KTN.R@0SF\BY+#[6I2S*QA0](;T3>%4=92OF&Q70 M63&>F6)\T2:Y;][RN6R/79ZW)'>8$2G Y);,EB8/>,.X7YX9<548$GTW;(TK ML&=4X GC,?'Q*PSO6=]B=#-^."D.-S+H+> 'W@_/\*,D):3(,;BG[ >MS1H21)YL3.M'.O2_77?QXI(LQ?(B M'<,XE-3:9W6BQN00)(AU2P:]S-'=8H9 T8A-SG9 >^$JMOS<=2/DDNU(RJ(IU+L=,$1=O10:M7U/?L 2C^S47Z0B>,PLB*9Q0MR#>YV-E*.'.YP!-HNG-E3?J 947L0@@\Q7-<*=>> M?Z&A/CQY:&VFJQ5NNQJ4;J#?0X4"A05/I<.XB\#]$PT'R .7CE3 &6;!^>R5 M(]>E\N"'X>.>7%6D2@8!=*(4/W3@ML<\/]S5LZU+L+;K?>E/4BYII>U=<51"#0$32[0<8K4\0&RM%9U8L4*A2@A^_RAX9<#T3P+5W*\'TCE4W6@%&^3&W_?X\L 8YA1)<7CH=G M'AV\_22J-L0WJ9MN39:W3D,IRB@A/O94ZS<"C<]<2 M(6P_!0::*-5ZAI4568N#(4^&5D_PKZ,*EZ,+UY+.1"C6:*IT]F_.S+_Y.YR- M9+1Y97Z=P4:WS,:\K5,#(,GW"ES7 $"U4*[[3P2=TS*'M_V,S?AU@>;7+W:[8B/E.O\VOTT?/GS[[ M+'WEY&N/[6O#:V:!0*1QX)9G,/;X>LFW> M6U775AKM.!%VU(3=JW9?YS7KA0]C&5XK M1BZ!*[+7@UU5^P@?#CDA\ M6U_5+MJ!%&.RRJ@G-TK7XA+'T.GD*]?N0;$=)74"YC1[5W,N?=2 0.YPL83 M7@Q9W?.NRS%@8P$;L.32*'JHY,AR'I?AEZJ@I0,>3U^N:176-71TJ,GN5 >I M?,NEID^YO66?Q8H?AO=UI4,[^.?)PFG^P*TRS;&#OJIHEV7-?Z/_X<9@^FWI MJF@5\K/,OHO7X==M@T3BFX_K1]+3)EF51";L8;ZH;X[#@X_V5!/A/#!KU"8\ MQ-S?B'($V((L86]T,-P9S8*>D$842O=9B7TH&W>Y!@P!PF?N:< +-HY=(3FZ M52$M=-9+'DSA&W=0U[ARDOH:7H8.*!/+_;.GAUD7PDDGWQXDUY*?&7UMH=/! M5"_0I3TER ,FR M;CR2X"SN9%:>AE0&9^^USR ?E+2D%351"CL'4JF0R[[] 7F$\)&C%411!]<) M2FF+KJ?'MX@-0/87<6_80"A^,1X>' T:\\.]LN@$NK=DBW$$-,\=(YBCTJ2G MI1#$'H/8XFCQCX)IO) M<:.\ORC!A,]LC":KU^.KF.9B)9>RL1X&D])IXM^BS/0)+S*)&PNR,#Z4&WE^ MACJ YJ$%0!DN**0PX]!4LR ^$G\ZWBYK/E'^)ZVY\1 6>/RG2W#2 +XCL M3RI-\A0=NX\+!S@2 @2=0 @P!PM\Z?(K)[FCESJ2&HDJ)*UNN MH MW-+1_F=#C:@1S\SF?:Z+]WT-C32E@K#$-3*I6\A.F5_S5GY% MPGZ#L1V%=@;['C'F%Z4J4?5GJG0#P9?VEV M@\],_T\6)@8RDP$G1N[%LF.5=TBOZHY9G?- [PTX>Q"<]%K(1H"_L!\R@#T: M2,WPLT@R,O_5+*F!@! DO,^P^/8Q5L#^,CQ\0?,<%^G?V.<:\:WX)KF5$:_.IO*\3.7W;Q=-L=HX.M%!"+[5U B?9_T" M'>GT;Z]9'7.2WW-NF V4GBY.KDS7LP'TN/SNA>3*PT",0%8A!>4DMVM;Q5P\ MKKAM3DLU-\BUS7 09*W*]%A>(_:3B( $ZT\FUF^SZR0BL0/BF!A% A_YTXCK M@@M.>$J)*2MWG4XSK_E)?-&#)9[J[MJQ9=^Y\.;Y]4R]'%\*>=?)'YWV*%2* M3GM45-6-/1Y9S_%<-+YO-'(MG1ZY]MM&4OYQ1E+>*Y+RCS.2!G1APR;AH_O MO.OOR+8,;\R516L2D/H0-[$?,BZ\2$#K[;#TC3.^CV+"4 T'?Q78M<5VK1OD M:!0AM@/!E^0D4XW5D3?EOT2 $O1<](H=06I56@<,)M"Q"Z VK=X75?12A#?- MH=0%, G7>"G0YAH#*9ZRD%0"O])"V[,^(LOUL ^4SKA!E2I+(N:%9=$L^YVG M_PUE-RY%\5DH?-G+! +.W9\^HIT-UBNV5F-K=N<''!BSDT;O$YB;R++=_OH3 M-O 3M5W![-UYN4\OGM^S[(U>.=G<,URDY ;^U[]]\?D?OOCS44C^B];\GB4Z MYY5IW.*,0+Q@(Y+O]\Q9+#PD4*$D<&'61,7AL?#R2Z,X^6J M^08 M\M@UA2+\U6^3XQ:IDI+EBJ5:M9OF?Y MON/*T4F,M:$VR M% QW+4MVY+MV%O%9Q.]5A6^9[A@9VBM7Z91B](IIR/I=79''\&W.94VH^:CN MA7ZRYY^^JY]L%M%91'^F%AX(*?KR='Y1-$\PC]A#U".PVHJ-'C)!5P9+7DRO!&-#U:+]@LVK-HWU6TJP.O M3:4-8DF2JDDTR!JG*AH*\#!;2,B=>;PJ"S^/?=\6^['XF[0?J6"]C7$,L\NA M%Y0D173169IG:;X/1W@I\WCA""/WAL2;:>4_D\#-4C9+V2^4,DQ_E=$DS"1/QEBY^J_[[WQ_ (!YXLIJ#Z/&K_;#NWCZO" M<]%W+OK.1=]S4,$RZA)=C%CAP/6T28%\> 6FL^3)33+WNNOF%,!L\^^\\A^,$4[J*"J!X$[SV9(\C78"2?$_^S5-Y=#5[5;R9D>]1NWG*S15LN4 MV1C!Q1B4BI0D]^=WX1M.("O+'*,GY)K,C;13U:JM*V^,@\#R2*LY#3I+__WX MD\SJ4W1]YUNE=O557AJ\Y2[%@&R",R#^?);765[OFK;?[^N"R8L$\Q0EUO/5 M%1@6!RI;5;@FX:T'0NO_ZG[.4CI+Z:\HI3*\T1>33I1/+32:\_2S^-UYY9XH MGE?H3;QO]M).M(7CA%$%3W.@-?-6.H!L.&H;VK\NYDS^SUO\4:+_OG.:WP@= M?9L< =\"S&A37,EV\_8J3]B^KXIVRUGQQ8$KUU(0Z/<0DC5P%MN^6@DK<=VW MW",YY -8(;U-8O+H[Z___?.G7V1_^.SSBV=/DP77'^LI"@2;$+=WFPU32\J0 MOI1;";GQ\-^?7OSQ.11G2A=]=O'TZ6.N*NWV34&JU!.VY1R3\?Q,K/3 ;2^ ME- AX. I"4^4!R)*(*UYV/"['^C9\^S9%Y]=/'O^F&_H2(V2&XS^T'4G3L65 ML VDC"- P,WS:W7@BZLC<;__B;4??2GY?[U.":VQ&0-"'.*59$W/.Z+V5Q] M=_"NJ(I=O_-#N)AOO6_V9=^J-I7ADYD?B17-@N".*AG^''_7>(7E+DFO&7K& M2-" Z\R.M;1?DWTC^:MRRZDLZZ91"*.Z8YX1**00XX%/,"U, M60U^(!UP3\+!Q,VY_P8&QH(Q6>=&1[8N)AC@&3SX"C@$"IWEX-N8LB$O0A/# M.CXB\W4S'\T7,Q_-O?+1?#'STN)90E$ PTAO_UK#/&6J\T_QK21*-D MF2TW=BG!L8*Y *JT9V;<<_/L?A+NY:/-EODU0L@GW&VHLT4C':+Y18@_>5B[ M$O-U%,3*/)PQ0)RI<-LI24GNZ#!>I%^93$7C(F3J''ZQ*N V+'I9(9,$'0FG M4>;*=.2"-N60R)QA#J1[7-N.G6Y:Y#F88'G8F90P3'&ZC((3#,,UWF$3- ]MD3+00 M)V+Q&C3*KH ">;PC5L@82W3IKEPYH".L3M 0CF9SC1A.?^8F^>XV6_A 3"+B M$9.4C\C/?#B+%_.G6G%$E=84[1L(,<:4%HOR(#PR2CH6S0HW@9/HC^>/K]V* MV3JBZ>-T!F=K>&;64"<1_KUBJ_,:DSE:F7]S&;;71G.\D!KJLR]^CZ"]%7@* M_>P1OH_,[O.G?Y[^&7_X[,^/,T_RUP9*,OX:+"*3R(I8\30A9I]?N4B&>-A/ MTU<#Z21]"Z76R923A8-\#DCAIX55[N8S>SI4=T-FU#5)R&-,/)#GEQ_8$4PH MB8AEU4'09'M8#Q=70%NSY@DH1Y^SHM8ON56"KT6+#Z]B,/0Q8H>_R:V(V$B, M:+\*/WB!EC=IK*1';?87Z5_K:Z2]>7I3 RHI;EG&0*@=3SY,;WQ-$!=A#);! MQ6CYW-!._TO]F\#WR/V?B/#H=1Z3/WIVH$3&"*_4=RETO,F>-@]:20:>3!#T MTHY 5CA7$OZ:;QHG]E/,-EP$_G'!B>$\HH[DA$VETQD3?)YRZ$\7WB!)PI=K M36N"$%E3,?S"/_^S_L\-R]:=L?)(>*_TVMV53!2SERZW2:;?^$7Z32UYISVF M>,G,+^Y.1!ZK6N6-3+3A.$9\#BAX\B2*?M?*H; 972272"NA8"),EE?.GE%< MBWJ=^,T-]#2:).,3O)+YT-;S:W?V#\-SA/B5(ZDGSW?M&G\@Z/5X)RZ:]L.' M!/-MG7N#1F$[M^\62./J'JL#/Q#P75?(= FJ-G U>4RXW*Q,7W_]4OS3P2@O MG14MM5C[S8 J.E8FYJ89"74U&I/)OFRZ ZC0OPQA"E6UF@S#%=:5\> V\L/S MDLTR]N2JJ&V:POU!^LB&O53Q=1X/ MI]JEK_=NR4>SQ%0\B7983=W=>6 5PF-O!$>LB8(3ZDIT#8>BME2F5$ 02.\" MD_YPL6VQ*+K'XP&I30Y@7%0.X ",!XS3JKM#[)QSYR:FKM5[KS2N\X9VBIR8 M1_$ W^DI&#RJEW:57BG&R]F G_9Q)H'T^/OPGZ0* 6T4I&;RR^3IR&1)6K]; MJ0:L@@X6$($WP%B+,D28-_9E38:/G*GT*\6QTJ;^<+=-R$L*:>U=IX^B$V:> MK#=A[>.;97S6I.>A2>.AG\D[3O5-GL-H[L5 ,[%UWNDL1?7HQ"YOBWWK!V?P MU^HF089L&08)(CS@CX8BM KZ M"7^3.FE(J)R0+BA\]*0()X>LXB) MBAW&U ^&Q/!)( ^D"9/9[!+#O_(2$PT1S/\&3( ,G;W,(RW=ZRA&04BN^L:< M8AV]Z7T(["]MVM3V\K[GB(Z;&URUCRG=>6-9_?G3N:Q^GV7UYT_GLOI<5C]W M+2%U!3\9,6DB7EA2QSX0RQ$U^D0HS$EF]B0;!JG!S8<50TQZ.GT233T>EKJ2 M:%3Y7(HX)__I10E4]F:;A,%X /5)5G_D%G.QU]JZ!HSRY.G$D^#B OTQ&IU= M=Q(8IFYK,;XO/=0]WR4)B6)?(/;YA$&YA+%U-I$\#(EMW%5!S\Z1;" +Y_EP M95[L!J/"(_^)\X/Q$UA>-1E/J!2L8/#]>-"L!?O9Q*5IYV2:T:#B'3F/W!(M M#+?Q"C1(P0'EZ#P9EX=EAF^<7:2+P_EC!= .1_9 MB(VNM:6SW:YSA/*I586@#- /RXY5PRM2ACNH0VM6M\19GJ55Q MK%-K%H^3*8-7AZ[Q+.&V64VQJ=LHPP&19,U(+*HG7!S51T?EW$B([PP?9F_U M>EOOZ+#0N2*S&572\!@RD##DL'[RQ^I-55];7R_??_+5>%J/3A+TB&H^(I?U M82O+P7PGS1.,IFYJ,Q X6:0EB,VLAD$KUW*"PQ=B!#*4L=J") CH&4N(CX?8 MXQ((%=4*R[YI6$6S]&,9JB,%&I2EFYJ_28 LZ,6IDQ'>XR6 MG/=D)YKB7V%)OV-=8P\BZ=>,I7N( +)F#!FZ*0/:AECK&T;[UDT(#&.-SF\A M;[S:$5(\%.B&.G0J^1RFA8[@X[AE!)MJ\TJN,M+QYA#I*^='9!WD=RSQKM;) M=H-#/"-OX(@%?JZ(6G$U37Y,FC,8KSQKJ@V&(V/O1L5,+[JROC8J4AY9('7+5^SJR M((OTP+$^04F:)$QS.!#&E5OG.*^"OBV:PO>FDM>F^D M$1NVA^:\T9]+EW.&$!H.D%=K:(T_0Z^IJ/-$U'FH>[$VW3G?CT@Z;=/G*+HA MVKB=\-M;6N35FZ;?=Q@Q2BO4WJG,(U6DH8?>7Y9X?4L6N=ZQYVC\1UG @M+Z MM&,J(^<@[WD(MSR!# !'813NHZZQO5,\GMPT 3N+WE&8W\'F$N#7=5E?SX6/ M#Z3I7P%*E;P*V #>QM?^\,QZ^$,:X5#43M3-_I&+(B\4JXDS] I%"SBJWSD* M(.@O_8[__@+)UU+:%5ZT;4W'C\_=(\5VVN>&YM3SKMH$&!+QWZ"OKY#P1SF* ML>(!P#E;ZO.RU.B/]_LNA>L F$ACP 2G8,JR1GH&1I1"NT;Z8C1\NE)2,&,A M04L*S+KTEDA#K/;#/(I:2!JMOT%>.1O!WWDL"0Z@4 KD!3D9N'84;)(U7NE_ M10;)T^O%(1U ?4[&HR+6V^"1$-991ZW_>=P\DR5"V0=+3R$LUPD-TSAX/&UA MD0P*$_T(IQ3_H>-]R*5IC/^BF4AF$K1)J\:T@D"UJ?<-:OL7Z0"6<&(S>%"Y M1L*2K<*F&-S5ORM[X5(TE7MST.GY#O%/ 2P-9D-[)TL-.@,]?3Z,WA=&C$L_ M<8/8TSL2<<0;? P%Y"N'41$$5 M6]IIEI8\)<==&0N#I,I.AU+\;);.R2R] *\";8V"L&0#6U-4=4,A)!)H'K-_ MU,)2=%940(Z4%!;ZZA!(:0M&O]MQ!L[+!@G2-1-,\/=#*KV8*AS9],OP8YZF MH#\^DD:36#%IT3=K]ISRZ#N98#H+M861'DT\.F;A*H7$C23?#+8[) MR1Z>P6]#ZXYX!VUBFZ&&A"$:&I N7'<-7-/)-X#?W.I+J)6<^@)7EQ+AVMGW M#7P,>IA'^6-[ %FAKIS[,5J_7=J9,=SLBJE/1SAC:?A(D;ZP'[%ILC0P?(1$ M*"8[:>DH"TD>%V*P=,*&DO7ZZ[;*M]I%J 66$EBDI ?/ M+=UH*^_XT/V8%^?X$0_ICI23N%)P6'SS"C+&^-W).TB&G']--ZNXBF*^%9=# M(5MYBOES!5?^Z,=]#,@;.#<3*TP\5M0V.7()!P6-J&O:-X^U@CZ7RH)1/X\? M/E!(1E%<'J(X5@O)+5^)O(L%(-J8J:J0.Z?8_"9GE1?41%=OQ,TVYCEND-8* MJX=E6TK*+/E 0.KF^$1DZ+.27CGI5Y*6N@D)/"D13"U4Q:*L!1O:D;V'Y*+6 M+)3<[J:78BWF0J=G3Q5O/:O$,'#^'0MCG$%5=P,V\-BLG%K OC?(X;1U^DO^ M+]NB" M1N=$K21D,[_8E4//O;6F>TR73#@F6M<49%YKB* X;#K12[<"S6&6 MW@B\OR"II*NI$D"&M54TAEY)N -/OF \'1K\1#7)"^:29,&AE1V$-J;?"HO[ MB *%FQ&=SV9$Y[TB.I_-B,X9T?D0X[3+*@EP!.DN8-19K!RMR8H-[YJDK 1Y MG;,D$(PCV@>MPI/O\G)#_\\,8A0:*=)L96A_%V/"N"];?+^5,-KN\G^07]4Q M)"4,N1.37.;"(#CTW)K(>C]JG.(/83[_\-E_X*)L%1]'X*N)14CG-,\'P?-@ MQ"S<*4:UA9?EKTZ7("/Z9 V[M>6XP9M>7JHX?.]<;V:!!0!SB7B.64"GV,VP M(AU)HD-OB\IHRE$3Y1U[>T >,V?F%O;^E<5%NS[KBOP?9WWD]$T-PB3RE(_! M@>Z]&?FE\JDNI)L$J,[1R_->I^%=@LOPEX;9>MFV3P:S%^E/6_)5F?9XRN=) MMOIZS.-!S1FIP- TB&MS& 3P* )/ 4_MV)]08@D5MRRZPC*O%/H@#H1@ M$_$U3F#&CUM@'D'PC^2$S#,7YYF+OSI__CQS\8:QMY/&+(2U/K3PY@8#G23$ MXB:_G>OF62(?:%4?@?0=Q>TL5(C1RT/P(E#:[V)S"[M.=K;U?E4WY(PV864B M.\&K+^H*I/DKYVNNR]HU2^07>5:]FO.BDE\*]'\'83<^H=9#.?EPU&&J#CLP M\S&8C\'// 8#OTG;)GQ;RL(I(BT'2=T@"*A8-DM:GWF_6_(K6_Q.TVTH<[-W MK:= 8.%[K72C\\&D^\^RDFHUB_$LQOWYN!(D]^W__K1U51)#9!BF4K0A09 OD;T6?175 MD+YX^A\C%F%899#WH^*[H_MLE:J1+RF=&YE]*4<]\ E_2ZD+4(/:H0\#%;Y* M:=CV1>,3+:Q338AK"JC;TH2!6K/\.U\F+%O5B_EC+S KC M"#!"!9L5HNWSJ[PH[1+3-^?3%]A3!0NC/68>&K,ZA8LQX&7RE2OSZYS! N$2 MEF.-1A8S!]+2 3*GU-ZIM.5N/9WC/^B*2Z&1BZI]<05Q1M)]:"3=7T5V#!4> M-;OXGF*91_K\ZD!?RB8FNHGY-+CK$!'2]I6J,.0@ ME!+$*5G#+8R^9V%=UAM0"@.MR"@KRB%7 ^?H6Q5OY$R\%#,?+T- 5F$& M_+*X*DH/-CE,\#8.^8'K# F==?29G2[GY!XI1Z.*DZ3U"\I5*&+'P MV/=H(-L@-$Q?#!OT/!5TQ%V.NY:UR%/==^A42*;$ARX&2FSIY(NAMP%U"T]! M>R10+5R2I\W&96B)(DR@38E8"[RF]=$/(NFA\+*H]ZVR!1AA7% "T0&AKT3* MP90 795I.50YW$T1V!N9'GAPF_,V^4KGPW<>A\^S$G5#)G5-H\>0XNL3 M(C?AG/LJ$/T'* M_4_1_"S,_:'=V";!X "V_8Z/M(3-_F<^?F:$9!999R8=UI,9J/[]#[FA9VG6 M/JQY0.5DF'C[%; 6:!.F-R*H/AM9B+:G?I=Q=FV8S>WRMWKZ=#APHT3H!T,T M0LO*[(6J,SCK:$?]JL.U30FT^0[)BZ[C[G!&?^2:Y8MV/E=":OF&I0'Q"MZ0 M'(L8#,@TUGX$@O)@-@??%P\HZ%)(63RR=@R-^-%D=U7W"]+06YWK,.%XW21^ MJ8B?#"P:>2E#Z4]\:F;*04N'#MK/5KT_WP>;5LIROPUY6SP(:VN]?''9%\E9 M2 QCBG)0W%RD,1G/E.M+'S,@A^ZM:%&W8D!, 5FOE$)G\ GN(Y-,S/GS%&,? MD6FX&63Z? :9WBO(]/D,,IU!I@_1!_L[)_))A59C8L)I-^HX7T2&SXF9;:-) M#IZY$.Y#G-T=IVYY[I$V#21'30-21Y I.+"UA:34=B *0RPT[#\ MDA)#2)KB8:T]7/TOR[!I.C8IJAM:&20:"K4;18=8K6A3"$E+_-2!VW!X8S)3 M6YBCLB"OP7K/HB\D?%''K@RX<6R$X8BM;)S"'FW3*)B%-3=R1+*@K4^V;US% M@99N39PB3.(M9\9+\?Q"PRC35C1>CT;*N-@K?]65)@Q[QO] 4%96,^E-S>LY^SN*Z9G[UR"-?A MHHI7'H-P=W4DFRT3";+?\Y8'$3686=IYF@@_7!(Q"_G+2^V!8I]<4,KPAFD- MY(+!%<5LEJ@[R)(AH3M(ISLEQPHBDP'T FR*#X4G5A2:)]KVIKC*XQ'NEEZ8 M)FKXB+RUA[/X4U0X_OR*%@6;R=(Z$104OPB+GJ<$Z.P665^#IH3%XB MBK:K0=ERBWTEZU8J6NS ,)<<^RMMA:J@$XO.EVS:6_UW,FA7D=49R\#Z'>]#/AG= MP$\+T;?@"6!DBH<>G@A[)%=.!L]_M.@6/*[+IEB$))B=REE5?DCJ3N6&]GR^ M?F)TO.G1V!E.I'!ZRH:<&.5U3$04H9?8])8'2_M+X@KH',QX7?EA8^(_L>@A MRF1"]@EV8_(6FR7@$[B#'U3&'C%#$^SS66>?F3[->#[92RSVCS3#^= ME!5-NI;NE+Z1NZC^I7_@SL@L)O$M!B)D/6A+H/4\B#@< F[QUXS=](%@JG6- M5N!R%Y45F^V'R3PV*/A2LD=#I%D MLKTU#,/19"!O^ 6;1_\K3WF=1^V7>IM$G\=A-*P]+Q,/*&/^ #UDEXSXS&0Q MB 9@O=5VHIHQ\@2$''T80MDC)!@B0O_KW&[X"M &.<0Z@5B@\IV+$8XA/Z:F MY;?-9Q1XS-.V( 7[D=[F,0L\'+ MTKI7H*D3U*BOL7 D"6>H+/5@[&;GXES88G_,W[+>FXWR!_;XCHG^60_K]IPH M9^L, QEWJ8S.@?DU(G2>':\S<[S^SJDOYJ AX]KYZ&+ $3"Y+.K $=()8LFZ MG<.,P9!?/\N&%ID*'HA-Q[4#P/#@\D83C"_(<)3I\T^S]/G39Y^RKR83H$"! M)$.@E%\B7W?6Q0!0P=&8U^C0Q'?GD?8V!9+]S[L=,:%\/<5_/DF7[J=QQIBN M\C"@7?>'U*UF6_CAU6XL#T,8@@')]!R9L,SZ],STZ10L,Z M8R#*&+ [-7$^ MQ@6I,VV3Y 0>WULPVS7.(* BA&'RHPQML$Y/HB;N&A,JJ86XE92 M:;-ZY,\7R5\-662H_LYS E6HF9%:*SB,YB1HCNJ7)_51JI=+X!T0)KQ"'K0' M<'7%@>"S+_[X^0VGYX0(U*FI]##:Z86+A!*+)7F5B MK_*UP&HSXZ^]?/4Z"S+!37)M*Q/#4)-NPL1%GM(27L'4,T\.1Y1PK6=$4_)S MI>PC,E@W0YX^G2%/]PIY^G2&/,V0IW/7$F//,#+P>?K#-Y,R3#TP MLS>7!]NMCPF"UET5;;ZZHN" MK,FI=STI>\1X6NJ DZ" F9/9G8^S\SY?!WB MO"1D@RV+^BZCRMZ-*L/6 %7"G"+M\O!.AA>QDOB6/-;KRHK.X@JH"[;/>;!& M8NC^,/DMYJ@F!XW=#P@V9^WU]D#@^ &Y44LR@][!SR(,V/Y0*+H(+@)4+R)\ M?TPRB=T397P6WG-!>RF8B=^$N&+%?33SYX> M%?)SVF7HXW_V>=,Q38@OEH0KZX.A0M');!NK^N@GPMS8U, VC.[.8'FZ'^,B M+ ,O7[5\R_ ''Y&#]K#UP@]Z!G4?P]&6OG\7R(PR/P8IGC0;G5G=V=2'=-') M811<"(9R*8W&,5&5^E&S28@04!SD=:Q"'@_ASTB%Z&ULY$&Q3G&(((B2R!-O M+'W^]/FSP;)P_;RIC/\U/LTRTUTZ3+@,)6/EHX@F6G$T>I;Y^HO!W24O^*Z; MZQ.AO$G[+FK(7DBT,'W&:#""Z#6O"@>#%\C\]]*MY)=JK9]'R8$;EY >+R$Y M5J@&6!T.&-#+1K.5X]'TGI??=B_(H)76-[S(1G!4SS_[CZ!]!S=*5%&9 HI7 MYK%2[!!Q$'[7-Y8=2=_4$R433Q1&<(2VV;+6#(O\QPKGG8\1B& K'E#"+#7; M7(-MH%+=*KY*XS 855+N_&>_G,3/4E9)C58:$L41 .'2LTOQ%-)!A]>[GGAJ M#TU[)$)8I=2]?<4C V[YZ'G9UD$-L46YU:_35>^A12H"B8J ,B33Z__^[:(I M5AM,J @/\JT"@''UZ OIWUY+X7YP/F2\QNGC,>%O9,CO XMA8_X%F#;X$8N M70.:$9L;5WGT#2PS./&HJ(MHH$P1/""&'\8'8[;$YV&)7_&X00!B$N[?O)\# MF/ZL XCSE_#YN_VQXTRC]GR(K_ASS]K.B=>MJ!MN_&1C(XG5GW,.<3DRP)_R M[>@_GHMIYL%0:J7W32%M!OA8:IMX ?$3)?9$"AR*J90F%HUORI+OYD0,!SJ. M7RLH4SQ8C)NG]72KVN/'1)\R/X\^YD^D$ 2OZ5&:S#>>2Z?-B?Y>:5 QE$[0 M(T65C#R;3UFY(K,L;"Y3L2 _2=]L- .M8]5*AC\U"!(YTJ20M&BE.8EBI

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�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end XML 96 form10-k_htm.xml IDEA: XBRL DOCUMENT 0001584831 2023-01-01 2023-12-31 0001584831 OXBR:OrdinarySharesParValue0.001UsdPerShareMember 2023-01-01 2023-12-31 0001584831 OXBR:WarrantsMember 2023-01-01 2023-12-31 0001584831 2023-06-30 0001584831 2024-03-26 0001584831 2023-10-01 2023-12-31 0001584831 2023-12-31 0001584831 2022-12-31 0001584831 2022-01-01 2022-12-31 0001584831 2021-12-31 0001584831 us-gaap:CommonStockMember 2021-12-31 0001584831 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001584831 us-gaap:RetainedEarningsMember 2021-12-31 0001584831 us-gaap:CommonStockMember 2022-12-31 0001584831 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001584831 us-gaap:RetainedEarningsMember 2022-12-31 0001584831 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001584831 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001584831 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001584831 us-gaap:CommonStockMember 2023-01-01 2023-12-31 0001584831 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-12-31 0001584831 us-gaap:RetainedEarningsMember 2023-01-01 2023-12-31 0001584831 us-gaap:CommonStockMember 2023-12-31 0001584831 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001584831 us-gaap:RetainedEarningsMember 2023-12-31 0001584831 OXBR:OxbridgeReinsuranceLimitedMember 2013-04-23 0001584831 OXBR:OxbridgeReNSMember 2017-12-22 0001584831 OXBR:SurancePlusIncMember 2022-12-19 0001584831 OXBR:SurancePlusIncMember 2023-01-01 2023-12-31 0001584831 srt:MaximumMember OXBR:EquityDistributionAgreementMember 2023-12-31 0001584831 us-gaap:FurnitureAndFixturesMember 2023-12-31 0001584831 us-gaap:ComputerEquipmentMember 2023-12-31 0001584831 OXBR:MotorVehiclesMember 2023-12-31 0001584831 OXBR:OxbridgeAcquisitionCorpMember 2023-01-01 2023-12-31 0001584831 OXBR:OxbridgeAcquisitionCorpMember OXBR:SeriesAOnePreferredStockMember 2023-01-01 2023-12-31 0001584831 OXBR:OxbridgeAcquisitionCorpMember OXBR:SeriesAOnePreferredStockMember 2023-12-31 0001584831 OXBR:OxbridgeAcquisitionCorpMember OXBR:PrivatePlacementWarrantsMember 2023-12-31 0001584831 OXBR:JetA1SeriesA1ConvertiblePreferredStockMember 2023-12-31 0001584831 OXBR:JetA1SeriesA1ConvertiblePreferredStockMember 2022-12-31 0001584831 OXBR:JetA1PromissoryNoteMember 2023-12-31 0001584831 OXBR:JetA1PromissoryNoteMember 2022-12-31 0001584831 OXBR:JetA1ClassBOrdinarySharesMember us-gaap:CommonClassBMember 2023-12-31 0001584831 OXBR:JetA1ClassBOrdinarySharesMember us-gaap:CommonClassBMember 2022-12-31 0001584831 us-gaap:FairValueInputsLevel1Member 2023-12-31 0001584831 us-gaap:FairValueInputsLevel2Member 2023-12-31 0001584831 us-gaap:FairValueInputsLevel3Member 2023-12-31 0001584831 us-gaap:FairValueInputsLevel1Member 2022-12-31 0001584831 us-gaap:FairValueInputsLevel2Member 2022-12-31 0001584831 us-gaap:FairValueInputsLevel3Member 2022-12-31 0001584831 us-gaap:FairValueInputsLevel3Member 2021-12-31 0001584831 us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-12-31 0001584831 us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001584831 OXBR:OxbridgeReNSMember 2017-12-22 0001584831 OXBR:OxbridgeReNSMember 2017-12-31 0001584831 OXBR:NotesPayableToSeries20201NoteholdersMember 2020-05-30 2020-06-01 0001584831 OXBR:OxbridgeReNSMember 2023-01-01 2023-12-31 0001584831 OXBR:OxbridgeReNSMember 2022-01-01 2022-12-31 0001584831 OXBR:SurancePlusIncMember 2023-03-27 0001584831 OXBR:SurancePlusIncMember 2023-03-26 2023-03-27 0001584831 OXBR:InvestorsAndNonUSPersonsMember OXBR:SubscriptionAgreementsMember OXBR:SurancePlusIncMember 2023-06-27 2023-06-27 0001584831 OXBR:InvestorsAndNonUSPersonsMember OXBR:SubscriptionAgreementsMember OXBR:SurancePlusIncMember 2023-06-27 0001584831 OXBR:SubscriptionAgreementsMember OXBR:SurancePlusIncMember 2023-06-27 2023-06-27 0001584831 OXBR:SurancePlusIncMember 2023-06-27 0001584831 OXBR:SurancePlusIncMember 2023-06-27 2023-06-27 0001584831 OXBR:ThirdPartyInvestorsMember OXBR:SurancePlusIncMember 2023-06-27 2023-06-27 0001584831 us-gaap:ParentMember OXBR:SurancePlusIncMember 2023-06-27 2023-06-27 0001584831 OXBR:SurancePlusFeeIncomeMember OXBR:SurancePlusIncMember 2023-01-01 2023-12-31 0001584831 OXBR:UnderwritingRelatedIncomeMember OXBR:SurancePlusIncMember 2023-01-01 2023-12-31 0001584831 OXBR:SurancePlusIncMember 2023-12-31 0001584831 us-gaap:RelatedPartyMember OXBR:SurancePlusIncMember 2023-12-31 0001584831 us-gaap:ParentMember OXBR:SurancePlusIncMember 2023-12-31 0001584831 us-gaap:ShortdurationInsuranceContractsAccidentYear2016Member 2016-12-31 0001584831 us-gaap:ShortdurationInsuranceContractsAccidentYear2016Member 2017-12-31 0001584831 us-gaap:ShortdurationInsuranceContractsAccidentYear2016Member 2018-12-31 0001584831 us-gaap:ShortdurationInsuranceContractsAccidentYear2016Member 2019-12-31 0001584831 us-gaap:ShortdurationInsuranceContractsAccidentYear2016Member 2020-12-31 0001584831 us-gaap:ShortdurationInsuranceContractsAccidentYear2016Member 2021-12-31 0001584831 us-gaap:ShortdurationInsuranceContractsAccidentYear2016Member 2022-12-31 0001584831 us-gaap:ShortdurationInsuranceContractsAccidentYear2016Member 2023-12-31 0001584831 us-gaap:ShortDurationInsuranceContractsAccidentYear2017Member 2017-12-31 0001584831 us-gaap:ShortDurationInsuranceContractsAccidentYear2017Member 2018-12-31 0001584831 us-gaap:ShortDurationInsuranceContractsAccidentYear2017Member 2019-12-31 0001584831 us-gaap:ShortDurationInsuranceContractsAccidentYear2017Member 2020-12-31 0001584831 us-gaap:ShortDurationInsuranceContractsAccidentYear2017Member 2021-12-31 0001584831 us-gaap:ShortDurationInsuranceContractsAccidentYear2017Member 2022-12-31 0001584831 us-gaap:ShortDurationInsuranceContractsAccidentYear2017Member 2023-12-31 0001584831 us-gaap:ShortDurationInsuranceContractsAccidentYear2018Member 2018-12-31 0001584831 us-gaap:ShortDurationInsuranceContractsAccidentYear2018Member 2019-12-31 0001584831 us-gaap:ShortDurationInsuranceContractsAccidentYear2018Member 2020-12-31 0001584831 us-gaap:ShortDurationInsuranceContractsAccidentYear2018Member 2021-12-31 0001584831 us-gaap:ShortDurationInsuranceContractsAccidentYear2018Member 2022-12-31 0001584831 us-gaap:ShortDurationInsuranceContractsAccidentYear2018Member 2023-12-31 0001584831 us-gaap:ShortDurationInsuranceContractAccidentYear2019Member 2019-12-31 0001584831 us-gaap:ShortDurationInsuranceContractAccidentYear2019Member 2020-12-31 0001584831 us-gaap:ShortDurationInsuranceContractAccidentYear2019Member 2021-12-31 0001584831 us-gaap:ShortDurationInsuranceContractAccidentYear2019Member 2022-12-31 0001584831 us-gaap:ShortDurationInsuranceContractAccidentYear2019Member 2023-12-31 0001584831 us-gaap:ShortDurationInsuranceContractAccidentYear2020Member 2020-12-31 0001584831 us-gaap:ShortDurationInsuranceContractAccidentYear2020Member 2021-12-31 0001584831 us-gaap:ShortDurationInsuranceContractAccidentYear2020Member 2022-12-31 0001584831 us-gaap:ShortDurationInsuranceContractAccidentYear2020Member 2023-12-31 0001584831 us-gaap:ShortDurationInsuranceContractAccidentYear2021Member 2021-12-31 0001584831 us-gaap:ShortDurationInsuranceContractAccidentYear2021Member 2022-12-31 0001584831 us-gaap:ShortDurationInsuranceContractAccidentYear2021Member 2023-12-31 0001584831 us-gaap:ShortDurationInsuranceContractAccidentYear2022Member 2022-12-31 0001584831 us-gaap:ShortDurationInsuranceContractAccidentYear2022Member 2023-12-31 0001584831 us-gaap:ShortDurationInsuranceContractAccidentYear2023Member 2022-12-31 0001584831 us-gaap:ShortDurationInsuranceContractAccidentYear2023Member 2023-12-31 0001584831 us-gaap:ShortDurationInsuranceContractAccidentYear2023Member 2021-12-31 0001584831 OXBR:PropertyCatastropheReinsuranceMember 2022-12-31 0001584831 us-gaap:CommonStockMember 2023-01-01 2023-12-31 0001584831 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001584831 us-gaap:WarrantMember 2023-12-31 0001584831 us-gaap:WarrantMember 2022-12-31 0001584831 us-gaap:CommonStockMember us-gaap:SubsequentEventMember 2024-01-29 0001584831 us-gaap:CommonStockMember us-gaap:SubsequentEventMember 2024-01-29 2024-01-29 0001584831 OXBR:TwoThousandFourteenOmnibusIncentivePlanMember 2023-01-01 2023-12-31 0001584831 us-gaap:RestrictedStockMember OXBR:TwoThousandTwentyOneOmnibusIncentivePlanMember 2023-01-01 2023-12-31 0001584831 OXBR:TwoThousandTwentyOneOmnibusIncentivePlanMember 2023-12-31 0001584831 OXBR:TwoThousandFourteenOmnibusIncentivePlanMember 2023-12-31 0001584831 us-gaap:GeneralAndAdministrativeExpenseMember 2023-01-01 2023-12-31 0001584831 us-gaap:GeneralAndAdministrativeExpenseMember 2022-01-01 2022-12-31 0001584831 us-gaap:RestrictedStockMember us-gaap:GeneralAndAdministrativeExpenseMember 2023-01-01 2023-12-31 0001584831 us-gaap:RestrictedStockMember us-gaap:GeneralAndAdministrativeExpenseMember 2022-01-01 2022-12-31 0001584831 us-gaap:RestrictedStockMember us-gaap:GeneralAndAdministrativeExpenseMember 2023-12-31 0001584831 us-gaap:RestrictedStockMember us-gaap:GeneralAndAdministrativeExpenseMember 2022-12-31 0001584831 OXBR:OxbridgeReinsuranceLimitedMember 2023-12-31 0001584831 OXBR:OxbridgeReinsuranceLimitedMember 2023-01-01 2023-12-31 0001584831 OXBR:OxbridgeReinsuranceLimitedMember 2022-01-01 2022-12-31 0001584831 OXBR:OxbridgeReNSMember 2023-12-31 0001584831 OXBR:OxbridgeReNSMember 2023-01-01 2023-12-31 0001584831 OXBR:OxbridgeReNSMember 2022-01-01 2022-12-31 0001584831 OXBR:OfficeLeaseMember 2023-12-31 0001584831 OXBR:ResidentialLeaseMember 2023-12-31 0001584831 OXBR:AdministrativeServicesAgreementMember 2023-01-01 2023-12-31 0001584831 OXBR:AdministrativeServicesAgreementMember 2022-01-01 2022-12-31 0001584831 us-gaap:RelatedPartyMember 2023-12-31 0001584831 us-gaap:RelatedPartyMember 2022-12-31 0001584831 OXBR:MrJayMadhuMember 2021-12-31 0001584831 OXBR:MrJayMadhuMember 2023-01-01 2023-12-31 0001584831 OXBR:MrJayMadhuMember 2023-12-31 0001584831 OXBR:ReinsuranceAgreementMember 2023-12-31 0001584831 OXBR:ReinsuranceAgreementMember 2023-01-01 2023-12-31 0001584831 us-gaap:InvestorMember OXBR:BridgeAgreementMember 2023-09-11 0001584831 us-gaap:InvestorMember OXBR:BridgeAgreementMember 2023-09-08 2023-09-11 0001584831 us-gaap:InvestorMember OXBR:BridgeAgreementMember 2023-09-11 2023-09-11 0001584831 us-gaap:SubsequentEventMember 2024-03-11 0001584831 us-gaap:LeaseholdImprovementsMember 2023-12-31 0001584831 us-gaap:LeaseholdImprovementsMember 2022-12-31 0001584831 us-gaap:FurnitureAndFixturesMember 2022-12-31 0001584831 us-gaap:VehiclesMember 2023-12-31 0001584831 us-gaap:VehiclesMember 2022-12-31 0001584831 us-gaap:ComputerEquipmentMember 2022-12-31 0001584831 us-gaap:EquitySecuritiesInvestmentSummaryMember 2023-12-31 0001584831 srt:ParentCompanyMember 2023-12-31 0001584831 srt:ParentCompanyMember 2022-12-31 0001584831 srt:ParentCompanyMember srt:SubsidiariesMember 2023-12-31 0001584831 srt:ParentCompanyMember srt:SubsidiariesMember 2022-12-31 0001584831 srt:ParentCompanyMember us-gaap:RelatedPartyMember 2023-12-31 0001584831 srt:ParentCompanyMember us-gaap:RelatedPartyMember 2022-12-31 0001584831 srt:ParentCompanyMember 2023-01-01 2023-12-31 0001584831 srt:ParentCompanyMember 2022-01-01 2022-12-31 0001584831 srt:ParentCompanyMember us-gaap:RelatedPartyMember 2023-01-01 2023-12-31 0001584831 srt:ParentCompanyMember us-gaap:RelatedPartyMember 2022-01-01 2022-12-31 0001584831 srt:ParentCompanyMember 2021-12-31 0001584831 us-gaap:PropertyLiabilityAndCasualtyInsuranceSegmentMember 2023-12-31 0001584831 us-gaap:PropertyLiabilityAndCasualtyInsuranceSegmentMember 2023-01-01 2023-12-31 0001584831 us-gaap:PropertyLiabilityAndCasualtyInsuranceSegmentMember 2022-12-31 0001584831 us-gaap:PropertyLiabilityAndCasualtyInsuranceSegmentMember 2022-01-01 2022-12-31 iso4217:USD shares iso4217:USD shares OXBR:Claims pure OXBR:Integer false FY 0001584831 10-K true 2023-12-31 --12-31 2023 false 1-36346 OXBRIDGE RE HOLDINGS LIMITED E9 98-1150254 Suite 201 42 Edward Street P.O. Box 469 Grand Cayman KY KY1-9006 (345) 749-7570 Ordinary Shares, par value $0.001 (USD) per share OXBR NASDAQ Warrants OXBRW NASDAQ No No Yes Yes Non-accelerated Filer true false false false false 10013951 5870234 Information required by Part III is incorporated by reference from registrant’s Proxy Statement for its 2024 annual meeting of stockholders or an amendment to this Annual Report on Form 10-K, which will be filed with the Securities and Exchange Commission within 120 days after the end of its fiscal year ended December 31, 2023. false false false false 400 HACKER, JOHNSON & SMITH PA Tampa, Florida 1926000 680000 642000 495000 1207000 3250000 2721000 977000 282000 2478000 11423000 100000 63000 45000 101000 9000 44000 96000 114000 133000 4000 5000 8253000 16616000 1523000 118000 216000 1073000 915000 9000 44000 356000 294000 2921000 1627000 0.001 0.001 50000000 50000000 5870234 5870234 5769587 5769587 6000 6000 32740000 32482000 -27414000 -17499000 5332000 14989000 8253000 16616000 2170000 645000 -915000 350000 1255000 995000 300000 303000 201000 27000 -8945000 -35000 38000 -338000 -7049000 850000 1073000 141000 110000 2183000 1413000 2324000 2596000 -9373000 -1746000 542000 43000 -9915000 -1789000 -1.69 -1.69 -0.31 -0.31 5867129 5867129 5772396 5772396 -9915000 -1789000 258000 127000 6000 4000 27000 300000 38000 -338000 -8945000 -35000 695000 -2000 18000 40000 101000 -38000 -18000 64000 -133000 133000 543000 -1073000 1073000 915000 -350000 62000 -43000 -1260000 -829000 1002000 100000 285000 626000 5000 -105000 -661000 98000 1280000 1182000 -183000 -1490000 3928000 5418000 3745000 3928000 5749587 6000 32355000 -15710000 16651000 -1789000 -1789000 20000 127000 127000 5769587 6000 32482000 -17499000 14989000 5769587 6000 32482000 -17499000 14989000 5769587 6000 32482000 -17499000 14989000 -9915000 -9915000 100647 258000 258000 5870234 6000 32740000 -27414000 5332000 5870234 6000 32740000 -27414000 5332000 <p id="xdx_80E_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_zyDsrzL6gm94" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1. <span id="xdx_820_z4aYY4zehRK4">ORGANIZATION AND BASIS OF PRESENTATION</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(a) Organization </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Oxbridge Re Holdings Limited (the “Company”) was incorporated as an exempted company on April 4, 2013 under the laws of the Cayman Islands. The Company directly owns <span id="xdx_903_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20130423__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--OxbridgeReinsuranceLimitedMember_z3jmIbI5Kduk">100</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of the equity interest in Oxbridge Reinsurance Limited, an exempted entity incorporated on April 23, 2013 under the laws of the Cayman Islands and for which a Class “C” Insurer’s license was granted on April 29, 2013 under the provisions of the Cayman Islands Insurance Law. The Company also indirectly owns <span id="xdx_90A_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20171222__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--OxbridgeReNSMember_zd5drtA1HxZk">100</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of the equity interest in Oxbridge Re NS, an entity incorporated as an exempted company on December 22, 2017 under the laws of the Cayman Islands to function as a reinsurance sidecar facility and to increase the underwriting capacity of Oxbridge Reinsurance Limited. The Company also indirectly owns <span id="xdx_905_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20221219__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SurancePlusIncMember_zmy5ksJJzFl6">100</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of the equity interest in SurancePlus, an entity incorporated as a business company on December 19, 2022 under the laws of the British Virgin Islands to issue digital securities. The Company and its subsidiaries (collectively “Oxbridge Re”) provide the following: SurancePlus; is a Web3-focused subsidiary that currently leverages blockchain technology to democratize access to high-return reinsurance contracts via digital securities. Oxbridge Reinsurance Limited; is a licensed reinsurance subsidiary that provides reinsurance business solutions primarily to property and casualty insurers in the Gulf Coast region of the United States; Oxbridge Re NS; a licensed reinsurance SPV/side car that provides third-party investors with access to reinsurance contracts with returns uncorrelated to the financial markets. The Company operates as a single business segment through its wholly-owned subsidiaries. The Company’s headquarters and principal executive offices are located at Suite 201, 42 Edward Street, George Town, Grand Cayman, Cayman Islands, and have their registered offices at P.O. Box 309, Ugland House, Grand Cayman, Cayman Islands.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s ordinary shares and warrants are listed on The NASDAQ Capital Market under the symbols “OXBR” and “OXBRW,” respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(b) Basis of Presentation and Consolidation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying consolidated financial statements for the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). All significant intercompany transactions and balances have been eliminated upon consolidation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company consolidates in these consolidated financial statements the results of operations and financial position of all voting interest entities (“VOE”) in which the Company has a controlling financial interest and all variable interest entities (“VIE”) in which the Company is considered to be the primary beneficiary. The consolidation assessment, including the determination as to whether an entity qualifies as a VIE or VOE, depends on the facts and circumstances surrounding each entity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 1 1 1 <p id="xdx_80D_eus-gaap--SignificantAccountingPoliciesTextBlock_z6BXcvAhpe7d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2. <span id="xdx_82E_zlEYs3zlZMAj">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--UseOfEstimates_zZUYjRvDJU45" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_865_zqY89rRNhd65">Use of Estimates</span></span>:</b> In preparing the consolidated financial statements, management was required to make certain estimates and assumptions that affect the reported amounts of the consolidated assets, liabilities, revenues, expenses and related disclosures at the financial reporting date and throughout the periods being reported upon. Certain of the estimates result from judgments that can be subjective and complex and consequently actual results may differ from these estimates, which would be reflected in future periods. Material estimates that are particularly susceptible to significant change in the near-term relate to the determination of the reserve for losses and loss adjustment expenses (if any), which may include amounts estimated for claims incurred but not yet reported. The Company uses various assumptions and actuarial data it believes to be reasonable under the circumstances to make these estimates. Although considerable variability is likely to be inherent in these estimates, management believes that the amounts provided are reasonable. These estimates are continually reviewed and adjusted if necessary. Such adjustments are reflected in current operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_eus-gaap--RevenueRecognitionPolicyTextBlock_zS97Ps5lBcPg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86F_zYxKZQBGK0og">Revenue Recognition</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SurancePlus incentive, technology, origination and management (“ITOM”) fee income represents fee income related to the completion of the DeltaCat tokenized reinsurance securities as well as placement of the underlying insurance policies. The Company recognizes the associated revenue at the time of the placement of the underlying insurance policies as the performance obligation is satisfied at that time.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p id="xdx_842_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zNOMtKl3oyWl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_86D_zbvqQZht3ktl">Cash and cash equivalents</span>:</span></b> Cash and cash equivalents are comprised of cash and short- term investments with original maturities of three months or less.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_eus-gaap--CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_zRgTTCQvnKVh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_86F_zvlS8vTtfqO7">Restricted cash and cash equivalents</span>:</span></b> Restricted cash and cash equivalents represent funds held in accordance with the Company’s trust agreements with ceding insurers and trustees, which requires the Company to maintain collateral with a market value greater than or equal to the limit of liability, less unpaid premium.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--InvestmentPolicyTextBlock_zYqJ48psUwWg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_863_z6Y6huaLLd8">Investments</span></span></b><span style="text-decoration: underline">: </span>The Company from time to time invests in fixed-maturity securities and equity securities, and for which its fixed-maturity securities are classified as available-for-sale. The Company’s available for sale fixed-maturity investments are carried at fair value with changes in fair value included as a separate component of accumulated other comprehensive income (loss) in shareholders’ equity. For the Company’s investment in equity securities, and for the Company’s investment in Jet.AI. classified as “other investments”, the changes in fair value are recorded within the consolidated statements of operations. At December 31, 2023 and 2022 the company did not own any fixed maturity debt securities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unrealized gains or losses are determined by comparing the fair market value of the securities with their cost or amortized cost. Realized gains and losses on investments are recorded on the trade date and are included in the consolidated statements of operations. The cost of securities sold is based on the specified identification method. Investment income is recognized as earned and discounts or premiums arising from the purchase of debt securities are recognized in investment income using the interest method over the remaining term of the security.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84C_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_zD2jh7whmw16" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_860_zsJQOtrQVkE1">Fair value measurement</span></span></b>: GAAP establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy under GAAP are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1 </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inputs that reflect unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date; </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2 </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inputs other than quoted prices that are observable for the asset or liability either directly or indirectly, including inputs in markets that are not considered to be active; and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3 </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inputs that are unobservable.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inputs are used in applying the various valuation techniques and broadly refer to the assumptions that market participants use to make valuation decisions, including assumptions about risk. For fixed maturity securities, inputs may include price information, volatility statistics, specific and broad credit data, liquidity statistics, broker quotes for similar securities and other factors. The fair value of investments in stocks and exchange-traded funds is based on the last traded price. A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. However, the determination of what constitutes “observable” requires significant judgment by the Company’s investment custodians and management. The investment custodians consider observable data to be market data which is readily available, regularly distributed or updated, reliable and verifiable, not proprietary, and provided by independent sources that are actively involved in the relevant markets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--CapitalizationOfDeferredPolicyAcquisitionCostsPolicy_zbS0W5iBwwF2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_861_zjhfcqBqLTPg">Deferred policy acquisition costs</span> (“DAC”):</span></b> Policy acquisition costs consist of brokerage fees, federal excise taxes and other costs related directly to the successful acquisition of new or renewal insurance contracts and are deferred and amortized over the terms of the reinsurance agreements to which they relate. The Company evaluates the recoverability of DAC by determining if the sum of future earned premiums and anticipated investment income is greater than the expected future claims and expenses. If a loss is probable on the unexpired portion of policies in force, a premium deficiency loss is recognized.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_ecustom--OfferingExpensesPolicyTextBlock_zYfPWSs1tGHe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b><span style="text-decoration: underline"><span id="xdx_866_zJHAAGDrtVTi">Offering Expenses</span>: </span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2023 the Company recognized offering costs totaling $<span id="xdx_907_ecustom--PrepaidOfferingCost_c20230101__20231231_z9vmqeu2kNne" title="Prepaid offering costs">133,000</span> on the consolidated statements of operations which was related to an equity distribution agreement with Maxim Group LLC (“Maxim”) for the sale of the ordinary shares. During the year ended December 31, 2023, the Company recognized in the consolidated statements of operations $<span id="xdx_904_eus-gaap--OperatingIncomeLoss_pn3d_c20230101__20231231__dei--LegalEntityAxis__custom--SurancePlusIncMember_zWirxbG5Tbq2" title="Offering expenses">236,000</span> of offering expenses in relation to the offering of Delta Cat Re digital securities issuable by the Company’s new subsidiary, SurancePlus Inc. (See Note 6)</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with the terms of the equity distribution agreement with Maxim, we intend to offer and sell ordinary shares having an aggregate offering price of up to $<span id="xdx_903_ecustom--AggregateOfferingPrice_iI_pn5n6_c20231231__srt--RangeAxis__srt--MaximumMember__us-gaap--TypeOfArrangementAxis__custom--EquityDistributionAgreementMember_zlIPvuEPpqD7" title="Aggregate offering price">6.3</span> million from time to time.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_846_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zYiErMLHfJA6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_867_zd9pxSIbY5D3">Property and equipment</span>:</span></b> Property and equipment are recorded at cost when acquired. Property and equipment are comprised of motor vehicles, furniture and fixtures, computer equipment and leasehold improvements and are depreciated, using the straight-line method, over their estimated useful lives, which are <span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dc_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zJLEHD1GMB9a" title="Estimated useful life"><span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dc_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zJxzbLkVk2ki" title="Estimated useful life">five years</span></span> for furniture and fixtures and computer equipment and <span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dc_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MotorVehiclesMember_zL7RrkzQCRr6" title="Estimated useful life">four years</span> for motor vehicles. Leasehold improvements are amortized over the lesser of the estimated useful lives of the assets or remaining lease term. The Company periodically reviews property and equipment that have finite lives, and that are not held for sale, for impairment by comparing the carrying value of the assets to their estimated future undiscounted cash flows. For the years ended December 31, 2023 and 2022, there were <span id="xdx_900_eus-gaap--ImpairmentOfLongLivedAssetsToBeDisposedOf_do_c20230101__20231231_zp25BuTcRgH1" title="Impairments in property and equipment"><span id="xdx_90A_eus-gaap--ImpairmentOfLongLivedAssetsToBeDisposedOf_do_c20220101__20221231_zNHbdzT5iVnj" title="Impairments in property and equipment">no</span></span> impairments in property and equipment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84A_eus-gaap--UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy_zD4qDJm7lCP4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_86F_zqqAusyI2j29">Reserves for losses and loss adjustment expenses</span>:</span></b> The Company determines its reserves for losses and loss adjustment expenses, if any, on the basis of the claims reported by the Company’s ceding insurers and for losses incurred but not reported (“IBNR”), management uses the assistance of an independent actuary. The reserves for losses and loss adjustment expenses represent management’s best estimate of the ultimate settlement costs of all losses and loss adjustment expenses. Management believes that the amounts are adequate; however, the inherent impossibility of predicting future events with precision, results in uncertainty as to the amount which will ultimately be required for the settlement of losses and loss expenses, and the differences could be material. Adjustments are reflected in the consolidated statements of operations in the period in which they are determined.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_eus-gaap--ReinsuranceAccountingPolicy_zzhwRfCk6FLh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_866_zOGF3NZUJOF6">Loss experience refund payable</span>:</span></b> Certain contracts include retrospective provisions that adjust premiums or result in profit commissions in the event losses are minimal or zero. In accordance with GAAP, the Company will recognize a liability in the period in which the absence of loss experience obligates the Company to pay cash or other consideration under the contracts. On the contrary, the Company will derecognize such liability in the period in which a loss experience arises. Such adjustments to the liability, which accrue throughout the contract terms, will reduce the liability should a catastrophic loss event covered by the Company occur.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--PremiumsReceivableBasisOfAccountingPolicy_zjOW9y84JD37" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_867_zItq4j9EZoEc">Premiums assumed</span>:</span></b> The Company records premiums assumed, net of loss experience refunds, as earned pro-rata over the terms of the reinsurance agreements, or period of risk, where applicable, and the unearned portion at the consolidated balance sheet date is recorded as unearned premiums reserve. A reserve is made for estimated premium deficiencies to the extent that estimated losses and loss adjustment expenses exceed related unearned premiums. Investment income is not considered in determining whether or not a deficiency exists.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsequent adjustments of premiums assumed, based on reports of actual premium by the ceding companies, or revisions in estimates of ultimate premium, are recorded in the period in which they are determined. Such adjustments are generally determined after the associated risk periods have expired, in which case the premium adjustments are fully earned when assumed.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain contracts allow for reinstatement premiums in the event of a full limit loss prior to the expiration of the contract. A reinstatement premium is not due until there is a full limit loss event and therefore, in accordance with GAAP, the Company records a reinstatement premium as written only in the event that the reinsured incurs a full limit loss on the contract and the contract allows for a reinstatement of coverage upon payment of an additional premium. For catastrophe contracts which contractually require the payment of a reinstatement premium equal to or greater than the original premium upon the occurrence of a full limit loss, the reinstatement premiums are earned over the original contract period. Reinstatement premiums that are contractually calculated on a pro-rata basis of the original premiums are earned over the remaining coverage period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_ecustom--UnearnedPremiumsCededPolicyTextBlock_zWBcU7jD4MO4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_861_zOaIrPYgjS0b">Unearned Premiums Ceded</span>:</span></b> The Company may reduce the risk of future losses on business assumed by reinsuring certain risks and exposures with other reinsurers (retrocessionaires). The Company remains liable to the extent that any retrocessionaire fails to meet its obligations and to the extent that the Company does not hold sufficient security for their unpaid obligations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ceded premiums are written during the period in which the risk incept and are expensed over the contract period in proportion to the period of protection. Unearned premiums ceded consist of the unexpired portion of the reinsurance obtained. There were no unearned premiums ceded at December 31, 2023 and 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_ecustom--SurancePlusFeeIncomePolicyTextBlock_z41PMat5adEk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_867_zZcnP0iPJtEe">SurancePlus Fee Income</span>: </span></b>SurancePlus incentive, technology, origination and management (“ITOM”) fee income represents fee income related to the completion of the DeltaCat tokenized reinsurance securities as well as placement of the underlying insurance policies. The Company recognizes the associated revenue at the time of the placement of the underlying insurance policies as the performance obligation is satisfied at that time.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--IncomeTaxUncertaintiesPolicy_z8RRrr17s4Qc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_864_zpQjDI90wv0k">Uncertain income tax positions</span>:</span></b> The authoritative GAAP guidance on accounting for, and disclosure of, uncertainty in income tax positions requires the Company to determine whether an income tax position of the Company is more likely than not to be sustained upon examination by the relevant tax authority, including resolution of any related appeals or litigation processes, based on the technical merits of the position. For income tax positions meeting the more likely than not threshold, the tax amount recognized in the consolidated financial statements, if any, is reduced by the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate settlement with the relevant taxing authority. The application of this authoritative guidance has had no effect on the Company’s consolidated financial statements because the Company had no uncertain tax positions at December 31, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eus-gaap--EarningsPerSharePolicyTextBlock_zBBzsCkPUd91" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_865_zezssTQAWK48">Loss Per Share</span>:</span></b> Basic loss per share has been computed on the basis of the weighted-average number of ordinary shares outstanding during the years presented. Diluted loss per share is computed based on the weighted-average number of ordinary shares outstanding and reflects the assumed exercise or conversion of diluted securities, such as stock options and warrants, computed using the treasury stock method.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zN4wGKlOUCQl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_86E_zQlOsP4LeqU9">Share-Based Compensation</span></span>:</b> The Company accounts for share-based compensation under the fair value recognition provisions of GAAP which requires the measurement and recognition of compensation for all stock-based awards made to employees and directors, including stock options and restricted stock issuances based on estimated fair values. The Company measures compensation for restricted stock based on the price of the Company’s ordinary shares at the grant date. Determining the fair value of stock options at the grant date requires significant estimation and judgment. The Company uses an option-pricing model (Black-Scholes option pricing model) to assist in the calculation of fair value for stock options. When estimating the expected volatility, the Company takes into consideration the historical volatility of entities similar to itself. The Company considers factors such as an entity’s industry, stage of life cycle, size and financial leverage when selecting similar entities. The Company may use a sample peer group of companies in the reinsurance industry and/or the Company’s own historical volatility in determining the expected volatility</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally, the Company uses the guidance in the SEC’s Staff Accounting Bulletin No. 107 to determine the estimated life of options issued and has assumed no forfeitures during the life of the options.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company uses the straight-line attribution method for all grants that include only a service condition. Compensation expense related to all awards is included in general and administrative expenses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zNfuqeqm2Et8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_86A_z6Xv3LdrYJs5">Segment Information</span></span>:</b> Under GAAP, operating segments are based on the internal information that management uses for allocating resources and assessing performance as the source of the Company’s reportable segments. The Company manages its business on the basis of one operating segment, Property and Casualty Reinsurance, in accordance with the qualitative and quantitative criteria established under GAAP.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zEbd4fz891n8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b><span style="text-decoration: underline"><span id="xdx_862_z6cjbIbHggIi">Reclassifications</span>: </span></b>Any reclassifications of prior period amounts have been made to conform to the current period presentation.</span></p> <p id="xdx_853_zDGDAruTs3uc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--UseOfEstimates_zZUYjRvDJU45" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_865_zqY89rRNhd65">Use of Estimates</span></span>:</b> In preparing the consolidated financial statements, management was required to make certain estimates and assumptions that affect the reported amounts of the consolidated assets, liabilities, revenues, expenses and related disclosures at the financial reporting date and throughout the periods being reported upon. Certain of the estimates result from judgments that can be subjective and complex and consequently actual results may differ from these estimates, which would be reflected in future periods. Material estimates that are particularly susceptible to significant change in the near-term relate to the determination of the reserve for losses and loss adjustment expenses (if any), which may include amounts estimated for claims incurred but not yet reported. The Company uses various assumptions and actuarial data it believes to be reasonable under the circumstances to make these estimates. Although considerable variability is likely to be inherent in these estimates, management believes that the amounts provided are reasonable. These estimates are continually reviewed and adjusted if necessary. Such adjustments are reflected in current operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_eus-gaap--RevenueRecognitionPolicyTextBlock_zS97Ps5lBcPg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86F_zYxKZQBGK0og">Revenue Recognition</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SurancePlus incentive, technology, origination and management (“ITOM”) fee income represents fee income related to the completion of the DeltaCat tokenized reinsurance securities as well as placement of the underlying insurance policies. The Company recognizes the associated revenue at the time of the placement of the underlying insurance policies as the performance obligation is satisfied at that time.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p id="xdx_842_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zNOMtKl3oyWl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_86D_zbvqQZht3ktl">Cash and cash equivalents</span>:</span></b> Cash and cash equivalents are comprised of cash and short- term investments with original maturities of three months or less.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_eus-gaap--CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_zRgTTCQvnKVh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_86F_zvlS8vTtfqO7">Restricted cash and cash equivalents</span>:</span></b> Restricted cash and cash equivalents represent funds held in accordance with the Company’s trust agreements with ceding insurers and trustees, which requires the Company to maintain collateral with a market value greater than or equal to the limit of liability, less unpaid premium.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--InvestmentPolicyTextBlock_zYqJ48psUwWg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_863_z6Y6huaLLd8">Investments</span></span></b><span style="text-decoration: underline">: </span>The Company from time to time invests in fixed-maturity securities and equity securities, and for which its fixed-maturity securities are classified as available-for-sale. The Company’s available for sale fixed-maturity investments are carried at fair value with changes in fair value included as a separate component of accumulated other comprehensive income (loss) in shareholders’ equity. For the Company’s investment in equity securities, and for the Company’s investment in Jet.AI. classified as “other investments”, the changes in fair value are recorded within the consolidated statements of operations. At December 31, 2023 and 2022 the company did not own any fixed maturity debt securities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unrealized gains or losses are determined by comparing the fair market value of the securities with their cost or amortized cost. Realized gains and losses on investments are recorded on the trade date and are included in the consolidated statements of operations. The cost of securities sold is based on the specified identification method. Investment income is recognized as earned and discounts or premiums arising from the purchase of debt securities are recognized in investment income using the interest method over the remaining term of the security.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84C_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_zD2jh7whmw16" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_860_zsJQOtrQVkE1">Fair value measurement</span></span></b>: GAAP establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy under GAAP are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1 </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inputs that reflect unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date; </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2 </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inputs other than quoted prices that are observable for the asset or liability either directly or indirectly, including inputs in markets that are not considered to be active; and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3 </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inputs that are unobservable.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inputs are used in applying the various valuation techniques and broadly refer to the assumptions that market participants use to make valuation decisions, including assumptions about risk. For fixed maturity securities, inputs may include price information, volatility statistics, specific and broad credit data, liquidity statistics, broker quotes for similar securities and other factors. The fair value of investments in stocks and exchange-traded funds is based on the last traded price. A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. However, the determination of what constitutes “observable” requires significant judgment by the Company’s investment custodians and management. The investment custodians consider observable data to be market data which is readily available, regularly distributed or updated, reliable and verifiable, not proprietary, and provided by independent sources that are actively involved in the relevant markets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--CapitalizationOfDeferredPolicyAcquisitionCostsPolicy_zbS0W5iBwwF2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_861_zjhfcqBqLTPg">Deferred policy acquisition costs</span> (“DAC”):</span></b> Policy acquisition costs consist of brokerage fees, federal excise taxes and other costs related directly to the successful acquisition of new or renewal insurance contracts and are deferred and amortized over the terms of the reinsurance agreements to which they relate. The Company evaluates the recoverability of DAC by determining if the sum of future earned premiums and anticipated investment income is greater than the expected future claims and expenses. If a loss is probable on the unexpired portion of policies in force, a premium deficiency loss is recognized.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_ecustom--OfferingExpensesPolicyTextBlock_zYfPWSs1tGHe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b><span style="text-decoration: underline"><span id="xdx_866_zJHAAGDrtVTi">Offering Expenses</span>: </span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2023 the Company recognized offering costs totaling $<span id="xdx_907_ecustom--PrepaidOfferingCost_c20230101__20231231_z9vmqeu2kNne" title="Prepaid offering costs">133,000</span> on the consolidated statements of operations which was related to an equity distribution agreement with Maxim Group LLC (“Maxim”) for the sale of the ordinary shares. During the year ended December 31, 2023, the Company recognized in the consolidated statements of operations $<span id="xdx_904_eus-gaap--OperatingIncomeLoss_pn3d_c20230101__20231231__dei--LegalEntityAxis__custom--SurancePlusIncMember_zWirxbG5Tbq2" title="Offering expenses">236,000</span> of offering expenses in relation to the offering of Delta Cat Re digital securities issuable by the Company’s new subsidiary, SurancePlus Inc. (See Note 6)</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with the terms of the equity distribution agreement with Maxim, we intend to offer and sell ordinary shares having an aggregate offering price of up to $<span id="xdx_903_ecustom--AggregateOfferingPrice_iI_pn5n6_c20231231__srt--RangeAxis__srt--MaximumMember__us-gaap--TypeOfArrangementAxis__custom--EquityDistributionAgreementMember_zlIPvuEPpqD7" title="Aggregate offering price">6.3</span> million from time to time.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> 133000 236000 6300000 <p id="xdx_846_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zYiErMLHfJA6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_867_zd9pxSIbY5D3">Property and equipment</span>:</span></b> Property and equipment are recorded at cost when acquired. Property and equipment are comprised of motor vehicles, furniture and fixtures, computer equipment and leasehold improvements and are depreciated, using the straight-line method, over their estimated useful lives, which are <span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dc_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zJLEHD1GMB9a" title="Estimated useful life"><span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dc_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zJxzbLkVk2ki" title="Estimated useful life">five years</span></span> for furniture and fixtures and computer equipment and <span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dc_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MotorVehiclesMember_zL7RrkzQCRr6" title="Estimated useful life">four years</span> for motor vehicles. Leasehold improvements are amortized over the lesser of the estimated useful lives of the assets or remaining lease term. The Company periodically reviews property and equipment that have finite lives, and that are not held for sale, for impairment by comparing the carrying value of the assets to their estimated future undiscounted cash flows. For the years ended December 31, 2023 and 2022, there were <span id="xdx_900_eus-gaap--ImpairmentOfLongLivedAssetsToBeDisposedOf_do_c20230101__20231231_zp25BuTcRgH1" title="Impairments in property and equipment"><span id="xdx_90A_eus-gaap--ImpairmentOfLongLivedAssetsToBeDisposedOf_do_c20220101__20221231_zNHbdzT5iVnj" title="Impairments in property and equipment">no</span></span> impairments in property and equipment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> P5Y P5Y P4Y 0 0 <p id="xdx_84A_eus-gaap--UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy_zD4qDJm7lCP4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_86F_zqqAusyI2j29">Reserves for losses and loss adjustment expenses</span>:</span></b> The Company determines its reserves for losses and loss adjustment expenses, if any, on the basis of the claims reported by the Company’s ceding insurers and for losses incurred but not reported (“IBNR”), management uses the assistance of an independent actuary. The reserves for losses and loss adjustment expenses represent management’s best estimate of the ultimate settlement costs of all losses and loss adjustment expenses. Management believes that the amounts are adequate; however, the inherent impossibility of predicting future events with precision, results in uncertainty as to the amount which will ultimately be required for the settlement of losses and loss expenses, and the differences could be material. Adjustments are reflected in the consolidated statements of operations in the period in which they are determined.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_eus-gaap--ReinsuranceAccountingPolicy_zzhwRfCk6FLh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_866_zOGF3NZUJOF6">Loss experience refund payable</span>:</span></b> Certain contracts include retrospective provisions that adjust premiums or result in profit commissions in the event losses are minimal or zero. In accordance with GAAP, the Company will recognize a liability in the period in which the absence of loss experience obligates the Company to pay cash or other consideration under the contracts. On the contrary, the Company will derecognize such liability in the period in which a loss experience arises. Such adjustments to the liability, which accrue throughout the contract terms, will reduce the liability should a catastrophic loss event covered by the Company occur.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--PremiumsReceivableBasisOfAccountingPolicy_zjOW9y84JD37" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_867_zItq4j9EZoEc">Premiums assumed</span>:</span></b> The Company records premiums assumed, net of loss experience refunds, as earned pro-rata over the terms of the reinsurance agreements, or period of risk, where applicable, and the unearned portion at the consolidated balance sheet date is recorded as unearned premiums reserve. A reserve is made for estimated premium deficiencies to the extent that estimated losses and loss adjustment expenses exceed related unearned premiums. Investment income is not considered in determining whether or not a deficiency exists.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsequent adjustments of premiums assumed, based on reports of actual premium by the ceding companies, or revisions in estimates of ultimate premium, are recorded in the period in which they are determined. Such adjustments are generally determined after the associated risk periods have expired, in which case the premium adjustments are fully earned when assumed.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain contracts allow for reinstatement premiums in the event of a full limit loss prior to the expiration of the contract. A reinstatement premium is not due until there is a full limit loss event and therefore, in accordance with GAAP, the Company records a reinstatement premium as written only in the event that the reinsured incurs a full limit loss on the contract and the contract allows for a reinstatement of coverage upon payment of an additional premium. For catastrophe contracts which contractually require the payment of a reinstatement premium equal to or greater than the original premium upon the occurrence of a full limit loss, the reinstatement premiums are earned over the original contract period. Reinstatement premiums that are contractually calculated on a pro-rata basis of the original premiums are earned over the remaining coverage period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_ecustom--UnearnedPremiumsCededPolicyTextBlock_zWBcU7jD4MO4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_861_zOaIrPYgjS0b">Unearned Premiums Ceded</span>:</span></b> The Company may reduce the risk of future losses on business assumed by reinsuring certain risks and exposures with other reinsurers (retrocessionaires). The Company remains liable to the extent that any retrocessionaire fails to meet its obligations and to the extent that the Company does not hold sufficient security for their unpaid obligations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ceded premiums are written during the period in which the risk incept and are expensed over the contract period in proportion to the period of protection. Unearned premiums ceded consist of the unexpired portion of the reinsurance obtained. There were no unearned premiums ceded at December 31, 2023 and 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_ecustom--SurancePlusFeeIncomePolicyTextBlock_z41PMat5adEk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_867_zZcnP0iPJtEe">SurancePlus Fee Income</span>: </span></b>SurancePlus incentive, technology, origination and management (“ITOM”) fee income represents fee income related to the completion of the DeltaCat tokenized reinsurance securities as well as placement of the underlying insurance policies. The Company recognizes the associated revenue at the time of the placement of the underlying insurance policies as the performance obligation is satisfied at that time.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--IncomeTaxUncertaintiesPolicy_z8RRrr17s4Qc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_864_zpQjDI90wv0k">Uncertain income tax positions</span>:</span></b> The authoritative GAAP guidance on accounting for, and disclosure of, uncertainty in income tax positions requires the Company to determine whether an income tax position of the Company is more likely than not to be sustained upon examination by the relevant tax authority, including resolution of any related appeals or litigation processes, based on the technical merits of the position. For income tax positions meeting the more likely than not threshold, the tax amount recognized in the consolidated financial statements, if any, is reduced by the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate settlement with the relevant taxing authority. The application of this authoritative guidance has had no effect on the Company’s consolidated financial statements because the Company had no uncertain tax positions at December 31, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eus-gaap--EarningsPerSharePolicyTextBlock_zBBzsCkPUd91" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_865_zezssTQAWK48">Loss Per Share</span>:</span></b> Basic loss per share has been computed on the basis of the weighted-average number of ordinary shares outstanding during the years presented. Diluted loss per share is computed based on the weighted-average number of ordinary shares outstanding and reflects the assumed exercise or conversion of diluted securities, such as stock options and warrants, computed using the treasury stock method.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zN4wGKlOUCQl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_86E_zQlOsP4LeqU9">Share-Based Compensation</span></span>:</b> The Company accounts for share-based compensation under the fair value recognition provisions of GAAP which requires the measurement and recognition of compensation for all stock-based awards made to employees and directors, including stock options and restricted stock issuances based on estimated fair values. The Company measures compensation for restricted stock based on the price of the Company’s ordinary shares at the grant date. Determining the fair value of stock options at the grant date requires significant estimation and judgment. The Company uses an option-pricing model (Black-Scholes option pricing model) to assist in the calculation of fair value for stock options. When estimating the expected volatility, the Company takes into consideration the historical volatility of entities similar to itself. The Company considers factors such as an entity’s industry, stage of life cycle, size and financial leverage when selecting similar entities. The Company may use a sample peer group of companies in the reinsurance industry and/or the Company’s own historical volatility in determining the expected volatility</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally, the Company uses the guidance in the SEC’s Staff Accounting Bulletin No. 107 to determine the estimated life of options issued and has assumed no forfeitures during the life of the options.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company uses the straight-line attribution method for all grants that include only a service condition. Compensation expense related to all awards is included in general and administrative expenses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zNfuqeqm2Et8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_86A_z6Xv3LdrYJs5">Segment Information</span></span>:</b> Under GAAP, operating segments are based on the internal information that management uses for allocating resources and assessing performance as the source of the Company’s reportable segments. The Company manages its business on the basis of one operating segment, Property and Casualty Reinsurance, in accordance with the qualitative and quantitative criteria established under GAAP.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zEbd4fz891n8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b><span style="text-decoration: underline"><span id="xdx_862_z6cjbIbHggIi">Reclassifications</span>: </span></b>Any reclassifications of prior period amounts have been made to conform to the current period presentation.</span></p> <p id="xdx_80E_eus-gaap--CashAndCashEquivalentsDisclosureTextBlock_zxCNnf6uSca6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3. <span id="xdx_82D_zmqOjIyG946d">CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AND CASH EQUIVALENTS</span></b></span></p> <p id="xdx_89A_eus-gaap--ScheduleOfCashAndCashEquivalentsTableTextBlock_zDgbbHIajWJh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B1_zXS6HSZjQbV9" style="display: none">SUMMARY OF CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AND CASH EQUIVALENTS </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20231231_zma28loEOHM9" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_494_20221231_z8hqalMSV2li" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">(in thousands)</td><td style="font-weight: bold"> </td></tr> <tr id="xdx_40A_eus-gaap--CashEquivalentsAtCarryingValue_iI_pn3n3_maCCEASzqZq_zIwuiDhhW8Fd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Cash held on deposit</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">495</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">1,207</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--RestrictedCashAndCashEquivalents_iI_pn3n3_maCCEASzqZq_zPkBCBQmLdX8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Restricted cash held in trust</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,250</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,721</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iTI_pn3n3_mtCCEASzqZq_z50Ptlorirz1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,745</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,928</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AA_zolE28s31qwc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash and cash equivalents are held by large and reputable counterparties in the United States of America and in the Cayman Islands. Restricted cash held in trust is custodied with Truist Bank, and is held in accordance with the Company’s trust agreements with the ceding insurers and trustees, which require that the Company provide collateral having a market value greater than or equal to the limit of liability, less unpaid premium.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89A_eus-gaap--ScheduleOfCashAndCashEquivalentsTableTextBlock_zDgbbHIajWJh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B1_zXS6HSZjQbV9" style="display: none">SUMMARY OF CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AND CASH EQUIVALENTS </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20231231_zma28loEOHM9" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_494_20221231_z8hqalMSV2li" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">(in thousands)</td><td style="font-weight: bold"> </td></tr> <tr id="xdx_40A_eus-gaap--CashEquivalentsAtCarryingValue_iI_pn3n3_maCCEASzqZq_zIwuiDhhW8Fd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Cash held on deposit</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">495</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">1,207</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--RestrictedCashAndCashEquivalents_iI_pn3n3_maCCEASzqZq_zPkBCBQmLdX8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Restricted cash held in trust</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,250</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,721</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iTI_pn3n3_mtCCEASzqZq_z50Ptlorirz1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,745</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,928</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 495000 1207000 3250000 2721000 3745000 3928000 <p id="xdx_809_eus-gaap--InvestmentTextBlock_zu5nhzbgD1G9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>4. <span id="xdx_820_zLeSDYISBXHf">INVESTMENTS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company from time to time invests in fixed-maturity securities and equity securities, with its fixed-maturity securities classified as available-for-sale. At December 31, 2023 and 2022, the Company did not hold any available-for-sale securities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_eus-gaap--ScheduleOfRealizedGainLossTableTextBlock_zPazAPfuvXod" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proceeds received, and the gross realized gains and losses from sale of equity securities, for the years ended December 31, 2023 and 2022 are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BF_zOFe9PHRwIcf" style="display: none">SCHEDULE OF GROSS REALIZED GAINS AND LOSSES FROM SALE OF EQUITY SECURITIES</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_48D_eus-gaap--ProceedsFromSaleOfEquitySecuritiesFvNi_pn3n3_zhOyHtkFrKta" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt">Gross</p> <p style="margin-top: 0pt; margin-bottom: 0pt">proceeds</p> <p style="margin-top: 0pt; margin-bottom: 0pt">from sales</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_488_eus-gaap--EquitySecuritiesFvNiRealizedGain_pn3n3_zMDRz9cWhorc" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt">Gross</p> <p style="margin-top: 0pt; margin-bottom: 0pt">Realized</p> <p style="margin-top: 0pt; margin-bottom: 0pt">Gains</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_485_eus-gaap--EquitySecuritiesFvNiRealizedLoss_pn3n3_zquOZNsTHcTb" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt">Gross</p> <p style="margin-top: 0pt; margin-bottom: 0pt">Realized</p> <p style="margin-top: 0pt; margin-bottom: 0pt">Losses</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">($ in thousands)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-style: italic">Year ended December 31, 2023</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_41E_20230101__20231231_zM1H7FVaW58g" style="vertical-align: bottom; background-color: White"> <td style="width: 40%; text-align: left; padding-bottom: 2.5pt">Equity securities</td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0515">-</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0516">-</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0517">-</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-style: italic">Year ended December 31, 2022</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_412_20220101__20221231_zE7rUoq29vKl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Equity securities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">626</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">27</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0520">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AC_zVz0tB3k9u88" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Other Investments </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 7, 2023, OXAC held an extraordinary general meeting at which the business combination with Jet Token, Inc. was approved by OXAC shareholders. In conjunction with the business combination, OXAC was redomesticated as a Delaware entity, and changed its name to Jet.AI Inc (“Jet.AI”). The business combination was closed on August 10, 2023, and on August 11, 2023, OXAC common stock and warrants began trading on the Nasdaq under the new ticker symbols JTAI and JTAIW.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s beneficial interests in Jet. AI’s ordinary shares, public warrants and Extension Loan are recorded at fair value and are classified in “Other Investments” on the consolidated balance sheets. The fair value calculation of the Company’s beneficial interest in Jet.AI’s ordinary shares and public warrants is dependent on the observable trading prices of JetAI’s Class A shares and public warrants. The fair value calculation of the Company’s beneficial interest in the Extension Loan is estimated to be the pro-rata original principal amount of the Extension Loan due to the short-term nature.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><br/> The Sponsor holds <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--OxbridgeAcquisitionCorpMember_zh4EF3rNirQe" title="Number of shares issued">2,875,000</span> ordinary shares, <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--OxbridgeAcquisitionCorpMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zVKFo6PHXOgd" title="Number of shares issued">575</span> Series A-1 preferred shares with purchase price of $<span id="xdx_907_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--OxbridgeAcquisitionCorpMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zzSgiTYHESb2" title="Number of shares in hold, par value per share">1,000</span> each, along with the <span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--OxbridgeAcquisitionCorpMember__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivatePlacementWarrantsMember_z2zPrLywpBkl" title="Number of warrants shares">4,897,500</span> warrants. One of the Company’s executive officers is an independent member of Jet.AI’s board.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As a result of the re-measurement of our investment in Jet.AI, we recognized for the year ended December 31, 2023, an unrealized loss of $<span id="xdx_90F_eus-gaap--UnrealizedGainLossOnInvestments_iN_di_c20230101__20231231_zMuIfslfoOg8" title="Unrealized loss on other investments">8,945,000</span> within our consolidated statements of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_890_ecustom--ScheduleOfOtherInvestmentsTableTextBlock_zzZpWUW1Uiik" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other investments as of December 31, 2023 and 2022 consist of the following (in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B4_zo4NNvMsSDil" style="display: none">SCHEDULE OF OTHER INVESTMENT</span></span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_497_20230101__20231231_zwOOLpnF8V79" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_494_20220101__20221231_zH0Q869jrpag" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_408_eus-gaap--OtherInvestments_iE_pn3n3_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JetA1SeriesA1ConvertiblePreferredStockMember_zeuE2hkDB6xk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Jet.AI Series A-1 Convertible Preferred Stock</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">285</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0535">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--OtherInvestments_iE_pn3n3_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JetA1PromissoryNoteMember_z27CvtPe5Eh9" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Jet.AI. Promissory Note</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0537">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">214</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--OtherInvestments_iE_pn3n3_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JetA1ClassBOrdinarySharesMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--CommonClassBMember_z6mjVB2YlJW3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Jet.AI. common stock (2022: Class B Ordinary Shares)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,193</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">11,209</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--OtherInvestments_iE_pn3n3_z191ZEzAmLD2" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,478</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">11,423</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--OtherInvestments_iS_pn3n3_zmZYy1EoSRj" style="vertical-align: bottom; background-color: White"> <td>Beginning of year</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">11,423</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">11,173</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_ecustom--InvestmentInAffiliate_pn3n3_zLYg8PJWyCyb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Investment in affiliate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0549">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">285</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_zILz4eZdnW7g" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Unrealized loss on investment in affiliate</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(8,945</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(35</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40E_eus-gaap--OtherInvestments_iE_pn3n3_zzf5UFfIqtD2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">End of year</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,478</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">11,423</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A2_zmNMuPNdv4V4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Assets Measured at Estimated Fair Value on a Recurring Basis</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table presents information about the Company’s financial assets measured at estimated fair value on a recurring basis that is reflected in the consolidated balance sheets at carrying value. The table indicates the fair value hierarchy of the valuation techniques utilized by the Company to determine such fair value as of December 31, 2023 and 2022:</span></p> <p id="xdx_898_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisTextBlock_ziBTo0aGZaC6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B1_z9JmQskCFoE7" style="display: none">SCHEDULE OF FAIR VALUE OF ASSETS MEASURED ON RECURRING BASIS</span></span></span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zJBovUEm7Nka" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Level 1)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_496_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zojqoy3o9ze4" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Level 2)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_491_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zX706j5lRxY" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Level 3)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_496_20231231_zB7PlqJp6zce" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair Value Measurements Using</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2"> </td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Level 1)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Level 2)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Level 3)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic">As of December 31, 2023</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">($ in thousands)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Financial Assets:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_maAFVDzDZa_zlscd1SWtxu1" style="vertical-align: bottom; background-color: White"> <td style="width: 40%; font-style: italic; text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Cash and cash equivalents</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 11%; text-align: right">495</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 11%; text-align: right">   <span style="-sec-ix-hidden: xdx2ixbrl0564">-</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0565">-</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 11%; text-align: right">495</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--RestrictedCashAndCashEquivalentsAtCarryingValue_iI_pn3n3_maAFVDzDZa_zRAu0vCGC3Bf" style="vertical-align: bottom; background-color: White"> <td style="font-style: italic; text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Restricted cash and cash equivalents</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,250</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0569">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0570">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,250</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--OtherInvestments_iI_pn3n3_maAFVDzDZa_zIuiSg3N2Sn2" style="vertical-align: bottom; background-color: White"> <td style="font-style: italic; text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Other investments</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2,193</p></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0574">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">285</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,478</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--EquitySecuritiesFvNi_iI_pn3n3_maAFVDzDZa_zLWRf0A7Gq4l" style="vertical-align: bottom; background-color: White"> <td style="font-style: italic; text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Equity securities</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">680</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0579">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0580">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">680</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--AssetsFairValueDisclosure_iTI_pn3n3_mtAFVDzDZa_zVHvUMfMC9K8" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">6,618</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0584">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">285</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">6,903</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_495_20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zsv8C65bIYB8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Level 1)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49A_20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zFxfTPnxcNC7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Level 2)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_493_20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zOlSP1uBOM4f" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Level 3)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_490_20221231_z0VO1n63gtfe" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair Value Measurements Using</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2"> </td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Level 1)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Level 2)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Level 3)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic">As of December 31, 2022</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">($ in thousands)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Financial Assets:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_maAFVDzlNu_z1HYtNtY6iua" style="vertical-align: bottom; background-color: White"> <td style="width: 40%; font-style: italic; text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Cash and cash equivalents</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 11%; text-align: right">1,207</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0589">-</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0590">-</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 11%; text-align: right">1,207</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-style: italic"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--RestrictedCashAndCashEquivalentsAtCarryingValue_iI_pn3n3_maAFVDzlNu_zL9RKsFaLYSd" style="vertical-align: bottom; background-color: White"> <td style="font-style: italic; text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Restricted cash and cash equivalents</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,721</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0594">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0595">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,721</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-style: italic"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--OtherInvestments_iI_pn3n3_maAFVDzlNu_zcZch1Q09Xo6" style="vertical-align: bottom; background-color: White"> <td style="font-style: italic; text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Other investments</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0598">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0599">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">11,423</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">11,423</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-style: italic"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--EquitySecuritiesFvNi_iI_pn3n3_maAFVDzlNu_z6xmjMi6jhni" style="vertical-align: bottom; background-color: White"> <td style="font-style: italic; text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Equity securities</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">642</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0604">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0605">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">642</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--AssetsFairValueDisclosure_iTI_mtAFVDzlNu_zQv0FQLQlanh" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Total</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,570</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0609">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">11,423</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">15,993</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AB_zsejzz6biXX" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Assets Measured at Estimated Fair Value on a Recurring Basis</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There were no transfers between Levels 1, 2 or 3 during the years ended December 31, 2023 and 2022 except as disclosed below.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the financial statements for the year ended December 31, 2023, there has been a notable change in the classification of our investment in Jet.AI from Level 3 to Level 1 within the fair value hierarchy. This change is attributed to Oxbridge Acquisition Corp. (“OXAC”) successfully completing a business combination with Jet.AI Inc (“Jet.AI”) in August 2023, resulting in the investment now having an active market with readily available quoted prices.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Previously classified as Level 3 due to the reliance on unobservable inputs, the investment is now categorized as Level 1, as it is valued based on quoted prices in an active market. This change reflects the increased liquidity and transparency associated with Jet.AI’s publicly traded status, allowing for a more reliable and market-driven valuation of our investments.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89B_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_zBOOlFmcXCg3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table provides a reconciliation of changes in fair value of the beginning and ending balances for the other investments classified as Level 3:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span id="xdx_8BE_zoMB0bVMRBxh" style="display: none">SCHEDULE OF RECONCILIATION OF CHANGES IN FAIR VALUE</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Year ended</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($ in thousands)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value of Level 3 other investments at beginning of year</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98B_eus-gaap--InvestmentOwnedAtFairValue_iS_pn3n3_c20230101__20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z96CGVbOfB39" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Fair value of Level 3 other investment, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,423</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_989_eus-gaap--InvestmentOwnedAtFairValue_iS_pn3n3_c20220101__20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z6bUEM7mbOAi" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Fair value of Level 3 other investment, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,173</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transfer to Level 1</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_ecustom--TransferToLevelOne_iN_pn3n3_di_c20230101__20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z3kCxpRFXSKc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Transfer to Level 1"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(11,138</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investment in affiliate</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_ecustom--InvestmentInAffiliate_pn3n3_c20230101__20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zbqksRp3vmR7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Investment in affiliate"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0624">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_ecustom--InvestmentInAffiliate_pn3n3_c20220101__20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zemeJY9dPYq" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Investment in affiliate"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">285</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change in valuation inputs or other assumptions</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_ecustom--ChangeInValuationInputsOrOtherAssumptions_pn3n3_c20230101__20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zUsKaVVozHge" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Change in valuation inputs or other assumptions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0628">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_ecustom--ChangeInValuationInputsOrOtherAssumptions_pn3n3_c20220101__20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zmIaOVSXkbTc" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Change in valuation inputs or other assumptions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(35</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value of Level 3 other investment at December 31, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_987_eus-gaap--InvestmentOwnedAtFairValue_iE_pn3n3_c20230101__20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zFjnUOWH9qy" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Fair value of Level 3 other investment, Ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">285</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98E_eus-gaap--InvestmentOwnedAtFairValue_iE_pn3n3_c20220101__20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zIIoglPtV11e" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Fair value of Level 3 other investment, Ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,423</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A1_zgqBRMvUoTx" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_eus-gaap--ScheduleOfRealizedGainLossTableTextBlock_zPazAPfuvXod" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proceeds received, and the gross realized gains and losses from sale of equity securities, for the years ended December 31, 2023 and 2022 are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BF_zOFe9PHRwIcf" style="display: none">SCHEDULE OF GROSS REALIZED GAINS AND LOSSES FROM SALE OF EQUITY SECURITIES</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_48D_eus-gaap--ProceedsFromSaleOfEquitySecuritiesFvNi_pn3n3_zhOyHtkFrKta" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt">Gross</p> <p style="margin-top: 0pt; margin-bottom: 0pt">proceeds</p> <p style="margin-top: 0pt; margin-bottom: 0pt">from sales</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_488_eus-gaap--EquitySecuritiesFvNiRealizedGain_pn3n3_zMDRz9cWhorc" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt">Gross</p> <p style="margin-top: 0pt; margin-bottom: 0pt">Realized</p> <p style="margin-top: 0pt; margin-bottom: 0pt">Gains</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_485_eus-gaap--EquitySecuritiesFvNiRealizedLoss_pn3n3_zquOZNsTHcTb" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt">Gross</p> <p style="margin-top: 0pt; margin-bottom: 0pt">Realized</p> <p style="margin-top: 0pt; margin-bottom: 0pt">Losses</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">($ in thousands)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-style: italic">Year ended December 31, 2023</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_41E_20230101__20231231_zM1H7FVaW58g" style="vertical-align: bottom; background-color: White"> <td style="width: 40%; text-align: left; padding-bottom: 2.5pt">Equity securities</td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0515">-</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0516">-</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0517">-</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-style: italic">Year ended December 31, 2022</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_412_20220101__20221231_zE7rUoq29vKl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Equity securities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">626</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">27</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0520">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 626000 27000 2875000 575 1000 4897500 -8945000 <p id="xdx_890_ecustom--ScheduleOfOtherInvestmentsTableTextBlock_zzZpWUW1Uiik" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other investments as of December 31, 2023 and 2022 consist of the following (in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B4_zo4NNvMsSDil" style="display: none">SCHEDULE OF OTHER INVESTMENT</span></span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_497_20230101__20231231_zwOOLpnF8V79" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_494_20220101__20221231_zH0Q869jrpag" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_408_eus-gaap--OtherInvestments_iE_pn3n3_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JetA1SeriesA1ConvertiblePreferredStockMember_zeuE2hkDB6xk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Jet.AI Series A-1 Convertible Preferred Stock</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">285</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0535">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--OtherInvestments_iE_pn3n3_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JetA1PromissoryNoteMember_z27CvtPe5Eh9" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Jet.AI. Promissory Note</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0537">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">214</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--OtherInvestments_iE_pn3n3_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JetA1ClassBOrdinarySharesMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--CommonClassBMember_z6mjVB2YlJW3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Jet.AI. common stock (2022: Class B Ordinary Shares)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,193</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">11,209</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--OtherInvestments_iE_pn3n3_z191ZEzAmLD2" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,478</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">11,423</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--OtherInvestments_iS_pn3n3_zmZYy1EoSRj" style="vertical-align: bottom; background-color: White"> <td>Beginning of year</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">11,423</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">11,173</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_ecustom--InvestmentInAffiliate_pn3n3_zLYg8PJWyCyb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Investment in affiliate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0549">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">285</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_zILz4eZdnW7g" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Unrealized loss on investment in affiliate</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(8,945</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(35</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40E_eus-gaap--OtherInvestments_iE_pn3n3_zzf5UFfIqtD2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">End of year</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,478</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">11,423</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 285000 214000 2193000 11209000 2478000 11423000 11423000 11173000 285000 -8945000 -35000 2478000 11423000 <p id="xdx_898_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisTextBlock_ziBTo0aGZaC6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B1_z9JmQskCFoE7" style="display: none">SCHEDULE OF FAIR VALUE OF ASSETS MEASURED ON RECURRING BASIS</span></span></span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zJBovUEm7Nka" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Level 1)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_496_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zojqoy3o9ze4" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Level 2)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_491_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zX706j5lRxY" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Level 3)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_496_20231231_zB7PlqJp6zce" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair Value Measurements Using</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2"> </td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Level 1)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Level 2)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Level 3)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic">As of December 31, 2023</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">($ in thousands)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Financial Assets:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_maAFVDzDZa_zlscd1SWtxu1" style="vertical-align: bottom; background-color: White"> <td style="width: 40%; font-style: italic; text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Cash and cash equivalents</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 11%; text-align: right">495</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 11%; text-align: right">   <span style="-sec-ix-hidden: xdx2ixbrl0564">-</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0565">-</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 11%; text-align: right">495</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--RestrictedCashAndCashEquivalentsAtCarryingValue_iI_pn3n3_maAFVDzDZa_zRAu0vCGC3Bf" style="vertical-align: bottom; background-color: White"> <td style="font-style: italic; text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Restricted cash and cash equivalents</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,250</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0569">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0570">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,250</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--OtherInvestments_iI_pn3n3_maAFVDzDZa_zIuiSg3N2Sn2" style="vertical-align: bottom; background-color: White"> <td style="font-style: italic; text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Other investments</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2,193</p></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0574">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">285</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,478</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--EquitySecuritiesFvNi_iI_pn3n3_maAFVDzDZa_zLWRf0A7Gq4l" style="vertical-align: bottom; background-color: White"> <td style="font-style: italic; text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Equity securities</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">680</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0579">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0580">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">680</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--AssetsFairValueDisclosure_iTI_pn3n3_mtAFVDzDZa_zVHvUMfMC9K8" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">6,618</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0584">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">285</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">6,903</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_495_20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zsv8C65bIYB8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Level 1)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49A_20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zFxfTPnxcNC7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Level 2)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_493_20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zOlSP1uBOM4f" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Level 3)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_490_20221231_z0VO1n63gtfe" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair Value Measurements Using</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2"> </td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Level 1)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Level 2)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Level 3)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic">As of December 31, 2022</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">($ in thousands)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Financial Assets:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_maAFVDzlNu_z1HYtNtY6iua" style="vertical-align: bottom; background-color: White"> <td style="width: 40%; font-style: italic; text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Cash and cash equivalents</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 11%; text-align: right">1,207</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0589">-</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0590">-</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 11%; text-align: right">1,207</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-style: italic"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--RestrictedCashAndCashEquivalentsAtCarryingValue_iI_pn3n3_maAFVDzlNu_zL9RKsFaLYSd" style="vertical-align: bottom; background-color: White"> <td style="font-style: italic; text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Restricted cash and cash equivalents</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,721</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0594">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0595">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,721</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-style: italic"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--OtherInvestments_iI_pn3n3_maAFVDzlNu_zcZch1Q09Xo6" style="vertical-align: bottom; background-color: White"> <td style="font-style: italic; text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Other investments</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0598">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0599">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">11,423</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">11,423</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-style: italic"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--EquitySecuritiesFvNi_iI_pn3n3_maAFVDzlNu_z6xmjMi6jhni" style="vertical-align: bottom; background-color: White"> <td style="font-style: italic; text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Equity securities</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">642</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0604">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0605">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">642</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--AssetsFairValueDisclosure_iTI_mtAFVDzlNu_zQv0FQLQlanh" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Total</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,570</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0609">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">11,423</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">15,993</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> 495000 495000 3250000 3250000 2193000 285000 2478000 680000 680000 6618000 285000 6903000 1207000 1207000 2721000 2721000 11423000 11423000 642000 642000 4570000 11423000 15993000 <p id="xdx_89B_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_zBOOlFmcXCg3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table provides a reconciliation of changes in fair value of the beginning and ending balances for the other investments classified as Level 3:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span id="xdx_8BE_zoMB0bVMRBxh" style="display: none">SCHEDULE OF RECONCILIATION OF CHANGES IN FAIR VALUE</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Year ended</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($ in thousands)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value of Level 3 other investments at beginning of year</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98B_eus-gaap--InvestmentOwnedAtFairValue_iS_pn3n3_c20230101__20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z96CGVbOfB39" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Fair value of Level 3 other investment, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,423</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_989_eus-gaap--InvestmentOwnedAtFairValue_iS_pn3n3_c20220101__20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z6bUEM7mbOAi" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Fair value of Level 3 other investment, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,173</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transfer to Level 1</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_ecustom--TransferToLevelOne_iN_pn3n3_di_c20230101__20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z3kCxpRFXSKc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Transfer to Level 1"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(11,138</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investment in affiliate</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_ecustom--InvestmentInAffiliate_pn3n3_c20230101__20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zbqksRp3vmR7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Investment in affiliate"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0624">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_ecustom--InvestmentInAffiliate_pn3n3_c20220101__20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zemeJY9dPYq" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Investment in affiliate"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">285</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change in valuation inputs or other assumptions</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_ecustom--ChangeInValuationInputsOrOtherAssumptions_pn3n3_c20230101__20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zUsKaVVozHge" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Change in valuation inputs or other assumptions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0628">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_ecustom--ChangeInValuationInputsOrOtherAssumptions_pn3n3_c20220101__20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zmIaOVSXkbTc" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Change in valuation inputs or other assumptions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(35</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value of Level 3 other investment at December 31, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_987_eus-gaap--InvestmentOwnedAtFairValue_iE_pn3n3_c20230101__20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zFjnUOWH9qy" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Fair value of Level 3 other investment, Ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">285</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98E_eus-gaap--InvestmentOwnedAtFairValue_iE_pn3n3_c20220101__20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zIIoglPtV11e" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Fair value of Level 3 other investment, Ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,423</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 11423000 11173000 11138000 285000 -35000 285000 11423000 <p id="xdx_805_eus-gaap--IncomeTaxDisclosureTextBlock_z46AkYNw08ha" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5. <span id="xdx_823_zJst2dTotUnh">TAXATION</span> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under current Cayman Islands law, no corporate entity, including the Company and the subsidiaries, is obligated to pay taxes in the Cayman Islands on either income or capital gains. The Company and Oxbridge Reinsurance Limited have an undertaking from the Governor-in-Cabinet of the Cayman Islands, pursuant to the provisions of the Tax Concessions Law, as amended, that, in the event that the Cayman Islands enacts any legislation that imposes tax on profits, income, gains or appreciations, or any tax in the nature of estate duty or inheritance tax, such tax will not be applicable to the Company and Oxbridge Reinsurance Limited, or their operations, or to the ordinary shares or related obligations, until April 23, 2033 and May 17, 2033, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company and its subsidiaries intend to conduct substantially all of their operations in the Cayman Islands in a manner such that they will not be engaged in a trade or business in the U.S. However, because there is no definitive authority regarding activities that constitute being engaged in a trade or business in the U.S. for federal income tax purposes, the Company cannot assure that the U.S. Internal Revenue Service will not contend, perhaps successfully, that the Company or its subsidiaries are engaged in a trade or business in the U.S. A foreign corporation deemed to be so engaged would be subject to U.S. federal income tax, as well as branch profits tax, on its income that is treated as effectively connected with the conduct of that trade or business unless the corporation is entitled to relief under an applicable tax treaty.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_80E_eus-gaap--VariableInterestEntityDisclosureTextBlock_zFWhIL8FsWkc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>6. <span id="xdx_82C_z70XVMQqntzj">VARIABLE INTEREST ENTITIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Oxbridge Re NS. </i>On December 22, 2017, the Company established Oxbridge Re NS, a Cayman domiciled and licensed special purpose insurer, formed to provide additional collateralized capacity to support Oxbridge Reinsurance Limited’s reinsurance business. In respect of the debt issued by Oxbridge Re NS to investors, Oxbridge Re NS has entered into a retrocession agreement with Oxbridge Reinsurance Limited effective June 1, 2020. Under this agreement, Oxbridge Re NS receives a quota share of Oxbridge Reinsurance Limited’s catastrophe business. Oxbridge Re NS is a non-rated insurer and the risks have been fully collateralized by way of funds held in trust for the benefit of Oxbridge Reinsurance Limited. Oxbridge Re NS is able to provide investors with access to natural catastrophe risk backed by the distribution, underwriting, analysis and research expertise of Oxbridge Re.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has determined that Oxbridge Re NS meets the definition of a VIE as it does not have sufficient equity capital to finance its activities. The Company concluded that it is the primary beneficiary and has consolidated the subsidiary upon its formation, as it owns <span id="xdx_90A_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_uPure_c20171222__us-gaap--BusinessAcquisitionAxis__custom--OxbridgeReNSMember_zllZF0rikHT9" title="Voting percentage">100</span>% of the voting shares, <span id="xdx_904_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20171231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--OxbridgeReNSMember_z0OEVWyQJIUj" title="Share capital percentage">100</span>% of the issued share capital and has a significant financial interest and the power to control the activities of Oxbridge Re NS that most significantly impacts its economic performance. The Company has no other obligation to provide financial support to Oxbridge Re NS. Neither the creditors nor beneficial interest holders of Oxbridge Re NS have recourse to the Company’s general credit.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon issuance of a series of participating notes by Oxbridge Re NS, all of the proceeds from the issuance are deposited into collateral accounts, to fund any potential obligation under the reinsurance agreements entered into with Oxbridge Reinsurance Limited underlying such series of notes. The outstanding principal amount of each series of notes generally is expected to be returned to holders of such notes upon the expiration of the risk period underlying such notes, unless an event occurs which causes a loss under the applicable series of notes, in which case the amount returned is expected to be reduced by such noteholder’s pro rata share of such loss, as specified in the applicable governing documents of such notes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In addition, holders of such notes are generally entitled to interest payments, payable annually, as determined by the applicable governing documents of each series of notes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Oxbridge Re Holdings Limited receives an origination and structuring fee in connection with the formation, operation, and management of Oxbridge Re NS.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes Payable to Series 2020-1 noteholders</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Oxbridge Re NS entered into a retrocession agreement with Oxbridge Reinsurance Ltd on June 1, 2020 and issued $<span id="xdx_90C_eus-gaap--NotesIssued1_c20200530__20200601__us-gaap--LongtermDebtTypeAxis__custom--NotesPayableToSeries20201NoteholdersMember_zheO65UdPGIk" title="Notes issued">216,000</span> of participating notes which provides quota share support for Oxbridge Re’s global property catastrophe excess of loss reinsurance business. The participating notes have been assigned Series 2020-1 and matured on <span id="xdx_901_eus-gaap--DebtInstrumentMaturityDate_c20200530__20200601__us-gaap--LongtermDebtTypeAxis__custom--NotesPayableToSeries20201NoteholdersMember_zllenfLDe7xg">June 1, 2023</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. Participating notes totaling $<span id="xdx_90B_eus-gaap--RepaymentsOfDebt_c20230101__20231231_zbmz3ZuooQuc">98,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">were redeemed during the year-ended December 31, 2023 resulting in a balance due of $<span id="xdx_90F_eus-gaap--ConvertibleNotesPayableCurrent_iI_c20231231_zxeQUFAnImq7">118,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">at December 31, 2023. None of the participating notes were redeemed during the year ended December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The income from Oxbridge Re NS operations that are attributable to the participating notes noteholders for year ended December 31, 2023 was $<span id="xdx_906_eus-gaap--IncomeLossIncludingPortionAttributableToNoncontrollingInterest_c20230101__20231231__us-gaap--BusinessAcquisitionAxis__custom--OxbridgeReNSMember_zmL1JDsLDRD5" title="Noncontrolling interest">0</span>. The income from Oxbridge Re NS operations that are attributable to the participating notes noteholders for the year ended December 31, 2022 was $<span id="xdx_90E_eus-gaap--IncomeLossIncludingPortionAttributableToNoncontrollingInterest_c20220101__20221231__us-gaap--BusinessAcquisitionAxis__custom--OxbridgeReNSMember_zHXz8re78xP4" title="Noncontrolling interest">43,000</span> and are included within accounts payable and other liabilities at December 31, 2023 and 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SurancePlus Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SurancePlus Inc., a wholly-owned subsidiary of Oxbridge Re Holdings Limited, was incorporated as a British Virgin Islands Business Company on December 19, 2022 for the purposes of tokenizing reinsurance contracts underwritten by its affiliated licensed reinsurer, Oxbridge Re NS.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 27, 2023, the Company and SurancePlus Inc. (“SurancePlus”), issued a press release announcing the commencement of an offering by SurancePlus of DeltaCat Re tokenized reinsurance securities (the “Tokens”), which represent Series DeltaCat Preferred Shares of SurancePlus (“Preferred Shares”, and together with the Tokens, the “Securities”). Each digital security or token, which will have a purchase price of $<span id="xdx_902_eus-gaap--SharesIssuedPricePerShare_iI_pid_uUSDPShares_c20230327__dei--LegalEntityAxis__custom--SurancePlusIncMember_z2oEheLBdBb3" title="Shares issued, price per share">10.00</span> per Token, will represent one Preferred Share of SurancePlus. On September 11, 2023, the DeltaCat Re tokens were reclassified as tokenized interests carrying rights equivalent to the DeltaCat Re Preferred Shares in accordance with the provisions of British Virgin Islands law.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--SaleOfStockDescriptionOfTransaction_c20230326__20230327__dei--LegalEntityAxis__custom--SurancePlusIncMember_zArRu7JdfKQh" title="Description for offer and sale of securities">The proceeds from the offer and sale of the Securities will be used by SurancePlus to purchase one or more participating notes of Oxbridge Re NS, and the proceeds from the sale of participating notes will be invested in collateralized reinsurance contracts to be underwritten by Oxbridge Re NS. The holders of the digital Securities will generally be entitled to proceeds from the payment of participating notes in the amount of a preferred return of 20% plus an additional 80% of any proceeds in excess of the amount necessary to pay the preferred return. Assuming no casualty losses to properties reinsured by Oxbridge Re’s reinsurance subsidiaries, DeltaCat Re token investors are expected to receive an annual return on the original purchase price of 42%.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 27, 2023, SurancePlus Inc. completed its private placement (the “Private Placement”) of Series DeltaCat Re Preferred Shares represented by DeltaCat Re Tokens (the “Securities”). On June 27, 2023, SurancePlus entered into subscription agreements with accredited investors and non-U.S. persons in the Private Placement with respect to <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230627__20230627__dei--LegalEntityAxis__custom--SurancePlusIncMember__srt--TitleOfIndividualAxis__custom--InvestorsAndNonUSPersonsMember__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementsMember_zuKvTTjmYRkc" title="Number of shares issued">229,766</span> of the Securities at a purchase price of $<span id="xdx_90E_eus-gaap--SharesIssuedPricePerShare_iI_pid_uUSDPShares_c20230627__dei--LegalEntityAxis__custom--SurancePlusIncMember__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementsMember__srt--TitleOfIndividualAxis__custom--InvestorsAndNonUSPersonsMember_z9JIG99trXfg" title="Shares issued, price per share">10.00</span> per token for aggregate gross proceeds of $<span id="xdx_909_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_c20230627__20230627__dei--LegalEntityAxis__custom--SurancePlusIncMember__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementsMember__srt--TitleOfIndividualAxis__custom--InvestorsAndNonUSPersonsMember_zw2eWDiRN5vb" title="Proceeds from issuance of private placement">2,297,660</span>. SurancePlus also previously entered into subscription agreements for and sold <span id="xdx_90B_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230627__20230627__dei--LegalEntityAxis__custom--SurancePlusIncMember__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementsMember__srt--TitleOfIndividualAxis__custom--InvestorsAndNonUSPersonsMember_zaKvgjTYLaY5" title="Sale of stock number of shares issued in transaction">15,010</span> of the Securities between April 5, 2023 and May 18, 2023 for gross proceeds of $<span id="xdx_902_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_c20230627__20230627__dei--LegalEntityAxis__custom--SurancePlusIncMember__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementsMember_zuNAiEJ0zM6j" title="Proceeds from issuance of private placement">150,100</span>, also at a purchase price of $<span id="xdx_903_eus-gaap--SharesIssuedPricePerShare_iI_pid_uUSDPShares_c20230627__dei--LegalEntityAxis__custom--SurancePlusIncMember_zjeGx2TSC4Ej" title="Shares issued, price per share">10.00</span> per token. The aggregate amount raised in the Private Placement was $<span id="xdx_905_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_c20230627__20230627__dei--LegalEntityAxis__custom--SurancePlusIncMember_znMlCol5ot4f" title="Proceeds from issuance of private placement">2,447,760</span> for the issuance of <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230627__20230627__dei--LegalEntityAxis__custom--SurancePlusIncMember_zQeMpmHskBM2" title="Number of shares issued">244,776</span> Securities of which approximately $<span id="xdx_900_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_c20230627__20230627__dei--LegalEntityAxis__custom--SurancePlusIncMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThirdPartyInvestorsMember_zWycNvyUG9Hc" title="Proceeds from issuance of private placement">1,280,000</span> was received from third-party investors and approximately $<span id="xdx_904_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_c20230627__20230627__dei--LegalEntityAxis__custom--SurancePlusIncMember__us-gaap--StatementEquityComponentsAxis__us-gaap--ParentMember_zuBFfQz5kb1" title="Proceeds from issuance of private placement">1,167,000</span> from Oxbridge Re Holdings Limited. Approximately $<span id="xdx_903_eus-gaap--InsuranceAgencyManagementFee_c20230627__20230627__dei--LegalEntityAxis__custom--SurancePlusIncMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThirdPartyInvestorsMember_zHhSXa4eFKF8" title="Management fee">300,000</span> and $<span id="xdx_90B_eus-gaap--InsuranceAgencyManagementFee_c20230627__20230627__dei--LegalEntityAxis__custom--SurancePlusIncMember__us-gaap--StatementEquityComponentsAxis__us-gaap--ParentMember_zcTT11JYjS9g" title="Management fee">274,000</span> of ITOM fees were deducted from the gross proceeds from the third-party investors and Oxbridge Re Holdings Limited, respectively., The tokens were issued on the Avalanche blockchain. Ownership of DeltaCat Re tokenized reinsurance securities indirectly confers fractionalized interests in reinsurance contracts underwritten by Oxbridge Re’s reinsurance subsidiary, Oxbridge Re NS, for the 2023-2024 treaty year.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 28, 2023, Oxbridge issued a press release announcing the completion of the Private Placement</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Securities have not been registered under the Securities Act of 1933, as amended (the “Securities Act”), or any state or other securities laws and may not be offered or sold in the United States absent an effective registration statement or an applicable exemption from registration requirements or a transaction not subject to the registration requirements of the Securities Act or any state or other securities laws. The Securities were sold in a transaction exempt from registration under the Securities Act and were sold only to persons reasonably believed to be accredited investors in the United States under SEC Rule 506(c) under the Securities Act and outside the United States only to non-U.S. persons in accordance with Regulation S under the Securities Act.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The selected unconsolidated historical financial information and other data presented below is derived from SurancePlus’ standalone unaudited financial statements for year ended December 31, 2023 and the balance sheet data as of December 31, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89A_eus-gaap--ScheduleOfQuarterlyFinancialInformationTableTextBlock_zyVO5Pn3Vtu2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BD_zh23UO9mmWgb">SCHEDULE OF FINANCIAL STATEMENTS</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_49C_20230101__20231231__dei--LegalEntityAxis__custom--SurancePlusIncMember_zUky79WBR7Ja" style="text-align: center; font-weight: bold">For Year Ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Statement of Operations Data:</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">December 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  <b> </b></span></td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)  </b></span></td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--Revenues_pn3n3_hsrt--ProductOrServiceAxis__custom--SurancePlusFeeIncomeMember_maNILzp5X_zP7jWcBcNLz5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; text-align: left">Surance Plus fee income </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">574</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--Revenues_pn3n3_hsrt--ProductOrServiceAxis__custom--UnderwritingRelatedIncomeMember_maNILzp5X_zJoOjEGnqlth" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Underwriting related income </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,140</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--Revenues_pn3n3_maNILzp5X_zfGPhD6pW531" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total revenue </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,714</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--OperatingExpenses_pn3n3_msNILzp5X_zbwdJdlyygzl" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Expenses </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(272</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr id="xdx_409_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_maNILzp5X_zUwGK5nvddr8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Income attributable to tokenholders </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(1,036</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr id="xdx_403_eus-gaap--NetIncomeLoss_iT_pn3n3_mtNILzp5X_zLmXbW77nnfe" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Net income </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">406</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Balance Sheet Data:</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_490_20231231__dei--LegalEntityAxis__custom--SurancePlusIncMember_zW3ggrhmFJS" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">At December 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(In thousands)</b></span></td><td style="font-weight: bold; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--Assets_iI_pn3n3_z7ORIVsh8Euf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; text-align: left">Total assets</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">3,588</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--OtherLiabilitiesCurrent_iI_pn3n3_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zp5150YTYSn5" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">Amounts due to Delta Cat Re Tokenholders<span id="xdx_F45_zgdn0JSl0WG8">*</span></td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">2,016</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--OtherLiabilitiesCurrent_iI_pn3n3_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--ParentMember_zF6jxDeAQUW1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt">Due to Parent</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">47</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--StockholdersEquity_iI_pn3n3_zHIDW3yLqCKk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Total shareholder’s equity</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">1,525</td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: right"><span id="xdx_F04_zisTGdzwvSVd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F16_zJHRMcKiaQO7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">includes underwriting profit of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEZJTkFOQ0lBTCBTVEFURU1FTlRTIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_902_eus-gaap--UnderwritingIncomeLoss_c20230101__20231231_zdOxc5NOZuI7" title="Underwriting profit">494,000</span> due to Parent.</span></td></tr> </table> <p id="xdx_8A8_zHjjsisp49rh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 1 1 216000 2023-06-01 98000 118000 0 43000 10.00 The proceeds from the offer and sale of the Securities will be used by SurancePlus to purchase one or more participating notes of Oxbridge Re NS, and the proceeds from the sale of participating notes will be invested in collateralized reinsurance contracts to be underwritten by Oxbridge Re NS. The holders of the digital Securities will generally be entitled to proceeds from the payment of participating notes in the amount of a preferred return of 20% plus an additional 80% of any proceeds in excess of the amount necessary to pay the preferred return. Assuming no casualty losses to properties reinsured by Oxbridge Re’s reinsurance subsidiaries, DeltaCat Re token investors are expected to receive an annual return on the original purchase price of 42%. 229766 10.00 2297660 15010 150100 10.00 2447760 244776 1280000 1167000 300000 274000 <p id="xdx_89A_eus-gaap--ScheduleOfQuarterlyFinancialInformationTableTextBlock_zyVO5Pn3Vtu2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BD_zh23UO9mmWgb">SCHEDULE OF FINANCIAL STATEMENTS</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_49C_20230101__20231231__dei--LegalEntityAxis__custom--SurancePlusIncMember_zUky79WBR7Ja" style="text-align: center; font-weight: bold">For Year Ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Statement of Operations Data:</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">December 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  <b> </b></span></td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)  </b></span></td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--Revenues_pn3n3_hsrt--ProductOrServiceAxis__custom--SurancePlusFeeIncomeMember_maNILzp5X_zP7jWcBcNLz5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; text-align: left">Surance Plus fee income </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">574</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--Revenues_pn3n3_hsrt--ProductOrServiceAxis__custom--UnderwritingRelatedIncomeMember_maNILzp5X_zJoOjEGnqlth" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Underwriting related income </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,140</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--Revenues_pn3n3_maNILzp5X_zfGPhD6pW531" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total revenue </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,714</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--OperatingExpenses_pn3n3_msNILzp5X_zbwdJdlyygzl" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Expenses </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(272</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr id="xdx_409_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_maNILzp5X_zUwGK5nvddr8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Income attributable to tokenholders </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(1,036</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr id="xdx_403_eus-gaap--NetIncomeLoss_iT_pn3n3_mtNILzp5X_zLmXbW77nnfe" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Net income </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">406</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Balance Sheet Data:</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_490_20231231__dei--LegalEntityAxis__custom--SurancePlusIncMember_zW3ggrhmFJS" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">At December 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(In thousands)</b></span></td><td style="font-weight: bold; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--Assets_iI_pn3n3_z7ORIVsh8Euf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; text-align: left">Total assets</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">3,588</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--OtherLiabilitiesCurrent_iI_pn3n3_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zp5150YTYSn5" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">Amounts due to Delta Cat Re Tokenholders<span id="xdx_F45_zgdn0JSl0WG8">*</span></td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">2,016</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--OtherLiabilitiesCurrent_iI_pn3n3_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--ParentMember_zF6jxDeAQUW1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt">Due to Parent</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">47</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--StockholdersEquity_iI_pn3n3_zHIDW3yLqCKk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Total shareholder’s equity</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">1,525</td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: right"><span id="xdx_F04_zisTGdzwvSVd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F16_zJHRMcKiaQO7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">includes underwriting profit of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEZJTkFOQ0lBTCBTVEFURU1FTlRTIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_902_eus-gaap--UnderwritingIncomeLoss_c20230101__20231231_zdOxc5NOZuI7" title="Underwriting profit">494,000</span> due to Parent.</span></td></tr> </table> 574000 1140000 1714000 -272000 -1036000 406000 3588000 2016000 47000 1525000 494000000 <p id="xdx_805_ecustom--ReserveForLossesAndLossAdjustmentExpensesDisclosureTextBlock_znsdgMHuqYal" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>7. <span id="xdx_82D_zgZYN4WS8V4i">RESERVE FOR LOSSES AND LOSS ADJUSTMENT EXPENSES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_eus-gaap--ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_zFSVyJ5BsRji" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes the Company’s loss and loss adjustment expenses (“LAE”) and the reserve for loss and LAE reserve movements for the years ended December 31, 2023 and 2022</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 4.5pt; text-align: justify; text-indent: 31.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B3_z5H8T2Bu9mj8" style="display: none">SCHEDULE OF LOSS ADJUSTMENT EXPENSE</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20230101__20231231_z8dTPAH1JDsk" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_491_20220101__20221231_z9qpZhfh9l0k" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">Year ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">($ in thousands)</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_40B_eus-gaap--LiabilityForClaimsAndClaimsAdjustmentExpense_iS_pn3n3_zlDrDP4Rl14j" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Gross balance, beginning of year</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">1,073</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0718">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Incurred, net of reinsurance, related to:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_pn3n3_maLFUCAzKTv_zs5aNt9ssTgb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt">Current year</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0720">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,073</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_pn3n3_maLFUCAzKTv_zf7bGxPAjrhi" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Prior year</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0723">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0724">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_iT_pn3n3_mtLFUCAzKTv_znN7UssIYOoi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 20pt">Total incurred</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0726">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,073</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Paid related to:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_iN_pn3n3_di_maPFLALzSy6_zO6ZVTi6hDWf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt">Current year</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0729">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0730">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_iN_pn3n3_di_maPFLALzSy6_zus63aGYE33f" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Prior year</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,073</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0733">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--PaymentsForLossesAndLossAdjustmentExpense_iNT_pn3n3_di_mtPFLALzSy6_zag0KeCgVAGj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 20pt">Total paid</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0735">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0736">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--LiabilityForClaimsAndClaimsAdjustmentExpense_iE_pn3n3_z0fz0UCXfqS2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Balance, end of year</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0738">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">1,073</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AE_z1AtdhTKLs4d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When losses occur, the reserves for losses and LAE are typically comprised of case reserves (which are based on claims that have been reported) and IBNR reserves (which are based on losses that are believed to have occurred but for which claims have not yet been reported and include a provision for expected future development on existing case reserves). The Company typically suffers limit losses in the event of a Category 3 or above hurricane making landfall in a populated area where the Company has catastrophe risk exposure. For the year ended December 31, 2023, the Company has recorded it’s reserves for losses and LAE based on the contractual maximum loss the Company can suffer under the affected contracts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 33.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The uncertainties inherent in the reserving process and potential delays by cedants and brokers in the reporting of loss information, together with the potential for unforeseen adverse developments, may result in the reserve for losses and LAE ultimately being significantly greater or less than the reserve provided at the end of any given reporting period. The degree of uncertainty is further increased when a significant loss event takes place near the end of a reporting period. Reserve for losses and LAE estimates are reviewed periodically on a contract-by-contract basis and updated as new information becomes known. Any resulting adjustments are reflected in income in the period in which they become known.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s reserving process is highly dependent on the timing of loss information received from its cedants and related brokers.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There were no losses incurred during the year ended December 31, 2023. The losses incurred during the year ended December 31, 2022 related to a first limit loss suffered by the Company as a result of underwriting exposure to Hurricane Ian, which made landfall in Florida on September 28, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Reserving methodologies and assumptions</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss reserves are generally established based on loss payments and case reserves reported by clients when, and if, received. Estimates for IBNR losses are added to the case reserves. To establish IBNR loss estimates, the Company uses quarterly actuarial estimates from its independent actuary, who utilizes loss data reported by the Company along with industry loss data and information, knowledge of the business written and actuary’s own professional judgment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The independent actuary employs standard actuarial methods for its analysis each quarter. Such methods may include the:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Reported Loss Development Method.</i></b> Ultimate losses are estimated by calculating past reported loss development factors and applying them to exposure periods with further expected reported loss development. Since reported losses include payments and case reserves, changes in both of these amounts are incorporated in this method.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Expected Loss Ratio Method. </i></b>Ultimate losses are estimated by multiplying earned premiums by an expected loss ratio. The expected loss ratio is selected using industry data, historical company data and actuarial professional judgment. This method is typically used for lines of business and contracts where there are no historical losses or where past loss experience is not credible.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Bornhuetter-Ferguson Reported Loss Method. </i></b>Ultimate losses are estimated by modifying expected loss ratios to the extent reported losses experienced to date differ from what would have been expected to have been reported based upon the selected reported loss development pattern. This method avoids some of the distortions that could result from a large development factor being applied to a small base of reported losses to calculate ultimate losses.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Frequency / Severity Method. </i></b>Ultimate losses are estimated under this method by multiplying the ultimate number of claims (i.e. the frequency multiplied by the exposure base on which the frequency has been determined), by the estimated ultimate average cost per claim (i.e. the severity). By analyzing claims experience by its frequency and severity components, the Company can examine trends and patterns in the rates of claims emergence (i.e. reporting) and settlement (i.e. closure) as well as in the average cost of claims.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The approach is valuable because sometimes there is more inherent stability in the frequency and severity data when viewed separately rather than in the total losses</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 33.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Reserving methodologies and assumptions (continued</span>)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 33.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 33.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In addition, the Company may supplement its analysis with other reserving methodologies that are deemed to be relevant to specific contracts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 33.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 33.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For each contract, the Company utilizes reserving methodologies that are deemed appropriate to calculate a best estimate, or point estimate, of reserves. The decision of whether to use a single methodology or a combination of multiple methodologies depends upon the judgment of the independent actuary, if utilized. The Company’s reserving methodology does not require a fixed weighting of the various methods used. Certain methods are considered more appropriate depending on the type and structure of the contract, the age and maturity of the contract, and the duration of the expected paid losses on the contract.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 33.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 33.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s gross aggregate reserves are the sum of the point estimate reserves of all portfolio exposures. Generally, IBNR loss reserves are calculated by estimating the ultimate incurred losses at any point in time and subtracting cumulative paid claims and case reserves, which incorporate specific exposures, loss payment and reporting patterns and other relevant factors.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 33.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 33.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There were no significant changes in the Company’s methodology or assumptions relating to the Company’s reserve for loss and loss adjustment expenses for the years ended December 31, 2023 or 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 33.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 33.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Claims Development Tables, IBNR Reserves and Claims Frequency</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 33.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 33.75pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table discloses information about the Company’s incurred and paid claims development as of December 31, 2023, as well as cumulative claim frequency and the total of incurred-but-not-reporting and expected development on reported claims included within the net incurred claims amounts. A claim is defined as a reported loss from a cedant on an excess-of-loss reinsurance contract arising from a loss event for which the Company records a paid loss or case reserve. The Company operates a single business segment, being property catastrophe reinsurance.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_897_eus-gaap--ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock_zTzbzSstIpLg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Property Catastrophe Reinsurance</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B3_zATQ0CBvMV0a" style="display: none">SCHEDULE OF INCURRED LOSSES AND ADJUSTMENT EXPENSES</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(in thousands) </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Incurred Losses and Loss Adjustment Expenses</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Accident Year</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2016</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2017</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2018</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>2023</b></td> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As of December 31, 2023 Total of Incurred-but<br/> -Not-Reported Liabilities<br/> Plus Expected Development on<br/> Reported Claims</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Cumulative Number of Reported Claims</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td><td style="font-style: italic"> </td> <td colspan="6" style="font-style: italic; text-align: center">(dollars in thousands)</td><td style="font-style: italic"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 30%; text-align: center">2016</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20161231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortdurationInsuranceContractsAccidentYear2016Member_zSh1bER4PQTa" style="width: 4%; text-align: right" title="Incurred Losses and Loss Adjustment Expenses">14,775</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20171231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortdurationInsuranceContractsAccidentYear2016Member_zNQFOgK2zPl6" style="width: 4%; text-align: right" title="Incurred Losses and Loss Adjustment Expenses">18,801</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20181231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortdurationInsuranceContractsAccidentYear2016Member_z2oXEyg0GzF5" style="width: 4%; text-align: right" title="Incurred Losses and Loss Adjustment Expenses">17,795</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20191231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortdurationInsuranceContractsAccidentYear2016Member_zCjnEn7IT6vi" style="width: 4%; text-align: right" title="Incurred Losses and Loss Adjustment Expenses">17,689</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20201231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortdurationInsuranceContractsAccidentYear2016Member_zFUW17Q1QMO4" style="width: 4%; text-align: right" title="Incurred Losses and Loss Adjustment Expenses">17,689</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20211231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortdurationInsuranceContractsAccidentYear2016Member_zBqtO8841Nyj" style="width: 4%; text-align: right" title="Incurred Losses and Loss Adjustment Expenses">17,689</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20221231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortdurationInsuranceContractsAccidentYear2016Member_zuEL9JRSXkUi" style="width: 4%; text-align: right" title="Incurred Losses and Loss Adjustment Expenses">17,689</td><td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td id="xdx_986_eus-gaap--ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20231231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortdurationInsuranceContractsAccidentYear2016Member_zIFkyU3pFjwg" style="text-align: right; width: 4%" title="Incurred Losses and Loss Adjustment Expenses">17,689</td> <td style="width: 1%"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet_iI_pn3n3_c20231231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortdurationInsuranceContractsAccidentYear2016Member_ziG9hx1wOYCl" style="width: 4%; text-align: right" title="Total of Incurred but Not Reported Liabilities Plus Expected Development on Reported Claims"><span style="-sec-ix-hidden: xdx2ixbrl0768">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShortdurationInsuranceContractsNumberOfReportedClaims_iI_uClaims_c20231231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortdurationInsuranceContractsAccidentYear2016Member_zTwz13wTuAVi" style="width: 4%; text-align: right" title="Cumulative Number of Reported Claims">5</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">2017</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20171231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractsAccidentYear2017Member_z5NBF7wWJYAg" style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses">38,401</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20181231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractsAccidentYear2017Member_zctr6VsXRmD1" style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses">38,401</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20191231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractsAccidentYear2017Member_z21X3Upv1hW1" style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses">38,401</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20201231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractsAccidentYear2017Member_znshmk26Zuci" style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses">38,401</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20211231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractsAccidentYear2017Member_zortc4gUDOOc" style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses">38,401</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20221231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractsAccidentYear2017Member_zj3V8VuJk8vk" style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses">38,401</td><td style="text-align: left"> </td> <td> </td> <td>$</td> <td id="xdx_987_eus-gaap--ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20231231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractsAccidentYear2017Member_znyYpD5ZExd1" style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses">38,401</td> <td> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet_iI_pn3n3_c20231231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractsAccidentYear2017Member_ztfpZ7XaRBL1" style="text-align: right" title="Total of Incurred but Not Reported Liabilities Plus Expected Development on Reported Claims"><span style="-sec-ix-hidden: xdx2ixbrl0786">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShortdurationInsuranceContractsNumberOfReportedClaims_iI_uClaims_c20231231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractsAccidentYear2017Member_zTVzlRgiABk5" style="text-align: right" title="Cumulative Number of Reported Claims">8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">2018</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20181231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractsAccidentYear2018Member_zLsy7KNX47d" style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses">10,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20191231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractsAccidentYear2018Member_zx7F2FBvJv0g" style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses">10,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20201231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractsAccidentYear2018Member_zqggqlwEbk8" style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses">10,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20211231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractsAccidentYear2018Member_z8RhzXVXeTve" style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses">10,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20221231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractsAccidentYear2018Member_zmOoLfEyVkK1" style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses">10,000</td><td style="text-align: left"> </td> <td> </td> <td>$</td> <td id="xdx_984_eus-gaap--ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20231231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractsAccidentYear2018Member_zZm5Aby1fE2g" style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses">10,000</td> <td> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet_iI_pn3n3_c20231231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractsAccidentYear2018Member_zozEp4bBReY7" style="text-align: right" title="Total of Incurred but Not Reported Liabilities Plus Expected Development on Reported Claims"><span style="-sec-ix-hidden: xdx2ixbrl0802">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ShortdurationInsuranceContractsNumberOfReportedClaims_iI_uClaims_c20231231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractsAccidentYear2018Member_zktUnDgAq5ya" style="text-align: right" title="Cumulative Number of Reported Claims">2</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">2019</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20191231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2019Member_z2BI05czk7F6" style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses"><span style="-sec-ix-hidden: xdx2ixbrl0806">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20201231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2019Member_zSmwMLICPjC9" style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses"><span style="-sec-ix-hidden: xdx2ixbrl0808">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20211231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2019Member_zqRACTfgnfHa" style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses"><span style="-sec-ix-hidden: xdx2ixbrl0810">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20221231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2019Member_zXdqyHImyGJl" style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses"><span style="-sec-ix-hidden: xdx2ixbrl0812">-</span></td><td style="text-align: left"> </td> <td> </td> <td>$</td> <td id="xdx_989_eus-gaap--ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20231231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2019Member_z3eTFBLDp5b9" style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses"><span style="-sec-ix-hidden: xdx2ixbrl0814">-</span></td> <td> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet_iI_pn3n3_c20231231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2019Member_z8uvHuDLFTme" style="text-align: right" title="Total of Incurred but Not Reported Liabilities Plus Expected Development on Reported Claims"><span style="-sec-ix-hidden: xdx2ixbrl0816">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ShortdurationInsuranceContractsNumberOfReportedClaims_iI_uClaims_c20231231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2019Member_zISE5LJnur0h" style="text-align: right" title="Cumulative Number of Reported Claims"><span style="-sec-ix-hidden: xdx2ixbrl0818">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">2020</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20201231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2020Member_zCjDCZ5RNCj5" style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses"><span style="-sec-ix-hidden: xdx2ixbrl0820">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20211231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2020Member_zk07BgttNFg" style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses"><span style="-sec-ix-hidden: xdx2ixbrl0822">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20221231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2020Member_zyUp1WmyFdF5" style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses"><span style="-sec-ix-hidden: xdx2ixbrl0824">-</span></td><td style="text-align: left"> </td> <td> </td> <td>$</td> <td id="xdx_98D_eus-gaap--ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20231231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2020Member_z8CaglGA2MAh" style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses"> <span style="-sec-ix-hidden: xdx2ixbrl0826">-</span></td> <td> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet_iI_pn3n3_c20231231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2020Member_zzcBVrbDERjf" style="text-align: right" title="Total of Incurred but Not Reported Liabilities Plus Expected Development on Reported Claims"><span style="-sec-ix-hidden: xdx2ixbrl0828">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShortdurationInsuranceContractsNumberOfReportedClaims_iI_uClaims_c20231231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2020Member_zNdLE8mzg6Ri" style="text-align: right" title="Cumulative Number of Reported Claims"><span style="-sec-ix-hidden: xdx2ixbrl0830">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">2021</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20211231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2021Member_zQPVR8JmFyTa" style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses">158</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20221231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2021Member_zVSP5oxmerh1" style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses">158</td><td style="text-align: left"> </td> <td> </td> <td>$</td> <td id="xdx_982_eus-gaap--ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20231231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2021Member_zbdaQdDZN2gg" style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses">158</td> <td> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet_iI_pn3n3_c20231231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2021Member_zhPB4SE97dlj" style="text-align: right" title="Total of Incurred but Not Reported Liabilities Plus Expected Development on Reported Claims"><span style="-sec-ix-hidden: xdx2ixbrl0838">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShortdurationInsuranceContractsNumberOfReportedClaims_iI_uClaims_c20231231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2021Member_zd2pmP2MJki" style="text-align: right" title="Cumulative Number of Reported Claims">1</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">2022</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20221231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2022Member_zwo4FfDVRV68" style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses">1,073</td><td style="text-align: left"> </td> <td> </td> <td>$</td> <td id="xdx_989_eus-gaap--ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20231231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2022Member_zmYSzFoVm1R1" style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses">1,073</td> <td> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet_iI_pn3n3_c20231231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2022Member_zHAEP33PGDni" style="text-align: right" title="Total of Incurred but Not Reported Liabilities Plus Expected Development on Reported Claims">              <span style="-sec-ix-hidden: xdx2ixbrl0846">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShortdurationInsuranceContractsNumberOfReportedClaims_iI_uClaims_c20231231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2022Member_zguAwbsESM4k" style="text-align: right" title="Cumulative Number of Reported Claims">      1</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center; padding-bottom: 1.5pt">2023</td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right" title="Incurred Losses and Loss Adjustment Expenses"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right" title="Incurred Losses and Loss Adjustment Expenses"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_986_eus-gaap--ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20221231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2023Member_zVI0e6Nh6CW9" style="border-bottom: Black 1.5pt solid; text-align: right" title="Incurred Losses and Loss Adjustment Expenses"><span style="-sec-ix-hidden: xdx2ixbrl0850">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid">$</td> <td id="xdx_989_eus-gaap--ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20231231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2023Member_z8TBCo1X9feb" style="border-bottom: Black 1.5pt solid; text-align: right" title="Incurred Losses and Loss Adjustment Expenses"><span style="-sec-ix-hidden: xdx2ixbrl0852">-</span></td> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_989_eus-gaap--ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet_iI_pn3n3_c20231231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2023Member_zC7IfbeXLLG" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total of Incurred but Not Reported Liabilities Plus Expected Development on Reported Claims"><span style="-sec-ix-hidden: xdx2ixbrl0854">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td id="xdx_980_eus-gaap--ShortdurationInsuranceContractsNumberOfReportedClaims_iI_uClaims_c20231231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2023Member_zSIbTGwvdte9" style="padding-bottom: 1.5pt; text-align: right" title="Cumulative Number of Reported Claims"><span style="-sec-ix-hidden: xdx2ixbrl0856">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total </span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right" title="Incurred Losses and Loss Adjustment Expenses"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20221231_zIHdPnbY7fXl" style="border-bottom: Black 2.5pt double; text-align: right" title="Incurred Losses and Loss Adjustment Expenses">67,321</td><td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double">$</td> <td id="xdx_989_eus-gaap--ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20231231_zvt6J9iR6d23" style="border-bottom: Black 2.5pt double; text-align: right" title="Incurred Losses and Loss Adjustment Expenses">67,321</td> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet_iI_pn3n3_c20231231_zQXHGgnJb54c" style="border-bottom: Black 2.5pt double; text-align: right" title="Total of Incurred but Not Reported Liabilities Plus Expected Development on Reported Claims"><span style="-sec-ix-hidden: xdx2ixbrl0862">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right" title="Cumulative Number of Reported Claims"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Cumulative Paid Losses and Loss Adjustment Expenses</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Accident Year</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2016</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2017</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2018</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>2023</b></td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 37%; text-align: left">2016</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20161231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortdurationInsuranceContractsAccidentYear2016Member_zHPAKE7shc3c" style="width: 5%; text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses">6,073</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20171231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortdurationInsuranceContractsAccidentYear2016Member_zxeJbFAZ14Wj" style="width: 5%; text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses">16,073</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20181231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortdurationInsuranceContractsAccidentYear2016Member_zukyO2y0qSNl" style="width: 5%; text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses">17,687</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20191231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortdurationInsuranceContractsAccidentYear2016Member_z0eywTLDkln" style="width: 5%; text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses">17,689</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_c20201231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortdurationInsuranceContractsAccidentYear2016Member_pn3n3" style="width: 5%; text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses">17,689</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_c20211231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortdurationInsuranceContractsAccidentYear2016Member_pn3n3" style="width: 5%; text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses">17,689</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20221231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortdurationInsuranceContractsAccidentYear2016Member_zraJyj3nCEPh" style="width: 5%; text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses">17,689</td><td style="width: 1%; text-align: left"> </td> <td style="width: 1%">$</td> <td id="xdx_98C_eus-gaap--ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20231231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortdurationInsuranceContractsAccidentYear2016Member_zPHZQlybZisk" style="text-align: right; width: 5%" title="Cumulative Paid Losses and Loss Adjustment Expenses">17,689</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2017</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20171231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractsAccidentYear2017Member_zpYwtLnZknT2" style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses">36,293</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20181231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractsAccidentYear2017Member_zrsqmIy2rq78" style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses">38,401</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20191231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractsAccidentYear2017Member_zDFySP8Pehqc" style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses">38,401</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20201231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractsAccidentYear2017Member_zej65XBkDt33" style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses">38,401</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20211231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractsAccidentYear2017Member_zCMCIaJsdBtb" style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses">38,401</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20221231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractsAccidentYear2017Member_ziOT7c6kni07" style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses">38,401</td><td style="text-align: left"> </td> <td>$</td> <td style="text-align: right"><p id="xdx_980_eus-gaap--ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20231231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractsAccidentYear2017Member_zVjohPWSqu0c" style="font: 10pt Times New Roman, Times, Serif; margin: 0" title="Cumulative Paid Losses and Loss Adjustment Expenses">38,401</p></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">2018</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20181231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractsAccidentYear2018Member_zZYmlUDqldq6" style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses">6,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20191231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractsAccidentYear2018Member_zfwxF2Yd5Rq2" style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses">10,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20201231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractsAccidentYear2018Member_ztMW2QXGeNyk" style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses">10,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20211231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractsAccidentYear2018Member_z3WGsKbKo41h" style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses">10,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20221231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractsAccidentYear2018Member_zJN9HYRIS28h" style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses">10,000</td><td style="text-align: left"> </td> <td>$</td> <td id="xdx_98F_eus-gaap--ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20231231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractsAccidentYear2018Member_zOsBpnDgElJh" style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses">10,000</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2019</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20191231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2019Member_zHVtCKI0u2Wc" style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"><span style="-sec-ix-hidden: xdx2ixbrl0906">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20201231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2019Member_zIVYEtnGUjga" style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"><span style="-sec-ix-hidden: xdx2ixbrl0908">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20211231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2019Member_zMxViLj7mzVg" style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"><span style="-sec-ix-hidden: xdx2ixbrl0910">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20221231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2019Member_zbdx7V2dUzXk" style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"><span style="-sec-ix-hidden: xdx2ixbrl0912">-</span></td><td style="text-align: left"> </td> <td>$</td> <td id="xdx_983_eus-gaap--ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20231231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2019Member_z52uV3Ax79yg" style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"><span style="-sec-ix-hidden: xdx2ixbrl0914">-</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">2020</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20201231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2020Member_zqtMeZSo7aZ7" style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"><span style="-sec-ix-hidden: xdx2ixbrl0916">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20211231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2020Member_zqzvD1qf0rQc" style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"><span style="-sec-ix-hidden: xdx2ixbrl0918">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20221231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2020Member_zcAG79bOHFR6" style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"><span style="-sec-ix-hidden: xdx2ixbrl0920">-</span></td><td style="text-align: left"> </td> <td>$</td> <td id="xdx_983_eus-gaap--ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20231231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2020Member_zN4io2GDFy4l" style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"><span style="-sec-ix-hidden: xdx2ixbrl0922">-</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2021</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20211231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2021Member_zgz6S16iOwJd" style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses">158</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20221231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2021Member_zzD2M92WEyq5" style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses">158</td><td style="text-align: left"> </td> <td>$</td> <td id="xdx_98B_eus-gaap--ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20231231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2021Member_zTeyx4yCXx3g" style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses">158</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">2022</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20221231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2022Member_zac1rMNx23I7" style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses">1,073</td><td style="text-align: left"> </td> <td>$</td> <td id="xdx_984_eus-gaap--ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20231231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2022Member_zNTbfmygoDM3" style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses">1,073</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">2023</td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20211231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2023Member_zGRfLOx8nTGe" style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"><span style="-sec-ix-hidden: xdx2ixbrl0934">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid">$</td> <td id="xdx_984_eus-gaap--ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20231231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2023Member_zUrWUGxgg1N7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"><span style="-sec-ix-hidden: xdx2ixbrl0936">-</span></td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_981_eus-gaap--ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20221231_zpbIkI0zVHd1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses">67,321</td><td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid">$</td> <td id="xdx_982_eus-gaap--ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20231231_z0ljdqvnHbT9" style="border-bottom: Black 1.5pt solid; text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses">67,321</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 10pt">Reserve for loss and loss adjustment expenses at December 31, 2023, net of reinsurance</td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">$</td><td id="xdx_98D_eus-gaap--ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20221231_z2WKZep0AvAb" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"> <span style="-sec-ix-hidden: xdx2ixbrl0942">-</span> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="border-bottom: Black 2.5pt double">$</td> <td id="xdx_988_eus-gaap--ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20231231_ztMTyr78USi" style="border-bottom: Black 2.5pt double; text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"><span style="-sec-ix-hidden: xdx2ixbrl0944">-</span></td> <td style="padding-bottom: 2.5pt"> </td></tr> </table> <p id="xdx_8A7_zqvIbkoN3t0c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89F_eus-gaap--ShortdurationInsuranceContractsScheduleOfHistoricalClaimsDurationTableTextBlock_z5boAHv2VGRj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table shows the historical average annual percentage payout of claims at December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B0_z7JqBl4zorEi" style="display: none">SCHEDULE OF HISTORICAL AVERAGE ANNUAL PERCENTAGE PAYOUT</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="22" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Average Annual Percentage Payout of Incurred Claims by Age</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; padding-bottom: 1.5pt">Years</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 6%; text-align: right">1</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 6%; text-align: right">2</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 6%; text-align: right">3</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 6%; text-align: right">4</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 6%; text-align: right">5</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 6%; text-align: right">6</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Property Catastrophe Reinsurance</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShortdurationInsuranceContractsHistoricalClaimsDurationYearOne_iI_pid_dp_uPure_c20221231__us-gaap--PlanNameAxis__custom--PropertyCatastropheReinsuranceMember_zGRkjObjUuab" style="border-bottom: Black 2.5pt double; text-align: right" title="Average Annual Percentage Payout of Incurred Claims by Age, Net of Reinsurance, Year 1">57.8</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShortdurationInsuranceContractsHistoricalClaimsDurationYearTwo_iI_pid_dp_uPure_c20221231__us-gaap--PlanNameAxis__custom--PropertyCatastropheReinsuranceMember_z1YJwQXr45zf" style="border-bottom: Black 2.5pt double; text-align: right" title="Average Annual Percentage Payout of Incurred Claims by Age, Net of Reinsurance, Year 2">34.0</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_985_eus-gaap--ShortdurationInsuranceContractsHistoricalClaimsDurationYearThree_iI_pid_dp_uPure_c20221231__us-gaap--PlanNameAxis__custom--PropertyCatastropheReinsuranceMember_z3TXoQ4iF1Mh" style="border-bottom: Black 2.5pt double; text-align: right" title="Average Annual Percentage Payout of Incurred Claims by Age, Net of Reinsurance, Year 3">9.1</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShortdurationInsuranceContractsHistoricalClaimsDurationYearFour_iI_pid_dp_uPure_c20221231__us-gaap--PlanNameAxis__custom--PropertyCatastropheReinsuranceMember_zIslkMDPDNA1" style="border-bottom: Black 2.5pt double; text-align: right" title="Average Annual Percentage Payout of Incurred Claims by Age, Net of Reinsurance, Year 4">0.0</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_981_eus-gaap--ShortdurationInsuranceContractsHistoricalClaimsDurationYearFive_iI_pid_dp_uPure_c20221231__us-gaap--PlanNameAxis__custom--PropertyCatastropheReinsuranceMember_za7rfv1FKRMa" style="border-bottom: Black 2.5pt double; text-align: right" title="Average Annual Percentage Payout of Incurred Claims by Age, Net of Reinsurance, Year 5">0.0</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShortdurationInsuranceContractsHistoricalClaimsDurationYearSix_iI_pid_dp_uPure_c20221231__us-gaap--PlanNameAxis__custom--PropertyCatastropheReinsuranceMember_zzVs6qecYIYe" style="border-bottom: Black 2.5pt double; text-align: right" title="Average Annual Percentage Payout of Incurred Claims by Age, Net of Reinsurance, Year 6">0</td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr> </table> <p id="xdx_8AE_ztIGRN5QEtM" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_eus-gaap--ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_zFSVyJ5BsRji" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes the Company’s loss and loss adjustment expenses (“LAE”) and the reserve for loss and LAE reserve movements for the years ended December 31, 2023 and 2022</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 4.5pt; text-align: justify; text-indent: 31.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B3_z5H8T2Bu9mj8" style="display: none">SCHEDULE OF LOSS ADJUSTMENT EXPENSE</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20230101__20231231_z8dTPAH1JDsk" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_491_20220101__20221231_z9qpZhfh9l0k" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">Year ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">($ in thousands)</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_40B_eus-gaap--LiabilityForClaimsAndClaimsAdjustmentExpense_iS_pn3n3_zlDrDP4Rl14j" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Gross balance, beginning of year</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">1,073</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0718">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Incurred, net of reinsurance, related to:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_pn3n3_maLFUCAzKTv_zs5aNt9ssTgb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt">Current year</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0720">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,073</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_pn3n3_maLFUCAzKTv_zf7bGxPAjrhi" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Prior year</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0723">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0724">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_iT_pn3n3_mtLFUCAzKTv_znN7UssIYOoi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 20pt">Total incurred</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0726">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,073</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Paid related to:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_iN_pn3n3_di_maPFLALzSy6_zO6ZVTi6hDWf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt">Current year</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0729">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0730">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_iN_pn3n3_di_maPFLALzSy6_zus63aGYE33f" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Prior year</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,073</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0733">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--PaymentsForLossesAndLossAdjustmentExpense_iNT_pn3n3_di_mtPFLALzSy6_zag0KeCgVAGj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 20pt">Total paid</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0735">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0736">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--LiabilityForClaimsAndClaimsAdjustmentExpense_iE_pn3n3_z0fz0UCXfqS2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Balance, end of year</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0738">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">1,073</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 1073000 1073000 1073000 1073000 1073000 <p id="xdx_897_eus-gaap--ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock_zTzbzSstIpLg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Property Catastrophe Reinsurance</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B3_zATQ0CBvMV0a" style="display: none">SCHEDULE OF INCURRED LOSSES AND ADJUSTMENT EXPENSES</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(in thousands) </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Incurred Losses and Loss Adjustment Expenses</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Accident Year</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2016</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2017</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2018</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>2023</b></td> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As of December 31, 2023 Total of Incurred-but<br/> -Not-Reported Liabilities<br/> Plus Expected Development on<br/> Reported Claims</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Cumulative Number of Reported Claims</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td><td style="font-style: italic"> </td> <td colspan="6" style="font-style: italic; text-align: center">(dollars in thousands)</td><td style="font-style: italic"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 30%; text-align: center">2016</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20161231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortdurationInsuranceContractsAccidentYear2016Member_zSh1bER4PQTa" style="width: 4%; text-align: right" title="Incurred Losses and Loss Adjustment Expenses">14,775</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20171231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortdurationInsuranceContractsAccidentYear2016Member_zNQFOgK2zPl6" style="width: 4%; text-align: right" title="Incurred Losses and Loss Adjustment Expenses">18,801</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20181231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortdurationInsuranceContractsAccidentYear2016Member_z2oXEyg0GzF5" style="width: 4%; text-align: right" title="Incurred Losses and Loss Adjustment Expenses">17,795</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20191231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortdurationInsuranceContractsAccidentYear2016Member_zCjnEn7IT6vi" style="width: 4%; text-align: right" title="Incurred Losses and Loss Adjustment Expenses">17,689</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20201231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortdurationInsuranceContractsAccidentYear2016Member_zFUW17Q1QMO4" style="width: 4%; text-align: right" title="Incurred Losses and Loss Adjustment Expenses">17,689</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20211231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortdurationInsuranceContractsAccidentYear2016Member_zBqtO8841Nyj" style="width: 4%; text-align: right" title="Incurred Losses and Loss Adjustment Expenses">17,689</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20221231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortdurationInsuranceContractsAccidentYear2016Member_zuEL9JRSXkUi" style="width: 4%; text-align: right" title="Incurred Losses and Loss Adjustment Expenses">17,689</td><td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td id="xdx_986_eus-gaap--ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20231231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortdurationInsuranceContractsAccidentYear2016Member_zIFkyU3pFjwg" style="text-align: right; width: 4%" title="Incurred Losses and Loss Adjustment Expenses">17,689</td> <td style="width: 1%"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet_iI_pn3n3_c20231231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortdurationInsuranceContractsAccidentYear2016Member_ziG9hx1wOYCl" style="width: 4%; text-align: right" title="Total of Incurred but Not Reported Liabilities Plus Expected Development on Reported Claims"><span style="-sec-ix-hidden: xdx2ixbrl0768">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShortdurationInsuranceContractsNumberOfReportedClaims_iI_uClaims_c20231231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortdurationInsuranceContractsAccidentYear2016Member_zTwz13wTuAVi" style="width: 4%; text-align: right" title="Cumulative Number of Reported Claims">5</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">2017</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20171231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractsAccidentYear2017Member_z5NBF7wWJYAg" style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses">38,401</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20181231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractsAccidentYear2017Member_zctr6VsXRmD1" style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses">38,401</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20191231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractsAccidentYear2017Member_z21X3Upv1hW1" style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses">38,401</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20201231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractsAccidentYear2017Member_znshmk26Zuci" style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses">38,401</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20211231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractsAccidentYear2017Member_zortc4gUDOOc" style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses">38,401</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20221231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractsAccidentYear2017Member_zj3V8VuJk8vk" style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses">38,401</td><td style="text-align: left"> </td> <td> </td> <td>$</td> <td id="xdx_987_eus-gaap--ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20231231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractsAccidentYear2017Member_znyYpD5ZExd1" style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses">38,401</td> <td> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet_iI_pn3n3_c20231231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractsAccidentYear2017Member_ztfpZ7XaRBL1" style="text-align: right" title="Total of Incurred but Not Reported Liabilities Plus Expected Development on Reported Claims"><span style="-sec-ix-hidden: xdx2ixbrl0786">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShortdurationInsuranceContractsNumberOfReportedClaims_iI_uClaims_c20231231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractsAccidentYear2017Member_zTVzlRgiABk5" style="text-align: right" title="Cumulative Number of Reported Claims">8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">2018</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20181231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractsAccidentYear2018Member_zLsy7KNX47d" style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses">10,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20191231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractsAccidentYear2018Member_zx7F2FBvJv0g" style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses">10,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20201231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractsAccidentYear2018Member_zqggqlwEbk8" style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses">10,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20211231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractsAccidentYear2018Member_z8RhzXVXeTve" style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses">10,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20221231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractsAccidentYear2018Member_zmOoLfEyVkK1" style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses">10,000</td><td style="text-align: left"> </td> <td> </td> <td>$</td> <td id="xdx_984_eus-gaap--ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20231231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractsAccidentYear2018Member_zZm5Aby1fE2g" style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses">10,000</td> <td> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet_iI_pn3n3_c20231231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractsAccidentYear2018Member_zozEp4bBReY7" style="text-align: right" title="Total of Incurred but Not Reported Liabilities Plus Expected Development on Reported Claims"><span style="-sec-ix-hidden: xdx2ixbrl0802">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ShortdurationInsuranceContractsNumberOfReportedClaims_iI_uClaims_c20231231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractsAccidentYear2018Member_zktUnDgAq5ya" style="text-align: right" title="Cumulative Number of Reported Claims">2</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">2019</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20191231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2019Member_z2BI05czk7F6" style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses"><span style="-sec-ix-hidden: xdx2ixbrl0806">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20201231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2019Member_zSmwMLICPjC9" style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses"><span style="-sec-ix-hidden: xdx2ixbrl0808">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20211231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2019Member_zqRACTfgnfHa" style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses"><span style="-sec-ix-hidden: xdx2ixbrl0810">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20221231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2019Member_zXdqyHImyGJl" style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses"><span style="-sec-ix-hidden: xdx2ixbrl0812">-</span></td><td style="text-align: left"> </td> <td> </td> <td>$</td> <td id="xdx_989_eus-gaap--ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20231231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2019Member_z3eTFBLDp5b9" style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses"><span style="-sec-ix-hidden: xdx2ixbrl0814">-</span></td> <td> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet_iI_pn3n3_c20231231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2019Member_z8uvHuDLFTme" style="text-align: right" title="Total of Incurred but Not Reported Liabilities Plus Expected Development on Reported Claims"><span style="-sec-ix-hidden: xdx2ixbrl0816">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ShortdurationInsuranceContractsNumberOfReportedClaims_iI_uClaims_c20231231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2019Member_zISE5LJnur0h" style="text-align: right" title="Cumulative Number of Reported Claims"><span style="-sec-ix-hidden: xdx2ixbrl0818">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">2020</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20201231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2020Member_zCjDCZ5RNCj5" style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses"><span style="-sec-ix-hidden: xdx2ixbrl0820">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20211231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2020Member_zk07BgttNFg" style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses"><span style="-sec-ix-hidden: xdx2ixbrl0822">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20221231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2020Member_zyUp1WmyFdF5" style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses"><span style="-sec-ix-hidden: xdx2ixbrl0824">-</span></td><td style="text-align: left"> </td> <td> </td> <td>$</td> <td id="xdx_98D_eus-gaap--ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20231231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2020Member_z8CaglGA2MAh" style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses"> <span style="-sec-ix-hidden: xdx2ixbrl0826">-</span></td> <td> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet_iI_pn3n3_c20231231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2020Member_zzcBVrbDERjf" style="text-align: right" title="Total of Incurred but Not Reported Liabilities Plus Expected Development on Reported Claims"><span style="-sec-ix-hidden: xdx2ixbrl0828">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShortdurationInsuranceContractsNumberOfReportedClaims_iI_uClaims_c20231231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2020Member_zNdLE8mzg6Ri" style="text-align: right" title="Cumulative Number of Reported Claims"><span style="-sec-ix-hidden: xdx2ixbrl0830">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">2021</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20211231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2021Member_zQPVR8JmFyTa" style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses">158</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20221231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2021Member_zVSP5oxmerh1" style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses">158</td><td style="text-align: left"> </td> <td> </td> <td>$</td> <td id="xdx_982_eus-gaap--ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20231231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2021Member_zbdaQdDZN2gg" style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses">158</td> <td> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet_iI_pn3n3_c20231231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2021Member_zhPB4SE97dlj" style="text-align: right" title="Total of Incurred but Not Reported Liabilities Plus Expected Development on Reported Claims"><span style="-sec-ix-hidden: xdx2ixbrl0838">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShortdurationInsuranceContractsNumberOfReportedClaims_iI_uClaims_c20231231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2021Member_zd2pmP2MJki" style="text-align: right" title="Cumulative Number of Reported Claims">1</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">2022</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20221231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2022Member_zwo4FfDVRV68" style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses">1,073</td><td style="text-align: left"> </td> <td> </td> <td>$</td> <td id="xdx_989_eus-gaap--ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20231231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2022Member_zmYSzFoVm1R1" style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses">1,073</td> <td> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet_iI_pn3n3_c20231231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2022Member_zHAEP33PGDni" style="text-align: right" title="Total of Incurred but Not Reported Liabilities Plus Expected Development on Reported Claims">              <span style="-sec-ix-hidden: xdx2ixbrl0846">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShortdurationInsuranceContractsNumberOfReportedClaims_iI_uClaims_c20231231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2022Member_zguAwbsESM4k" style="text-align: right" title="Cumulative Number of Reported Claims">      1</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center; padding-bottom: 1.5pt">2023</td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right" title="Incurred Losses and Loss Adjustment Expenses"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right" title="Incurred Losses and Loss Adjustment Expenses"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_986_eus-gaap--ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20221231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2023Member_zVI0e6Nh6CW9" style="border-bottom: Black 1.5pt solid; text-align: right" title="Incurred Losses and Loss Adjustment Expenses"><span style="-sec-ix-hidden: xdx2ixbrl0850">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid">$</td> <td id="xdx_989_eus-gaap--ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20231231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2023Member_z8TBCo1X9feb" style="border-bottom: Black 1.5pt solid; text-align: right" title="Incurred Losses and Loss Adjustment Expenses"><span style="-sec-ix-hidden: xdx2ixbrl0852">-</span></td> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_989_eus-gaap--ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet_iI_pn3n3_c20231231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2023Member_zC7IfbeXLLG" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total of Incurred but Not Reported Liabilities Plus Expected Development on Reported Claims"><span style="-sec-ix-hidden: xdx2ixbrl0854">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td id="xdx_980_eus-gaap--ShortdurationInsuranceContractsNumberOfReportedClaims_iI_uClaims_c20231231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2023Member_zSIbTGwvdte9" style="padding-bottom: 1.5pt; text-align: right" title="Cumulative Number of Reported Claims"><span style="-sec-ix-hidden: xdx2ixbrl0856">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total </span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Incurred Losses and Loss Adjustment Expenses"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right" title="Incurred Losses and Loss Adjustment Expenses"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20221231_zIHdPnbY7fXl" style="border-bottom: Black 2.5pt double; text-align: right" title="Incurred Losses and Loss Adjustment Expenses">67,321</td><td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double">$</td> <td id="xdx_989_eus-gaap--ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20231231_zvt6J9iR6d23" style="border-bottom: Black 2.5pt double; text-align: right" title="Incurred Losses and Loss Adjustment Expenses">67,321</td> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet_iI_pn3n3_c20231231_zQXHGgnJb54c" style="border-bottom: Black 2.5pt double; text-align: right" title="Total of Incurred but Not Reported Liabilities Plus Expected Development on Reported Claims"><span style="-sec-ix-hidden: xdx2ixbrl0862">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right" title="Cumulative Number of Reported Claims"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Cumulative Paid Losses and Loss Adjustment Expenses</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Accident Year</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2016</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2017</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2018</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>2023</b></td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 37%; text-align: left">2016</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20161231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortdurationInsuranceContractsAccidentYear2016Member_zHPAKE7shc3c" style="width: 5%; text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses">6,073</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20171231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortdurationInsuranceContractsAccidentYear2016Member_zxeJbFAZ14Wj" style="width: 5%; text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses">16,073</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20181231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortdurationInsuranceContractsAccidentYear2016Member_zukyO2y0qSNl" style="width: 5%; text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses">17,687</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20191231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortdurationInsuranceContractsAccidentYear2016Member_z0eywTLDkln" style="width: 5%; text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses">17,689</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_c20201231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortdurationInsuranceContractsAccidentYear2016Member_pn3n3" style="width: 5%; text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses">17,689</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_c20211231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortdurationInsuranceContractsAccidentYear2016Member_pn3n3" style="width: 5%; text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses">17,689</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20221231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortdurationInsuranceContractsAccidentYear2016Member_zraJyj3nCEPh" style="width: 5%; text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses">17,689</td><td style="width: 1%; text-align: left"> </td> <td style="width: 1%">$</td> <td id="xdx_98C_eus-gaap--ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20231231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortdurationInsuranceContractsAccidentYear2016Member_zPHZQlybZisk" style="text-align: right; width: 5%" title="Cumulative Paid Losses and Loss Adjustment Expenses">17,689</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2017</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20171231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractsAccidentYear2017Member_zpYwtLnZknT2" style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses">36,293</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20181231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractsAccidentYear2017Member_zrsqmIy2rq78" style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses">38,401</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20191231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractsAccidentYear2017Member_zDFySP8Pehqc" style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses">38,401</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20201231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractsAccidentYear2017Member_zej65XBkDt33" style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses">38,401</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20211231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractsAccidentYear2017Member_zCMCIaJsdBtb" style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses">38,401</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20221231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractsAccidentYear2017Member_ziOT7c6kni07" style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses">38,401</td><td style="text-align: left"> </td> <td>$</td> <td style="text-align: right"><p id="xdx_980_eus-gaap--ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20231231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractsAccidentYear2017Member_zVjohPWSqu0c" style="font: 10pt Times New Roman, Times, Serif; margin: 0" title="Cumulative Paid Losses and Loss Adjustment Expenses">38,401</p></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">2018</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20181231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractsAccidentYear2018Member_zZYmlUDqldq6" style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses">6,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20191231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractsAccidentYear2018Member_zfwxF2Yd5Rq2" style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses">10,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20201231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractsAccidentYear2018Member_ztMW2QXGeNyk" style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses">10,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20211231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractsAccidentYear2018Member_z3WGsKbKo41h" style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses">10,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20221231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractsAccidentYear2018Member_zJN9HYRIS28h" style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses">10,000</td><td style="text-align: left"> </td> <td>$</td> <td id="xdx_98F_eus-gaap--ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20231231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractsAccidentYear2018Member_zOsBpnDgElJh" style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses">10,000</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2019</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20191231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2019Member_zHVtCKI0u2Wc" style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"><span style="-sec-ix-hidden: xdx2ixbrl0906">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20201231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2019Member_zIVYEtnGUjga" style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"><span style="-sec-ix-hidden: xdx2ixbrl0908">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20211231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2019Member_zMxViLj7mzVg" style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"><span style="-sec-ix-hidden: xdx2ixbrl0910">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20221231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2019Member_zbdx7V2dUzXk" style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"><span style="-sec-ix-hidden: xdx2ixbrl0912">-</span></td><td style="text-align: left"> </td> <td>$</td> <td id="xdx_983_eus-gaap--ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20231231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2019Member_z52uV3Ax79yg" style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"><span style="-sec-ix-hidden: xdx2ixbrl0914">-</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">2020</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20201231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2020Member_zqtMeZSo7aZ7" style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"><span style="-sec-ix-hidden: xdx2ixbrl0916">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20211231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2020Member_zqzvD1qf0rQc" style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"><span style="-sec-ix-hidden: xdx2ixbrl0918">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20221231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2020Member_zcAG79bOHFR6" style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"><span style="-sec-ix-hidden: xdx2ixbrl0920">-</span></td><td style="text-align: left"> </td> <td>$</td> <td id="xdx_983_eus-gaap--ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20231231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2020Member_zN4io2GDFy4l" style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"><span style="-sec-ix-hidden: xdx2ixbrl0922">-</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2021</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20211231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2021Member_zgz6S16iOwJd" style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses">158</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20221231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2021Member_zzD2M92WEyq5" style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses">158</td><td style="text-align: left"> </td> <td>$</td> <td id="xdx_98B_eus-gaap--ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20231231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2021Member_zTeyx4yCXx3g" style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses">158</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">2022</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20221231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2022Member_zac1rMNx23I7" style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses">1,073</td><td style="text-align: left"> </td> <td>$</td> <td id="xdx_984_eus-gaap--ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20231231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2022Member_zNTbfmygoDM3" style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses">1,073</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">2023</td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20211231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2023Member_zGRfLOx8nTGe" style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"><span style="-sec-ix-hidden: xdx2ixbrl0934">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid">$</td> <td id="xdx_984_eus-gaap--ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20231231__us-gaap--ShortdurationInsuranceContractsAccidentYearAxis__us-gaap--ShortDurationInsuranceContractAccidentYear2023Member_zUrWUGxgg1N7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"><span style="-sec-ix-hidden: xdx2ixbrl0936">-</span></td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_981_eus-gaap--ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20221231_zpbIkI0zVHd1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses">67,321</td><td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid">$</td> <td id="xdx_982_eus-gaap--ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20231231_z0ljdqvnHbT9" style="border-bottom: Black 1.5pt solid; text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses">67,321</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 10pt">Reserve for loss and loss adjustment expenses at December 31, 2023, net of reinsurance</td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">$</td><td id="xdx_98D_eus-gaap--ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20221231_z2WKZep0AvAb" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"> <span style="-sec-ix-hidden: xdx2ixbrl0942">-</span> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="border-bottom: Black 2.5pt double">$</td> <td id="xdx_988_eus-gaap--ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_iI_pn3n3_c20231231_ztMTyr78USi" style="border-bottom: Black 2.5pt double; text-align: right" title="Cumulative Paid Losses and Loss Adjustment Expenses"><span style="-sec-ix-hidden: xdx2ixbrl0944">-</span></td> <td style="padding-bottom: 2.5pt"> </td></tr> </table> 14775000 18801000 17795000 17689000 17689000 17689000 17689000 17689000 5000 38401000 38401000 38401000 38401000 38401000 38401000 38401000 8000 10000000 10000000 10000000 10000000 10000000 10000000 2000 158000 158000 158000 1000 1073000 1073000 1000 67321000 67321000 6073000 16073000 17687000 17689000 17689000 17689000 17689000 17689000 36293000 38401000 38401000 38401000 38401000 38401000 38401000 6000000 10000000 10000000 10000000 10000000 10000000 158000 158000 158000 1073000 1073000 67321000 67321000 <p id="xdx_89F_eus-gaap--ShortdurationInsuranceContractsScheduleOfHistoricalClaimsDurationTableTextBlock_z5boAHv2VGRj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table shows the historical average annual percentage payout of claims at December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B0_z7JqBl4zorEi" style="display: none">SCHEDULE OF HISTORICAL AVERAGE ANNUAL PERCENTAGE PAYOUT</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="22" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Average Annual Percentage Payout of Incurred Claims by Age</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; padding-bottom: 1.5pt">Years</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 6%; text-align: right">1</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 6%; text-align: right">2</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 6%; text-align: right">3</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 6%; text-align: right">4</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 6%; text-align: right">5</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 6%; text-align: right">6</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Property Catastrophe Reinsurance</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShortdurationInsuranceContractsHistoricalClaimsDurationYearOne_iI_pid_dp_uPure_c20221231__us-gaap--PlanNameAxis__custom--PropertyCatastropheReinsuranceMember_zGRkjObjUuab" style="border-bottom: Black 2.5pt double; text-align: right" title="Average Annual Percentage Payout of Incurred Claims by Age, Net of Reinsurance, Year 1">57.8</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShortdurationInsuranceContractsHistoricalClaimsDurationYearTwo_iI_pid_dp_uPure_c20221231__us-gaap--PlanNameAxis__custom--PropertyCatastropheReinsuranceMember_z1YJwQXr45zf" style="border-bottom: Black 2.5pt double; text-align: right" title="Average Annual Percentage Payout of Incurred Claims by Age, Net of Reinsurance, Year 2">34.0</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_985_eus-gaap--ShortdurationInsuranceContractsHistoricalClaimsDurationYearThree_iI_pid_dp_uPure_c20221231__us-gaap--PlanNameAxis__custom--PropertyCatastropheReinsuranceMember_z3TXoQ4iF1Mh" style="border-bottom: Black 2.5pt double; text-align: right" title="Average Annual Percentage Payout of Incurred Claims by Age, Net of Reinsurance, Year 3">9.1</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShortdurationInsuranceContractsHistoricalClaimsDurationYearFour_iI_pid_dp_uPure_c20221231__us-gaap--PlanNameAxis__custom--PropertyCatastropheReinsuranceMember_zIslkMDPDNA1" style="border-bottom: Black 2.5pt double; text-align: right" title="Average Annual Percentage Payout of Incurred Claims by Age, Net of Reinsurance, Year 4">0.0</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_981_eus-gaap--ShortdurationInsuranceContractsHistoricalClaimsDurationYearFive_iI_pid_dp_uPure_c20221231__us-gaap--PlanNameAxis__custom--PropertyCatastropheReinsuranceMember_za7rfv1FKRMa" style="border-bottom: Black 2.5pt double; text-align: right" title="Average Annual Percentage Payout of Incurred Claims by Age, Net of Reinsurance, Year 5">0.0</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShortdurationInsuranceContractsHistoricalClaimsDurationYearSix_iI_pid_dp_uPure_c20221231__us-gaap--PlanNameAxis__custom--PropertyCatastropheReinsuranceMember_zzVs6qecYIYe" style="border-bottom: Black 2.5pt double; text-align: right" title="Average Annual Percentage Payout of Incurred Claims by Age, Net of Reinsurance, Year 6">0</td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr> </table> 0.578 0.340 0.091 0.000 0.000 0 <p id="xdx_80B_eus-gaap--EarningsPerShareTextBlock_zUHbXATCjtnb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>8. <span id="xdx_820_zBlwNP934Zrd">LOSS PER SHARE</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_891_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zuXZ08xfVPYa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A summary of the numerator and denominator of the basic and diluted loss per share is presented below (dollars in thousands except per share amounts):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B0_z4Fz8DRumize">SCHEDULE OF COMPUTATION OF BASIC AND DILUTED LOSS EARNING PER SHARE</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_494_20230101__20231231_zwDR2qSOWKg6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20220101__20221231_zv8dUH0fjvtk" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Years ended December 31</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Numerator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--NetIncomeLoss_pn3n3_zEL7dfm22YO7" style="vertical-align: bottom; background-color: White"> <td style="width: 60%; text-align: left; padding-bottom: 2.5pt; padding-left: 10pt">Net loss</td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right">(9,915</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">)</td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right">(1,789</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold">Denominator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_zo9drQNyg6D6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">Weighted average shares - basic</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,867,129</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,772,396</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_pid_zH0yOEf9auDk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">Effect of dilutive securities - Stock options</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0972">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0973">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_407_ecustom--SharesIssuableUponConversionOfWarrants_pid_zgHeinczazd5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Shares issuable upon conversion of warrants</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0975">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0976">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_zrqrMLcJ6fO5" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; padding-left: 10pt">Weighted average shares - diluted</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">5,867,129</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">5,772,396</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--EarningsPerShareBasic_pid_zwRBSYcUvEk8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Loss per share - basic</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(1.69</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.31</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr id="xdx_40C_eus-gaap--EarningsPerShareDiluted_pid_z013vekF0OTg" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Loss earnings per share - diluted</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(1.69</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.31</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <p id="xdx_8A1_z7bQXZ0teIa4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the years ended December 31, 2023, and 2022, options to purchase <span id="xdx_903_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--CommonStockMember_zWhmnPBikLfh" title="Anti-dilutive shares"><span id="xdx_90F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--CommonStockMember_zRUUFLxTaYoh" title="Anti-dilutive shares">871,250</span> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ordinary shares were anti-dilutive due to the net losses during those years</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">GAAP requires the Company to use the two-class method in computing basic loss per share since holders of the Company’s restricted stock have the right to share in dividends, if declared, equally with common stockholders. These participating securities effect the computation of both basic and diluted loss per share during the years ended December 31, 2023 and 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_891_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zuXZ08xfVPYa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A summary of the numerator and denominator of the basic and diluted loss per share is presented below (dollars in thousands except per share amounts):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B0_z4Fz8DRumize">SCHEDULE OF COMPUTATION OF BASIC AND DILUTED LOSS EARNING PER SHARE</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_494_20230101__20231231_zwDR2qSOWKg6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20220101__20221231_zv8dUH0fjvtk" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Years ended December 31</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Numerator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--NetIncomeLoss_pn3n3_zEL7dfm22YO7" style="vertical-align: bottom; background-color: White"> <td style="width: 60%; text-align: left; padding-bottom: 2.5pt; padding-left: 10pt">Net loss</td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right">(9,915</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">)</td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right">(1,789</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold">Denominator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_zo9drQNyg6D6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">Weighted average shares - basic</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,867,129</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,772,396</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_pid_zH0yOEf9auDk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">Effect of dilutive securities - Stock options</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0972">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0973">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_407_ecustom--SharesIssuableUponConversionOfWarrants_pid_zgHeinczazd5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Shares issuable upon conversion of warrants</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0975">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0976">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_zrqrMLcJ6fO5" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; padding-left: 10pt">Weighted average shares - diluted</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">5,867,129</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">5,772,396</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--EarningsPerShareBasic_pid_zwRBSYcUvEk8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Loss per share - basic</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(1.69</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.31</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr id="xdx_40C_eus-gaap--EarningsPerShareDiluted_pid_z013vekF0OTg" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Loss earnings per share - diluted</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(1.69</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.31</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> -9915000 -1789000 5867129 5772396 5867129 5772396 -1.69 -0.31 -1.69 -0.31 871250 871250 <p id="xdx_80E_ecustom--DisclosureOfWarrantsTextBlock_z21oEaxPI0z4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>9. <span id="xdx_825_zVzV9bCJqhr9">WARRANTS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There were <span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zkDVtevdvCDe" title="Warrant outstanding"><span id="xdx_904_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z62wtlWRADG5" title="Warrant outstanding">8,230,700</span></span> warrants outstanding at December 31, 2023 and 2022. One warrant may be exercised to acquire one ordinary share at an exercise price equal to $<span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z4QIogZlrL89" title="Exercise price">7.50</span> per share on or before March 26, 2024. The Company at its option may cancel the warrants in whole or in part, provided that the closing price per ordinary share has exceeded $<span id="xdx_90D_eus-gaap--SharePrice_iI_pid_c20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zdG9sh7IkW3e" title="Closing price per share">9.38</span> for at least ten trading days within any period of twenty consecutive trading days, including the last trading day of the period. <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_do_c20230101__20231231_zP1lCZ0wcggk" title="Warrants exercised"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_do_c20220101__20221231_zZeCVe5zKRUc" title="Warrants exercised">No</span></span> warrants were exercised during the years ended December 31, 2023 and 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 29, 2024, the Company extended the expiration date of the warrants (NASDAQ: OXBRW) (the “Warrants”) to 5:00 p.m. Philadelphia time on the earlier to occur of (a) <span id="xdx_90B_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20240129__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z1NwCkiAKhAi" title="Warrant expiration date">March 26, 2029</span> and (b) the date fixed for cancellation by the Company following any <span id="xdx_909_eus-gaap--DebtInstrumentConvertibleThresholdTradingDays_uInteger_c20240129__20240129__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zAJ84FWRbjg" title="Trading days">20</span>-trading day period in which the Company’s ordinary shares traded above $<span id="xdx_908_eus-gaap--SharePrice_iI_pid_c20240129__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zWt8d8291K55" title="Ordinary share price, per share">9.38</span> per share for at least ten trading days.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 8230700 8230700 7.50 9.38 0 0 2029-03-26 20 9.38 <p id="xdx_805_ecustom--DividendsTextBlock_zXp29W8ORId9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10. <span id="xdx_82B_zyTTMfVGCjS8">DIVIDENDS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2023, none of the Company’s accumulated deficit were restricted from payment of dividends to the company’s shareholders. However, since most of the Company’s capital and retained earnings may be invested in its subsidiaries, a dividend from the subsidiaries would likely be required in order to fund a dividend to the Company’s shareholders and would require notification to the Cayman Islands Monetary Authority (“CIMA”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under Cayman Islands law, the use of additional paid-in capital is restricted, and the Company will not be allowed to pay dividends out of additional paid-in capital if such payments result in breaches of the prescribed and minimum capital requirement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_806_eus-gaap--DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_zqtaXLg9jlpa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>11. <span id="xdx_821_z7femyraP5O2">SHARE-BASED COMPENSATION</span> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company currently has outstanding share-based awards granted under the 2014 Omnibus Incentive Plan (the “2014 Plan”) and the 2021 Omnibus Incentive Plan (the “2021 Plan”) (herein collectively referred to as “the Plans”). Under each of the Plans, the Company has discretion to grant equity and cash incentive awards to eligible individuals, including the issuance of up to <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandFourteenOmnibusIncentivePlanMember_zgzySdPYetF4" title="Options, granted">1,000,000</span> of the Company’s ordinary shares. During the year ended December 31, 2023, the Company granted an aggregated of <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pid_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneOmnibusIncentivePlanMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zdlLZ4rHEkX8" title="Restricted stock, grant">100,647</span> of restricted stock to directors, officers and employees under the 2021 Plan. At December 31, 2023, there were <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneOmnibusIncentivePlanMember_zOFbAJKmleag" title="Options, granted">895,353</span> shares and <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_pid_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandFourteenOmnibusIncentivePlanMember_zIxkKPtS85J3" title="Shares available for grant">11,750</span> shares available for grant under the 2021 Plan and the 2014 Plan, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Stock options</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock options granted and outstanding under the Plans vests quarterly over four years and are exercisable over the contractual term of <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_dc_c20230101__20231231_z5cgZ7loNwH5" title="Vesting period, contractual term">ten years</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89B_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_z4O6USUcD3E" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A summary of the stock option activity for the years ended December 31, 2023 and 2022 is as follows (option amounts not in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B3_zQKJU9XCQ898" style="display: none">SCHEDULE OF STOCK OPTION ACTIVITY</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of Options</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted-</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Price</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted- Average Remaining Contractual Term</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Aggregate Intrinsic Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; padding-bottom: 2.5pt">Outstanding at December 31, 2022</td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20220101__20221231_zCxG1pbALWKf" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Number of Options, Outstanding, Beginning Balance">871,250</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; width: 1%; text-align: left">$</td><td style="padding-bottom: 2.5pt; width: 11%; text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20220101__20221231_zPcHym5lvjTd" title="Weighted-Average Exercise Price, Outstanding, Beginning Balance">4.67</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; width: 1%; text-align: left"> </td><td style="padding-bottom: 2.5pt; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231_zpofwqYRjQLd" title="Weighted-Average Remaining Contractual Term, Outstanding">5.8</span> years</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_c20220101__20221231_zKux1ozCr5Tg" style="padding-bottom: 2.5pt; width: 11%; text-align: right" title="Aggregate Intrinsic Value"><span style="-sec-ix-hidden: xdx2ixbrl1035">-</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Exercisable at December 31, 2022</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iS_pid_c20220101__20221231_z1nQDaKVN9Pe" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Exercisable, Beginning Balance">721,250</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iS_pid_c20220101__20221231_zof20AcuDbS9" title="Weighted-Average Exercise Price, Exercisable, Beginning Balance">4.39</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20220101__20221231_zuRkuZfMRPaf" title="Weighted-Average Remaining Contractual Term, Exercisable">5.3</span> years</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iS_c20220101__20221231_zGOWwJGcIuC5" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value"><span style="-sec-ix-hidden: xdx2ixbrl1043">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Outstanding at December 31, 2022</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20230101__20231231_zqq9XILNciza" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Outstanding, Beginning Balance">871,250</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230101__20231231_zziBNMHkq4P8" title="Weighted-Average Exercise Price, Outstanding, Beginning Balance">4.67</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231_zFBcDeODz537" title="Weighted-Average Remaining Contractual Term, Outstanding">5.8</span> years</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_c20230101__20231231_zQbcnP10zpjh" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value">     <span style="-sec-ix-hidden: xdx2ixbrl1051">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Forfeited</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_c20230101__20231231_z9AwlTNoFfPg" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Forfeited">(25,000</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_iN_pid_di_c20230101__20231231_zbxtbPbeQiB7" title="Weighted-Average Exercise Price, Forfeited">(6.00</span></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Outstanding at December 31, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20230101__20231231_zGyxFUtsnPfk" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options Outstanding, Ending Balance">846,250</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20230101__20231231_zcXofZ8xBdC9" title="Weighted-Average Exercise Price, Outstanding, Ending Balance">4.63</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231_zIRq7OkWiJvd" title="Weighted-Average Remaining Contractual Term, Outstanding">4.8</span> years</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_c20230101__20231231_zkOcF4DMZcVk" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value"><span style="-sec-ix-hidden: xdx2ixbrl1063">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Exercisable at December 31, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20230101__20231231_zOLMBoRKsK36" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options Exercisable, Ending Balance">783,750</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20230101__20231231_zC6xXnoARLz1" title="Weighted-Average Exercise Price, Exercisable, Ending Balance">4.52</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230101__20231231_zbdBnbzT9CHb" title="Weighted-Average Remaining Contractual Term, Exercisable">4.6</span> years</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_c20230101__20231231_zPjBNGWlbefe" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value"><span style="-sec-ix-hidden: xdx2ixbrl1071">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A4_zKZSAcDcRnAi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compensation expense recognized for the years ended December 31, 2023 and 2022 totaled $<span id="xdx_90A_eus-gaap--AllocatedShareBasedCompensationExpense_c20230101__20231231__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zQCdZDvf8WXg" title="Compensation expense">20,000</span> and $<span id="xdx_901_eus-gaap--AllocatedShareBasedCompensationExpense_c20220101__20221231__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zwCzvkET5F3a" title="Compensation expense">58,000</span>, respectively, and is included in general and administrative expenses. At December 31, 2023 and 2022, there was approximately $<span id="xdx_90F_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_iI_c20231231_zp4tsq6Fna8d" title="Unrecognized compensation expense, non-vested stock options">20,000</span> and $<span id="xdx_901_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_iI_c20221231_zdeotRFrL7ja" title="Unrecognized compensation expense, non-vested stock options">48,000</span>, respectively, of total unrecognized compensation expense related to non-vested stock options granted under the Plans. The Company expects to recognize the remaining compensation expense over a weighted-average period of twelve (<span id="xdx_902_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dtM_c20230101__20231231_zTw2TkjFDJNk" title="Weighted-average period">12</span>) months.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There were <span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_do_c20230101__20231231_zum2gfWcsz28" title="Number of options granted"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_do_c20220101__20221231_zi48Wingysu7" title="Number of options granted">no</span></span> options granted during the year ended December 31, 2023 or 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Restricted Stock Awards</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company may grant restricted stock awards to eligible individuals in connection with their service to the Company. The terms of the Company’s outstanding restricted stock grants may include service, performance and market-based conditions. The fair value of the awards with market-based conditions is determined using a Monte Carlo simulation method, which calculates many potential outcomes for an award and then establishes fair value based on the most likely outcome. The determination of fair value with respect to the awards with only performance or service-based conditions is based on the value of the Company’s stock on the grant date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89B_eus-gaap--NonvestedRestrictedStockSharesActivityTableTextBlock_zIuL0kK52Rhh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information with respect to the activity of unvested restricted stock awards during the year ended December 31, 2023 is as follows (share amounts not in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B5_zYp8nFeDaLP4" style="display: none">SCHEDULE OF ACTIVITY OF UNVESTED RESTRICTED STOCK AWARDS</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted-</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Restricted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stock Awards </b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted-</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Grant Date</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fair Value</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; font-style: italic"> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%">Nonvested at January 1, 2022</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_pid_c20220101__20221231_znDxRjZG8s87" style="width: 16%; text-align: right" title="Weighted-Number of Restricted Stock Awards, Beginning balance">15,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pid_c20220101__20221231_zbg6gnP4ahb1" style="text-align: right" title="Weighted-Number of Restricted Stock Awards, Granted">32,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20220101__20221231_zvi3fxYQo5f6" style="text-align: right" title="Weighted-Average Grant Date Fair Value, Granted">3.57</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Vested</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_pid_di_c20220101__20221231_znT1oQaxda5" style="text-align: right" title="Weighted-Number of Restricted Stock Awards, Vested">(12,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Forfeited</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_iN_pid_di_c20220101__20221231_zedyx8X6Tao4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted-Number of Restricted Stock Awards, Forfeited">(12,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_pid_c20220101__20221231_z21pDb3D28L3" style="padding-bottom: 1.5pt; text-align: right" title="Weighted-Average Grant Date Fair Value, Forfeited">3.57</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Nonvested at December 31, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_pid_c20230101__20231231_zzj84uNLnYuf" style="padding-bottom: 1.5pt; text-align: right" title="Weighted-Number of Restricted Stock Awards, Beginning balance">23,000</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pid_c20230101__20231231_zFHRyRh2Snf5" style="text-align: right" title="Weighted-Number of Restricted Stock Awards, Granted">100,647</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20230101__20231231_zj9QevQkGk5j" style="text-align: right" title="Weighted-Average Grant Date Fair Value, Granted">2.37</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Vested</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_pid_di_c20230101__20231231_zAQZFq3afMCe" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted-Number of Restricted Stock Awards, Vested">(77,574</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td id="xdx_988_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_pid_c20230101__20231231_zdiALBkzi4Y5" style="padding-bottom: 1.5pt; text-align: right" title="Weighted-Average Grant Date Fair Value, Vested">2.37</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Nonvested at December 31, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_pid_c20230101__20231231_zHwMJNaxVTqb" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted-Number of Restricted Stock Awards, Ending balance">46,073</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AB_zjzvAd0tcnYg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compensation expense recognized for the years ended December 31, 2023 and 2022 totaled $<span id="xdx_90C_eus-gaap--AllocatedShareBasedCompensationExpense_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zVSgL1xST7H" title="Compensation expense">238,000</span> and $<span id="xdx_90D_eus-gaap--AllocatedShareBasedCompensationExpense_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zhGzNQuBGa68" title="Compensation expense">69,000</span>, respectively, and is included in general and administrative expenses. At December 31, 2023 and 2022, there was approximately $<span id="xdx_90C_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_iI_c20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zdQmLL4KoxX7" title="Unrecognized compensation expense, non-vested stock options">133,000</span> and $<span id="xdx_901_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_iI_c20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zDinR6S6oAr2" title="Unrecognized compensation expense, non-vested stock options">121,000</span>, respectively, of unrecognized compensation expense related to non-vested restricted stock granted under the Plans. The Company expects to recognize the remaining compensation expense over a weighted-average period of seven (7) months.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 33.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> 1000000 100647 895353 11750 P10Y <p id="xdx_89B_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_z4O6USUcD3E" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A summary of the stock option activity for the years ended December 31, 2023 and 2022 is as follows (option amounts not in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B3_zQKJU9XCQ898" style="display: none">SCHEDULE OF STOCK OPTION ACTIVITY</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of Options</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted-</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Price</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted- Average Remaining Contractual Term</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Aggregate Intrinsic Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; padding-bottom: 2.5pt">Outstanding at December 31, 2022</td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20220101__20221231_zCxG1pbALWKf" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Number of Options, Outstanding, Beginning Balance">871,250</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; width: 1%; text-align: left">$</td><td style="padding-bottom: 2.5pt; width: 11%; text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20220101__20221231_zPcHym5lvjTd" title="Weighted-Average Exercise Price, Outstanding, Beginning Balance">4.67</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; width: 1%; text-align: left"> </td><td style="padding-bottom: 2.5pt; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231_zpofwqYRjQLd" title="Weighted-Average Remaining Contractual Term, Outstanding">5.8</span> years</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_c20220101__20221231_zKux1ozCr5Tg" style="padding-bottom: 2.5pt; width: 11%; text-align: right" title="Aggregate Intrinsic Value"><span style="-sec-ix-hidden: xdx2ixbrl1035">-</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Exercisable at December 31, 2022</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iS_pid_c20220101__20221231_z1nQDaKVN9Pe" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Exercisable, Beginning Balance">721,250</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iS_pid_c20220101__20221231_zof20AcuDbS9" title="Weighted-Average Exercise Price, Exercisable, Beginning Balance">4.39</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20220101__20221231_zuRkuZfMRPaf" title="Weighted-Average Remaining Contractual Term, Exercisable">5.3</span> years</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iS_c20220101__20221231_zGOWwJGcIuC5" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value"><span style="-sec-ix-hidden: xdx2ixbrl1043">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Outstanding at December 31, 2022</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20230101__20231231_zqq9XILNciza" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Outstanding, Beginning Balance">871,250</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230101__20231231_zziBNMHkq4P8" title="Weighted-Average Exercise Price, Outstanding, Beginning Balance">4.67</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231_zFBcDeODz537" title="Weighted-Average Remaining Contractual Term, Outstanding">5.8</span> years</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_c20230101__20231231_zQbcnP10zpjh" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value">     <span style="-sec-ix-hidden: xdx2ixbrl1051">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Forfeited</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_c20230101__20231231_z9AwlTNoFfPg" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Forfeited">(25,000</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_iN_pid_di_c20230101__20231231_zbxtbPbeQiB7" title="Weighted-Average Exercise Price, Forfeited">(6.00</span></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Outstanding at December 31, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20230101__20231231_zGyxFUtsnPfk" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options Outstanding, Ending Balance">846,250</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20230101__20231231_zcXofZ8xBdC9" title="Weighted-Average Exercise Price, Outstanding, Ending Balance">4.63</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231_zIRq7OkWiJvd" title="Weighted-Average Remaining Contractual Term, Outstanding">4.8</span> years</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_c20230101__20231231_zkOcF4DMZcVk" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value"><span style="-sec-ix-hidden: xdx2ixbrl1063">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Exercisable at December 31, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20230101__20231231_zOLMBoRKsK36" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options Exercisable, Ending Balance">783,750</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20230101__20231231_zC6xXnoARLz1" title="Weighted-Average Exercise Price, Exercisable, Ending Balance">4.52</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230101__20231231_zbdBnbzT9CHb" title="Weighted-Average Remaining Contractual Term, Exercisable">4.6</span> years</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_c20230101__20231231_zPjBNGWlbefe" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value"><span style="-sec-ix-hidden: xdx2ixbrl1071">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 871250 4.67 P5Y9M18D 721250 4.39 P5Y3M18D 871250 4.67 P5Y9M18D 25000 6.00 846250 4.63 P4Y9M18D 783750 4.52 P4Y7M6D 20000 58000 20000 48000 P12M 0 0 <p id="xdx_89B_eus-gaap--NonvestedRestrictedStockSharesActivityTableTextBlock_zIuL0kK52Rhh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information with respect to the activity of unvested restricted stock awards during the year ended December 31, 2023 is as follows (share amounts not in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B5_zYp8nFeDaLP4" style="display: none">SCHEDULE OF ACTIVITY OF UNVESTED RESTRICTED STOCK AWARDS</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted-</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Restricted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stock Awards </b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted-</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Grant Date</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fair Value</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; font-style: italic"> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%">Nonvested at January 1, 2022</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_pid_c20220101__20221231_znDxRjZG8s87" style="width: 16%; text-align: right" title="Weighted-Number of Restricted Stock Awards, Beginning balance">15,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pid_c20220101__20221231_zbg6gnP4ahb1" style="text-align: right" title="Weighted-Number of Restricted Stock Awards, Granted">32,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20220101__20221231_zvi3fxYQo5f6" style="text-align: right" title="Weighted-Average Grant Date Fair Value, Granted">3.57</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Vested</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_pid_di_c20220101__20221231_znT1oQaxda5" style="text-align: right" title="Weighted-Number of Restricted Stock Awards, Vested">(12,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Forfeited</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_iN_pid_di_c20220101__20221231_zedyx8X6Tao4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted-Number of Restricted Stock Awards, Forfeited">(12,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_pid_c20220101__20221231_z21pDb3D28L3" style="padding-bottom: 1.5pt; text-align: right" title="Weighted-Average Grant Date Fair Value, Forfeited">3.57</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Nonvested at December 31, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_pid_c20230101__20231231_zzj84uNLnYuf" style="padding-bottom: 1.5pt; text-align: right" title="Weighted-Number of Restricted Stock Awards, Beginning balance">23,000</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pid_c20230101__20231231_zFHRyRh2Snf5" style="text-align: right" title="Weighted-Number of Restricted Stock Awards, Granted">100,647</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20230101__20231231_zj9QevQkGk5j" style="text-align: right" title="Weighted-Average Grant Date Fair Value, Granted">2.37</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Vested</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_pid_di_c20230101__20231231_zAQZFq3afMCe" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted-Number of Restricted Stock Awards, Vested">(77,574</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td id="xdx_988_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_pid_c20230101__20231231_zdiALBkzi4Y5" style="padding-bottom: 1.5pt; text-align: right" title="Weighted-Average Grant Date Fair Value, Vested">2.37</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Nonvested at December 31, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_pid_c20230101__20231231_zHwMJNaxVTqb" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted-Number of Restricted Stock Awards, Ending balance">46,073</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 15000 32000 3.57 12000 12000 3.57 23000 100647 2.37 77574 2.37 46073 238000 69000 133000 121000 <p id="xdx_80E_ecustom--NetWorthForRegulatoryPurposesTextBlock_z81HOQRj0qi6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>12. <span id="xdx_823_z7LY8HQ2gkf3">NET WORTH FOR REGULATORY PURPOSES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 33.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The subsidiaries are subject to a minimum and prescribed capital requirement as established by CIMA. <span id="xdx_90D_ecustom--StatutoryAccountingPracticeStatutoryCapitalAndSurplusRequired_c20230101__20231231_zgP6lnctDTMc" title="Minimum prescribed capital requirement description">Under the terms of their respective licenses, Oxbridge Reinsurance Limited and Oxbridge Re NS are required to maintain a minimum and prescribed capital requirement of $500 in accordance with the relevant subsidiary’s approved business plan filed with CIMA.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 33.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 33.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At December 31, 2023, the Oxbridge Reinsurance Limited’s net worth of $<span id="xdx_90D_eus-gaap--StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance_iI_pn3n3_c20231231__dei--LegalEntityAxis__custom--OxbridgeReinsuranceLimitedMember_zBRAT3GReffl" title="Subsidiary net worth">10</span> thousand exceeded the minimum and prescribed capital requirement. For the years ended December 31, 2023 and 2022, Oxbridge Reinsurance Ltd.’s net loss was approximately $<span id="xdx_90F_eus-gaap--IncomeLossFromSubsidiariesNetOfTax_pn4n6_c20230101__20231231__dei--LegalEntityAxis__custom--OxbridgeReinsuranceLimitedMember_zVMg3M8UR1Dl" title="Subsidiary's net (loss) income">11.29</span> million and $<span id="xdx_904_eus-gaap--IncomeLossFromSubsidiariesNetOfTax_pn5n6_c20220101__20221231__dei--LegalEntityAxis__custom--OxbridgeReinsuranceLimitedMember_z36keeuUMvH9" title="Subsidiary's net (loss) income">2.0</span> million, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 33.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 33.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At December 31, 2023, the Oxbridge Re NS’ net worth of $<span id="xdx_909_eus-gaap--StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance_iI_pn3n3_c20231231__dei--LegalEntityAxis__custom--OxbridgeReNSMember_zqL586auzCu9">223 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">thousand exceeded the minimum and prescribed capital requirement. For the years ended December 31, 2023 and 2022, Oxbridge Re NS’ net income was approximately $<span id="xdx_90E_eus-gaap--IncomeLossFromSubsidiariesNetOfTax_c20230101__20231231__dei--LegalEntityAxis__custom--OxbridgeReNSMember_zGHDUmdxpGEa" title="Net income">68,000</span> and $<span id="xdx_90B_eus-gaap--IncomeLossFromSubsidiariesNetOfTax_c20220101__20221231__dei--LegalEntityAxis__custom--OxbridgeReNSMember_zbUXJ24R3Mn5" title="Net income">11,000</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 33.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 33.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Subsidiaries are not required to prepare separate statutory financial statements for filing with CIMA, and there were no material differences between the Subsidiaries’ GAAP capital, surplus and net income, and its statutory capital, surplus and net income as of December 31, 2023 or for the year then ended.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 33.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> Under the terms of their respective licenses, Oxbridge Reinsurance Limited and Oxbridge Re NS are required to maintain a minimum and prescribed capital requirement of $500 in accordance with the relevant subsidiary’s approved business plan filed with CIMA. 10000 11290000 2000000.0 223000 68000 11000 <p id="xdx_80E_eus-gaap--FairValueDisclosuresTextBlock_zEAsBdklTmy8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>13. <span id="xdx_829_zx6Mk7a5oybj">FAIR VALUE AND CERTAIN RISKS AND UNCERTAINTIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fair values</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With the exception of balances in respect of insurance contracts (which are specifically excluded from fair value disclosures under GAAP) and investment securities as disclosed in Note 4 of these consolidated financial statements, the carrying amounts of all other financial instruments, which consist of cash and cash equivalents, restricted cash and cash equivalents, premiums receivable and other assets, loan receivable, notes payable, and accounts payable and other liabilities, approximate their fair values due to their short-term nature.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Concentration of underwriting risk</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A substantial portion of the Company’s current reinsurance business ultimately relates to the risks of a limited number of entities; accordingly, the Company’s underwriting risks are not diversified.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Concentrations of Credit and Counterparty Risk</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 33.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company markets retrocessional and reinsurance policies worldwide through its brokers. Credit risk exists to the extent that any of these brokers may be unable to fulfill their contractual obligations to the Company. For example, the Company is required to pay amounts owed on claims under policies to brokers, and these brokers, may fail to pay over the money to the cedants. In some jurisdictions, if a broker fails to make such a payment, the Company might remain liable to the ceding company for the deficiency. In addition, in certain jurisdictions, when the ceding company pays premiums for these policies to brokers, these premiums are considered to have been paid and the ceding insurer is no longer liable to the Company for those amounts, whether or not the premiums have actually been received.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 33.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 33.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company remains liable for losses it incurs to the extent that any third-party reinsurer is unable or unwilling to make timely payments under reinsurance agreements. The Company would also be liable in the event that its ceding companies were unable to collect amounts due from underlying third-party reinsurers.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 33.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 33.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company mitigates its concentration of credit risk and counterparty risk by using reputable several counterparties which decreases the likelihood of any significant concentration of credit risk with any one counterparty.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Market risk</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Market risk exists to the extent that the values of the Company’s monetary assets fluctuate as a result of changes in market prices. Changes in market prices can arise from factors specific to individual securities or their respective issuers, or factors affecting all securities traded in a particular market. Relevant factors for the Company are both volatility and liquidity of specific securities and markets in which the Company holds investments. The Company has established investment guidelines that seek to mitigate significant exposure to market risk.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_801_eus-gaap--LesseeOperatingLeasesTextBlock_zRt9OtjXnaW7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>14. <span id="xdx_823_zRvZeSWF9Bj4">LEASES </span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating lease right-of-use assets and operating lease liabilities are recognized in the consolidated balance sheets. We determine if a contract contains a lease at inception and recognize operating lease right-of-use assets and operating lease liabilities based on the present value of the future minimum lease payments at the commencement date. As our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at the commencement date in determining the present value of future payments. Lease agreements that have lease and non-lease components, are accounted for as a single lease component. Lease expense is recognized on a straight-line basis over the lease term.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has two operating lease obligations namely for the Company’s office facilities located at Suite 201, 42 Edward Street Grand Cayman, Cayman Islands and residential space at Turnberry Villas in Grand Cayman, Cayman Islands. The office lease has a remaining lease term of approximately two (<span id="xdx_90C_eus-gaap--LesseeOperatingLeaseRemainingLeaseTerm_iI_dtM_c20231231__us-gaap--LeaseContractualTermAxis__custom--OfficeLeaseMember_z9z9FUgDYGPh" title="Remaining lease term">2</span>) month and was renewed subsequent to year end for a period of five (<span id="xdx_90D_eus-gaap--LesseeOperatingLeaseRenewalTerm_iI_dtY_c20231231__us-gaap--LeaseContractualTermAxis__custom--OfficeLeaseMember_zQK2hOrx1Qfd" title="Renewal term">5</span>) years. The residential lease has a remaining lease term of less than <span id="xdx_90D_eus-gaap--LesseeOperatingLeaseRemainingLeaseTerm_iI_dtM_c20231231__us-gaap--LeaseContractualTermAxis__custom--ResidentialLeaseMember_zSjQ4iUg9UUh" title="Remaining lease term">1</span> month and was renewed subsequent to year end for a period of three (<span id="xdx_906_eus-gaap--LesseeOperatingLeaseRenewalTerm_iI_dtY_c20231231__us-gaap--LeaseContractualTermAxis__custom--ResidentialLeaseMember_zRCRktebh6Of" title="Renewal term">3</span>) years.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_896_eus-gaap--LeaseCostTableTextBlock_zl0yb46mlz8d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The components of lease expense and other lease information as of and during the years ended December 31, 2023 and 2022 are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BB_zT7JphVBK9Ad" style="display: none">SCHEDULE OF OPERATING LEASE COST</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">(in thousands)</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_491_20230101__20231231_zOdnVrxR3xsh" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_493_20220101__20221231_zrPtluld52ui" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Year Ended December 31,</b></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">(in thousands)</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_408_eus-gaap--OperatingLeaseCost_pn3n3_zxkRj54PKRRf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating Lease Cost <sup id="xdx_F40_zDsoBC4GmSYb">(1)</sup></span></td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">108</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">96</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Cash paid for amounts included in the measurement of lease liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--OperatingLeasePayments_pn3n3_zEJh9yrdHSok" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">Operating cash flows from operating leases</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">108</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">96</td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: right"><span id="xdx_F0C_zzIFLSpzrQZc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1) </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F18_zOu7tYuWKKo1" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Includes short-term leases</span></td></tr> </table> <p id="xdx_8A2_zkox1LY33op7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_891_ecustom--ScheduleOfOperatingLeaseObligationsTableTextBlock_zKE5sSHNDZd3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; display: none; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B2_zA7uj1yFMOHe" style="display: none">SCHEDULE OF OPERATING LEASE OBLIGATIONS</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">(in thousands)</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20231231_znLrhZuVerg1" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49E_20221231_zmWQwmH7C6gj" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">At December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">(in thousands)</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_406_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pn3n3_zJU8vivjllYi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Operating lease right-of-use assets</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">9</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">44</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--OperatingLeaseLiability_iI_pn3n3_zN0L1Ewgph66" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Operating lease liabilities</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">9</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">44</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Weighted-average remaining lease term - operating leases</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20231231_zeFXg2NaXkr8" title="Weighted-average remaining lease term - operating leases">0.39</span> years </span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20221231_zU3LqHi0uCVa" title="Weighted-average remaining lease term - operating leases">1.17</span> years</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_zOSgpjYbwZh6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Weighted-average discount rate - operating leases</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7.13</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6.5</td><td style="text-align: left">%</td></tr> </table> <p id="xdx_8A0_zxVgwADM7W37" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89B_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zqxnOrKYxnE" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future minimum lease payments under non-cancellable leases as of December 31, 2023 and 2022, reconciled to our discounted operating lease liability presented on the consolidated balance sheets are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B0_zPN5qrT94D9c" style="display: none">SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">(in thousands)</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_493_20231231_zFiRzRhiAJh3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20221231_zRZk2KT8itZ3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">At December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">(in thousands)</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_405_ecustom--LesseeOperatingLeaseLiabilityPaymentsDuePrevioulyReported_iI_pn3n3_maLOLLPzFM0_zrPqYO33ssa6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">2023</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1185">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">40</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pn3n3_maLOLLPzFM0_zSNz8odmCZWg" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">2024</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">         9</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">       6</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pn3n3_mtLOLLPzFM0_znKQSQ9R4el4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Total future minimum lease payments</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">9</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">46</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pn3n3_di_ztUV0KVZRxbl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Less imputed interest</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1194">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_409_eus-gaap--OperatingLeaseLiability_iI_pn3n3_zBaT6E80o4w" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total operating lease liabilities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">9</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">44</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AE_zTHLQjdgpuw4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> P2M P5Y P1M P3Y <p id="xdx_896_eus-gaap--LeaseCostTableTextBlock_zl0yb46mlz8d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The components of lease expense and other lease information as of and during the years ended December 31, 2023 and 2022 are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BB_zT7JphVBK9Ad" style="display: none">SCHEDULE OF OPERATING LEASE COST</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">(in thousands)</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_491_20230101__20231231_zOdnVrxR3xsh" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_493_20220101__20221231_zrPtluld52ui" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Year Ended December 31,</b></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">(in thousands)</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_408_eus-gaap--OperatingLeaseCost_pn3n3_zxkRj54PKRRf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating Lease Cost <sup id="xdx_F40_zDsoBC4GmSYb">(1)</sup></span></td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">108</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">96</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Cash paid for amounts included in the measurement of lease liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--OperatingLeasePayments_pn3n3_zEJh9yrdHSok" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">Operating cash flows from operating leases</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">108</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">96</td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: right"><span id="xdx_F0C_zzIFLSpzrQZc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1) </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F18_zOu7tYuWKKo1" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Includes short-term leases</span></td></tr> </table> 108000 96000 108000 96000 <p id="xdx_891_ecustom--ScheduleOfOperatingLeaseObligationsTableTextBlock_zKE5sSHNDZd3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; display: none; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B2_zA7uj1yFMOHe" style="display: none">SCHEDULE OF OPERATING LEASE OBLIGATIONS</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">(in thousands)</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20231231_znLrhZuVerg1" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49E_20221231_zmWQwmH7C6gj" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">At December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">(in thousands)</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_406_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pn3n3_zJU8vivjllYi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Operating lease right-of-use assets</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">9</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">44</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--OperatingLeaseLiability_iI_pn3n3_zN0L1Ewgph66" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Operating lease liabilities</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">9</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">44</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Weighted-average remaining lease term - operating leases</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20231231_zeFXg2NaXkr8" title="Weighted-average remaining lease term - operating leases">0.39</span> years </span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20221231_zU3LqHi0uCVa" title="Weighted-average remaining lease term - operating leases">1.17</span> years</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_zOSgpjYbwZh6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Weighted-average discount rate - operating leases</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7.13</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6.5</td><td style="text-align: left">%</td></tr> </table> 9000 44000 9000 44000 P0Y4M20D P1Y2M1D 0.0713 0.065 <p id="xdx_89B_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zqxnOrKYxnE" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future minimum lease payments under non-cancellable leases as of December 31, 2023 and 2022, reconciled to our discounted operating lease liability presented on the consolidated balance sheets are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B0_zPN5qrT94D9c" style="display: none">SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">(in thousands)</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_493_20231231_zFiRzRhiAJh3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20221231_zRZk2KT8itZ3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">At December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">(in thousands)</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_405_ecustom--LesseeOperatingLeaseLiabilityPaymentsDuePrevioulyReported_iI_pn3n3_maLOLLPzFM0_zrPqYO33ssa6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">2023</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1185">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">40</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pn3n3_maLOLLPzFM0_zSNz8odmCZWg" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">2024</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">         9</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">       6</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pn3n3_mtLOLLPzFM0_znKQSQ9R4el4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Total future minimum lease payments</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">9</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">46</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pn3n3_di_ztUV0KVZRxbl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Less imputed interest</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1194">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_409_eus-gaap--OperatingLeaseLiability_iI_pn3n3_zBaT6E80o4w" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total operating lease liabilities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">9</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">44</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 40000 9000 6000 9000 46000 2000 9000 44000 <p id="xdx_80C_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_z23eYb14E5kd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>15. <span id="xdx_826_zLgQxT2VXPB8">RELATED PARTY TRANSACTIONS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Administrative Services Agreement</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_ecustom--AdministrativeServicesAgreementDescription_c20230101__20231231__us-gaap--TypeOfArrangementAxis__custom--AdministrativeServicesAgreementMember_zyjnNKbu04ni" title="Administrative services agreement description">Commencing on the effective date of the SPAC’s IPO, the Sponsor agreed to pay the Company a total of up to $10,000</span> per month for office space, utilities, secretarial and administrative support to the Sponsor and the SPAC. Upon completion of the SPAC’s initial Business Combination or the SPAC’s liquidation, the Sponsor will cease paying these monthly fees. For the years ended December 31, 2023 and 2022, the company recorded income of $<span id="xdx_90A_eus-gaap--AdministrativeFeesExpense_c20230101__20231231__us-gaap--TypeOfArrangementAxis__custom--AdministrativeServicesAgreementMember_zRUYAorykgO8" title="Administrative fees expense">80,000</span> and $<span id="xdx_90B_eus-gaap--AdministrativeFeesExpense_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--AdministrativeServicesAgreementMember_zmIOPjyAXuI5" title="Administrative fees expense">90,000</span>, respectively, from the Sponsor under the Administrative Services Agreement, which is included in “net investment and other income” in the consolidated statements of operations. At December 31, 2023, the Company recorded a receivable of $<span id="xdx_90E_eus-gaap--OtherReceivables_iI_c20231231__us-gaap--RelatedPartyTransactionAxis__us-gaap--RelatedPartyMember_zPxD2IXAOPB3" title="Due from related parties">62,000</span> relating to the Oxbridge Reinsurance portion of the working capital loan which is included in “due from related parties” in the consolidated balance sheets. At December 31, 2022, the Company recorded a receivable of $<span id="xdx_90F_eus-gaap--OtherReceivables_iI_c20221231__us-gaap--RelatedPartyTransactionAxis__us-gaap--RelatedPartyMember_zmieTa49Lgoe" title="Due from related parties">45,000</span> which is included in “due from related parties” in the consolidated balance sheets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Participating Notes</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ending December 31, 2021, Mr. Jay Madhu, a director and officer of the Company and its subsidiaries, invested a principal amount of $<span id="xdx_902_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20211231__srt--TitleOfIndividualAxis__custom--MrJayMadhuMember_zhOdEuxllWZj">68,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in Series 2020-1 participating notes. During the year ended December 31, 2023, Mr. Madhu received a payment of $<span id="xdx_907_eus-gaap--ProceedsFromRelatedPartyDebt_c20230101__20231231__srt--TitleOfIndividualAxis__custom--MrJayMadhuMember_zjaSTik39uKh">76,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">representing partial redemption of principal and return on investment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>DeltaCat Re Tokens</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2023, Mr. Jay Madhu, a director and officer of the Company and its subsidiaries, entered into subscription agreement to purchase a total of <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20230101__20231231__srt--TitleOfIndividualAxis__custom--MrJayMadhuMember_zQqzLIpdEj39" title="Number of shares issued">6,200</span> Series DeltaCat Re tokens at a purchase price of $<span id="xdx_905_eus-gaap--SharesIssuedPricePerShare_iI_pid_uUSDPShares_c20231231__srt--TitleOfIndividualAxis__custom--MrJayMadhuMember_zansAtXs3ehl" title="Shares issued, price per share">10.00</span> per token for aggregate gross proceeds of $<span id="xdx_90F_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20230101__20231231__srt--TitleOfIndividualAxis__custom--MrJayMadhuMember_zEEwVWf3Nyt3" title="Aggregate purchase price">62,000</span>. Ownership of DeltaCat Re tokenized reinsurance securities indirectly confers fractionalized interests in reinsurance contracts underwritten by Oxbridge Re NS for the 2023-2024 treaty year.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>TypTap Insurance Company (“TypTap”) Contract</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2023 the Company entered into a reinsurance agreement with TypTap, an insurance subsidiary of HCI Group, Inc., which is a related entity through common directorship. At December 31, 2023, included within premium receivable, deferred acquisition costs and unearned premiums on the consolidated balance sheets are amounts equal to $<span id="xdx_900_eus-gaap--PremiumsReceivableAtCarryingValue_iI_c20231231__us-gaap--TypeOfArrangementAxis__custom--ReinsuranceAgreementMember_zHTAUukIApig" title="Premiums receivable">489,000</span>, $<span id="xdx_902_eus-gaap--DeferredPolicyAcquisitionCosts_iI_c20231231__us-gaap--TypeOfArrangementAxis__custom--ReinsuranceAgreementMember_z6GpCcPgG4c" title="Deferred acquisition cost">50,000</span> and $<span id="xdx_90B_eus-gaap--UnearnedPremiums_iI_c20231231__us-gaap--TypeOfArrangementAxis__custom--ReinsuranceAgreementMember_zQ5nrmn9Ejj6" title="Unearned premiums">458,000</span> respectively, relating to the reinsurance agreement with TypTap. During the year ended December 31, 2023, included within assumed premiums, change in unearned premium reserve and policy acquisition costs and underwriting expenses on the consolidated statements of operations are amounts equal to $<span id="xdx_905_eus-gaap--IncreaseDecreaseInPremiumsReceivable_c20230101__20231231__us-gaap--TypeOfArrangementAxis__custom--ReinsuranceAgreementMember_zQ35blDMN4I4" title="Change in unearned premium reserve">1,099,000</span>, ($<span id="xdx_909_eus-gaap--DeferredPolicyAcquisitionCostsAdditions_c20230101__20231231__us-gaap--TypeOfArrangementAxis__custom--ReinsuranceAgreementMember_zjza4JRwyFl5" title="Deferred policy acquisition cost">458,000</span>) and $<span id="xdx_90D_eus-gaap--ForeignReinsuranceTransactionsExpenseAdditionsToUnderwritingBalances_c20230101__20231231__us-gaap--TypeOfArrangementAxis__custom--ReinsuranceAgreementMember_zXdLToBNW7X8" title="Underwriting expenses">70,000</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Bridge Loan with Affiliate</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 11, 2023, the Company, along with seven (7) other investors, entered into a binding term sheet (“Bridge Agreement”) with Jet.AI to provide Jet.AI with an aggregate sum of $<span id="xdx_909_eus-gaap--ShortTermInvestments_iI_c20230911__us-gaap--TypeOfArrangementAxis__custom--BridgeAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zuZU0KCt7AGk" title="Short-term bridge funds">500,000</span> of short-term bridge financing pending its receipt of funds from its other existing financing arrangements. During the month of September 2023, and prior to the Bridge Agreement, Jet.AI had engaged in discussions with numerous third parties to secure short-term bridge funding but was not offered terms it found acceptable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Bridge Agreement provides for the issuance of Notes in an aggregate principal amount of $<span id="xdx_90C_eus-gaap--DebtInstrumentFaceAmount_iI_c20230911__us-gaap--TypeOfArrangementAxis__custom--BridgeAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zVmONa4h36Mi" title="Debt face amount">625,000</span>, reflecting a <span id="xdx_90D_ecustom--PercentageOfOriginalIssueDiscount_iI_pid_dp_uPure_c20230911__us-gaap--TypeOfArrangementAxis__custom--BridgeAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zTMPEjZK25Vj" title="Percentage of original issue discount">20</span>% original issue discount. The Notes bear interest at <span id="xdx_907_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20230911__us-gaap--TypeOfArrangementAxis__custom--BridgeAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zb1Di0F6zBZ" title="Notes interest rate">5</span>% per annum and mature on <span id="xdx_905_eus-gaap--DebtInstrumentMaturityDate_c20230908__20230911__us-gaap--TypeOfArrangementAxis__custom--BridgeAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_z9LcP0w421ge" title="Notes maturity date">March 11, 2024</span>. Jet.AI is required to redeem the <span id="xdx_90F_eus-gaap--DebtInstrumentDescription_c20230911__20230911__us-gaap--TypeOfArrangementAxis__custom--BridgeAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zcGImRV52Xqe" title="Debt, description">Notes with 100% of the proceeds of any equity or debt financing at a redemption premium of 110% of the principal amount of the Notes</span>. Jet.AI anticipates redeeming the Notes in full with proceeds expected to be received over the next several months from existing financing arrangements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An event of default under the Notes includes failing to redeem the Notes as provided above and other typical bankruptcy events of Jet.AI. In an event of default, the outstanding principal amount of the Notes will increase by 120%, and the company may convert its Note into shares of common stock of Jet.AI at the conversion price set forth in the Bridge Agreement with registration rights associated with those shares.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company invested the sum of $<span id="xdx_90C_eus-gaap--PolicyLoansReceivable_iI_c20231231_ztUNoq0CFSg8">100,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in the Notes and is recorded as “Loan Receivable” on the consolidated balance sheets at cost. </span>On March 11, 2024, the Notes matured and were redeemed by Jet.AI in accordance with the Bridge Agreement. The Company receive an aggregate of $<span id="xdx_903_ecustom--RedemptionOfNotesPayable_iI_c20240311__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zF2Zvos1x8Z" title="Redemption of notes payable">140,000</span> upon the redemption of the Notes.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> Commencing on the effective date of the SPAC’s IPO, the Sponsor agreed to pay the Company a total of up to $10,000 80000 90000 62000 45000 68000000 76000 6200 10.00 62000 489000 50000 458000 1099000 458000 70000 500000 625000 0.20 0.05 2024-03-11 Notes with 100% of the proceeds of any equity or debt financing at a redemption premium of 110% of the principal amount of the Notes 100000 140000 <p id="xdx_805_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zVFrX7EHcnz5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>16. <span id="xdx_82F_znkncbu2McP6">PROPERTY AND EQUIPMENT, NET</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89F_eus-gaap--PropertyPlantAndEquipmentTextBlock_zvek16IVbHhf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment, net consist of the following (in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B3_zREqeIRJ4PFd" style="display: none">SCHEDULE OF PROPERTY AND EQUIPMENT,NET</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49A_20231231_zLcZVe890UQ9" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20221231_zDs1gzzlT9K9" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">At December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_408_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_ztx44hHNQDjj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Leasehold improvements</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">21</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">21</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zWvlSpFPtgN6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Furniture and Fixtures</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">41</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">38</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_zkzZ1b9kLb41" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Motor vehicle</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">34</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">34</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zlM0TFgFYmL2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Computer equipment and software</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">39</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">37</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_maPPAENzXxI_zvWn3W4Hfu54" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 20pt">Total, at cost</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">135</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">130</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pn3n3_di_msPPAENzXxI_ztvuzow4Ou0a" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">less accumulated depreciation and amortization</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(131</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(125</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40D_eus-gaap--PropertyPlantAndEquipmentNet_iTI_pn3n3_mtPPAENzXxI_zk70p7AgDWZa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Property and equipment, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A6_zYLrBSmKSrp8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89F_eus-gaap--PropertyPlantAndEquipmentTextBlock_zvek16IVbHhf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment, net consist of the following (in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B3_zREqeIRJ4PFd" style="display: none">SCHEDULE OF PROPERTY AND EQUIPMENT,NET</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49A_20231231_zLcZVe890UQ9" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20221231_zDs1gzzlT9K9" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">At December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_408_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_ztx44hHNQDjj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Leasehold improvements</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">21</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">21</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zWvlSpFPtgN6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Furniture and Fixtures</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">41</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">38</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_zkzZ1b9kLb41" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Motor vehicle</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">34</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">34</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zlM0TFgFYmL2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Computer equipment and software</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">39</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">37</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_maPPAENzXxI_zvWn3W4Hfu54" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 20pt">Total, at cost</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">135</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">130</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pn3n3_di_msPPAENzXxI_ztvuzow4Ou0a" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">less accumulated depreciation and amortization</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(131</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(125</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40D_eus-gaap--PropertyPlantAndEquipmentNet_iTI_pn3n3_mtPPAENzXxI_zk70p7AgDWZa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Property and equipment, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 21000 21000 41000 38000 34000 34000 39000 37000 135000 130000 131000 125000 4000 5000 <p id="xdx_801_eus-gaap--SubsequentEventsTextBlock_zIredKujLO0e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>17. <span id="xdx_821_zGkhDpaAeHdk">SUBSEQUENT EVENTS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We evaluate all subsequent events and transactions for potential recognition or disclosure in our consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other than as disclosed in Notes 9 and 15 above, there were no events subsequent to December 31, 2023 for which disclosure was required.</span></p> <p id="xdx_806_esrt--SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesTextBlock_zZUwHUTsFSkl" style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_825_zoWRclyAir43" style="display: none">Schedule I - Summary of Investments - Other Than Investments in Related Parties</span> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_308_134_z1nvbS6vidvk" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Schedule I - Summary of Investments - Other Than Investments in Related Parties (Details)"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Cost or</td><td style="font-weight: bold"> </td><td> </td> <td colspan="2"> </td><td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Consolidated</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Amortized</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Fair</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Balance Sheet</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Type of investment</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Cost</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left; padding-bottom: 1.5pt">Equity securities</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesCost_iI_pn3n3_c20231231__us-gaap--InvestmentTypeAxis__us-gaap--EquitySecuritiesInvestmentSummaryMember_zWzwjJvSkwrl" style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right" title="Cost or amortized cost">1,926</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesFairValue_iI_pn3n3_c20231231__us-gaap--InvestmentTypeAxis__us-gaap--EquitySecuritiesInvestmentSummaryMember_zaaZICwbN0K5" style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right" title="Fair value">680</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesCarryingAmount_iI_pn3n3_c20231231__us-gaap--InvestmentTypeAxis__us-gaap--EquitySecuritiesInvestmentSummaryMember_zOzDcZD14hKf" style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right" title="Balance sheet value">680</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total investments</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesCost_iI_pn3n3_c20231231_zwvStWuhJwf9" style="border-bottom: Black 2.5pt double; text-align: right" title="Total investments, Cost or amortized cost">1,926</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesFairValue_iI_pn3n3_c20231231_zd15RDmxNuHh" style="border-bottom: Black 2.5pt double; text-align: right" title="Total investments, Fair value">680</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesCarryingAmount_iI_pn3n3_c20231231_zeQ9IrkZ0nng" style="border-bottom: Black 2.5pt double; text-align: right" title="Total investments, Balance sheet value">680</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 1926000 680000 680000 1926000 680000 680000 <p id="xdx_806_eus-gaap--CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock_zNIf1o8a4k2a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_82C_zDyWAimwTKSe">Schedule II - Condensed Financial Information of Registrant</span> </b></span></span></p> <table cellpadding="0" cellspacing="0" id="xdx_304_134_zTHTjStfpxFb" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Schedule II Condensed Balance Sheet Parent Company Only (Details)"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_497_20231231__srt--ConsolidatedEntitiesAxis__srt--ParentCompanyMember_zQCD45B0y249" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_496_20221231__srt--ConsolidatedEntitiesAxis__srt--ParentCompanyMember_zhVFFwOfq8hh" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">At December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_405_eus-gaap--AssetsAbstract_iB_zsZpiECVKued" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pn3n3_zp6DaMxwgmr3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left; padding-left: 10pt">Cash and cash equivalents</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">247</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">931</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--EquitySecuritiesFvNi_iI_pn3n3_z1WMpwTqxtJl" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">Equity securities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">680</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">642</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_iI_pn3n3_zXQosJSwDsNi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt">Investment in subsidiaries</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,757</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">9,389</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--OtherReceivables_iI_pn3n3_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--SubsidiariesMember_zEirzJsy5Y77" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">Due from subsidiaries</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,905</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,872</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--OtherReceivables_iI_pn3n3_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zT0Um4Re4WDa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt">Due from related party</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1309">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">35</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--ReceivablesNetCurrent_iI_pn3n3_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_z0KJWmDTgHwb" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">Loan receivable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">100</p></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1313">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--PrepaidExpenseAndOtherAssets_iI_pn3n3_zXMXdLnwnqd9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt">Prepayment and other assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">82</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">105</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_ecustom--PrepaidOfferingCosts_iI_pn3n3_zxsHm01oUEv3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">Prepaid offering costs</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1318">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">133</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pn3n3_zElWMn9pmwQf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt">Operating lease right-of-use assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">9</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">44</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_zKq8fftrHpE8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Property and equipment, net</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">4</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">5</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--Assets_iI_pn3n3_zu97ZReyeeu" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 30pt">Total assets</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,784</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">15,156</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--LiabilitiesAndStockholdersEquityAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Liabilities and Shareholders’ Equity</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--LiabilitiesAbstract_i01B" style="vertical-align: bottom; background-color: White"> <td>Liabilities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--OperatingLeaseLiability_i02I_pn3n3_zHoB8fYwVazl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt">Operating lease liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">9</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">44</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--OtherLiabilities_i02I_pn3n3_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--SubsidiariesMember_zeR46Rftlu88" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Due to Subsidiary</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right">250</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1340">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--AccountsPayableAndOtherAccruedLiabilities_i02I_pn3n3_zkJdKJ01Lpv9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Accounts payable and other liabilities</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">193</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">123</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--LiabilitiesNoncurrent_i02I_pn3n3_z3eiOIvzLzO4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 30pt">Total liabilities</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">452</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">167</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--StockholdersEquityAbstract_i02B" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Shareholders’ equity:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--CommonStockValue_i03I_pn3n3_z6CFTJlHq67" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 20pt">Ordinary share capital</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--AdditionalPaidInCapital_i03I_pn3n3_zYH7yrS2S5cj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 20pt">Additional paid-in capital</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">32,740</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">32,482</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--RetainedEarningsAccumulatedDeficit_i03I_pn3n3_zQBPBp3QflS1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 20pt">Accumulated Deficit</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(27,414</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(17,499</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_402_eus-gaap--StockholdersEquity_i03I_pn3n3_z2SiwPBm9Tcg" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 20pt">Total shareholders’ equity</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,332</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">14,989</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--LiabilitiesAndStockholdersEquity_i03I_pn3n3_ztNLhwsGugcj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 20pt">Total liabilities and shareholders’ equity</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,784</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">15,156</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SCHEDULE II (continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>OXBRIDGE RE HOLDINGS LIMITED </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONDENSED FINANCIAL INFORMATION OF REGISTRANT</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONDENSED STATEMENTS OF OPERATIONS - PARENT COMPANY ONLY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(expressed in thousands of U.S. Dollars)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_30D_134_zRvIkPagn5bf" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Schedule II Condensed Statements of Income Parent Company Only (Details)"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_496_20230101__20231231__srt--ConsolidatedEntitiesAxis__srt--ParentCompanyMember_zwihORNENFo5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49E_20220101__20221231__srt--ConsolidatedEntitiesAxis__srt--ParentCompanyMember_zRXdgbZghGn5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Years Ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_40C_eus-gaap--RevenuesAbstract_iB_zXUU7GfGMIY8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Revenue</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--InvestmentIncomeNet_pn3n3_zGwl6CHYNud4" style="vertical-align: bottom; background-color: White"> <td style="width: 60%; text-align: left">Net investment income</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">71</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">47</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--EquitySecuritiesFvNiGainLoss_pn3n3_zDUkIU9nAs59" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Change in fair value of equity securities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">38</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(338</td><td style="text-align: left">)</td></tr> <tr id="xdx_402_eus-gaap--RealizedInvestmentGainsLosses_pn3n3_zKONvg9hcpX2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Net realized investment gain</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1375">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">27</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--ManagementFeeExpense_pn3n3_zFzK6JGdmfT1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Management fees and other income</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,978</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,883</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--OperatingExpenses_pn3n3_zSDy5otZsCel" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Operating expenses</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,912</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,406</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_407_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_pn3n3_zchyRmpOgUa4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt">Income before equity in loss of subsidiaries</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,175</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">213</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_ecustom--GainLossFromEquityMethodInvestments_pn3n3_zYllKZvaikaf" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Equity in loss of subsidiaries</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(11,090</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,002</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--NetIncomeLoss_pn3n3_zchc0wrPQkc3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 10pt">Net loss</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(9,915</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">(1,789</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SCHEDULE II (continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>OXBRIDGE RE HOLDINGS LIMITED </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONDENSED FINANCIAL INFORMATION OF REGISTRANT</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONDENSED STATEMENT OF CASH FLOWS - PARENT COMPANY ONLY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(expressed in thousands of U.S. Dollars)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_30B_134_z4FaETDfww6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Schedule II Condensed Statement of Cash Flows - Parent Company Only (Details)"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_491_20230101__20231231__srt--ConsolidatedEntitiesAxis__srt--ParentCompanyMember_zVi1PttPzTJ2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2023</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_497_20220101__20221231__srt--ConsolidatedEntitiesAxis__srt--ParentCompanyMember_zJLaN5w8b4J5" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2022</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Years Ended December 31,</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2023</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2022</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40D_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Operating activities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--NetIncomeLoss_i01_pn3n3_zdpDU2lFMk8l" style="vertical-align: bottom; background-color: White"> <td style="width: 60%; text-align: left; padding-left: 10pt">Net loss</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(9,915</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">(1,789</td><td style="width: 1%; text-align: left">)</td></tr> <tr id="xdx_405_eus-gaap--AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_i01B" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Adjustments to reconcile net loss to net cash provided by (used in) operating activities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--IncomeLossFromEquityMethodInvestments_i02N_pn3n3_di_zuZ7uC5kzntj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">Equity in loss of subsidiaries</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">11,090</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,002</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--ShareBasedCompensation_i02_pn3n3_zwiyhCjM1t1j" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt">Share-based compensation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">258</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">127</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--UnderwritingIncomeLoss_i02_pn3n3_zZZZPFHZlq3l" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">Underwriting Income – SurancePlus</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(494</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1409">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--Depreciation_i02_pn3n3_zPg5uo1kEa35" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">Depreciation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--RealizedInvestmentGainsLosses_i02N_pn3n3_di_zfX1d0cTZCUe" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">Net realized investment gain</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1414">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(27</td><td style="text-align: left">)</td></tr> <tr id="xdx_40F_eus-gaap--EquitySecuritiesFvNiGainLoss_i02N_pn3n3_di_zNe6dN2ThS8f" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt">Change in fair value of equity securities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(38</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">338</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--IncreaseDecreaseInOperatingCapitalAbstract_i02B" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Change in operating assets and liabilities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--IncreaseDecreaseInDueFromAffiliatesCurrent_i03N_pn3n3_di_zKe1LcYvjlP4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 20pt">Due from subsidiary</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">967</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,763</td><td style="text-align: left">)</td></tr> <tr id="xdx_406_eus-gaap--IncreaseDecreaseInDueFromRelatedParties_i03N_pn3n3_di_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zIz3C6bAUWx8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 20pt">Due from related party</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">35</td><td style="text-align: left"></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(30</td><td style="text-align: left">)</td></tr> <tr id="xdx_405_eus-gaap--IncreaseDecreaseInDueToEmployeesCurrent_i03_pn3n3_zQajdFOJ53la" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 20pt">Due to subsidiary</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">250</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1430">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_i03N_pn3n3_di_zNvpllOY5RUc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 20pt">Prepayment and other assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">23</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(55</td><td style="text-align: left">)</td></tr> <tr id="xdx_406_ecustom--IncreaseDecreaseInPrepaidOfferingCosts_i03N_pn3n3_di_zgOflg4p6Fr4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 20pt">Prepaid offering costs</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">133</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(133</td><td style="text-align: left">)</td></tr> <tr id="xdx_40A_eus-gaap--IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities_i03_pn3n3_zWKixmTjbiOh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 20pt">Accounts payable and other liabilities</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">70</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(87</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i03_pn3n3_z8ggA9OJnnfc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Net cash provided by (used in) operating activities</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,385</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,413</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_i03B" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left">Investing activities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--PaymentsToAcquireEquitySecuritiesFvNi_i04N_pn3n3_di_z4S9PrhAmk23" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Purchase of equity securities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1447">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,002</td><td style="text-align: left">)</td></tr> <tr id="xdx_403_eus-gaap--PaymentsToAcquireLoansReceivable_i04N_pn3n3_di_zp6sWqcuc8ie" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Purchase of loan receivable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(100</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1451">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_ecustom--InvestmentInSubsidiary_iN_di_zMq5Lmrj5qdl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Investment in subsidiary</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(2,964</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(507</td><td style="text-align: left">)</td></tr> <tr id="xdx_402_eus-gaap--ProceedsFromSaleOfEquitySecuritiesFvNi_i04_pn3n3_zQ9Nz5QHalff" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Proceeds from sale of equity securities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1456">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">626</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_i04N_pn3n3_di_zUbOjuQFghl6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Purchase of property and equipment</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(5</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1460">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--NetCashProvidedByUsedInInvestingActivities_i04_pn3n3_zVO1CdiaTzH" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Net cash used in investing activities</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,069</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(883</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_i04_pn3n3_zeixUbYGWrjb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Net change in cash and cash equivalents</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(684</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(2,296</td><td style="text-align: left">)</td></tr> <tr id="xdx_401_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_i04S_pn3n3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Cash and cash equivalents at beginning of year</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">931</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,227</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_i04E_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Cash and cash equivalents at end of year</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">247</td><td style="padding-bottom: 1.5pt; text-align: left"></td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">931</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> 247000 931000 680000 642000 1757000 9389000 2905000 3872000 35000 100000 82000 105000 133000 9000 44000 4000 5000 5784000 15156000 9000 44000 250000 193000 123000 452000 167000 6000 6000 32740000 32482000 -27414000 -17499000 5332000 14989000 5784000 15156000 71000 47000 38000 -338000 27000 2978000 1883000 -1912000 -1406000 1175000 213000 -11090000 -2002000 -9915000 -1789000 -9915000 -1789000 -11090000 -2002000 258000 127000 -494000 6000 4000 27000 38000 -338000 -967000 1763000 -35000 30000 250000 -23000 55000 -133000 133000 70000 -87000 2385000 -1413000 1002000 100000 2964 507 626000 5000 -3069000 -883000 -684000 -2296000 931000 3227000 247000 931000 <p id="xdx_80A_esrt--SupplementaryInsuranceInformationForInsuranceCompaniesDisclosureTextBlock_zC8gV9NN8L62" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_82E_zwSPOLD7ocN">Schedule III - Supplementary Insurance Information</span> </b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_30A_134_zIAdhq4BDzj9" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Schedule III Supplementary Insurance Information (Details)"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Year</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Segment</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Deferred</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>acquisition</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>costs, net</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reserves</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>for losses</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>and loss</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>adjustment</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>expenses</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>– gross</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unearned</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>premiums</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>– gross</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Net</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>premiums</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>earned</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Investment </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>income</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Net losses,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>and loss</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>adjustment</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>expenses</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amortization</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>of deferred</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>acquisition</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>costs</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Operating</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>expenses</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gross</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>premiums</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>written</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; width: 7%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property &amp; Casualty</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_986_eus-gaap--SupplementaryInsuranceInformationDeferredPolicyAcquisitionCosts_iI_pn3n3_c20231231__srt--ProductOrServiceAxis__us-gaap--PropertyLiabilityAndCasualtyInsuranceSegmentMember_zx9ABjZTiGsk" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right" title="Deferred acquisition costs, net">        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1476">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_987_eus-gaap--SupplementaryInsuranceInformationLiabilityForFuturePolicyBenefitsLossesClaimsAndLossExpenseReserves_iI_pn3n3_c20231231__srt--ProductOrServiceAxis__us-gaap--PropertyLiabilityAndCasualtyInsuranceSegmentMember_z1m4EpMPlZ3d" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right" title="Reserves for losses and loss adjustment expenses - gross">    <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1478">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98E_eus-gaap--SupplementaryInsuranceInformationUnearnedPremiums_iI_pn3n3_c20231231__srt--ProductOrServiceAxis__us-gaap--PropertyLiabilityAndCasualtyInsuranceSegmentMember_zUs2eRQVHFG" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right" title="Unearned premiums - gross"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1480">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_980_eus-gaap--SupplementaryInsuranceInformationPremiumRevenue_pn3n3_c20230101__20231231__srt--ProductOrServiceAxis__us-gaap--PropertyLiabilityAndCasualtyInsuranceSegmentMember_zSQPyjrg8pbb" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right" title="Net premiums earned"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,255</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_eus-gaap--SupplementaryInsuranceInformationNetInvestmentIncome_pn3n3_c20230101__20231231__srt--ProductOrServiceAxis__us-gaap--PropertyLiabilityAndCasualtyInsuranceSegmentMember_zpc1iegvadp2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right" title="Investment income (loss)">   <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1484">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_987_eus-gaap--SupplementaryInsuranceInformationBenefitsClaimsLossesAndSettlementExpense_pn3n3_c20230101__20231231__srt--ProductOrServiceAxis__us-gaap--PropertyLiabilityAndCasualtyInsuranceSegmentMember_znRBLR95ntod" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right" title="Net losses, and loss adjustment expenses"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1486">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98A_eus-gaap--SupplementaryInsuranceInformationAmortizationOfDeferredPolicyAcquisitionCosts_pn3n3_c20230101__20231231__srt--ProductOrServiceAxis__us-gaap--PropertyLiabilityAndCasualtyInsuranceSegmentMember_zxZLCyx2JVB9" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right" title="Amortization of deferred acquisition costs"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">141</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98A_eus-gaap--SupplementaryInsuranceInformationOtherOperatingExpense_pn3n3_c20230101__20231231__srt--ProductOrServiceAxis__us-gaap--PropertyLiabilityAndCasualtyInsuranceSegmentMember_zH2zwy7GBUFl" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right" title="Operating expenses"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,183</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98B_eus-gaap--SupplementaryInsuranceInformationPremiumsWritten_pn3n3_c20230101__20231231__srt--ProductOrServiceAxis__us-gaap--PropertyLiabilityAndCasualtyInsuranceSegmentMember_zPEZJavE86r6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right" title="Gross premiums written"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,170</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property &amp; Casualty</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_989_eus-gaap--SupplementaryInsuranceInformationDeferredPolicyAcquisitionCosts_iI_pn3n3_c20221231__srt--ProductOrServiceAxis__us-gaap--PropertyLiabilityAndCasualtyInsuranceSegmentMember_zCSQGM2Ms1v9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Deferred acquisition costs, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1494">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_983_eus-gaap--SupplementaryInsuranceInformationLiabilityForFuturePolicyBenefitsLossesClaimsAndLossExpenseReserves_iI_pn3n3_c20221231__srt--ProductOrServiceAxis__us-gaap--PropertyLiabilityAndCasualtyInsuranceSegmentMember_zZmBe9JyWeul" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Reserves for losses and loss adjustment expenses - gross"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,073</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98C_eus-gaap--SupplementaryInsuranceInformationUnearnedPremiums_iI_pn3n3_c20221231__srt--ProductOrServiceAxis__us-gaap--PropertyLiabilityAndCasualtyInsuranceSegmentMember_zQiDimrXJgEa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unearned premiums - gross"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1498">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98A_eus-gaap--SupplementaryInsuranceInformationPremiumRevenue_pn3n3_c20220101__20221231__srt--ProductOrServiceAxis__us-gaap--PropertyLiabilityAndCasualtyInsuranceSegmentMember_z8KZcbQUw6Ya" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net premiums earned"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">995</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_982_eus-gaap--SupplementaryInsuranceInformationNetInvestmentIncome_pn3n3_c20220101__20221231__srt--ProductOrServiceAxis__us-gaap--PropertyLiabilityAndCasualtyInsuranceSegmentMember_z0vo6bs8Pvq3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Investment income (loss)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_989_eus-gaap--SupplementaryInsuranceInformationBenefitsClaimsLossesAndSettlementExpense_pn3n3_c20220101__20221231__srt--ProductOrServiceAxis__us-gaap--PropertyLiabilityAndCasualtyInsuranceSegmentMember_zwFtALB5jHH2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net losses, and loss adjustment expenses"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,073</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_983_eus-gaap--SupplementaryInsuranceInformationAmortizationOfDeferredPolicyAcquisitionCosts_pn3n3_c20220101__20221231__srt--ProductOrServiceAxis__us-gaap--PropertyLiabilityAndCasualtyInsuranceSegmentMember_zo8sMcXTaC6i" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Amortization of deferred acquisition costs"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">110</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_eus-gaap--SupplementaryInsuranceInformationOtherOperatingExpense_pn3n3_c20220101__20221231__srt--ProductOrServiceAxis__us-gaap--PropertyLiabilityAndCasualtyInsuranceSegmentMember_zxKgxFY3RCNd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Operating expenses"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,413</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98E_eus-gaap--SupplementaryInsuranceInformationPremiumsWritten_pn3n3_c20220101__20221231__srt--ProductOrServiceAxis__us-gaap--PropertyLiabilityAndCasualtyInsuranceSegmentMember_zZZl7DmcSiEa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Gross premiums written"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">645</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 1255000 141000 2183000 2170000 1073000 995000 27000 1073000 110000 1413000 645000 <p id="xdx_801_esrt--SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock_zQnYC0J30Uqg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_827_z4wvpRuvbnBg">Schedule IV - Reinsurance Information</span> </b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_301_134_zcNRtUdBegE1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Schedule IV Reinsurance Information (Details)"> <tr style="display: none; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Year</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Segment</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Direct</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gross</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Premiums</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Premiums</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ceded to</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>other </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>companies</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Premiums </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>assumed</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>from other</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>companies</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Net amount</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>of amount</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>assumed to</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>net</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; width: 14%">2023</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="width: 34%; text-align: left; padding-bottom: 1.5pt">Property &amp; Casualty</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--DirectPremiumsEarned_pn3n3_c20230101__20231231__srt--ProductOrServiceAxis__us-gaap--PropertyLiabilityAndCasualtyInsuranceSegmentMember_zIHRnHhUr2kb" style="border-bottom: Black 1.5pt solid; width: 6%; text-align: right" title="Direct gross premiums"><span style="-sec-ix-hidden: xdx2ixbrl1514">-</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--CededPremiumsEarned_pn3n3_c20230101__20231231__srt--ProductOrServiceAxis__us-gaap--PropertyLiabilityAndCasualtyInsuranceSegmentMember_zamcaxtiTKGk" style="border-bottom: Black 1.5pt solid; width: 6%; text-align: right" title="Premiums ceded to other companies"><span style="-sec-ix-hidden: xdx2ixbrl1516">-</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--AssumedPremiumsEarned_pn3n3_c20230101__20231231__srt--ProductOrServiceAxis__us-gaap--PropertyLiabilityAndCasualtyInsuranceSegmentMember_zGP2VPR416F1" style="border-bottom: Black 1.5pt solid; width: 6%; text-align: right" title="Premiums assumed from other companies">2,170</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--PremiumsEarnedNet_pn3n3_c20230101__20231231__srt--ProductOrServiceAxis__us-gaap--PropertyLiabilityAndCasualtyInsuranceSegmentMember_zleRZ8QrwH6f" style="border-bottom: Black 1.5pt solid; width: 6%; text-align: right" title="Net premiums earned">2,170</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 6%; text-align: right"><span id="xdx_905_eus-gaap--PremiumsPercentageAssumedToNet_pid_dp_uPure_c20230101__20231231__srt--ProductOrServiceAxis__us-gaap--PropertyLiabilityAndCasualtyInsuranceSegmentMember_zkQo5rQLjMUf" title="Percentage of amount assumed to net">100</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: right"> </td><td> </td> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">      </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">2022</td><td> </td> <td style="text-align: left">Property &amp; Casualty</td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--DirectPremiumsEarned_pn3n3_c20220101__20221231__srt--ProductOrServiceAxis__us-gaap--PropertyLiabilityAndCasualtyInsuranceSegmentMember_zY4kpxASUN49" style="text-align: right" title="Direct gross premiums"><span style="-sec-ix-hidden: xdx2ixbrl1524">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--CededPremiumsEarned_pn3n3_c20220101__20221231__srt--ProductOrServiceAxis__us-gaap--PropertyLiabilityAndCasualtyInsuranceSegmentMember_zY97VkdoJOxj" style="text-align: right" title="Premiums ceded to other companies">      <span style="-sec-ix-hidden: xdx2ixbrl1526">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--AssumedPremiumsEarned_pn3n3_c20220101__20221231__srt--ProductOrServiceAxis__us-gaap--PropertyLiabilityAndCasualtyInsuranceSegmentMember_zvp2QEnEscdh" style="text-align: right" title="Premiums assumed from other companies">645</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--PremiumsEarnedNet_pn3n3_c20220101__20221231__srt--ProductOrServiceAxis__us-gaap--PropertyLiabilityAndCasualtyInsuranceSegmentMember_zJ392bwwDwL4" style="text-align: right" title="Net premiums earned">645</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--PremiumsPercentageAssumedToNet_pid_dp_uPure_c20220101__20221231__srt--ProductOrServiceAxis__us-gaap--PropertyLiabilityAndCasualtyInsuranceSegmentMember_z8TTV5P3mdB5" title="Percentage of amount assumed to net">100</span></td><td style="text-align: left">%</td></tr> </table> 2170000 2170000 1 645000 645000 1 includes underwriting profit of $494,000 due to Parent. Includes short-term leases

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